dls_datetime,drug_link,x1,x2
2020-09-18T01:02:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-labeled-substance-p-antagonist-receptor-quantifier,Abbreviation:,[18F]SPA-RQ
2020-09-18T01:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac,Abbreviation:,[18]F-FAC
2020-09-18T01:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac,Abbreviation:,[18F]FAc
2020-09-18T01:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac,Abbreviation:,[18F]FAC
2020-09-18T01:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac,Abbreviation:,18F-FAC
2020-09-18T01:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac,Chemical structure:,1-(2′-deoxy-2′-[18F]fluoroarabinofuranosyl) cytosine
2020-09-18T01:02:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fmac,Synonym:,L-fluorine F 18-FMAC
2020-09-18T01:02:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fmac,Chemical structure:,2’-deoxy-2’-18F-fluoro-5-methyl-beta-L-arabinofuranosylcytosine
2020-09-18T01:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-ml-10,Synonym:,Fluorine F 18 ML-10
2020-09-18T01:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-ml-10,Foreign brand name:,[18F]-ApoSense
2020-09-18T01:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-ml-10,Chemical structure:,[18F]-2-(5-fluoro-pentyl)-2-methyl-malonic-acid
2020-09-18T01:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/61cu-atsm,NA,NA
2020-09-18T01:07:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18hx4,NA,NA
2020-09-18T01:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f18vm4-037,NA,NA
2020-09-18T01:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797962,Code name:,GAST 17
2020-09-18T01:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797962,Code name:,GAST17
2020-09-18T01:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797962,Code name:,GAST-17
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Synonym:,11-beta-hydroxysteroid dehydrogenase type 1 inhibitor AZD4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Synonym:,11bHSD1 inhibitor AZD4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Synonym:,11b-HSD1 inhibitor AZD4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Synonym:,11β-HSD1 inhibitor AZD4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Code name:,AZD 4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Code name:,AZD4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Code name:,AZD-4017
2020-09-18T01:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/11c-topotecan,NA,NA
2020-09-18T01:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/123-i-mip-1095,Synonym:,iodine I 123 IMP-1095
2020-09-18T01:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/123-i-mip-1095,Chemical structure:,2-(3-{l-carboxy-5-[3-(4-iodo-phenyl)-ureido]-pentyl}-ureido)-pentanedioic acid
2020-09-18T01:10:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/14c-bms-275183,NA,NA
2020-09-18T01:10:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/16-16-dimethyl-prostaglandin-e2,Abbreviation:,dmPGE2
2020-09-18T01:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fhbg,Synonym:,reporter probe 18F-FHBG
2020-09-18T01:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fhbg,Chemical structure:,9-(4-18F-fluoro-3-[hydroxymethyl]butyl)guanine
2020-09-18T01:10:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18-f-fluoroacetate,Synonym:,fluorine F 18 fluoroacetate
2020-09-18T01:10:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18-f-fluoroacetate,Abbreviation:,(18)F-FAC
2020-09-18T01:10:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18-f-fluoroacetate,Abbreviation:,F-AC
2020-09-18T01:11:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fluoromisonidazole,Abbreviation:,18F-FMISO
2020-09-18T01:11:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-labeled-mini-peg-spacered-rgd-dimer,Abbreviation:,(18)F-FB-mini-PEG-E[c(RGDyK)](2)
2020-09-18T01:11:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-labeled-mini-peg-spacered-rgd-dimer,Abbreviation:,[18F] FPRGD2
2020-09-18T01:11:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-labeled-mini-peg-spacered-rgd-dimer,Abbreviation:,18F-FPRGD2
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Synonym:,O-desulfated heparin
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Synonym:,PGX-ODSH
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Abbreviation:,ODSH
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Code name:,CX 01
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Code name:,CX01
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Code name:,CX-01
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Code name:,PGX100
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Code name:,PGX-100
2020-09-18T01:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-f-ara-deoxyuridine,Synonym:,FAU
2020-09-18T01:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-f-ara-deoxyuridine,Chemical structure:,1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl) uracil
2020-09-18T01:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluorofucose-containing-sgn-2ff,Synonym:,2-FF containing SGN-2FF
2020-09-18T01:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluorofucose-containing-sgn-2ff,Synonym:,2FF-containing SGN-2FF
2020-09-18T01:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluorofucose-containing-sgn-2ff,Code name:,SGN-2FF
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Synonym:,fluorine 18 ((18)F) FPPRGD2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Abbreviation:,[18F] FPPRGD2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Abbreviation:,18F-FP-PEG3-RGD2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Abbreviation:,18F-FPPRGD2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Abbreviation:,18F-FP-PRGD2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Abbreviation:,PEG3-E[c(RGDyk)]2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Code name:,104150
2020-09-18T01:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2g-1-tcr-retroviral-vector-transduced-lymphocytes,NA,NA
2020-09-18T01:11:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyflutamide-depot,Synonym:,2-hydroxyflutamide controlled-release formulation
2020-09-18T01:11:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyflutamide-depot,Foreign brand name:,Liproca
2020-09-18T01:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyoleic-acid,Foreign brand name:,Minerval
2020-09-18T01:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyoleic-acid,Abbreviation:,2OHOA
2020-09-18T01:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyoleic-acid,Abbreviation:,2-OHOA
2020-09-18T01:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol,Synonym:,2-ME
2020-09-18T01:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol,Synonym:,2-Methoxy Estradiol
2020-09-18T01:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol,US brand name:,Panzem
2020-09-18T01:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol,Abbreviation:,2ME2
2020-09-18T01:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol,Chemical structure:,"(17beta)-2-Methoxyestra-1,3,5(10)-triene-3,17-diol"
2020-09-18T01:11:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/34-methylenedioxymethamphetamine,Abbreviation:,MDMA
2020-09-18T01:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-aminomethyl-nicotine-p-aeruginosa-r-exoprotein-a-conjugate-vaccine,Synonym:,nicotine conjugate vaccine
2020-09-18T01:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-aminomethyl-nicotine-p-aeruginosa-r-exoprotein-a-conjugate-vaccine,US brand name:,NicVax
2020-09-18T01:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-c-ethynylcytidine,Abbreviation:,ECyd
2020-09-18T01:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-c-ethynylcytidine,Code name:,TAS-106
2020-09-18T01:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-c-ethynylcytidine,Chemical structure:,1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine
2020-09-18T01:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-deazauridine,Synonym:,deazauridine
2020-09-18T01:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-deazauridine,Abbreviation:,DAU
2020-09-18T01:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-deazauridine,Chemical structure:,"2(1H)-pyridinone, 4-hydroxy-1-beta-D-ribofuranosyl4-hydroxy-1-(beta-D-ribopentofuranosyl)-2-pyridone"
2020-09-18T01:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18,Synonym:,PLacental eXpanded-R18
2020-09-18T01:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18,Synonym:,PLX-R18 cells
2020-09-18T01:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18,Code name:,PLX R18
2020-09-18T01:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18,Code name:,PLX RAD
2020-09-18T01:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18,Code name:,PLX-R18
2020-09-18T01:12:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797360,US brand name:,3M Cavilon Advanced Skin Protectant
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Synonym:,(2S)-2-amino-4-[F-18]-fluoro pentanedioic acid
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Synonym:,[F-18]BAY 85-8050
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Synonym:,4-[(18)F]fluoro L-glutamic acid
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Synonym:,fluorine F 18-BAY 85-8050
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Code name:,BAY 858050
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Code name:,BAY 85-8050
2020-09-18T01:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes,Synonym:,4H11-28z/fIL-12/EFGRt+ genetically-modified T cells
2020-09-18T01:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes,Synonym:,4H11-28z/fIL-12/EFGRt+ T cells
2020-09-18T01:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes,Synonym:,autologous 4H11-28z/fIL-12/EFGRt+ genetically-modified T cells
2020-09-18T01:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes,Synonym:,autologous HLA-A2/NY-ESO-1-specific TCR gene-transduced T lymphocytes
2020-09-18T01:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes,Synonym:,autologous MUC16ecto-targeting EGFR-secreting T lymphocytes
2020-09-18T01:12:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-iodo-4-deoxydoxorubicin,Synonym:,iododoxorubicin
2020-09-18T01:12:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-iodo-4-deoxydoxorubicin,Abbreviation:,IDOX
2020-09-18T01:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-nitroestrone-3-methyl-ether,Synonym:,4-Nitroestrone
2020-09-18T01:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-peptide-melanoma-vaccine,NA,NA
2020-09-18T01:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes,Synonym:,4SCAR-GD2
2020-09-18T01:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes,Synonym:,4SCAR-GD2 T cells
2020-09-18T01:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes,Synonym:,4SCAR-GD2-modified T cells
2020-09-18T01:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes,Synonym:,4S-GD2-CAR-T cells
2020-09-18T01:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes,Synonym:,GD2-specific 4th generation chimeric antigen receptor-modified T Cells
2020-09-18T01:13:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-thio-2-deoxycytidine,Synonym:,4'-thio-2'-deoxycytidine
2020-09-18T01:13:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-thio-2-deoxycytidine,Abbreviation:,TdCyd
2020-09-18T01:13:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-thio-2-deoxycytidine,Abbreviation:,T-dCyd
2020-09-18T01:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-18ffluorouracil,NA,NA
2020-09-18T01:13:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/50pct-oxygen-50pct-nitrous-oxide-premix,Foreign brand name:,Entonox
2020-09-18T01:13:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/50pct-oxygen-50pct-nitrous-oxide-premix,Foreign brand name:,Kalinox 170 bar
2020-09-18T01:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794175,Abbreviation:,5-Aza-TdCyd
2020-09-18T01:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794175,Abbreviation:,Aza-TdC
2020-09-18T01:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794175,Abbreviation:,Aza-TdCyd
2020-09-18T01:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794175,Chemical structure:,5-aza-4-thio-2-deoxycytidine
2020-09-18T01:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-colon-heptapeptide,Synonym:,KCC colon heptapeptide
2020-09-18T01:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-colon-heptapeptide,Synonym:,KCCFPAQ-GGGSK-(5-FITC)-NH2
2020-09-18T01:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-gi-heptapeptide,Synonym:,5-FITC-labeled 7-AA peptide
2020-09-18T01:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-gi-heptapeptide,Synonym:,GI heptapeptide
2020-09-18T01:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-gi-heptapeptide,Chemical structure:,Ala1-Ser2-Tyr3-Asn4-Tyr5-Asp6-Ala7-Gly8- Gly9-Gly10-Ser11-Lys12 (5-FITC) -NH213
2020-09-18T01:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluoro-2-deoxycytidine,Abbreviation:,FdCyd
2020-09-18T01:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluorouracil-salicylic-acid-topical-solution,Synonym:,low-dose 5-fluorouracil/salicylic acid
2020-09-18T01:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluorouracil-salicylic-acid-topical-solution,Foreign brand name:,Actikerall
2020-09-18T01:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluorouracil-salicylic-acid-topical-solution,Abbreviation:,low-dose 5-FU/SA
2020-09-18T01:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluorouracil-salicylic-acid-topical-solution,Code name:,LAS 41005
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Synonym:,serotonin 4 receptor agonist TAK-954
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Synonym:,serotonin agonist TAK-954
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Code name:,TAK 954
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Code name:,TAK954
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Code name:,TAK-954
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Code name:,TD-8954
2020-09-18T01:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794177,Synonym:,6MHP vaccine
2020-09-18T01:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794177,Abbreviation:,6MHP
2020-09-18T01:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/68-bisbenzylthiooctanoic-acid,Synonym:,alpha-lipoic acid analogue CPI-613
2020-09-18T01:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/68-bisbenzylthiooctanoic-acid,Code name:,CPI 613
2020-09-18T01:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/68-bisbenzylthiooctanoic-acid,Code name:,CPI-613
2020-09-18T01:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine,Synonym:,6-azauracil riboside
2020-09-18T01:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine,Synonym:,azauridine
2020-09-18T01:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine,Synonym:,riboazauracil
2020-09-18T01:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine,Abbreviation:,6-AZUR
2020-09-18T01:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine,Chemical structure:,"1,2,4-triazine-3,5(2H,4H)-dione, 2-beta-D-ribofuranosyl2-beta-D-ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine riboside6-azauracil-.beta.-D-riboside"
2020-09-18T01:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/757225,Synonym:,PFKFB3 Inhibitor PFK-158
2020-09-18T01:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/757225,Code name:,ACT-PFK-158
2020-09-18T01:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/757225,Code name:,PFK-158
2020-09-18T01:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Synonym:,17βHSD5 inhibitor ASP9521
2020-09-18T01:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Code name:,ASP 9521
2020-09-18T01:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Code name:,ASP9521
2020-09-18T01:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Chemical structure:,(4-(2-hydroxy-2-methylpropyl)piperidin-1-yl)(5-methoxy-1H-indol-2-yl)methanone
2020-09-18T01:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7-cyanoquinocarcinol,Code name:,DX-52-1
2020-09-18T01:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7-hydroxystaurosporine,Code name:,UCN-01
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Vesanoid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Airol
2020-09-18T01:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7-hydroxystaurosporine,Chemical structure:,"8,12-epoxy-1H,8H-2,7b,12a-triazadibenzo[a, g]cyclonona[cde] trinden-1-one, 2,3,9,10,11, 12-hexahydro-3-hydroxy-9-methoxy-8-methyl-10-(methylamino)"
2020-09-18T01:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/851b-gel,NA,NA
2020-09-18T01:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/852a,Synonym:,TLR7 agonist 852A
2020-09-18T01:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/852a,Synonym:,Toll-like receptor agonist 852A
2020-09-18T01:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/8-hydroxyquinoline-sulfate-ointment,US brand name:,Bag Balm
2020-09-18T01:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/8-hydroxyquinoline-sulfate-ointment,Foreign brand name:,Bag Balm
2020-09-18T01:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792737,Synonym:,A-101 solution
2020-09-18T01:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792737,Code name:,A-101
2020-09-18T01:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801361,Code name:,EOS 100850
2020-09-18T01:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801361,Code name:,EOS100850
2020-09-18T01:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801361,Code name:,EOS-100850
2020-09-18T01:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abacavir-sulfate,US brand name:,Ziagen
2020-09-18T01:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abacavir-sulfate,Code name:,1592U89
2020-09-18T01:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abagovomab,Synonym:,monoclonal antibody ACA125 anti-idiotype vaccine
2020-09-18T01:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abagovomab,Foreign brand name:,VaccinOvar
2020-09-18T01:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abarelix,Synonym:,Plenaxis
2020-09-18T01:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abarelix,Code name:,PPI-149
2020-09-18T01:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abarelix,Code name:,R-3827
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,Synonym:,CTL A4-Ig B7 Inhibitor
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,Synonym:,CTLA4-Ig
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,Synonym:,cytotoxic T lymphocyte-associated antigen-4
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,US brand name:,Orencia
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,Code name:,BMS-188667
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,Code name:,RG2077
2020-09-18T01:15:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abbv-221,NA,NA
2020-09-18T01:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-amphotericin-b,Synonym:,amphotericin B-lipid complex
2020-09-18T01:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-amphotericin-b,US brand name:,Abelcet
2020-09-18T01:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-amphotericin-b,US brand name:,AmBisome
2020-09-18T01:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-amphotericin-b,Acronym:,L-AMB
2020-09-18T01:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abemaciclib,Synonym:,CDK4/6 dual inhibitor LY2835219
2020-09-18T01:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abemaciclib,US brand name:,Verzenio
2020-09-18T01:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abemaciclib,Code name:,LY2835219
2020-09-18T01:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abemaciclib,Chemical structure:,"2-pyrimidinamine, N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)"
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,all-trans retinoic acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,all-trans vitamin A acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,beta-retinoic acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,retinoic acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,TRA
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,trans retinoic acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,trans vitamin A acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,tretinoinum
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,Vitamin A Acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Aberel
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Aknoten
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Avita
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Renova
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Retin-A
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Retin-A MICRO
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Cordes Vas
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Dermairol
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Epi-Aberel
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Eudyna
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Retisol-A
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Stieva-A
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Stieva-A Forte
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Vitinoin
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Abbreviation:,ATRA
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Acronym:,ATRA
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Acronym:,TRA
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Code name:,Ro 5488
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Chemical structure:,"(All-E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid"
2020-09-18T01:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abexinostat,Code name:,PCI-24781
2020-09-18T01:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abiraterone-acetate,US brand name:,Zytiga
2020-09-18T01:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abiraterone-acetate,Code name:,CB7630
2020-09-18T01:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadofosveset-trisodium,US brand name:,Ablavar
2020-09-18T01:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadofosveset-trisodium,US brand name:,Vasovist
2020-09-18T01:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadofosveset-trisodium,Code name:,MS 325
2020-09-18T01:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadofosveset-trisodium,Code name:,MS-325
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,albumin-bound paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,Albumin-Stabilized Nanoparticle Paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,nab paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,nab-paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,nanoparticle albumin-bound paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,Nanoparticle Paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,protein-bound paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,US brand name:,Abraxane
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Code name:,ABI-007
2020-09-18T01:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-adhesion-barrier-gel,Synonym:,oxiplex/AP gel
2020-09-18T01:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-adhesion-barrier-gel,US brand name:,Intercoat
2020-09-18T01:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-fibrin-sealant-patch,Synonym:,human fibrinogen/thrombin patch
2020-09-18T01:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-fibrin-sealant-patch,US brand name:,TachoSil
2020-09-18T01:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-fibrin-sealant-patch,Abbreviation:,HFTP
2020-09-18T01:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-gelatin-sponge,US brand name:,Gelfoam
2020-09-18T01:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-modified-polymer-hemostatic-powder,Synonym:,AMP hemostatic powder
2020-09-18T01:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-modified-polymer-hemostatic-powder,Synonym:,Endo-Clot
2020-09-18T01:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-modified-polymer-hemostatic-powder,US brand name:,EndoClot
2020-09-18T01:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-modified-polymer-hemostatic-powder,Abbreviation:,AMP
2020-09-18T01:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abt-510,NA,NA
2020-09-18T01:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abt-751,Code name:,E7010
2020-09-18T01:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abt-751,Chemical structure:,N-[2-[(4-Hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide
2020-09-18T01:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abvd-regimen,Synonym:,ABVD
2020-09-18T01:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abvd-regimen,Synonym:,Adriamycin-bleomycin-vinblastine-dacarbazine regimen
2020-09-18T01:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abvd-regimen,Synonym:,bleomycin/dacarbazine/doxorubicin/vinblastine
2020-09-18T01:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abvd-regimen,Abbreviation:,BLEO/DOX/DTIC/VBL
2020-09-18T01:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-regimen,Synonym:,ABVE
2020-09-18T01:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-regimen,Synonym:,Adriamycin-bleomycin-vincristine-etoposide regimen
2020-09-18T01:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-regimen,Synonym:,DBVE
2020-09-18T01:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-regimen,Synonym:,DBVE regimen
2020-09-18T01:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-pc-regimen,Synonym:,ABVE-PC
2020-09-18T01:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-pc-regimen,Synonym:,Adriamycin-bleomycin-vincristine-etoposide-prednisone-cyclophosphamide regimen
2020-09-18T01:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-pc-regimen,Synonym:,DBVE-PC
2020-09-18T01:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-pc-regimen,Synonym:,DBVE-PC regimen
2020-09-18T01:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ac-regimen,Synonym:,Adriamycin-cyclophosphamide regimen
2020-09-18T01:17:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acadesine,Chemical structure:,5-aminoimidazole-4-carboxamide riboside
2020-09-18T01:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acai-berry-juice,Synonym:,acai juice
2020-09-18T01:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalabrutinib,Synonym:,Bruton tyrosine kinase inhibitor ACP-196
2020-09-18T01:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalabrutinib,Synonym:,BTK inhibitor ACP-196
2020-09-18T01:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalabrutinib,US brand name:,Calquence
2020-09-18T01:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalabrutinib,Code name:,ACP-196
2020-09-18T01:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p110beta-delta-pi3k-inhibitor-gs-9820,Synonym:,p110beta/delta PI3K Inhibitor GS-9820
2020-09-18T01:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p110beta-delta-pi3k-inhibitor-gs-9820,Code name:,CAL-120
2020-09-18T01:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p110beta-delta-pi3k-inhibitor-gs-9820,Code name:,GS-9820
2020-09-18T01:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acarbose,US brand name:,Precose
2020-09-18T01:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acarbose,Code name:,Bay g 5421
2020-09-18T01:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acarbose,Chemical structure:,"O-4,6-dideoxy-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-alpha-D-glucopyranosyl-(1-4)-O-alpha-D-glucopyranosyl-(1-4)-D-glucose"
2020-09-18T01:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zafirlukast,US brand name:,Accolate
2020-09-18T01:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zafirlukast,Chemical structure:,"carbamic Acid,(3-((2-methoxy-4-((((2-methylphenyl)sulfonyl)amino)carbonyl)phenyl)methyl)-1-methyl-1H-indol-5-yl)-, cyclopentyl estercyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate"
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,13-cis-retinoic acid
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,13-cis-vitamin A acid
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,cis-retinoic acid
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,isotretinoinum
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,neovitamin A
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,Neovitamin A Acid
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,US brand name:,Accutane
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,US brand name:,Amnesteem
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,US brand name:,Cistane
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,US brand name:,Claravis
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,US brand name:,Sotret
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Accure
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Isotrex
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Isotrexin
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Oratane
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Roaccutan
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Roaccutane
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Roacutan
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Abbreviation:,13-CRA
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Code name:,Ro 4-3780
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Chemical structure:,"3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic Acid3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)2cis-4-trans-6-trans-8-trans-nonatetraenoic Acid"
2020-09-18T01:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-phosphoramidate-nuc-1031,Synonym:,gemcitabine ProTide
2020-09-18T01:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-phosphoramidate-nuc-1031,US brand name:,Acelarin
2020-09-18T01:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-phosphoramidate-nuc-1031,Code name:,NUC 1031
2020-09-18T01:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-phosphoramidate-nuc-1031,Code name:,NUC-1031
2020-09-18T01:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acelullar-cadaveric-dermal-matrix,US brand name:,AlloDerm
2020-09-18T01:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acelullar-cadaveric-dermal-matrix,US brand name:,DermaMatrix
2020-09-18T01:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acelullar-cadaveric-dermal-matrix,Acronym:,ACDM
2020-09-18T01:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acenocoumarol,NA,NA
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,Synonym:,perindopril tert-butylamine
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,US brand name:,Aceon
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,Foreign brand name:,Coversyl
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,Code name:,MCN-A-2833-109
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,Code name:,S-9490-3
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,Chemical structure:,"1H-indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-,(2S-(1(R*(R*))2alpha,3abeta,7abeta))-, compound with 2-methyl-2-propanamine(1:1)"
2020-09-18T01:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetaminophen,Synonym:,paracetamol
2020-09-18T01:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetaminophen,US brand name:,Tylenol
2020-09-18T01:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetaminophen,Abbreviation:,ACMP
2020-09-18T01:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetaminophen,Chemical structure:,N-(4-hydroxyphenyl)acetamide
2020-09-18T01:18:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetic-acid,Synonym:,"acetic acid, glacial"
2020-09-18T01:18:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetic-acid,Synonym:,glacial acetic acid
2020-09-18T01:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetohexamide,Synonym:,Cyclamide
2020-09-18T01:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetohexamide,US brand name:,Dymelor
2020-09-18T01:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetohexamide,Foreign brand name:,Dimelin
2020-09-18T01:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetohexamide,Chemical structure:,1-(p-acetylbenzenesulfonyl)-3-cyclohexylurea3-cyclohexyl-1-(p-acetylphenylsulfonyl)urea4-acetyl-N-((cyclohexylamino)carbonyl)benzenesulfonamideN-(p-acetylbenzenesulfonyl)-N'-cyclohexylureaN-(p-acetylphenylsulfonyl)-N'-cyclohexylurea
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Synonym:,L-Alpha-acetamido-beta-mercaptopropionic Acid
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Synonym:,N-Acetyl Cysteine
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Synonym:,N-acetyl-3-mercaptoalanine
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Synonym:,N-acetylcysteine
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Synonym:,N-acetyl-L-cysteine
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,US brand name:,Mucomyst
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Airbron
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Broncholysin
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Brunac
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Fabrol
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Fluatox
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Fluimucetin
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Fluimucil
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Fluprowit
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Muco Sanigen
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Mucocedyl
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Mucolator
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Mucolyticum
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Mucosolvin
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Mucret
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Neo-Fluimucil
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Parvolex
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Respaire
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Tixair
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Abbreviation:,NAC
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,Synonym:,aspirin
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Aspergum
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Ecotrin
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Empirin
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Entericin
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Extren
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Measurin
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,Abbreviation:,ASA
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,Chemical structure:,2-(acetyloxy)benzoic Acid
2020-09-18T01:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid-simvastatin-atenolol-ramipril-thiazide-capsule,Synonym:,aspirin/simvastatin/atenolol/ramipril/thiazide capsule
2020-09-18T01:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid-simvastatin-atenolol-ramipril-thiazide-capsule,Synonym:,aspirin/simvastatin/atenolol/ramipril/thiazide tablet
2020-09-18T01:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid-simvastatin-atenolol-ramipril-thiazide-capsule,Synonym:,Polycap
2020-09-18T01:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid-simvastatin-atenolol-ramipril-thiazide-capsule,Foreign brand name:,Quintapill
2020-09-18T01:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetracycline-hydrochloride,US brand name:,Achromycin
2020-09-18T01:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetracycline-hydrochloride,Chemical structure:,"(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride"
2020-09-18T01:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole-sodium,US brand name:,Aciphex
2020-09-18T01:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole-sodium,Foreign brand name:,Pariet
2020-09-18T01:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole-sodium,Foreign brand name:,Rablet
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,Synonym:,Trimethylmethoxyphenyl-retinoic acid
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,US brand name:,Etretin
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,US brand name:,Soriatane
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,Foreign brand name:,Neotigason
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,Code name:,Ro 10-1670
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,Code name:,Ro-10-1670
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,Chemical structure:,"(All-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic Acid"
2020-09-18T01:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acivicin,Code name:,AT-125
2020-09-18T01:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acivicin,Code name:,U-42126
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Synonym:,diethylstilbestrol dipropionate
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Synonym:,diethylstilbestrolum
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Synonym:,Sinestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Synonym:,stilboestrol dipropionate
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Acnestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Cyren A
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Deladumone
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Diastyl
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Domestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Estrobene
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Estrosyn
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Fonatol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Makarol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Milestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Neo-Oestronol I
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Oestrogenine
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Oestromenin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Oestromon
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Palestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Stilbestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Stilbetin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Stilboestroform
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Stilboestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Synestrin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Synthoestrin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Vagestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Antigestil
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Apstil
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Boestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Bufon
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Distilbene
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Estrogenine
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Estromenin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Grafestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Microest
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Oestromensyl
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Serral
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Sexocretin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Sibol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Stilboefral
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Stilkap
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Abbreviation:,DES
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Chemical structure:,"(E)-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol3,4-bis(p-hydroxyphenyl)-3-hexene4,4'-dihydroxy-alpha,beta-diethylstilbenealpha,alpha'-diethylstilbenedioltrans-bis-(hydroxy-4-phenyl)-3,4 hexene-3"
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,Synonym:,Nimustine Hydrochloride
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,Synonym:,pimustine hydrochloride
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,US brand name:,ACNU 50
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,Foreign brand name:,Nidran
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,Abbreviation:,ACNU
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,Chemical structure:,N'-[4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitrosourea
2020-09-18T01:19:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acodazole,Synonym:,acodazole hydrochloride
2020-09-18T01:19:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acodazole,Chemical structure:,"acetamide, N-methyl-N-[4-[(7-methyl-1H-imidazo[4, 5-f]quinolin-9-yl)amino]phenyl]-, monohydrochloride (9CI)"
2020-09-18T01:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acoustic-coupling-fluid,Synonym:,acoustic fluid
2020-09-18T01:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acoustic-coupling-fluid,Synonym:,brain mimicking fluid
2020-09-18T01:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acoustic-coupling-fluid,Abbreviation:,BMF
2020-09-18T01:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acridine-carboxamide,Abbreviation:,DACA
2020-09-18T01:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acridine-carboxamide,Code name:,XR5000
2020-09-18T01:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ac-t-regimen,Synonym:,AC-T
2020-09-18T01:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ac-t-regimen,Synonym:,AC-Taxol regimen
2020-09-18T01:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ac-t-regimen,Synonym:,Adriamycin cyclophosphamide-Taxol regimen
2020-09-18T01:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab,Synonym:,"immunoglobulin G1, anti-(human interleukin 6 receptor) (human-mouse monoclonal MRA heavy chain), disulfide with human-mouse monoclonal MRA kappa chain dimer"
2020-09-18T01:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab,US brand name:,Actemra
2020-09-18T01:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab,Foreign brand name:,RoActemra
2020-09-18T01:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab,Abbreviation:,MRA
2020-09-18T01:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab,Code name:,R-1569
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,Synonym:,Haemophilus b conjugate vaccine
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,Synonym:,Haemophilus b oligosaccharide conjugate vacccine
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,Synonym:,Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-OMP)
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,Synonym:,Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-T)
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,Synonym:,Hib TITER vaccine
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,US brand name:,ActHIB
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,US brand name:,HibTITER
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,US brand name:,PedvaxHIB
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,Synonym:,ursodeoxycholic acid
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,US brand name:,Actigall
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,US brand name:,URSO
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,Foreign brand name:,Deursil
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,Abbreviation:,UDCA
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,Chemical structure:,"(3alpha,5beta,7beta)-3,7-Dihydroxycholan-24-oic acid"
2020-09-18T01:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-1b,Synonym:,N(sup 2)-L-methionyl-1-139-interferon G
2020-09-18T01:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-1b,Synonym:,recombinant interferon gamma-1b
2020-09-18T01:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-1b,US brand name:,Actimmune
2020-09-18T01:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masoprocol,Synonym:,nordihydroguaiaretic acid
2020-09-18T01:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masoprocol,US brand name:,Actinex
2020-09-18T01:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masoprocol,Abbreviation:,NDGA
2020-09-18T01:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masoprocol,Chemical structure:,"4,4'-(2,3-Dimethyl-1,4-butanediyl)bis[1,2-benzenediol]"
2020-09-18T01:20:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797359,US brand name:,Tymlos
2020-09-18T01:20:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797359,Code name:,BA058
2020-09-18T01:20:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797359,Code name:,BIM-44058
2020-09-18T01:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etaracizumab,Synonym:,humanized monoclonal antibody MEDI-522
2020-09-18T01:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etaracizumab,Synonym:,monoclonal antibody anti-alpha V beta 3 integrin MEDI-522
2020-09-18T01:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etaracizumab,US brand name:,Abegrin
2020-09-18T01:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etaracizumab,Code name:,MEDI-522
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,aclacinomycin
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,Aclacinomycin A
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,Aclacinomycin A hydrochloride
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,aclacinomycin-A
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,Aclarubicin Hydrochloride
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,Antibiotic MA144-A1
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Foreign brand name:,Aclacin
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Foreign brand name:,Aclacinomycine
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Foreign brand name:,Aclacinon
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Foreign brand name:,Aclaplastin
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Foreign brand name:,Jaclacin
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Abbreviation:,ACM
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Abbreviation:,ACM-A
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Code name:,MA144-A1
2020-09-18T01:21:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-lintuzumab,Synonym:,actinium-225-labeled humanized anti-CD33 monoclonal antibody HuM195
2020-09-18T01:21:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-lintuzumab,Abbreviation:,225Ac-HuM195
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Synonym:,[Ac-225]-FPI-1434
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Synonym:,225Ac-FPI-1434
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Synonym:,actinium Ac 225-FPI-1397-FPI-1175
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Synonym:,actinium Ac 225-labeled FPI-1434
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Code name:,[225Ac]-FPI-1434
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Code name:,FPX 01
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Code name:,FPX01
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Code name:,FPX-01
2020-09-18T01:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793676,Synonym:,Ac 225 MOAB J591
2020-09-18T01:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793676,Synonym:,Ac 225 monoclonal antibody J591
2020-09-18T01:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793676,Synonym:,actinium Ac-225 anti-prostate-specific membrane antigen monoclonal antibody J591
2020-09-18T01:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793676,Abbreviation:,225Ac-J591
2020-09-18T01:21:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate,US brand name:,Actiq
2020-09-18T01:21:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate,US brand name:,Oralet
2020-09-18T01:21:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate,US brand name:,Sublimaze
2020-09-18T01:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alteplase,Synonym:,recombinant tissue plasminogen activator
2020-09-18T01:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alteplase,Synonym:,t-PA
2020-09-18T01:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alteplase,US brand name:,Activase
2020-09-18T01:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alteplase,Abbreviation:,rt-PA
2020-09-18T01:21:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activated-marrow-infiltrating-lymphocytes,Abbreviation:,aMIL
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Code name:,SCM010
2020-09-18T01:21:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activated-marrow-infiltrating-lymphocytes,Abbreviation:,MIL
2020-09-18T01:21:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estradiol-norethindrone-acetate-tablet,US brand name:,Activella
2020-09-18T01:21:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ih636-grape-seed-proanthocyanidin-extract,US brand name:,ActiVin
2020-09-18T01:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activin-type-2b-receptor-fc-fusion-protein-stm-434,Synonym:,activin A inhibitor STM 434
2020-09-18T01:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activin-type-2b-receptor-fc-fusion-protein-stm-434,Code name:,STM 434
2020-09-18T01:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801849,Synonym:,activin type 2A receptor Fc fusion protein KER-050
2020-09-18T01:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801849,Code name:,KER 050
2020-09-18T01:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801849,Code name:,KER050
2020-09-18T01:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801849,Code name:,KER-050
2020-09-18T01:21:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-expanded-autologous-t-cells-ima101,Synonym:,IMA101 T cells
2020-09-18T01:21:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-expanded-autologous-t-cells-ima101,US brand name:,ACTolog IMA101
2020-09-18T01:21:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-expanded-autologous-t-cells-ima101,Code name:,IMA101
2020-09-18T01:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium,Synonym:,Risedronate
2020-09-18T01:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium,US brand name:,Actonel
2020-09-18T01:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium,Abbreviation:,RISE
2020-09-18T01:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium,Code name:,NE-58095
2020-09-18T01:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium,Chemical structure:,monosodium (1-hydroxy-2-(3-pyridinyl)ethylidene)bisphosphonate hemipentahydrate
2020-09-18T01:22:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformide-hydrochloride-pioglitazone-hydrochloride-extended-release-tablet,Synonym:,metformide HCl/pioglitazone HCl ER tablet
2020-09-18T01:22:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformide-hydrochloride-pioglitazone-hydrochloride-extended-release-tablet,US brand name:,ACTOplus Met XR
2020-09-18T01:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pioglitazone-hydrochloride,Synonym:,pioglitazone HCl
2020-09-18T01:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pioglitazone-hydrochloride,US brand name:,Actos
2020-09-18T01:22:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793142,Code name:,ABI1968
2020-09-18T01:22:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793142,Code name:,ABI-1968
2020-09-18T01:22:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793142,Code name:,HTI 1968
2020-09-18T01:22:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/531923,US brand name:,Zovirax
2020-09-18T01:22:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acyclovir-sodium,US brand name:,Zovirax for injection
2020-09-18T01:22:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acyclovir-sodium,Chemical structure:,"2-amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one monosodium salt9-[(2-hydroxyethoxy)methyl]guanine monosodium salt"
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,croysulfone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,diphenasone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,dumitone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,novophone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,sulfona-mae
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,sulphadione
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,US brand name:,Aczone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,US brand name:,Avlosulfon
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,US brand name:,Disulone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Foreign brand name:,Eporal
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Foreign brand name:,Undolac
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Abbreviation:,DADPS
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Abbreviation:,DDS
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Code name:,1358F
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Chemical structure:,"4,4'-sulfonylbisbenzamine4,4'-sulfonylbisbenzeneamine4,4'-sulfonyldianilinebis(4-aminophenyl)sulfone"
2020-09-18T01:22:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone-gel-5pct,US brand name:,Aczone Gel
2020-09-18T01:22:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793072,Synonym:,"Ad5 [E1-, E2b-]-HER2/neu vaccine"
2020-09-18T01:22:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793072,Synonym:,adenovirus type 5 E1/E2b-deleted HER2/neu vaccine ETBX-021
2020-09-18T01:22:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793072,Code name:,ETBX-021
2020-09-18T01:22:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5sstr-tkrgd,NA,NA
2020-09-18T01:22:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-cmv-nis,Synonym:,recombinant type 5 adenovirus carrying the human NIS gene linked to the CMV promotor
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Synonym:,Adeno-p53
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Synonym:,Adenovirus p53
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,US brand name:,ADVEXIN
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Abbreviation:,Ad5CMV-p53
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Abbreviation:,Ad-p53
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Code name:,INGN-201
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Code name:,RPR/INGN-201
2020-09-18T01:23:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5f35-lmp1-lmp2-transduced-autologous-dendritic-cells,NA,NA
2020-09-18T01:23:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800680,Synonym:,Ad5-SGE-REIC/Dkk-3
2020-09-18T01:23:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800680,Code name:,MTG 201
2020-09-18T01:23:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800680,Code name:,MTG201
2020-09-18T01:23:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800680,Code name:,MTG-201
2020-09-18T01:23:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-survivin-transduced-autologous-dendritic-cell-vaccine,Synonym:,Ad5-survivin-transduced autologous DC vaccine
2020-09-18T01:23:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-survivin-transduced-autologous-dendritic-cell-vaccine,Synonym:,autologous dendritic cell adenovirus type 5-survivin vaccine
2020-09-18T01:23:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-survivin-transduced-autologous-dendritic-cell-vaccine,Code name:,autologous DC:AdmS
2020-09-18T01:23:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-ycd-muttksr39rep-adp,NA,NA
2020-09-18T01:23:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-ycd-muttksr39rep-hil12,Synonym:,oncolytic adenovirus Ad5-yCD/mutTKSR39rep-hIL12
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,Synonym:,diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,US brand name:,Adacel
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,US brand name:,Daptacel
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,US brand name:,Infanrix
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,US brand name:,Tripedia
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,Abbreviation:,DTaP
2020-09-18T01:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adagloxad-simolenin,Synonym:,Globo H-KLH immunostimulant OPT-822
2020-09-18T01:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adagloxad-simolenin,Code name:,OBI-822
2020-09-18T01:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adagloxad-simolenin,Code name:,OPT-822
2020-09-18T01:23:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adalimumab,US brand name:,Humira
2020-09-18T01:23:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adalimumab,Code name:,D2E7
2020-09-18T01:23:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adalimumab,Code name:,LU200134
2020-09-18T01:23:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adalimumab,Chemical structure:,"immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain), disulfide with human monoclonal D2E7 light chain, dimer"
2020-09-18T01:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride,US brand name:,Adanon
2020-09-18T01:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride,US brand name:,Althose
2020-09-18T01:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride,US brand name:,Dolophine
2020-09-18T01:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride,US brand name:,Methadose
2020-09-18T01:23:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxepin-hydrochloride,US brand name:,Adapin
2020-09-18T01:23:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxepin-hydrochloride,US brand name:,Sinequan
2020-09-18T01:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775,Code name:,AZD1775
2020-09-18T01:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775,Code name:,AZD-1775
2020-09-18T01:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775,Code name:,MK1775
2020-09-18T01:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775,Code name:,MK-1775
2020-09-18T01:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775,Chemical structure:,"2-allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one"
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,Synonym:,antibody-drug conjugate SGN-35
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,Synonym:,anti-CD30 ADC SGN-35
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,Synonym:,anti-CD30 antibody-drug conjugate SGN-35
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,US brand name:,Adcetris
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,Abbreviation:,cAC10-vcMMAE
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,Code name:,SGN-35
2020-09-18T01:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,Synonym:,"D,L-amphetamine"
2020-09-18T01:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,US brand name:,Adderall
2020-09-18T01:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,US brand name:,Adderall XR
2020-09-18T01:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,Abbreviation:,SLI381
2020-09-18T01:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,Synonym:,"D,L-amphetamine"
2020-09-18T01:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,US brand name:,Adderall
2020-09-18T01:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,US brand name:,Adderall XR
2020-09-18T01:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,Abbreviation:,SLI381
2020-09-18T01:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen,Synonym:,ADE
2020-09-18T01:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen,Synonym:,AraC-daunorubicin-etoposide regimen
2020-09-18T01:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen,Synonym:,cytarabine/daunorubicin/etoposide
2020-09-18T01:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen,Synonym:,cytarabine-daunorubicin-etoposide regimen
2020-09-18T01:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen,Abbreviation:,ARA-C/DNR/VP-16
2020-09-18T01:24:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adecatumumab,Code name:,MT201
2020-09-18T01:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adefovir-dipivoxil,US brand name:,Hepsera
2020-09-18T01:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adefovir-dipivoxil,Code name:,GS-0840
2020-09-18T01:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793151,Synonym:,A2AR antagonist NIR178
2020-09-18T01:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793151,Code name:,NIR 178
2020-09-18T01:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-pbf-509,Synonym:,A2AR antagonist PBF-509
2020-09-18T01:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-pbf-509,Code name:,PBF-509
2020-09-18T01:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796763,Synonym:,A2A/PDE-10 inhibitor PBF-999
2020-09-18T01:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796763,Code name:,PBF 999
2020-09-18T01:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796763,Code name:,PBF999
2020-09-18T01:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796763,Code name:,PBF-999
2020-09-18T01:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798,Synonym:,A2AR/A2BR antagonist AB928
2020-09-18T01:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798,Synonym:,dual A2AR/A2BR antagonist AB928
2020-09-18T01:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798,Code name:,AB 928
2020-09-18T01:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798,Code name:,AB928
2020-09-18T01:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798,Code name:,AB-928
2020-09-18T01:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793680,Synonym:,A2BR Antagonist PBF-1129
2020-09-18T01:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793680,Code name:,PBF 1129
2020-09-18T01:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793680,Code name:,PBF1129
2020-09-18T01:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a3-receptor-agonist-cf102,Synonym:,A3AR agonist CF102
2020-09-18T01:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a3-receptor-agonist-cf102,Abbreviation:,Cl-IB-MECA
2020-09-18T01:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a3-receptor-agonist-cf102,Code name:,CF102
2020-09-18T01:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a3-receptor-agonist-cf102,Chemical structure:,2-chloro-N6-(3-iodobenzyl)-9-[5-(methylcarbamoyl)--D-ribofuranosyl]adenine
2020-09-18T01:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-cpi-444,Synonym:,adenosine-A2A receptor-targeting agent CPI-444
2020-09-18T01:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-cpi-444,Code name:,CPI-444
2020-09-18T01:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovector-encoding-mda7,Synonym:,adenovector encoding IL24
2020-09-18T01:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovector-encoding-mda7,Code name:,INGN 241
2020-09-18T01:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/748904,Code name:,BPX-201
2020-09-18T01:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-brachyury-vaccine-etbx-051,Code name:,ETBX 051
2020-09-18T01:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-brachyury-vaccine-etbx-051,Code name:,ETBX-051
2020-09-18T01:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795350,Code name:,PF 06936308
2020-09-18T01:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795350,Code name:,PF06936308
2020-09-18T01:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795350,Code name:,PF-06936308
2020-09-18T01:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-muc1-vaccine-etbx-061,Code name:,ETBX 061
2020-09-18T01:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-muc1-vaccine-etbx-061,Code name:,ETBX-061
2020-09-18T01:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795436,Synonym:,Adenoviral PSA Prostate Cancer Vaccine ETBX-071
2020-09-18T01:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795436,Code name:,ETBX-071
2020-09-18T01:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799098,Synonym:,GAd-209-FSP
2020-09-18T01:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799098,Synonym:,great ape adenoviral tumor-specific neoantigen priming vaccine GAd-209-FSP
2020-09-18T01:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478,Synonym:,adenoviral TSNA priming vaccine GRT-C901
2020-09-18T01:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478,US brand name:,priming cancer vaccine GRT-C901
2020-09-18T01:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478,Code name:,GRT C901
2020-09-18T01:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478,Code name:,GRTC901
2020-09-18T01:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478,Code name:,GRT-C901
2020-09-18T01:38:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-ad5-cea6d-vaccine,Synonym:,"adenoviral vector Ad5 [E1-, E2b-]-CEA vaccine"
2020-09-18T01:38:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-ad5-cea6d-vaccine,Abbreviation:,"Ad5[E1-,E2b-]-CEA vaccine"
2020-09-18T01:38:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-ad5-cea6d-vaccine,Code name:,ETBX-011
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Synonym:,AdAptVEGF-C adenoviral vector LX-1101
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Synonym:,VEGFC-expressing gene therapeutic LX-1101
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Foreign brand name:,Lymfactin
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Code name:,LX 1101
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Code name:,LX1101
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Code name:,LX-1101
2020-09-18T01:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/733561,Synonym:,DC-RTS-IL-12
2020-09-18T01:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/733561,Code name:,INXN-3001/1001
2020-09-18T01:38:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-5-human-guanylyl-cyclase-c-padre-vaccine,Synonym:,Ad5-hGCC-PADRE vaccine
2020-09-18T01:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-b7-1,NA,NA
2020-09-18T01:38:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-ecoli-pnp,Synonym:,adenovirus encoding purine nucleoside phosphorylase
2020-09-18T01:38:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-ecoli-pnp,US brand name:,Gedeptin
2020-09-18T01:38:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-ecoli-pnp,Code name:,Ad/PNP
2020-09-18T01:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-human-aquaporin-1,Abbreviation:,AdhAQP1
2020-09-18T01:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-rat-her-2-neu,NA,NA
2020-09-18T01:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-recombinant-human-endostatin,Abbreviation:,Ad-rhENDO
2020-09-18T01:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-recombinant-human-endostatin,Code name:,E10A
2020-09-18T01:39:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/735883,Synonym:,AdVTMM2-transduced dendritic cell vaccine
2020-09-18T01:39:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-her2-transduced-autologous-dendritic-cell-vaccine,NA,NA
2020-09-18T01:39:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-vector,Synonym:,Adenoviral Vector
2020-09-18T01:39:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-vector,Abbreviation:,ADV
2020-09-18T01:39:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/727131,NA,NA
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,Ad-E6/E7
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,Ad-E6E7
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,adenoviral-expressing mutant HPV E6/E7
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,adenoviral-HPV E6E7 vaccine
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,adenoviral-HPV E6E7 vaccine
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,adenovirus vaccine expressing mutant HPV E6 and E7
2020-09-18T01:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-expressing-tlr5-tlr5-agonist-nanoformulation-m-vm3,US brand name:,Mobilan
2020-09-18T01:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-expressing-tlr5-tlr5-agonist-nanoformulation-m-vm3,Code name:,M-VM3
2020-09-18T01:39:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12,Synonym:,adenovirus-interleukin-12
2020-09-18T01:39:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12,Abbreviation:,Ad.hIL-12
2020-09-18T01:39:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12-inxn-2001-plus-veledimex,Synonym:,adenovirus-mediated human interleukin-12 INXN-2001 plus activator ligand INXN-1001
2020-09-18T01:39:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12-inxn-2001-plus-veledimex,Abbreviation:,Ad-RTS-IL-12 plus AL
2020-09-18T01:39:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12-inxn-2001-plus-veledimex,Code name:,INXN-2001/1001
2020-09-18T01:39:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12-inxn-2001-plus-veledimex,Code name:,ZIN ATI-001
2020-09-18T01:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-p53-transduced-dendritic-cell-vaccine,Abbreviation:,Ad.p53-DC vaccine
2020-09-18T01:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-psa-prostate-cancer-vaccine,Synonym:,Ad/PSA vaccine
2020-09-18T01:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-psa-prostate-cancer-vaccine,Synonym:,adenovirus/PSA vaccine
2020-09-18T01:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adgmcaix-transduced-autologous-dendritic-cells,Synonym:,DCs expressing CMCA9 gene
2020-09-18T01:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adgmcaix-transduced-autologous-dendritic-cells,Synonym:,dendritic cells transduced with AdGMCA9 expressing GM-CSF-carbonic anhydrase IX fusion protein
2020-09-18T01:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adgmcaix-transduced-autologous-dendritic-cells,Abbreviation:,DC-AdGMCAIX
2020-09-18T01:40:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adh-1,US brand name:,Exherin
2020-09-18T01:40:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-hcmv-flt3l,NA,NA
2020-09-18T01:40:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-hcmv-tk,NA,NA
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Synonym:,adipose derived stem cells SCM-010
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Synonym:,adipose-derived expanded MSCs SCM-010
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Synonym:,ADSCs SCM-010
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Code name:,SCM 010
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Code name:,SCM-010
2020-09-18T01:40:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-regenerative-cells,Acronym:,ADRC
2020-09-18T01:40:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-stromal-vascular-fraction-cells,Synonym:,adipose-derived SVF cells
2020-09-18T01:40:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-isf35,Synonym:,Ad-CD154 ISF35
2020-09-18T01:40:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-isf35,Synonym:,Ad-CD40L ISF35
2020-09-18T01:40:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-isf35,Synonym:,recombinant adenovirus encoding CD40 ligand ISF35-transduced B lymphocytes
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Synonym:,trastuzumab emtansine
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Synonym:,trastuzumab-DM1
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Synonym:,trastuzumab-MCC-DM1
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Synonym:,trastuzumab-MCC-DM1 antibody-drug conjugate
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Synonym:,trastuzumab-MCC-DM1 immunoconjugate
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,US brand name:,Kadcyla
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Abbreviation:,T-DM1
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Code name:,PRO132365
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Code name:,RO5304020
2020-09-18T01:40:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adozelesin,Code name:,"U-73,975"
2020-09-18T01:41:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-reic-dkk3-vaccine,Synonym:,adenovirus-mediated REIC/Dkk-3 secretory protein
2020-09-18T01:41:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-reic-dkk3-vaccine,Synonym:,Ad-REIC/dickkopf homolog 3
2020-09-18T01:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone,Synonym:,ACTH
2020-09-18T01:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone,Synonym:,acthar
2020-09-18T01:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone,Synonym:,adrenocorticotropin
2020-09-18T01:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone,Synonym:,corticotropin
2020-09-18T01:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone,Abbreviation:,CCTROP
2020-09-18T01:41:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792151,Synonym:,adaoviral-rheoswitch therapeutic system-human interleukin 12
2020-09-18T01:41:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792151,Code name:,INXN 2001
2020-09-18T01:41:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792151,Code name:,INXN-2001
2020-09-18T01:41:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrtvp-1-transduced-prostate-cancer-cell-based-vaccine,Synonym:,Adenoviral vector-mediated RTVP-1 gene-modified prostate cancer cell-based vaccine
2020-09-18T01:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-sig-hmuc-1-ecdcd40l-vaccine,Synonym:,Ad-sig-hMUC1/ecdCD40L adenoviral vector vaccine
2020-09-18T01:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ae37-peptide-gm-csf-vaccine,NA,NA
2020-09-18T01:41:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aee788,NA,NA
2020-09-18T01:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aeg35156,US brand name:,GEM640
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Synonym:,Barseb-HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Synonym:,Cortifan
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Synonym:,cortisol
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Synonym:,Domolene
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Synonym:,Komed-HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Aeroseb-HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Barseb HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cetacort
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cort-Dome
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cortef
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cortenema
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cortispray
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cortril
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Dermacort
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Domolene-HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Eldecort
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Hydrocortone
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Hytone
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Komed HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Nutracort
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Proctocort
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Rectoid
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Abbreviation:,HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Chemical structure:,"(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione"
2020-09-18T01:41:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793934,Synonym:,aerosolized GCB
2020-09-18T01:41:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793934,Synonym:,aerosolized gemcitabine
2020-09-18T01:41:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosol-sargramostim,Synonym:,aerosol GM-CSF
2020-09-18T01:42:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosolized-aldesleukin,Synonym:,aerosolized recombinant IL-2
2020-09-18T01:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosolized-liposomal-rubitecan,Synonym:,aerosolized liposomal 9-nitrocamptothecin
2020-09-18T01:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosolized-liposomal-rubitecan,Code name:,L9NC
2020-09-18T01:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane,US brand name:,Aerrane
2020-09-18T01:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane,US brand name:,Forane
2020-09-18T01:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane,US brand name:,Isoflo
2020-09-18T01:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane,Chemical structure:,"1-chloro-2,2,2-trifluoroethyl difluoromethyl ether (SN); 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane"
2020-09-18T01:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenersen,Synonym:,OL(1)p53
2020-09-18T01:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenersen,US brand name:,Aezea®
2020-09-18T01:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenersen,Code name:,EL625
2020-09-18T01:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afamelanotide,Code name:,CUV1647
2020-09-18T01:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afamelanotide,Chemical structure:,N-acetyl-L-serinyl-L-tyrosyl-L-seryl-(2S)-2-aminohexanoyl-L-glutamyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophanylglycyl-L-lysyl-L-prolyl-L-valinamide
2020-09-18T01:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afatinib-dimaleate,US brand name:,Gilotrif
2020-09-18T01:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afatinib-dimaleate,Code name:,BIBW 2992 MA2
2020-09-18T01:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,Synonym:,"DNA, d(P-thio)(GTTCTCGCTGGTGAGTTTCA)"
2020-09-18T01:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,US brand name:,Affinitac
2020-09-18T01:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,US brand name:,Affinitak
2020-09-18T01:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,Code name:,CGP 64128A
2020-09-18T01:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,Code name:,LY900003
2020-09-18T01:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,Synonym:,"DNA, d(P-thio)(GTTCTCGCTGGTGAGTTTCA)"
2020-09-18T01:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,US brand name:,Affinitac
2020-09-18T01:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,US brand name:,Affinitak
2020-09-18T01:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,Code name:,CGP 64128A
2020-09-18T01:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,Code name:,LY900003
2020-09-18T01:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afimoxifene,Synonym:,4-Hydroxy-Tamoxifen
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Synonym:,42-O-(2-hydroxy)ethyl rapamycin
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,US brand name:,Afinitor
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,US brand name:,Afinitor Disperz
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,US brand name:,Zortress
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Foreign brand name:,Certican
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Foreign brand name:,Votubia
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Code name:,RAD001
2020-09-18T01:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Synonym:,42-O-(2-hydroxy)ethyl rapamycin
2020-09-18T01:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,US brand name:,Afinitor
2020-09-18T01:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,US brand name:,Afinitor Disperz
2020-09-18T01:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,US brand name:,Zortress
2020-09-18T01:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Foreign brand name:,Certican
2020-09-18T01:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Foreign brand name:,Votubia
2020-09-18T01:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Code name:,RAD001
2020-09-18T01:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus-tablets-for-oral-suspension,US brand name:,Afinitor Disperz
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Synonym:,Sulindac Sulfoxide
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,US brand name:,Aflodac
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,US brand name:,Clinoril
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Algocetil
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Apo-Sulin
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Arthrocine
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Artribid
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Citireuma
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Clisundac
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Imbaral
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Novo-Sundac
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Reumofil
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Reumyl
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Sudac
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Sulinol
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Sulreuma
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Abbreviation:,SULIN
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Code name:,MK-231
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Chemical structure:,(Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acidcis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid
2020-09-18T01:43:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afp-gene-hepatocellular-carcinoma-vaccine,NA,NA
2020-09-18T01:43:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afp464,NA,NA
2020-09-18T01:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afuresertib,Code name:,Akt inhibitor GSK2110183
2020-09-18T01:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afuresertib,Code name:,GSK2110183
2020-09-18T01:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ag-024322,NA,NA
2020-09-18T01:43:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agaricus-blazei-murill-extract,NA,NA
2020-09-18T01:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agatolimod-sodium,Code name:,CpG 7909
2020-09-18T01:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agatolimod-sodium,Code name:,PF-3512676
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,AC 013773
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,CEP32496
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,CEP-32496
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,RXDX 105
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,RXDX105
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,RXDX-105
2020-09-18T01:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec,Synonym:,adenoviral vector encoding herpes simplex virus thymidine kinase
2020-09-18T01:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec,Synonym:,adenoviral vector encoding HSV thymidine kinase
2020-09-18T01:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec,Abbreviation:,Ad HSV-tk
2020-09-18T01:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec,Abbreviation:,adeno-HSV-tk
2020-09-18T01:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec,Abbreviation:,ADV-tk
2020-09-18T01:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-cd40-monoclonal-antibody-adc-1013,Code name:,ADC-1013
2020-09-18T01:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785256,Synonym:,anti-OX40 agonist antibody INCAGN01949
2020-09-18T01:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785256,Synonym:,anti-OX40 monoclonal antibody INCAGN0194
2020-09-18T01:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785256,Synonym:,monoclonal antibody INCAGN01949
2020-09-18T01:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785256,Code name:,INCAGN01949
2020-09-18T01:44:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-medi6383,Code name:,MEDI6383
2020-09-18T01:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-medi6469,Synonym:,agonistic anti-CD134 monoclonal antibody MEDI6469
2020-09-18T01:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-medi6469,Code name:,MEDI6469
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,Synonym:,Influenza Vaccine
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,Synonym:,"influenza virus vaccine, trivalent, types A and B"
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,Synonym:,TIV
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Agriflu
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Fluarix
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Flublok
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,FluLaval
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Flushield
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Fluvirin
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Fluzone
2020-09-18T01:44:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-hydrochloride,US brand name:,Agrylin
2020-09-18T01:44:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-hydrochloride,Foreign brand name:,Thromboreductin
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,cortisol sodium succinate
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Hycorace
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,RG7853
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Hydrocortisone 21-Sodium Succinate
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Hydrocortisone Na succinate
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Nordicort
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Sodium hydrocortisone succinate
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Solu-Cortef
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Solu-Glyc
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,US brand name:,A-Hydrocort
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,US brand name:,Emergent-EZ
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,US brand name:,Solu-Cortef
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Buccalsone
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Corlan
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Cortop
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Efcortelan
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Flebocortid
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Hidroc Clora
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Hydro-Adreson
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Hydrocort
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Kinogen
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Nordicort
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Nositrol
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Sinsurrene
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Solu-Glyc
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Abbreviation:,HDC
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Chemical structure:,"(11beta)-21-(3-carboxy-1-oxopropyl)-11,17-dihydroxypregn-4-ene-3,20-dione, monosodium salt"
2020-09-18T01:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aim2-1-ht001-1-taf1b-1-frameshift-peptide-vaccine,Abbreviation:,AIM2(-1)/HT001(-1)/TAF1B(-1) FSP vaccine
2020-09-18T01:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ak-3012,NA,NA
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Synonym:,AKR1C3-activated prodrug TH-3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Synonym:,aldo-keto reductase 1c3-activated prodrug OBI-3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,OBI 3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,OBI3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,OBI-3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,TH 3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,TH3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,TH-3424
2020-09-18T01:44:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-1-2-inhibitor-bay1125976,Code name:,BAY1125976
2020-09-18T01:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-antisense-oligonucleotide-rx-0201,US brand name:,Archexin
2020-09-18T01:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-antisense-oligonucleotide-rx-0201,Code name:,RX-0201
2020-09-18T01:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-arq-092,Code name:,ARQ 092
2020-09-18T01:45:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-gsk2141795,Code name:,GSK2141795
2020-09-18T01:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-ly2780301,Code name:,LY2780301
2020-09-18T01:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-mk2206,Code name:,MK2206
2020-09-18T01:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-sr13668,Code name:,SRI13668
2020-09-18T01:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-sr13668,Chemical structure:,"2,10-dicarbethoxy-6-methoxy-5,7-dihydro-indolo[2,3-b]carbazole"
2020-09-18T01:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-erk-inhibitor-onc201,Code name:,ONC201
2020-09-18T01:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-erk-inhibitor-onc201,Code name:,TIC10
2020-09-18T01:45:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-hydrochloride-ophthalmic-gel,Synonym:,lidocaine HCl ophthalmic gel
2020-09-18T01:45:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-hydrochloride-ophthalmic-gel,US brand name:,Akten
2020-09-18T01:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akti-1-2-inhibitor-treated-tumor-infiltrating-lymphocytes,Synonym:,Akti-1/2-treated Tumor Infiltrating Lymphocytes
2020-09-18T01:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akti-1-2-inhibitor-treated-tumor-infiltrating-lymphocytes,Synonym:,Akti-treated TIL
2020-09-18T01:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akti-1-2-inhibitor-treated-tumor-infiltrating-lymphocytes,Synonym:,AKTi-treated TILs
2020-09-18T01:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant-and-palonosetron-hydrochloride,Synonym:,netupitant/palonosetron hydrochloride
2020-09-18T01:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant-and-palonosetron-hydrochloride,US brand name:,Akynzeo
2020-09-18T01:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799796,US brand name:,Alantel
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Synonym:,Bilutac
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Synonym:,Proftril
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,US brand name:,Albenza
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,US brand name:,Zentel
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Code name:,SKF 62979
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Chemical structure:,"Carbamic Acid,(5-(Propylthio)-1H-benzimidazol-2-yl)-, Methyl Ester"
2020-09-18T01:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Synonym:,Bilutac
2020-09-18T01:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Synonym:,Proftril
2020-09-18T01:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,US brand name:,Albenza
2020-09-18T01:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,US brand name:,Zentel
2020-09-18T01:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Code name:,SKF 62979
2020-09-18T01:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Chemical structure:,"Carbamic Acid,(5-(Propylthio)-1H-benzimidazol-2-yl)-, Methyl Ester"
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Synonym:,albumin-conjugating platinum-prodrug BTP-114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Synonym:,cisplatin prodrug BTP-114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Synonym:,cisplatin/maleimide-based complex BTP-114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Synonym:,platinum-prodrug BTP-114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Synonym:,prodrug BTP-114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Code name:,BTP 114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Code name:,BTP-114
2020-09-18T01:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albuterol-sulfate,Synonym:,salbutamol sulfate
2020-09-18T01:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albuterol-sulfate,US brand name:,Proventil
2020-09-18T01:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albuterol-sulfate,US brand name:,Ventolin
2020-09-18T01:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol,Synonym:,absolute ethanol
2020-09-18T01:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol,Synonym:,ethanol
2020-09-18T01:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol,Synonym:,ethyl alcohol
2020-09-18T01:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol,Synonym:,methylcarbinol
2020-09-18T01:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone,US brand name:,Aldactone
2020-09-18T01:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone,Foreign brand name:,Spiroctan
2020-09-18T01:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone,Abbreviation:,SPL
2020-09-18T01:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone,Code name:,SC 9420
2020-09-18T01:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone,Chemical structure:,"17-hydroxy-7alpha-mercapto-3-oxo-17alpha-pregn-4-ene-21-carboxylic Acid, gamma Lactone, Acetate"
2020-09-18T01:46:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod,US brand name:,Aldara
2020-09-18T01:46:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod,Abbreviation:,IMQ
2020-09-18T01:46:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod,Code name:,R 837
2020-09-18T01:46:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod,Code name:,S 26308
2020-09-18T01:46:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod,Chemical structure:,"1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline"
2020-09-18T01:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin,Synonym:,recombinant human IL-2
2020-09-18T01:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin,Synonym:,recombinant human interleukin-2
2020-09-18T01:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin,US brand name:,Proleukin
2020-09-18T01:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin,Abbreviation:,r-serHuIL-2
2020-09-18T01:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin,Chemical structure:,125-L-serine-2-133-interleukin 2
2020-09-18T01:46:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldoxorubicin,Synonym:,doxorubicin prodrug INNO-206
2020-09-18T01:46:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldoxorubicin,Code name:,INNO-206
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Synonym:,ALK inhibitor CH5424802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Synonym:,anaplastic lymphoma kinase inhibitor CH5424802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,US brand name:,Alecensa
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Foreign brand name:,Alecensa
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,AF802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,AF-802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,CH5424802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,RO5424802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,UNII-LIJ4CT1Z3Y
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Chemical structure:,"5H-benzo(b)carbazole-3-carbonitrile, 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-(4-(4-morpholinyl)-1-piperidinyl)-11-oxo-"
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Synonym:,ALK inhibitor CH5424802
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Synonym:,anaplastic lymphoma kinase inhibitor CH5424802
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,US brand name:,Alecensa
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Foreign brand name:,Alecensa
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,AF802
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,AF-802
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,CH5424802
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,RG7853
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,RO5424802
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,UNII-LIJ4CT1Z3Y
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Chemical structure:,"5H-benzo(b)carbazole-3-carbonitrile, 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-(4-(4-morpholinyl)-1-piperidinyl)-11-oxo-"
2020-09-18T01:46:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alefacept,US brand name:,Amevive
2020-09-18T01:46:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alefacept,Code name:,LFA3TIP
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Synonym:,anti-CD52 monoclonal antibody
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Synonym:,Campath-1H
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Synonym:,Monoclonal Antibody Campath-1H
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Synonym:,Monoclonal Antibody CD52
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,US brand name:,Campath
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Foreign brand name:,MabCampath
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Abbreviation:,MoAb CD52
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Synonym:,Alendronate
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Synonym:,Alendronic Acid Monosodium Salt Trihydrate
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,US brand name:,Binosto
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,US brand name:,Fosamax
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Foreign brand name:,Adronat
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Foreign brand name:,Alendros
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Foreign brand name:,Onclast
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Code name:,G-704650
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Code name:,MK-217
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Alesse
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Aviane
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Enpresse
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Lessina
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Levlite
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Levora
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Microgynon
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Nordette
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Portia
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Seasonale
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Seasonique
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Trivora
2020-09-18T01:47:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfentanil-hydrochloride,US brand name:,Alfenta
2020-09-18T01:47:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfentanil-hydrochloride,Foreign brand name:,Rapifen
2020-09-18T01:47:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfentanil-hydrochloride,US brand name:,Alfenta
2020-09-18T01:47:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfentanil-hydrochloride,Foreign brand name:,Rapifen
2020-09-18T01:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa,Synonym:,alpha interferon
2020-09-18T01:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa,Synonym:,leukocyte interferon
2020-09-18T01:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa,Synonym:,lymphoblast interferon
2020-09-18T01:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa,Synonym:,lymphoblastoid interferon
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Synonym:,gammaphos
2020-09-18T01:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa,US brand name:,Alferon
2020-09-18T01:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alflutinib-mesylate,Synonym:,ASK120067
2020-09-18T01:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alflutinib-mesylate,Code name:,AST 2818
2020-09-18T01:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alflutinib-mesylate,Code name:,AST2818
2020-09-18T01:47:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfuzosin-hydrochloride,US brand name:,Uroxatrol
2020-09-18T01:47:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/algenpantucel-l,Synonym:,"Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Pancreatic Tumor Cell Vaccine"
2020-09-18T01:47:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/algenpantucel-l,Synonym:,Alpha-Gal Pancreatic Cancer Vaccine
2020-09-18T01:47:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/algenpantucel-l,US brand name:,Hyperacute-Pancreatic Cancer Vaccine
2020-09-18T01:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium,Synonym:,multitargeted antifolate
2020-09-18T01:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium,US brand name:,Alimta
2020-09-18T01:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium,Abbreviation:,MTA
2020-09-18T01:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium,Code name:,LY231514
2020-09-18T01:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium,Chemical structure:,"L-glutamic acid, N-(4-(2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt"
2020-09-18T01:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitazoxanide,US brand name:,Alinia
2020-09-18T01:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitazoxanide,Chemical structure:,"benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-salicylamide, N-(5-nitro-2-thiazolyl)-, acetate(ester)"
2020-09-18T01:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copanlisib-hydrochloride,Synonym:,BAY-80-6946 dihydrochloride
2020-09-18T01:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copanlisib-hydrochloride,Synonym:,copanlisib dihydrochloride
2020-09-18T01:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copanlisib-hydrochloride,US brand name:,Aliqopa
2020-09-18T01:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copanlisib-hydrochloride,Chemical structure:,"5-pyrimidinecarboxamide, 2-amino-N-(2,3-dihydro-7-methoxy-8-(3-(4-morpholinyl)propoxy)imidazo(1,2-C)quinazolin-5-yl)-, hydrochloride (1:2)"
2020-09-18T01:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alisertib,Synonym:,Aurora A kinase inhibitor MLN8237
2020-09-18T01:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alisertib,Code name:,MLN8237
2020-09-18T01:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alisertib,Chemical structure:,"benzoic acid, 4-((9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)-2-methoxy-"
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Synonym:,9-cis-retinoic acid
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,US brand name:,Panretin
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Foreign brand name:,Panretyn
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Foreign brand name:,Panrexin
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Abbreviation:,9-CRA
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Acronym:,9-cis-RA
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Code name:,ALRT1057
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Code name:,LGD1057
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Chemical structure:,"3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic Acid3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-trans-4-trans-6-cis-8-trans-nonatetraenoic Acid"
2020-09-18T01:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-asp3026,Code name:,ASP3026
2020-09-18T01:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-asp3026,Code name:,ASP-3026
2020-09-18T01:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-asp3026,Chemical structure:,"N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine"
2020-09-18T01:48:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792707,Code name:,PLB 1003
2020-09-18T01:48:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792707,Code name:,PLB1003
2020-09-18T01:48:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792707,Code name:,PLB-1003
2020-09-18T01:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-ro5424802,Code name:,RO5424802
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Synonym:,FL-006
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Code name:,FL 006
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Code name:,FL006
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Code name:,WX 0593
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Code name:,WX0593
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Code name:,WX-0593
2020-09-18T01:48:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792652,Code name:,TQ B3139
2020-09-18T01:48:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792652,Code name:,TQ-B3139
2020-09-18T01:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-fak-pyk2-inhibitor-ct-707,Code name:,CT 707
2020-09-18T01:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-fak-pyk2-inhibitor-ct-707,Code name:,CT-707
2020-09-18T01:48:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-trk-inhibitor-tsr-011,Code name:,TSR-011
2020-09-18T01:48:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-bicarbonate-potassium-bicarbonate-anhydrous-citric-acid,US brand name:,Alka Seltzer Gold
2020-09-18T01:48:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/708408,US brand name:,Alkagin
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,alanine nitrogen mustard
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,L-phenylalanine mustard
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,L-sarcolysin
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,L-sarcolysin phenylalanine mustard
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,L-sarcolysine
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,phenylalanine mustard
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,phenylalanine nitrogen mustard
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,sarcoclorin
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,US brand name:,Alkeran
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Foreign brand name:,Melphalanum
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Foreign brand name:,Sarkolysin
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Abbreviation:,L-PAM
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Code name:,CB-3025
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Code name:,WR-19813
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Chemical structure:,4-[bis(2-chloroethyl)amino]-L-phenylalaninep-di(chloroethyl)amino-L-phenylalanine
2020-09-18T01:49:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-fak-inhibitor-cep-37440,Code name:,CEP-37440
2020-09-18T01:49:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799671,Code name:,ZG 0418
2020-09-18T01:49:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799671,Code name:,ZG0418
2020-09-18T01:49:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799671,Code name:,ZG-0418
2020-09-18T01:49:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795374,Synonym:,alkylglycerol and rosemary capsules
2020-09-18T01:49:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795374,Synonym:,rosemary/alkylglycerol dietary supplement
2020-09-18T01:49:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fexofenadine-hydrochloride,Synonym:,fexofenadine HCl
2020-09-18T01:49:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fexofenadine-hydrochloride,US brand name:,Allegra
2020-09-18T01:49:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide,US brand name:,AllerNaze
2020-09-18T01:49:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide,US brand name:,Aristocort A
2020-09-18T01:49:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide,US brand name:,Kenalog
2020-09-18T01:49:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide,US brand name:,Nasacort
2020-09-18T01:49:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide,Chemical structure:,"9-alpha-fluoro-11-beta,21-dihydroxy-16-alpha-isopropylidenedioxy-1,4-pregnadiene,3,20-dione"
2020-09-18T01:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10,Synonym:,alloantigen-specific TR1 cells Allo10
2020-09-18T01:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10,Synonym:,alloantigen-specific type 1 Tregs T-allo10
2020-09-18T01:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10,Synonym:,donor-derived host alloantigen-specific IL-10 anergized T cells
2020-09-18T01:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10,Synonym:,T-allo10 cells
2020-09-18T01:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10,Abbreviation:,T-allo10
2020-09-18T01:49:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-haploidentical-t-cells-expressing-inducible-caspase-9,Synonym:,iCasp9 allogeneic T cells
2020-09-18T01:49:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,Synonym:,ATIR
2020-09-18T01:49:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,Synonym:,Theralux-ATIR
2020-09-18T01:49:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,US brand name:,Allodepleted T-cell ImmunotheRapeutics
2020-09-18T01:49:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,Code name:,ATIR101
2020-09-18T01:49:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,Synonym:,ATIR
2020-09-18T01:49:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,Synonym:,Theralux-ATIR
2020-09-18T01:49:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,US brand name:,Allodepleted T-cell ImmunotheRapeutics
2020-09-18T01:49:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,Code name:,ATIR101
2020-09-18T01:49:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-acute-myeloid-leukemia-antigen-expressing-dendritic-cell-vaccine,Code name:,DCOne
2020-09-18T01:49:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-acute-myeloid-leukemia-antigen-expressing-dendritic-cell-vaccine,Code name:,DCP-001
2020-09-18T01:49:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-adenovirus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic adenovirus-specific CTLs
2020-09-18T01:50:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801471,Synonym:,allogeneic adipose-derived MSCs
2020-09-18T01:50:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801471,Synonym:,allogeneic adipose-derived stem/stromal cells
2020-09-18T01:50:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801471,Synonym:,allogeneic mesenchymal stem/stromal cells
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Synonym:,ALLO-715 cells
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Synonym:,alloCAR T ALLO-715
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Synonym:,anti-BCMA allogeneic CAR T cells ALLO-715
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Synonym:,BCMA allogeneic CAR T cells ALLO-715
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Code name:,ALLO 715
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Code name:,ALLO715
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Code name:,ALLO-715
2020-09-18T01:50:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802179,Synonym:,allogeneic anti-BCMA/SLAMF7 bispecific CAR-T cells
2020-09-18T01:50:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802179,Synonym:,allogeneic BCMA/CS1 bispecific CAR-T cells
2020-09-18T01:50:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802179,Synonym:,allogeneic BCMA/SLAMF7 bispecific CAR-T cells
2020-09-18T01:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801229,Synonym:,allogeneic anti-BCMA CAR T cells PBCAR269A
2020-09-18T01:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801229,Synonym:,allogeneic anti-BCMA-CAR T lymphocytes PBCAR269A
2020-09-18T01:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801229,Code name:,PBCAR269A
2020-09-18T01:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167,Synonym:,allogeneic anti-CD19 UCAR-T cells CTA101
2020-09-18T01:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167,Synonym:,universal CD19-directed CAR-T cells CTA101
2020-09-18T01:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167,Code name:,CTA 101
2020-09-18T01:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167,Code name:,CTA101
2020-09-18T01:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167,Code name:,CTA-101
2020-09-18T01:50:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797475,Synonym:,allogeneic anti-CD19-CAR T lymphocytes PBCAR0191
2020-09-18T01:50:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797475,Synonym:,anti-CD19-CAR allogeneic T cells PBCAR0191
2020-09-18T01:50:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797475,Code name:,PBCAR0191
2020-09-18T01:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802323,Synonym:,LUCAR-20S CAR-T cells
2020-09-18T01:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802323,Code name:,LUCAR 20S
2020-09-18T01:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802323,Code name:,LUCAR20S
2020-09-18T01:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802323,Code name:,LUCAR-20S
2020-09-18T01:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800688,Synonym:,allogeneic anti-CD20 CAR T lymphocytes PBCAR20A
2020-09-18T01:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800688,Code name:,BCAR20A
2020-09-18T01:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800688,Code name:,PBCAR 20A
2020-09-18T01:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800688,Code name:,PBCAR-20A
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,allogeneic DRibble vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,allogeneic DRibble vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,dribble cancer vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,DRibble vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,dribbles vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,DRiPs and SLiPs-containing blebs vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Code name:,DPV 001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Code name:,DPV001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Code name:,DPV-001
2020-09-18T01:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-b71-hla-a1-transfected-tumor-cell-vaccine,NA,NA
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Synonym:,allogeneic engineered T cells expressing anti-CD123 chimeric antigen receptor
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Synonym:,UCART123 T cells
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Synonym:,universal chimeric antigen receptor T cell 123
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Synonym:,universal chimeric antigen receptor T cells targeting CD123
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Synonym:,universal TALEN gene-edited CART123 cells
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Code name:,UCART123
2020-09-18T01:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794267,Synonym:,allogeneic CARCIK-CD19 cells
2020-09-18T01:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794267,Synonym:,transposon-manipulated allogeneic CARCIK-CD19 cells
2020-09-18T01:51:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/717909,Synonym:,allogeneic CD19CAR-TCM cells
2020-09-18T01:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-nk-92,US brand name:,haNK
2020-09-18T01:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-nk-92,Code name:,NK-92
2020-09-18T01:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-nk-92,Code name:,NK-92 cells
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Synonym:,TCR/CD52-deficient RQR8+ CD19-CAR+ T cells
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Synonym:,UCART 19
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Synonym:,UCART19 cells
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Synonym:,universal chimeric antigen receptor T cell 19
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Synonym:,universal TALEN gene-edited CART19 cells
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Code name:,ALLO-501
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Code name:,S68587
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Synonym:,adaptive memory natural killer cells FATE-NK100
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Synonym:,adaptive memory NKs cells FATE-NK100
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Synonym:,adaptive NK cells FATE-NK100
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Synonym:,NKG2C/CD57-expressing adaptive memory natural killer cells FATE-NK100
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Code name:,FATE NK100
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Code name:,FATE-NK100
2020-09-18T01:51:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794297,Synonym:,allogeneic CD34+E- T-cell depleted PBSCs
2020-09-18T01:51:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794297,Synonym:,allogeneic CD34+E- T-cell depleted peripheral blood stem cells
2020-09-18T01:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794648,Synonym:,allogeneic CD34+E- T-cell-depleted PBSCs
2020-09-18T01:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794648,Synonym:,allogeneic CD34+E- T-cell-depleted peripheral blood stem cells
2020-09-18T01:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/580835,Foreign brand name:,AlloStim
2020-09-18T01:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801194,Code name:,NEXI 001
2020-09-18T01:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801194,Code name:,NEXI001
2020-09-18T01:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801194,Code name:,NEXI-001
2020-09-18T01:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796811,Synonym:,allogeneic CMV-specific antigen-selected T cells
2020-09-18T01:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796811,Synonym:,allogeneic cytomegalovirus-specific CD4+ and CD8+ T cells
2020-09-18T01:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796811,Synonym:,allogeneic cytomegalovirus-specific CD4+ and CD8+ T lymphocytes
2020-09-18T01:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cmv-adv-specific-cytotoxic-t-lymphocytes,NA,NA
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Synonym:,allogeneic anti-CD19 CAR CRISPR-edited T cells CTX110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Synonym:,allogeneic anti-CD19 CAR-T cells CTX110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Synonym:,allogeneic CRISPR-Cas9 gene-editing CD19-directed CAR T cells CTX110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Synonym:,allogeneic CRISPR-Cas9-engineered anti-CD19 CAR T cells CTX110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Code name:,CTX 110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Code name:,CTX101
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Code name:,CTX110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Code name:,CTX-110
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Synonym:,allogeneic gene-edited CAR T cells UCARTCS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Synonym:,allogeneic TALEN gene-edited CAR T cells UCARTCS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Synonym:,allogenic engineered T cells expressing anti- CS1 CAR UCARTCS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Synonym:,UCARTCS1A cells
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Code name:,UCART CS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Code name:,UCARTCS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Code name:,UCART-CS1A
2020-09-18T01:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cytomegalovirus-specific-cytotoxic-t-lymphocytes,Abbreviation:,allogeneic CMV-specific CTLs
2020-09-18T01:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-dendritic-cell-vaccine-combig-dc,Synonym:,COMBIG-DC
2020-09-18T01:52:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-dendritic-cell-myeloma-idiotype-vaccine,NA,NA
2020-09-18T01:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792387,Synonym:,allogeneic DNT cells
2020-09-18T01:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792387,Code name:,DNT-UHN-1
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Urosin
2020-09-18T01:52:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-epstein-barr-virus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic EBV-specific CTL
2020-09-18T01:52:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801494,Synonym:,allogeneic glial restricted progenitor cells
2020-09-18T01:52:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801494,Synonym:,Q-cells
2020-09-18T01:52:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801494,Abbreviation:,GRPs
2020-09-18T01:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/756037,NA,NA
2020-09-18T01:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-breast-cancer-vaccine,Abbreviation:,GM-CSF BREAST VAC
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,Synonym:,GM-CSF gene-transfected breast cancer vaccine SV-BR-1-GM
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,Synonym:,SV-BR-1 breast cancer cell line vaccine
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,Synonym:,SV-BR-1-GM
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,Synonym:,SV-BR1-GM breast cancer vaccine
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,Synonym:,SV-BR-1-GM vaccine
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,US brand name:,Bria-IMT
2020-09-18T01:53:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794145,Synonym:,GVAX allogeneic irradiated pancreatic tumor cell vaccine
2020-09-18T01:53:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794145,Synonym:,irradiated allogeneic GM-CSF-secreting pancreatic tumor cell vaccine
2020-09-18T01:53:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-lethally-irradiated-whole-melanoma-cell-vaccine,Synonym:,GVAX melanoma vaccine
2020-09-18T01:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798454,Synonym:,allogeneic GM-CSF-secreting multiple myeloma vaccine
2020-09-18T01:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798454,Synonym:,allogeneic GVAX myeloma vaccine
2020-09-18T01:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798454,Synonym:,allogeneic myeloma vaccine with GM-CSF-secreting K562 cells
2020-09-18T01:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798454,Synonym:,GVAX allogeneic myeloma vaccine
2020-09-18T01:53:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-tumor-vaccine-panc-1005-pcdna-1-gm-neo,Synonym:,PANC 10.05 pcDNA-1/GM-Neo
2020-09-18T01:53:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-tumor-vaccine-panc-603-pcdna-1-gm-neo,Synonym:,PANC 6.03 pcDNA-1/GM-Neo
2020-09-18T01:53:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-transfected-myeloma-cell-vaccine,Synonym:,allogeneic GM-CSF-based myeloma cell vaccine
2020-09-18T01:53:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-transfected-myeloma-cell-vaccine,Synonym:,allogeneic granulocyte macrophage colony-stimulating factor-transfected myeloma cell vaccine
2020-09-18T01:53:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796810,Synonym:,allogeneic HAdV antigen-selected T cells
2020-09-18T01:53:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796810,Synonym:,allogeneic HAdV antigen-selected T lymphocytes
2020-09-18T01:53:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796810,Synonym:,allogeneic HAdV antigen-specific T cells
2020-09-18T01:53:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796810,Synonym:,allogeneic human adenovirus-specific T lymphocytes
2020-09-18T01:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-hla-a2-4-1bb-ligand-expressing-melanoma-vaccine,NA,NA
2020-09-18T01:53:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794788,Synonym:,allogeneic HPV-specific immune lymphocytes
2020-09-18T01:53:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794788,Abbreviation:,allogeneic HPV-CTLs
2020-09-18T01:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530,Synonym:,allogeneic iC9/CAR19/IL15-transduced CB-NK cells
2020-09-18T01:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530,Synonym:,CAR-CD19-CD28-zeta-2A-iCasp9-IL15-transduced CB-NK cells
2020-09-18T01:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530,Synonym:,iC9/CAR19/IL15-transduced CB-NKs
2020-09-18T01:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530,Synonym:,iC9/CAR-CD19-CD28-zeta-2A/IL-15 CB-NK cells
2020-09-18T01:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530,Synonym:,UCB-derived CAR-CD19-CD28-zeta-2A-iCasp9-IL15 engineered NK cells
2020-09-18T01:53:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/668180,Synonym:,cytotoxic T lymphocytes GRm13Z40-2
2020-09-18T01:53:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/668180,Code name:,GRm13Z40-2
2020-09-18T01:53:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792631,Synonym:,allogeneic IL-17+ CD8 T cells
2020-09-18T01:53:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792631,Synonym:,allogeneic IL-17-producing CD8+ T cells
2020-09-18T01:53:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792631,Synonym:,allogeneic Tc17 cells
2020-09-18T01:54:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-irradiated-melanoma-cell-vaccine-csf470,Synonym:,CSF 470 vaccine
2020-09-18T01:54:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-irradiated-melanoma-cell-vaccine-csf470,Synonym:,CSF470 vaccine
2020-09-18T01:54:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-large-multivalent-immunogen-breast-cancer-vaccine,Synonym:,allogeneic LMI breast cancer vaccine
2020-09-18T01:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-large-multivalent-immunogen-melanoma-vaccine-lp2307,Synonym:,allogeneic LMI melanoma vaccine LP2307
2020-09-18T01:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-large-multivalent-immunogen-melanoma-vaccine-lp2307,Code name:,LP2307
2020-09-18T01:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-lmp1--lmp2--specific-cytotoxic-t-lymphocytes,NA,NA
2020-09-18T01:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-melanoma-vaccine-agi-101h,Code name:,AGI-101H
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Synonym:,ethiofos
2020-09-18T01:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/770460,Synonym:,allogeneic mesothelioma tumor lysate-pulsed autologous DC vaccine
2020-09-18T01:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/770460,Synonym:,MesoCancerVac
2020-09-18T01:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793439,Synonym:,most closely HLA-matched third-party donor adenovirus Specific CTLs
2020-09-18T01:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793439,Synonym:,most closely HLA-matched third-party donor adenovirus-specific T cells
2020-09-18T01:54:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multipotent-adult-progenitor-cells,US brand name:,MultiStem
2020-09-18T01:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multivirus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic EBV/CMV/AdV/HHV6/BKV-specific CTLs
2020-09-18T01:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multivirus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic multivirus-specific CTLs
2020-09-18T01:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multivirus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic partially HLA-matched virus-specific T cells
2020-09-18T01:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multivirus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic partially HLA-matched VST
2020-09-18T01:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-mg4101,Abbreviation:,allogeneic NK cell line MG4101
2020-09-18T01:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-mg4101,Code name:,MG4101
2020-09-18T01:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-nicotinamide-expanded-natural-killer-cells,Synonym:,allogeneic NAM NK cells
2020-09-18T01:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-nicotinamide-expanded-natural-killer-cells,Synonym:,allogeneic NAM NKs
2020-09-18T01:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-nicotinamide-expanded-natural-killer-cells,Synonym:,donor nicotinamide-expanded natural killer cells
2020-09-18T01:55:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800069,Synonym:,allogeneic NKG2DL-targeting CAR-gd T cells
2020-09-18T01:55:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800069,Code name:,CTM-N2D
2020-09-18T01:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801755,Synonym:,allogeneic pDCs- expressing lung tumor antigens PDC*lung01
2020-09-18T01:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801755,Synonym:,therapeutic cancer vaccine PDC*lung01
2020-09-18T01:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801755,Code name:,PDC*lung01
2020-09-18T01:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801755,Code name:,PDClung01
2020-09-18T01:55:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-renal-cell-carcinoma-vaccine-mgn1601,Synonym:,IL-7/GM-CSF/CD80/CD154-encoding synthetic dSLIM-30L1 allogeneic renal cell carcinoma vaccine MGN1601
2020-09-18T01:55:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-renal-cell-carcinoma-vaccine-mgn1601,Code name:,MGN1601
2020-09-18T01:55:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793046,Synonym:,allogeneic NY-ESO-1-c259 T cells
2020-09-18T01:55:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793046,Synonym:,NY-ESO-1 c259 T cells
2020-09-18T01:55:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792505,Synonym:,allogeneic TCR a/b T cell-depleted PBSCs
2020-09-18T01:55:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792505,Synonym:,allogeneic TCR alpha/beta T cell-depleted PBSCs
2020-09-18T01:55:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802327,Abbreviation:,CTL 19
2020-09-18T01:55:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802327,Code name:,CTL19
2020-09-18T01:55:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802327,Code name:,CTL-19
2020-09-18T01:55:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796718,Synonym:,allogeneic CD19-TriCAR SILK cells
2020-09-18T01:55:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796718,Synonym:,allogeneic CD19-TriCAR-T/SILK
2020-09-18T01:55:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796718,Synonym:,allogeneic CD19-TriCAR-T/SILK cells
2020-09-18T01:55:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-tumor-cell-vaccine,Synonym:,Allogenic Cell Vaccine
2020-09-18T01:55:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-tumor-cell-vaccine,Abbreviation:,ALLOTCV
2020-09-18T01:55:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792373,Synonym:,allogeneic UCB-derived hematopoietic stem and progenitor cells NLA101
2020-09-18T01:55:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792373,Code name:,NLA101
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Alositol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Anoprolin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Anzief
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Apurol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Bleminol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Bloxanth
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Embarin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Epidropal
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Folligan
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Geapur
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Ketobun-A
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,sodium allopurinol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Urbol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Uricemil
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Xanturat
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Zyloric
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Aloprim
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Lopurin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Zurinol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Zyloprim
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Adenock
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Allo-Puren
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Allozym
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Allural
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Aloral
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Alositol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Anoprolin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Anzief
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Apulonga
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Apurin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Apurol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Bleminol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Bloxanth
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Caplenal
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Cellidrin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Cosuric
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Dabroson
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Embarin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Epidropal
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Folligan
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Geapur
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Gichtex
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Hamarin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Hexanurat
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Ketanrift
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Ketobun-A
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Ledopur
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Lysuron
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Miniplanor
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Monarch
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Nektrohan
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Remid
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Riball
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Sigapurol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Suspendol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Takanarumin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Urbol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Uricemil
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Uripurinol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Urosin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Urtias
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Xanturat
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Zyloric
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Abbreviation:,4'-HPP
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Code name:,BW 56158
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Code name:,BW-56158
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Chemical structure:,"1,5-dihydro-4H-pyrazolo[3,4-d]pryimidin-4-one monosodium salt1H-pyrazolo[3,4-d]pyrimidin-4-ol monosodium salt4-hydroxypyrazolo[3,4-d]pyrimidine"
2020-09-18T01:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228,Synonym:,EGFR/HER2 inhibitor BDTX-189
2020-09-18T01:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228,Synonym:,ErbB mutant-specific inhibitor BDTX-189
2020-09-18T01:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228,Code name:,BDTX 189
2020-09-18T01:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228,Code name:,BDTX189
2020-09-18T01:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228,Code name:,BDTX-189
2020-09-18T01:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide,Synonym:,n-muramyldipeptide derivative
2020-09-18T01:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide,Synonym:,norMDP
2020-09-18T01:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide,Synonym:,nor-MDP
2020-09-18T01:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide,Code name:,Cgp-11637
2020-09-18T01:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide,Chemical structure:,N-acetyl-nor-muramyl-L-alanyl-D-isoglutamine
2020-09-18T01:56:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/injectable-liposomal-vinorelbine,Synonym:,vinorelbine liposomes injection
2020-09-18T01:56:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/injectable-liposomal-vinorelbine,US brand name:,Alocrest
2020-09-18T01:56:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/injectable-liposomal-vinorelbine,Acronym:,VLI
2020-09-18T01:56:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aloe-vera-gel,NA,NA
2020-09-18T01:56:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799796,US brand name:,Alantel
2020-09-18T01:56:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751302,NA,NA
2020-09-18T01:56:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alogliptin,Chemical structure:,"benzonitrile, 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)- pyrimidinyl]methyl]-"
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Alositol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Anoprolin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Anzief
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Apurol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Bleminol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Bloxanth
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Embarin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Epidropal
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Folligan
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Geapur
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Ketobun-A
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,sodium allopurinol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Urbol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Uricemil
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Urosin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Xanturat
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Zyloric
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Aloprim
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Lopurin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Zurinol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Zyloprim
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Adenock
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Allo-Puren
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Allozym
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Allural
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Aloral
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Alositol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Anoprolin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Anzief
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Apulonga
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Apurin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Apurol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Bleminol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Bloxanth
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Caplenal
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Cellidrin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Cosuric
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Dabroson
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Embarin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Epidropal
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Folligan
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Geapur
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Gichtex
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Hamarin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Hexanurat
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Ketanrift
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Ketobun-A
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Ledopur
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Lysuron
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Miniplanor
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Monarch
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Nektrohan
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Remid
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Riball
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Sigapurol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Suspendol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Takanarumin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Urbol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Uricemil
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Uripurinol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Urosin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Urtias
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Xanturat
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Zyloric
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Abbreviation:,4'-HPP
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Code name:,BW 56158
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Code name:,BW-56158
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Chemical structure:,"1,5-dihydro-4H-pyrazolo[3,4-d]pryimidin-4-one monosodium salt1H-pyrazolo[3,4-d]pyrimidin-4-ol monosodium salt4-hydroxypyrazolo[3,4-d]pyrimidine"
2020-09-18T01:56:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palonosetron-hydrochloride,US brand name:,Aloxi
2020-09-18T01:56:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palonosetron-hydrochloride,Code name:,RS 25259-197
2020-09-18T01:56:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palonosetron-hydrochloride,Chemical structure:,"1H-Benz(de)isoquinolin-1-one, 2-(3S)-1-azabicyclo(2.2.2)oct-3-yl-2,3,3a,4,5,6-hexahydro-, Monohydrochloride,(3aS)-"
2020-09-18T01:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpelisib,Synonym:,phosphoinositide 3-kinase inhibitor BYL719
2020-09-18T01:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpelisib,Synonym:,PI3K inhibitor BYL719
2020-09-18T01:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpelisib,US brand name:,Piqray
2020-09-18T01:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpelisib,Code name:,BYL719
2020-09-18T01:56:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-fetoprotein-adenoviral-vector-vaccine,Abbreviation:,AdVhAFP
2020-09-18T01:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-fetoprotein-plasmid-dna-vaccine,Abbreviation:,phAFP
2020-09-18T01:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503,Synonym:,aGal AGI-134
2020-09-18T01:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503,Synonym:,anti-alpha Gal immunotherapeutic AGI-134
2020-09-18T01:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503,Code name:,AGI 134
2020-09-18T01:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503,Code name:,AGI134
2020-09-18T01:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503,Code name:,AGI-134
2020-09-18T01:57:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797965,Synonym:,alpha/beta T-cell and CD19+ B-cell-depleted allogeneic PBSCs derived from an unrelated or partially matched donor
2020-09-18T01:57:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797965,Synonym:,alpha/beta T-cell/CD19+ B-cell-depleted unrelated or partially matched donor-derived allogeneic PBSCs
2020-09-18T01:57:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/539100,US brand name:,HyperAcute-Lung Cancer Vaccine
2020-09-18T01:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/756792,US brand name:,HyperAcute™ Renal
2020-09-18T01:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/756792,Abbreviation:,HAR
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Synonym:,alpha 1 antitrypsin
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Synonym:,alpha-1 antitrypsin
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Synonym:,alpha-1-antiproteinase
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,US brand name:,Aralast
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,US brand name:,Prolastin-C
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Abbreviation:,A1AT
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Abbreviation:,A1P1
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Abbreviation:,AAT
2020-09-18T01:57:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-fetoprotein-peptide-pulsed-autologous-dendritic-cell-vaccine,Abbreviation:,AFP peptide-pulsed autologous dendritic cell vaccine
2020-09-18T01:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-folate-receptor-targeting-thymidylate-synthase-inhibitor-onx-0801,Synonym:,BGC 945
2020-09-18T01:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-folate-receptor-targeting-thymidylate-synthase-inhibitor-onx-0801,Code name:,ONX 0801
2020-09-18T01:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-folate-receptor-targeting-thymidylate-synthase-inhibitor-onx-0801,Code name:,ONX-0801
2020-09-18T01:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-folate-receptor-targeting-thymidylate-synthase-inhibitor-onx-0801,Chemical structure:,"N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-l-γ-glutamyl-D-glutamic acid"
2020-09-18T01:57:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-gal-glycosphingolipids,Synonym:,"galactose(alpha1,3,)galactose glycosphingolipids"
2020-09-18T01:57:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-gal-glycosphingolipids,Abbreviation:,GSL alpha-GAL
2020-09-18T01:57:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-galactosylceramide-pulsed-autologous-dendritic-cells,Synonym:,KRN7000-pulsed autologous dendritic cells
2020-09-18T01:57:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-galactosylceramide-pulsed-autologous-dendritic-cells,Abbreviation:,DC-KRN7000
2020-09-18T01:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brimonidine-tartrate,Synonym:,"6-Quinoxalinamine, 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-,(2R,3R)-2,3-dihydroxybutanedioate(1:1)"
2020-09-18T01:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brimonidine-tartrate,US brand name:,Alphagan
2020-09-18T01:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid,Synonym:,thioctic acid
2020-09-18T01:57:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802261,Foreign brand name:,Opera
2020-09-18T01:58:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-vitamin-mineral-supplement-polymva,Synonym:,palladium lipoic complex
2020-09-18T01:58:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-vitamin-mineral-supplement-polymva,US brand name:,PolyMVA
2020-09-18T01:58:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-vitamin-mineral-supplement-polymva,Abbreviation:,LAPd
2020-09-18T01:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside,Synonym:,a-methyl-4[18F]-4-deoxy-D-glucopyranoside
2020-09-18T01:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside,Synonym:,Me-4(18F)DG
2020-09-18T01:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside,Abbreviation:,Me4FDG
2020-09-18T01:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside,Abbreviation:,Me-4FDG
2020-09-18T01:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside,Chemical structure:,alpha-methyl-4-[F-18]-fluoro-4-deoxy-d-glucopyranosidealpha-methyl-4-deoxy-4-(18F)fluoro-D-glucopyranoside
2020-09-18T01:58:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-tocopherol,Chemical structure:,"3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol"
2020-09-18T01:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-tocopheryloxyacetic-acid,Abbreviation:,α-TEA
2020-09-18T01:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-tocopheryloxyacetic-acid,Chemical structure:,"2,5,7,8-tetramethyl-(2R-(4R,8R,12-trimethyltridecyl) chroman-6-yloxy) acetic acid"
2020-09-18T01:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-type-1-polarized-dendritic-cells,Abbreviation:,alphaDC1
2020-09-18T01:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprazolam,US brand name:,Xanax
2020-09-18T01:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprazolam,Foreign brand name:,Apo-Alpzar
2020-09-18T01:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprazolam,Foreign brand name:,Nu-Alpraz
2020-09-18T01:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil,Synonym:,prostaglandin E1
2020-09-18T01:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil,US brand name:,Caverject
2020-09-18T01:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil,US brand name:,MUSE
2020-09-18T01:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil,Abbreviation:,PGE1
2020-09-18T01:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil,Chemical structure:,"(11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid"
2020-09-18T01:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramipril,US brand name:,Altace
2020-09-18T01:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altiratinib,Code name:,DCC-2701
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Synonym:,Hemel
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Synonym:,Hexaloids
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,US brand name:,Hexalen
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,US brand name:,hexamethylmelamine
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Foreign brand name:,Hexastat
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Foreign brand name:,Hexinawas
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Abbreviation:,HMM
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Abbreviation:,HXM
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Code name:,ENT-50852
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Code name:,RB-1515
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Code name:,WR-95704
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Chemical structure:,"2,4,6-tris(dimethylamino)-s-triazineN,N,N',N',N"",N""-hexamethyl-1,3,5-triazine-2,4,6-triamine"
2020-09-18T01:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aluminum-hydroxide,NA,NA
2020-09-18T01:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brigatinib,Synonym:,dual ALK/EGFR inhibitor AP26113
2020-09-18T01:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brigatinib,US brand name:,Alunbrig
2020-09-18T01:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brigatinib,Code name:,AP26113
2020-09-18T01:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac2-melanoma-multi-antigen-therapeutic-vaccine,NA,NA
2020-09-18T01:59:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac2-ny-eso-1-m-tricom-vaccine,Code name:,vCP2292
2020-09-18T01:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-cea-vaccine,Synonym:,ALVAC-CEA
2020-09-18T01:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-cea-vaccine,Abbreviation:,ALVAC-CEA
2020-09-18T01:59:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-eso-1-vaccine,NA,NA
2020-09-18T01:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-hb71,NA,NA
2020-09-18T01:59:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-mart-1-vaccine,NA,NA
2020-09-18T01:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat,Code name:,AZD 9668
2020-09-18T01:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat,Code name:,AZD9668
2020-09-18T01:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat,Code name:,AZD-9668
2020-09-18T01:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat,Code name:,MPH-966
2020-09-18T01:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat,Chemical structure:,"6-methyl-5-(1-methyl-1H-pyrazol-5-yl)-N-((5-(methylsulfonyl)pyridin-2-yl)methyl)-2-oxo-1-(3-(trifluoromethyl)phenyl)-1,2-dihydropyridine-3-carboxamide"
2020-09-18T01:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvespimycin-hydrochloride,Abbreviation:,17-DMAG HCL
2020-09-18T01:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvespimycin-hydrochloride,Code name:,BMS-826476
2020-09-18T01:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvespimycin-hydrochloride,Code name:,KOS-1022
2020-09-18T01:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvespimycin-hydrochloride,Chemical structure:,"geldanamycin,17-demethoxy-17-[[2-(dimethylamino)ethyl]amino]-,monohydrochloride"
2020-09-18T01:59:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvimopan,US brand name:,Entereg
2020-09-18T01:59:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvimopan,Code name:,ADL8-2698
2020-09-18T01:59:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvimopan,Code name:,LY-246376
2020-09-18T01:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib,Synonym:,flavopiridol
2020-09-18T01:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib,Abbreviation:,FLAVO
2020-09-18T01:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib,Code name:,HMR 1275
2020-09-18T01:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib,Code name:,L-868275
2020-09-18T01:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib,Chemical structure:,"(-)-2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3R,4S)-3-hydroxy-1-methyl-4-piperidinyl]-4H-1-benzopyran-4-one hydrochloride"
2020-09-18T01:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663,Synonym:,alvocidib phosphate
2020-09-18T01:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663,Synonym:,alvocidib phosphate TP-1287
2020-09-18T01:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663,Code name:,TP 1287
2020-09-18T01:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663,Code name:,TP1287
2020-09-18T01:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663,Code name:,TP-1287
2020-09-18T02:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amantadine-hydrochloride,Synonym:,Amantadine HCl
2020-09-18T02:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amantadine-hydrochloride,US brand name:,Symadine
2020-09-18T02:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amantadine-hydrochloride,US brand name:,Symmetrel
2020-09-18T02:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glimepiride,US brand name:,Amaryl
2020-09-18T02:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amatuximab,Synonym:,anti-mesothelin monoclonal antibody MORAb-009
2020-09-18T02:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amatuximab,Code name:,MORAb-009
2020-09-18T02:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolpidem-tartrate,US brand name:,Ambien
2020-09-18T02:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolpidem-tartrate,Abbreviation:,ZPD
2020-09-18T02:00:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792680,NA,NA
2020-09-18T02:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valspodar,US brand name:,Amdray
2020-09-18T02:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valspodar,Code name:,PSC 833
2020-09-18T02:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valspodar,Chemical structure:,"6-[(2S,4R,6E)-4-methyl-2-(methylamino)-3-oxo-6-octenoic acid]cyclosporin Dcyclo((2S,4R,6E)-4-methyl-2-(methylamino)-3-oxo-6-octenoyl)-L-valyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-me"
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,ALA HCl
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,aminolevulinic acid HCl
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,amino-levulinic acid hydrochloride
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,delta-aminolevulinic acid hydrochloride
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,US brand name:,Ameluz
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,US brand name:,Levulan Kerastick
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Foreign brand name:,Ameluz
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Abbreviation:,5-ALA HCl
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Abbreviation:,ALA HCl
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Chemical structure:,5-amino-4-oxopentanoic acid HCl5-Amino-4-oxopentanoic Acid Hydrochlorided-Amino-Levulinic Acid HCl
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Synonym:,depot-medroxyprogestereone acetate
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Synonym:,metipregnone
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,US brand name:,Amen
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,US brand name:,Depo-Provera
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,US brand name:,Provera
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Aragest
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Ciclotal
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Clinofem
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Clinovir
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Depo-Clinovir
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Farlutal
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Gestapuran
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,G-Farlutal
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Hysron
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Lutoral
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Perlutex
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Prodasone
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Sodelut G
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Veramix
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Abbreviation:,MPA
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Chemical structure:,"(6alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione17-(acetyloxy)-6alpha-methylpregn-4-ene-3,20-dione17alpha-acetoxy-6alpha-methylprogesterone17-hydroxy-6alpha-methylpregn-4-ene-3,20-dione acetate6-alpha-methyl-17alpha-acetoxyprogesterone"
2020-09-18T02:00:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/american-ginseng,Synonym:,Panax ginseng
2020-09-18T02:00:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/american-ginseng,Synonym:,Panax quinquifolius
2020-09-18T02:00:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alefacept,US brand name:,Amevive
2020-09-18T02:00:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alefacept,Code name:,LFA3TIP
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,US brand name:,Amfebutamone
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,US brand name:,Forfivo XL
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,US brand name:,Wellbutrin
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,US brand name:,Zyban
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,Code name:,BW 323U66
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,Chemical structure:,"(+-)-1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone hydrochloride"
2020-09-18T02:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,Synonym:,6-aminocaproic acid
2020-09-18T02:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,Synonym:,6-aminohexanoic acid
2020-09-18T02:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,Synonym:,epsilon S
2020-09-18T02:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,US brand name:,Amicar
2020-09-18T02:01:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifampridine,US brand name:,Firdapse
2020-09-18T02:01:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifampridine,Chemical structure:,"3,4-diaminopyridine"
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Synonym:,amifostine trihydrate
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Synonym:,aminopropylaminoethylthiophosphoric acid trihydrate
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,US brand name:,Ethyol
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Foreign brand name:,Cytofos
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Abbreviation:,APAETP
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Code name:,WR 2721
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Code name:,WR2721
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Code name:,WR-2721
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Code name:,YM-08310
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Chemical structure:,2-[(3-aminopropyl)amino]ethanethiol dihydrogen phosphate ester trihydrateS-(N-(3-aminopropyl)-2-aminoethyl)thiophosphoric acid trihydrateS-2-(3-aminopropylamino)ethylphosphorothioic acid trihydrate
2020-09-18T02:01:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amikacin-inhalation-solution,Code name:,BAY41 6551
2020-09-18T02:01:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amikacin-inhalation-solution,Code name:,BAY41-6551
2020-09-18T02:01:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-injection,Synonym:,multi-amino acid injection
2020-09-18T02:01:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-injection,US brand name:,Travasol
2020-09-18T02:01:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-electrolyte-mixture-based-dietary-supplement,Synonym:,amino acid/electrolyte-coupled transport supplement
2020-09-18T02:01:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-electrolyte-mixture-based-dietary-supplement,Synonym:,proprietary amino acid mixture
2020-09-18T02:01:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-electrolyte-mixture-based-dietary-supplement,US brand name:,Enterade
2020-09-18T02:01:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminobenzoate-potassium,Synonym:,Potaba
2020-09-18T02:01:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminobenzoate-potassium,Synonym:,potassium p-aminobenzoate
2020-09-18T02:01:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminobenzoate-potassium,Synonym:,potassium para-aminobenzoate
2020-09-18T02:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin,Synonym:,9-aminocamptothecin
2020-09-18T02:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin,Synonym:,9-amino-camptothecin
2020-09-18T02:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin,Synonym:,9-amino-CPT
2020-09-18T02:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin,Abbreviation:,9-AC
2020-09-18T02:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin,Chemical structure:,9-amino-20(S)-camptothecin9-amino-20-camptothecin
2020-09-18T02:01:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,Synonym:,6-aminocaproic acid
2020-09-18T02:01:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,Synonym:,6-aminohexanoic acid
2020-09-18T02:01:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,Synonym:,epsilon S
2020-09-18T02:01:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,US brand name:,Amicar
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Synonym:,5-aminolaevulinic acid
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Synonym:,5-aminolevulinic acid
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Synonym:,amino-levulinic acid
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Synonym:,delta aminolevulinic acid
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Synonym:,delta-aminolevulinic acid
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Abbreviation:,5-ALA
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Chemical structure:,5-amino-4-oxopentanoic acidd-amino-levulinic acid
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,ALA HCl
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,aminolevulinic acid HCl
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,amino-levulinic acid hydrochloride
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,delta-aminolevulinic acid hydrochloride
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,US brand name:,Ameluz
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,US brand name:,Levulan Kerastick
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Foreign brand name:,Ameluz
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Abbreviation:,5-ALA HCl
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Abbreviation:,ALA HCl
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Chemical structure:,5-amino-4-oxopentanoic acid HCl5-Amino-4-oxopentanoic Acid Hydrochlorided-Amino-Levulinic Acid HCl
2020-09-18T02:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline,Synonym:,ammophyllin
2020-09-18T02:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline,Synonym:,theophyline ethylenediamine
2020-09-18T02:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline,US brand name:,Phyllocontin
2020-09-18T02:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline,US brand name:,Truphylline
2020-09-18T02:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline,Chemical structure:,"1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, compound with 1,2-Ethanediamine(2:1)"
2020-09-18T02:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin,Synonym:,4-aminofolic acid
2020-09-18T02:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin,Synonym:,4-aminopteroylglutamic acid
2020-09-18T02:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin,Synonym:,aminopterin aodium
2020-09-18T02:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin,Synonym:,aminopteroylglutamic acid
2020-09-18T02:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin,Abbreviation:,APGA
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Synonym:,2-Aminothiadiazole
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Synonym:,Amino 134-Thiadiazole
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Abbreviation:,A-TD
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Abbreviation:,ATDA
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Code name:,FDA 0084
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Chemical structure:,"1,3, 4-Thiadiazol-2-amine (9CI)1,3, 4-Thiadiazole, 2-Amino- (8CI)1,3,4-Thiadiazole, 2-Amino2-Amino-1,3,4-thiadiazole2-Amino-1-thia-3,4-diazole"
2020-09-18T02:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amiodarone-hydrochloride,US brand name:,Cordarone
2020-09-18T02:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amiodarone-hydrochloride,US brand name:,Nexterone
2020-09-18T02:02:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lubiprostone,US brand name:,Amitiza
2020-09-18T02:02:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amitriptyline-hydrochloride,NA,NA
2020-09-18T02:02:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aml-mrna-plus-lysate-loaded-autologous-dendritic-cell-vaccine,Synonym:,acute myelogenous leukemia mRNA plus lysate loaded autologous dendritic cell vaccine
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Synonym:,8-methoxypsoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Synonym:,Methoxypsoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,US brand name:,Ammoidin
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,US brand name:,Oxsoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,US brand name:,Oxsoralen-Ultra
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,US brand name:,Uvadex
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,US brand name:,Xanthotoxin
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Deltasoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Dermox
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Geralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Geroxalen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Meladinina
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Meladinine
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Metoxaleno
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Mopsoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Puvasoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Ultramop
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Abbreviation:,8-MOP
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Chemical structure:,"9-Methoxy-7H-furo[3,2-g][1]benzopyran-7-one"
2020-09-18T02:02:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonia-n-13,Synonym:,ammonia-(sup 13)N
2020-09-18T02:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonium-trichlorotellurate,US brand name:,Ossirene
2020-09-18T02:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonium-trichlorotellurate,Code name:,AS-101
2020-09-18T02:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonium-trichlorotellurate,Code name:,IVX-Q-101
2020-09-18T02:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonium-trichlorotellurate,Chemical structure:,"tellurate(1-), trichloro[1,2-ethanediolato(2-)-.kappa.O,.kappa.O']-,ammonium, (SP-5-22)-"
2020-09-18T02:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dehydrated-human-amnion-chorion-membrane,US brand name:,AmnioFix
2020-09-18T02:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dehydrated-human-amnion-chorion-membrane,Abbreviation:,dHACM
2020-09-18T02:03:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amnion-derived-cellular-cytokine-solution,Abbreviation:,ACCS
2020-09-18T02:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zopiclone,Synonym:,(+-)-zopiclone
2020-09-18T02:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zopiclone,US brand name:,Amoban
2020-09-18T02:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zopiclone,Code name:,RP 27267
2020-09-18T02:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zopiclone,Chemical structure:,"1-piperazinecarboxylic acid, 4-methyl-, 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo(3,4-b)pyrazin-5-yl ester6-(5-chloropyrid-2-yl)-5-(4-methylpiperazin-1-yl)carbonyloxy-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazine"
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Synonym:,amonafide
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Synonym:,amonafide hydrochloride
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Synonym:,benzisoquinolinedione
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Synonym:,nafidimide
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,US brand name:,Quinamed
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Abbreviation:,AMON
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Abbreviation:,BIDA
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Code name:,M-FA-142
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Chemical structure:,"1H-benz(de)isoquinoline-1,3(2H)-dione, 5-amino-2-(2-(dimethylamino)ethyl)"
2020-09-18T02:03:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-l-malate,NA,NA
2020-09-18T02:03:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792531,Abbreviation:,ACC
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Amoxil
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Polymox
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Trimox
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Utimox
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Wymox
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,Abbreviation:,AMOX
2020-09-18T02:03:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin-clavulanate-potassium,US brand name:,Augmentin
2020-09-18T02:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Amoxil
2020-09-18T02:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Polymox
2020-09-18T02:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Trimox
2020-09-18T02:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Utimox
2020-09-18T02:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Wymox
2020-09-18T02:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,Abbreviation:,AMOX
2020-09-18T02:03:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amphotericin-b-deoxycholate,US brand name:,Fungizone
2020-09-18T02:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram,Synonym:,Teturamin
2020-09-18T02:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram,US brand name:,Antabuse
2020-09-18T02:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram,Abbreviation:,DS
2020-09-18T02:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram,Abbreviation:,TTD
2020-09-18T02:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram,Chemical structure:,bis(diethylthiocarbamoyl) disulfidetetraethylthioperoxydicarbonic diamidetetraethylthiuram disulfide
2020-09-18T02:03:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ampicillin-sodium-sulbactam-sodium,US brand name:,Unasyn
2020-09-18T02:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rintatolimod,Synonym:,atvogen
2020-09-18T02:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rintatolimod,US brand name:,Ampligen
2020-09-18T02:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rintatolimod,Abbreviation:,poly(I):poly(C12U) RNA
2020-09-18T02:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rintatolimod,Chemical structure:,"poly(inosinic acid) poly(cytidylic(12), uridylic)acid"
2020-09-18T02:04:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imexon,US brand name:,Amplimexon
2020-09-18T02:04:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imexon,Chemical structure:,"4-imino-1,3-diazabicyclo[3,1,0]-hexan-2-one"
2020-09-18T02:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amrubicin-hydrochloride,Synonym:,Amirubicin Hydrochloride
2020-09-18T02:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amrubicin-hydrochloride,Foreign brand name:,Calsed
2020-09-18T02:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amrubicin-hydrochloride,Abbreviation:,AMR
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Synonym:,acridinyl anisidide
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Synonym:,Cain's Acridine
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,US brand name:,Amsa P-D
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Amekrin
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Amsidine
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Amsidyl
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Lamasine
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Abbreviation:,AMSA
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Abbreviation:,m-AMSA
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Code name:,CI-880
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Code name:,SN-11841
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Chemical structure:,4'-(9-acridinylamino)methane-sulfon-m-anisidideN-[4-(9-acridinylamino)-3-methoxyphenyl]methanesulfonamide
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Synonym:,acridinyl anisidide
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Synonym:,Cain's Acridine
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,US brand name:,Amsa P-D
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Amekrin
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Amsidine
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Amsidyl
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Lamasine
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Abbreviation:,AMSA
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Abbreviation:,m-AMSA
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Code name:,CI-880
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Code name:,SN-11841
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Chemical structure:,4'-(9-acridinylamino)methane-sulfon-m-anisidideN-[4-(9-acridinylamino)-3-methoxyphenyl]methanesulfonamide
2020-09-18T02:04:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsilarotene,Code name:,TAC 101
2020-09-18T02:04:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsilarotene,Code name:,TAC-101
2020-09-18T02:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amuvatinib,Synonym:,multitargeted receptor tyrosine kinase inhibitor MP470
2020-09-18T02:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amuvatinib,Code name:,HPK56
2020-09-18T02:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amuvatinib,Code name:,MP470
2020-09-18T02:04:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-hydrochloride,US brand name:,Agrylin
2020-09-18T02:04:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-hydrochloride,Foreign brand name:,Thromboreductin
2020-09-18T02:04:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-prolonged-release-formulation,Synonym:,anagrelide retard
2020-09-18T02:04:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anakinra,Synonym:,IL-1ra
2020-09-18T02:04:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anakinra,Synonym:,interleukin-1 receptor antagonist
2020-09-18T02:04:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anakinra,US brand name:,Kineret
2020-09-18T02:04:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anamorelin-hydrochloride,Code name:,RC-1291
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,US brand name:,Arimidex
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,Abbreviation:,ANAS
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,Code name:,ICI D1033
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,Code name:,ICI-D1033
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,Code name:,ZD-1033
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,Chemical structure:,"2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropionitrile)alpha,alpha,alpha', alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile"
2020-09-18T02:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anaxirone,Synonym:,triglycidylurazol
2020-09-18T02:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anaxirone,Abbreviation:,TGU
2020-09-18T02:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anaxirone,Chemical structure:,"1,2,4-triglycidylurazol"
2020-09-18T02:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefazolin-sodium,US brand name:,Ancef
2020-09-18T02:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefazolin-sodium,US brand name:,Kefzol
2020-09-18T02:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefazolin-sodium,Code name:,SKF 41558
2020-09-18T02:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefazolin-sodium,Chemical structure:,"(6R-trans)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, sodium salt"
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Synonym:,Cyclo-C
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Synonym:,cycloCMP hydrochloride
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Synonym:,cyclocytidine HCL
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Synonym:,cyclocytidine hydrochloride
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Foreign brand name:,Ancid
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Code name:,"U-33, 624A"
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Chemical structure:,"6H-furo(2',3':4,5)oxazolo(3,2-a)pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-,(2R(2alpha,3beta,3a beta,9a beta))"
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Synonym:,5-fluorocytosine
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,US brand name:,Ancobon
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Foreign brand name:,Alcobon
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Foreign brand name:,Ancotil
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Abbreviation:,5-FC
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Code name:,Ro 2-9915
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Code name:,Ro-2-9915
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Chemical structure:,4-amino-5-fluoro-2(1H)-pyrimidinone
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,US brand name:,Andro LA
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,US brand name:,Delatestryl
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,US brand name:,Everone
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,US brand name:,Primosteston
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,US brand name:,Testate
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,Foreign brand name:,Androtardyl
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,Foreign brand name:,Testinon
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,Foreign brand name:,Testo-Enant
2020-09-18T02:05:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-gel,US brand name:,AndroGel
2020-09-18T02:05:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-antagonist-apc-100,Code name:,APC-100
2020-09-18T02:05:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-antagonist-apc-100,Chemical structure:,"pentamethylchromanol, 2,2,5,7,8-pentamethyl-6"
2020-09-18T02:05:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792679,Synonym:,AR antagonist BAY 1161116
2020-09-18T02:05:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792679,Code name:,BAY 1161116
2020-09-18T02:05:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792679,Code name:,BAY1161116
2020-09-18T02:05:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792679,Code name:,BAY-1161116
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Synonym:,AR antagonist ONC1-0013B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC 10013B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC 113 B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC1-0013B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC-10013B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC113B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC1-13B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Chemical structure:,"(R)-4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-4-oxo-2-thioxo-7-oxa-1,3-diazaspiro[4.4]nonan-1-yl)-2-fluoro-N-methylbenzamide"
2020-09-18T02:05:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-shr3680,Code name:,SHR 3680
2020-09-18T02:05:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-shr3680,Code name:,SHR3680
2020-09-18T02:06:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-tas3681,Synonym:,androgen receptor inhibitor TAS3681
2020-09-18T02:06:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-tas3681,Synonym:,AR antagonist TAS3681
2020-09-18T02:06:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-tas3681,Code name:,TAS 3681
2020-09-18T02:06:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-tas3681,Code name:,TAS3681
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Synonym:,AR antagonist TRC253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,JNJ 63576253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,JNJ -63576253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,JNJ63576253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,TRC 253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,TRC253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,TRC-253
2020-09-18T02:06:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-azd5312,Synonym:,ISIS-ARRx
2020-09-18T02:06:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-azd5312,Synonym:,ISIS-AZ1Rx
2020-09-18T02:06:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-azd5312,Code name:,AZD5312
2020-09-18T02:06:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-ezn-4176,Synonym:,androgen receptor mRNA antagonist LNA antisense oligonucleotide EZN-4176
2020-09-18T02:06:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-ezn-4176,Synonym:,androgen receptor mRNA antagonist locked nucleic acid antisense oligonucleotide EZN-4176
2020-09-18T02:06:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-ezn-4176,Code name:,EZN-4176
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Synonym:,androgen receptor PROTAC degrader ARV-110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Synonym:,AR PROTAC ARV-110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Synonym:,AR-targeted PROTAC protein degrader ARV-110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Synonym:,PROTAC protein degrader ARV-110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Code name:,ARV 110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Code name:,ARV110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Code name:,ARV-110
2020-09-18T02:06:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801809,Synonym:,AR degrader CC-94676
2020-09-18T02:06:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801809,Code name:,CC 94676
2020-09-18T02:06:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801809,Code name:,CC94676
2020-09-18T02:06:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801809,Code name:,CC-94676
2020-09-18T02:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-inhibitor-epi-506,Synonym:,AR inhibitor EPI-506
2020-09-18T02:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-inhibitor-epi-506,Code name:,EPI-506
2020-09-18T02:06:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801842,Synonym:,AR inhibitor EPI-7386
2020-09-18T02:06:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801842,Code name:,EPI 7386
2020-09-18T02:06:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801842,Code name:,EPI7386
2020-09-18T02:06:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801842,Code name:,EPI-7386
2020-09-18T02:06:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/771098,Synonym:,AR LBD-encoding plasmid DNA vaccine MVI-118
2020-09-18T02:06:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/771098,Synonym:,pTVG-AR
2020-09-18T02:06:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/771098,Synonym:,pTVG-AR vaccine
2020-09-18T02:06:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/771098,Code name:,MVI-118
2020-09-18T02:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352,Synonym:,AR/GR antagonist CB-03-10
2020-09-18T02:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352,Code name:,CB 03 10
2020-09-18T02:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352,Code name:,CB0310
2020-09-18T02:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352,Code name:,CB-03-10
2020-09-18T02:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352,Chemical structure:,cortexolone 17alpha-valerate-21-propionate
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Synonym:,Androfluorene
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Synonym:,Androsterolo
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,US brand name:,Android-F
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,US brand name:,Halodrin
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,US brand name:,Halotestin
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,US brand name:,Ora-Testryl
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,US brand name:,Ultandren
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Foreign brand name:,Oratestin
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Foreign brand name:,Stenox
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Foreign brand name:,Testoral
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Abbreviation:,FXM
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Chemical structure:,"(11Beta,17beta)-9-fluoro-11,17-dihydroxy-17-methylandrost-4-en-3-one11Beta,17beta-dihydroxy-9alpha-fluoro-17alpha-methyl-4-androsten-3-one9Alpha-fluoro-11beta-hydroxy-17alpha-methyltestosterone"
2020-09-18T02:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androstane-steroid-he3235,US brand name:,APOTONE
2020-09-18T02:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androstane-steroid-he3235,Chemical structure:,"17alpha-ethynyl-5alpha-androstane-3alpha, 17beta-diol"
2020-09-18T02:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795677,Synonym:,Suxamethonium Chloride
2020-09-18T02:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795677,US brand name:,Anectine
2020-09-18T02:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795677,US brand name:,Quelicin
2020-09-18T02:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795677,Chemical structure:,"Ethanaminium, 2,2'-((1,4-Dioxo-1,4-butanediyl)bis(oxy))bis(N,N,N-trimethyl-)"
2020-09-18T02:07:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anetumab-ravtansine,Synonym:,anti-mesothelin antibody-drug conjugate BAY 94-9343
2020-09-18T02:07:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anetumab-ravtansine,Code name:,BAY 94-9343
2020-09-18T02:07:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multifunctional-multitargeted-anticancer-agent-omn54,Synonym:,MFMT OMN54
2020-09-18T02:07:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multifunctional-multitargeted-anticancer-agent-omn54,US brand name:,Aneustat
2020-09-18T02:07:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multifunctional-multitargeted-anticancer-agent-omn54,Code name:,OMN54
2020-09-18T02:07:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim-anti-neutropenic-factor,Synonym:,PEG G-CSF ANF
2020-09-18T02:07:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim-anti-neutropenic-factor,Synonym:,pegfilgrastim ANF
2020-09-18T02:07:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim-anti-neutropenic-factor,US brand name:,ANF-Rho
2020-09-18T02:07:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ang2-vegf-binding-peptides-antibody-fusion-protein-cvx-241,Code name:,CVX-241
2020-09-18T02:07:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ang2-vegf-binding-peptides-antibody-fusion-protein-cvx-241,Code name:,PF-05057459
2020-09-18T02:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angelica-sinensis-root-extract,Synonym:,dong quai
2020-09-18T02:07:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-anticalin-prs-050-peg40,Synonym:,pegylated anti-VEGF anticalin PRS-050-PEG40
2020-09-18T02:07:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-anticalin-prs-050-peg40,US brand name:,Angiocal
2020-09-18T02:07:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-anticalin-prs-050-peg40,Code name:,PRS-050-PEG40
2020-09-18T02:07:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegdinetanib,Synonym:,VEGFR-2 inhibitor peptide CT-322
2020-09-18T02:07:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegdinetanib,US brand name:,Angiocept
2020-09-18T02:07:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegdinetanib,Code name:,CT-322
2020-09-18T02:07:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiogenesis-inhibitor-ji-101,Code name:,JI-101
2020-09-18T02:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiogenesis-heparanase-inhibitor-pg545,Code name:,PG545
2020-09-18T02:07:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiostatin,Synonym:,Kringles 1-4 of Plasminogen
2020-09-18T02:07:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiostatin,Synonym:,PLG
2020-09-18T02:08:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme,US brand name:,Angiozyme
2020-09-18T02:08:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme,Foreign brand name:,Angiozyme
2020-09-18T02:08:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme,Code name:,RPI.4610
2020-09-18T02:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anguidine,Synonym:,Anguidin
2020-09-18T02:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anguidine,Synonym:,diacetoxyscirpenol
2020-09-18T02:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anguidine,Abbreviation:,DAS
2020-09-18T02:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anguidine,Code name:,MM 4462
2020-09-18T02:08:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800694,Abbreviation:,AEO
2020-09-18T02:08:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin,Synonym:,V-echinocandin
2020-09-18T02:08:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin,Synonym:,VER-002
2020-09-18T02:08:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin,US brand name:,Eraxis
2020-09-18T02:08:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin,Foreign brand name:,Eraxis
2020-09-18T02:08:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin,Code name:,LY303366
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Synonym:,lymphochin
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Synonym:,lymphocin
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Synonym:,lymphoquin
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Synonym:,mesylerythrol
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Code name:,A 14489
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Code name:,CB 1074
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Code name:,SK 592
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Code name:,TL 476
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Chemical structure:,"benzenamine, N, N-bis(2-chloroethyl)-(9CI)beta, beta'-dichlorodiethylanilineN,N-bis(2-chloroethyl)anilineN,N-bis(2-chloroethyl)benzenaminephenylbis[2-chloroethylamine]"
2020-09-18T02:08:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anlotinib-hydrochloride,Synonym:,"1-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-quinolyl)oxymethyl)cyclopropanamine, dihydrochloride"
2020-09-18T02:08:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anlotinib-hydrochloride,Abbreviation:,ALTN HCl
2020-09-18T02:08:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anlotinib-hydrochloride,Chemical structure:,"cyclopropanamine, 1-(((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-quinolinyl)oxy)methyl)-, hydrochloride (1:2)"
2020-09-18T02:08:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/annonaceous-acetogenins,Synonym:,acetogenins
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,US brand name:,Ansaid
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,Code name:,"BTS 18,322"
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,Code name:,E-7869
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,Code name:,MPC-7869
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,Code name:,"U-27,182"
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,Chemical structure:,"2-fluoro-alpha-methyl[1,1'-biphenyl]-4-acetic Acid"
2020-09-18T02:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anthocyanin-rich-corn-extract,NA,NA
2020-09-18T02:08:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anthracycline-analogue-gpx-150,Code name:,GPX-150
2020-09-18T02:08:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anthracycline-analogue-gpx-150,Chemical structure:,5-imino-13-deoxydoxoubicin
2020-09-18T02:08:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-kit-antibody-drug-conjugate-lop628,Abbreviation:,anti c-KIT ADC LOP628
2020-09-18T02:08:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-kit-antibody-drug-conjugate-lop628,Code name:,LOP628
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Synonym:,5T4-ADC ASN004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Synonym:,5T4-targeted antibody-drug conjugate ASN004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Synonym:,5T4-targeted dolaflexin ADC ASN004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Synonym:,anti-5T4 ADC ASN004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Code name:,ASN 004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Code name:,ASN004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Code name:,ASN-004
2020-09-18T02:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-5t4-antibody-drug-conjugate-pf-06263507,Code name:,PF-06263507
2020-09-18T02:09:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-a33-monoclonal-antibody-krn330,Code name:,KRN330
2020-09-18T02:09:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-a5b1-integrin-monoclonal-antibody-pf-04605412,Synonym:,anti-alpha5beta1 integrin monoclonal antibody PF-04605412
2020-09-18T02:09:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-a5b1-integrin-monoclonal-antibody-pf-04605412,Code name:,PF-04605412
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Synonym:,anti-ACTR viral vector-transduced autologous T lymphocytes ACTR087
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Synonym:,CD16-41BB-CD3zeta ACTR autologous T cells
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Synonym:,viral ATCR autologous T cells
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Synonym:,virally-delivered antibody-coupled TCR ACTR087
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Code name:,ACTR087
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Code name:,ACTR-087
2020-09-18T02:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-16-monoclonal-antibody-ags-16m18,Code name:,AGS-16M18
2020-09-18T02:09:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-5-antibody-drug-conjugate-asg-5me,Abbreviation:,anti-AGS-5 Ab-drug conjugate ASG-5ME
2020-09-18T02:09:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-5-antibody-drug-conjugate-asg-5me,Code name:,ASG-5ME
2020-09-18T02:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-8-monoclonal-antibody-ags-8m4,Code name:,AGS-8M4
2020-09-18T02:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-alk-1-monoclonal-antibody-pf-03446962,Synonym:,anti-activin receptor-like kinase 1 monoclonal antibody PF-03446962
2020-09-18T02:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-alk-1-monoclonal-antibody-pf-03446962,Code name:,PF-03446962
2020-09-18T02:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707,Synonym:,anti-BCMA x aCD3 T-BsAb TNB-383B
2020-09-18T02:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707,Synonym:,anti-BCMA x aCD3 T-cell engaging bispecific antibody TNB-383B
2020-09-18T02:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707,Code name:,TNB 383B
2020-09-18T02:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707,Code name:,TNB383B
2020-09-18T02:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707,Code name:,TNB-383B
2020-09-18T02:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102,Synonym:,anti-AMHR2 monoclonal antibody GM10II
2020-09-18T02:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102,Synonym:,GM102 antibody
2020-09-18T02:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102,Code name:,3C23K
2020-09-18T02:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102,Code name:,GM102
2020-09-18T02:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102,Code name:,GM10II
2020-09-18T02:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amyloid-monoclonal-antibody-neod001,Code name:,NEOD001
2020-09-18T02:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-androgen-sirna-sxl01,Code name:,SXL 01
2020-09-18T02:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-androgen-sirna-sxl01,Code name:,SXL01
2020-09-18T02:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-androgen-sirna-sxl01,Code name:,SXL-01
2020-09-18T02:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ang2-monoclonal-antibody-medi-3617,Abbreviation:,anti-ANG2 MAb MEDI-3617
2020-09-18T02:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ang2-monoclonal-antibody-medi-3617,Abbreviation:,anti-ANG2 MoAb MEDI-3617
2020-09-18T02:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ang2-monoclonal-antibody-medi-3617,Code name:,MEDI-3617
2020-09-18T02:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antiangiogenic-drug-combination-tl-118,Foreign brand name:,Hamsa-1
2020-09-18T02:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antiangiogenic-drug-combination-tl-118,Code name:,TL-118
2020-09-18T02:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-april-monoclonal-antibody-bion-1301,Synonym:,anti-A proliferation-inducing ligand monoclonal antibody BION-1301
2020-09-18T02:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-april-monoclonal-antibody-bion-1301,Synonym:,anti-TNFSF13 monoclonal antibody BION-1301
2020-09-18T02:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-april-monoclonal-antibody-bion-1301,Code name:,BION-1301
2020-09-18T02:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795349,Synonym:,AXL Fc fusion protein AVB-S6-500
2020-09-18T02:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795349,Code name:,AVB S6 500
2020-09-18T02:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795349,Code name:,AVBS6500
2020-09-18T02:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795349,Code name:,AVB-S6-500
2020-09-18T02:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-monoclonal-antibody-mmae-conjugate,Synonym:,anti-AXL/MMAE ADC
2020-09-18T02:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-monoclonal-antibody-mmae-conjugate,Synonym:,anti-AXL/MMAE antibody-drug conjugate
2020-09-18T02:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-monoclonal-antibody-mmae-conjugate,Abbreviation:,HuMax-AXL-ADC
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Synonym:,ADC ADCT-601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Synonym:,anti-AXL/PBD ADC ADCT-601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,ADCT 601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,ADCT601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,ADCT-601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,BGB 601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,BGB601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,BGB-601
2020-09-18T02:10:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b4-blocked-ricin-immunotoxin,Synonym:,anti-B4 blocked ricin
2020-09-18T02:10:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b4-blocked-ricin-immunotoxin,Synonym:,monoclonal antibody anti-B4 blocked ricin
2020-09-18T02:10:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b4-blocked-ricin-immunotoxin,Abbreviation:,anti-B4-BR
2020-09-18T02:10:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b4-blocked-ricin-immunotoxin,Abbreviation:,MOAB anti-B4-bR
2020-09-18T02:10:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b7-h3-antibody-ds-5573a,Code name:,DS-5573a
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Synonym:,anti-B7-H3/DXd ADC DS-7300a
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Synonym:,anti-B7H3/DXd antibody-drug conjugate DS-7300a
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Code name:,DS 7300
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Code name:,DS 7300a
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Code name:,DS7300
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Code name:,DS7300a
2020-09-18T02:10:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795341,Code name:,FPA 150
2020-09-18T02:10:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795341,Code name:,FPA150
2020-09-18T02:11:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795105,Code name:,FPA 150
2020-09-18T02:11:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795105,Code name:,FPA150
2020-09-18T02:11:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795105,Code name:,FPA-150
2020-09-18T02:11:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793894,Synonym:,Anti-BCMA Afucosylated Monoclonal Antibody SEA-BCMA
2020-09-18T02:11:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793894,Code name:,SEA-BCMA
2020-09-18T02:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800471,Synonym:,anti-TAG ARC-T cells directed by BCMA bi-valent/TAG SparX protein
2020-09-18T02:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800471,Synonym:,ARC-T plus anti-BCMA SparX
2020-09-18T02:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800471,Synonym:,immunotherapeutic combination agent SparX protein plus CART-ddBCMA
2020-09-18T02:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800471,Synonym:,TAG-containing SparX /bivalent BCMA-targeted ARC-T cells
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Synonym:,anti-BCMA x anti-CD3 bispecific antibody REGN5459
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Synonym:,anti-BCMA/CD3 bispecific antibody REGN5459
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Synonym:,anti-CD3/anti-BCMA bispecific antibody REGN5459
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Code name:,REGN 5459
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Code name:,REGN5459
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Code name:,REGN-5459
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Synonym:,anti-BCMA x anti-CD3 BiTE AMG 420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Synonym:,BCMA/CD3-directed bispecific T-cell engager antibody AMG 420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Synonym:,bispecific T-cell engager antibody AMG 420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Synonym:,BiTE antibody AMG 420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Code name:,AMG 420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Code name:,AMG-420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Code name:,BI 836909
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Code name:,BI836909
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Synonym:,anti-BCMA x anti-CD3 BiTE AMG 701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Synonym:,BCMA/CD3-directed bispecific T-cell engager antibody AMG 701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Synonym:,bispecific T-cell engager antibody AMG 701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Synonym:,BiTE antibody AMG 701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Code name:,AMG 701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Code name:,AMG701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Code name:,AMG-701
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Synonym:,anti-BCMA x anti-CD3 BiTE REGN5458
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Synonym:,bispecific BCMA x CD3 T-cell engaging antibody REGN5458
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Synonym:,BiTE antibody REGN5458
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Code name:,REGN 5458
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Code name:,REGN5458
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Code name:,REGN-5458
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Synonym:,ADC MEDI2228
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Synonym:,anti-BCMA ADC MEDI2228
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Synonym:,Anti-BCMA/PBD MEDI2228
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Synonym:,Antibody-drug Conjugate MEDI2228
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Code name:,MEDI 2228
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Code name:,MEDI-2228
2020-09-18T02:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibiotic-sq109,Code name:,SQ109
2020-09-18T02:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibiotic-sq109,Chemical structure:,"N-geranyl-N?-(2-adamantyl) ethane-1,2-diamine"
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,ABBV 011
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,ABBV011
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,ABBV-011
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,SC 011
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,SC011
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,SC-011
2020-09-18T02:11:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-085,Synonym:,ADC ABBV-085
2020-09-18T02:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793089,Code name:,YS110
2020-09-18T02:11:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-085,Code name:,ABBV-085
2020-09-18T02:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796806,Synonym:,ADC ABBV-155
2020-09-18T02:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796806,Code name:,ABBV 155
2020-09-18T02:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796806,Code name:,ABBV155
2020-09-18T02:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796806,Code name:,ABBV-155
2020-09-18T02:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-176,Synonym:,ADC ABBV-176
2020-09-18T02:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-176,Code name:,ABBV 176
2020-09-18T02:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-176,Code name:,ABBV176
2020-09-18T02:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-176,Code name:,ABBV-176
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Synonym:,ADC XMT-1536
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Synonym:,anti-NaPi2b ADC XMT-1536
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Synonym:,anti-NaPi2b/auristatin F-HPA ADC XMT-1536
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Code name:,XMT 1536
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Code name:,XMT1536
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Code name:,XMT-1536
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Synonym:,ADC anti-TIM-1-vcMMAE CDX-014
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Synonym:,ADC CDX-014
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Synonym:,antibody-drug conjugate CDX-014
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Synonym:,CR014-vcMMAE
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Synonym:,CR014-vc-MMAE
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Code name:,CDX-014
2020-09-18T02:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-bay79-4620,Synonym:,ADC BAY79-4620
2020-09-18T02:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-bay79-4620,Synonym:,MN-IC
2020-09-18T02:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-bay79-4620,Code name:,BAY79-4620
2020-09-18T02:12:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-dfrf4539a,Synonym:,ADC DFRF4539A
2020-09-18T02:12:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-dfrf4539a,Code name:,DFRF4539A
2020-09-18T02:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-medi7247,Synonym:,ADC MEDI7247
2020-09-18T02:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-medi7247,Code name:,MEDI 7247
2020-09-18T02:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-medi7247,Code name:,MEDI7247
2020-09-18T02:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-002,Synonym:,ADC SC-002
2020-09-18T02:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-002,Code name:,SC-002
2020-09-18T02:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-003,Synonym:,ADC SC-003
2020-09-18T02:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-003,Code name:,SC 003
2020-09-18T02:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-003,Code name:,SC003
2020-09-18T02:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-003,Code name:,SC-003
2020-09-18T02:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-004,Synonym:,ADC SC-004
2020-09-18T02:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-004,Code name:,SC 004
2020-09-18T02:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-004,Code name:,SC004
2020-09-18T02:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-004,Code name:,SC-004
2020-09-18T02:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794353,Code name:,ADC SC-005
2020-09-18T02:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794353,Code name:,SC 005
2020-09-18T02:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794353,Code name:,SC005
2020-09-18T02:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794353,Code name:,SC-005
2020-09-18T02:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-006,Synonym:,ADC SC-006
2020-09-18T02:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-006,Code name:,SC 006
2020-09-18T02:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-006,Code name:,SC006
2020-09-18T02:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-006,Code name:,SC-006
2020-09-18T02:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792378,Code name:,ADC SC-007
2020-09-18T02:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792378,Code name:,SC-007
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Synonym:,CD95-Fc fusion protein CAN008
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Synonym:,Fas-Fc fusion protein CAN008
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Code name:,APG101
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Code name:,APG-101
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Code name:,CAN008
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Code name:,CAN-008
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Synonym:,anti-B- and T-lymphocyte attenuator monoclonal antibody TAB004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,JS 004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,JS004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,JS-004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,TAB 004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,TAB004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,TAB-004
2020-09-18T02:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c44a-antibody-drug-conjugate-bay1129980,Abbreviation:,anti-C4.4a ADC BAY1129980
2020-09-18T02:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c44a-antibody-drug-conjugate-bay1129980,Code name:,BAY1129980
2020-09-18T02:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c44a-antibody-drug-conjugate-bay1129980,Code name:,BAY112-9980
2020-09-18T02:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798695,Synonym:,anti-C5aR-215
2020-09-18T02:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798695,Code name:,IPH 5401
2020-09-18T02:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798695,Code name:,IPH5401
2020-09-18T02:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798695,Code name:,NN 8210
2020-09-18T02:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca19-9-monoclonal-antibody-5b1,Synonym:,HuMab 5B1
2020-09-18T02:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca19-9-monoclonal-antibody-5b1,Synonym:,HuMab-5B1
2020-09-18T02:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca19-9-monoclonal-antibody-5b1,Code name:,5B1
2020-09-18T02:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca19-9-monoclonal-antibody-5b1,Code name:,MVT-5873
2020-09-18T02:13:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca6-dm4-immunoconjugate-sar566658,Abbreviation:,huDs6-DM4
2020-09-18T02:13:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca6-dm4-immunoconjugate-sar566658,Code name:,SAR566658
2020-09-18T02:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anticachexia-agent-mt-102,Synonym:,anti-catabolic/anabolic transforming agent MT-102
2020-09-18T02:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anticachexia-agent-mt-102,Code name:,MT-102
2020-09-18T02:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150,Synonym:,antibody-drug conjugate IMGN632
2020-09-18T02:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150,Synonym:,CD123-targeted ADC IMGN632
2020-09-18T02:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150,Code name:,IMGN 632
2020-09-18T02:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150,Code name:,IMGN632
2020-09-18T02:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150,Code name:,IMGN-632
2020-09-18T02:13:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-monoclonal-antibody-khk2823,Code name:,KHK2823
2020-09-18T02:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-x-anti-cd3-bispecific-antibody-xmab14045,Synonym:,anti-CD123/anti-CD3 bispecific antibody XmAb1404
2020-09-18T02:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-x-anti-cd3-bispecific-antibody-xmab14045,Code name:,XmAb14045
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Synonym:,anti-CD123 x anti-CD3 bispecific antibody APVO436
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Synonym:,bispecific anti-CD123 x anti-CD3 antibody APVO436
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Synonym:,CD123 x CD3 targeting bispecific antibody APVO436
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Code name:,APVO 436
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Code name:,APVO436
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Code name:,APVO-436
2020-09-18T02:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bispecific-antibody-jnj-63709178,Synonym:,humanized CD123 x CD3 duobody JNJ-63709178
2020-09-18T02:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bispecific-antibody-jnj-63709178,Code name:,JNJ-63709178
2020-09-18T02:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798327,Synonym:,bispecific T-cell engager antibody SAR440234
2020-09-18T02:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798327,Synonym:,CD123xCD3 bispecific T-cell engager SAR440234
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Synonym:,ADC SGN-CD123A
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Synonym:,antibody-drug conjugate SGN-CD123A
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Synonym:,anti-CD123 ADC SGN-CD123A
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Synonym:,anti-CD123-PBD ADC SGN-CD123A
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Code name:,SGN CD123A
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Code name:,SGN-CD123A
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,BNT312
2020-09-18T02:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-car-vector-transduced-allogeneic-t-lymphocytes,Synonym:,allogeneic anti-CD133 CAR T cells
2020-09-18T02:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-car-vector-transduced-allogeneic-t-lymphocytes,Synonym:,allogeneic CART133
2020-09-18T02:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein,Synonym:,anti-CD133-deimmunized pseudomonas exotoxin A-KDEL fusion protein
2020-09-18T02:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein,Synonym:,deimmunized CD133KDEL
2020-09-18T02:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein,Synonym:,deimmunized CD133KDEL toxin
2020-09-18T02:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein,Code name:,CD133KDEL
2020-09-18T02:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein,Code name:,dCD133KDEL
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Synonym:,4-1BB-directed agonistic monoclonal antibody ADG106
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Synonym:,anti-4-1BB agonistic monoclonal antibody ADG106
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Synonym:,CD137-directed agonistic monoclonal antibody ADG106
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Code name:,ADG 106
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Code name:,ADG106
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Code name:,ADG-106
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Synonym:,anti-4-1BB agonistic monoclonal antibody AGEN2373
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Synonym:,anti-CD137 agonist monoclonal antibody AGEN2373
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Synonym:,anti-CD137 monoclonal antibody AGEN2373
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Code name:,AGEN 2373
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Code name:,AGEN2373
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Code name:,AGEN-2373
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Synonym:,anti-4-1BB monoclonal antibody ATOR-1017
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Synonym:,anti-CD137 agonist monoclonal antibody ATOR-1017
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Synonym:,anti-CD137 monoclonal antibody ATOR-1017
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Code name:,ATOR 1017
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Code name:,ATOR1017
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Code name:,ATOR-1017
2020-09-18T02:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798594,Synonym:,anti-4-1BB agonistic monoclonal antibody CTX-471
2020-09-18T02:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798594,Code name:,CTX 471
2020-09-18T02:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798594,Code name:,CTX471
2020-09-18T02:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798594,Code name:,CTX-471
2020-09-18T02:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858,Synonym:,anti-4-1BB agonistic monoclonal antibody LVGN6051
2020-09-18T02:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858,Synonym:,anti-CD137 agonist monoclonal antibody LVGN6051
2020-09-18T02:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858,Synonym:,anti-CD137 monoclona antibody LVGN6051
2020-09-18T02:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858,Code name:,LVGN 6051
2020-09-18T02:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858,Code name:,LVGN-6051
2020-09-18T02:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd157-monoclonal-antibody-men1112,Code name:,MEN1112
2020-09-18T02:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd157-monoclonal-antibody-men1112,Code name:,OBT357NF
2020-09-18T02:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd166-probody-drug-conjugate-cx-2009,Synonym:,ADC CX-2009
2020-09-18T02:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd166-probody-drug-conjugate-cx-2009,Synonym:,anti-CD166-DM4 CX-2009
2020-09-18T02:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd166-probody-drug-conjugate-cx-2009,Synonym:,PDC CX-2009
2020-09-18T02:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd166-probody-drug-conjugate-cx-2009,Code name:,CX-2009
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Synonym:,anti-CD19 AbTCR-expressing T cells ET019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Synonym:,anti-CD19 T cells ET019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Synonym:,anti-CD19-TCR T cells ET019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Synonym:,CD19-targeted T cells ET019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Synonym:,ET019003-T cells
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Code name:,ET 019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Code name:,ET019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Code name:,ET-019003
2020-09-18T02:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799644,Synonym:,CD19-specific CAR-T cells XLCART001
2020-09-18T02:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799644,Code name:,XLCART001
2020-09-18T02:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-fully-human-monoclonal-antibody-mdx-1342,Code name:,MDX-1342
2020-09-18T02:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-di-b4,Synonym:,anti-CD19 MoAb DI-B4
2020-09-18T02:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-di-b4,Abbreviation:,anti-CD19 MAb DI-B4
2020-09-18T02:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-di-b4,Code name:,DI-B4
2020-09-18T02:15:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-medi-551,Code name:,MEDI-551
2020-09-18T02:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793132,Synonym:,anti-CD19/CD20/CD22/CD30 chimeric antigen receptor-T cells
2020-09-18T02:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793132,Synonym:,CAR-T CD19/CD20/CD22/CD30
2020-09-18T02:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd22-bispecific-ligand-directed-toxin-dt2219arl,Synonym:,anti-CD19/CD22 BLT DT2219ARL
2020-09-18T02:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd22-bispecific-ligand-directed-toxin-dt2219arl,Code name:,DT2219ARL
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Synonym:,bispecific T-cell engager antibody AMG 562
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Synonym:,BiTE antibody AMG 562
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Synonym:,CD19/CD3-directed bispecific T-cell engager antibody AMG 562
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Code name:,AMG 562
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Code name:,AMG562
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Code name:,AMG-562
2020-09-18T02:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd3-tetravalent-antibody-afm11,Code name:,AFM11
2020-09-18T02:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751864,Synonym:,FMC63-28Z CAR-transduced allogeneic T lymphocytes
2020-09-18T02:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751864,Synonym:,MSGV1-FMC63-28Z anti-CD19 CAR-transduced allogeneic T lymphocytes
2020-09-18T02:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-retroviral-vector-transduced-autologous-t-cells,NA,NA
2020-09-18T02:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800198,Synonym:,anti-CD19/CD20 CAR autologous T lymphocytes Hu1928-Hu20BB
2020-09-18T02:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800198,Synonym:,autologous CAR-19/CAR-20-T cells Hu1928-Hu20BB
2020-09-18T02:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800198,Synonym:,Hu1928-Hu20BB
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Synonym:,anti-CD19 redirected NK cells
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing allogenic NK cells
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing donor natural killer cells
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing donor NK cells
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing NK cells
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Code name:,NKCARCD19
2020-09-18T02:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd20-car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,Synonym:,anti-CD19/CD20 CAR autologous T lymphocytes
2020-09-18T02:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd20-car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,Synonym:,autologous CAR-20/19-T cells
2020-09-18T02:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd28-zeta-modified-car-cd3-t-lymphocytes-jcar015,Synonym:,anti-CD19/CD28/zeta modified CAR CD3+ T lymphocytes JCAR015
2020-09-18T02:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd28-zeta-modified-car-cd3-t-lymphocytes-jcar015,Code name:,JCAR 015
2020-09-18T02:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd28-zeta-modified-car-cd3-t-lymphocytes-jcar015,Code name:,JCAR 15
2020-09-18T02:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd28-zeta-modified-car-cd3-t-lymphocytes-jcar015,Code name:,JCAR015
2020-09-18T02:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-dm4-immunoconjugate-sar3419,Code name:,SAR3419
2020-09-18T02:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein,Synonym:,anti-CD20 B9E9 scFv-SA fusion protein
2020-09-18T02:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein,Synonym:,anti-CD20 B9E9-SA fusion protein
2020-09-18T02:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein,Synonym:,B9E9 scFvSA fusion protein
2020-09-18T02:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein,Synonym:,recombinant anti-CD20 B9E9 scFvSA fusion protein
2020-09-18T02:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein,Synonym:,scFv B9E9-streptavidin fusion protein
2020-09-18T02:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794877,Code name:,B 001
2020-09-18T02:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794877,Code name:,B001
2020-09-18T02:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802165,Code name:,BAT 4306F
2020-09-18T02:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802165,Code name:,BAT4306F
2020-09-18T02:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802165,Code name:,BAT-4306F
2020-09-18T02:16:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799905,Code name:,MIL 62
2020-09-18T02:16:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799905,Code name:,MIL62
2020-09-18T02:16:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799905,Code name:,MIL-62
2020-09-18T02:17:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-sct400,Code name:,SCT400
2020-09-18T02:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-tl011,Code name:,TL011
2020-09-18T02:17:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-interferon-alpha-fusion-protein-ign002,Synonym:,anti-CD20 monoclonal antibody-IFN-a fusion protein IGN002
2020-09-18T02:17:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-interferon-alpha-fusion-protein-ign002,Code name:,IGN002
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Synonym:,bispecific CD20xCD3 IgM antibody IGM2323
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Synonym:,bispecific IgM antibody IGM2323
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Synonym:,IgM pentamer IGM2323
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Code name:,IGM 2323
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Code name:,IGM2323
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Code name:,IGM-2323
2020-09-18T02:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-cd3-monoclonal-antibody-regn1979,Synonym:,anti-CD20 x anti-CD3 bispecific monoclonal antibody REGN1979
2020-09-18T02:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-cd3-monoclonal-antibody-regn1979,Code name:,REGN1979
2020-09-18T02:17:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-cd3-monoclonal-antibody-xmab13676,Synonym:,anti-CD20 x anti-CD3 bispecific monoclonal antibody XmAb13676
2020-09-18T02:17:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-cd3-monoclonal-antibody-xmab13676,Code name:,XmAb13676
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,ADC OBT076
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,Anti-CD205
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,MEN 1309
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,MEN1309
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,MEN-1309
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,OBT 076
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,OBT076
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,OBT-076
2020-09-18T02:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,NA,NA
2020-09-18T02:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-engineered-toxin-body-mt-3724,Code name:,MT-3724
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Synonym:,anti-CD22 antibody-drug conjugate TRPH-222
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Synonym:,anti-CD22-4AP ADC TRPH-222
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Code name:,CAT-02-106
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Code name:,TRPH 222
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Code name:,TRPH222
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Code name:,TRPH-222
2020-09-18T02:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-car-expressing-t-lymphocytes,Synonym:,anti-CD22 CAR-expressing T cells
2020-09-18T02:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-car-expressing-t-lymphocytes,Abbreviation:,CD22 CAR-T
2020-09-18T02:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-monoclonal-antibody-mmae-conjugate-dcdt2980s,Synonym:,ADC DCDT2980S
2020-09-18T02:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-monoclonal-antibody-mmae-conjugate-dcdt2980s,Synonym:,antibody-drug conjugate DCDT2980S
2020-09-18T02:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-monoclonal-antibody-mmae-conjugate-dcdt2980s,Code name:,DCDT2980S
2020-09-18T02:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776843,Synonym:,autologous T lymphocytes expressing CD22 CARs-expressing tandem TCR-zeta/4-1BB
2020-09-18T02:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776843,Synonym:,autologous T lymphocytes expressing CD22 chimeric antigen receptors expressing tandem TCR-zeta and 4-1BB
2020-09-18T02:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776843,Synonym:,TCRzeta/4-1BB CART22 cells
2020-09-18T02:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776843,Synonym:,TCRζ/4-1BB CART22 cells
2020-09-18T02:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848,Synonym:,Anti-CD228 Antibody-drug Conjugate SGN-CD228A
2020-09-18T02:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848,Synonym:,Anti-CD228-MMAE ADC SGN-CD228A
2020-09-18T02:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848,Synonym:,anti-melanotransferrin ADC SGN-CD228A
2020-09-18T02:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848,Code name:,SGN CD228A
2020-09-18T02:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848,Code name:,SGNCD228A
2020-09-18T02:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/767368,Synonym:,anti-CD22-CAR m971-BBz cells
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Synonym:,anti-CD25 monoclonal antibody RG6292
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Synonym:,T-regulatory cell-depleting antibody RO7296682
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RG 6292
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RG6292
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RG-6292
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RO 7296682
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RO7296682
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RO-7296682
2020-09-18T02:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd27l-antibody-drug-conjugate-amg-172,Synonym:,anti-epithelial cell adhesion molecule /anti-CD3 antibody-drug conjugate AMG 172
2020-09-18T02:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd27l-antibody-drug-conjugate-amg-172,Code name:,AMG 172
2020-09-18T02:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-immunotoxin-a-dmdt390-bisfvucht1,Synonym:,A-dmDT390-bisFv(UCHT1) fusion protein
2020-09-18T02:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-immunotoxin-a-dmdt390-bisfvucht1,Synonym:,anti-T cell immunotoxin A-dmDT390-bisFv(UCHT1)
2020-09-18T02:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-immunotoxin-a-dmdt390-bisfvucht1,US brand name:,Resimmune
2020-09-18T02:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-immunotoxin-a-dmdt390-bisfvucht1,Abbreviation:,A-dmDT390-bisFv(UCHT1)
2020-09-18T02:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-x-anti-cd20-bispecific-antibody-armed-activated-t-cells,Synonym:,CD20Bi-armed activated T cells
2020-09-18T02:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-x-anti-cd20-bispecific-antibody-armed-activated-t-cells,Abbreviation:,anti-CD3 x anti-CD20 bi-armed ATC
2020-09-18T02:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801833,Synonym:,duobody-CD3x5T4
2020-09-18T02:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801833,Code name:,GEN 1044
2020-09-18T02:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801833,Code name:,GEN1044
2020-09-18T02:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801833,Code name:,GEN-1044
2020-09-18T02:18:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957,Synonym:,BCMA x CD3 bispecific antibody JNJ-64007957
2020-09-18T02:18:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957,Synonym:,BCMA x CD3 duobody antibody JNJ-64007957
2020-09-18T02:18:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957,Synonym:,humanized BCMA/CD3 duobody antibody JNJ-64007957
2020-09-18T02:18:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957,Code name:,JNJ 64007957
2020-09-18T02:18:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957,Code name:,JNJ64007957
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Synonym:,anti-CD3/anti-BCMA bispecific antibody PF-06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Synonym:,B-cell maturation antigen-CD3 bispecific antibody PF-06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Synonym:,BCMA x CD3 bispecific antibody PF-06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Synonym:,BCMA-CD3 bispecific Ab PF-06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Code name:,PF 06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Code name:,PF06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Code name:,PF-06863135
2020-09-18T02:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-cd20-trifunctional-bispecific-monoclonal-antibody-fbta05,Synonym:,Bi20
2020-09-18T02:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-cd20-trifunctional-bispecific-monoclonal-antibody-fbta05,Code name:,FBTA05
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Synonym:,GPRC5D x CD3 bispecific antibody JNJ-64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Synonym:,GPRC5D x CD3 duobody antibody JNJ-64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Synonym:,GPRC5D/CD3 duobody antibody JNJ-64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Synonym:,humanized GPRC5D x CD3 duobody antibody JNJ-64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Code name:,JNJ 64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Code name:,JNJ64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Code name:,JNJ-64407564
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Synonym:,anti-CD3 x anti-GUCY2C bispecific antibody PF-07062119
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Synonym:,anti-GUCY2C/anti-CD3 bispecific antibody PF-07062119
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Synonym:,T-cell bispecific antibody PF-07062119
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Code name:,PF 07062119
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Code name:,PF07062119
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Code name:,PF-07062119
2020-09-18T02:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798973,US brand name:,DuoBody-CD3xCD20
2020-09-18T02:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798973,Code name:,GEN 3013
2020-09-18T02:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798973,Code name:,GEN3013
2020-09-18T02:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798973,Code name:,GEN-3013
2020-09-18T02:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793935,NA,NA
2020-09-18T02:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799985,Synonym:,anti-CD3/CD7-RTA immunotoxin
2020-09-18T02:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799985,Synonym:,CD3/CD7-ricin A IT
2020-09-18T02:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799985,US brand name:,T-Guard
2020-09-18T02:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-humanized-3f8-bispecific-antibody-activated-t-lymphocytes,Synonym:,anti-CD3 x hu3F8 bispecific antibody-armed ATC
2020-09-18T02:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-humanized-3f8-bispecific-antibody-activated-t-lymphocytes,Synonym:,OKT3/humanized 3F8 bispecific antibody-activated T lymphocytes
2020-09-18T02:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-humanized-3f8-bispecific-antibody-activated-t-lymphocytes,Abbreviation:,GD2Bi-a ATC
2020-09-18T02:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-humanized-3f8-bispecific-antibody-activated-t-lymphocytes,Abbreviation:,Hu3F8Bi-armed ATC
2020-09-18T02:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792734,Synonym:,anti-CD3/MUC1-armed PD-1 inhibitor-induced CIK cells
2020-09-18T02:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792734,Synonym:,PD-1 activated CIK armed with anti-CD3/Anti-MUC1 bispecific antibody
2020-09-18T02:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-monoclonal-antibody-mdx-1401,Code name:,MDX-1401
2020-09-18T02:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-monoclonal-antibody-xmab2513,Code name:,XmAb2513
2020-09-18T02:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-cd16a-monoclonal-antibody-afm13,Code name:,AFM13
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Synonym:,anti-CD30/DM1 ADC F0002
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Synonym:,F0002-ADC
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Synonym:,FADC F0002
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Code name:,F 0002
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Code name:,F0002
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Code name:,F-0002
2020-09-18T02:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804,Synonym:,anti-hFcγRIIB monoclonal antibody BI-1206
2020-09-18T02:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804,Synonym:,hFcgammaRIIB mAb BI-1206
2020-09-18T02:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804,Code name:,BI 1206
2020-09-18T02:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804,Code name:,BI1206
2020-09-18T02:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804,Code name:,BI-1206
2020-09-18T02:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564,Synonym:,CD33 x CD3 tandem diabody AMV-564
2020-09-18T02:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564,Synonym:,CD33/CD3 TandAbs AMV564
2020-09-18T02:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564,Code name:,AMV 564
2020-09-18T02:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564,Code name:,AMV564
2020-09-18T02:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564,Code name:,AMV-564
2020-09-18T02:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-monoclonal-antibody-bi-836858,Code name:,BI 836858
2020-09-18T02:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-monoclonal-antibody-dm4-conjugate-ave9633,Code name:,AVE9633
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Synonym:,anti-CD33 bispecific antibody GEM 333
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Synonym:,anti-CD33/anti-CD3 bispecific antibody GEM 333
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Synonym:,anti-CD33/CD3 antibody GEM 333
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Code name:,GEM 333
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Code name:,GEM333
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Code name:,GEM-333
2020-09-18T02:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798705,Synonym:,anti-CD33/anti-CD3 bispecific antibody JNJ-67571244
2020-09-18T02:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798705,Code name:,JNJ 67571244
2020-09-18T02:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798705,Code name:,JNJ67571244
2020-09-18T02:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798705,Code name:,JNJ-67571244
2020-09-18T02:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330,Synonym:,bispecific T-cell engager antibody AMG 330
2020-09-18T02:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330,Synonym:,BiTE antibody AMG 330
2020-09-18T02:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330,Synonym:,CD33/CD3-directed bispecific T-cell engager antibody AMG 33
2020-09-18T02:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330,Code name:,AMG 330
2020-09-18T02:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330,Code name:,AMG330
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Synonym:,anti-CD33 x anti-CD3 BiTE AMG 673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Synonym:,bispecific T-cell engager antibody AMG 673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Synonym:,BiTE antibody AMG 673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Synonym:,CD33/CD3-directed bispecific T-cell engager antibody AMG 673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Code name:,AMG 673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Code name:,AMG673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Code name:,AMG-673
2020-09-18T02:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a,Synonym:,ADC SGN-CD352A
2020-09-18T02:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a,Synonym:,PBD dimer ADC SGN-CD352A
2020-09-18T02:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a,Synonym:,PBD-based anti-CD352 ADC SGN-CD352A
2020-09-18T02:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a,Synonym:,PBD-based anti-CD352 antibody-drug conjugate SGN-CD352A
2020-09-18T02:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a,Code name:,SGN-CD352A
2020-09-18T02:20:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-antibody-drug-conjugate-imgn529,Code name:,IMGN529
2020-09-18T02:21:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-monoclonal-antibody-bi-836826,Code name:,BI 836826
2020-09-18T02:21:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-monoclonal-antibody-bi-836826,Code name:,mAb 37.1
2020-09-18T02:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801227,Synonym:,anti-CD37-CAR T cells
2020-09-18T02:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801227,Synonym:,anti-CD37-CAR-T cells
2020-09-18T02:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801227,Synonym:,CAR-37 T cells
2020-09-18T02:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800231,Code name:,SAR 442085
2020-09-18T02:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800231,Code name:,SAR442085
2020-09-18T02:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800231,Code name:,SAR-442085
2020-09-18T02:21:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795705,Synonym:,anti-CD38 MAb TAK-079
2020-09-18T02:21:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795705,Code name:,TAK 079
2020-09-18T02:21:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795705,Code name:,TAK-079
2020-09-18T02:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-monoclonal-antibody-mor03087,Code name:,MOR03087
2020-09-18T02:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-monoclonal-antibody-mor03087,Code name:,MOR202
2020-09-18T02:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-monoclonal-antibody-mor03087,Code name:,TJ202/MOR202
2020-09-18T02:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797082,Synonym:,anti-CD38/anti-BCMA CAR T cells
2020-09-18T02:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797082,Synonym:,anti-CD38/anti-BCMA CAR T lymphocytes
2020-09-18T02:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797082,Synonym:,anti-CD38/BCMA CAR T cells
2020-09-18T02:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802010,Synonym:,tri-specific T-cell engager SAR442257
2020-09-18T02:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802010,Code name:,SAR 442257
2020-09-18T02:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802010,Code name:,SAR442257
2020-09-18T02:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802010,Code name:,SAR-442257
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Synonym:,anti-CD38 x anti-CD3 bispecific monoclonal antibody GBR 1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Synonym:,anti-CD38/anti-CD3 bispecific monoclonal antibody GBR 1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Synonym:,BEAT GBR 1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Synonym:,CD38xCD3 BsAb GBR 1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Code name:,GBR 1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Code name:,GBR1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Code name:,GBR-1342
2020-09-18T02:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-targeted-igg4-attenuated-ifna-tak-573,Synonym:,anti-CD38-targeted IgG4-attenuated interferon alpha TAK-573
2020-09-18T02:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-targeted-igg4-attenuated-ifna-tak-573,Synonym:,CD38-targeted IgG4 fused with attenuated IFNa
2020-09-18T02:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-targeted-igg4-attenuated-ifna-tak-573,Code name:,TAK-573
2020-09-18T02:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-targeted-igg4-attenuated-ifna-tak-573,Code name:,TEV-48573
2020-09-18T02:21:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798967,Code name:,TTX 030
2020-09-18T02:21:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798967,Code name:,TTX030
2020-09-18T02:21:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798967,Code name:,TTX-030
2020-09-18T02:21:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802265,Synonym:,CD4 CAR T cells
2020-09-18T02:21:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802265,Synonym:,CD4-specific CAR T cells
2020-09-18T02:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-abbv-927,Synonym:,agonistic anti-CD40 monoclonal antibody ABBV-927
2020-09-18T02:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-abbv-927,Synonym:,anti-CD40 monoclonal antibody ABBV-927
2020-09-18T02:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-abbv-927,Code name:,ABBV-927
2020-09-18T02:22:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793440,Synonym:,agonist CD40 antibody CDX-1140
2020-09-18T02:22:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793440,Synonym:,anti-CD40 agonistic monoclonal antibody CDX-1140
2020-09-18T02:22:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793440,Code name:,CDX 1140
2020-09-18T02:22:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793440,Code name:,CDX-1140
2020-09-18T02:22:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-monoclonal-antibody-chi-lob-7-4,Code name:,Chi Lob 7/4
2020-09-18T02:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-monoclonal-antibody-sea-cd40,Code name:,SEA-CD40
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Synonym:,anti-CD40/anti-CD137 bispecific agonist monoclonal antibody GEN1042
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Synonym:,DuoBody-CD40x4-1BB GEN1042
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,BNT 312
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,BNT-312
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,GEN 1042
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,GEN1042
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,GEN-1042
2020-09-18T02:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40l-fc-fusion-protein-bms-986004,Synonym:,Fc-fusion protein BMS986004
2020-09-18T02:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40l-fc-fusion-protein-bms-986004,Code name:,BMS986004
2020-09-18T02:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40l-fc-fusion-protein-bms-986004,Code name:,BMS-986004
2020-09-18T02:22:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd44-monoclonal-antibody-ro5429083,Code name:,RG 7356
2020-09-18T02:22:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd44-monoclonal-antibody-ro5429083,Code name:,RO5429083
2020-09-18T02:22:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody,NA,NA
2020-09-18T02:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-ahn-12,Code name:,AHN-12
2020-09-18T02:22:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-bc8,Abbreviation:,MOAB BC8
2020-09-18T02:22:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-bc8-streptavidin-conjugate,Synonym:,anti-CD45 BC8 antibody-streptavidin fusion protein
2020-09-18T02:22:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-bc8-streptavidin-conjugate,Synonym:,BC8 scFv4SA fusion protein
2020-09-18T02:22:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-bc8-streptavidin-conjugate,Abbreviation:,BC8-SA
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Synonym:,ADC FOR46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Synonym:,antibody-drug conjugate FOR46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Synonym:,anti-CD46 ADC FOR46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Synonym:,CD46-ADC FOR46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Code name:,FOR 46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Code name:,FOR46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Code name:,FOR-46
2020-09-18T02:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749,Synonym:,ADC SGN-CD47M
2020-09-18T02:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749,Synonym:,anti-CD47 antibody-drug conjugate SGN-CD47M
2020-09-18T02:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749,Code name:,SGN CD47M
2020-09-18T02:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749,Code name:,SGNCD47M
2020-09-18T02:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749,Code name:,SGN-CD47M
2020-09-18T02:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797803,Code name:,AO 176
2020-09-18T02:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797803,Code name:,AO176
2020-09-18T02:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797803,Code name:,AO-176
2020-09-18T02:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-cc-90002,Synonym:,anti-CD47 Mab CC-90002
2020-09-18T02:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-cc-90002,Code name:,CC 90002
2020-09-18T02:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-cc-90002,Code name:,CC-90002
2020-09-18T02:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797797,Synonym:,OA3-targeted antineoplastic agent SHR-1603
2020-09-18T02:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797797,Code name:,SHR 1603
2020-09-18T02:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797797,Code name:,SHR1603
2020-09-18T02:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797797,Code name:,SHR-1603
2020-09-18T02:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795110,Code name:,SRF 231
2020-09-18T02:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795110,Code name:,SRF231
2020-09-18T02:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795110,Code name:,SRF-231
2020-09-18T02:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801670,Code name:,TJ 011133
2020-09-18T02:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801670,Code name:,TJ-011133
2020-09-18T02:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801670,Code name:,TJC4
2020-09-18T02:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799809,Synonym:,bispecific monoclonal antibody TG-1801
2020-09-18T02:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799809,Code name:,TG 1801
2020-09-18T02:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799809,Code name:,TG1801
2020-09-18T02:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799809,Code name:,TG-1801
2020-09-18T02:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794392,Synonym:,Anti-CD48 ADC SGN-CD48A
2020-09-18T02:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794392,Code name:,SGN CD48A
2020-09-18T02:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794392,Code name:,SGNCD48A
2020-09-18T02:23:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798418,Code name:,ALLO 647
2020-09-18T02:23:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798418,Code name:,ALLO647
2020-09-18T02:23:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798418,Code name:,ALLO-647
2020-09-18T02:23:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801681,Synonym:,anti-CD7 CAR T lymphocytes
2020-09-18T02:23:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-antibody-drug-conjugate-mdx-1203,Abbreviation:,anti-CD70 ADC MDX-1203
2020-09-18T02:23:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-antibody-drug-conjugate-mdx-1203,Code name:,MDX-1203
2020-09-18T02:24:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-antibody-drug-conjugate-sgn-cd70a,Code name:,SGN-CD70A
2020-09-18T02:24:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-monoclonal-antibody-mdx-1411,Code name:,MDX-1411
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,antibody prodrug-drug conjugate CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,anti-CD71 Probody/vcMMAE drug conjugate CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,CD71-directed PDC CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,CD71-directed probody therapeutic CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,PDC CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,PDC-targeting CD71 CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Code name:,CX 2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Code name:,CX2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Code name:,CX-2029
2020-09-18T02:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-bms-986179,Code name:,BMS 986179
2020-09-18T02:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-bms-986179,Code name:,BMS-986179
2020-09-18T02:24:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795397,Code name:,CPI 006
2020-09-18T02:24:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795397,Code name:,CPI006
2020-09-18T02:24:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795397,Code name:,CPI-006
2020-09-18T02:24:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795397,Code name:,CPX-006
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,NZV 930
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,NZV930
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,NZV-930
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,SRF 373
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,SRF373
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,SRF-373
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ 004309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ 4309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ004309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ-004309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ4309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ-4309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJD5
2020-09-18T02:24:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd98-monoclonal-antibody-ign523,Code name:,IGN523
2020-09-18T02:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288,Synonym:,CDH6 ADC HKT288
2020-09-18T02:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288,Synonym:,maytansine-based ADC HKT-288
2020-09-18T02:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288,Abbreviation:,CDH6-ADC
2020-09-18T02:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288,Code name:,HKT 288
2020-09-18T02:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288,Code name:,HKT288
2020-09-18T02:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-bite-monoclonal-antibody-amg211,Synonym:,anti-CEA BiTE monoclonal antibody MEDI-565
2020-09-18T02:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-bite-monoclonal-antibody-amg211,Code name:,AMG211
2020-09-18T02:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-bite-monoclonal-antibody-amg211,Code name:,MEDI-565
2020-09-18T02:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-bite-monoclonal-antibody-amg211,Code name:,MT111
2020-09-18T02:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-igcd28tcr-transduced-autologous-t-cells,NA,NA
2020-09-18T02:25:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-tcr-retroviral-vector-transduced-autologous-lymphocytes,NA,NA
2020-09-18T02:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-bay1179470,Code name:,BAY1179470
2020-09-18T02:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-anti-dtpa-in-f6-734-bispecific-antibody,NA,NA
2020-09-18T02:25:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-anti-hsg-bispecific-monoclonal-antibody-tf2,Synonym:,anti-CEA x anti-histamine-succinyl-glycine bispecific monoclonal antibody TF2
2020-09-18T02:25:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam1-monoclonal-antibody-cm-24,Code name:,CM-24
2020-09-18T02:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam5-antibody-drug-conjugate-sar408701,Synonym:,ADC SAR408701
2020-09-18T02:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam5-antibody-drug-conjugate-sar408701,Code name:,SAR408701
2020-09-18T02:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/768359,Synonym:,immunoconjugate L-DOS47
2020-09-18T02:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/768359,Code name:,L-DOS47
2020-09-18T02:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797774,Code name:,BAY 1834942
2020-09-18T02:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797774,Code name:,BAY1834942
2020-09-18T02:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797774,Code name:,BAY-1834942
2020-09-18T02:25:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-car-autologous-t-lymphocytes,Synonym:,autologous anti-CEA CAR-T cells
2020-09-18T02:25:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-fms-monoclonal-antibody-amg-820,Code name:,AMG 820
2020-09-18T02:25:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-kit-monoclonal-antibody-ktn0158,Code name:,KTN0158
2020-09-18T02:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802013,Synonym:,anti-CLDN18.2 monoclonal antibody AB011
2020-09-18T02:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802013,Code name:,AB 011
2020-09-18T02:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802013,Code name:,AB011
2020-09-18T02:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802013,Code name:,AB-011
2020-09-18T02:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802035,Code name:,TST 001
2020-09-18T02:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802035,Code name:,TST001
2020-09-18T02:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802035,Code name:,TST-001
2020-09-18T02:26:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cldn6-monoclonal-antibody-imab027,Code name:,ASP1650
2020-09-18T02:26:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cldn6-monoclonal-antibody-imab027,Code name:,IMAB027
2020-09-18T02:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475,Synonym:,anti-CLEC12A x CD3 bispecific antibody MCLA117
2020-09-18T02:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475,Synonym:,bispecific antibody MCLA-117
2020-09-18T02:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475,Code name:,MCLA 117
2020-09-18T02:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475,Code name:,MCLA117
2020-09-18T02:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475,Code name:,MCLA-117
2020-09-18T02:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792156,Synonym:,ADC HTI-1066
2020-09-18T02:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792156,Code name:,HTI 1066
2020-09-18T02:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792156,Code name:,HTI-1066
2020-09-18T02:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792156,Code name:,SHR-A1403
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Synonym:,anti-c-Met ADC TR1801
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Synonym:,TR1801-ADC
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,MT 8633
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,MT8633
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,MT-8633
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,TR 1801
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,TR1801
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,TR-1801
2020-09-18T02:26:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-abt-700,Code name:,ABT-700
2020-09-18T02:26:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-argx-111,Code name:,ARGX-111
2020-09-18T02:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802302,Code name:,HLX 55
2020-09-18T02:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802302,Code name:,HLX55
2020-09-18T02:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802302,Code name:,HLX-55
2020-09-18T02:26:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-ly2875358,Code name:,LY2875358
2020-09-18T02:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-sait301,Code name:,SAIT301
2020-09-18T02:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324,Synonym:,anti–M-CSF mAb PD-0360324
2020-09-18T02:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324,Code name:,PD 0360324
2020-09-18T02:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324,Code name:,PD 360324
2020-09-18T02:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324,Code name:,PD-0360324
2020-09-18T02:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324,Code name:,"PD-360,324"
2020-09-18T02:27:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf-1r-monoclonal-antibody-imc-cs4,Code name:,IMC-CS4
2020-09-18T02:27:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf-1r-monoclonal-antibody-imc-cs4,Code name:,LY3022855
2020-09-18T02:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081,Synonym:,anti-M-CSFR monoclonal antibody SNDX-6352
2020-09-18T02:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081,Code name:,SNDX 6352
2020-09-18T02:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081,Code name:,SNDX6352
2020-09-18T02:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081,Code name:,SNDX-6352
2020-09-18T02:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081,Code name:,UCB6352
2020-09-18T02:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801856,Synonym:,anti-CTLA4 antibody fusion protein KN044
2020-09-18T02:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801856,Code name:,KN 044
2020-09-18T02:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801856,Code name:,KN044
2020-09-18T02:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801856,Code name:,KN-044
2020-09-18T02:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-mab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb heavy and light chain RNA/GITRL RNA-transfected autologous DC
2020-09-18T02:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-mab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb heavy and light chain RNA/GITRL RNA-transfected autologous dendritic cell
2020-09-18T02:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cxcr4-monoclonal-antibody-pf-06747143,Code name:,PF-06747143
2020-09-18T02:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-mab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA4 MoAb RNA/GITRL RNA-transfected autologous dendritic cell vaccine
2020-09-18T02:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-mab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Abbreviation:,GITRL/antiCTLA4 RNA DC
2020-09-18T02:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-mab-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb RNA-transfected autologous DC
2020-09-18T02:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-mab-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb RNA-transfected autologous dendritic cells
2020-09-18T02:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799904,Code name:,ADG 116
2020-09-18T02:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799904,Code name:,ADG116
2020-09-18T02:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799904,Code name:,ADG-116
2020-09-18T02:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798657,Code name:,ADU 1604
2020-09-18T02:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798657,Code name:,ADU1604
2020-09-18T02:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798657,Code name:,ADU-1604
2020-09-18T02:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797474,Code name:,AGEN 1181
2020-09-18T02:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797474,Code name:,AGEN1181
2020-09-18T02:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797474,Code name:,AGEN-1181
2020-09-18T02:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-agen1884,Code name:,AGEN1884
2020-09-18T02:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-agen1884,Code name:,AGEN-1884
2020-09-18T02:27:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-monoclonal-antibody-bms-986218,Synonym:,monoclonal antibody BMS-986218
2020-09-18T02:27:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-monoclonal-antibody-bms-986218,Code name:,BMS 986218
2020-09-18T02:27:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-monoclonal-antibody-bms-986218,Code name:,BMS-986218
2020-09-18T02:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801868,Code name:,HBM 4003
2020-09-18T02:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801868,Code name:,HBM4003
2020-09-18T02:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801868,Code name:,HBM-4003
2020-09-18T02:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793094,Code name:,MK 1308
2020-09-18T02:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793094,Code name:,MK1308
2020-09-18T02:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793094,Code name:,MK-1308
2020-09-18T02:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801887,Synonym:,anti-CTLA4 monoclonal antibody ONC-392
2020-09-18T02:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801887,Code name:,ONC 392
2020-09-18T02:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801887,Code name:,ONC392
2020-09-18T02:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801887,Code name:,ONC-392
2020-09-18T02:28:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797920,Code name:,REGN 4659
2020-09-18T02:28:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797920,Code name:,REGN4659
2020-09-18T02:28:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797920,Code name:,REGN-4659
2020-09-18T02:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801762,Synonym:,probody BMS-986288
2020-09-18T02:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801762,Code name:,BMS 986288
2020-09-18T02:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801762,Code name:,BMS986288
2020-09-18T02:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801762,Code name:,BMS-986288
2020-09-18T02:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536,Synonym:,anti-CTLA4/anti-PD1 monoclonal antibody combination BCD-217
2020-09-18T02:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536,Synonym:,anti-CTLA-4/PD-1 monoclonal antibody combination BCD-217
2020-09-18T02:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536,Code name:,BCD 217
2020-09-18T02:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536,Code name:,BCD217
2020-09-18T02:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536,Code name:,BCD-217
2020-09-18T02:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814,Synonym:,anti-CTLA-4/anti-LAG-3 bispecific monoclonal antibody XmAb22841
2020-09-18T02:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814,Synonym:,CTLA-4xLAG-3 bispecific antibody XmAb22841
2020-09-18T02:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814,Code name:,XmAb 22841
2020-09-18T02:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814,Code name:,XmAb22841
2020-09-18T02:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814,Code name:,XmAb-22841
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Synonym:,CTLA-4 x OX40 bispecific antibody ATOR-1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ADC 1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ADC1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ADC-1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ATOR 1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ATOR1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ATOR-1015
2020-09-18T02:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cxcr4-monoclonal-antibody-pf-06747143,Synonym:,anti-CXCR4 IgG1 antibody PF-06747143
2020-09-18T02:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cxcr4-monoclonal-antibody-pf-06747143,Code name:,PF 06747143
2020-09-18T02:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-denatured-collagen-recombinant-monoclonal-antibody-trc093,Synonym:,anti-dn collagen monoclonal antibody TRC093
2020-09-18T02:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-denatured-collagen-recombinant-monoclonal-antibody-trc093,Code name:,D93
2020-09-18T02:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-denatured-collagen-recombinant-monoclonal-antibody-trc093,Code name:,TRC093
2020-09-18T02:28:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dkk1-monoclonal-antibody-bhq880,Code name:,BHQ880
2020-09-18T02:28:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dkk-1-monoclonal-antibody-ly2812176,Code name:,LY2812176
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Synonym:,anti-DLL3 x anti-CD3 BiTE AMG 757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Synonym:,bispecific T-cell engager antibody AMG 757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Synonym:,BiTE antibody AMG 757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Synonym:,DLL3/CD3-directed bispecific T-cell engager antibody AMG 757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Code name:,AMG 757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Code name:,AMG757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Code name:,AMG-757
2020-09-18T02:29:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll4-monoclonal-antibody-medi0639,Code name:,MEDI0639
2020-09-18T02:29:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll4-monoclonal-antibody-regn421,Synonym:,anti-Delta-like 4 monoclonal antibody REGN421
2020-09-18T02:29:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll4-monoclonal-antibody-regn421,Code name:,REGN421
2020-09-18T02:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll4-vegf-bispecific-monoclonal-antibody-omp-305b83,Code name:,OMP-305B83
2020-09-18T02:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dr5-agonist-monoclonal-antibody-tra-8,Synonym:,anti-death receptor 5 agonist monoclonal antibody TRA-8
2020-09-18T02:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dr5-agonist-monoclonal-antibody-tra-8,Code name:,TRA-8
2020-09-18T02:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796494,Code name:,INBRX 109
2020-09-18T02:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796494,Code name:,INBRX109
2020-09-18T02:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796494,Code name:,INBRX-109
2020-09-18T02:29:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfl7-monoclonal-antibody-megf0444a,Synonym:,anti-epidermal growth factor-like domain 7 monoclonal antibody MEGF0444A
2020-09-18T02:29:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfl7-monoclonal-antibody-megf0444a,Code name:,MEGF0444A
2020-09-18T02:29:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797091,Synonym:,EGFR-IL12-CAR-T cells
2020-09-18T02:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-fluorescence-imaging-agent-aby-029,Synonym:,ABY-029 trifluoroacetate salt
2020-09-18T02:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-fluorescence-imaging-agent-aby-029,Synonym:,fluorescently-labeled Anti-EGFR affibody molecule ABY-029
2020-09-18T02:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-fluorescence-imaging-agent-aby-029,Synonym:,IRDye 800CW maleimide-labeled affibody peptide
2020-09-18T02:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-fluorescence-imaging-agent-aby-029,Code name:,ABY-029
2020-09-18T02:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-abt-806,Abbreviation:,anti-EGFR mAb ABT-806
2020-09-18T02:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-abt-806,Abbreviation:,anti-EGFR MoAb ABT-806
2020-09-18T02:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-abt-806,Code name:,ABT-806
2020-09-18T02:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-abt-806,Code name:,mAb-806
2020-09-18T02:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794677,Code name:,CPGJ 602
2020-09-18T02:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794677,Code name:,CPGJ602
2020-09-18T02:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794677,Code name:,CPGJ-602
2020-09-18T02:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-gc1118,Code name:,GC1118
2020-09-18T02:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799130,Synonym:,cetuximab biobetter HLX07
2020-09-18T02:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799130,Code name:,HLX 07
2020-09-18T02:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799130,Code name:,HLX07
2020-09-18T02:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799130,Code name:,HLX-07
2020-09-18T02:30:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-mixture-mm-151,Code name:,MM-151
2020-09-18T02:30:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-mixture-sym004,Code name:,sym004
2020-09-18T02:30:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-ro5083945,Synonym:,anti-epidermal growth factor receptor GFR monoclonal antibody RO5083945
2020-09-18T02:30:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-syn004,Code name:,SYN004
2020-09-18T02:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-tap-antibody-drug-conjugate-imgn289,Synonym:,anti-EGFR-SMCC-DM1
2020-09-18T02:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-tap-antibody-drug-conjugate-imgn289,Code name:,IMGN289
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Synonym:,anti-cMET/EGFR bispecific antibody EMB-01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Synonym:,anti-EGFR/anti-c-Met bispecific antibody EMB-01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Synonym:,bispecific antibody EMB-01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Synonym:,FIT-013a
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Code name:,EMB 01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Code name:,EMB01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Code name:,EMB-01
2020-09-18T02:30:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-c-met-bispecific-antibody-jnj-61186372,Code name:,JNJ-61186372
2020-09-18T02:30:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792639,Synonym:,ADC AVID100
2020-09-18T02:30:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792639,Synonym:,antibody-drug conjugate AVID100
2020-09-18T02:30:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792639,Code name:,AVID100
2020-09-18T02:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her2-her3-monoclonal-antibody-mixture-sym013,Synonym:,pan-HER mAb mixture Sym013
2020-09-18T02:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her2-her3-monoclonal-antibody-mixture-sym013,Code name:,Sym013
2020-09-18T02:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her2-her3-monoclonal-antibody-mixture-sym013,Code name:,Sym-013
2020-09-18T02:30:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her3-monoclonal-antibody-mehd7945a,Synonym:,anti-erbB1/erbB3 monoclonal antibody MEHD7945A
2020-09-18T02:30:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her3-monoclonal-antibody-mehd7945a,Code name:,MEHD7945A
2020-09-18T02:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472,Synonym:,ADC ABBV-321
2020-09-18T02:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472,Synonym:,anti-EGFR/PBD ADC ABBV-321
2020-09-18T02:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472,Code name:,ABBV 321
2020-09-18T02:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472,Code name:,ABBV321
2020-09-18T02:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472,Code name:,ABBV-321
2020-09-18T02:31:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-antibody-drug-conjugate-amg-595,Synonym:,anti-EGFRvIII-DM1 immunoconjugate AMG 595
2020-09-18T02:31:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-antibody-drug-conjugate-amg-595,Code name:,AMG 595
2020-09-18T02:31:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-car-transduced-allogeneic-t-lymphocytes,Synonym:,anti-EGFRvIII CAR PG13-139-CD8-CD28BBZ-transduced T lymphocytes
2020-09-18T02:31:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-immunotoxin-mr1-1,Synonym:,MR1-1KDEL
2020-09-18T02:31:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-immunotoxin-mr1-1,Synonym:,MR1scFvPE38KDEL
2020-09-18T02:31:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-immunotoxin-mr1-1,Code name:,MR1-1
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Synonym:,anti-EGFRvIII x anti-CD3 bi-specific T-cell engager AMG 596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Synonym:,bispecific BITE antibody AMG 596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Synonym:,BiTE antibody AMG 596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Synonym:,EGFRvIII specific BiTE antibody AMG 596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Code name:,AMG 596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Code name:,AMG596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Code name:,AMG-596
2020-09-18T02:31:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egp-2-immunotoxin-moc31-pe,Synonym:,anti-epithelial glycoprotein-2 immunotoxin MOC31-PE
2020-09-18T02:31:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egp-2-immunotoxin-moc31-pe,Code name:,MOC31-PE
2020-09-18T02:31:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-endosialin-tem1-monoclonal-antibody-morab-004,Code name:,MORAb-004
2020-09-18T02:31:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-enpp3-antibody-drug-conjugate-ags-16c3f,Abbreviation:,ADC AGS-16C3F
2020-09-18T02:31:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-enpp3-antibody-drug-conjugate-ags-16c3f,Code name:,AGS-16C3F
2020-09-18T02:31:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ep-cam-monoclonal-antibody-ing-1,Code name:,ING 1
2020-09-18T02:31:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ep-cam-monoclonal-antibody-ing-1,Code name:,ING-1
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Synonym:,anti-EphA2 antibody-targeted nanoliposome MM-310
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Synonym:,anti-EphA2 docetaxel-based nanoliposome MM-310
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Synonym:,EphA2-targeted docetaxel nanoliposome MM-310
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Code name:,MM 310
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Code name:,MM310
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Code name:,MM-310
2020-09-18T02:31:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-monoclonal-antibody-ds-8895a,Code name:,DS-8895a
2020-09-18T02:32:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-monoclonal-antibody-mmaf-immunoconjugate-medi-547,Synonym:,1C1-mcMMAF
2020-09-18T02:32:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-monoclonal-antibody-mmaf-immunoconjugate-medi-547,Code name:,MEDI-547
2020-09-18T02:32:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha3-monoclonal-antibody-kb004,Abbreviation:,anti-EphA3 mAb KB004
2020-09-18T02:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152,Code name:,DP 303c
2020-09-18T02:32:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha3-monoclonal-antibody-kb004,Code name:,KB004
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer T cells
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,anti-ERBB2 antibody expressing pluripotent killer T cells
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,anti-ERBB2 antibody expressing pluripotent killer T lymphocytes
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,anti-HER2 antibody expressing pluripotent killer T cells
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,anti-HER2 antibody expressing pluripotent killer T lymphocytes
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,PIK-HER2
2020-09-18T02:32:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb2-anti-erbb3-bispecific-monoclonal-antibody-mm-111,Code name:,MM-111
2020-09-18T02:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797411,Synonym:,anti-HER3 antibody ISU104
2020-09-18T02:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797411,Code name:,ISU 104
2020-09-18T02:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797411,Code name:,ISU104
2020-09-18T02:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797411,Code name:,ISU-104
2020-09-18T02:32:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-av-203,Synonym:,anti-ErbB3 MoAb AV-203
2020-09-18T02:32:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-av-203,Code name:,AV-203
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Synonym:,anti-ErbB3 monoclonal antibody KTN3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Synonym:,anti-HER3 monoclonal antibody CDX-3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,CDX 3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,CDX3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,CDX-3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,KTN 3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,KTN3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,KTN-3379
2020-09-18T02:32:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-regn1400,Code name:,REGN1400
2020-09-18T02:32:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-anti-igf-1r-bispecific-monoclonal-antibody-mm-141,Code name:,MM-141
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Synonym:,aFAP-IL2v RO6874281
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Synonym:,FAP-IL2v FP RO6874281
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Synonym:,FAP-IL2v RO6874281
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Code name:,RG 7461
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Code name:,RG7461
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Code name:,RG-7461
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Code name:,RO6874281
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Code name:,RO-6874281
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Synonym:,anti-FCRH5 × anti-CD3 bi-specific T-cell engager BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Synonym:,anti-FCRH5/CD3 TDB BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Synonym:,FCRH5/CD3 T cell-dependent bispecific antibody BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Synonym:,FCRH5/CD3 TDB antibody BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Synonym:,recombinant anti-FCRH5 × anti-CD3 bi-specific T-cell engager BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Code name:,BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Code name:,RO7187797
2020-09-18T02:33:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrn-monoclonal-antibody-synt001,Code name:,SYNT 001
2020-09-18T02:33:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrn-monoclonal-antibody-synt001,Code name:,SYNT001
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,Synonym:,androgen receptor antagonist ARN-509
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,US brand name:,Erleada
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,Abbreviation:,AR antagonist ARN-509
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,Code name:,ARN-509
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,Code name:,JNJ-56021927
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,Chemical structure:,"4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide"
2020-09-18T02:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-antibody-drug-conjugate-ly3076226,Synonym:,ADC LY3076226
2020-09-18T02:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-antibody-drug-conjugate-ly3076226,Synonym:,anti-FGFR3 ADC LY3076226
2020-09-18T02:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-antibody-drug-conjugate-ly3076226,Synonym:,anti-fibroblast growth factor receptor 3 antibody-drug conjugate LY3076226
2020-09-18T02:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-antibody-drug-conjugate-ly3076226,Code name:,LY3076226
2020-09-18T02:33:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-monoclonal-antibody-mfgr1877s,Code name:,MFGR1877S
2020-09-18T02:33:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr4-monoclonal-antibody-u3-1784,Code name:,U3 1784
2020-09-18T02:33:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr4-monoclonal-antibody-u3-1784,Code name:,U3-1784
2020-09-18T02:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797354,Synonym:,antiFL(FITCE2) CAR expressing T cells
2020-09-18T02:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797354,Synonym:,anti-FL(FITCE2) CAR expressing T cells
2020-09-18T02:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797354,Synonym:,anti-FL(FITC-E2) CAR T lymphocytes
2020-09-18T02:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797354,Synonym:,fluorescein-specific (FITC-E2)-CAR T cells
2020-09-18T02:33:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme,US brand name:,Angiozyme
2020-09-18T02:33:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme,Foreign brand name:,Angiozyme
2020-09-18T02:33:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme,Code name:,RPI.4610
2020-09-18T02:33:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-monoclonal-antibody-4g8-sdiem,Synonym:,FLYSYN
2020-09-18T02:33:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-monoclonal-antibody-4g8-sdiem,Code name:,4G8-SDIEM
2020-09-18T02:33:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-monoclonal-antibody-imc-eb10,Code name:,IMC-EB10
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Synonym:,anti-FLT3 x anti-CD3 BiTE AMG 427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Synonym:,bispecific T-cell engager antibody AMG 427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Synonym:,BiTE antibody AMG 427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Synonym:,FLT3/CD3-directed bispecific T-cell engager antibody AMG 427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Code name:,AMG 427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Code name:,AMG427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Code name:,AMG-427
2020-09-18T02:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174,Synonym:,anti-FolRa ADC STRO-002
2020-09-18T02:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174,Synonym:,anti-FolRalpha ADC STRO-002
2020-09-18T02:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174,Code name:,STRO 002
2020-09-18T02:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174,Code name:,STRO002
2020-09-18T02:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174,Code name:,STRO-002
2020-09-18T02:33:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fucosyl-gm1-monoclonal-antibody-bms-986012,Code name:,BMS-986012
2020-09-18T02:34:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-agent-f901318,Code name:,F901318
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,ASP 2397
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,ASP2397
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,ASP-2397
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,VL 2397
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,VL2397
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,VL-2397
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Synonym:,inhaled antifungal PC945
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Synonym:,triazole antifungal PC945
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Code name:,PC 945
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Code name:,PC945
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Code name:,PC-945
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Chemical structure:,"4-[4-(4-{[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy}-3-methylphenyl)piperazin-1-yl]-N-(4-fluorophenyl)benzamide"
2020-09-18T02:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ganglioside-gm2-monoclonal-antibody-biw-8962,Synonym:,anti-GM2 monoclonal antibody BIW-8962
2020-09-18T02:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ganglioside-gm2-monoclonal-antibody-biw-8962,Code name:,BIW-8962
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Synonym:,anti-glycoprotein A repetitions predominant monoclonal antibody ABBV-151
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ABBV 151
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ABBV151
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ABBV-151
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ARGX 115
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ARGX115
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ARGX-115
2020-09-18T02:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152,Code name:,DP303c
2020-09-18T02:34:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gcc-antibody-drug-conjugate-mln0264,Code name:,MLN0264
2020-09-18T02:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795729,Synonym:,anti-GCC ADC TAK-164
2020-09-18T02:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795729,Code name:,TAK 164
2020-09-18T02:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795729,Code name:,TAK164
2020-09-18T02:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795729,Code name:,TAK-164
2020-09-18T02:34:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd2-monoclonal-antibody-hu1418k322a,Code name:,hu14.18K322A
2020-09-18T02:34:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd2-monoclonal-antibody-morab-028,Synonym:,anti-G-28 monoclonal antibody MORAb-028
2020-09-18T02:34:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd2-monoclonal-antibody-morab-028,Code name:,MORAb-028
2020-09-18T02:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd3-antibody-drug-conjugate-pf-06688992,Synonym:,anti GD3 ADC PF-06688992
2020-09-18T02:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd3-antibody-drug-conjugate-pf-06688992,Synonym:,GD3 ADC PF-06688992
2020-09-18T02:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd3-antibody-drug-conjugate-pf-06688992,Code name:,PF 06688992
2020-09-18T02:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd3-antibody-drug-conjugate-pf-06688992,Code name:,PF-06688992
2020-09-18T02:34:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799743,Synonym:,APCs expressing HPV16 E6/E7 SQZ-PBMC-HPV
2020-09-18T02:34:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799743,Code name:,SQZ PBMC HPV
2020-09-18T02:34:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799743,Code name:,SQZ-PBMC-HPV
2020-09-18T02:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antigen-targeted-personalized-breast-cancer-vaccine,Synonym:,IVAC_W_bre1_uID
2020-09-18T02:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antigen-targeted-personalized-breast-cancer-vaccine,Foreign brand name:,IVAC ® Warehouse vaccine
2020-09-18T02:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799444,Synonym:,GFRAL antagonistic monoclonal antibody NGM120
2020-09-18T02:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799444,Code name:,NGM 120
2020-09-18T02:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799444,Code name:,NGM120
2020-09-18T02:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799444,Code name:,NGM-120
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Synonym:,anti-GITR agonistic monoclonal antibody PTZ-522
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,ASP 1951
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,ASP1951
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,ASP-1951
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,PTZ 522
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,PTZ522
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,PTZ-522
2020-09-18T02:35:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-incagn01876,Code name:,INCAGN01876
2020-09-18T02:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156,Synonym:,anti-GITR MoAb BMS-986156
2020-09-18T02:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156,Synonym:,GITR agonist BMS-986156
2020-09-18T02:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156,Synonym:,TNFRSF18 agonist BMS-986156
2020-09-18T02:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156,Code name:,BMS 986156
2020-09-18T02:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156,Code name:,BMS-986156
2020-09-18T02:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-monoclonal-antibody-gwn-323,Code name:,GWN 323
2020-09-18T02:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-monoclonal-antibody-gwn-323,Code name:,GWN323
2020-09-18T02:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-monoclonal-antibody-mk-4166,Code name:,MK-4166
2020-09-18T02:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794060,Code name:,OBI 888
2020-09-18T02:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794060,Code name:,OBI888
2020-09-18T02:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794060,Code name:,OBI-888
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Synonym:,ADC OBI 999
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Synonym:,anti-globo H/MMAE ADC OBI 999
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Synonym:,OBI-888/MMAE ADC OBI-999
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Code name:,OBI 999
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Code name:,OBI999
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Code name:,OBI-999
2020-09-18T02:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes,Synonym:,anti-GPC3-scFvGC33-CAR autologous T lymphocytes
2020-09-18T02:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes,Synonym:,autologous GAP T cells
2020-09-18T02:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes,Synonym:,autologous GPC3-CAR T cells
2020-09-18T02:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes,Synonym:,glypican 3-specific chimeric antigen receptor expressed in autologous T cells
2020-09-18T02:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes,Synonym:,glypican 3-specific chimeric antigen receptor-expressing autologous T cells
2020-09-18T02:35:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gnrh-vaccine-pep223,Code name:,PEP223
2020-09-18T02:36:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpa33-cd3-monoclonal-antibody-mgd007,Synonym:,humanized gpA33 x CD3 DART™ protein MGD007
2020-09-18T02:36:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpa33-cd3-monoclonal-antibody-mgd007,Code name:,MGD007
2020-09-18T02:36:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-monoclonal-antibody-gc33,Synonym:,anti-glypican 3 monoclonal antibody GC33
2020-09-18T02:36:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-monoclonal-antibody-gc33,Code name:,GC33
2020-09-18T02:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801493,Synonym:,anti-GPC3 CAR autologous T cells
2020-09-18T02:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801493,Synonym:,CAR-GPC3 T cells
2020-09-18T02:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801493,Synonym:,glypican-3-specific CAR T cells
2020-09-18T02:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801493,Synonym:,GPC3-targeted CAR autologous T cells
2020-09-18T02:36:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-car-autologous-t-lymphocytes,Synonym:,anti-GPC3 CAR autologous T cells
2020-09-18T02:36:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-car-autologous-t-lymphocytes,Synonym:,GPC3-targeted CAR autologous T cells
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Synonym:,anti-GPC3 CAR T cells TAK-102
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Synonym:,CAR T cells TAK-102
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Synonym:,glypican-3-specific CAR T cells TAK-102
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Code name:,TAK 102
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Code name:,TAK102
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Code name:,TAK-102
2020-09-18T02:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802055,Synonym:,anti-GREM1 antibody monoclonal UCB6114
2020-09-18T02:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802055,Code name:,UCB 6114
2020-09-18T02:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802055,Code name:,UCB6114
2020-09-18T02:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802055,Code name:,UCB-6114
2020-09-18T02:36:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-grp78-monoclonal-antibody-pat-sm6,Code name:,PAT-SM6
2020-09-18T02:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ha-epitope-monoclonal-antibody-medi8852,Synonym:,anti-influenza A hemagglutinin epitope mAb MEDI8852
2020-09-18T02:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ha-epitope-monoclonal-antibody-medi8852,Synonym:,pan-influenza A mAb MEDI8852
2020-09-18T02:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ha-epitope-monoclonal-antibody-medi8852,Code name:,MEDI 8852
2020-09-18T02:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ha-epitope-monoclonal-antibody-medi8852,Code name:,MEDI8852
2020-09-18T02:36:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hb-egf-monoclonal-antibody-khk2866,Synonym:,anti-HB-EGF MoAb KHK2866
2020-09-18T02:36:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hb-egf-monoclonal-antibody-khk2866,Code name:,KHK2866
2020-09-18T02:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hbegf-monoclonal-antibody-u3-1565,Code name:,U3-1565
2020-09-18T02:36:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hcd70-car-retroviral-vector-transduced-autologous-pbls,Synonym:,anti-hCD70 autologous CAR-transduced T cells
2020-09-18T02:36:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hcd70-car-retroviral-vector-transduced-autologous-pbls,Synonym:,anti-hCD70 CAR autologous PBLs
2020-09-18T02:36:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hcd70-car-retroviral-vector-transduced-autologous-pbls,Synonym:,anti-hCD70-CAR retroviral vector-transduced autologous peripheral blood lymphocytes
2020-09-18T02:36:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hcv-e2-monoclonal-antibody-mbl-hcv1,Synonym:,MBL-HCV1
2020-09-18T02:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antihemophilic-factor-human-recombinant,Synonym:,Factor VIII
2020-09-18T02:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antihemophilic-factor-human-recombinant,Abbreviation:,FVIII
2020-09-18T02:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antihemophilic-factor-human-recombinant,Code name:,BAY94-9027
2020-09-18T02:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827,Synonym:,ADC A166
2020-09-18T02:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827,Synonym:,anti-HER2 ADC A166
2020-09-18T02:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827,Code name:,A 166
2020-09-18T02:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827,Code name:,A166
2020-09-18T02:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827,Code name:,A-166
2020-09-18T02:37:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-arx788,Synonym:,ADC ARX788
2020-09-18T02:37:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-arx788,Synonym:,anti-HER2 ADC ARX788
2020-09-18T02:37:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-arx788,Code name:,ARX788
2020-09-18T02:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162,Synonym:,ADC BAT8001
2020-09-18T02:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162,Synonym:,anti-HER2 ADC BAT8001
2020-09-18T02:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162,Code name:,BAT 8001
2020-09-18T02:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162,Code name:,BAT8001
2020-09-18T02:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162,Code name:,BAT-8001
2020-09-18T02:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152,Synonym:,ADC DP303c
2020-09-18T02:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152,Synonym:,antibody-drug conjugate DP303c
2020-09-18T02:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152,Code name:,DP-303c
2020-09-18T02:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-medi4276,Synonym:,ADC MEDI4276
2020-09-18T02:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-medi4276,Code name:,MEDI4276
2020-09-18T02:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-medi4276,Code name:,MEDI-4276
2020-09-18T02:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-rc48,Synonym:,ADC RC48
2020-09-18T02:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-rc48,Synonym:,anti-HER2 ADC RC48
2020-09-18T02:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-rc48,Code name:,RC48
2020-09-18T02:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-rc48,Code name:,RC48-ACD
2020-09-18T02:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820,Synonym:,anti-HER2 heterodimeric antibody KN026
2020-09-18T02:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820,Synonym:,HER2 bispecific antibody KN026
2020-09-18T02:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820,Code name:,KN 026
2020-09-18T02:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820,Code name:,KN026
2020-09-18T02:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820,Code name:,KN-026
2020-09-18T02:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798595,Synonym:,anti-HER2 bispecific ADC ZW49
2020-09-18T02:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798595,Code name:,ADC ZW49
2020-09-18T02:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798595,Code name:,ZW49
2020-09-18T02:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798595,Code name:,ZW-49
2020-09-18T02:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798283,Synonym:,anti-HER2 ISAC NJH395
2020-09-18T02:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798283,Code name:,NJH 395
2020-09-18T02:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798283,Code name:,NJH395
2020-09-18T02:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798283,Code name:,NJH395
2020-09-18T02:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798283,Code name:,NJH-395
2020-09-18T02:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802228,Code name:,B 002
2020-09-18T02:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802228,Code name:,B002
2020-09-18T02:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802228,Code name:,B-002
2020-09-18T02:38:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-monoclonal-antibody-ct-p6,Code name:,CT-P06
2020-09-18T02:38:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-monoclonal-antibody-ct-p6,Code name:,CT-P6
2020-09-18T02:38:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801537,Code name:,HLX 22
2020-09-18T02:38:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801537,Code name:,HLX22
2020-09-18T02:38:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801537,Code name:,HLX-22
2020-09-18T02:38:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791831,Code name:,PRS-343
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Synonym:,anti-HER2 x anti-CD3 bispecific monoclonal antibody BTRC 4017A
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Synonym:,anti-HER2 x anti-CD3 bispecific monoclonal antibody RG 6194
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Synonym:,anti-HER2/anti-CD3 bispecific monoclonal antibody 4017A
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,ARG-6194
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,BTRC 4017A
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,BTRC-4017
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,BTRC4017A
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,RG 6194
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,RG6194
2020-09-18T02:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-gbr-1302,Synonym:,anti-HER2 x anti-CD3 bispecific monoclonal antibody GBR 1302
2020-09-18T02:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-gbr-1302,Code name:,GBR1302
2020-09-18T02:38:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794043,Synonym:,anti-HER2 x anti-HER3 bispecific monoclonal antibody MCLA-128
2020-09-18T02:38:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794043,Code name:,MCLA 128
2020-09-18T02:38:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794043,Code name:,MCLA128
2020-09-18T02:38:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794043,Code name:,MCLA-128
2020-09-18T02:38:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-auristatin-payload-antibody-drug-conjugate-xmt-1522,Synonym:,ADC XMT-1522
2020-09-18T02:38:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-auristatin-payload-antibody-drug-conjugate-xmt-1522,Synonym:,anti-HER2 ADC XMT-1522
2020-09-18T02:38:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-auristatin-payload-antibody-drug-conjugate-xmt-1522,Code name:,XMT-1522
2020-09-18T02:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-bi-specific-monoclonal-antibody-zw25,Synonym:,HER2 x HER2 bispecific antibody ZW25
2020-09-18T02:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-bi-specific-monoclonal-antibody-zw25,Code name:,ZW25
2020-09-18T02:38:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801200,Synonym:,anti-HER2/3 DC vaccine
2020-09-18T02:38:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801200,Synonym:,anti-HER2/3 DC vaccine
2020-09-18T02:38:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801200,Synonym:,anti-HER2/3 dendritic cell vaccine
2020-09-18T02:38:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795265,Synonym:,ADC DHES0815A
2020-09-18T02:38:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795265,Synonym:,anti-HER2/PBD-MA ADC DHES0815A
2020-09-18T02:38:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795265,Synonym:,anti-HER2/PBD-monoamide ADC DHES0815A
2020-09-18T02:38:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795265,Code name:,DHES0815A
2020-09-18T02:38:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-car-autologous-cmv-specific-cytotoxic-t-lymphocytes,NA,NA
2020-09-18T02:39:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/629766,Synonym:,anti-Her-2-CAR-engineered autologous PBLs
2020-09-18T02:39:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/629766,Synonym:,anti-Her-2-chimeric antigen receptor-engineered autologous peripheral blood lymphocytes
2020-09-18T02:39:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/629766,Synonym:,CART-HER-2 cells
2020-09-18T02:39:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/629766,Synonym:,HER-2 CAR-expressing autologous T-lymphocytes
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Synonym:,ADC B003
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Synonym:,anti-HER2-DM1 antibody-drug conjugate B003
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Synonym:,recombinant humanized anti-HER2 monoclonal antibody-MCC-DM1 B003
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Code name:,B 003
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Code name:,B003
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Code name:,B-003
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Synonym:,antibody-drug conjugate PF-0680410
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Synonym:,anti-HER2-vcAur0101 ADC PF-06804103
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Synonym:,anti-NG-HER2 ADC PF-06804103
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Synonym:,anti-NG-Her2-vc0101 ADC PF-06804103
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Code name:,PF 06804103
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Code name:,PF06804103
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Code name:,PF-068041033
2020-09-18T02:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-antibody-drug-conjugate-u3-1402,Synonym:,ADC U3 1402
2020-09-18T02:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-antibody-drug-conjugate-u3-1402,Code name:,U3 1402
2020-09-18T02:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-antibody-drug-conjugate-u3-1402,Code name:,U3-1402
2020-09-18T02:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-antibody-drug-conjugate-u3-1402,Code name:,U3-1402a
2020-09-18T02:39:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-monoclonal-antibody-gsk2849330,Code name:,GSK2849330
2020-09-18T02:39:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-monoclonal-antibody-ljm716,Code name:,LJM716
2020-09-18T02:39:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hgf-monoclonal-antibody-tak-701,Synonym:,anti-hepatocyte growth factor monoclonal antibody TAK-701
2020-09-18T02:39:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hgf-monoclonal-antibody-tak-701,Code name:,TAK-701
2020-09-18T02:39:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hif-1alpha-lna-antisense-oligonucleotide-ezn-2968,Code name:,EZN-2968
2020-09-18T02:39:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hif-1alpha-lna-antisense-oligonucleotide-ezn-2968,Code name:,RO7070179
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,anti-HIV-1 lentiviral vector sh5/C46
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,anti-HIV-1 LV-expressing sh5/C46 Cal-1
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,anti-HIV-1 LVsh5/C46
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,Cal-1 vector
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,LVsh5/C46
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,LVsh5/C46 vector
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Code name:,Cal-1
2020-09-18T02:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-a2-ny-eso-1-tcr-transduced-autologous-t-lymphocytes,Synonym:,anti-HLA-A2/NY-ESO1 TCR-transduced autologous T cells
2020-09-18T02:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-a2-ny-eso-1-tcr-transduced-autologous-t-lymphocytes,Synonym:,autologous anti-HLA-A2/NY-ESO1 TCR-transduced T lymphocytes
2020-09-18T02:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-a2-ny-eso-1-tcr-transduced-autologous-t-lymphocytes,Synonym:,autologous HLA-A2/NY-ESO-1-specific TCR gene-transduced T lymphocytes
2020-09-18T02:39:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-dr-monoclonal-antibody-immu-114,Synonym:,anti-HLA-DR moAb L243
2020-09-18T02:39:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-dr-monoclonal-antibody-immu-114,Synonym:,hL243gamma4P
2020-09-18T02:39:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-dr-monoclonal-antibody-immu-114,Code name:,IMMU-114
2020-09-18T02:40:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-chorionic-gonadotropin-vaccine,NA,NA
2020-09-18T02:40:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-gitr-monoclonal-antibody-trx518,Synonym:,anti-huGITR monoclonal antibody TRX518
2020-09-18T02:40:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-gitr-monoclonal-antibody-trx518,Abbreviation:,anti-huGITR mAb TRX518
2020-09-18T02:40:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-gitr-monoclonal-antibody-trx518,Abbreviation:,anti-huGITR MoAb TRX518
2020-09-18T02:40:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-gitr-monoclonal-antibody-trx518,Code name:,TRX518
2020-09-18T02:40:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-integrin-alpha-v-subunit-monoclonal-antibody-emd-525797,Synonym:,anti-human CD51 monoclonal antibody EMD 525797
2020-09-18T02:40:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-integrin-alpha-v-subunit-monoclonal-antibody-emd-525797,Code name:,EMD 525797
2020-09-18T02:40:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icam-1-monoclonal-antibody-bi-505,Synonym:,anti-intercellular adhesion molecule-1 monoclonal antibody BI-505
2020-09-18T02:40:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icam-1-monoclonal-antibody-bi-505,Code name:,BI-505
2020-09-18T02:40:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-agonist-antibody-gsk3359609,Code name:,GSK3359609
2020-09-18T02:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161,Synonym:,anti-ICOS BMS-986226
2020-09-18T02:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161,Synonym:,anti-inducible T-cell co-stimulator BMS-986226
2020-09-18T02:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161,Code name:,BMS 986226
2020-09-18T02:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161,Code name:,BMS986226
2020-09-18T02:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161,Code name:,BMS-986226
2020-09-18T02:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798819,Synonym:,anti-ICOS antibody KY1044
2020-09-18T02:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798819,Code name:,KY 1044
2020-09-18T02:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798819,Code name:,KY1044
2020-09-18T02:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798819,Code name:,KY-1044
2020-09-18T02:40:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-monoclonal-antibody-medi-570,Code name:,MEDI-570
2020-09-18T02:40:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf1-2-monoclonal-antibody-medi-573,Synonym:,anti-insulin-like growth factor 1/2 monoclonal antibody MEDI-573
2020-09-18T02:40:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf1-2-monoclonal-antibody-medi-573,Code name:,MEDI-573
2020-09-18T02:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf-1r-monoclonal-antibody-ave1642,Synonym:,anti-CD122 monoclonal antibody AVE1642
2020-09-18T02:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf-1r-monoclonal-antibody-ave1642,Code name:,AVE1642
2020-09-18T02:40:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf-1r-recombinant-monoclonal-antibody-biib022,Code name:,BIIB022
2020-09-18T02:40:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-1-alpha-monoclonal-antibody-ca-18c3,Code name:,CA-18C3
2020-09-18T02:41:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-13-humanized-monoclonal-antibody-tnx-650,Synonym:,monoclonal antibody TNX-650
2020-09-18T02:41:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-13-humanized-monoclonal-antibody-tnx-650,Code name:,TNX-650
2020-09-18T02:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatinib,Synonym:,ATAN
2020-09-18T02:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatinib,Foreign brand name:,Aitan
2020-09-18T02:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatinib,Foreign brand name:,Rivoceranib
2020-09-18T02:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatinib,Code name:,YN968D1
2020-09-18T02:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-15-monoclonal-antibody-amg-714,Synonym:,HuMab-IL15 AMG 714
2020-09-18T02:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-15-monoclonal-antibody-amg-714,Code name:,AMG 714
2020-09-18T02:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-15-monoclonal-antibody-amg-714,Code name:,AMG714
2020-09-18T02:41:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792169,Code name:,CJM 112
2020-09-18T02:41:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792169,Code name:,CJM112
2020-09-18T02:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258,Synonym:,dectrekumab/VAK296
2020-09-18T02:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258,Code name:,QBX258
2020-09-18T02:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258,Code name:,QBX-258
2020-09-18T02:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258,Code name:,VAK694 plus QAX576
2020-09-18T02:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258,Code name:,VAK694/QAX576
2020-09-18T02:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-humax-il8,Synonym:,BMS-986253
2020-09-18T02:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-humax-il8,Code name:,HuMax-IL8
2020-09-18T02:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-humax-il8,Code name:,MDX 018
2020-09-18T02:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-humax-il8,Code name:,MDX-018
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Synonym:,anti-ILDR2 inhibitor BAY1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Synonym:,anti-immunoglobulin-like domain containing receptor 2 MoAb BAY1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Synonym:,ILDR2 function-blocking antibody BAY1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Synonym:,immune checkpoint inhibitor BAY1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Code name:,BAY 1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Code name:,BAY1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Code name:,BAY-1905254
2020-09-18T02:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844,Synonym:,anti-leukocyte immunoglobulin-like receptor 2 monoclonal antibody MK-4830
2020-09-18T02:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844,Synonym:,anti-LIR2 monoclonal antibody MK-4830
2020-09-18T02:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844,Code name:,MK 4830
2020-09-18T02:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844,Code name:,MK4830
2020-09-18T02:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844,Code name:,MK-4830
2020-09-18T02:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antibody-alxn1007,Code name:,ALXN 1007
2020-09-18T02:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antibody-alxn1007,Code name:,ALXN1007
2020-09-18T02:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antibody-alxn1007,Code name:,ALXN-1007
2020-09-18T02:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antimicrobial-analgesic-aqueous-mouth-rinse,Synonym:,Dentoxol mouthrinse
2020-09-18T02:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antimicrobial-analgesic-aqueous-mouth-rinse,Foreign brand name:,Dentoxol
2020-09-18T02:41:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-integrin-monoclonal-antibody-dm4-immunoconjugate-imgn388,Synonym:,integrin-targeted immunoconjugate IMGN388
2020-09-18T02:41:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-integrin-monoclonal-antibody-dm4-immunoconjugate-imgn388,Code name:,IMGN388
2020-09-18T02:42:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-6-monoclonal-antibody-ald518,Synonym:,anti-IL6 monoclonal antibody ALD518
2020-09-18T02:42:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-6-monoclonal-antibody-ald518,Code name:,ALD518
2020-09-18T02:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-1-alpha-monoclonal-antibody-mabp1,Synonym:,Anti-IL-1 alpha monoclonal antibody MABp1
2020-09-18T02:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-1-alpha-monoclonal-antibody-mabp1,Synonym:,Anti-IL-1amonoclonal antibody
2020-09-18T02:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-1-alpha-monoclonal-antibody-mabp1,US brand name:,Xilonix
2020-09-18T02:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-1-alpha-monoclonal-antibody-mabp1,Code name:,MABp1
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Synonym:,anti-IRF4 ASO ION251
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Synonym:,anti-IRF4 ASO IONIS-IRF4-2.5Rx
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Synonym:,IONIS-IRF4-2.5Rx
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Code name:,ION 251
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Code name:,ION251
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Code name:,ION-251
2020-09-18T02:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir-monoclonal-antibody-ihp-2101,Code name:,1-7F9
2020-09-18T02:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir-monoclonal-antibody-ihp-2101,Code name:,IPH 2101
2020-09-18T02:42:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir3dl2-monoclonal-antibody-iph4102,Synonym:,anti-KIR3DL2 mAb IPH4102
2020-09-18T02:42:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir3dl2-monoclonal-antibody-iph4102,Code name:,IPH4102
2020-09-18T02:42:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796467,Synonym:,anti-KRAS G12D mTCR autologous PBL
2020-09-18T02:42:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796467,Synonym:,anti-K-RAS G12D mTCR-transduced autologous PBLs
2020-09-18T02:42:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796467,Synonym:,anti-KRAS G12D mTCR-transduced autologous peripheral blood lymphocytes
2020-09-18T02:42:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796467,Synonym:,autologous PBL transduced with anti-KRAS G12D mTCR
2020-09-18T02:42:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-k-ras-g12v-mtcr-transduced-autologous-peripheral-blood-lymphocytes,Synonym:,anti-K-RAS G12V mTCR-transduced autologous PBLs
2020-09-18T02:42:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-k-ras-g12v-mtcr-transduced-autologous-peripheral-blood-lymphocytes,Synonym:,anti-KRAS G12V mTCR-transduced autologous peripheral blood lymphocytes
2020-09-18T02:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792749,Synonym:,anti LAG-3 MoAb
2020-09-18T02:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792749,Synonym:,anti-LAG-3 monoclonal antibody
2020-09-18T02:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792749,Code name:,BI 754111
2020-09-18T02:42:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800401,Synonym:,anti-LAG-3 monoclonal antibody IBI110
2020-09-18T02:42:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800401,Code name:,IBI 110
2020-09-18T02:42:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800401,Code name:,IBI110
2020-09-18T02:42:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800401,Code name:,IBI-110
2020-09-18T02:42:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-lag525,Code name:,LAG525
2020-09-18T02:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-mk-4280,Code name:,MK 4280
2020-09-18T02:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-mk-4280,Code name:,MK4280
2020-09-18T02:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-mk-4280,Code name:,MK-4280
2020-09-18T02:43:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-regn3767,Synonym:,anti-LAG-3 MoAb REGN3767
2020-09-18T02:43:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-regn3767,Code name:,REGN 3767
2020-09-18T02:43:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-regn3767,Code name:,REGN3767
2020-09-18T02:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795379,Code name:,Sym 022
2020-09-18T02:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795379,Code name:,Sym022
2020-09-18T02:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795379,Code name:,Sym-022
2020-09-18T02:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033,Synonym:,anti-LAG-3 monoclonal antibody TSR-033
2020-09-18T02:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033,Synonym:,anti-lymphocyte activation gene 3 protein monoclonal antibody TSR-033
2020-09-18T02:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033,Code name:,TSR 033
2020-09-18T02:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033,Code name:,TSR033
2020-09-18T02:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033,Code name:,TSR-033
2020-09-18T02:43:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793522,Synonym:,LAG-3/PD-L1 bispecific antibody FS118
2020-09-18T02:43:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793522,Synonym:,LAG-3/PD-L1 Mab2 FS118
2020-09-18T02:43:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793522,Synonym:,Mab2 FS118
2020-09-18T02:43:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793522,Code name:,FS118
2020-09-18T02:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lamp1-antibody-drug-conjugate-sar428926,Synonym:,anti-LAMP1 ADC SAR428926
2020-09-18T02:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lamp1-antibody-drug-conjugate-sar428926,Code name:,ADC SAR428926
2020-09-18T02:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lamp1-antibody-drug-conjugate-sar428926,Code name:,SAR428926
2020-09-18T02:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ley-car-transduced-autologous-t-lymphocytes,Synonym:,autologous-derived LeY-targeted CAR-T cells
2020-09-18T02:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ley-car-transduced-autologous-t-lymphocytes,Synonym:,LeY-targeted autologous CAR-T cells
2020-09-18T02:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ley-car-transduced-autologous-t-lymphocytes,Synonym:,LeY-targeted CAR-T cells
2020-09-18T02:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lgr5-monoclonal-antibody-bnc101,Synonym:,ET-101
2020-09-18T02:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lgr5-monoclonal-antibody-bnc101,Code name:,BNC101
2020-09-18T02:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lgr5-monoclonal-antibody-bnc101,Code name:,BNC-101
2020-09-18T02:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795377,Code name:,MSC 1
2020-09-18T02:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795377,Code name:,MSC1
2020-09-18T02:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795377,Code name:,MSC-1
2020-09-18T02:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-loxl2-monoclonal-antibody-gs-6634,Code name:,AB0024
2020-09-18T02:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-loxl2-monoclonal-antibody-gs-6634,Code name:,GS-6624
2020-09-18T02:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ly6e-antibody-drug-conjugate-dlye5953a,Synonym:,ADC DLYE5953A
2020-09-18T02:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ly6e-antibody-drug-conjugate-dlye5953a,Code name:,DLYE5953A
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Synonym:,ImmTAC IMC-C103C
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Synonym:,ImmTAC Molecule IMC-C103C
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Synonym:,immune mobilizing monoclonal TCR against cancer IMC-C103C
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Synonym:,T-cell redirecting bi-specific biologic IMC-C103C
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Code name:,IMC C103C
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Code name:,IMCC103C
2020-09-18T02:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-masp-2-monoclonal-antibody-oms721,Code name:,OMS721
2020-09-18T02:44:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-m-csf-monoclonal-antibody-mcs110,Code name:,MCS110
2020-09-18T02:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-antibody-drug-conjugate-bms-986148,Code name:,BMS-986148
2020-09-18T02:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-vector-transduced-autologous-t-lymphocytes,Synonym:,anti-meso-CAR vector-transduced autologous T cells
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Synonym:,anti-mesothelin recombinant cytolytic fusion protein RO6927005
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Synonym:,anti-MSLN cFP RO6927005
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Synonym:,anti-MSLN-PE24 cFP LMB-100
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,LMB-100
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,RG 7787
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,RG7787
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,RG-7787
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,RO 6927005
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,RO6927005
2020-09-18T02:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-icasp9m28z-car-transduced-autologous-t-lymphocytes,Synonym:,iCasp9M28z T cells
2020-09-18T02:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312,Synonym:,anti-mesothelin/MMAE ADC RC88
2020-09-18T02:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312,Code name:,ADC RC88
2020-09-18T02:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312,Code name:,RC 88
2020-09-18T02:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312,Code name:,RC88
2020-09-18T02:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312,Code name:,RC-88
2020-09-18T02:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes,Synonym:,anti-mesothelin CIR mRNA-electroporated autologous T cells
2020-09-18T02:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes,Synonym:,autologous anti-mesothelin mRNA-transfected CIR T cells
2020-09-18T02:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes,Synonym:,autologous redirected RNA meso-CIR T cells
2020-09-18T02:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes,Synonym:,meso-CART
2020-09-18T02:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes,Abbreviation:,CART-meso
2020-09-18T02:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-monoclonal-antibody-mixture-sym015,Synonym:,Hu9006/Hu9338
2020-09-18T02:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-monoclonal-antibody-mixture-sym015,Synonym:,Hu9006-Hu9338
2020-09-18T02:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-monoclonal-antibody-mixture-sym015,Code name:,Sym015
2020-09-18T02:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-monoclonal-antibody-mixture-sym015,Code name:,Sym-015
2020-09-18T02:44:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-egfr-monoclonal-antibody-ly3164530,Code name:,LY3164530
2020-09-18T02:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antimetabolite-ff-10502,Code name:,FF-10502
2020-09-18T02:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antimetabolite-ff-10502,Code name:,FF-10502-01
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,anti-MiHA donor T lymphocytes
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,anti-MiHA T cells
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,GLIDE
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,GLIDE cells
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,GLIDE T lymphocytes
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,guided lymphocyte immunopeptide derived expansion against MiHAs cells
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,guided lymphocyte immunopeptide-derived expansion cells
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,MiHA T lympocytes
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,MiHA-specific T cells
2020-09-18T02:45:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mmp-9-monoclonal-antibody-gs-5745,Code name:,GS-5745
2020-09-18T02:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc1-car-transduced-autologous-t-lymphocytes,Synonym:,anti-MUC1 CAR T Cells
2020-09-18T02:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc1-car-transduced-autologous-t-lymphocytes,Synonym:,anti-MUC1 CAR-transduced autologous T cells
2020-09-18T02:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc1-car-transduced-autologous-t-lymphocytes,Synonym:,anti-mucin1 autologous CAR T cells
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Synonym:,bispecific T-cell engager antibody REGN4018
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Synonym:,MUC16/CD3-directed bispecific T-cell engager antibody REGN4018
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Synonym:,MUC16xCD3 bispecific T-cell engager REGN4018
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Code name:,REGN 4018
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Code name:,REGN4018
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Code name:,REGN-4018
2020-09-18T02:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792380,Synonym:,ADC DMUC4064A
2020-09-18T02:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792380,Synonym:,THIOMAB-drug conjugate DMUC4064A
2020-09-18T02:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792380,Code name:,DMUC4064A
2020-09-18T02:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792380,Code name:,RG7882
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,anti-MUC17 x anti-CD3 BiTE AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,anti-MUC17/CD3 bispecific antibody AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,bispecific T-cell engager antibody AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,BiTE antibody AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,MUC17/CD3-directed bispecific T-cell engager antibody AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,MUC17xCD3 bispecific T-cell engager AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Code name:,AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Code name:,AMG199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Code name:,AMG-199
2020-09-18T02:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-myeloma-monoclonal-antibody-dm4-immunoconjugate-bt-062,Synonym:,maytansinoid-conjugated anti-myeloma monoclonal antibody BT-062
2020-09-18T02:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-myeloma-monoclonal-antibody-dm4-immunoconjugate-bt-062,Code name:,BT-062
2020-09-18T02:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-myostatin-monoclonal-antibody-ly2495655,Code name:,LY2495655
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Synonym:,anti-NaPi2b ADC XMT-1592
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Synonym:,anti-NaPi2b/auristatin F-HPA ADC XMT-1592
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Synonym:,NaPi2b-targeted antibody-drug conjugate XMT-1592
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Code name:,XMT 1592
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Code name:,XMT1592
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Code name:,XMT-1592
2020-09-18T02:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494,Synonym:,anti-NaPi2b MoAb XMT-1535
2020-09-18T02:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494,Synonym:,MoAb XMT-1535
2020-09-18T02:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494,Code name:,XMT 1535
2020-09-18T02:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494,Code name:,XMT1535
2020-09-18T02:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494,Code name:,XMT-1535
2020-09-18T02:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-napi2b-mmae-antibody-drug-conjugate-dnib0600a,Synonym:,ADC DNIB0600A
2020-09-18T02:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-napi2b-mmae-antibody-drug-conjugate-dnib0600a,Code name:,DNIB0600A
2020-09-18T02:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nectin-4-monoclonal-antibody-drug-conjugate-ags-22m6e,Code name:,AGS-22M6E
2020-09-18T02:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-a10,US brand name:,Atengenal
2020-09-18T02:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-a10,Abbreviation:,A10
2020-09-18T02:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-a10,Chemical structure:,"3-phenylacetylamino-2, 6-piperidinedionebenzeneacetamide, N-(2,6-dioxo-3-piperidinyl)-, (S)-"
2020-09-18T02:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-as2-1,US brand name:,Astugenal
2020-09-18T02:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-as2-1,Abbreviation:,AS2-1
2020-09-18T02:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-as2-1,Chemical structure:,"L-glutamine, N2-(phenylacetyl)-, monosodium salt, mixture with sodium benzeneacetate"
2020-09-18T02:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-neuropilin-1-monoclonal-antibody-mnrp1685a,Code name:,MNRP1685A
2020-09-18T02:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nf-p2x7-antibody-ointment-bil-010t,Synonym:,BSCT 10 % ointment
2020-09-18T02:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nf-p2x7-antibody-ointment-bil-010t,Code name:,BIL-010t
2020-09-18T02:46:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nucleolin-aptamer-as1411,Code name:,AS1411
2020-09-18T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792389,Synonym:,anti-NY-ESO-1 TCR transduced autologous T cells TAEST16001
2020-09-18T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792389,Synonym:,NY-ESO-1 antigen specific affinity-enhanced TCR transduced autologous T cells
2020-09-18T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792389,Code name:,TAEST 16001
2020-09-18T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792389,Code name:,TAEST16001
2020-09-18T03:42:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ny-eso1-tcr-transduced-autologous-cd62l-derived-t-lymphocytes,Synonym:,autologous CD62L+-derived T lymphocytes transduced with NY-ESO-1-specific TCR
2020-09-18T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793936,Synonym:,bispecific NY-ESO-1- and LAGE-1A-specific TCR/anti-CD3
2020-09-18T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793936,Synonym:,HLA- A*0201-restricted NY-ESO-1- and LAGE-1A-specific soluble TCR/anti-CD3 bispecific molecule
2020-09-18T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793936,Code name:,IMCnyeso
2020-09-18T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559,Synonym:,agonistic anti-OX40 monoclonal antibody ABBV-368
2020-09-18T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559,Synonym:,anti-OX40 agonistic monoclonal antibody ABBV-368
2020-09-18T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559,Code name:,ABBV 368
2020-09-18T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559,Code name:,ABBV368
2020-09-18T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559,Code name:,ABBV-368
2020-09-18T03:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-antibody-bms-986178,Code name:,BMS 986178
2020-09-18T03:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-antibody-bms-986178,Code name:,BMS-986178
2020-09-18T03:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-antibody-pf-04518600,Code name:,PF-04518600
2020-09-18T03:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody,Synonym:,anti-CD134 monoclonal antibody
2020-09-18T03:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody,Abbreviation:,anti-CD134 MoAb
2020-09-18T03:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody,Abbreviation:,anti-OX40 MoAb
2020-09-18T03:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797150,Code name:,IBI 101
2020-09-18T03:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797150,Code name:,IBI101
2020-09-18T03:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797150,Code name:,IBI-101
2020-09-18T03:43:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody-medi0562,Code name:,MEDI0562
2020-09-18T03:43:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody-medi0562,Code name:,MEDI-0562
2020-09-18T03:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-p53-t-cell-receptor-transduced-peripheral-blood-lymphocytes,Synonym:,Anti-p53 TCR Retroviral Vector-Transduced PBL
2020-09-18T03:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-p53-t-cell-receptor-transduced-peripheral-blood-lymphocytes,Synonym:,Anti-p53 TCR-Transduced PBL
2020-09-18T03:43:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-fusion-protein-amp-224,Code name:,AMP-224
2020-09-18T03:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801688,Code name:,609 A
2020-09-18T03:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801688,Code name:,609A
2020-09-18T03:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801688,Code name:,609-A
2020-09-18T03:43:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-monoclonal-antibody-agen2034,Code name:,AGEN 2034
2020-09-18T03:43:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-monoclonal-antibody-agen2034,Code name:,AGEN2034
2020-09-18T03:43:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794779,Code name:,AK 105
2020-09-18T03:43:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794779,Code name:,AK105
2020-09-18T03:43:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794779,Code name:,AK-105
2020-09-18T03:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798431,Code name:,AMG 404
2020-09-18T03:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798431,Code name:,AMG404
2020-09-18T03:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798431,Code name:,AMG-404
2020-09-18T03:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792520,Code name:,BCD 100
2020-09-18T03:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792520,Code name:,BCD100
2020-09-18T03:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792520,Code name:,BCD-100
2020-09-18T03:43:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-bi-754091,Code name:,BI 754091
2020-09-18T03:43:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798724,Code name:,F 520
2020-09-18T03:43:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798724,Code name:,F520
2020-09-18T03:43:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798724,Code name:,F-520
2020-09-18T03:43:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797959,Code name:,HX 008
2020-09-18T03:43:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797959,Code name:,HX008
2020-09-18T03:43:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797959,Code name:,HX-008
2020-09-18T03:44:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796722,Code name:,JTX 4014
2020-09-18T03:44:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796722,Code name:,JTX4014
2020-09-18T03:44:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796722,Code name:,JTX-4014
2020-09-18T03:44:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793463,Synonym:,LZM009
2020-09-18T03:44:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793463,Code name:,LZM 009
2020-09-18T03:44:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793463,Code name:,LZM-009
2020-09-18T03:44:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-medi0680,Synonym:,antprogrammed cell death 1 monoclonal antibody AMP-514
2020-09-18T03:44:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-medi0680,Code name:,AMP-514
2020-09-18T03:44:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-medi0680,Code name:,MEDI0680
2020-09-18T03:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012,Code name:,INCMGA 0012
2020-09-18T03:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012,Code name:,INCMGA00012
2020-09-18T03:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012,Code name:,INCMGA-0012
2020-09-18T03:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012,Code name:,MGA 012
2020-09-18T03:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012,Code name:,MGA012
2020-09-18T03:44:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-sym021,Synonym:,anti-PD1 monoclonal antibody Sym021
2020-09-18T03:44:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-sym021,Code name:,Sym021
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Synonym:,anti-PD-1/anti-CTLA-4 monoclonal antibody mixture PSB205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Synonym:,anti-PD1/CTLA4 antibodies PSB205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Synonym:,anti-PD-1/CTLA-4 MabPair PSB205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Synonym:,bifunctional MabPair product PSB205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Code name:,PSB 205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Code name:,PSB205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Code name:,PSB-205
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Synonym:,bispecific DART protein MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Synonym:,dual-affinity retargeting protein MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Synonym:,PD-1 x CTLA4 bispecific DART molecule MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Synonym:,PD-1 x CTLA4 DART protein MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Synonym:,PD-1 x CTLA4 DART protein MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Code name:,MGD 019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Code name:,MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Code name:,MGD-019
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Synonym:,HER2/PD-1 bi-specific antibody BH 2950
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,BH 2950
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,BH2950
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,BH-2950
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,IBI 315
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,IBI315
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,IBI-315
2020-09-18T03:44:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801886,Synonym:,anti-PD1/anti-LAG3 bispecific antibody RO7247669
2020-09-18T03:44:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801886,Code name:,RO 7247669
2020-09-18T03:44:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801886,Code name:,RO7247669
2020-09-18T03:44:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801886,Code name:,RO-7247669
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Synonym:,bispecific DART protein MGD013
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Synonym:,dual-affinity retargeting protein MGD013
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Synonym:,PD-1 x LAG-3 bispecific DART molecule MGD013
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Synonym:,PD-1 x LAG-3 DART molecule MGD013
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Synonym:,PD-1 x LAG-3 DART protein MGD013
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Code name:,MGD013
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Synonym:,anti-PD-1/PD-L1 bispecific antibody IBI318
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Synonym:,bispecific antibody IBI318
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Synonym:,recombinant anti-PD-1/anti-PD-L1 bispecific antibody IBI318
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Code name:,IBI 318
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Code name:,IBI318
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Code name:,IBI-318
2020-09-18T03:45:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801671,Synonym:,anti-PD-1/PD-L1 bispecific antibody LY3434172
2020-09-18T03:45:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801671,Synonym:,bispecific antibody LY3434172
2020-09-18T03:45:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801671,Code name:,LY 3434172
2020-09-18T03:45:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801671,Code name:,LY3434172
2020-09-18T03:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800318,Synonym:,anti-PD1/CD47 bi-specific antibody fusion protein HX009
2020-09-18T03:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800318,Code name:,HX 009
2020-09-18T03:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800318,Code name:,HX009
2020-09-18T03:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800318,Code name:,HX-009
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Synonym:,anti-PD-1 x CTLA-4 bispecific antibody AK104
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Synonym:,anti-PD1/anti-CTLA4 bispecific antibody AK104
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Synonym:,PD-1 x CTLA-4 dual checkpoint inhibitor AK104
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Code name:,AK 104
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Code name:,AK104
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Code name:,AK-104
2020-09-18T03:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410,Synonym:,anti-PD-1/anti-CTLA-4 XmAb20717
2020-09-18T03:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410,Synonym:,PD-1 x CTLA-4 bispecific antibody XmAb20717
2020-09-18T03:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410,Synonym:,PD-1 x CTLA-4 dual checkpoint inhibitor XmAb20717
2020-09-18T03:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410,Code name:,XmAb 20717
2020-09-18T03:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410,Code name:,XmAb20717
2020-09-18T03:45:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973,Synonym:,anti-PD1/anti-ICOS bispecific monoclonal antibody XmAb23104
2020-09-18T03:45:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973,Synonym:,PD1 x ICOS bispecific monoclonal antibody XmAb23104
2020-09-18T03:45:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973,Code name:,XmAb 23104
2020-09-18T03:45:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973,Code name:,XmAb23104
2020-09-18T03:45:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973,Code name:,XmAb-23104
2020-09-18T03:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892,Synonym:,anti-PD-1 x TIM-3 bispecific antibody RO7121661
2020-09-18T03:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892,Synonym:,anti-PD-1/anti-TIM-3 bispecific antibody RO7121661
2020-09-18T03:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892,Code name:,RO 7121661
2020-09-18T03:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892,Code name:,RO7121661
2020-09-18T03:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892,Code name:,RO-7121661
2020-09-18T03:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdgfr-alpha-monoclonal-antibody-medi-575,Synonym:,anti-platelet-derived growth factor receptor alpha monoclonal antibody MEDI-575
2020-09-18T03:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdgfr-alpha-monoclonal-antibody-medi-575,Code name:,MEDI-575
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,A 167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,A167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,A-167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,KL A167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,KL A167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,KLA167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,KL-A167
2020-09-18T03:45:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795701,Code name:,BCD 135
2020-09-18T03:45:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795701,Code name:,BCD135
2020-09-18T03:45:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795701,Code name:,BCD-135
2020-09-18T03:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794412,Code name:,BGB A333
2020-09-18T03:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794412,Code name:,BGBA333
2020-09-18T03:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794412,Code name:,BGB-A333
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Synonym:,anti-PD-L1 monoclonal antibody TQB2450
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,CBT 502
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,CBT502
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,CBT-502
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,TQB 2450
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,TQB2450
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,TQB-2450
2020-09-18T03:45:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793157,Code name:,CK 301
2020-09-18T03:45:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793157,Code name:,CK-301
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Synonym:,anti-PD-L1 monoclonal antibody WBP 3155
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,CS 1001
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,CS1001
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,CS-1001
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,WBP 3155
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,WBP-3155
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,WPB3155
2020-09-18T03:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-faz053,Code name:,FAZ 053
2020-09-18T03:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-faz053,Code name:,FAZ053
2020-09-18T03:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-faz053,Code name:,FAZ-053
2020-09-18T03:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799415,Synonym:,PD-L1-targeting Monoclonal Antibody HLX20
2020-09-18T03:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799415,Code name:,HLX 20
2020-09-18T03:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799415,Code name:,HLX20
2020-09-18T03:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799415,Code name:,HLX-20
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,IMC 001
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,IMC001
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,IMC-001
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,STI 3031
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,STI3031
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,STI-3031
2020-09-18T03:46:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-kn035,Synonym:,anti-PD-L1 MoAb KN035
2020-09-18T03:46:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-kn035,Synonym:,KN 035
2020-09-18T03:46:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-kn035,Synonym:,KN035
2020-09-18T03:46:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-mdx-1105,Code name:,MDX-1105
2020-09-18T03:46:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264,Synonym:,anti-PDL1 monoclonal antibody MSB2311
2020-09-18T03:46:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264,Synonym:,humanized anti-PD-L1 monoclonal antibody MSB2311
2020-09-18T03:46:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264,Code name:,MSB 2311
2020-09-18T03:46:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264,Code name:,MSB2311
2020-09-18T03:46:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264,Code name:,MSB-2311
2020-09-18T03:46:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792709,Code name:,HTI-1088
2020-09-18T03:46:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792709,Code name:,SHR-1316
2020-09-18T03:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797005,Synonym:,anti-PDL1 monoclonal antibody TG-1501
2020-09-18T03:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797005,Code name:,TG 1501
2020-09-18T03:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797005,Code name:,TG1501
2020-09-18T03:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797005,Code name:,TG-1501
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Synonym:,anti-PDL1 monoclonal antibody ZKAB001
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Synonym:,STI-A1014
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Code name:,STI A1014
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Code name:,STIA1014
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Code name:,ZKAB 001
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Code name:,ZKAB001
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Code name:,ZKAB-001
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Synonym:,anti-PD-L1/CD137 bispecific antibody INBRX-105
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Synonym:,PDL1 x 41BB bispecific antibody INBRX-105
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Synonym:,PDL1 x CD137 bispecific antibody INBRX-105
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Code name:,ES101
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Code name:,INBRX 105
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Code name:,INBRX105
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Code name:,INBRX-105
2020-09-18T03:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801584,Synonym:,duoBody PD-L1 x 4-1BB GEN1046
2020-09-18T03:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801584,Code name:,BNT 311
2020-09-18T03:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801584,Code name:,GEN 1046
2020-09-18T03:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801584,Code name:,GEN-1046
2020-09-18T03:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796892,Synonym:,anti-PD-L1 x CTLA-4 bispecific antibody KN046
2020-09-18T03:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796892,Code name:,KN 046
2020-09-18T03:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796892,Code name:,KN046
2020-09-18T03:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796892,Code name:,KN-046
2020-09-18T03:47:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796576,Code name:,LY 3415244
2020-09-18T03:47:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796576,Code name:,LY3415244
2020-09-18T03:47:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796576,Code name:,LY-3415244
2020-09-18T03:47:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antiperspirant-cream-f511,Synonym:,F511 cream
2020-09-18T03:47:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pgf-monoclonal-antibody-ro5323441,Code name:,RO5323441
2020-09-18T03:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pkn3-sirna-atu027,Synonym:,anti-protein kinase N3 siRNA Atu027
2020-09-18T03:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pkn3-sirna-atu027,Code name:,Atu027
2020-09-18T03:47:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-plgf-monoclonal-antibody-tb-403,Synonym:,anti-placental growth factor monoclonal antibody TB-403
2020-09-18T03:47:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-plgf-monoclonal-antibody-tb-403,Code name:,TB-403
2020-09-18T03:47:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pr1-hla-a2-monoclonal-antibody-hu8f4,Code name:,Hu8F4
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Synonym:,ImmTAC IMC-F106C
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Synonym:,ImmTAC molecule IMC-F106C
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Synonym:,immune mobilizing monoclonal TCR against cancer IMC-F106C
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Code name:,IMC F106C
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Code name:,IMCF106C
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Code name:,IMC-F106C
2020-09-18T03:47:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793124,Synonym:,PRL3 zumab
2020-09-18T03:47:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793124,Synonym:,PRL3-zumab
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Synonym:,anti-PD-1 antibody expressing pluripotent killer T cells
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Synonym:,anti-PD-1 antibody expressing pluripotent killer T lymphocytes
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Synonym:,anti-PDCD1 antibody expressing pluripotent killer T cells
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Synonym:,anti-PDCD1 antibody expressing pluripotent killer T lymphocytes
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Synonym:,anti-programmed cell death protein 1 antibody expressing pluripotent killer T cells
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Code name:,PIK-PD-1
2020-09-18T03:48:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-prolactin-receptor-antibody-lfa102,Code name:,LFA102
2020-09-18T03:48:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psca-fully-human-monoclonal-antibody-ags-1c4d4,Code name:,AGS-PSCA
2020-09-18T03:48:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mdx1201-a488,Code name:,MDX1201
2020-09-18T03:48:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mdx1201-a488,Code name:,MDX1201-A488
2020-09-18T03:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mmae-conjugate,Synonym:,anti-PSMA monoclonal antibody-monomethylauristatin E conjugate
2020-09-18T03:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mmae-conjugate,Synonym:,prostate-specific membrane antigen antibody-drug conjugate
2020-09-18T03:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mmae-conjugate,Abbreviation:,anti-PSMA-MMAE-ADC
2020-09-18T03:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mmae-conjugate,Code name:,PSMA ADC
2020-09-18T03:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093,Synonym:,anti-PSMA/anti-CD28 bispecific antibody REGN5678
2020-09-18T03:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093,Synonym:,anti-PSMAxCD28 antibody REGN5678
2020-09-18T03:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093,Code name:,REGN 5678
2020-09-18T03:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093,Code name:,REGN5678
2020-09-18T03:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093,Code name:,REGN-5678
2020-09-18T03:48:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800617,Code name:,CCW 702
2020-09-18T03:48:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800617,Code name:,CCW702
2020-09-18T03:48:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800617,Code name:,CCW-702
2020-09-18T03:48:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801628,Code name:,JNJ 63898081
2020-09-18T03:48:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801628,Code name:,JNJ63898081
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Synonym:,anti-PSMA/CD3 bispecific T-cell engager antibody AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Synonym:,bispecific T-cell engager antibody AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Synonym:,BITE AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Synonym:,half-life extended bispecific T-cell engager antibody AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Synonym:,HLE-BiTE AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Code name:,AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Code name:,AMG160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Code name:,AMG-160
2020-09-18T03:48:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-monoclonal-antibody-mt112,Code name:,BAY2010112
2020-09-18T03:48:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-monoclonal-antibody-mt112,Code name:,MT112
2020-09-18T03:48:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-monoclonal-antibody-mor209-es414,Code name:,MOR209/ES414
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Synonym:,ADC MEDI3726
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Synonym:,ADCT 401 ADCT401
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Code name:,ADCT-401
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Code name:,MEDI 3726
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Code name:,MEDI3726
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Code name:,MEDI-3726
2020-09-18T03:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463,Synonym:,anti-poliovirus receptor-related immunoglobulin COM701
2020-09-18T03:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463,Synonym:,PVRIG inhibitor COM701
2020-09-18T03:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463,Code name:,COM 701
2020-09-18T03:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463,Code name:,COM701
2020-09-18T03:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463,Code name:,COM-701
2020-09-18T03:49:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802325,Code name:,GB 223
2020-09-18T03:49:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802325,Code name:,GB223
2020-09-18T03:49:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802325,Code name:,GB-223
2020-09-18T03:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797160,Synonym:,anti-ROR1 antibody-drug conjugate VLS-101
2020-09-18T03:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797160,Code name:,VLS 101
2020-09-18T03:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797160,Code name:,VLS101
2020-09-18T03:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797160,Code name:,VLS-101
2020-09-18T03:49:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-rspo3-monoclonal-antibody-omp-131r10,Code name:,OMP-131R10
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Synonym:,anti-RSV F nanobody ALX-0171
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Synonym:,anti-RSV protein F nanobody ALX-0171
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Synonym:,RSV-specific nanobody ALX-0171
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Code name:,ALX 0171
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Code name:,ALX0171
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Code name:,ALX-0171
2020-09-18T03:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496,Synonym:,anti-S15 mAb NC318
2020-09-18T03:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496,Synonym:,anti-Siglec-15 monoclonal antibody NC318
2020-09-18T03:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496,Code name:,NC 318
2020-09-18T03:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496,Code name:,NC318
2020-09-18T03:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496,Code name:,NC-318
2020-09-18T03:49:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-sclu-monoclonal-antibody-ab-16b5,Code name:,AB-16B5
2020-09-18T03:49:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799798,Synonym:,AF-enriched egg yolk powder supplement
2020-09-18T03:49:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799798,Foreign brand name:,Salovum
2020-09-18T03:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-sema4d-monoclonal-antibody-vx15-2503,Synonym:,moAb VX15/2503
2020-09-18T03:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-sema4d-monoclonal-antibody-vx15-2503,Code name:,VX15/2503
2020-09-18T03:49:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798741,Code name:,QR 313
2020-09-18T03:49:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798741,Code name:,QR313
2020-09-18T03:49:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798741,Code name:,QR-313
2020-09-18T03:49:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796792,Code name:,CC 95251
2020-09-18T03:49:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796792,Code name:,CC95251
2020-09-18T03:49:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796792,Code name:,CC-95251
2020-09-18T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-slitrk6-monoclonal-antibody-mmae-conjugate-ags15e,Synonym:,anti-SLITRK6 antibody-drugconjugate AGS15E
2020-09-18T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-slitrk6-monoclonal-antibody-mmae-conjugate-ags15e,Abbreviation:,anti-SLITRK6 ADC AGS15E
2020-09-18T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-slitrk6-monoclonal-antibody-mmae-conjugate-ags15e,Code name:,AGS15E
2020-09-18T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-slitrk6-monoclonal-antibody-mmae-conjugate-ags15e,Code name:,ASG-15ME
2020-09-18T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792257,Synonym:,anti-SSTR2 x anti-CD3 monoclonal antibody XmAb18087
2020-09-18T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792257,Code name:,XmAb 18087
2020-09-18T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792257,Code name:,XmAb18087
2020-09-18T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792257,Code name:,XmAb-18087
2020-09-18T03:50:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tag-72-monoclonal-antibody-cc49-streptavidin-conjugate,Synonym:,CC49-streptavidin
2020-09-18T03:50:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tf-monoclonal-antibody-alt-836,Synonym:,anti-TF moAb ALT-836
2020-09-18T03:50:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tf-monoclonal-antibody-alt-836,Code name:,ALT-836
2020-09-18T03:50:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-monoclonal-antibody-nis793,Code name:,NIS793
2020-09-18T03:50:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270,Synonym:,anti-TGFb SAR-439459
2020-09-18T03:50:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270,Synonym:,anti-transforming growth factor-beta mAb SAR439459
2020-09-18T03:50:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270,Code name:,SAR 439459
2020-09-18T03:50:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270,Code name:,SAR439459
2020-09-18T03:50:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270,Code name:,SAR-439459
2020-09-18T03:50:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-rii-monoclonal-antibody-imc-tr1,Code name:,IMC-TR1
2020-09-18T03:50:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-rii-monoclonal-antibody-imc-tr1,Code name:,LY3022859
2020-09-18T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,Synonym:,lymphocyte immune globulin
2020-09-18T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,US brand name:,ATGAM
2020-09-18T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,US brand name:,Thymoglobulin
2020-09-18T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,Abbreviation:,ATG
2020-09-18T03:50:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thyroglobulin-mtcr-transduced-autologous-peripheral-blood-lymphocytes,Synonym:,anti-thyroglobulin mTCR-transduced autologous PBL
2020-09-18T03:50:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-bms-986207,Code name:,BMS-986207
2020-09-18T03:50:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-omp-313m32,Synonym:,anti-TIGIT (OMP-313M32)
2020-09-18T03:50:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-omp-313m32,Synonym:,anti-TIGIT OMP-313M32
2020-09-18T03:50:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-omp-313m32,Code name:,OMP 313M32
2020-09-18T03:50:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-omp-313m32,Code name:,OMP-313M32
2020-09-18T03:50:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795721,Synonym:,anti-TIM3 antibody BMS-986258
2020-09-18T03:50:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795721,Code name:,BMS 986258
2020-09-18T03:50:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795721,Code name:,BMS-986258
2020-09-18T03:50:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796770,Code name:,BGB A425
2020-09-18T03:50:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796770,Code name:,BGBA425
2020-09-18T03:50:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796770,Code name:,BGB-A425
2020-09-18T03:51:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798754,Code name:,INCAGN 02390
2020-09-18T03:51:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798754,Code name:,INCAGN02390
2020-09-18T03:51:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798754,Code name:,INCAGN-02390
2020-09-18T03:51:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim3-monoclonal-antibody-ly3321367,Code name:,LY 3321367
2020-09-18T03:51:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim3-monoclonal-antibody-ly3321367,Code name:,LY3321367
2020-09-18T03:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801357,Code name:,SHR 1702
2020-09-18T03:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801357,Code name:,SHR1702
2020-09-18T03:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801357,Code name:,SHR-1702
2020-09-18T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793443,Synonym:,anti-TIM3 monoclonal antibody Sym023
2020-09-18T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793443,Code name:,Sym 023
2020-09-18T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793443,Code name:,Sym023
2020-09-18T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793443,Code name:,Sym-023
2020-09-18T03:51:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-tsr-022,Synonym:,anti-TIM3 checkpoint inhibitor TSR-022
2020-09-18T03:51:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-tsr-022,Code name:,TSR-022
2020-09-18T03:51:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tissue-factor-monoclonal-antibody-morab-066,Synonym:,anti-TF monoclonal antibody MORAb-066
2020-09-18T03:51:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tissue-factor-monoclonal-antibody-morab-066,Code name:,MORAb-066
2020-09-18T03:51:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tlr2-monoclonal-antibody-opn-305,Code name:,OPN-305
2020-09-18T03:51:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873,Synonym:,bi-specific agent BI 905711
2020-09-18T03:51:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873,Synonym:,CDH17-targeting TRAILR2 agonist BI 905711
2020-09-18T03:51:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873,Code name:,BI 905711
2020-09-18T03:51:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873,Code name:,BI905711
2020-09-18T03:51:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873,Code name:,BI-905711
2020-09-18T03:51:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-transthyretin-sirna-aln-ttr02,Synonym:,RNAi therapeutic-targeting transthyretin ALN-TTR02
2020-09-18T03:51:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-transthyretin-sirna-aln-ttr02,US brand name:,Patisiran
2020-09-18T03:51:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-transthyretin-sirna-aln-ttr02,Code name:,ALN-TTR02
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Synonym:,anti-TRBC1 CAR T cells AUTO4
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Synonym:,RQR8/TRBC1 CAR T cells AUTO4
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Synonym:,TRBC1-targeting CAR T cells AUTO4
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Code name:,AUTO 4
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Code name:,AUTO4
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Code name:,AUTO-4
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Synonym:,ADC BAT8003
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Synonym:,anti-TROP2 ADC BAT8003
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Synonym:,anti-Trop-2 antibody-drug conjugate BAT8003
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Code name:,BAT 8003
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Code name:,BAT8003
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Code name:,BAT-8003
2020-09-18T03:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800236,Code name:,ADC SKB264
2020-09-18T03:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800236,Code name:,SKB 264
2020-09-18T03:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800236,Code name:,SKB264
2020-09-18T03:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800236,Code name:,SKB-264
2020-09-18T03:52:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793720,Synonym:,ADC DS-1062a
2020-09-18T03:52:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793720,Code name:,DS 1062a
2020-09-18T03:52:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793720,Code name:,DS-1062
2020-09-18T03:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795710,Synonym:,antitumor B KAC-a
2020-09-18T03:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795710,Synonym:,antitumor B KAC-α
2020-09-18T03:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795710,Synonym:,ATB-KAC-alpha
2020-09-18T03:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795710,Synonym:,Chinese herbal mixture antitumor B KAC-a
2020-09-18T03:52:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tweak-monoclonal-antibody-ro5458640,Code name:,RO5458640
2020-09-18T03:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278,Synonym:,anti-VEGF MAb hPV19
2020-09-18T03:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278,Synonym:,MAb hPV19
2020-09-18T03:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278,Code name:,hPV 19
2020-09-18T03:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278,Code name:,hPV19
2020-09-18T03:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278,Code name:,hPV-19
2020-09-18T03:52:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-ang2-nanobody-bi-836880,Synonym:,anti-VEGF/ANG2 BI 836880
2020-09-18T03:52:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-ang2-nanobody-bi-836880,Synonym:,bi-specific anti-VEGF/Ang2 nanobody BI 836880
2020-09-18T03:52:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-ang2-nanobody-bi-836880,Code name:,BI 836880
2020-09-18T03:52:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-c-monoclonal-antibody-vgx-100,Synonym:,VEGF-C mAb VGX-100
2020-09-18T03:52:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-c-monoclonal-antibody-vgx-100,Code name:,VGX-100
2020-09-18T03:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795367,Code name:,HLX 06
2020-09-18T03:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795367,Code name:,HLX06
2020-09-18T03:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795367,Code name:,HLX-06
2020-09-18T03:52:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802274,Code name:,MSB 0254
2020-09-18T03:52:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802274,Code name:,MSB0254
2020-09-18T03:52:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802274,Code name:,MSB-0254
2020-09-18T03:52:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr2-car-retroviral-vector-transduced-autologous-t-lymphocytes,Synonym:,anti-VEGFR2 gene engineered CD8+ lymphocytes
2020-09-18T03:52:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr3-monoclonal-antibody-imc-3c5,Synonym:,anti-VEGFR3 MoAb IMC-3C5
2020-09-18T03:52:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr3-monoclonal-antibody-imc-3c5,Synonym:,anti-VEGFR-3 monoclonal antibody IMC-3C5
2020-09-18T03:52:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr3-monoclonal-antibody-imc-3c5,Code name:,IMC-3C5
2020-09-18T03:53:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antiviral-agent-csj148,Code name:,CSJ148
2020-09-18T03:53:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vista-monoclonal-antibody-jnj-61610588,Code name:,JNJ 61610588
2020-09-18T03:53:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vista-monoclonal-antibody-jnj-61610588,Code name:,JNJ-61610588
2020-09-18T03:53:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-von-willebrand-factor-nanobody,Synonym:,anti-vWf nanobody
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,Synonym:,lutetium texaphrin
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,Synonym:,lutetium texaphyrin
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,US brand name:,Antrin
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,US brand name:,Lutex
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,US brand name:,Lutrin
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,Code name:,PCI-0123
2020-09-18T03:53:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antrodia-cinnamomea-supplement,Synonym:,OB318
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,Synonym:,ammonia oxidizing bacteria-containing probiotic Mist
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,Synonym:,AO bacteria-containing mist
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,Synonym:,AOB-based probiotic sprayt
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,Synonym:,topical probiotic solution
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,Synonym:,topical probiotic spray
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,US brand name:,AO+ Mist
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,rADAMTS13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,recombinant a disintegrin and metalloproteinase with a thrombospondin type 1 motif member 13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,recombinant a disintegrin and metalloproteinase with thrombospondin motifs 13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,recombinant ADAMTS13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,recombinant human ADAMTS13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,recombinant human ADAMTS-13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,BAX 930
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,BAX930
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,BAX-930
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,SHP 655
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,SHP655
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,SHP-655
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,TAK 755
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,TAK755
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,TAK-755
2020-09-18T03:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatorsen,Synonym:,Hsp27 antisense oligonucleotide OGX-427
2020-09-18T03:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatorsen,Code name:,ISIS 306053
2020-09-18T03:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatorsen,Code name:,OGX-427
2020-09-18T03:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,US brand name:,Eoquin
2020-09-18T03:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,US brand name:,Neoquin
2020-09-18T03:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,US brand name:,Qapzola
2020-09-18T03:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,Code name:,E09
2020-09-18T03:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,Chemical structure:,"3-hydroxymethyl-5-aziridinyl-1-methyl-2-(1H-indole-4,7-dione) prop-beta-en-alpha-ol"
2020-09-18T03:53:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apc8015f,NA,NA
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Synonym:,APE1/Ref-1 Inhibitor APX3330
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Code name:,APX 3330
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Code name:,APX3330
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Code name:,E 3330
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Code name:,E3330
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Chemical structure:,"[(2E)-2-[(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene]-undecanoic Acid"
2020-09-18T03:53:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apf530,NA,NA
2020-09-18T03:54:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apilimod-dimesylate-capsule,Code name:,LAM 002A
2020-09-18T03:54:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apilimod-dimesylate-capsule,Code name:,LAM-002A
2020-09-18T03:54:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apixaban,US brand name:,Eliquis
2020-09-18T03:54:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apixaban,Code name:,BMS-562247
2020-09-18T03:54:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apixaban,Code name:,BMS-562247-01
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Synonym:,bupropion HCl controlled-release
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Synonym:,bupropion HCl extended release
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Synonym:,bupropion hydrochloride extended-release
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Aplenzin
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Wellbutrin SR
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Wellbutrin XL
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Zyban
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Foreign brand name:,Forfivo XL
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Synonym:,aplidine
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Synonym:,dehydrodemnin B
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Synonym:,dehydrodidemnin B
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,US brand name:,Aplidin
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Abbreviation:,APLD
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Abbreviation:,DDB
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Chemical structure:,"N-[1-(1,2-dioxopropyl)-L-prolyl]didemnin A"
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,Synonym:,1D1O Anti-lymphoma Antibody
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,Synonym:,Monoclonal antibody 1D10
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,Synonym:,Monoclonal Antibody Hu1D10
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,US brand name:,Remitogen
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,Abbreviation:,MOAB 1D10
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,Abbreviation:,MoAb Hu1D10
2020-09-18T03:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apomab,NA,NA
2020-09-18T03:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apoptosis-inducer-bzl101,Code name:,BZL101
2020-09-18T03:54:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apoptosis-inducer-gcs-100,Code name:,GCS-100
2020-09-18T03:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apoptosis-inducer-mpc-2130,Code name:,MPC-2130
2020-09-18T03:54:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/739744,NA,NA
2020-09-18T03:54:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,US brand name:,Emend
2020-09-18T03:54:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,Code name:,L-754030
2020-09-18T03:54:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,Code name:,MK-0869
2020-09-18T03:54:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,Code name:,ONO-7436
2020-09-18T03:55:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apricoxib,Code name:,TG01
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,Synonym:,mesalazine
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Apriso
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Asacol
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Lialda
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Pentasa
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Rowasa
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,Abbreviation:,5-ASA
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,Chemical structure:,5-amino-2-hydroxybenzoic acid5-aminosalicylic acid
2020-09-18T03:55:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprotinin-bovine,US brand name:,Trasylol
2020-09-18T03:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-drug-conjugate-bay1187982,Synonym:,ADC BAY1187982
2020-09-18T03:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-drug-conjugate-bay1187982,Synonym:,anti-FGFR2 antibody-drug conjugate BAY1187982
2020-09-18T03:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-drug-conjugate-bay1187982,Code name:,BAY 1187982
2020-09-18T03:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-drug-conjugate-bay1187982,Code name:,BAY1187982
2020-09-18T03:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,Synonym:,Sulindac Sulfone
2020-09-18T03:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,US brand name:,Aptosyn
2020-09-18T03:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,Code name:,FGN-1
2020-09-18T03:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,Chemical structure:,"(Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfonyl)phenyl]methylene]-1H-indene-3-acetic Acid1H-Indene-3-acetic Acid, 5-Fluoro-2-methyl-1-((4-(methylsulfonyl)phenyl)methylene), (Z)"
2020-09-18T03:55:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/632702,US brand name:,Aquacel AG with Hydrofiber
2020-09-18T03:55:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-carboxymethylcellulose-dressing,US brand name:,Aquacel Dressing
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Synonym:,17 beta-estradiol
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Synonym:,Estraldine
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Aquadiol
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Estrace
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Vagifem
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Vivelle
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Dimenformon
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Diogyn
2020-09-18T03:56:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leflunomide,Code name:,SU101
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Diogynets
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Ovocylin
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Progynon
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Abbreviation:,ESDL
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Chemical structure:,"(17beta)-estra-1,3,5(10)-triene-3,17-diol"
2020-09-18T03:55:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/petrolatum-mineral-oil-lanolin-ceresin-ointment,US brand name:,Aquaphor
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,anti-infective vitamin
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,antixerophthalmic vitamin
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Axerophthol
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Axerophtholum
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Biosterol
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Lard-Factor
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Oleovitamin A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Ophthalamin
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,vitamin A alcohol
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,vitamin A USP
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,vitamin A1
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Vitaminum A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,US brand name:,Aquasol A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,US brand name:,Del-Vi-A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,US brand name:,Pedi-Vit-A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,A 313
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Arovit
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Avibon
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Avitol
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Axerol
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Biovit-A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Ido A 50
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Idrurto A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Ledovit A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Micelle A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Mulsal A Megadosis
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Rinocusi Vitaminico
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Vitaminoftalmina
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Vogan
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Chemical structure:,"3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol"
2020-09-18T03:55:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-bms-641988,Code name:,BMS-641988
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,Synonym:,Ortho-Novum 1/35
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Aranelle
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Balziva
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Brevicon
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Gencept
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Modicon
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norcept-E
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norethin
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norinyl
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Nortrel
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Ortho-Novum
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Ovcon
2020-09-18T03:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Synonym:,Novel Erythropoiesis Stimulating Protein
2020-09-18T03:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,US brand name:,Aranesp
2020-09-18T03:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Foreign brand name:,Nespo
2020-09-18T03:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Abbreviation:,NESP
2020-09-18T03:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Code name:,KRN321
2020-09-18T03:56:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leflunomide,US brand name:,Arava
2020-09-18T03:56:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leflunomide,Chemical structure:,"4-isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)-"
2020-09-18T03:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455,Synonym:,agonist redirected checkpoint fusion protein SL-279252
2020-09-18T03:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455,Synonym:,PD1-Fc-OX40L ARC fusion protein
2020-09-18T03:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455,Code name:,SL 279252
2020-09-18T03:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455,Code name:,SL279252
2020-09-18T03:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455,Code name:,SL-279252
2020-09-18T03:56:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arcitumomab,Synonym:,anti-Carcinoembryonic Antigen Monoclonal Antibody Fab' Fragment
2020-09-18T03:56:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arcitumomab,Synonym:,IMMU-4
2020-09-18T03:56:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arcitumomab,US brand name:,CEA-Scan
2020-09-18T03:56:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,US brand name:,Arcoxia
2020-09-18T03:56:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,Code name:,L-791456
2020-09-18T03:56:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,Code name:,MK-0663
2020-09-18T03:56:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,Chemical structure:,5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl) Pyridine
2020-09-18T03:56:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamidronate-disodium,US brand name:,Aredia
2020-09-18T03:56:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamidronate-disodium,Foreign brand name:,Aminomux
2020-09-18T03:56:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamidronate-disodium,Code name:,GCP-23339A
2020-09-18T03:56:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796585,Synonym:,6R-5-10-methylenetetrahydrofolate
2020-09-18T03:56:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796585,US brand name:,Modufolin
2020-09-18T03:56:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796585,Abbreviation:,6R-MTHF
2020-09-18T03:56:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796585,Chemical structure:,"(6R)-5,10-methylenetetrahydrofolate[6R] 5,10-methylenetetrahydrofolate[6R]-5,10-methylene-tetrahydrofolate6R-5,10-methyleneTHF6R-methylene THFmethylenetetrahydrofolic acid, L-(+)-"
2020-09-18T03:56:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginase-inhibitor-incb001158,Code name:,CB1158
2020-09-18T03:56:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginase-inhibitor-incb001158,Code name:,CB-1158
2020-09-18T03:56:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginase-inhibitor-incb001158,Code name:,INCB001158
2020-09-18T03:56:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798381,Synonym:,ARG-1 peptide vaccine
2020-09-18T03:56:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-butyrate,Synonym:,"L-arginine, butanoate (3:4)"
2020-09-18T03:56:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-butyrate,Code name:,VX-105
2020-09-18T03:57:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793609,US brand name:,R-Gene 10
2020-09-18T03:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800949,Synonym:,arginine/nucleotides/omega-3 fatty acids/olive oil polyphenols/antioxidants/L-carnitine nutritional supplement
2020-09-18T03:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800949,Foreign brand name:,Bi1 Procare
2020-09-18T03:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-omega-3-fatty-acids-nucleotides-oral-supplement,US brand name:,Immun-Aid
2020-09-18T03:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-omega-3-fatty-acids-nucleotides-oral-supplement,US brand name:,Impact
2020-09-18T03:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-arginine-korean-ginseng--gingko-biloba-damiana-based-supplement,US brand name:,ArginMax
2020-09-18T03:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donepezil-hydrochloride,US brand name:,Aricept
2020-09-18T03:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donepezil-hydrochloride,Code name:,E-2020
2020-09-18T03:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donepezil-hydrochloride,Chemical structure:,"1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine Hydrochloride"
2020-09-18T03:57:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone,US brand name:,Aristocort
2020-09-18T03:57:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone,Chemical structure:,"(11beta,16alpha)-9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione"
2020-09-18T03:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fondaparinux-sodium,US brand name:,Arixtra
2020-09-18T03:57:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/armodafinil,US brand name:,Nuvigil
2020-09-18T03:57:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/armodafinil,Chemical structure:,(–)-2-[(R)-(diphenylmethyl)sulfinyl]acetamide
2020-09-18T03:57:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arnebia-indigo-jade-pearl-topical-cream,Acronym:,AIJP
2020-09-18T03:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,US brand name:,Aromasin
2020-09-18T03:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,Abbreviation:,PNU 155971
2020-09-18T03:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,Code name:,FCE-24304
2020-09-18T03:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,Chemical structure:,"6-Methyleneandrosta-1,4-diene-3,17-dione"
2020-09-18T03:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp,Synonym:,liposomal neodecanoic acid platinum complex
2020-09-18T03:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp,Synonym:,L-NDDP
2020-09-18T03:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp,US brand name:,Aroplatin
2020-09-18T03:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp,Abbreviation:,L-NDDP
2020-09-18T03:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp,Chemical structure:,"liposome-entrapped cis-bis-neodecanoate-trans-R,R-1,2-diaminocyclohexane platinum (II)"
2020-09-18T03:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelarabine,US brand name:,Arranon
2020-09-18T03:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelarabine,Code name:,506U78
2020-09-18T03:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelarabine,Code name:,GW506U78
2020-09-18T03:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelarabine,Chemical structure:,2-amino-6-methoxypurine arabinoside2-amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,Arsenic (III) Oxide
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,Arsenic Sesquioxide
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,Arsenous Acid
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,Arsenous Acid Anhydride
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,Arsenous Oxide
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,White Arsenic
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,US brand name:,Trisenox
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Abbreviation:,AS2O3
2020-09-18T03:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014,Synonym:,arsenic trioxide formulation ORH 2014
2020-09-18T03:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014,Synonym:,As2O3 formulation ORH 2014
2020-09-18T03:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014,Synonym:,oral arsenic trioxide formulation
2020-09-18T03:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014,Code name:,ORH 2014
2020-09-18T03:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014,Code name:,ORH-2014
2020-09-18T03:58:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artemether-sublingual-spray,Synonym:,sublingual artemether spray
2020-09-18T03:58:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artemether-sublingual-spray,Code name:,LON002
2020-09-18T03:58:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artesunate,Abbreviation:,ART
2020-09-18T03:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artichoke-whole-phytocomplex-concentrate,Synonym:,artichoke extract
2020-09-18T03:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artichoke-whole-phytocomplex-concentrate,Synonym:,artichoke W.P.C.
2020-09-18T03:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artificial-saliva-spray,Foreign brand name:,Hypozalix spray
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Synonym:,AhR antagonist BAY2416964
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Synonym:,AhR inhibitor BAY2416964
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Synonym:,aryl hydrocarbon receptor inhibitor BAY2416964
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Code name:,BAY 2416964
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Code name:,BAY2416964
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Code name:,BAY-2416964
2020-09-18T03:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofatumumab,US brand name:,Arzerra
2020-09-18T03:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofatumumab,Foreign brand name:,HuMax-CD20
2020-09-18T03:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofatumumab,Code name:,2F2
2020-09-18T03:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofatumumab,Code name:,GSK1841157
2020-09-18T03:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arzoxifene-hydrochloride,Synonym:,LY353381 Hydrochloride
2020-09-18T03:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arzoxifene-hydrochloride,Synonym:,SERM-3
2020-09-18T03:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arzoxifene-hydrochloride,Code name:,LY353381.HCl
2020-09-18T03:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arzoxifene-hydrochloride,Chemical structure:,2-(4-methoxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]benzo[b]thiophene-6-ol hydrochloride
2020-09-18T03:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/as03-adjuvanted-h1n1-pandemic-influenza-vaccine,Foreign brand name:,Arepanrix
2020-09-18T03:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/as03-adjuvanted-h1n1-pandemic-influenza-vaccine,Foreign brand name:,Pandemrix
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,Synonym:,mesalazine
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Apriso
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Asacol
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Lialda
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Pentasa
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Rowasa
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,Abbreviation:,5-ASA
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,Chemical structure:,5-amino-2-hydroxybenzoic acid5-aminosalicylic acid
2020-09-18T03:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asaley,Synonym:,Asalex
2020-09-18T03:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allosteric-bcr-abl-tyrosine-kinase-inhibitor-abl001,Synonym:,allosteric Bcr-Abl tyrosine kinase inhibitor ABL001
2020-09-18T03:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allosteric-bcr-abl-tyrosine-kinase-inhibitor-abl001,Code name:,ABL001
2020-09-18T03:59:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797212,Synonym:,aethoxysklerol
2020-09-18T03:59:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797212,Synonym:,dodecylnonaoxyethylene glycol monoether
2020-09-18T03:59:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797212,Synonym:,Laureth-9
2020-09-18T03:59:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797212,US brand name:,Asclera
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,C vitamin
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,L-ascorbic acid
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,vitamin C
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Asorbicap
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cecon
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cenolate
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cetane
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cevalin
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Ce-Vi-Sol
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Foreign brand name:,C-Long
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Abbreviation:,VIT C
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Chemical structure:,"2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one"
2020-09-18T03:59:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ashwagandha-root-powder-extract,NA,NA
2020-09-18T03:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asian-ginseng,Synonym:,ginseng root
2020-09-18T03:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asian-ginseng,Synonym:,Korean ginseng
2020-09-18T03:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asian-ginseng,Synonym:,Panax ginseng
2020-09-18T03:59:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ask1-inhibitor-gs-4997,Code name:,GS-4997
2020-09-18T03:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonepcizumab,US brand name:,ASONEP
2020-09-18T03:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonepcizumab,Code name:,LT1009
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,C vitamin
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,L-ascorbic acid
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,vitamin C
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Asorbicap
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cecon
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cenolate
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cetane
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cevalin
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Ce-Vi-Sol
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Foreign brand name:,C-Long
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Abbreviation:,VIT C
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Chemical structure:,"2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one"
2020-09-18T03:59:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asp4132,NA,NA
2020-09-18T03:59:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asp9853,NA,NA
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,ASP-1
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,asparaginase II
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,Colaspase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,L-ASP
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,L-asparaginase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,L-asparagine amidohydrolase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,US brand name:,Elspar
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,US brand name:,L-Asnase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Kidrolase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Laspar
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Leucogen
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Leunase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Paronal
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Spectrila
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Abbreviation:,L-ASP
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Abbreviation:,Lcf-ASP
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Code name:,MK-965
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Code name:,Re-82-TAD-15
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,asparaginase-Erwinia
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,crisantaspasum
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,cristantaspase
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Abbreviation:,eATG
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,Erwinia L-asparginase
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,krisantaspaasi
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,krisantaspas
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,US brand name:,Erwinaze
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Foreign brand name:,Erwinase
2020-09-18T04:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Synonym:,calaspargase pegol
2020-09-18T04:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Synonym:,SC-PEG E. coli L-asparaginase
2020-09-18T04:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Synonym:,succinimidyl carbonate monomethoxypolyethylene glycol E. coli L-asparaginase
2020-09-18T04:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,US brand name:,Asparlas
2020-09-18T04:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Code name:,EZN-2285
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,[211At]OKT10-B10
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,211At-OKT10-B10
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,astatine 211-labeled anti-CD38 monoclonal antibody OKT10-B10
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,astatine At 211 anti-CD38 MoAb OKT10-B10
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,astatine-211-OKT10-B10
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,At211-OKT10-B10
2020-09-18T04:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801793,Synonym:,Astaxanthine
2020-09-18T04:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801793,Foreign brand name:,Algalif
2020-09-18T04:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801793,Chemical structure:,"(3S,3'S)-3,3'-dihydroxy-beta,beta-carotene-4,4'-dione"
2020-09-18T04:00:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792574,Synonym:,Am/Ag/Tk herbal extract SH003
2020-09-18T04:00:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792574,Code name:,SH003
2020-09-18T04:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astragalus-based-formulation-qing-shu-yi-qi-tang,Synonym:,Astragalus membranaceus/Panax ginseng/Atractylodes chinensis Koidz/ Cimicifuga foetida/A. macrocephala Koidz/Alisma orientale Juzep/Citrus reticulata Blanco herbal supplement
2020-09-18T04:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astragalus-based-formulation-qing-shu-yi-qi-tang,Synonym:,QING SHU YI Qi Tang
2020-09-18T04:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astragalus-based-formulation-qing-shu-yi-qi-tang,Abbreviation:,QSYQT
2020-09-18T04:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astuprotimut-r,Synonym:,recombinant MAGE-A3 antigen-specific cancer immunotherapeutic GSK1203486A
2020-09-18T04:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astuprotimut-r,Abbreviation:,recombinant MAGE-A3 ASCI GSK1203486A
2020-09-18T04:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astuprotimut-r,Code name:,GSK1203486A
2020-09-18T04:00:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asulacrine-isethionate,Synonym:,amsalog
2020-09-18T04:00:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asulacrine-isethionate,Code name:,CI-921
2020-09-18T04:00:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asulacrine-isethionate,Chemical structure:,"4-acridinecarboxamide,9-((2-methoxy-4-((methylsulfonyl)amino)phenyl)amino-N,5-dimethyl"
2020-09-18T04:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asunaprevir,Abbreviation:,ASV
2020-09-18T04:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asunaprevir,Code name:,BMS-650032
2020-09-18T04:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candesartan-cilexetil,US brand name:,Atacand
2020-09-18T04:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candesartan-cilexetil,US brand name:,Biopress
2020-09-18T04:00:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atamestane,NA,NA
2020-09-18T04:01:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atenolol,NA,NA
2020-09-18T04:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab,Synonym:,anti-PD-L1 monoclonal antibody MPDL3280A
2020-09-18T04:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab,US brand name:,Tecentriq
2020-09-18T04:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab,Code name:,MPDL3280A
2020-09-18T04:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab,Code name:,RG7446
2020-09-18T04:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab,Code name:,RO5541267
2020-09-18T04:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,Synonym:,lymphocyte immune globulin
2020-09-18T04:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,US brand name:,ATGAM
2020-09-18T04:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,US brand name:,Thymoglobulin
2020-09-18T04:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,Abbreviation:,ATG
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,antithymocyte globulin equine
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,anti-thymocyte globulin equine
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,ATG equine
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,equine ATG
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,horse ATG
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,"lymphocyte immune globulin, anti-thymocyte globulin equine"
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,US brand name:,Atgam
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Abbreviation:,hATG
2020-09-18T04:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atiprimod,Synonym:,azaspirane
2020-09-18T04:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atiprimod,Code name:,SK&F106615
2020-09-18T04:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atiprimod,Chemical structure:,"N,N-diethyl-8,8-dipropyl-2-azaspiro(4.5)decane-2-propanamine"
2020-09-18T04:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorazepam,US brand name:,Ativan
2020-09-18T04:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorazepam,Chemical structure:,"7-chloro-5-(2-chlorophenyl)-1, 3-dihydro-3-Hydroxy-1,4- benzodiazepin-2-one"
2020-09-18T04:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-inhibitor-m-3541,Synonym:,ataxia telangiectasia mutated kinase inhibitor M 3541
2020-09-18T04:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-inhibitor-m-3541,Code name:,M 3541
2020-09-18T04:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-inhibitor-m-3541,Code name:,M3541
2020-09-18T04:01:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-kinase-inhibitor-azd0156,Code name:,AZD0156
2020-09-18T04:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atn-161,NA,NA
2020-09-18T04:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atomoxetine-hydrochloride,US brand name:,Strattera
2020-09-18T04:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atomoxetine-hydrochloride,Chemical structure:,(-)-N -methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride(-)-N-methyl-gamma(2-methylphenoxy)benzenepropamine Hydrochloride
2020-09-18T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atorvastatin-calcium,Synonym:,atorvastatin calcium trihydrate
2020-09-18T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atorvastatin-calcium,US brand name:,Lipitor
2020-09-18T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atorvastatin-calcium,Code name:,CI-981
2020-09-18T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792166,Synonym:,ATR inhibitor BAY1895344
2020-09-18T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792166,Code name:,BAY 1895344
2020-09-18T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792166,Code name:,BAY1895344
2020-09-18T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792166,Code name:,BAY-1895344
2020-09-18T04:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801231,Code name:,M 1774
2020-09-18T04:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801231,Code name:,M1774
2020-09-18T04:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801231,Code name:,M-1774
2020-09-18T04:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-vx-970,Code name:,M 6620
2020-09-18T04:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-vx-970,Code name:,M6620
2020-09-18T04:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-vx-970,Code name:,VX-970
2020-09-18T04:02:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-101,NA,NA
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Synonym:,All-trans-retinoic acid liposomal
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Synonym:,tretinoin liposomal
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Synonym:,tretinoin liposome
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Synonym:,tretinoinLF
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,US brand name:,Atragen
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Abbreviation:,L-ATRA
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Code name:,AR-623
2020-09-18T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride,US brand name:,Xinlay
2020-09-18T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride,Code name:,(+)-A 127722
2020-09-18T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride,Code name:,ABT 627
2020-09-18T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride,Code name:,ABT-627
2020-09-18T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride,Chemical structure:,"(2R,3R,4S)-4-(1,3-benzodioxo-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic acid monohydrochloride"
2020-09-18T04:02:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofibrate,US brand name:,Atromid-S
2020-09-18T04:02:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofibrate,Abbreviation:,CFB
2020-09-18T04:02:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofibrate,Chemical structure:,2-(4-chlorophenoxy)-2-methylpropanoic acid ethyl esterethyl 2-(4-chlorophenoxy)-2-methylpropanoateethyl p-chlorophenoxyisobyturate
2020-09-18T04:02:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atropine-sulfate,NA,NA
2020-09-18T04:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/attenuated-chimpanzee-adenovirus-5t4-vaccine,Synonym:,ChAdOx.5T4 vaccine
2020-09-18T04:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/attenuated-chimpanzee-adenovirus-5t4-vaccine,Synonym:,ChAdOx1.5T4 vaccine
2020-09-18T04:02:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/attenuated-listeria-monocytogenes-crs-100,NA,NA
2020-09-18T04:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/auranofin,US brand name:,Ridaura
2020-09-18T04:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Synonym:,colloidal gold-bound recombinant human tumor necrosis factor
2020-09-18T04:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Synonym:,colloidal gold-bound rhTNF
2020-09-18T04:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Synonym:,colloidal gold-bound TNF
2020-09-18T04:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,US brand name:,Aurimmune
2020-09-18T04:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Code name:,CYT-6091
2020-09-18T04:03:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792533,Synonym:,aurixim antibody conjugate
2020-09-18T04:03:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792533,US brand name:,Aurixim
2020-09-18T04:03:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792533,Code name:,CON-4619
2020-09-18T04:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gold-sodium-thiomalate,Synonym:,sodium aurothiomalate
2020-09-18T04:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gold-sodium-thiomalate,US brand name:,Aurolate
2020-09-18T04:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gold-sodium-thiomalate,US brand name:,Myochrysine
2020-09-18T04:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635,Synonym:,AK 01 erbumine
2020-09-18T04:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635,Synonym:,aurora kinase A inhibitor LY3295668 erbumine
2020-09-18T04:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635,Synonym:,LY 3295668 erbumine
2020-09-18T04:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635,Synonym:,LY3295668 erbumine
2020-09-18T04:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635,Synonym:,LY-3295668 erbumine
2020-09-18T04:03:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-inhibitor-tas-119,Synonym:,TAS-2104
2020-09-18T04:03:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-inhibitor-tas-119,Code name:,TAS-119
2020-09-18T04:03:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-tyrosine-kinase-inhibitor-enmd-2076,Code name:,ENMD-2076
2020-09-18T04:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-b-kinase-inhibitor-tak-901,Code name:,TAK-901
2020-09-18T04:03:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-b-c-kinase-inhibitor-gsk1070916a,Code name:,GSK1070916A
2020-09-18T04:03:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739,Synonym:,AK A/B inhibitor TT-00420
2020-09-18T04:03:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739,Synonym:,multi-kinase inhibitor TT-00420
2020-09-18T04:03:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739,Synonym:,TT 00420
2020-09-18T04:03:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739,Code name:,TT00420
2020-09-18T04:03:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739,Code name:,TT-00420
2020-09-18T04:03:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-amg-900,NA,NA
2020-09-18T04:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-bi-811283,Code name:,BI 811283
2020-09-18T04:03:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-mln8054,Code name:,MLN8054
2020-09-18T04:04:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-pf-03814735,Code name:,PF-03814735
2020-09-18T04:04:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-sns-314,Code name:,SNS-314
2020-09-18T04:04:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-ttp607,Code name:,TTP607
2020-09-18T04:04:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-vegfr2-inhibitor-cyc116,Code name:,CYC116
2020-09-18T04:04:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-actr-cd16-cd28-expressing-t-lymphocytes-actr707,Synonym:,ACTR707 cells
2020-09-18T04:04:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-actr-cd16-cd28-expressing-t-lymphocytes-actr707,Synonym:,ACTR707 T cells
2020-09-18T04:04:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-actr-cd16-cd28-expressing-t-lymphocytes-actr707,Code name:,ACTR707
2020-09-18T04:04:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ad-cd154-transduced-cll-b-cells,Synonym:,autologous Ad-ISF35-transduced CLL B cells
2020-09-18T04:04:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801757,Synonym:,autologous AFP-specific TCR-transduced T cells C-TCR055
2020-09-18T04:04:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801757,Code name:,C-TCR 055
2020-09-18T04:04:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801757,Code name:,C-TCR055
2020-09-18T04:04:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801757,Code name:,C-TCR055
2020-09-18T04:04:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801757,Code name:,C-TCR-055
2020-09-18T04:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792537,Synonym:,autologous AML/DC fusion vaccine
2020-09-18T04:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792537,Synonym:,autologous DC/AML fusion vaccine
2020-09-18T04:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792537,Synonym:,autologous dendritic cell/AML fusion vaccine
2020-09-18T04:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792537,Synonym:,DC/AML fusion cell vaccine
2020-09-18T04:04:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797877,Synonym:,autologous BCMA-specific CAR T-cells IM21
2020-09-18T04:04:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797877,Synonym:,IM21 CAR-T cells
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Synonym:,autologous genetically-modified anti-BCMA CAR-T cells KITE-585
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Synonym:,autologous genetically-modified anti-BCMA CAR-transduced T Cells KITE-585
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Synonym:,autologous T Cells KITE-585
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Code name:,KITE 585
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Code name:,KITE585
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Code name:,KITE-585
2020-09-18T04:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760,Synonym:,autologous CD8+ T cells expressing anti-BCMA CAR Descartes-11
2020-09-18T04:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760,Code name:,Descartes 11
2020-09-18T04:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760,Code name:,Descartes-011
2020-09-18T04:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760,Code name:,Descartes11
2020-09-18T04:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760,Code name:,Descartes-11
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Synonym:,autologous anti-BCMA CAR-T cells JCARH 125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Synonym:,autologous BCMA 41BBz CAR-T cells JCARH-125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Synonym:,autologous BCMA-specific CAR4-1BB-CD3zeta-expressing CD4+/CD8+ T lymphocytes JCARH 125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Synonym:,autologous BCMA-specific CAR-T cells JCARH125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Code name:,JCARH 125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Code name:,JCARH125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Code name:,JCARH-125
2020-09-18T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791258,Synonym:,autologous anti-BCMA-CAR-4-1BB-CD3zeta-expressing memory T cells bb21217
2020-09-18T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791258,Code name:,BB 21217
2020-09-18T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791258,Code name:,bb21217
2020-09-18T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791258,Code name:,bb-21217
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Synonym:,anti-BCMA-CAR-41BB-CD3zeta-expressing T cells CT053
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Synonym:,BCMA Car-T (CT053)
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Synonym:,CAR-BCMA T cells CT053
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Synonym:,CT053 CAR-BCMA T
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Synonym:,CT053 CAR-BCMA T cells
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Code name:,CT 053
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Code name:,CT053
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Code name:,CT-053
2020-09-18T04:05:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794992,Synonym:,autologous anti-BCMA-CAR CD4+/CD8+ cells
2020-09-18T04:05:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794992,Synonym:,BCMA CAR-CD4+/CD8+ T cells
2020-09-18T04:05:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794992,Synonym:,BCMA-specific CAR-expressing CD4+/CD8+ T lymphocytes
2020-09-18T04:05:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794992,Code name:,FCARH143
2020-09-18T04:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-stem-memory-t-cells-p-bcma-101,Synonym:,autologous anti-BCMA centyrin-based chimeric antigen receptor-expressing Tscm
2020-09-18T04:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-stem-memory-t-cells-p-bcma-101,Synonym:,autologous P-BCMA-101 CAR-T cells
2020-09-18T04:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-stem-memory-t-cells-p-bcma-101,Synonym:,autologous P-BCMA-101 CARTyrin-T cells
2020-09-18T04:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-stem-memory-t-cells-p-bcma-101,Code name:,P-BCMA-101
2020-09-18T04:05:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795728,Synonym:,anti-BCMA-CAR-mRNA-transfected autologous CD8+ T cells
2020-09-18T04:05:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795728,Synonym:,autologous anti-BCMA-CAR-mRNA-transfected CD8+ T cells
2020-09-18T04:05:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795728,Synonym:,autologous anti-BCMA-CAR-mRNA-transfected CD8-positive T cells
2020-09-18T04:05:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795728,Code name:,Descartes-08
2020-09-18T04:05:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795542,Synonym:,autologous BCMA 4-1BBz CAR T cells CART-BCMA
2020-09-18T04:05:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795542,Synonym:,autologous BCMA-specific CAR-TCRz/4-1BB-expressing T lymphocytes CART-BCMA
2020-09-18T04:05:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795542,Synonym:,CART-BCMA cells
2020-09-18T04:05:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795542,Abbreviation:,CART-BCMA
2020-09-18T04:05:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd123-car-tcr-4-1bb-expressing-t-lymphocytes,Synonym:,autologous RNA CART123 cells
2020-09-18T04:05:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd123-car-tcr-4-1bb-expressing-t-lymphocytes,Synonym:,RNA Anti-CD123 CAR T Cells
2020-09-18T04:05:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd123-car-tcr-4-1bb-expressing-t-lymphocytes,Synonym:,RNA CART123 cells
2020-09-18T04:05:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd123-car-tcr-4-1bb-expressing-t-lymphocytes,Synonym:,snti-CD123 CAR mRNA-electroporated autologous T lymphocytes
2020-09-18T04:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792748,Synonym:,autologous anti-CD19 CAR TCR-zeta/4-1BB-transduced T cells BinD19
2020-09-18T04:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792748,Code name:,BinD 19
2020-09-18T04:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792748,Code name:,BinD19
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,anti-CD19 CAR-T cells huCART19
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,anti-CD19 Humanized scFv TCRz-41BB-CAR lentiviral vector-transduced autologous T lymphocytes
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,autologous anti-CD19 CAR-CD3zeta-4-1BB-expressing T cells huCART19
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,CTL119
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,CTL119 cells
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,huCART19 cells
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,huCART19 T lymphocytes
2020-09-18T04:05:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793525,Synonym:,autologous CD19CAR-CD3zeta-4-1BB-expressing T lymphocytes
2020-09-18T04:05:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793525,Synonym:,autologous CD3zeta-4-1BB-expressing CART-19 cells
2020-09-18T04:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793588,Synonym:,autologous CD19-specific CAR-T cells PZ01
2020-09-18T04:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793588,Synonym:,autologous PZ01 CAR-T cells
2020-09-18T04:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793588,Code name:,PZ01
2020-09-18T04:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-expressing-t-lymphocytes,Synonym:,autologous anti-CD19-CAR T cells
2020-09-18T04:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797095,Synonym:,autologous CLIC-1901 CAR-T cells
2020-09-18T04:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797095,Code name:,CLIC 1901
2020-09-18T04:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797095,Code name:,CLIC1901
2020-09-18T04:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797095,Code name:,CLIC-1901
2020-09-18T04:06:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794869,Synonym:,autologous CD19-specific CAR-T cells IM19
2020-09-18T04:06:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794869,Code name:,IM19
2020-09-18T04:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746,Synonym:,anti-CD19-CAR T cells TBI-1501
2020-09-18T04:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746,Synonym:,autologous anti-CD19 chimeric antigen receptor T cells TBI-1501
2020-09-18T04:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746,Synonym:,CAR19 T lymphocytes TBI-1501
2020-09-18T04:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746,Synonym:,CD19-CAR-T TBI-1501
2020-09-18T04:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746,Code name:,TBI-1501
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,AUTO1 CAR-T Cells
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,Autologous Anti-CD19 CAR T-cells AUTO1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,Autologous Anti-CD19 Chimeric Antigen Receptor T-lymphocytes AUTO1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,Autologous CD19-targeted CAR T-cells AUTO1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,CD19CAR T-cells AUTO1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,CD19CAT-41BBZ CAR T-cells AUTO1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Code name:,AUTO 1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Code name:,AUTO-1
2020-09-18T04:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-c-car011,Synonym:,autologous anti-CD19 CART cells C-CAR011
2020-09-18T04:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-c-car011,Synonym:,autologous anti-CD19 CAR-T cells C-CAR011
2020-09-18T04:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-c-car011,Synonym:,autologous CD19-specific CAR-T cells C-CAR011
2020-09-18T04:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-c-car011,Code name:,C-CAR011
2020-09-18T04:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-sjcar19,Synonym:,autologous anti-CD19 CART cells SJCAR19
2020-09-18T04:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-sjcar19,Synonym:,autologous anti-CD19 CAR-T cells SJCAR19
2020-09-18T04:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-sjcar19,Synonym:,autologous CD19-specific CAR-T cells SJCAR19
2020-09-18T04:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-sjcar19,Code name:,SJCAR19
2020-09-18T04:06:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801474,Synonym:,CD19-targeted T cell antigen coupler TAC01-CD19
2020-09-18T04:06:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801474,Synonym:,TAC01-CD19
2020-09-18T04:06:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801474,Code name:,TAC01 CD19
2020-09-18T04:06:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801474,Code name:,TAC01CD19
2020-09-18T04:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393,Synonym:,ET190L1-ARTEMIS (TM)
2020-09-18T04:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393,Synonym:,ET190L1-ARTEMIS (TM) T Cells
2020-09-18T04:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393,Code name:,ET 190
2020-09-18T04:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393,Code name:,ET190
2020-09-18T04:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393,Code name:,ET190L1
2020-09-18T04:06:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798415,Synonym:,autologous anti-CD19/20 bispecific CAR-CD28-BBz-EGFRt+-expressing Tn/mem cells
2020-09-18T04:06:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798415,Synonym:,autologous Anti-CD19/20 CAR-CD28-4-1BB-CD3zeta-EGFRt+-expressing naive and memory T lymphocytes
2020-09-18T04:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801489,Synonym:,autologous anti-CD19/20 bispecific CAR-T cells
2020-09-18T04:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801489,Synonym:,autologous anti-CD19/CD20 bispecific nanobody-derived CAR-T cells
2020-09-18T04:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801489,Synonym:,autologous CD19/CD20 bispecific CAR T cells
2020-09-18T04:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798924,Synonym:,anti-CD19/CD22 CAR autologous T lymphocytes AUTO3
2020-09-18T04:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798924,Code name:,AUTO 3
2020-09-18T04:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798924,Code name:,AUTO3
2020-09-18T04:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798924,Code name:,AUTO-3
2020-09-18T04:07:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780444,Synonym:,autologous anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ CM T lymphocytes JCAR014
2020-09-18T04:07:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780444,Code name:,JCAR014
2020-09-18T04:07:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19car-4-1bb-cd3zeta-egfrt-expressing-t-lymphocytes,NA,NA
2020-09-18T04:07:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797052,Synonym:,autologous CD19CAR-CD28tm/4-1BBzeta-T2A-EGFRt CART cells
2020-09-18T04:07:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797052,Synonym:,SCRI-huCAR19v1
2020-09-18T04:07:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795364,Synonym:,autologous TriCAR-T-CD19 cells
2020-09-18T04:07:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795364,Synonym:,autologous trifunctional anti-CD19 CAR T cells
2020-09-18T04:07:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794873,Synonym:,anti-CD19/CD22CAR-HER2t-EGFRt-expressing autologous T cells
2020-09-18T04:07:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794873,Synonym:,autologous CD19/CD22CAR-HER2t-EGFRt-expressing T lymphocytes
2020-09-18T04:07:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794873,Synonym:,bispecific anti-CD19/CD22CAR-HER2t-EGFRt-expressing autologous T cells
2020-09-18T04:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801497,Synonym:,anti-CD20 CAR T cells MB-CART20.1
2020-09-18T04:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801497,Synonym:,autologous CD20-targeted CAR-transduced CD4/CD8-enriched T cells MB-CART20.1
2020-09-18T04:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801497,Synonym:,CD20-targeting CAR T cells MB-CART20.1
2020-09-18T04:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801497,Synonym:,MB-CART20.1
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Synonym:,autologous anti-CD22 CAR T cells CART22-65s
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Synonym:,autologous anti-CD22 scFv CAR 4-1BB-TCRz-expressing T lymphocytes CART22-65s
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Synonym:,autologous CART22-65s cells
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Synonym:,autologous CART22-65s T cells
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Synonym:,autologous CART22-65s-expressing T cells
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Code name:,CART22-65s
2020-09-18T04:07:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795452,Synonym:,autologous anti-CD38 A2 CAR2 T cells
2020-09-18T04:07:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795452,Synonym:,autologous CAR2 anti-CD38 A2 CAR T cells
2020-09-18T04:07:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795452,Synonym:,autologous CAR2 anti-CD38 A2 T lymphocytes
2020-09-18T04:07:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795452,Synonym:,autologous CD38-A2 CAR2-expressing T lymphocytes
2020-09-18T04:07:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798380,Synonym:,autologous CRISPR-edited CD7-targeting CAR-CD28zeta T cells
2020-09-18T04:07:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798380,Synonym:,CD7.CAR/28zeta CAR CRISPR-edited T cells
2020-09-18T04:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788,Synonym:,autologous anti-Claudin18.2 CAR-T cells
2020-09-18T04:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788,Synonym:,autologous CAR-CLD18 T cells
2020-09-18T04:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788,Synonym:,autologous CAR-CLD18.2 T cells
2020-09-18T04:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788,Synonym:,Claudin18.2-redirected autologous T cells
2020-09-18T04:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788,Code name:,CT041
2020-09-18T04:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881,Synonym:,anti-CS1 hinge-optimized CAR-4-1BB-EGFRt-expressing memory-enriched autologous T cells
2020-09-18T04:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881,Synonym:,anti-CS1 hinge-optimized CAR-4-1BB-EGFRt-expressing memory-enriched autologous T lymphocytes
2020-09-18T04:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881,Synonym:,autologous anti-CS1 hinge-optimized CAR-4-1BB-EGFRt-expressing memory-enriched T lymphocytes
2020-09-18T04:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881,Synonym:,CS1 CAR-T cells
2020-09-18T04:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881,Synonym:,CS1-CAR T lymphocytes
2020-09-18T04:08:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802166,Synonym:,autologous anti-EGFR CAR-transduced CXCR 5-modified T cells
2020-09-18T04:08:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802166,Synonym:,autologous CXCR5-modified anti-EGFR CAR-T cells
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,anti-PD-1/PD-L1-antibodies-expressing
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,autologous anti-PD-1/anti-PD-L1 antibodies-expressing anti-EGFRvIII CAR T cells
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,autologous EGFRvIII-4SCAR-IgT
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,autologous GBM-specific CAR-T cells
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,EGFRvIII-4SCAR-IgT cells-producing PD1 and PD-L1 antibodies
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,PD-1/PD-L1 antibody-producing T cells (IgT)
2020-09-18T04:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528,Synonym:,autologous anti-FLT3 CAR T lymphocytes AMG 553
2020-09-18T04:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528,Synonym:,autologous FLT3 CAR-T cells AMG 553
2020-09-18T04:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528,Code name:,AMG 553
2020-09-18T04:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528,Code name:,AMG553
2020-09-18T04:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528,Code name:,AMG-553
2020-09-18T04:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797483,Synonym:,autologous anti-GD2CAR-CD28-CD3zeta-IL-15-expressing NKTs
2020-09-18T04:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797483,Synonym:,G28z.15 NKTs
2020-09-18T04:08:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/560190,NA,NA
2020-09-18T04:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798757,Synonym:,GPA-TriMAR lentiviral vector-transduced autologous T cells
2020-09-18T04:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798757,Synonym:,GPA-TriMAR-T cells
2020-09-18T04:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794190,Synonym:,autologous HER2(EQ)BBζ/CD19t+ Tcm cells
2020-09-18T04:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794190,Synonym:,autologous memory enriched HER2(EQ)BBzeta/CD19t+-expressing T cells
2020-09-18T04:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798638,Synonym:,ET140202 autologous T cells
2020-09-18T04:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798638,Code name:,ET 140202
2020-09-18T04:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798638,Code name:,ET140202
2020-09-18T04:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798638,Code name:,ET-140202
2020-09-18T04:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793,Synonym:,autologous AFP-CAR-T cells
2020-09-18T04:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793,Synonym:,autologous AFP-CAR-transduced T cells ET1402L1
2020-09-18T04:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793,Synonym:,autologous ET1402L1-CAR-T cells
2020-09-18T04:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793,Synonym:,autologous T cells transduced with ET1402L1-CAR
2020-09-18T04:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793,Synonym:,ET1402L1-CAR-T cells
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Synonym:,autologous ICAM-1-targeted CAR T cells AIC100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Synonym:,autologous ICAM-1-targeted CAR-T cells AIC100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Synonym:,autologous ICAM-1-targeted CAR-T lymphocytes AIC100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Synonym:,CAR-T cells AIC100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Code name:,AIC 100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Code name:,AIC100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Code name:,AIC-100
2020-09-18T04:08:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/560192,NA,NA
2020-09-18T04:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795279,Synonym:,autologous anti-mesothelin CAR-CD3zeta-4-1-BB-expressing T lymphocytes
2020-09-18T04:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795279,Synonym:,Hu-CART-meso cells
2020-09-18T04:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795279,Synonym:,mesothelin-specific CAR-T cells
2020-09-18T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes,Synonym:,autologous anti-MG7 CAR-T cells
2020-09-18T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes,Synonym:,autologous anti-MG7-CAR T-lymphocytes
2020-09-18T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes,Synonym:,autologous MG7-CART
2020-09-18T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes,Synonym:,autologous MG7-CART cells
2020-09-18T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes,Synonym:,MG7-targeted chimeric antigen receptor T cells
2020-09-18T04:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801391,Synonym:,anti-MUC1*-CAR-4-1BB-CD3zeta-expressing autologous T lymphocytes
2020-09-18T04:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801391,Synonym:,autologous HuMNC2-CAR44
2020-09-18T04:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801391,Synonym:,autologous huMNC2-CAR44 CAR T cells
2020-09-18T04:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801391,Synonym:,autologous huMNC2-CAR44 T lymphocytes
2020-09-18T04:09:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793184,Synonym:,autologous Muc1/CD33/CD38/CD56/CD123-specific gene-engineered CAR-T cells
2020-09-18T04:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796924,Synonym:,anti-NY-ESO-1 mTCR retroviral vector-transduced autologous peripheral blood lymphocytes
2020-09-18T04:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796924,Synonym:,autologous anti-NY-ESO-1 Murine TCR retroviral vector-transduced peripheral blood lymphocytes
2020-09-18T04:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796924,Synonym:,NY-ESO-1-specific mTCR retroviral vector-transduced autologous PBLs
2020-09-18T04:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-ny-eso-1-lage-1-tcr-transduced-c259-t-lymphocytes,Synonym:,autologous NY-ESOc259T GSK3377794
2020-09-18T04:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-ny-eso-1-lage-1-tcr-transduced-c259-t-lymphocytes,Synonym:,genetically engineered NY-ESO-1/LAGE-1 specific (c259) T cells GSK3377794
2020-09-18T04:09:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801527,Synonym:,anti-PD1 antibody-activated autologous TILs
2020-09-18T04:09:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801527,Synonym:,autologous anti-PD-1 antibody-activated TILs
2020-09-18T04:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797158,Synonym:,autologous anti-PSCA(dCH2)BBz-CAR T cells
2020-09-18T04:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797158,Synonym:,autologous anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T cells
2020-09-18T04:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797158,Synonym:,PSCA(dCH2)BBzeta-CAR T cells
2020-09-18T04:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-psma-gene-modified-t-cells,Synonym:,autologous anti-prostate-specific membrane antigen gene-modified T-cells
2020-09-18T04:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798436,Synonym:,anti-CS1 CAR-expressing T cells
2020-09-18T04:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798436,Synonym:,anti-SLAMF7 CAR-expressing T lymphocytes
2020-09-18T04:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798436,Synonym:,autologous anti-SLAMF7 CAR T cells
2020-09-18T04:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160,Synonym:,autologous anti-AXL CAR-T Cells CCT30138
2020-09-18T04:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160,Synonym:,autologous CAR-T cells targeting AXL CCT301-38
2020-09-18T04:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160,Synonym:,CCT30138 CAR-T cells
2020-09-18T04:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160,Code name:,CCT301 38
2020-09-18T04:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160,Code name:,CCT301-38
2020-09-18T04:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795331,Synonym:,HER2/neu-specific autologous B-cell/monocyte vaccine BVAC-B
2020-09-18T04:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795331,Code name:,BVAC B
2020-09-18T04:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795331,Code name:,BVACB
2020-09-18T04:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795331,Code name:,BVAC-B
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Synonym:,APRIL CAR T cells (AUTO2) targeting BCMA and TACI
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Synonym:,APRIL CAR T cells targeting BCMA and TACI
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Synonym:,autologous APRIL CAR T cells
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Synonym:,autologous CAR T product AUTO2
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Code name:,AUTO 2
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Code name:,AUTO2
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Code name:,SUB-96123
2020-09-18T04:10:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792637,Synonym:,autologous anti-BCMA CAR4-1BBz T cells
2020-09-18T04:10:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792637,Synonym:,autologous anti-BCMA:TCRz-4-1-BB CAR-T cells
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Synonym:,autologous LCAR-B4822M CAR T cells
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Synonym:,BCMA-specific CAR-expressing T lymphocytes LCAR-B4822M
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Synonym:,LCAR-B4822M CAR T lymphocytes
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Synonym:,LCAR-B4822M-02 cells
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Code name:,LCARB4822M
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Code name:,LCAR-B4822M
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Code name:,LLCAR B4822M
2020-09-18T04:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802040,Synonym:,autologous BCMA-targeted NEX-T CAR-T Cells CC-98633
2020-09-18T04:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802040,Code name:,CC 98633
2020-09-18T04:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802040,Code name:,CC98633
2020-09-18T04:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802040,Code name:,CC-98633
2020-09-18T04:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells,Synonym:,autologous CD34+ HSCs transduced with LentiGlobin BB305
2020-09-18T04:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells,Synonym:,LentiGlobin BB305 lentiviral vector-transduced autologous CD34+ HSCs
2020-09-18T04:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells,Synonym:,LentiGlobin BB305-transduced CD34-positive cells
2020-09-18T04:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells,Synonym:,lentiviral b-A(T87Q)-globin-transduced CD34-positive cells
2020-09-18T04:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells,US brand name:,LentiGlobin BB305 Drug Product
2020-09-18T04:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630,Synonym:,autologous anti-BCMA CAR-T cells JNJ-68284528
2020-09-18T04:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630,Synonym:,autologous bi-epitope CAR T cells JNJ-68284528
2020-09-18T04:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630,Synonym:,LCAR-B38M-transduced CAR-T cells JNJ-68284528
2020-09-18T04:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630,Code name:,JNJ-68284528
2020-09-18T04:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630,Code name:,LCAR-B38M
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Synonym:,bispecific CAR T cells GC022
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Synonym:,dual CAR-T cells GC022
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Code name:,GC 022
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Code name:,GC022
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Code name:,GC-022
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Code name:,GC022F
2020-09-18T04:10:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801525,Synonym:,betaglucin soluble gel
2020-09-18T04:10:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801525,Synonym:,epiglucan gel
2020-09-18T04:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bone-marrow-derived-cd34-cxcr4-positive-stem-cells-amr-001,Code name:,AMR-001
2020-09-18T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798420,Synonym:,autologous CAR T cells PRGN-3006
2020-09-18T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798420,Code name:,PRGN 3006
2020-09-18T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798420,Code name:,PRGN3006
2020-09-18T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798420,Code name:,PRGN-3006
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,anti-CD30-CAR/CD28z-CCR4 retroviral vector-transduced autologous T cells
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,ATLCAR.CD30.CCR4 cells
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,ATLCAR.CD30-CD28zeta-CCR4 cells
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,ATLs co-expressing CD30-CARCD28zeta and CCR4
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,autologous CCR4-CAR-CD19-CD28-zeta-transduced T lymphocytes
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,CCR4-CAR-CD30-28zeta-specific autologous T cells
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,SFG.CCR4-CAR.CD30 autologous T lymphocytess
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,4SCAR123 T cells
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,4S-CD123-CAR-T cell
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,anti-CD123 CAR-T cells 4SCAR123
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,anti-CD123-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR123
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,CD123-4SCAR-expressing T lymphocytes
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,CD123-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,CD123-specific 4th generation chimeric antigen receptor-modified T cells
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Code name:,4SCAR123
2020-09-18T04:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123car-cd28-cd3zeta-egfrt-expressing-t-lymphocytes,Synonym:,anti-CD123-CAR/CD28-costimulatory retroviral vector-transduced autologous T lymphocytes
2020-09-18T04:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123car-cd28-cd3zeta-egfrt-expressing-t-lymphocytes,Synonym:,CD123R(EQ)28zeta/EGFRt+ T cells
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Synonym:,anti CD123-CAR/CD28-CD3zeta-EGFRt-expressing autologous T lymphocytes MB-102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Synonym:,autologous CD123CAR-CD28-CD3zeta/EGFRt+ T cells MB-102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Synonym:,CD123CAR-CD28-CD3zeta-EGFRt lentiviral-transduced autologous T lymphocytes MB-102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Synonym:,CD123-CD28-CD3zeta.EGFRt+ autologous T cells MB-102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Code name:,MB 102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Code name:,MB102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Code name:,MB-102
2020-09-18T04:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/642488,Synonym:,autologous CD133-positive brain tumor stem cell mRNA-pulsed autologous dendritic cell vaccine
2020-09-18T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798661,Synonym:,autologous CD138-specific CAR T lymphocytes
2020-09-18T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798661,Synonym:,autologous syndecan-1-sepcific CAR T cells
2020-09-18T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798661,Synonym:,autologous syndecan-1-specific CAR T lymphocytes
2020-09-18T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798661,Synonym:,autologous syndecan-1-specific CAR T lymphocytes
2020-09-18T04:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/767199,Synonym:,CD171 CAR+ T cells
2020-09-18T04:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/767199,Synonym:,CE7R CAR T cells
2020-09-18T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801342,Synonym:,autologous CD19 CAR-transduced CD4/CD8 enriched T cells MB-CART19.1
2020-09-18T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801342,Code name:,MB CART19.1
2020-09-18T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801342,Code name:,MBCART19.1
2020-09-18T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801342,Code name:,MB-CART19.1
2020-09-18T04:11:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-cd22-chimeric-antigen-receptor-t-cells,Synonym:,autologous CD19/CD22 CAR T cells
2020-09-18T04:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801669,Synonym:,autologous Anti-CD19/PD-1 bispecific CAR-T cells
2020-09-18T04:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801669,Synonym:,CD19/PD-1 bispecific CAR T cells
2020-09-18T04:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801669,Synonym:,MC-19PD1 CAR-T cells
2020-09-18T04:11:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-28z-chimeric-antigen-receptor-expressing-t-lymphocytes,Synonym:,CAR 19-28z T cells
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Synonym:,4SCAR19 cells
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Synonym:,4S-CAR-T19
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Synonym:,autologous anti-CD19 CAR-T cells 4SCAR19
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Synonym:,autologous CD19- scFv/CD28/CD137/CD27/CD3z-iCasp9 4SCAR-19 T cells
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Synonym:,autologous CD19-scFv/CD28/CD137/CD27/CD3z-iCasp9 CAR-T cells
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Code name:,4SCAR19
2020-09-18T04:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472,Synonym:,autologous shLAMP-1-pp65-DC vaccine
2020-09-18T04:12:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-cells,Synonym:,CD19-CAR-specific/truncated EGFR lentiviral vector-transduced autologous T cells
2020-09-18T04:12:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-cells,Synonym:,CD19R:CD28:lentiviral/EGFRt+ T cells
2020-09-18T04:12:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793561,Synonym:,autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-EGFRt T cells
2020-09-18T04:12:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793561,Synonym:,CD19-CD8CD28zCAR-specific-mbIL15-HER1t T lymphocytes
2020-09-18T04:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794777,Synonym:,autologous anti-CD19 CAR T cells JWCAR029
2020-09-18T04:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794777,Code name:,JWCAR 029
2020-09-18T04:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794777,Code name:,JWCAR029
2020-09-18T04:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794777,Code name:,JWCAR-029
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,autologous anti-CD19-CAR-T cells GC007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,autologous CAR-T cells GC007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,CD19 FasT CAR-T cells GC007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,FasT CAR-19
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,FasTCAR-19
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,GC007F CAR-T cells
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Code name:,GC 007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Code name:,GC007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Code name:,GC-007F
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,4SCAR20 T cells
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,4S-CD20-CAR-T cell
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,anti-CD20 CAR-T cells 4SCAR20
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,anti-CD20-CD28-CD137-CD27-CD3z-iCasp9 CAR T-cells 4SCAR20
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,CD20-4SCAR-expressing T lymphocytes
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,CD20-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,CD20-specific 4th generation chimeric antigen receptor-modified T cells
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Code name:,4SCAR20
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,4SCAR22 T cells
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,4S-CD22-CAR-T cell
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,anti-CD22 CAR-T cells 4SCAR22
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,anti-CD22-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR22
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,CD22-4SCAR-expressing T lymphocytes
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,CD22-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,CD22-specific 4th generation chimeric antigen receptor-modified T cells
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Code name:,4SCAR22
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,anti-CD30-CAR/CD28z retroviral vector-transduced autologous T cells
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,ATLCAR.CD30 cells
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,ATLCAR.CD30-CD28zeta cells
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,ATL-expressing CD30-CAR-CD28zeta
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,autologous CAR-CD19-CD28-zeta-transduced T lymphocytes
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,CAR-CD30-28zeta-specific autologous T cells
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,SFG.CAR.CD30 autologous T lymphocytes
2020-09-18T04:12:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801353,US brand name:,Temferon
2020-09-18T04:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965,Synonym:,autologous BCL11A-edited CD34+ hematopoietic stem/progenitor cells
2020-09-18T04:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965,Synonym:,autologous CD34+ hematopoietic stem cells BIVV003
2020-09-18T04:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965,Synonym:,autologous CD34-positive BCL11A-disrupted HPCs BIVV003
2020-09-18T04:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965,Synonym:,HSPCs BIVV003
2020-09-18T04:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965,Code name:,BIVV003
2020-09-18T04:12:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd34-positive-hematopoietic-progenitor-cells,Synonym:,autologous CD34-positive HPCs
2020-09-18T04:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800131,Synonym:,autologous CD34+ PBSCs
2020-09-18T04:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800131,Synonym:,autologous CD34-positive PBSCs
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,4SCAR38 T cells
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,4S-CD38-CAR-T cell
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,anti-CD38 CAR-T cells 4SCAR38
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,anti-CD38-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR38
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,CD38-4SCAR-expressing T lymphocytes
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,CD38-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,CD38-specific 4th generation chimeric antigen receptor-modified T cells
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Code name:,4SCAR38
2020-09-18T04:13:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791464,Synonym:,autologous CD19t T-antigen presenting cells
2020-09-18T04:13:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791464,Synonym:,autologous CD19t T-APC
2020-09-18T04:13:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791464,Synonym:,autologous T-cell antigen presenting cells expressing CD19t
2020-09-18T04:13:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791464,Synonym:,autologous T-cell antigen presenting cells expressing truncated CD19
2020-09-18T04:13:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796591,Synonym:,autologous CD4+/CD8+ T cells expressing EGFR806-specific CAR/EGFRt and CD19-specific CAR/HER2tG
2020-09-18T04:13:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796591,Synonym:,autologous EGFR806/CD19-specific CAR T cells
2020-09-18T04:13:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796466,Synonym:,autologous CD4+/CD8+ T cells expressing EGFR806-specific CAR/EGFRt
2020-09-18T04:13:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796466,Synonym:,autologous EGFR806 specific CAR T cells
2020-09-18T04:13:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796466,Synonym:,autologous EGFR806-specific CAR T cells
2020-09-18T04:13:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796590,Synonym:,autologous CD4+/CD8+ T cells expressing EGFR806-specific CAR/EGFRt
2020-09-18T04:13:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796590,Synonym:,autologous EGFR806 specific CAR T cells
2020-09-18T04:13:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796590,Synonym:,autologous EGFR806-specific CAR T cells
2020-09-18T04:13:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792575,Synonym:,autologous CD5.CAR/28zeta CAR T cells
2020-09-18T04:13:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792575,Synonym:,autologous CD5-specific CAR-28 zeta CAR T lymphocytes
2020-09-18T04:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd8-melanoma-specific-t-cells,Synonym:,autologous melanoma-specific cytotoxic T lymphocytes
2020-09-18T04:13:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/693322,Synonym:,autologous CD8+ PBL sensitized To Drosophila cell-presented melanoma peptides
2020-09-18T04:13:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cea-specific-cytotoxic-t-lymphocytes,Synonym:,CEA-specific AAV-DC-CTLs
2020-09-18T04:13:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cea-specific-cytotoxic-t-lymphocytes,Synonym:,CEA-specific CTLs
2020-09-18T04:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794651,Synonym:,autologous CC-EIE cells
2020-09-18T04:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794651,Synonym:,autologous CC-EIEs
2020-09-18T04:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793668,Synonym:,autologous CISH-inactivated T lymphocytes
2020-09-18T04:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793668,Synonym:,autologous CISH-inactivated TIL
2020-09-18T04:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793668,Synonym:,autologous CISH-inactivated tumor-infiltrating lymphocytes
2020-09-18T04:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793668,Synonym:,autologous CRISPR/Cas 9-CISH knockout TILs
2020-09-18T04:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670,Synonym:,autologous anti-CLL1/anti-CD33 CARs-expressing T lymphocytes
2020-09-18T04:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670,Synonym:,autologous CLL1-CD33 cCAR
2020-09-18T04:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670,Synonym:,autologous CLL1-CD33 cCAR T cells
2020-09-18T04:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670,Synonym:,autologous CLL1-CD33 cCAR T lymphocytes
2020-09-18T04:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670,Synonym:,CLL1-CD33 cCAR T cells
2020-09-18T04:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800942,Synonym:,autologous cNeT ATL001
2020-09-18T04:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800942,Code name:,ATL 001
2020-09-18T04:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800942,Code name:,ATL001
2020-09-18T04:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800942,Code name:,ATL-001
2020-09-18T04:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798662,Synonym:,autologous anti-c-Met/PD-L1 CAR T cells
2020-09-18T04:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798662,Synonym:,autologous c-Met/PD-L1-specific CAR T lymphocytes
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous CMV pp65-LAMP mRNA-loaded DC vaccine
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous CMV-pp65-flLamp DCs
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous flLAMP-pp65 mRNA-pulsed DC vaccine
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous flLAMP-pp65-DC vaccine
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous flLAMP-pp65-DCs
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous pp65-flLAMP DC vaccine
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous pp65-flLAMP DCs
2020-09-18T04:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472,Synonym:,autologous pp65-shLAMP-1 DC vaccine
2020-09-18T04:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472,Synonym:,autologous shLAMP-1-pp65 mRNA-pulsed DC vaccine
2020-09-18T04:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472,Synonym:,autologous shLAMP-1-pp65-DCs
2020-09-18T04:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472,Synonym:,pp65-shLAMP-1 mRNA DCs
2020-09-18T04:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-colon-cancer-cell-vaccine,Synonym:,OncoVAX
2020-09-18T04:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-colorectal-tumor-antigen-pulsed-dendritic-cell-vaccine,Synonym:,APDC vaccine
2020-09-18T04:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-colorectal-tumor-antigen-pulsed-dendritic-cell-vaccine,Synonym:,autologous colorectal tumor antigen-pulsed DC vaccine
2020-09-18T04:14:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755477,Code name:,CT7/MAGE-A3/WT1 mRNA-electroporated LCs
2020-09-18T04:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796813,Synonym:,anti-CT-RCC-1 HERV-E-TCR-transduced-HLA-A11-restricted autologous CD8+/CD34t+ T cells
2020-09-18T04:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796813,Synonym:,autologous CT-RCC-1 HERV-E-TCR-transduced-HLA-A11-restricted CD8+/CD34t+ T lymphocytes
2020-09-18T04:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cultured-acute-myeloid-leukemia-specific-cytotoxic-t-lymphocytes,Synonym:,autologous AML-reactive cultured CTLs
2020-09-18T04:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cultured-acute-myeloid-leukemia-specific-cytotoxic-t-lymphocytes,Synonym:,autologous AML-specific CTL
2020-09-18T04:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cytokine-induced-killer-cells,Foreign brand name:,Immuncell-LC
2020-09-18T04:14:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797088,Synonym:,autologous CAR19 T cells carrying cytoplasmic activated PD-1
2020-09-18T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090,Synonym:,6B11 anti-idiotype minibody-pulsed DCs induced autologous CTLs
2020-09-18T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090,Synonym:,autologous CTLs exposed to 6B11mini-ovarian-cytokine-induced-killer cells
2020-09-18T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090,Synonym:,autologous CTLs exposed to 6B11-OCIK
2020-09-18T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090,Synonym:,autologous CTLs induced with 6B11 anti-idiotype minibody-pulsed DCs
2020-09-18T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090,Synonym:,autologous cytotoxic T cells induced by autologous dendritic cells loaded with 6B11 anti-idiotype minibody
2020-09-18T04:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777274,Synonym:,MUC1-DC-CTL
2020-09-18T04:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777274,Synonym:,MUC1-gene-DC-CTL
2020-09-18T04:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777275,Synonym:,MUC1-peptide-DC-CTL
2020-09-18T04:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797353,Synonym:,IL-15 loaded autologous T lymphocytes TRQ15-01
2020-09-18T04:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797353,Code name:,TRQ15-01
2020-09-18T04:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-vaccine-act2001,Synonym:,autologous DC vaccine ACT2001
2020-09-18T04:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-vaccine-act2001,Code name:,ACT2001
2020-09-18T04:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-adenovirus-ccl21-vaccine,Abbreviation:,Ad-CCL21-DC
2020-09-18T04:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-adenovirus-ccl21-vaccine,Abbreviation:,DC-AdCCL21
2020-09-18T04:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-adenovirus-p53-vaccine,NA,NA
2020-09-18T04:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-allogeneic-melanoma-tumor-cell-lysate-vaccine,Synonym:,Allogeneic Melanoma Cell-Loaded Dendritic Cell Vaccine
2020-09-18T04:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-allogeneic-melanoma-tumor-cell-lysate-vaccine,US brand name:,Uvidem
2020-09-18T04:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-allogeneic-melanoma-tumor-cell-lysate-vaccine,Code name:,IDD-3
2020-09-18T04:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-autologous-tumor-mrna-human-cd40l-vaccine,Synonym:,Autologous Dendritic Cell and Tumor mRNA Human CD40L Vaccine
2020-09-18T04:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-based-immunotherapeutic-av0113,Synonym:,autologous DC-based immunotherapeutic AV0113
2020-09-18T04:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-based-immunotherapeutic-av0113,Synonym:,AV0113 DC-CIT
2020-09-18T04:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-based-immunotherapeutic-av0113,Synonym:,AV0113 dendritic cell cancer immune therapy
2020-09-18T04:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-based-immunotherapeutic-av0113,Code name:,AV0113
2020-09-18T04:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cells-pulsed-with-mart-1-26-35-peptide,Synonym:,autologous MART-1 (26-35) peptide pulsed DC vaccine
2020-09-18T04:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cells-pulsed-with-mart-1-26-35-peptide,Synonym:,autologous MART-1 (26-35) peptide pulsed dendritic cell vaccine
2020-09-18T04:15:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-tumor-fusion-vaccine,NA,NA
2020-09-18T04:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dinitrophenyl-modified-ovarian-cancer-vaccine,Synonym:,autologous DNP-modified ovarian cancer vaccine
2020-09-18T04:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dinitrophenyl-modified-ovarian-cancer-vaccine,US brand name:,OVax
2020-09-18T04:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793136,Synonym:,autologous anti-HPV-16 E6 TCR T cells
2020-09-18T04:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793136,Synonym:,autologous E6 TCR T cells
2020-09-18T04:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793136,Synonym:,autologous HPV-16 E6 TCR T cells
2020-09-18T04:16:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ebv-ctl-cd19car-zeta,NA,NA
2020-09-18T04:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ebv-transformed-b-lymphoblastoid-tumor-fusion-cell-vaccine,NA,NA
2020-09-18T04:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793115,Synonym:,autologous anti-CTLA-4/PD-1-expressing EGFR-CAR-T cells
2020-09-18T04:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793115,Synonym:,autologous anti-PD-1/CTLA4-targeting antibodies-expressing EGFR-specific CAR-T cells
2020-09-18T04:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793115,Synonym:,autologous CTLA-4 and PD-1 antibodies expressing EGFR-CAR-T cells
2020-09-18T04:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792554,Synonym:,autologous EGFRt/BCMA-41BBz CAR T cells
2020-09-18T04:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792554,Synonym:,B-cell maturation antigen-targeted EGFRt/BCMA-41BBz CAR-modified T cells
2020-09-18T04:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792554,Synonym:,EGFRt/BCMA-41BBz CAR T cell
2020-09-18T04:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-epstein-barr-virus-specific-cytotoxic-t-lymphocytes,Synonym:,EBV-specific cytotoxic T lymphocytes
2020-09-18T04:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-epstein-barr-virus-specific-cytotoxic-t-lymphocytes,Synonym:,Epstein-Barr virus-specific cytotoxic T lymphocytes
2020-09-18T04:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-epstein-barr-virus-transformed-b-lymphoblastoid-cell-vaccine,Synonym:,autologous EBV-transformed B-lymphoblastoid cell vaccine
2020-09-18T04:16:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-expanded-mesenchymal-stem-cells-oti-010,US brand name:,Stromagen
2020-09-18T04:16:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-expanded-mesenchymal-stem-cells-oti-010,Code name:,OTI-010
2020-09-18T04:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118,Synonym:,autologous 4S-FRa-CAR-T cells
2020-09-18T04:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118,Synonym:,autologous anti-FRa-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR-FRa
2020-09-18T04:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118,Synonym:,chimeric antigen receptor T cells 4SCAR-FRa
2020-09-18T04:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118,Synonym:,FRa-specific 4th generation CART cells
2020-09-18T04:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118,Abbreviation:,4SCAR-FRa
2020-09-18T04:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799772,Synonym:,human gamma-globinG16D/short-hairpin RNA734-transduced CD34-positive cells CSL200
2020-09-18T04:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799772,Code name:,CSL 200
2020-09-18T04:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799772,Code name:,CSL200
2020-09-18T04:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799772,Code name:,CSL-200
2020-09-18T04:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791887,Synonym:,gamma-retroviral MSGV1 139 scFv EGFRvIII CAR gene-modified autologous T lymphocytes
2020-09-18T04:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791887,Synonym:,MSGv1-EGFRvIII-CAR autologous T cells
2020-09-18T04:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791887,Synonym:,MSGV1-EGFRvIII-specific CAR-transduced autologous T lymphocytes
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,autologous genetically-modified MAGE-A4 C1032 T lymphocytes
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,autologous genetically-modified melanoma antigen A4 T cells
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,autologous MAGE-A4 C1032 TCR-modified T cells
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,autologous TCR-transduced MAGE-A4 C1032 T cells
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,MAGE-A4 SPEAR T cells
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,MAGE-A4 TCR
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,MAGE-A4-specific TCR gene-transduced C1032 T lymphocytes
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Code name:,ADP-A2M4
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,ADP-A2M4CD8
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,autologous genetically-modified MAGE-A4 C1032 CD8alpha T lymphocytes
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,autologous genetically-modified melanoma antigen A4 CD8alpha T cells
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,autologous MAGE-A4 C1032 TCR-modified CD8alpha T cells
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,autologous TCR-transduced MAGE-A4 C1032 CD8alpha T cells
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,MAGE-A4 SPEAR CD8alpha T cells
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,MAGE-A4-specific TCR gene-transduced C1032 CD8alpha T lymphocytes
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,SPEAR T-cell ADP-A2M4CD8
2020-09-18T04:17:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-glioma-cell-lysate,NA,NA
2020-09-18T04:17:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gm-csf-secreting-breast-cancer-vaccine,NA,NA
2020-09-18T04:17:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/754007,Synonym:,GVAX colorectal cancer vaccine
2020-09-18T04:17:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gvax-lung-cancer-vaccine,Synonym:,autologous GVAX lung cancer vaccine
2020-09-18T04:17:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gvax-lung-cancer-vaccine,Synonym:,GVAX autologous lung cancer vaccine
2020-09-18T04:17:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gvax-lung-cancer-vaccine,Code name:,CG8123
2020-09-18T04:17:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gvax-lung-cancer-vaccine,Code name:,CG8123V
2020-09-18T04:17:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793088,Synonym:,autologous HCC antigens-specific CD8+ T lymphocytes
2020-09-18T04:17:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793088,Synonym:,autologous HCC antigens-specific CD8-positive T lymphocytes
2020-09-18T04:17:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793088,Synonym:,autologous specific HCC antigens CD8+ T cells
2020-09-18T04:17:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hbv-specific-tcr-redirected-t-lymphocytes,Synonym:,autologous HBV antigen-specific TCR-redirected T cells
2020-09-18T04:17:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hbv-specific-tcr-redirected-t-lymphocytes,Synonym:,autologous HBV/TCR-T cells
2020-09-18T04:17:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-heat-shock-protein-70-peptide-vaccine-ag-858,Code name:,AG-858
2020-09-18T04:17:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/643475,Synonym:,autologous TGF beta-resistant HER2/EBV-CTLs
2020-09-18T04:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396,Synonym:,HER2-AdVST
2020-09-18T04:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396,Synonym:,HER2-CAR-modified adenovirus-specific CTLs
2020-09-18T04:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396,Synonym:,HER2-CAR-modified Ad-specific CTLs
2020-09-18T04:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396,Synonym:,HER2-CAR-modified autologous AdVSTs
2020-09-18T04:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396,Abbreviation:,HER2.CAR AdVST
2020-09-18T04:18:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795343,Synonym:,autologous HER2 CAR/EGFRt-expressing CD4+ and CD8+ T cells
2020-09-18T04:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hnscc-dna-transfected-semi-allogeneic-fibroblasts-mrc-5-vaccine,NA,NA
2020-09-18T04:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966,Synonym:,HPV16 E7 T-cell receptor engineered T cells KITE-439
2020-09-18T04:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966,Synonym:,HPV16 E7-specific HLA-A*02:01-restricted TCR gene engineered autologous T lymphocytes KITE-439
2020-09-18T04:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966,Code name:,KITE 439
2020-09-18T04:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966,Code name:,KITE439
2020-09-18T04:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966,Code name:,KITE-439
2020-09-18T04:18:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hpv-16-18-e6-e7-specific-tgf-beta-resistant-t-lymphocytes,Synonym:,HPVST cells
2020-09-18T04:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794787,Synonym:,autologous HPV-specific immune lymphocytes
2020-09-18T04:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794787,Abbreviation:,autologous HPV-CTLs
2020-09-18T04:18:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788957,Synonym:,anti-CD19-CAR genetically engineered autologous T lymphocytes huJCAR014
2020-09-18T04:18:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788957,Synonym:,anti-CD19-CAR genetically-engineered autologous T lymphocytes huJCAR014
2020-09-18T04:18:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788957,Synonym:,autologous anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T lymphocytes
2020-09-18T04:18:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788957,Code name:,huJCAR014
2020-09-18T04:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795822,Synonym:,autologous iC9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing T cells
2020-09-18T04:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795822,Synonym:,iCasp9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing autologous T cells
2020-09-18T04:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795822,Synonym:,iCasp9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing autologous T lymphocytes
2020-09-18T04:18:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797486,Synonym:,autologous iC9-GD2CAR-CD28-CD3zeta-IL-15-expressing T cells
2020-09-18T04:18:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797486,Synonym:,iC9.GD2.CAR.IL-15 T-cells
2020-09-18T04:18:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ic9-gd2-car-expressing-vzv-specific-t-lymphocytes,Synonym:,autologous iC9-GD2-CAR-VZV-CTLs
2020-09-18T04:18:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791844,Synonym:,ATL-iC9-CAR-CD19
2020-09-18T04:18:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791844,Synonym:,autologous iC9-CAR19 T cells
2020-09-18T04:18:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791844,Synonym:,autologous iC9-CARCD19 T cells
2020-09-18T04:18:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791844,Abbreviation:,autologous iC9-CARCD19 T cells
2020-09-18T04:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-icasp9-cd19-expressing-t-lymphocytes,Synonym:,autologous iC9.2A.deltaNGFR.2A.CAR.CD19 T cells
2020-09-18T04:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-icasp9-cd19-expressing-t-lymphocytes,Synonym:,autologous inducible caspase 9-CD19-expressing autologous T lymphocytes
2020-09-18T04:19:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-il-21-modulated-cd8-mart1-specific-t-cells,NA,NA
2020-09-18T04:19:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine,Synonym:,autologous immunoglobulin idiotype-keyhole limpet hemocyanin conjugate vaccine
2020-09-18T04:19:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine,Synonym:,GTOP-99
2020-09-18T04:19:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine,Synonym:,Id-KLH conjugate vaccine
2020-09-18T04:19:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine,Synonym:,recombinant Id-KLH
2020-09-18T04:19:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine,Abbreviation:,Id-KLH
2020-09-18T04:19:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-interferon-producing-killer-dendritic-cells,Synonym:,autologous IKDC-like cells
2020-09-18T04:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793116,Synonym:,OC-IgT cells
2020-09-18T04:19:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-interferon-producing-killer-dendritic-cells,Abbreviation:,autologous IKDC
2020-09-18T04:19:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lmp1--lmp2--specific-cytotoxic-t-lymphocytes,NA,NA
2020-09-18T04:19:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798763,Synonym:,autologous EBV-specific TCR T cells YT-E001
2020-09-18T04:19:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798763,Code name:,YT E001
2020-09-18T04:19:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798763,Code name:,YTE001
2020-09-18T04:19:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798763,Code name:,YT-E001
2020-09-18T04:19:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lymphoid-effector-cells-specific-against-tumor-cells,Synonym:,autologous activated cytotoxic T lymphocytes/natural killer cells
2020-09-18T04:19:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lymphoid-effector-cells-specific-against-tumor-cells,Foreign brand name:,ALECSAT
2020-09-18T04:19:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lymphoma-cell-lysate-pulsed-autologous-dendritic-cell-vaccine,NA,NA
2020-09-18T04:19:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/642645,NA,NA
2020-09-18T04:19:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/642644,NA,NA
2020-09-18T04:19:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lymphoma-immunoglobulin-derived-scfv-chemokine-dna-vaccine,NA,NA
2020-09-18T04:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786272,Synonym:,autologous genetically-modified T cells MAGEA10c796
2020-09-18T04:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786272,Synonym:,autologous MAGE A10c796 T cells
2020-09-18T04:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786272,Synonym:,autologous MAGE-A10-specific HLA-A2-restricted TCR c796 gene-engineered lymphocytes
2020-09-18T04:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786272,Abbreviation:,MAGEA10c796 T
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,autologous anti-MAGE-A3/A6 TCR-transduced T cells KITE-718
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,MAGE-A3/A6 T cell receptor engineered T cells
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,MAGE-A3/A6 T cell receptor engineered T cells KITE-718
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,MAGE-A3/A6 TCR engineered T lymphocytes
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,MAGEA3/A6-targeted TCR-transduced T cells KITE-718
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,TCR-transduced autologous T cells KITE-718
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Code name:,KITE 718
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Code name:,KITE-718
2020-09-18T04:20:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/762213,Synonym:,anti-MAGE-A3 HLA-A*01-restricted TCR-gene engineered lymphocytes
2020-09-18T04:20:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795693,Synonym:,autologous CD8+ and CD4+ T cells transduced with TCR A2-MCC1
2020-09-18T04:20:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795693,Synonym:,FH-MCVA2TCR autologous CD8+ and CD4+ T cells transduced with TCR A2-MCC1
2020-09-18T04:20:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795693,Code name:,FH-MCVA2TCR
2020-09-18T04:20:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798639,NA,NA
2020-09-18T04:20:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798704,Synonym:,autologous -peptide-pulsed mDC3/8 KRAS vaccine
2020-09-18T04:20:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-melanoma-lysate-klh-pulsed-autologous-dendritic-cell-vaccine,NA,NA
2020-09-18T04:20:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/753553,NA,NA
2020-09-18T04:20:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-melanoma-lysate-pulsed-autologous-dendritic-cell-vaccine,Synonym:,TLPLDC vaccine
2020-09-18T04:20:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mesenchymal-stem-cells-apceth-101,Synonym:,Agenmestencel-T
2020-09-18T04:20:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mesenchymal-stem-cells-apceth-101,Synonym:,autologous MSC_apceth_101
2020-09-18T04:20:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792529,Synonym:,autologous CART-meso
2020-09-18T04:20:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792529,Synonym:,Hu-CART meso cells
2020-09-18T04:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793113,Synonym:,autologous anti-CTLA-4/PD-1 antibodies-expressing meso-CAR-T cells
2020-09-18T04:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793113,Synonym:,autologous anti-CTLA-4/PD-1 antibodies-expressing mesothelin-targeted CAR-T cells
2020-09-18T04:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793113,Synonym:,autologous CTLA-4 and PD-1 antibodies expressing mesothelin-CAR-T cells
2020-09-18T04:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793113,Synonym:,autologous CTLA4/PD-1-targeting antibodies-expressing mesothelin-CAR-T cells
2020-09-18T04:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794988,Synonym:,anti-mesothelin mRNA-transfected autologous PBMCs MCY-M11
2020-09-18T04:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794988,Code name:,MCY-M11
2020-09-18T04:21:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801794,Synonym:,autologous monocyte-derived lysate pulsed DCs PV-001-DC
2020-09-18T04:21:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801794,Synonym:,PV-001-dendritic cell
2020-09-18T04:21:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801794,Code name:,PV-001-DC
2020-09-18T04:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792542,Synonym:,autologous cMET redirected CAR-T cells
2020-09-18T04:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792542,Synonym:,autologous mRNA CART-cMET
2020-09-18T04:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792542,Synonym:,cMET CAR-mRNA-electroporated autologous T lymphocytes
2020-09-18T04:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-muc1-mannan-fusion-protein-pulsed-dendritic-cell-vaccine,Foreign brand name:,CVac
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,autologous aDC1-induced CTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,autologous CTLs sensitized ex-vivo with autologous TAA-loaded alphaDC1
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,autologous natural killer-like cytotoxic lymphocytes
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,autologous nCTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,autologous NK-like CTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,in vitro DC-sensitized CTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,in-vitro DC-sensitized autologous CTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,therapeutic nCTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,tumor neo-antigen-specific nCTLs
2020-09-18T04:21:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801659,Synonym:,autologous anti-nectin-4/anti-FAP CAR-T cells
2020-09-18T04:21:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801659,Synonym:,autologous anti-nectin4/FAP CAR-T cells
2020-09-18T04:21:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-neuroblastoma-lysate-klh-pulsed-dendritic-cell-vaccine,Synonym:,autologous neuroblastoma lysate/KLH-pulsed DC vaccine
2020-09-18T04:21:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-neuroblastoma-lysate-klh-pulsed-dendritic-cell-vaccine,Synonym:,keyhole limpet hemocyanin-pulsed dendritic cell vaccine
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous CAR NKG2D
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous CAR-T NKG2D
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous CAR-T NKR-2
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous NKG2D CAR-CD3zeta-DAP10-expressing T cells CYAD-01
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous NKR 2 T cells
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous NKR-2 CAR-T cells
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,CM CS-1
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,CM-CS-1
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,CYAD-01
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,CYAD-101
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,NKR 2
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,NKR-2
2020-09-18T04:21:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nsclc-dna-transfected-semi-allogeneic-fibroblasts-mrc-5-vaccine,Synonym:,autologous non-small cell lung cancer DNA-transfected semi-allogeneic fibroblasts MRC-5 vaccine
2020-09-18T04:21:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nsclc-peptide-specific-dendritic-cell-vaccine,Synonym:,autologous NSCLC peptide-specific DC vaccine
2020-09-18T04:21:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792517,Synonym:,NY-ESO-1 T Cell receptor genetically modified autologous T cells
2020-09-18T04:21:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-melanoma-specific-cd8-t-cells,NA,NA
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,autologous NYCE cells
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,autologous NYCE T cells
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,autologous NY-ESO-1 TCR-expressing CRISPR-edited (TCR and PD-1) T cells
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,autologous NY-ESO-1 transgenic TCR-expressing endogenous TCR-PD-1 gene-edited T cells
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,NY-ESO-1 TCR-PD-1-CRISPR-gene-edited autologous T lymphocytes
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,NY-ESO-1-redirected autologous T cells with CRISPR edited endogenous TCR and PD-1
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,NY-ESO-1-redirected autologous T cells with CRISPR-edited endogenous TCR and PD-1
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,NY-ESO-1-redirected CRISPR edited T cells
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,NY-ESO-1-redirected CRISPR-TCRendo/PD1-edited T cells
2020-09-18T04:22:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795738,NA,NA
2020-09-18T04:22:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ofa-ilrp-rna-transfected-dendritic-cell-vaccine,Synonym:,oncofetal antigen-immature laminin receptor protein-loaded autologous dendritic cell vaccine
2020-09-18T04:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793116,Synonym:,autologous human OC-IgT cells
2020-09-18T04:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794654,Synonym:,autologous OC-CTLs
2020-09-18T04:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794654,Synonym:,autologous ovarian cancer-specific CTLs
2020-09-18T04:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794654,Abbreviation:,OC-CTLs
2020-09-18T04:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ovarian-tumor-cell-lysate-pulsed-dendritic-cell-vaccine,Synonym:,autologous OC-DC vaccine
2020-09-18T04:22:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-oxidized-ovarian-tumor-cell-lysate-vaccine,Synonym:,autologous OC-L vaccine
2020-09-18T04:22:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802181,Synonym:,autologous pancreatic adenocarcinoma lysate- and mRNA-loaded DC vaccine
2020-09-18T04:22:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802181,Synonym:,autologous pancreatic adenocarcinoma lysate and mRNA-loaded DCs
2020-09-18T04:22:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802181,Synonym:,autologous pancreatic adenocarcinoma lysate and mRNA-loaded dendritic cells
2020-09-18T04:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330,Synonym:,autologous PBLs expressing mutated neoantigen-specific T-cell receptors
2020-09-18T04:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330,Synonym:,autologous peripheral blood lymphocytes retrovirally-transduced with TCRs targeting neoantigens
2020-09-18T04:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330,Synonym:,individual patient TCR-transduced autologous PBLs
2020-09-18T04:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330,Synonym:,neoantigen-reactive TCRs-transduced autologous PBLs
2020-09-18T04:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330,Synonym:,neoantigen-specific TCRs gene-transduced autologous PBLs
2020-09-18T04:22:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792459,Synonym:,autologous PD-1 antibody expressing mesothelin specific CAR-T cells
2020-09-18T04:22:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793152,Synonym:,autologous iPD1 CD19 eCAR T cells
2020-09-18T04:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-1-targeted-chimeric-switch-receptor-modified-t-lymphocytes,Synonym:,autologous chimeric switch receptor PD-1:CD28 modified T cells
2020-09-18T04:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-1-targeted-chimeric-switch-receptor-modified-t-lymphocytes,Synonym:,autologous PD-1-targeted CSR T cells
2020-09-18T04:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-1-targeted-chimeric-switch-receptor-modified-t-lymphocytes,Synonym:,chimeric switch receptor PD1CD28 modified T cells
2020-09-18T04:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-1-targeted-chimeric-switch-receptor-modified-t-lymphocytes,Synonym:,PD1CD28 CSR T cells
2020-09-18T04:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792541,Synonym:,autologous CAR-T Cells Targeting PD-L1 and CD80/CD86
2020-09-18T04:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792541,Synonym:,Zeushield CTLs
2020-09-18T04:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792541,Synonym:,Zeushield cytotoxic T lymphocytes
2020-09-18T04:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792541,Abbreviation:,Z-CTLs
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,autologous lymphocytes cotransduced with genes encoding IL-12 and anti-NY-ESO-1 TCR
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,autologous PBL cotransduced with retroviral vectors encoding inducible IL-12 and anti-NY-ESO-1 TCR
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,IL-12 plus anti-ESO-1 TCR PBL
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,IL-12/Anti-NY-ESO-1 TCR-expressing autologous PBL
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,IL-12/anti-NY-ESO-1 TCR-expressing autologous peripheral blood lymphocytes
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,IL-12/Anti-NY-ESO-1 TCR-expressing autologous peripheral blood lymphocytes
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,inducible IL-12/Anti-NY-ESO-1 TCR-expressing autologous PBL
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,inducible IL-12/Anti-NY-ESO-1 TCR-expressing autologous peripheral blood lymphocytes
2020-09-18T04:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421,Synonym:,autologous PBLs from ibrutinib-treated CLL patients
2020-09-18T04:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421,Synonym:,autologous PBLs IOV-2001
2020-09-18T04:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421,Code name:,IOV 2001
2020-09-18T04:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421,Code name:,IOV2001
2020-09-18T04:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421,Code name:,IOV-2001
2020-09-18T04:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pluripotent-aldhbr-stem-cells-ald-451,Synonym:,ALD-451 bright cells
2020-09-18T04:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pluripotent-aldhbr-stem-cells-ald-451,Code name:,ALD-451
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Synonym:,autologous anti-PRAME-TCR-expressing T cells MDG1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Synonym:,autologous PRAME TCR-modified T cells MDG1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Synonym:,autologous TCR-modified T cells MDG1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Synonym:,PRAME-TCR gene-modified autologous T cells MDG1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Code name:,MDG 1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Code name:,MDG1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Code name:,MDG-1011
2020-09-18T04:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/640422,Code name:,BP-GMAX-CD1
2020-09-18T04:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/640422,Code name:,BPX-101
2020-09-18T04:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prostate-stem-cell-antigen-specific-car-t-cells-bpx-601,Synonym:,autologous PSCA-specific CAR T cells BPX-601
2020-09-18T04:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prostate-stem-cell-antigen-specific-car-t-cells-bpx-601,Synonym:,autologous PSCA-specific chimeric antigen receptor engineered T cells BPX-601
2020-09-18T04:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prostate-stem-cell-antigen-specific-car-t-cells-bpx-601,Synonym:,GoCART BPX-601
2020-09-18T04:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prostate-stem-cell-antigen-specific-car-t-cells-bpx-601,Code name:,BPX-601
2020-09-18T04:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119,Synonym:,4SCAR-PSMA
2020-09-18T04:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119,Synonym:,autologous 4S-PSMA-CAR-T cells
2020-09-18T04:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119,Synonym:,autologous anti-PSMA-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR-PSMA
2020-09-18T04:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119,Synonym:,chimeric antigen receptor T cells 4SCAR-PSMA
2020-09-18T04:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119,Synonym:,PSMA-specific 4th generation CART cells
2020-09-18T04:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792627,Synonym:,autologous CART-PSMA-TGFbRDN T cells
2020-09-18T04:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792627,Synonym:,autologous CART-PSMA-TGFβRDN cells
2020-09-18T04:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792627,Synonym:,PSMA-specific/TGFb-resistant CAR-modified autologous T cells
2020-09-18T04:23:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802318,Code name:,RAPA 201
2020-09-18T04:23:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802318,Code name:,RAPA201
2020-09-18T04:23:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802318,Code name:,RAPA-201
2020-09-18T04:23:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-renal-cell-carcinoma-tumor-lysate-dendritic-cell-vaccine,Abbreviation:,autologous RCC tumor lysate-DC vaccine
2020-09-18T04:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161,Synonym:,autologous anti-ROR2 CAR-T cells CCT301-59
2020-09-18T04:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161,Synonym:,autologous CAR-T cells targeting ROR2 CCT301-59
2020-09-18T04:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161,Synonym:,autologous CCT301-59 CAR-T cells
2020-09-18T04:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161,Code name:,CCT301 59
2020-09-18T04:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161,Code name:,CCT301-59
2020-09-18T04:24:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-sarcoma-cell-lysate,NA,NA
2020-09-18T04:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-sarcoma-lysate-pulsed-dendritic-cell-vaccine,NA,NA
2020-09-18T04:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776841,Synonym:,"autologous T lymphocytes expressing NY-ESO-1-specific, enhanced TCRs"
2020-09-18T04:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776841,Synonym:,NY-ESO-1/C259T
2020-09-18T04:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776841,Synonym:,NY-ESO-1C259T
2020-09-18T04:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776841,Synonym:,NY-ESOc259T
2020-09-18T04:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138,Synonym:,autologous dendritic cells loaded with autologous tumor associated antigens
2020-09-18T04:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138,Synonym:,autologous TAAs-loaded autologous DCs AV-GBM-1
2020-09-18T04:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138,Synonym:,neoantigen-loaded autologous dendritic cells AV-GBM-1
2020-09-18T04:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138,Code name:,AV GBM 1
2020-09-18T04:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138,Code name:,AV-GBM-1
2020-09-18T04:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318,Synonym:,autologous PBMCs TBX-3400
2020-09-18T04:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318,Synonym:,autologous TBX-4000-treated human PBMCs
2020-09-18T04:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318,Synonym:,TBX-3400 cells
2020-09-18T04:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318,Code name:,TBX 3400
2020-09-18T04:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318,Code name:,TBX-3400
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Synonym:,ACTengine IMA201
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Synonym:,autologous T-cell receptor-engineered T cells IMA201
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Synonym:,IMA201 autologous T lymphocytes
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Synonym:,IMA201 T cells
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Code name:,IMA 201
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Code name:,IMA201
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Code name:,IMA-201
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Synonym:,ACTengine IMA202
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Synonym:,IMA202 T cells
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Synonym:,IMA202 T-cell product
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Code name:,IMA 202
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Code name:,IMA202
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Code name:,IMA-202
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Synonym:,ACTengine IMA203
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Synonym:,IMA203 T cells
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Synonym:,IMA203 T-cell product
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Code name:,IMA 2013
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Code name:,IMA203
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Code name:,IMA-203
2020-09-18T04:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800431,Synonym:,autologous DC vaccine MIDRIX4-LUNG
2020-09-18T04:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800431,Synonym:,autologous tetravalent DC vaccine MIDRIX4-LUNG
2020-09-18T04:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800431,Synonym:,tetravalent autologous dendritic cell vaccine MIDRIX4-LUNG
2020-09-18T04:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800431,Code name:,MIDRIX4-LUNG
2020-09-18T04:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771,Synonym:,anti-TnMUC1-CAR-expressing autologous T lymphocytes
2020-09-18T04:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771,Synonym:,autologous anti-TnMUC1-CAR-expressing T lymphocytes
2020-09-18T04:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771,Synonym:,autologous CART-TnMUC1 cells
2020-09-18T04:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771,Synonym:,autologous Tn-MUC1-specific CAR T cells
2020-09-18T04:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771,Synonym:,autologous TnMUC1-targeted genetically-modified CAR T cells
2020-09-18T04:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-proteoliposome-chronic-lymphocytic-leukemia-vaccine,US brand name:,Oncoquest-L vaccine
2020-09-18T04:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-vaccine,Synonym:,AC vaccine
2020-09-18T04:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-vaccine,Synonym:,Autologous Cell Vaccine
2020-09-18T04:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-vaccine,Abbreviation:,ATCV
2020-09-18T04:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-144,Synonym:,autologous TIL LN-144
2020-09-18T04:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-144,US brand name:,Contego
2020-09-18T04:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-144,Code name:,LN-144
2020-09-18T04:25:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-145,Synonym:,autologous TILs LN-145
2020-09-18T04:25:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-145,Synonym:,autologous tumor-infiltrating lymphocytes LN-145
2020-09-18T04:25:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-145,Code name:,LN145
2020-09-18T04:25:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-145,Code name:,LN-145
2020-09-18T04:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802263,Code name:,CS 3002
2020-09-18T04:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802263,Code name:,CS3002
2020-09-18T04:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802263,Code name:,CS-3002
2020-09-18T04:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753,Synonym:,autologous tumor antigen-associated cytotoxic T lymphocytes
2020-09-18T04:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753,Synonym:,patient-derived multi-antigen associated cytotoxic T lymphocytes
2020-09-18T04:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753,Synonym:,patient-derived WT1/PRAME/survivin-specific T lymphocytes
2020-09-18T04:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753,Abbreviation:,TAA-T
2020-09-18T04:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753,Abbreviation:,TAATs
2020-09-18T04:25:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-associated-peptide-antigen-pulsed-dendritic-cell-vaccine,Synonym:,autologous tumor-associated peptide antigen-pulsed DC vaccine KiroVAX
2020-09-18T04:25:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-associated-peptide-antigen-pulsed-dendritic-cell-vaccine,Synonym:,KiroVAX
2020-09-18T04:25:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-associated-peptide-antigen-pulsed-dendritic-cell-vaccine,Synonym:,TAPA loaded DC vaccine
2020-09-18T04:25:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-associated-peptide-antigen-pulsed-dendritic-cell-vaccine,Abbreviation:,autologous TAPA-pulsed DC vaccine KiroVAX
2020-09-18T04:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794072,Synonym:,MDA autologous TILs
2020-09-18T04:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794072,Synonym:,MDA autologous tumor-infiltrating lymphocytes
2020-09-18T04:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794072,Code name:,MDA-TILs
2020-09-18T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117,Synonym:,autologous TSA-DC
2020-09-18T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117,Synonym:,autologous TSA-DC vaccine
2020-09-18T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117,Synonym:,autologous TSA-DCs
2020-09-18T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117,Synonym:,autologous TSA-loaded dendritic cells
2020-09-18T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117,Synonym:,tumor specific antigen-loaded autologous dendritic cells
2020-09-18T04:25:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-wt1-tcrc4-gene-transduced-cd8-positive-tcm-tn-lymphocytes,Synonym:,autologous WT1-transduced CD8-positive Tcm/Tn lymphocytes
2020-09-18T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798417,Code name:,CC 122
2020-09-18T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798417,Code name:,CC122
2020-09-18T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798417,Code name:,CC-122
2020-09-18T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798417,Chemical structure:,"2,6-piperidinedione, 3-(5-amino-2-methyl-4-oxo-3(4H)-quinazolinyl)-"
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,US brand name:,Avage
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,US brand name:,Tazorac
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Foreign brand name:,Retisol-A
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Foreign brand name:,Stieva-A
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Foreign brand name:,Stieva-A Forte
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Foreign brand name:,Vitinoin
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Code name:,AGN-190168
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Chemical structure:,"6-[(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]- 3-Pyridinecarboxylic Acid, Ethyl EsterEthyl 6-(2-(4,4-Dimethylthiochroman-6-yl)ethynyl)nicotinate"
2020-09-18T04:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avanafil,NA,NA
2020-09-18T04:26:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosiglitazone-maleate,US brand name:,Avandia
2020-09-18T04:26:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosiglitazone-maleate,Abbreviation:,ROS
2020-09-18T04:26:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosiglitazone-maleate,Code name:,BRL49653
2020-09-18T04:26:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosiglitazone-maleate,Chemical structure:,"(+/-)-5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, ( Z )-2-Butenedioate (1:1)"
2020-09-18T04:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdgfr-alpha-kit-mutant-specific-inhibitor-blu-285,Synonym:,PDGFR alpha/KIT mutant-specific inhibitor BLU-285
2020-09-18T04:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdgfr-alpha-kit-mutant-specific-inhibitor-blu-285,US brand name:,Ayvakit
2020-09-18T04:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdgfr-alpha-kit-mutant-specific-inhibitor-blu-285,Code name:,BLU-285
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,anti-VEGF humanized monoclonal antibody
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,anti-VEGF monoclonal antibody
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,anti-VEGF rhuMAb
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar BAT1706
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar BEVZ92
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar BI 695502
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar CBT 124
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar CT-P16
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar FKB238
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar GB-222
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar HD204
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar HLX04
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar IBI305
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar LY01008
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar MB02
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar MIL60
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar PF-06439535
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar QL 1101
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar RPH-001
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar SCT510
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar TRS003
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,"immunoglobulin G1 (human-mouse monoclonal rhuMab-VEGF gamma-chain anti-human vascular endothelial growth factor), disulfide with human-mouse monoclonal rhuMab-VEGF light chain, dimer"
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,recombinant humanized anti-VEGF monoclonal antibody
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,rhuMAb VEGF
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,US brand name:,Avastin
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,US brand name:,Mvasi
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,US brand name:,Zirabev
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Abbreviation:,rhuMAb VEGF
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Abbreviation:,rhuMab-VEGF
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Code name:,HD204
2020-09-18T04:26:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793425,US brand name:,Doptelet
2020-09-18T04:26:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-oatmeal-cream,US brand name:,Aveeno cream
2020-09-18T04:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxifloxacin-hydrochloride,US brand name:,Avelox
2020-09-18T04:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxifloxacin-hydrochloride,US brand name:,Viagmox
2020-09-18T04:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxifloxacin-hydrochloride,Abbreviation:,MOXI
2020-09-18T04:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxifloxacin-hydrochloride,Code name:,BAY 128039
2020-09-18T04:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avelumab,Synonym:,anti-PD-L1 monoclonal antibody MSB0010718C
2020-09-18T04:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avelumab,US brand name:,Bavencio
2020-09-18T04:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avelumab,Code name:,MSB0010718C
2020-09-18T04:26:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-wheat-germ-extract,US brand name:,Avemar
2020-09-18T04:26:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-wheat-germ-extract,Foreign brand name:,Avemar
2020-09-18T04:26:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-wheat-germ-extract,Acronym:,FWGE
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Avinza
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Infumorph
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Kadian
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,MS Contin
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,MSir
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Oramorph
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Oramorph SR
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Roxanol
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Statex SR
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,Abbreviation:,MORPH
2020-09-18T04:26:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avitinib-maleate,Synonym:,AC0010 maleate
2020-09-18T04:26:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avitinib-maleate,Code name:,AC0010MA
2020-09-18T04:27:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broccoli-sprout-broccoli-seed-extract-supplement,US brand name:,Avmacol
2020-09-18T04:27:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avn944,NA,NA
2020-09-18T04:27:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutasteride,US brand name:,Avodart
2020-09-18T04:27:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutasteride,Code name:,GG 745
2020-09-18T04:27:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutasteride,Chemical structure:,"alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidideAvolve,(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide"
2020-09-18T04:27:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-avibactam-sodium,Synonym:,CAZ-AVI
2020-09-18T04:27:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-avibactam-sodium,Synonym:,ceftazidime-avibactam sodium
2020-09-18T04:27:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-avibactam-sodium,US brand name:,Avycaz
2020-09-18T04:27:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axicabtagene-ciloleucel,Synonym:,anti-CD19/CD28/CD3zeta CAR gammaretroviral vector-transduced autologous T lymphocytes KTE-C19
2020-09-18T04:27:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axicabtagene-ciloleucel,Synonym:,autologous anti-CD19 CAR-positive T lymphocytes KTE-C19
2020-09-18T04:27:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axicabtagene-ciloleucel,Synonym:,KTE-C19 CAR
2020-09-18T04:27:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axicabtagene-ciloleucel,US brand name:,Yescarta
2020-09-18T04:27:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axicabtagene-ciloleucel,Code name:,KTE-C19
2020-09-18T04:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axitinib,US brand name:,Inlyta
2020-09-18T04:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axitinib,Code name:,AG-013736
2020-09-18T04:27:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-inhibitor-bgb324,Code name:,BGB324
2020-09-18T04:27:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793863,Code name:,DS 1205c
2020-09-18T04:27:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793863,Code name:,DS1205c
2020-09-18T04:27:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793863,Code name:,DS-1205c
2020-09-18T04:27:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801796,Code name:,SLC 391
2020-09-18T04:27:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801796,Code name:,SLC391
2020-09-18T04:27:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801796,Code name:,SLC-391
2020-09-18T04:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-kinase-inhibitor-tp-0903,Code name:,TP 0903
2020-09-18T04:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-kinase-inhibitor-tp-0903,Code name:,TP0903
2020-09-18T04:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-kinase-inhibitor-tp-0903,Code name:,TP-0903
2020-09-18T04:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-kinase-inhibitor-tp-0903,Chemical structure:,"2-((5-chloro-2-((4-((4-methylpiperazin-1-yl)methyl)phenyl)amino)pyrimidin-4-yl)amino)-N,N-dimethylbenzenesulfonamide"
2020-09-18T04:27:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802085,Code name:,KC 1036
2020-09-18T04:27:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802085,Code name:,KC1036
2020-09-18T04:27:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802085,Code name:,KC-1036
2020-09-18T04:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-cmet-receptor-tyrosine-kinase-inhibitor-bpi-9016m,Synonym:,AXL receptor tyrosine kinase/c-MET inhibitor BPI-9016M
2020-09-18T04:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-cmet-receptor-tyrosine-kinase-inhibitor-bpi-9016m,Synonym:,AXL/cMET inhibitor BPI-9016M
2020-09-18T04:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-cmet-receptor-tyrosine-kinase-inhibitor-bpi-9016m,Code name:,BPI 9016
2020-09-18T04:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-cmet-receptor-tyrosine-kinase-inhibitor-bpi-9016m,Code name:,BPI-9016
2020-09-18T04:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-cmet-receptor-tyrosine-kinase-inhibitor-bpi-9016m,Code name:,BPI-9016M
2020-09-18T04:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793938,Code name:,INCB 081776
2020-09-18T04:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793938,Code name:,INCB 81776
2020-09-18T04:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793938,Code name:,INCB081776
2020-09-18T04:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793938,Code name:,INCB-081776
2020-09-18T04:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793938,Code name:,INCB81776
2020-09-18T04:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793938,Code name:,INCB-81776
2020-09-18T04:28:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-mer-inhibitor-ono-7475,Synonym:,Axl/Mer RTK inhibitor ONO-7475
2020-09-18T04:28:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-mer-inhibitor-ono-7475,Code name:,ONO 7475
2020-09-18T04:28:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-mer-inhibitor-ono-7475,Code name:,ONO-7475
2020-09-18T04:28:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluciclovine,Synonym:,anti-1-amino-3-[18F ]fluorocyclobutane-1-carboxylic acid
2020-09-18T04:28:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluciclovine,Synonym:,fluciclovine (18F)
2020-09-18T04:28:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluciclovine,US brand name:,Axumin
2020-09-18T04:28:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluciclovine,Abbreviation:,[18F]FACBC
2020-09-18T04:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norethindrone-acetate,Synonym:,norethisterone acetate
2020-09-18T04:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norethindrone-acetate,Synonym:,nor-Q.D.
2020-09-18T04:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norethindrone-acetate,US brand name:,Aygestin
2020-09-18T04:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norethindrone-acetate,US brand name:,Norlutate
2020-09-18T04:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norethindrone-acetate,Foreign brand name:,Ortho Micronor
2020-09-18T04:28:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdgfr-alpha-kit-mutant-specific-inhibitor-blu-285,Synonym:,PDGFR alpha/KIT mutant-specific inhibitor BLU-285
2020-09-18T04:28:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdgfr-alpha-kit-mutant-specific-inhibitor-blu-285,US brand name:,Ayvakit
2020-09-18T04:28:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdgfr-alpha-kit-mutant-specific-inhibitor-blu-285,Code name:,BLU-285
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Synonym:,5-AC
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Synonym:,5-azacytidine
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Synonym:,azacytidine
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Synonym:,ladakamycin
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,US brand name:,Onureg
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,US brand name:,Vidaza
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Abbreviation:,5-AC
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Abbreviation:,5-AZC
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Abbreviation:,AZA-CR
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Code name:,U-18496
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Chemical structure:,"4-amino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one"
2020-09-18T04:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aztreonam,US brand name:,Azactam
2020-09-18T04:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aztreonam,Code name:,"SQ 26,776"
2020-09-18T04:28:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azapicyl,Code name:,P-2292
2020-09-18T04:28:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azapicyl,Chemical structure:,1-acetyl-2-picolinoylhydrazine2-acetylhydrazide-2-pyridinecarboxylic acid
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Synonym:,diazoacetate (ester) L-Serine
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Synonym:,diazoacetic acid ester with serine
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Synonym:,diazoacetylserine
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Synonym:,serine diazoacetate
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Abbreviation:,AZAS
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Abbreviation:,AZS
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Code name:,CL-337
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Code name:,CN-15757
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Code name:,P-165
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Chemical structure:,L-diazoacetate (ester) serineL-serine diazoacetate (ester)O-diazoacetyl-L-serine
2020-09-18T04:28:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azithromycin,US brand name:,AzaSite
2020-09-18T04:28:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azithromycin,US brand name:,Zithromax
2020-09-18T04:28:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azithromycin,Code name:,CP 62993
2020-09-18T04:28:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azithromycin,Code name:,XZ-450
2020-09-18T04:28:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azathioprine-sodium,US brand name:,Imuran
2020-09-18T04:28:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azathioprine-sodium,Foreign brand name:,Imurel
2020-09-18T04:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131,Synonym:,(131)I-MIBG
2020-09-18T04:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131,Synonym:,131I-MIBG
2020-09-18T04:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131,Synonym:,I 131 metaiodobenzylguanidine
2020-09-18T04:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131,Synonym:,I-131 meta-iodobenzylguanidine
2020-09-18T04:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131,Synonym:,iodine I 131 metaiodobenzylguanidine
2020-09-18T04:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131,Synonym:,MIBG I-131
2020-09-18T04:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131,US brand name:,Azedra
2020-09-18T04:29:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cold-contaminant-free-iobenguane-i-131,Synonym:,cold contaminant-free I 131-MIBG
2020-09-18T04:29:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cold-contaminant-free-iobenguane-i-131,Synonym:,cold contaminant-free iodine I 131 metaiodobenzylguanidine
2020-09-18T04:29:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cold-contaminant-free-iobenguane-i-131,Synonym:,ultratrace iodine I 131 metaiodobenzylguanidine
2020-09-18T04:29:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cold-contaminant-free-iobenguane-i-131,US brand name:,Azedra
2020-09-18T04:29:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aziridinylbenzoquinone-rh1,Code name:,RH1
2020-09-18T04:29:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aziridinylbenzoquinone-rh1,Chemical structure:,"2,5-diaziridinyl-3-hydroxymethyl-6-methyl-1,4-benzoquinone"
2020-09-18T04:29:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azithromycin,US brand name:,AzaSite
2020-09-18T04:29:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azithromycin,US brand name:,Zithromax
2020-09-18T04:29:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azithromycin,Code name:,CP 62993
2020-09-18T04:29:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azithromycin,Code name:,XZ-450
2020-09-18T04:29:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verubulin-hydrochloride,US brand name:,Azixa
2020-09-18T04:29:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verubulin-hydrochloride,Code name:,MPC-6827
2020-09-18T04:29:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azp,Chemical structure:,"1,3-Diaziridino-2,4,6-Triaza-1,3,5,5-Tetraaminomethyl-1,3,5-TriphosphorinN(3)P(3)Az(2)(NHMe)4"
2020-09-18T04:29:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aztreonam,US brand name:,Azactam
2020-09-18T04:29:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aztreonam,Code name:,"SQ 26,776"
2020-09-18T04:29:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfasalazine,Synonym:,salazosulfapyridine
2020-09-18T04:29:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfasalazine,Synonym:,sulphasalazine
2020-09-18T04:29:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfasalazine,US brand name:,Azulfidine
2020-09-18T04:29:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfasalazine,Chemical structure:,2-hydroxy-5-[[4-[(2-pyridinylamino)sulfonyl]phenyl]azo]benzoic acid
2020-09-18T04:29:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azurin-derived-cell-penetrating-peptide-p28,Abbreviation:,azurin-derived CPP p28
2020-09-18T04:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b16alphagal-melanoma-vaccine,US brand name:,Hyperacute Melanoma
2020-09-18T04:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b43-pap-immunotoxin,Synonym:,anti-CD19 immunotoxin
2020-09-18T04:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b43-pap-immunotoxin,Synonym:,B43 immunotoxin
2020-09-18T04:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b43-pap-immunotoxin,Synonym:,B43-pokeweed antiviral protein immunotoxin
2020-09-18T04:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b43-pap-immunotoxin,Abbreviation:,B43-PAP
2020-09-18T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobalamin,Synonym:,B12 vitamin
2020-09-18T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobalamin,Synonym:,cobalamin (1+)
2020-09-18T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobalamin,Synonym:,vitamin B12
2020-09-18T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobalamin,Synonym:,vitamin B-12
2020-09-18T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobalamin,Synonym:,vitamin-B12
2020-09-18T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobalamin,Abbreviation:,vit B12
2020-09-18T04:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b7-dc-cross-linking-antibody-rhigm12b7,Abbreviation:,rHIgM12B7
2020-09-18T04:30:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795030,Synonym:,babao dan
2020-09-18T04:30:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795030,Abbreviation:,BBD
2020-09-18T04:30:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795030,Abbreviation:,BD
2020-09-18T04:30:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bacitracin,Acronym:,BAC
2020-09-18T04:30:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baclofen,US brand name:,Lioresal
2020-09-18T04:30:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baclofen,Code name:,BA34647
2020-09-18T04:30:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baclofen,Chemical structure:,4-Amino-3-(4-chlorophenyl)-butanoic Acidbeta-(Aminomethyl)-4-chlorobenzenepropanoic acid
2020-09-18T04:30:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baclofen-amitriptyline-ketamine-gel,Synonym:,BAK Gel
2020-09-18T04:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bacteriophage-phi-x-174,Synonym:,phi X 174
2020-09-18T04:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bacteriophage-phi-x-174,Synonym:,phi X174
2020-09-18T04:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bacteriophage-phi-x-174,Synonym:,phiX174
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Synonym:,cotrimoxazole
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Synonym:,Eslectin
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Synonym:,insozalin
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Synonym:,trimedin
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Synonym:,trimezole
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Bactrim
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Cotrim
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Septra
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Sulfamethoprim
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Sulfatrim
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Sulmeprim
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Abbreviation:,SMZ-TMP
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Abbreviation:,TMP-SMX
2020-09-18T04:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bafetinib,Synonym:,dual Bcr-Abl/Lyn tyrosine kinase inhibitor INNO-406
2020-09-18T04:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bafetinib,Code name:,INNO-406
2020-09-18T04:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bafetinib,Code name:,NS-187
2020-09-18T04:30:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/balanced-crystalloid-solution,Synonym:,sodium chloride/sodium gluconate/sodium acetate/potassium chloride/magnesium chloride solution
2020-09-18T04:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-pol6326,Synonym:,CXCR4 inhibitor POL6326
2020-09-18T04:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-pol6326,Code name:,POL6326
2020-09-18T04:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800205,Synonym:,"carbonic acid, (((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-3,4,6,8,12,12a-hexahydro-6,8-dioxo-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl ester"
2020-09-18T04:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800205,US brand name:,Xofluza
2020-09-18T04:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800205,Abbreviation:,BXM
2020-09-18T04:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800205,Chemical structure:,"(((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12ahexahydro-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl carbonate"
2020-09-18T04:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baltaleucel-t,Synonym:,baltaleucel T
2020-09-18T04:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baltaleucel-t,Synonym:,Cytorex EBV
2020-09-18T04:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baltaleucel-t,Synonym:,Epstein-Barr virus-specific LMP1/LMP2/EBNABARF1-targeting autologous cytotoxic T lymphocytes
2020-09-18T04:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baltaleucel-t,Code name:,CMD-003
2020-09-18T04:31:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erdafitinib,Synonym:,pan-FGFR tyrosine kinase inhibitor JNJ-42756493
2020-09-18T04:31:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erdafitinib,US brand name:,Balversa
2020-09-18T04:31:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erdafitinib,Code name:,JNJ-42756493
2020-09-18T04:31:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,Synonym:,Ortho-Novum 1/35
2020-09-18T04:31:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Aranelle
2020-09-18T04:31:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Balziva
2020-09-18T04:31:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Brevicon
2020-09-18T04:31:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Gencept
2020-09-18T04:31:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Modicon
2020-09-18T04:31:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norcept-E
2020-09-18T04:31:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norethin
2020-09-18T04:31:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norinyl
2020-09-18T04:31:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Nortrel
2020-09-18T04:31:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Ortho-Novum
2020-09-18T04:31:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Ovcon
2020-09-18T04:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/banoxantrone,Code name:,AQ 4N
2020-09-18T04:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/banoxantrone,Code name:,AQ4N
2020-09-18T04:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/banoxantrone,Chemical structure:,"9,10-anthracenedione, 1,4-bis((2-(dimethylamino)ethyl)amino)-5,8-dihydroxy-, N,N'-dioxide"
2020-09-18T04:31:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entecavir,US brand name:,Baraclude
2020-09-18T04:31:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entecavir,Abbreviation:,ETV
2020-09-18T04:31:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/barasertib,Synonym:,Aurora kinase inhibitor AZD1152
2020-09-18T04:31:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/barasertib,Code name:,AZD1152
2020-09-18T04:31:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/barasertib,Code name:,AZD2811
2020-09-18T04:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bardoxolone,Code name:,CDDO
2020-09-18T04:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bardoxolone,Code name:,RTA 401
2020-09-18T04:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bardoxolone,Chemical structure:,"(+)-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acidoleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-"
2020-09-18T04:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baricitinib,Code name:,INCB 028050
2020-09-18T04:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baricitinib,Code name:,INCB028050
2020-09-18T04:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baricitinib,Code name:,LY 3009104
2020-09-18T04:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baricitinib,Code name:,LY3009104
2020-09-18T04:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baricitinib,Chemical structure:,"3-azetidineacetonitrile, 1-(ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)-"
2020-09-18T04:31:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/barium-sulfate,NA,NA
2020-09-18T04:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voglibose,US brand name:,Basen
2020-09-18T04:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voglibose,Code name:,A-71100
2020-09-18T04:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voglibose,Code name:,AO-128
2020-09-18T04:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voglibose,Chemical structure:,"3,4-dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-C-(hydroxymethyl)-D-epi-inositolN-(1,3-dihydroxy-2-propyl)valiolamine"
2020-09-18T04:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/basiliximab,US brand name:,Simulect
2020-09-18T04:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/basiliximab,Code name:,SDZ-CHI-621
2020-09-18T04:32:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/batabulin-sodium,Code name:,T138067
2020-09-18T04:32:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/batabulin-sodium,Chemical structure:,"2-fluoro-1-methoxy-4-(pentafluorophenyl-sulfonamido)benzene, sodium salt2-fluoro-1-methoxy-4-pentafluorophenylsulfonamidobenzene"
2020-09-18T04:32:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avelumab,Synonym:,anti-PD-L1 monoclonal antibody MSB0010718C
2020-09-18T04:32:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avelumab,US brand name:,Bavencio
2020-09-18T04:32:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avelumab,Code name:,MSB0010718C
2020-09-18T04:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bavituximab,US brand name:,Tarvacin
2020-09-18T04:32:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bay-56-3722,Code name:,BAY 38-3441
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,Synonym:,immune globulin intravenous
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,Synonym:,immune globulin IV
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,Synonym:,therapeutic immunoglobulin
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,BayGam
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Gamimune N
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Gammagard S/D
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Gammar-P
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Iveegam EN
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Panglobulin
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Polygam S/D
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Sandoglobulin
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Venoglobulin-I
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Venoglobulin-S
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,WinRho SDF
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,Abbreviation:,IG
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,Abbreviation:,IgIV
2020-09-18T04:32:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bazedoxifene,Code name:,TSE-424
2020-09-18T04:32:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bazedoxifene,Code name:,WAY 140424
2020-09-18T04:32:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bazedoxifene,Chemical structure:,"1H-indol-5-ol, 1-((4-(2-(hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-"
2020-09-18T04:32:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bc-819-plasmid-polyethylenimine-complex,Abbreviation:,BC-819/PEI
2020-09-18T04:32:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bc-819-plasmid-polyethylenimine-complex,Abbreviation:,DTA-H19/PEI
2020-09-18T04:32:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-solution,Synonym:,Bacillus Calmette-Guerin solution
2020-09-18T04:32:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-solution,Synonym:,BCG intravesical solution
2020-09-18T04:32:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-solution,US brand name:,TICE BCG solution
2020-09-18T04:32:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792633,Synonym:,bacillus Calmette-Guerin Tokyo-172 strain vaccine
2020-09-18T04:32:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-vaccine,Synonym:,bacillus Calmette-Guerin vaccine
2020-09-18T04:32:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-vaccine,Synonym:,oncotice
2020-09-18T04:32:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795558,Code name:,APG 2575
2020-09-18T04:32:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795558,Code name:,APG2575
2020-09-18T04:32:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795558,Code name:,APG-2575
2020-09-18T04:32:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-bcl201,Synonym:,Servier 1
2020-09-18T04:32:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-bcl201,Synonym:,Servier-1
2020-09-18T04:35:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belinostat,Code name:,PXD 101
2020-09-18T04:32:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-bcl201,Code name:,BCL201
2020-09-18T04:32:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-bcl201,Code name:,BCL-201
2020-09-18T04:32:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-bcl201,Code name:,S55746
2020-09-18T04:32:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-bcl201,Code name:,S-55746
2020-09-18T04:33:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801885,Code name:,LP 108
2020-09-18T04:33:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801885,Code name:,LP108
2020-09-18T04:33:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801885,Code name:,LP-108
2020-09-18T04:33:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797175,Code name:,S 65487
2020-09-18T04:33:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797175,Code name:,S65487
2020-09-18T04:33:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797175,Code name:,S-65487
2020-09-18T04:33:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792573,Code name:,APG 1252
2020-09-18T04:33:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792573,Code name:,APG-1252
2020-09-18T04:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802262,Synonym:,BCMA-PD1-CAR T cells
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Synonym:,anti-BCMA/CD3 bispecific antibody CC-93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Synonym:,BCMA x CD3 T Cell-engaging antibody CC-93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Synonym:,BCMA/CD3 T-cell bi-specific antibody CC-93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Synonym:,BCMA/CD3-directed bispecific T-cell engager antibody CC-93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Synonym:,BCMAxCD3 BiTE antibody CC-93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Synonym:,BCMAxCD3 TCB CC-93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Synonym:,bi-specific antibody CC-93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Code name:,CC 93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Code name:,CC-93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Code name:,EM901
2020-09-18T04:33:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795784,Synonym:,BCMA-CD19 cCAR T cells
2020-09-18T04:33:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795784,Synonym:,BCMA-CD19 cCAR-T cells
2020-09-18T04:33:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-specific-car-expressing-t-lymphocytes,Synonym:,anti-BCMA-CAR T cells
2020-09-18T04:33:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-specific-car-expressing-t-lymphocytes,Synonym:,anti-BCMA-CAR-transduced T cells
2020-09-18T04:33:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-specific-car-expressing-t-lymphocytes,Code name:,bb2121
2020-09-18T04:33:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-b2a2-derived-peptide-vaccine,Code name:,CML-VAX B2
2020-09-18T04:33:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-b3a2-derived-peptide-vaccine,Code name:,CML-VAX B3
2020-09-18T04:33:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kinase-inhibitor-k0706,Code name:,K0706
2020-09-18T04:33:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kinase-inhibitor-k0706,Code name:,SUN K706
2020-09-18T04:33:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kinase-inhibitor-k0706,Code name:,SUN-K0706
2020-09-18T04:33:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kinase-inhibitor-k0706,Code name:,SUN-K706
2020-09-18T04:33:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kinase-inhibitor-pf-114,Synonym:,Bcr-Abl inhibitor PF-114
2020-09-18T04:33:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kinase-inhibitor-pf-114,Code name:,PF-114
2020-09-18T04:34:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-p210-b3a2-breakpoint-derived-multipeptide-vaccine,Synonym:,CMLVAX100
2020-09-18T04:34:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-p210-b3a2-breakpoint-derived-multipeptide-vaccine,Synonym:,p210-B3A2-derived peptide vaccine
2020-09-18T04:34:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-peptide-vaccine,Synonym:,bcr-abl vaccine
2020-09-18T04:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799639,Synonym:,multi-kinase inhibitor HQP1351
2020-09-18T04:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799639,Code name:,HQP 1351
2020-09-18T04:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799639,Code name:,HQP1351
2020-09-18T04:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799639,Code name:,HQP-1351
2020-09-18T04:34:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beacopp-regimen,Synonym:,BEACOPP
2020-09-18T04:34:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beacopp-regimen,Synonym:,bleomycin/cyclophosphamide/doxorubicin/etoposide/prednisone/procarbazine/vincristine
2020-09-18T04:34:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beacopp-regimen,Synonym:,bleomycin-etoposide-Adriamycin-cyclophosphamide-Oncovin-procarbazine-prednisone regimen
2020-09-18T04:34:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pva-microporous-hydrospheres,US brand name:,Bead Block Compressible Microspheres
2020-09-18T04:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/becatecarin,Synonym:,DEAE-rebeccamycin
2020-09-18T04:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/becatecarin,Synonym:,rebeccamycin analogue
2020-09-18T04:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/becatecarin,Synonym:,"rebeccamycin analogue, tartrate salt"
2020-09-18T04:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/becatecarin,Code name:,BMS-181176
2020-09-18T04:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/becatecarin,Code name:,BMY-27557-14
2020-09-18T04:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/becatecarin,Code name:,XL119
2020-09-18T04:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/becatecarin,Chemical structure:,"5H-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione, 1,11-dichloro-6-(2-(diethylamino)ethyl)-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl)-"
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Beclovent
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Beconase
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Qnasl
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Qvar
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Vancenase
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Vanceril
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,Code name:,SCH-18020W
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,Chemical structure:,"(11beta,16beta)-9-chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione dipropionate"
2020-09-18T04:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Beclovent
2020-09-18T04:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Beconase
2020-09-18T04:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Qnasl
2020-09-18T04:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Qvar
2020-09-18T04:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Vancenase
2020-09-18T04:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Vanceril
2020-09-18T04:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,Code name:,SCH-18020W
2020-09-18T04:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,Chemical structure:,"(11beta,16beta)-9-chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione dipropionate"
2020-09-18T04:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Beclovent
2020-09-18T04:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Beconase
2020-09-18T04:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Qnasl
2020-09-18T04:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Qvar
2020-09-18T04:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Vancenase
2020-09-18T04:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Vanceril
2020-09-18T04:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,Code name:,SCH-18020W
2020-09-18T04:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,Chemical structure:,"(11beta,16beta)-9-chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione dipropionate"
2020-09-18T04:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyridoxine-hydrochloride,Synonym:,vitamin B6 hydrochloride
2020-09-18T04:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyridoxine-hydrochloride,US brand name:,Beesix
2020-09-18T04:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyridoxine-hydrochloride,US brand name:,Hexa-Betalin
2020-09-18T04:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyridoxine-hydrochloride,Chemical structure:,"5-hydroxy-6-methyl-3,4-pyridinedimethanol hydrochloride"
2020-09-18T04:34:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/concentrated-beet-crystals,US brand name:,BeetElite NeoShot
2020-09-18T04:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beetroot-juice,Synonym:,beet juice
2020-09-18T04:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/begelomab,Synonym:,murine anti-CD26 BT 5/9
2020-09-18T04:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/begelomab,US brand name:,Begedina
2020-09-18T04:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/begelomab,Code name:,BT 5/9
2020-09-18T04:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/begelomab,Code name:,SAND-26
2020-09-18T04:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/begelomab,Synonym:,murine anti-CD26 BT 5/9
2020-09-18T04:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/begelomab,US brand name:,Begedina
2020-09-18T04:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/begelomab,Code name:,BT 5/9
2020-09-18T04:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/begelomab,Code name:,SAND-26
2020-09-18T04:35:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belagenpumatucel-l,US brand name:,Lucanix
2020-09-18T04:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-drug-conjugate-gsk2857916,Synonym:,belantamab mafodotin
2020-09-18T04:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-drug-conjugate-gsk2857916,US brand name:,Blenrep
2020-09-18T04:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-drug-conjugate-gsk2857916,Abbreviation:,J6M0-mcMMAF
2020-09-18T04:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-drug-conjugate-gsk2857916,Code name:,GSK2857916
2020-09-18T04:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belinostat,US brand name:,Beleodaq
2020-09-18T04:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belinostat,Code name:,PXD 101
2020-09-18T04:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belinostat,Code name:,PXD101
2020-09-18T04:35:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belimumab,US brand name:,Benlysta
2020-09-18T04:35:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belimumab,US brand name:,LymphoStat-B antibody
2020-09-18T04:35:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belinostat,US brand name:,Beleodaq
2020-09-18T04:35:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belinostat,Code name:,PXD101
2020-09-18T04:35:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belotecan-hydrochloride,Code name:,CKD-602
2020-09-18T04:35:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-monoclonal-antibody-fpa144,Synonym:,anti-FGFR2 monoclonal antibody FPA144
2020-09-18T04:35:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-monoclonal-antibody-fpa144,Code name:,FPA144
2020-09-18T04:35:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemiparin-sodium,Foreign brand name:,Badyket
2020-09-18T04:35:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemiparin-sodium,Foreign brand name:,Hibor
2020-09-18T04:35:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemiparin-sodium,Foreign brand name:,Ivor
2020-09-18T04:35:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemiparin-sodium,Foreign brand name:,Zibor
2020-09-18T04:35:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785056,Code name:,NKTR-214
2020-09-18T04:36:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride,US brand name:,Benadryl
2020-09-18T04:36:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride,US brand name:,SK-Diphenhydramine
2020-09-18T04:36:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride,Foreign brand name:,Bendylate
2020-09-18T04:36:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride,Foreign brand name:,Eldadryl
2020-09-18T04:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benazepril-hydrochloride,US brand name:,Lotensin
2020-09-18T04:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benazepril-hydrochloride,Abbreviation:,benazepril HCl
2020-09-18T04:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benazepril-hydrochloride,Code name:,CGS14824A
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Synonym:,bendamustin hydrochloride
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Synonym:,CEP-18083
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Synonym:,cytostasan hydrochloride
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,US brand name:,Bendeka
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,US brand name:,Treanda
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Foreign brand name:,Levact
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Foreign brand name:,Ribomustin
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Foreign brand name:,SyB L-0501
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Code name:,SDX-105
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Chemical structure:,"2-benzimidazolinebutryric acid, 1-methyl-5-bis(2-chloroethyl)amino-, hydrochloride"
2020-09-18T04:36:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-containing-nanoparticle-based-formulation-rxdx-107,Code name:,CEP-40125
2020-09-18T04:36:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-containing-nanoparticle-based-formulation-rxdx-107,Code name:,RXDX 107
2020-09-18T04:36:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-containing-nanoparticle-based-formulation-rxdx-107,Code name:,RXDX-107
2020-09-18T04:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Synonym:,bendamustin hydrochloride
2020-09-18T04:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Synonym:,CEP-18083
2020-09-18T04:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Synonym:,cytostasan hydrochloride
2020-09-18T04:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,US brand name:,Bendeka
2020-09-18T04:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,US brand name:,Treanda
2020-09-18T04:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Foreign brand name:,Levact
2020-09-18T04:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Foreign brand name:,Ribomustin
2020-09-18T04:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Foreign brand name:,SyB L-0501
2020-09-18T04:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Code name:,SDX-105
2020-09-18T04:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Chemical structure:,"2-benzimidazolinebutryric acid, 1-methyl-5-bis(2-chloroethyl)amino-, hydrochloride"
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Synonym:,L-dopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Bendopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Dopar
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Eldopar
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Laradopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Larodopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Levopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Cidandopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Deadopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopaflex
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopaidan
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopal
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopalina
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Doparkine
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Doparl
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopasol
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopaston
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopastral
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Doprin
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Eldopal
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Eldopatec
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Eurodopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Ledopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Maipedopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Parda
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Veldopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Chemical structure:,"(--)-2amino-3-)3,4-dihydroxyphenyl)propanoic acid(--)-3-(3,4-dihydroxyphenyl)-L-alanine3-hydroxy-L-tyrosinebeta-(3,4-dihydroxyphenyl)-L-alanine"
2020-09-18T04:36:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage,US brand name:,Benefin
2020-09-18T04:36:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage,US brand name:,Cartilade
2020-09-18T04:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benegrastim,Synonym:,recombinant dimeric G-CSF fusion protein F627
2020-09-18T04:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benegrastim,Synonym:,rh G-CSF Fc fusion protein
2020-09-18T04:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benegrastim,Code name:,F627
2020-09-18T04:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benegrastim,Code name:,F-627
2020-09-18T04:36:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/probenecid,US brand name:,Benemid
2020-09-18T04:36:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/probenecid,US brand name:,SK-Probenecid
2020-09-18T04:36:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/probenecid,Abbreviation:,PROB
2020-09-18T04:36:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligofructose-enriched-inulin,Synonym:,Synergy 1
2020-09-18T04:36:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligofructose-enriched-inulin,US brand name:,Beneo Synergy 1
2020-09-18T04:36:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligofructose-enriched-inulin,Foreign brand name:,Beneo Synergy 1
2020-09-18T04:36:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belimumab,US brand name:,Benlysta
2020-09-18T04:36:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belimumab,US brand name:,LymphoStat-B antibody
2020-09-18T04:36:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monobenzone,Synonym:,monobenzyl ether of hydroquinone
2020-09-18T04:36:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monobenzone,US brand name:,Benoquin
2020-09-18T04:36:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monobenzone,Abbreviation:,MBEH
2020-09-18T04:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794137,Synonym:,"anti-CD125 humanized monoclonal antibody, IgG1-kappa"
2020-09-18T04:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794137,Code name:,BIW-8405
2020-09-18T04:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794137,Code name:,KHK-4563
2020-09-18T04:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794137,Code name:,MEDI-563
2020-09-18T04:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzaldehyde-dimethane-sulfonate,Code name:,DMS612
2020-09-18T04:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzaldehyde-dimethane-sulfonate,Code name:,NSC 281612
2020-09-18T04:37:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzoylphenylurea,Abbreviation:,BPU
2020-09-18T04:37:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzydamine-hydrochloride,Synonym:,benzydamine HCl
2020-09-18T04:37:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzydamine-hydrochloride,US brand name:,Difflam
2020-09-18T04:37:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzydamine-hydrochloride,Foreign brand name:,Tantum
2020-09-18T04:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bep-regimen,Synonym:,BEP
2020-09-18T04:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bep-regimen,Synonym:,bleomycin-etoposide-cisplatin regimen
2020-09-18T04:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bep-regimen,Synonym:,bleomycin-etoposide-Platinol regimen
2020-09-18T04:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berberine-chloride,Synonym:,berberine chloride dihydrate
2020-09-18T04:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berberine-chloride,Synonym:,berberine hydrochloride
2020-09-18T04:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berberine-chloride,Synonym:,berberinum chloride
2020-09-18T04:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berberine-chloride,Chemical structure:,"5,6-dihydro-9,10-dimethoxybenzo(G)-1,3-benzodioxolo(5,6-A)quinolizinium chloride"
2020-09-18T04:37:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berubicin-hydrochloride,Synonym:,topoisomerase II inhibitor RTA 744
2020-09-18T04:37:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berubicin-hydrochloride,Code name:,RTA 744
2020-09-18T04:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,Synonym:,vitamin B12
2020-09-18T04:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Berubigen
2020-09-18T04:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Betalin 12
2020-09-18T04:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Calomist
2020-09-18T04:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Cobavite
2020-09-18T04:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inotuzumab-ozogamicin,US brand name:,Besponsa
2020-09-18T04:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inotuzumab-ozogamicin,Code name:,CMC-544
2020-09-18T04:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inotuzumab-ozogamicin,Code name:,Way 207294
2020-09-18T04:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inotuzumab-ozogamicin,Code name:,WAY-207294
2020-09-18T04:37:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomain-inhibitor-zen-3694,Synonym:,BETi ZEN-3694
2020-09-18T04:37:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomain-inhibitor-zen-3694,Code name:,ZEN-3694
2020-09-18T04:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomains-2-3-4-inhibitor-mk-8628,Synonym:,"BET bromodomain proteins 2, 3, and 4 inhibitor MK-8628"
2020-09-18T04:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomains-2-3-4-inhibitor-mk-8628,Synonym:,BRD 2/3/4 inhibitor MK-8628
2020-09-18T04:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomains-2-3-4-inhibitor-mk-8628,Code name:,MK-8628
2020-09-18T04:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomains-2-3-4-inhibitor-mk-8628,Code name:,OTX015
2020-09-18T04:38:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794664,Synonym:,BD2-selective BET inhibitor ABBV-744
2020-09-18T04:38:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794664,Code name:,ABBV 744
2020-09-18T04:38:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794664,Code name:,ABBV-744
2020-09-18T04:38:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-bay1238097,Code name:,BAY 1238097
2020-09-18T04:38:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-bay1238097,Code name:,BAY1238097
2020-09-18T04:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-bms-986158,Code name:,BMS-986158
2020-09-18T04:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793170,Code name:,CC 90010
2020-09-18T04:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793170,Code name:,CC-90010
2020-09-18T04:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-cpi-0610,Code name:,CPI-0610
2020-09-18T04:38:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ft-1101,Code name:,CC-95775
2020-09-18T04:38:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ft-1101,Code name:,FT1101
2020-09-18T04:38:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ft-1101,Code name:,FT-1101
2020-09-18T04:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-gs-5829,Code name:,GS 5829
2020-09-18T04:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-gs-5829,Code name:,GS5829
2020-09-18T04:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-gs-5829,Code name:,GS-5829
2020-09-18T04:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-gsk2820151,Code name:,GSK 2820151
2020-09-18T04:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-gsk2820151,Code name:,GSK2820151
2020-09-18T04:38:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-incb054329,Code name:,INCB054329
2020-09-18T04:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ro6870810,Synonym:,bromodomain and extra-terminal protein inhibitor RO6870810
2020-09-18T04:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ro6870810,Code name:,RG6146
2020-09-18T04:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ro6870810,Code name:,RO6870810
2020-09-18T04:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ro6870810,Code name:,TEN-010
2020-09-18T04:38:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-carotene,US brand name:,Lumitene
2020-09-18T04:38:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-carotene,US brand name:,Solatene
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Synonym:,Betadine topical
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Synonym:,iodine povidone topical
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Synonym:,iodopovidone solution
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Betadine
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Betadine Solution
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,E-Z Prep
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,E-Z Scrub
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Traumasept
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Ultradine
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Videne
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Foreign brand name:,Betaisodona
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Abbreviation:,PVP iodine
2020-09-18T04:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Synonym:,Betadine topical
2020-09-18T04:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Synonym:,iodine povidone topical
2020-09-18T04:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Synonym:,iodopovidone solution
2020-09-18T04:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Betadine
2020-09-18T04:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Betadine Solution
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Code name:,BCM-95CG
2020-09-18T04:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,E-Z Prep
2020-09-18T04:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,E-Z Scrub
2020-09-18T04:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Traumasept
2020-09-18T04:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Ultradine
2020-09-18T04:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Videne
2020-09-18T04:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Foreign brand name:,Betaisodona
2020-09-18T04:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Abbreviation:,PVP iodine
2020-09-18T04:39:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-elemene,Foreign brand name:,Elemene
2020-09-18T04:39:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-elemene,Chemical structure:,"1alpha,2beta,4beta)-1-methyl-2,4-bis(methylvinyl)-1-vinylcyclohexane (SN)"
2020-09-18T04:39:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-glucan,US brand name:,Immucell WGP
2020-09-18T04:39:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-glucan,Abbreviation:,b-GLUC
2020-09-18T04:39:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-glucan-mm-10-001,Code name:,MM-10-001
2020-09-18T04:39:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/717605,Foreign brand name:,Neoviderm
2020-09-18T04:39:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-glucan-lactobacillus-casei-bifidobacterium-lactis-based-supplement,Foreign brand name:,Citogenex
2020-09-18T04:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801531,Synonym:,betahistine dihydrochloride nasal spray
2020-09-18T04:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801531,Code name:,AM 125
2020-09-18T04:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801531,Code name:,AM125
2020-09-18T04:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801531,Code name:,AM-125
2020-09-18T04:39:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-hydroxy-beta-methylbutyrate-supplement,Synonym:,β-hydroxy-β-methylbutyrate supplement
2020-09-18T04:39:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-hydroxy-beta-methylbutyrate-supplement,Abbreviation:,HMB supplement
2020-09-18T04:39:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-lapachone,Synonym:,b-lapachone
2020-09-18T04:39:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-lapachone,Synonym:,β-lapachone
2020-09-18T04:39:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-lapachone,Code name:,ARQ 501
2020-09-18T04:39:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-lapachone,Code name:,ARQ501
2020-09-18T04:39:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-lapachone,Chemical structure:,"3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione"
2020-09-18T04:39:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-lapachone-prodrug-arq-761,Code name:,ARQ 761
2020-09-18T04:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,Synonym:,vitamin B12
2020-09-18T04:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Berubigen
2020-09-18T04:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Betalin 12
2020-09-18T04:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Calomist
2020-09-18T04:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Cobavite
2020-09-18T04:40:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formoterol-fumarate-roxithromycin,US brand name:,BetaMarc
2020-09-18T04:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betamethasone,US brand name:,Celestone
2020-09-18T04:40:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-thioguanine-deoxyriboside,Abbreviation:,BTG
2020-09-18T04:40:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-thioguanine-deoxyriboside,Abbreviation:,B-TGDR
2020-09-18T04:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792467,Synonym:,BET inhibitor ODM-207
2020-09-18T04:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792467,Synonym:,bromodomain and extraterminal domain protein inhibitor ODM-207
2020-09-18T04:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792467,Code name:,ODM 207
2020-09-18T04:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792467,Code name:,ODM207
2020-09-18T04:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792467,Code name:,ODM-207
2020-09-18T04:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bethanechol-chloride,Synonym:,"2-[(aminocarbonyl)oxy]-N,N,N-trimethyl-1-propanaminium chloride"
2020-09-18T04:40:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betulinic-acid,Synonym:,Mairin
2020-09-18T04:40:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betulinic-acid,Acronym:,BA
2020-09-18T04:40:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betulinic-acid,Code name:,ALS-357
2020-09-18T04:40:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betulinic-acid,Chemical structure:,(3beta)-3-Hydroxy-lup-20(29)-en-28-oic Acid
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,anti-VEGF humanized monoclonal antibody
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,anti-VEGF monoclonal antibody
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,anti-VEGF rhuMAb
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar BAT1706
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar BEVZ92
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar BI 695502
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar CBT 124
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar CT-P16
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar FKB238
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar GB-222
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar HD204
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar HLX04
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar IBI305
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar LY01008
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar MB02
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar MIL60
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar PF-06439535
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar QL 1101
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar RPH-001
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar SCT510
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar TRS003
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,"immunoglobulin G1 (human-mouse monoclonal rhuMab-VEGF gamma-chain anti-human vascular endothelial growth factor), disulfide with human-mouse monoclonal rhuMab-VEGF light chain, dimer"
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,recombinant humanized anti-VEGF monoclonal antibody
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,rhuMAb VEGF
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,US brand name:,Avastin
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,US brand name:,Mvasi
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,US brand name:,Zirabev
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Abbreviation:,rhuMAb VEGF
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Abbreviation:,rhuMab-VEGF
2020-09-18T04:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Code name:,HD204
2020-09-18T04:40:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab-irdye-800cw,NA,NA
2020-09-18T04:40:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bexarotene,Synonym:,3-methyl TTNEB
2020-09-18T04:40:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bexarotene,US brand name:,Targretin
2020-09-18T04:40:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bexarotene,Code name:,LGD1069
2020-09-18T04:40:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bexarotene,Chemical structure:,"4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]benzoic acid"
2020-09-18T04:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valdecoxib,US brand name:,Bextra
2020-09-18T04:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valdecoxib,Code name:,SC 65872
2020-09-18T04:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valdecoxib,Chemical structure:,4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide
2020-09-18T04:40:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tositumomab-and-iodine-i-131-tositumomab,Synonym:,Bexxar therapeutic regimen
2020-09-18T04:40:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tositumomab-and-iodine-i-131-tositumomab,US brand name:,Bexxar
2020-09-18T04:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793939,US brand name:,Zinplava
2020-09-18T04:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793939,Code name:,MK 6072
2020-09-18T04:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793939,Code name:,MK6072
2020-09-18T04:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793939,Code name:,MK-6072
2020-09-18T04:41:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bf-200-gel-formulation,Synonym:,BF-200 ALA
2020-09-18T04:41:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bf-200-gel-formulation,Code name:,BF-200
2020-09-18T04:41:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bh3-mimetic-abt-737,Code name:,ABT-737
2020-09-18T04:41:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-2536,NA,NA
2020-09-18T04:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clarithromycin,Synonym:,Abbott-56268
2020-09-18T04:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clarithromycin,US brand name:,Biaxin
2020-09-18T04:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clarithromycin,Abbreviation:,CLARITH
2020-09-18T04:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clarithromycin,Chemical structure:,6-O-Methylerythromycin
2020-09-18T04:41:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bibx-1382,NA,NA
2020-09-18T04:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bicalutamide,US brand name:,Casodex
2020-09-18T04:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bicalutamide,Foreign brand name:,Cosudex
2020-09-18T04:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bicalutamide,Abbreviation:,CDX
2020-09-18T04:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bicalutamide,Code name:,"ICI 176,334"
2020-09-18T04:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-citrate,Synonym:,Albright's Solution
2020-09-18T04:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-citrate,Synonym:,Modified Shohl's Solution
2020-09-18T04:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-citrate,US brand name:,Bicitra
2020-09-18T04:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-citrate,US brand name:,Oracit
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Synonym:,bis(chloroethyl) nitrosourea
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Synonym:,bis-chloronitrosourea
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Synonym:,carmustin
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,US brand name:,BiCNU
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Foreign brand name:,Becenun
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Foreign brand name:,Carmustinum
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Foreign brand name:,Nitrourean
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Foreign brand name:,Nitrumon
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Abbreviation:,BCNU
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Code name:,FDA 0345
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Code name:,SK 27702
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Code name:,SRI 1720
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Code name:,WR-139021
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Chemical structure:,"1,3-bis(2-chloroethyl)-1-nitrosourea1,3-bis(beta-chloroethyl)-1-nitrosoureaN,N'-bis(2-chloroethyl)-N-nitrosourea"
2020-09-18T04:41:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bifidobacterium-animalis-lactobacillus-rhamnosus-probiotic-supplement,Synonym:,Bifidobacterium animalis/Lactobacillus rhamnosus probiotic
2020-09-18T04:41:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bifidobacterium-animalis-lactobacillus-rhamnosus-probiotic-supplement,Synonym:,Lactobacillus rhamnosus GG/ Bifidobacterium animalis subsp. lactis BB-12
2020-09-18T04:41:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bifidobacterium-animalis-lactobacillus-rhamnosus-probiotic-supplement,Synonym:,Lactobacillus rhamnosus/Bifidobacterium animalis subsp. lactis
2020-09-18T04:41:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bifidobacterium-animalis-lactobacillus-rhamnosus-probiotic-supplement,Foreign brand name:,PROBIO-FIX INUM
2020-09-18T04:41:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bifidobacterium-animalis-lactobacillus-rhamnosus-probiotic-supplement,Abbreviation:,BB-12/LGG
2020-09-18T04:41:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792560,Synonym:,B. lactis/L. acidophilus/inulin probiotic supplement
2020-09-18T04:41:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792560,Foreign brand name:,ProBion Clinica
2020-09-18T04:42:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/758035,Foreign brand name:,Lactibiane Tolerance
2020-09-18T04:42:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798827,Synonym:,B. longum/L. acidophilus/E. faecalis probiotic supplement
2020-09-18T04:42:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798827,Synonym:,Bifidobacterium longum/Lactobacillus acidophilus/Enterococcus faecalis supplement
2020-09-18T04:42:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798827,Foreign brand name:,Bifico
2020-09-18T04:42:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-functional-alkylating-agent-val-083,Code name:,VAL083
2020-09-18T04:42:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-functional-alkylating-agent-val-083,Code name:,VAL-083
2020-09-18T04:42:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780967,Synonym:,pbi-functional short hairpin RNA EWS/FLI1 type 1 lipoplex
2020-09-18T04:42:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780967,Synonym:,pbi-functional shRNA EWS-FLI1 type 1 lipoplex
2020-09-18T04:42:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780967,Synonym:,pbi-shRNA EWS/FLI1 type 1 lipoplex
2020-09-18T04:42:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780967,Synonym:,pbi-shRNA EWS/FLI1 Type 1 LP
2020-09-18T04:42:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780967,Synonym:,pbi-shRNA EWS/FLI1 type 1 LPX
2020-09-18T04:42:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bimagrumab,Synonym:,HuCAL-based antibody BYM338
2020-09-18T04:42:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bimagrumab,Synonym:,human combinatorial antibody library-based monoclonal antibody BYM338
2020-09-18T04:42:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bimagrumab,Code name:,BYM338
2020-09-18T04:42:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bimatoprost-ophthalmic-solution,NA,NA
2020-09-18T04:42:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binimetinib,US brand name:,Mektovi
2020-09-18T04:42:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binimetinib,Code name:,ARRY-162
2020-09-18T04:42:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binimetinib,Code name:,ARRY-438162
2020-09-18T04:42:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binimetinib,Code name:,MEK162
2020-09-18T04:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795582,Synonym:,anti-PDL1/TGFb Trap MSB0011359C
2020-09-18T04:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795582,Synonym:,anti-PD-L1/TGFbetaRII fusion protein M7824
2020-09-18T04:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795582,Synonym:,M7824
2020-09-18T04:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795582,Code name:,MSB0011359C
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Synonym:,BCM-95 (R) CG
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Synonym:,BCM-95 CG curcumin
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Synonym:,BCM-95 CG curcumin extract
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Synonym:,bio-enhanced BCM-95 CG curcumin
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Synonym:,curcumin BCM-95CG
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,US brand name:,Biocurcumax
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Code name:,BCM 95CG
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Code name:,BCM95CG
2020-09-18T04:42:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Synonym:,BCM-95 (R) CG
2020-09-18T04:42:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Synonym:,BCM-95 CG curcumin
2020-09-18T04:42:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Synonym:,BCM-95 CG curcumin extract
2020-09-18T04:42:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Synonym:,bio-enhanced BCM-95 CG curcumin
2020-09-18T04:42:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Synonym:,curcumin BCM-95CG
2020-09-18T04:42:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,US brand name:,Biocurcumax
2020-09-18T04:42:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Code name:,BCM 95CG
2020-09-18T04:42:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Code name:,BCM95CG
2020-09-18T04:42:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Code name:,BCM-95CG
2020-09-18T04:42:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/biomed-101,NA,NA
2020-09-18T04:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperine-extract-standardized,US brand name:,Bioperine
2020-09-18T04:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperine-extract-standardized,Abbreviation:,PIPE
2020-09-18T04:43:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candesartan-cilexetil,US brand name:,Atacand
2020-09-18T04:43:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candesartan-cilexetil,US brand name:,Biopress
2020-09-18T04:43:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-microencapsulated-diindolylmethane,US brand name:,BioResponse DIM
2020-09-18T04:43:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-microencapsulated-diindolylmethane,Abbreviation:,BR-DIM
2020-09-18T04:43:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-c-immune-globulin-intravenous,Synonym:,anti-HCV immunoglobulin
2020-09-18T04:43:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-c-immune-globulin-intravenous,US brand name:,Biotest-HCIG
2020-09-18T04:43:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-c-immune-globulin-intravenous,US brand name:,Civacir
2020-09-18T04:43:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-c-immune-globulin-intravenous,Abbreviation:,HCIG
2020-09-18T04:43:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/biricodar-dicitrate,Synonym:,Incel VX-710
2020-09-18T04:43:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/biricodar-dicitrate,US brand name:,Incel
2020-09-18T04:43:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/biricodar-dicitrate,Code name:,VX-710
2020-09-18T04:43:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/birinapant,Synonym:,Smac mimetic TL32711
2020-09-18T04:43:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/birinapant,Code name:,TL32711
2020-09-18T04:43:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/birinapant,Chemical structure:,"propanamide, N,N'-[(6,6'-difluoro[2,2'-bi-1H-indole]-3,3'-diyl)bis[methylene[(2R,4S)-4-hydroxy-2,1-pyrrolidinediyl][(1S)-1-ethyl-2-oxo-2,1-ethanediyl]]]bis[2-(methylamino)-,(2S,2'S)-"
2020-09-18T04:43:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisacodyl,NA,NA
2020-09-18T04:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride,Synonym:,bisantrene dihydrochloride
2020-09-18T04:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride,Synonym:,bisantrene HCL
2020-09-18T04:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride,Synonym:,orange crush
2020-09-18T04:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride,Foreign brand name:,Zantrene
2020-09-18T04:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride,Code name:,CL 216942
2020-09-18T04:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride,Code name:,CL-216942
2020-09-18T04:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride,Chemical structure:,"9, 10-anthracenedicarboxaldehyde, bis(4, 5-dihydro-1H-imidazol-2-ylhydrazone),dihydrochloride9,10,Anthracenedicarboxaldehyde dihydrochloride9,10-Anthracenedicarboxaldehyde bis(2-imidazolin-2-yl)hydrazone dihydrochloride"
2020-09-18T04:43:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-shrna-furin-gmcsf-expressing-autologous-tumor-cell-vaccine,Synonym:,bi-shRNA-furin and granulocyte macrophage colony stimulating factor augmented autologous tumor cell vaccine
2020-09-18T04:43:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-shrna-furin-gmcsf-expressing-autologous-tumor-cell-vaccine,Synonym:,FANG vaccine
2020-09-18T04:43:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-shrna-furin-gmcsf-expressing-autologous-tumor-cell-vaccine,US brand name:,Vigil
2020-09-18T04:43:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bismuth-bi213-monoclonal-antibody-m195,Abbreviation:,Bi213 MOAB M195
2020-09-18T04:43:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bismuth-subsalicylate,US brand name:,Pepto-Bismol
2020-09-18T04:43:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisoprolol-fumarate,Chemical structure:,(±)-1-[4-[[2-(1-ethylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol(E)-2-butenedioate (2:1) (fumarate)
2020-09-18T04:44:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-2b1,Synonym:,2B1
2020-09-18T04:44:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-2b1,Synonym:,"2B1 antibody, bispecific"
2020-09-18T04:44:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-2b1,Synonym:,2B1 Bispecific MAb
2020-09-18T04:44:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-2b1,Synonym:,2B1 Bispecific Murine MAb
2020-09-18T04:44:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-2b1,Synonym:,MoAb 2B1 Bispecific
2020-09-18T04:44:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-2b1,Abbreviation:,BsAb 2B1
2020-09-18T04:44:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-4g7xh22,NA,NA
2020-09-18T04:44:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800690,Code name:,AMG 509
2020-09-18T04:44:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800690,Code name:,AMG509
2020-09-18T04:44:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800690,Code name:,AMG-509
2020-09-18T04:44:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800422,Code name:,AGEN 1423
2020-09-18T04:44:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800422,Code name:,AGEN1423
2020-09-18T04:44:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800422,Code name:,AGEN-1423
2020-09-18T04:44:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800422,Code name:,GS 1423
2020-09-18T04:44:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800422,Code name:,GS1423
2020-09-18T04:44:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800422,Code name:,GS-1423
2020-09-18T04:44:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-mdx447,Synonym:,BsAb MDX447
2020-09-18T04:44:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-mdx447,Code name:,EMD 82633
2020-09-18T04:44:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-mdx447,Code name:,MDX-447
2020-09-18T04:44:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-mdx-h210,Code name:,MDX-H210
2020-09-18T04:44:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799197,Code name:,CF367
2020-09-18T04:44:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799197,Code name:,CF367-C
2020-09-18T04:44:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799197,Code name:,CFH367 C
2020-09-18T04:44:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799197,Code name:,CFH367-C
2020-09-18T04:44:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799197,Code name:,PY-1
2020-09-18T04:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801178,Synonym:,bispecific antibody AMG 910
2020-09-18T04:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801178,Synonym:,bispecific T-cell engager AMG 910
2020-09-18T04:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801178,Synonym:,bispecific T-cell engager antibody AMG 910
2020-09-18T04:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801178,Code name:,AMG 910
2020-09-18T04:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801178,Code name:,AMG910
2020-09-18T04:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801178,Code name:,AMG-910
2020-09-18T04:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793144,Synonym:,BET inhibitor AZD5153
2020-09-18T04:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793144,Synonym:,bivalent BET bromodomain inhibitor AZD5153
2020-09-18T04:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793144,Synonym:,BRD4/BET bromodomain antagonist AZD5153
2020-09-18T04:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793144,Code name:,AZD 5153
2020-09-18T04:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793144,Code name:,AZD5153
2020-09-18T04:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793144,Chemical structure:,"(R)-4-(2-(4-(1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)-1,3-dimethylpiperazin-2-one"
2020-09-18T04:44:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bivalent-hpv16-18-therapeutic-cervical-cancer-vaccine,Foreign brand name:,ProCervix
2020-09-18T04:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bizelesin,Code name:,U-77779
2020-09-18T04:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bizelesin,Chemical structure:,"benzo(1,2-b:4,3-b')dipyrrol-4-ol,6,6'-(carbonylbis(imino-1H-indole-5,2-diylcarbonyl))bis(8-(chloromethyl)-3,6,7,8-tetrahydro-1-methyl-,(S-(R*,R*))"
2020-09-18T04:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bl22-immunotoxin,Synonym:,Anti-CD22 Recombinant Immunotoxin BL22
2020-09-18T04:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bl22-immunotoxin,Synonym:,BL22
2020-09-18T04:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bl22-immunotoxin,Synonym:,BL22 Immunotoxin [RFB4(dsFv) - PE38
2020-09-18T04:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bl22-immunotoxin,Synonym:,RFB4(dsFv)-PE38 immunotoxin
2020-09-18T04:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bl22-immunotoxin,Abbreviation:,BL22
2020-09-18T04:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bl22-immunotoxin,Code name:,CAT-3888
2020-09-18T04:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/black-cohosh,US brand name:,Remifemin
2020-09-18T04:45:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797026,Synonym:,Ribes nigrum L. juice
2020-09-18T04:45:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/black-raspberry-nectar,Synonym:,BRB nectar
2020-09-18T04:45:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/black-tea,NA,NA
2020-09-18T04:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-drug-conjugate-gsk2857916,Synonym:,belantamab mafodotin
2020-09-18T04:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-drug-conjugate-gsk2857916,US brand name:,Blenrep
2020-09-18T04:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-drug-conjugate-gsk2857916,Abbreviation:,J6M0-mcMMAF
2020-09-18T04:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-drug-conjugate-gsk2857916,Code name:,GSK2857916
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Synonym:,bleomycin sulfas
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Synonym:,bleomycin sulphate
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Synonym:,bleomycini sulfas
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Synonym:,blexane
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Foreign brand name:,Blanoxan
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Foreign brand name:,Bleo-cell
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Foreign brand name:,Bleocin
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Foreign brand name:,Bleolem
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Foreign brand name:,Bleo-S
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Foreign brand name:,Oil Bleo
2020-09-18T04:45:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bli850,NA,NA
2020-09-18T04:45:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab,Synonym:,anti-CD19/anti-CD3 recombinant bispecific monoclonal antibody MT103
2020-09-18T04:45:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab,Synonym:,bispecific T-cell engager MT103
2020-09-18T04:45:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab,US brand name:,Blincyto
2020-09-18T04:45:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab,Code name:,MEDI-538
2020-09-18T04:45:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab,Code name:,MT-103
2020-09-18T04:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab,Synonym:,anti-CD19/anti-CD3 recombinant bispecific monoclonal antibody MT103
2020-09-18T04:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab,Synonym:,bispecific T-cell engager MT103
2020-09-18T04:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab,US brand name:,Blincyto
2020-09-18T04:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab,Code name:,MEDI-538
2020-09-18T04:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab,Code name:,MT-103
2020-09-18T04:45:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blue-citrus-based-herbal-capsule,NA,NA
2020-09-18T04:45:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blueberry-powder-supplement,US brand name:,VitaBlue tablet formation
2020-09-18T04:46:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bmi1-inhibitor-ptc596,Synonym:,polycomb ring finger oncogene inhibitor PTC596
2020-09-18T04:46:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bmi1-inhibitor-ptc596,Code name:,PTC596
2020-09-18T04:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bms-214662,Synonym:,farnesyltransferase inhibitor BMS-214662
2020-09-18T04:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bms-214662,Abbreviation:,FTI BMS 214662
2020-09-18T04:46:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boanmycin-hydrochloride,Synonym:,bleomycin A6 hydrochloride
2020-09-18T04:46:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boanmycin-hydrochloride,Abbreviation:,BAM HCl
2020-09-18T04:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boceprevir,US brand name:,Victrelis
2020-09-18T04:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boceprevir,Code name:,EBP 520
2020-09-18T04:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boceprevir,Code name:,SCH 503034
2020-09-18T04:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boceprevir,Chemical structure:,"3-azabicyclo(3.1.0)hexane-2-carboxamide, N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-((2S)-2-((((1,1- dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6- dimethyl-, (1R,2S,5S)-"
2020-09-18T04:46:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bone-metastasis-targeting-peptide-11,Acronym:,BMTP-11
2020-09-18T04:46:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibandronate-sodium,Synonym:,ibandronate
2020-09-18T04:46:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibandronate-sodium,US brand name:,Boniva
2020-09-18T04:46:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibandronate-sodium,Foreign brand name:,Bondronate
2020-09-18T04:46:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritional-supplement-drink,US brand name:,Boost
2020-09-18T04:46:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritional-supplement-drink,US brand name:,Ensure
2020-09-18T04:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797097,US brand name:,Boost Breeze
2020-09-18T04:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boron-dipyrromethene-modified-olaparib-fluorescent-imaging-agent,Synonym:,AZD2281-BODIPY FL
2020-09-18T04:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boron-dipyrromethene-modified-olaparib-fluorescent-imaging-agent,Synonym:,BODIPY-modified olaparib fluorescent imaging agent
2020-09-18T04:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boron-dipyrromethene-modified-olaparib-fluorescent-imaging-agent,Synonym:,fluorescent PARP1 inhibitor PARPi-FL
2020-09-18T04:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boron-dipyrromethene-modified-olaparib-fluorescent-imaging-agent,Synonym:,fluorescent PARPi binding imaging agent PARPi-FL
2020-09-18T04:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boron-dipyrromethene-modified-olaparib-fluorescent-imaging-agent,Synonym:,olaparib-BODIPY FL
2020-09-18T04:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boron-dipyrromethene-modified-olaparib-fluorescent-imaging-agent,Abbreviation:,PARPi-FL
2020-09-18T04:46:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boronophenylalanine-fructose-complex,Synonym:,p-Boronophenylalanine-Fructose Complex
2020-09-18T04:46:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boronophenylalanine-fructose-complex,Abbreviation:,BPA-F
2020-09-18T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bortezomib,Synonym:,PS-341
2020-09-18T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bortezomib,US brand name:,Velcade
2020-09-18T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bortezomib,Code name:,LDP 341
2020-09-18T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bortezomib,Code name:,MLN341
2020-09-18T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bortezomib,Code name:,PS-341
2020-09-18T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bortezomib,Chemical structure:,[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
2020-09-18T04:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bosutinib,US brand name:,Bosulif
2020-09-18T04:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bosutinib,Code name:,SKI-606
2020-09-18T04:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bosutinib,Chemical structure:,"4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile4-anilino-3-quinolinecarbonitrile4-anilinobenzo(g)quinoline-3-carbonitrile"
2020-09-18T04:47:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bosutinib,US brand name:,Bosulif
2020-09-18T04:47:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bosutinib,Code name:,SKI-606
2020-09-18T04:47:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bosutinib,Chemical structure:,"4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile4-anilino-3-quinolinecarbonitrile4-anilinobenzo(g)quinoline-3-carbonitrile"
2020-09-18T04:47:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boswellia-serrata-extract,NA,NA
2020-09-18T04:47:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793949,Synonym:,botanical agent BEL X HG
2020-09-18T04:47:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793949,Code name:,BEL X HG
2020-09-18T04:47:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793949,Code name:,BELXHG
2020-09-18T04:47:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793949,Code name:,BEL-X-HG
2020-09-18T04:47:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-agent-leac-102,Synonym:,LEAC 102
2020-09-18T04:47:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-agent-leac-102,Code name:,LEAC-102
2020-09-18T04:47:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-extract-dcb-bo1301,Synonym:,Zhaohe Cao-based botanical drug DCB-BO1301
2020-09-18T04:47:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-extract-dcb-bo1301,Code name:,DCB BO 1301
2020-09-18T04:47:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-extract-dcb-bo1301,Code name:,DCB BO1301
2020-09-18T04:47:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-extract-dcb-bo1301,Code name:,DCB-BO1301
2020-09-18T04:47:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-extracts-rinse-izn-6n4,Synonym:,oral botanical extracts mucositis rinse IZN-6N4
2020-09-18T04:47:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-extracts-rinse-izn-6n4,Code name:,IZN-6N4
2020-09-18T04:47:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-lotion-cg428,Code name:,CG428
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,abobotulinumtoxinA
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,botulinum A toxin
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,botulinum neurotoxin type A
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,botulinum toxin A
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,onabotulinumtoxinA
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,onaclostox
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,US brand name:,BOTOX
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,US brand name:,Botox cosmetic
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,US brand name:,Dysport
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Abbreviation:,BTX-A
2020-09-18T04:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,abobotulinumtoxinA
2020-09-18T04:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,botulinum A toxin
2020-09-18T04:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,botulinum neurotoxin type A
2020-09-18T04:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,botulinum toxin A
2020-09-18T04:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,onabotulinumtoxinA
2020-09-18T04:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,onaclostox
2020-09-18T04:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,US brand name:,BOTOX
2020-09-18T04:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,US brand name:,Botox cosmetic
2020-09-18T04:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,US brand name:,Dysport
2020-09-18T04:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Abbreviation:,BTX-A
2020-09-18T04:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797646,Synonym:,BoNT/E EB-001
2020-09-18T04:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797646,Synonym:,botulinum EB-001
2020-09-18T04:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797646,Synonym:,botulinum type E EB-001
2020-09-18T04:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797646,Synonym:,toxin E EB-001
2020-09-18T04:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797646,Code name:,EB 001
2020-09-18T04:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797646,Code name:,EB001
2020-09-18T04:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,abobotulinumtoxinA
2020-09-18T04:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,botulinum A toxin
2020-09-18T04:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,botulinum neurotoxin type A
2020-09-18T04:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,botulinum toxin A
2020-09-18T04:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,onabotulinumtoxinA
2020-09-18T04:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,onaclostox
2020-09-18T04:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,US brand name:,BOTOX
2020-09-18T04:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,US brand name:,Botox cosmetic
2020-09-18T04:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,US brand name:,Dysport
2020-09-18T04:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Abbreviation:,BTX-A
2020-09-18T04:48:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bovine-lactoferrin-supplement,Synonym:,bLF supplement
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,SHR1459
2020-09-18T04:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bowman-birk-inhibitor-concentrate,Abbreviation:,BBIC
2020-09-18T04:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bowman-birk-inhibitor-concentrate,Acronym:,BBIC
2020-09-18T04:48:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bp-cx1-platinum-complex-bp-c1,Code name:,BP-C1
2020-09-18T04:48:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brachyury-expressing-modified-vaccinia-ankara-tricom-vaccine,Abbreviation:,MVA brachyury-TRICOM
2020-09-18T04:48:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brachyury-expressing-yeast-vaccine-gi-6301,Code name:,GI-6301
2020-09-18T04:48:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-inhibitor-arq-736,Code name:,AQ 736
2020-09-18T04:48:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-inhibitor-arq-736,Code name:,ARQ 736
2020-09-18T04:48:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797806,Code name:,LUT 014
2020-09-18T04:48:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797806,Code name:,LUT014
2020-09-18T04:48:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797806,Code name:,LUT-014
2020-09-18T04:48:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-inhibitor-plx8394,Code name:,PLX8394
2020-09-18T04:48:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-v600e-kinase-inhibitor-ro5212054,Synonym:,B-Raf inhibitor RO5212054
2020-09-18T04:48:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-v600e-kinase-inhibitor-ro5212054,Code name:,PLX3603
2020-09-18T04:48:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-v600e-kinase-inhibitor-ro5212054,Code name:,RO5212054
2020-09-18T04:48:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600e-inhibitor-cep-32496,Code name:,AC013773
2020-09-18T04:48:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600e-inhibitor-cep-32496,Code name:,CEP-32496
2020-09-18T04:48:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600e-inhibitor-cep-32496,Chemical structure:,"1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride"
2020-09-18T04:48:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801208,Code name:,ABM 1310
2020-09-18T04:48:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801208,Code name:,ABM1310
2020-09-18T04:48:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801208,Code name:,ABM-1310
2020-09-18T04:49:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-egfr-inhibitor-bgb-283,Code name:,BGB-283
2020-09-18T04:49:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b-raf-vegfr-2-inhibitor-raf265,Code name:,CHIR-265
2020-09-18T04:49:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b-raf-vegfr-2-inhibitor-raf265,Code name:,RAF265
2020-09-18T04:49:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encorafenib,US brand name:,Braftovi
2020-09-18T04:49:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encorafenib,Code name:,LGX 818
2020-09-18T04:49:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encorafenib,Code name:,LGX818
2020-09-18T04:49:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encorafenib,Code name:,LGX-818
2020-09-18T04:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600-pi3k-inhibitor-asn003,Code name:,ASN 003
2020-09-18T04:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600-pi3k-inhibitor-asn003,Code name:,ASN003
2020-09-18T04:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600-pi3k-inhibitor-asn003,Code name:,ASN-003
2020-09-18T04:49:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brain-tumor-initiating-cell-vaccine,Synonym:,BTIC vaccine
2020-09-18T04:49:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-topotecan-hydrochloride,Synonym:,topotecan hydrochloride liposomes
2020-09-18T04:49:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-topotecan-hydrochloride,US brand name:,Brakiva
2020-09-18T04:49:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/branched-chain-amino-acid-supplement,Abbreviation:,BCAA supplement
2020-09-18T04:49:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brassica-vegetable,NA,NA
2020-09-18T04:49:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792077,Code name:,PLX 2853
2020-09-18T04:49:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792077,Code name:,PLX2853
2020-09-18T04:49:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792077,Code name:,PLX-2853
2020-09-18T04:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brd4-inhibitor-plx51107,Code name:,PLX 51107
2020-09-18T04:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brd4-inhibitor-plx51107,Code name:,PLX51107
2020-09-18T04:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brd4-inhibitor-plx51107,Code name:,PLX-51107
2020-09-18T04:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798452,Synonym:,TYK2/JAK1 inhibitor PF-06700841
2020-09-18T04:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798452,Synonym:,UNII 3X8387Q25N
2020-09-18T04:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798452,Code name:,PF 06700841
2020-09-18T04:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798452,Code name:,PF06700841
2020-09-18T04:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798452,Code name:,PF-06700841
2020-09-18T04:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798452,Code name:,PF-841
2020-09-18T04:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798452,Chemical structure:,"((S)-2,2-difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone"
2020-09-18T04:50:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brequinar,Synonym:,Bipenquinate
2020-09-18T04:50:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brequinar,Chemical structure:,"6-Fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-methyl-4-quinolinecarboxylic Acid"
2020-09-18T04:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,Synonym:,Ortho-Novum 1/35
2020-09-18T04:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Aranelle
2020-09-18T04:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Balziva
2020-09-18T04:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Brevicon
2020-09-18T04:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Gencept
2020-09-18T04:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Modicon
2020-09-18T04:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norcept-E
2020-09-18T04:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norethin
2020-09-18T04:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norinyl
2020-09-18T04:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Nortrel
2020-09-18T04:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Ortho-Novum
2020-09-18T04:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Ovcon
2020-09-18T04:50:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802259,Synonym:,anti-CD19 autologous CAR-CD28 T cells KTE-X19
2020-09-18T04:50:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802259,Synonym:,autologous anti-CD19 CAR-CD28 T cells KTE-X19
2020-09-18T04:50:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802259,US brand name:,Tecartus
2020-09-18T04:50:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802259,Code name:,KTE X19
2020-09-18T04:50:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802259,Code name:,KTEX19
2020-09-18T04:50:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802259,Code name:,KTE-X19
2020-09-18T04:50:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/briciclib-sodium,Synonym:,cyclin D modulator ON 013105
2020-09-18T04:50:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/briciclib-sodium,Code name:,ON 013105
2020-09-18T04:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sugammadex-sodium,US brand name:,Bridion
2020-09-18T04:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sugammadex-sodium,Code name:,Org 25969
2020-09-18T04:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brilacidin-oral-rinse,Synonym:,PMX30063 oral rinse
2020-09-18T04:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797485,Code name:,OCU 300
2020-09-18T04:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797485,Code name:,OCU300
2020-09-18T04:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797485,Code name:,OCU-300
2020-09-18T04:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brincidofovir,Synonym:,hexadecyloxypropyl-cidofovir
2020-09-18T04:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brincidofovir,Abbreviation:,BCV
2020-09-18T04:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brincidofovir,Abbreviation:,HDP-Cidofovir
2020-09-18T04:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brincidofovir,Code name:,CMX001
2020-09-18T04:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vortioxetine-hydrobromide,US brand name:,Brintellix
2020-09-18T04:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vortioxetine-hydrobromide,Foreign brand name:,Trintellix
2020-09-18T04:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vortioxetine-hydrobromide,Chemical structure:,"1-(2-((2,4-dimethylphenyl)sulfanyl)phenyl)piperazine monohydrobromidepiperazine, 1-(2-((2,4-dimethylphenyl)thio)phenyl)-, hydrobromide (1:1)"
2020-09-18T04:50:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivanib-alaninate,Code name:,BMS-582664
2020-09-18T04:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792577,US brand name:,Briviact
2020-09-18T04:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792577,Code name:,UCB34714
2020-09-18T04:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792577,Chemical structure:,"1-pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-"
2020-09-18T04:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792577,US brand name:,Briviact
2020-09-18T04:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792577,Code name:,UCB34714
2020-09-18T04:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792577,Chemical structure:,"1-pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-"
2020-09-18T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivudine-phosphoramidate,US brand name:,Thymectacin
2020-09-18T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivudine-phosphoramidate,Code name:,NB1011
2020-09-18T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivudine-phosphoramidate,Chemical structure:,(E)-5-(2-Bromovinyl)-2'-deoxy-5'-uridyl phenyl L-methoxyalaninylphosphoramidate
2020-09-18T04:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broad-spectrum-human-papillomavirus-vaccine-v505,Code name:,V505
2020-09-18T04:51:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broccoli-sprout-extract,NA,NA
2020-09-18T04:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broccoli-sprout-broccoli-seed-extract-supplement,US brand name:,Avmacol
2020-09-18T04:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromelain,Synonym:,Bromelase
2020-09-18T04:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromelain,Synonym:,EC 3.4.22.33
2020-09-18T04:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromelain,Synonym:,Pineapple Enzyme
2020-09-18T04:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromocriptine-mesylate,US brand name:,Parlodel
2020-09-18T04:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromocriptine-mesylate,Chemical structure:,"2-Bromo-alpha-ergocryptine Mesylateergotaman-3´,6´,18-trione, 2-bromo-12´-hydroxy-2´-(1-methylethyl)-5´-(2-methylpropyl)-, (5´a)-mono-methanesulfonate (salt), (5'alpha)-"
2020-09-18T04:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromodeoxyuridine,Synonym:,5-bromodeoxyuridine
2020-09-18T04:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromodeoxyuridine,Synonym:,broxuridine
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,SHR-1459
2020-09-18T04:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromodeoxyuridine,Abbreviation:,5-BrdU
2020-09-18T04:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromodeoxyuridine,Abbreviation:,BrdU
2020-09-18T04:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromodeoxyuridine,Chemical structure:,5-bromouracil-2-deoxyriboside
2020-09-18T04:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromodomain-inhibitor-abbv-075,Code name:,ABBV-075
2020-09-18T04:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromovinyl-deoxyuridine,Abbreviation:,BVDU
2020-09-18T04:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromovinyl-deoxyuridine,Code name:,RP101
2020-09-18T04:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromovinyl-deoxyuridine,Chemical structure:,(E)-5-(2-bromovinyl)-2'-deoxyuridine
2020-09-18T04:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brontictuzumab,Synonym:,anti-Notch1 monoclonal antibody OMP-52M51
2020-09-18T04:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brontictuzumab,Abbreviation:,anti-Notch receptor MoAb OMP-52M51
2020-09-18T04:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brontictuzumab,Code name:,OMP-52M51
2020-09-18T04:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brostallicin,Code name:,PNU-166196
2020-09-18T04:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-bgb-3111,Synonym:,BTK-InhB
2020-09-18T04:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-bgb-3111,US brand name:,Brukinsa
2020-09-18T04:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-bgb-3111,Code name:,BGB-3111
2020-09-18T04:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-bgb-3111,Chemical structure:,"(S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide"
2020-09-18T04:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brussels-sprout,NA,NA
2020-09-18T04:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bryostatin-1,Synonym:,Bryostatin
2020-09-18T04:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bryostatin-1,Abbreviation:,BRYO
2020-09-18T04:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bryostatin-1,Code name:,B705008K112
2020-09-18T04:52:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-arq-531,Synonym:,Bruton's tyrosine kinase inhibitor ARQ 531
2020-09-18T04:52:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-arq-531,Code name:,ARQ 531
2020-09-18T04:52:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-arq-531,Code name:,ARQ-531
2020-09-18T04:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-cc-292,Synonym:,Bruton's tyrosine kinase inhibitor AVL-292
2020-09-18T04:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-cc-292,Synonym:,Bruton's tyrosine kinase inhibitor CC-292
2020-09-18T04:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-cc-292,Synonym:,BTK inhibitor AVL-292
2020-09-18T04:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-cc-292,Code name:,AVL-292
2020-09-18T04:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-cc-292,Code name:,CC-292
2020-09-18T04:52:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-ct-1530,Code name:,CT 1530
2020-09-18T04:52:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-ct-1530,Code name:,CT1530
2020-09-18T04:52:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-ct-1530,Code name:,CT-1530
2020-09-18T04:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-dtrmwxhs-12,Code name:,DTRMWXHS 12
2020-09-18T04:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-dtrmwxhs-12,Code name:,DTRMWXHS-12
2020-09-18T04:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-gdc-0853,Synonym:,Bruton tyrosine kinase inhibitor GDC-0853
2020-09-18T04:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-gdc-0853,Code name:,GDC-0853
2020-09-18T04:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802311,Synonym:,Bruton’s tyrosine kinase inhibitor HZ-A-018
2020-09-18T04:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802311,Code name:,HZ-A 018
2020-09-18T04:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802311,Code name:,HZ-A018
2020-09-18T04:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802311,Code name:,HZ-A-018
2020-09-18T04:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795368,Code name:,ICP 022
2020-09-18T04:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795368,Code name:,ICP022
2020-09-18T04:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795368,Code name:,ICP-022
2020-09-18T04:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797383,Code name:,LOXO 305
2020-09-18T04:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797383,Code name:,LOXO305
2020-09-18T04:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797383,Code name:,LOXO-305
2020-09-18T04:53:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-m7583,Synonym:,Bruton's tyrosine kinase inhibitor M7583
2020-09-18T04:53:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-m7583,Code name:,M7583
2020-09-18T04:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801899,Synonym:,Bruton's tyrosine kinase inhibitor SAR442168
2020-09-18T04:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801899,Code name:,SAR 442168
2020-09-18T04:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801899,Code name:,SAR442168
2020-09-18T04:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801899,Code name:,SAR-442168
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,EBI 1459
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,EBI1459
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,EBI-1459
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,SHR 1459
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,TG 1701
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,TG1701
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,TG-1701
2020-09-18T04:53:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/budesonide-formoterol-fumarate-dihydrate-inhalation-aerosol,US brand name:,Symbicort
2020-09-18T04:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-monoclonal-antibody-abbv-181,Code name:,ABBV 181
2020-09-18T04:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-monoclonal-antibody-abbv-181,Code name:,ABBV181
2020-09-18T04:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-monoclonal-antibody-abbv-181,Code name:,ABBV-181
2020-09-18T04:53:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buformin-hydrochloride,Synonym:,1-butylbiguanide HCl
2020-09-18T04:53:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buformin-hydrochloride,Synonym:,N-butylbiguanide HCl
2020-09-18T04:53:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buformin-hydrochloride,Chemical structure:,"imidodicarbonimidic diamide, N-butyl-, hydrochloride"
2020-09-18T04:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyacrylamide-hydrogel,US brand name:,Bulkamid
2020-09-18T04:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyacrylamide-hydrogel,Foreign brand name:,Aquamid
2020-09-18T04:53:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buparlisib,Synonym:,PI3K inhibitor BKM120
2020-09-18T04:53:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buparlisib,Code name:,BKM120
2020-09-18T04:53:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buparlisib,Code name:,PI3K_Inhibitor_BKM120
2020-09-18T04:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-phenylbutyrate,Synonym:,sodium 4-phenylbutyrate
2020-09-18T04:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-phenylbutyrate,US brand name:,Buphenyl
2020-09-18T04:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride,US brand name:,Marcaine
2020-09-18T04:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride,US brand name:,Sensorcaine
2020-09-18T04:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride,Foreign brand name:,Marcain
2020-09-18T04:53:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride-liposome-injectable-suspension,Synonym:,bupivacaine liposome injectable suspension
2020-09-18T04:53:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride-liposome-injectable-suspension,US brand name:,Exparel
2020-09-18T04:54:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buprenorphine-transdermal-matrix-patch,NA,NA
2020-09-18T04:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Synonym:,bupropion HCl controlled-release
2020-09-18T04:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Synonym:,bupropion HCl extended release
2020-09-18T04:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Synonym:,bupropion hydrochloride extended-release
2020-09-18T04:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Aplenzin
2020-09-18T04:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Wellbutrin SR
2020-09-18T04:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Wellbutrin XL
2020-09-18T04:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Zyban
2020-09-18T04:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Foreign brand name:,Forfivo XL
2020-09-18T04:54:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/burixafor,Code name:,TG-0054
2020-09-18T04:54:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/burixafor,Chemical structure:,"phosphonic Acid, p-(2-(4-(6-Amino-2-(((trans-4-(((3-(cyclohexylamino)propyl)amino)methyl)cyclohexyl)methyl)amino)-4-pyrimidinyl)-1-piperazinyl)ethyl)-"
2020-09-18T04:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgf23-igg1-monoclonal-antibody-krn23,Synonym:,anti-FGF23 IgG1 monoclonal antibody KRN23
2020-09-18T04:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgf23-igg1-monoclonal-antibody-krn23,Code name:,KRN23
2020-09-18T04:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgf23-igg1-monoclonal-antibody-krn23,Code name:,UX023
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Synonym:,buserelin acetate
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Synonym:,busereline
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,US brand name:,Etilamide
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Bigonist
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Profact
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Profact Depot
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Receptal
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Suprecur
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Suprefact
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Suprefact Depot
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Suprefact Flakon
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Abbreviation:,BSRL
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Code name:,HOE 766
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Code name:,ICI 123215
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Code name:,S74-6766
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Chemical structure:,"6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide luteinizing hormone-releasing factor (pig)D-ser (bu(t))(6) pro(9) NEt LHRH Acetate"
2020-09-18T04:54:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797882,Synonym:,Bushen Culuan TCM decoction
2020-09-18T04:54:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797882,Synonym:,Bushen Culuan traditional Chinese medicine decoction
2020-09-18T04:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793123,Synonym:,Jianpi Bushen
2020-09-18T04:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793123,Synonym:,Jianpi-Bushen decoction
2020-09-18T04:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793123,Abbreviation:,BJD
2020-09-18T04:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793123,Abbreviation:,BJHD
2020-09-18T04:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793123,Abbreviation:,BSJPD
2020-09-18T04:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793123,Abbreviation:,JPBS
2020-09-18T04:54:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buspirone-hydrochloride,US brand name:,Buspar
2020-09-18T04:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buspirone-hydrochloride,US brand name:,Buspar
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,BSF
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Bussulfam
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Busulfanum
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,busulphan
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,glyzophrol
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,"methanesulfonic acid, tetramethylene ester"
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Myeleukon
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Myeloleukon
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Myelosan
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Mylecytan
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Sulfabutin
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,tetramethylene bis(methanesulfonate)
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,US brand name:,Busulfex
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,US brand name:,Myleran
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Foreign brand name:,Mielucin
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Foreign brand name:,Misulban
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Foreign brand name:,Misulfan
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Foreign brand name:,Mitosan
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Abbreviation:,BU
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Abbreviation:,BUS
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Code name:,CB-2041
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Code name:,GT-41
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Code name:,WR-19508
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Chemical structure:,"1,4-bis(methanesulfonoxy)butane1,4-bitanediol dimethanesulfonate esters1,4-butanediol dimethylsulfonate1,4-di(methanesulfonyloxy)butane1,4-di(methylsulfonyloxy)butane"
2020-09-18T04:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan-melphalan-regimen,Synonym:,BuMel regimen
2020-09-18T04:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan-melphalan-regimen,Synonym:,busulfan/melphalan regimen
2020-09-18T04:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan-melphalan-regimen,Abbreviation:,BuMel
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,BSF
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Bussulfam
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Busulfanum
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,busulphan
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,glyzophrol
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,"methanesulfonic acid, tetramethylene ester"
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Myeleukon
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Myeloleukon
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Myelosan
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Mylecytan
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Sulfabutin
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,tetramethylene bis(methanesulfonate)
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,US brand name:,Busulfex
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,US brand name:,Myleran
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Foreign brand name:,Mielucin
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Foreign brand name:,Misulban
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Foreign brand name:,Misulfan
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Foreign brand name:,Mitosan
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Abbreviation:,BU
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Abbreviation:,BUS
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Code name:,CB-2041
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Code name:,GT-41
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Code name:,WR-19508
2020-09-18T04:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Chemical structure:,"1,4-bis(methanesulfonoxy)butane1,4-bitanediol dimethanesulfonate esters1,4-butanediol dimethylsulfonate1,4-di(methanesulfonyloxy)butane1,4-di(methylsulfonyloxy)butane"
2020-09-18T04:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buthionine-sulfoximine,Synonym:,"d,l-buthionine-s,r-sulfoximine"
2020-09-18T04:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buthionine-sulfoximine,Synonym:,L-buthionine sulfoximine
2020-09-18T04:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buthionine-sulfoximine,Abbreviation:,BSO
2020-09-18T04:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buthionine-sulfoximine,Chemical structure:,"2-amino-4-(S-butylsulfonimidoyl) butanoic acidbutanoic acid, 2-amino-4-(S-butylsulfonimidoyl)-S-(3-amino-3-carboxypropyl)-S-butylsulfoximineS-(n-butyl)homocysteine sulfoximine"
2020-09-18T04:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/butylscopolamine-bromide,Synonym:,buscopan
2020-09-18T04:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/butylscopolamine-bromide,Synonym:,butylscopolamine
2020-09-18T04:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/butylscopolamine-bromide,Synonym:,oral hyoscine butylbromide
2020-09-18T04:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bxq-350-nanovesicle-formulation,Synonym:,SapC-DOPS nanovesicles
2020-09-18T04:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bxq-350-nanovesicle-formulation,Synonym:,saposin C–dioleoylphosphatidylserine complexes
2020-09-18T04:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bxq-350-nanovesicle-formulation,Synonym:,saposin C-dioleoylphosphatidylserine nanovesicles
2020-09-18T04:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bxq-350-nanovesicle-formulation,Code name:,BXQ-350
2020-09-18T04:55:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exenatide,US brand name:,Byetta
2020-09-18T04:55:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c3-targeted-complement-inhibitor-apl-2,Code name:,APL2
2020-09-18T04:55:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c3-targeted-complement-inhibitor-apl-2,Code name:,APL-2
2020-09-18T04:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabazitaxel,Synonym:,taxoid XRP6258
2020-09-18T04:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabazitaxel,US brand name:,Jevtana
2020-09-18T04:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabazitaxel,Code name:,RPR-116258A
2020-09-18T04:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabazitaxel,Code name:,XRP6258
2020-09-18T04:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabazitaxel,Chemical structure:,"1-hydroxy-7β,10β-dimethoxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-{[(tertbutoxycarbonyl]amino}-2-hydroxy-3-phenylpropanoate]"
2020-09-18T04:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabergoline,US brand name:,Dostinex
2020-09-18T04:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabergoline,Code name:,FCE 21336
2020-09-18T04:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabergoline,Chemical structure:,1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
2020-09-18T04:55:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabiralizumab,Code name:,BMS-986227
2020-09-18T04:55:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabiralizumab,Code name:,FPA 008
2020-09-18T04:55:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabiralizumab,Code name:,FPA008
2020-09-18T04:55:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabiralizumab,Code name:,FPA-008
2020-09-18T04:55:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Synonym:,caplacizumab
2020-09-18T04:55:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,US brand name:,Cablivi
2020-09-18T04:55:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Code name:,ALX 0081
2020-09-18T04:55:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Code name:,ALX 0681
2020-09-18T04:55:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Code name:,ALX0081
2020-09-18T04:55:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Code name:,ALX-0081
2020-09-18T04:55:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Code name:,ALX0681
2020-09-18T04:55:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,US brand name:,Cabometyx
2020-09-18T04:55:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,US brand name:,Cometriq
2020-09-18T04:55:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,Code name:,BMS-907351
2020-09-18T04:55:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,Code name:,XL184
2020-09-18T04:55:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,Chemical structure:,"butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1)"
2020-09-18T04:55:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,US brand name:,Cabometyx
2020-09-18T04:55:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,US brand name:,Cometriq
2020-09-18T04:55:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,Code name:,BMS-907351
2020-09-18T04:55:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,Code name:,XL184
2020-09-18T04:55:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,Chemical structure:,"butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1)"
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Synonym:,ADC BA3021
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Synonym:,antibody-drug conjugate BA3021
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Synonym:,anti-ROR2 CAB ADC
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Synonym:,CAB anti-ROR2 ADC BA3021
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Synonym:,CAB-ROR2-ADC
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Synonym:,conditionally active biologic anti-ROR2 antibody-drug conjugate
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Synonym:,ROR2-targeted ADC BA3021
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Code name:,BA 3021
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Code name:,BA3021
2020-09-18T04:56:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cadazolid,Code name:,ACT-179811
2020-09-18T04:56:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cadazolid,Chemical structure:,"1-Cyclopropyl-6-fluoro-7-(4-((2-fluoro-4-((R)-5-hydroxymethyl-2-oxooxazolidin-3-yl)phenoxy)methyl)-4-hydroxypiperidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid"
2020-09-18T04:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caf-regimen,Synonym:,CAFFI
2020-09-18T04:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caf-regimen,Synonym:,CDF
2020-09-18T04:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caf-regimen,Synonym:,cyclophosphamide/doxorubicin/fluorouracil
2020-09-18T04:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caf-regimen,Synonym:,cyclophosphamide-Adriamycin-fluorouracil regimen
2020-09-18T04:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caf-regimen,Synonym:,FAC
2020-09-18T04:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caf-regimen,Abbreviation:,CTX/DOX/5-FU
2020-09-18T04:56:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caffeine,Synonym:,methyltheobromine
2020-09-18T04:56:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caffeine,Synonym:,theine
2020-09-18T04:56:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caffeine,Abbreviation:,CAF
2020-09-18T04:56:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caffeine,Chemical structure:,"1,3,7-trimethylxanthine3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione"
2020-09-18T04:56:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caix-inhibitor-dtp348,Code name:,DTP348
2020-09-18T04:56:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caix-inhibitor-dtp348,Chemical structure:,2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethylsulfamide
2020-09-18T04:56:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Synonym:,calaspargase pegol
2020-09-18T04:56:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Synonym:,SC-PEG E. coli L-asparaginase
2020-09-18T04:56:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Synonym:,succinimidyl carbonate monomethoxypolyethylene glycol E. coli L-asparaginase
2020-09-18T04:56:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,US brand name:,Asparlas
2020-09-18T04:56:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Code name:,EZN-2285
2020-09-18T04:56:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcipotriene,Synonym:,calcipotriol
2020-09-18T04:56:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcipotriene,US brand name:,Dovonex
2020-09-18T04:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcitriol,Synonym:,"1,25-dihydroxycholecalciferol"
2020-09-18T04:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcitriol,US brand name:,Rocaltrol
2020-09-18T04:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcitriol,Abbreviation:,"1,25(OH)2-D3"
2020-09-18T04:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcitriol,Abbreviation:,CALTROL
2020-09-18T04:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcitriol,Chemical structure:,"(1alpha,3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol"
2020-09-18T04:56:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-aluminosilicate-anti-diarrheal,Abbreviation:,CASAD
2020-09-18T04:56:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-carbonate,Abbreviation:,CaCO3
2020-09-18T04:56:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-chloride,Synonym:,calcium chloride anhydrous
2020-09-18T04:56:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-chloride,Synonym:,calcium chloride dihydrate
2020-09-18T04:56:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-chloride,Synonym:,calcium chloride hexahydrate
2020-09-18T04:57:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate,Synonym:,Tricalcium Citrate
2020-09-18T04:57:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate,US brand name:,Citracal
2020-09-18T04:57:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate,Foreign brand name:,Acicontral
2020-09-18T04:57:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate,Abbreviation:,CALCIT
2020-09-18T04:57:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate,Chemical structure:,"2-Hydroxy-1,2,3-propanetricarboxylic Acid, Calcium Salt (2:3)"
2020-09-18T04:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-glucarate,Synonym:,antacidin
2020-09-18T04:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-glucarate,Synonym:,calcium D-glucarate
2020-09-18T04:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-glucarate,Synonym:,calcium D-saccharate
2020-09-18T04:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-glucarate,Synonym:,calcium saccharate
2020-09-18T04:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-glucarate,Synonym:,saccharated lime
2020-09-18T04:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-glucarate,Abbreviation:,CGT
2020-09-18T04:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-glucarate,Chemical structure:,"2,3,4,5-tetrahydroxy-1,6- dioxido-hexane-1,6-dione, calcium"
2020-09-18T04:57:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-gluconate,Synonym:,Calcium D-gluconate
2020-09-18T04:57:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-gluconate,Synonym:,Calglucon
2020-09-18T04:57:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-gluconate,Abbreviation:,CALGLUC
2020-09-18T04:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800239,Synonym:,CRAC inhibitor CM4620
2020-09-18T04:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800239,Synonym:,orai Ca2+ channel inhibitor CM4620
2020-09-18T04:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800239,Synonym:,orai1 inhibitor CM4620
2020-09-18T04:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800239,Code name:,CM 4620
2020-09-18T04:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800239,Code name:,CM4620
2020-09-18T04:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800239,Code name:,CM-4620
2020-09-18T04:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channels-inhibitor-rp4010,Synonym:,CRAC inhibitor RP4010
2020-09-18T04:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channels-inhibitor-rp4010,Code name:,RP 4010
2020-09-18T04:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channels-inhibitor-rp4010,Code name:,RP4010
2020-09-18T04:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channels-inhibitor-rp4010,Code name:,RP-4010
2020-09-18T04:57:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-41-chloride-aqueous-solution,NA,NA
2020-09-18T04:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-46-chloride-aqueous-solution,NA,NA
2020-09-18T04:57:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793192,Synonym:,CaSR agonist SK 1403
2020-09-18T04:57:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793192,Code name:,AJT-240
2020-09-18T04:57:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793192,Code name:,SK 1403
2020-09-18T04:57:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793192,Code name:,SK1403
2020-09-18T04:57:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calculus-bovis-moschus-olibanum-myrrha-capsule,Synonym:,wangbang pharmaceutical Xihuang capsule
2020-09-18T04:57:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calculus-bovis-moschus-olibanum-myrrha-capsule,Synonym:,Xihuang capsule
2020-09-18T04:57:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calculus-bovis-moschus-olibanum-myrrha-capsule,Abbreviation:,XHP
2020-09-18T04:57:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibuprofen-intravenous,US brand name:,Caldolor
2020-09-18T04:57:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/666847,Foreign brand name:,Homeodent
2020-09-18T04:58:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calfactant,US brand name:,Infasurf Intratracheal Suspension
2020-09-18T04:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,Synonym:,vitamin B12
2020-09-18T04:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Berubigen
2020-09-18T04:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Betalin 12
2020-09-18T04:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Calomist
2020-09-18T04:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Cobavite
2020-09-18T04:58:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797846,Synonym:,CALR exon 9 mutant peptide vaccine With Montanide ISA-51
2020-09-18T04:58:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797846,Synonym:,CALRLong36 peptide vaccine/Montanide ISA-51
2020-09-18T04:58:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calusterone,Synonym:,dimethyltestosterone
2020-09-18T04:58:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calusterone,US brand name:,Methosarb
2020-09-18T04:58:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calusterone,Code name:,"U-22,550"
2020-09-18T04:58:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-pbd-antibody-drug-conjugate-adct-301,Synonym:,ADC ADCT-301
2020-09-18T04:58:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-pbd-antibody-drug-conjugate-adct-301,Synonym:,anti-CD25-PBD antibody-drug conjugate ADCT-301
2020-09-18T04:58:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-pbd-antibody-drug-conjugate-adct-301,Code name:,ADCT-301
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,Synonym:,9-nitrocamptothecin
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,Synonym:,9-nitro-CPT
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,Synonym:,nitrocamptothecin
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,US brand name:,Camptogen
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,US brand name:,Orathecin
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,Abbreviation:,9-NC
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,Code name:,RFS 2000
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,Chemical structure:,9-nitro-20 (S-)camptothecin
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,Synonym:,camptothecin-11
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,Synonym:,irinotecan
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,Synonym:,irinotecan HCl
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,US brand name:,Camptosar
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,Foreign brand name:,Campto
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,Foreign brand name:,Irinomedac
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,Code name:,CPT-11
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,Code name:,U-101440E
2020-09-18T04:58:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camptothecin-analogue-tlc388,US brand name:,Lipotecan
2020-09-18T04:58:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camptothecin-analogue-tlc388,Foreign brand name:,Lipotecan
2020-09-18T04:58:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camptothecin-analogue-tlc388,Code name:,TLC388
2020-09-18T04:58:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camptothecin-20s-o-propionate-hydrate,Code name:,CZ48
2020-09-18T04:58:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-shr-1210,Synonym:,AiRuiKa
2020-09-18T04:58:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-shr-1210,Synonym:,carrizumab
2020-09-18T04:58:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-shr-1210,Code name:,HR-301210
2020-09-18T04:58:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-shr-1210,Code name:,SHR1210
2020-09-18T04:58:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-shr-1210,Code name:,SHR-1210
2020-09-18T04:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800676,Code name:,JNJ-24831754-ZAE
2020-09-18T04:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800676,Code name:,JNJ-28431754
2020-09-18T04:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800676,Code name:,JNJ-28431754-AAA
2020-09-18T04:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800676,Code name:,TA-7284
2020-09-18T04:58:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795723,US brand name:,Ilaris
2020-09-18T04:58:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795723,Code name:,ACZ885
2020-09-18T04:59:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canarypox-hil-12-melanoma-vaccine,Synonym:,ALVAC-hIL-12
2020-09-18T04:59:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canarypox-hil-12-melanoma-vaccine,Synonym:,ALVAC-hIL-12 melanoma vaccine
2020-09-18T04:59:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cancer-peptide-vaccine-s-588410,Code name:,S-588410
2020-09-18T04:59:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cancer-stemness-kinase-inhibitor-bbi503,Code name:,BBI503
2020-09-18T04:59:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caspofungin-acetate,US brand name:,Cancidas
2020-09-18T04:59:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caspofungin-acetate,Code name:,"L-743,873"
2020-09-18T04:59:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caspofungin-acetate,Code name:,MK-0991
2020-09-18T04:59:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candesartan-cilexetil,US brand name:,Atacand
2020-09-18T04:59:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candesartan-cilexetil,US brand name:,Biopress
2020-09-18T04:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792750,Synonym:,C. albicans test antigen injection
2020-09-18T04:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792750,Synonym:,Candida albicans skin test antigen
2020-09-18T04:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792750,US brand name:,Candin
2020-09-18T04:59:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792750,Synonym:,C. albicans test antigen injection
2020-09-18T04:59:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792750,Synonym:,Candida albicans skin test antigen
2020-09-18T04:59:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792750,US brand name:,Candin
2020-09-18T04:59:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsv-1-hf10,Synonym:,herpes simplex virus type 1 HF10
2020-09-18T04:59:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsv-1-hf10,Code name:,HF10
2020-09-18T04:59:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsv-1-hf10,Code name:,Msc 2
2020-09-18T04:59:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsv-1-hf10,Code name:,TBI-1401
2020-09-18T04:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canertinib-dihydrochloride,Synonym:,CI-1033/PD183805
2020-09-18T04:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canertinib-dihydrochloride,Code name:,CI-1033
2020-09-18T04:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canertinib-dihydrochloride,Code name:,PD183805
2020-09-18T04:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canertinib-dihydrochloride,Chemical structure:,N-[-4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamideN-[-4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide Dihydrochloride
2020-09-18T04:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canfosfamide-hydrochloride,US brand name:,TELCYTA
2020-09-18T04:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canfosfamide-hydrochloride,Code name:,TLK286
2020-09-18T04:59:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabis-extract-oil-sr-capsule,Synonym:,Cannabis SR capsule
2020-09-18T04:59:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabis-extract-oil-sr-capsule,US brand name:,Cannabics SR
2020-09-18T04:59:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabis-extract-oil-sr-capsule,US brand name:,Cannabics SR capsules
2020-09-18T05:00:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabis-extract-oil-sr-capsule,Synonym:,Cannabis SR capsule
2020-09-18T05:00:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabis-extract-oil-sr-capsule,US brand name:,Cannabics SR
2020-09-18T05:00:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabis-extract-oil-sr-capsule,US brand name:,Cannabics SR capsules
2020-09-18T05:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol,Synonym:,CBD oil
2020-09-18T05:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol,US brand name:,Epidiolex
2020-09-18T05:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol,Abbreviation:,CBD
2020-09-18T05:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol,Code name:,GWP42003-P
2020-09-18T05:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol,Chemical structure:,"1,3-benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-"
2020-09-18T05:00:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801683,Synonym:,synthetic CBD PPP011
2020-09-18T05:00:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801683,Foreign brand name:,Caumz
2020-09-18T05:00:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801683,Foreign brand name:,Caumz
2020-09-18T05:00:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801683,Code name:,PPP 011
2020-09-18T05:00:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801683,Code name:,PPP011
2020-09-18T05:00:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801683,Code name:,PPP-011
2020-09-18T05:00:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabinol,Chemical structure:,"3-amyl-1-hydroxy-6,6,9-trimethyl-6H-dibenzo(b,d)pyran"
2020-09-18T05:00:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabis-extract-oil-sr-capsule,Synonym:,Cannabis SR capsule
2020-09-18T05:00:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabis-extract-oil-sr-capsule,US brand name:,Cannabics SR
2020-09-18T05:00:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabis-extract-oil-sr-capsule,US brand name:,Cannabics SR capsules
2020-09-18T05:00:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797919,Code name:,TRX E 002 1
2020-09-18T05:00:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797919,Code name:,TRXE0021
2020-09-18T05:00:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797919,Code name:,TRX-E-002-1
2020-09-18T05:00:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797919,Chemical structure:,"cis-4-(para-hydroxyphenyl)-7,4′-dihydroxy-3′,5′-dimethoxy-8-methylisoflavan"
2020-09-18T05:00:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cantuzumab-ravtansine,Synonym:,maytansinoid DM4-conjugated humanized monoclonal antibody huC242
2020-09-18T05:00:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cantuzumab-ravtansine,Code name:,HuC242-DM4
2020-09-18T05:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797148,Synonym:,CBC 80/20 binder ABX-464
2020-09-18T05:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797148,Synonym:,Rev inhibitor ABX-464
2020-09-18T05:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797148,Code name:,ABX 464
2020-09-18T05:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797148,Code name:,ABX464
2020-09-18T05:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797148,Code name:,ABX-464
2020-09-18T05:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797148,Chemical structure:,8-chloro-N-(4-(trifluoromethoxy)phenyl)quinolin-2-amine
2020-09-18T05:00:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine,US brand name:,Xeloda
2020-09-18T05:00:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine,Abbreviation:,CAPE
2020-09-18T05:00:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine,Code name:,Ro 09-1978/000
2020-09-18T05:00:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine,Chemical structure:,5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-cytidine
2020-09-18T05:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine-rapidly-disintegrating-tablet,Synonym:,capecitabine RDT
2020-09-18T05:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine-methotrexate-vinorelbine-regimen,Synonym:,capecitabine-methotrexate-vinorelbine regimen
2020-09-18T05:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine-methotrexate-vinorelbine-regimen,Synonym:,Xeloda/methotrexate/navelbine regimen
2020-09-18T05:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine-methotrexate-vinorelbine-regimen,Synonym:,Xeloda-methotrexate-navelbine regimen
2020-09-18T05:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine-methotrexate-vinorelbine-regimen,Synonym:,XMV regimen
2020-09-18T05:01:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogen-receptor-agonist-gtx-758,US brand name:,Capesaris
2020-09-18T05:01:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogen-receptor-agonist-gtx-758,Code name:,GTx-758
2020-09-18T05:01:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/supersaturated-calcium-phosphate-rinse,US brand name:,Caphosol
2020-09-18T05:01:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/supersaturated-calcium-phosphate-rinse,Foreign brand name:,Caphosol
2020-09-18T05:01:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-azd5363,Synonym:,Akt inhibitor AZD5363
2020-09-18T05:01:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-azd5363,Code name:,AZD5363
2020-09-18T05:01:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Synonym:,caplacizumab
2020-09-18T05:01:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,US brand name:,Cablivi
2020-09-18T05:01:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Code name:,ALX 0081
2020-09-18T05:01:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Code name:,ALX 0681
2020-09-18T05:01:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Code name:,ALX0081
2020-09-18T05:01:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Code name:,ALX-0081
2020-09-18T05:01:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Code name:,ALX0681
2020-09-18T05:01:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capmatinib,US brand name:,Tabrecta
2020-09-18T05:01:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capmatinib,Code name:,NVP-INC280-AAA
2020-09-18T05:01:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/captopril,US brand name:,Capoten
2020-09-18T05:01:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/captopril,Abbreviation:,CPT
2020-09-18T05:01:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/captopril,Chemical structure:,(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline
2020-09-18T05:01:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capox-regimen,Synonym:,capecitabine-oxaliplatin regimen
2020-09-18T05:01:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capox-regimen,Synonym:,CAPEOX regimen
2020-09-18T05:01:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vandetanib,US brand name:,Caprelsa
2020-09-18T05:01:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vandetanib,Code name:,AZD6474
2020-09-18T05:01:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vandetanib,Code name:,ZD6474
2020-09-18T05:05:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-ac0010,Synonym:,14C-labeled AC0010
2020-09-18T05:01:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-hydrochloride-sulfobutyl-ether-beta-cyclodextrin-complex,US brand name:,Captisol-enabled Melphalan IV
2020-09-18T05:01:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/captopril,US brand name:,Capoten
2020-09-18T05:01:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/captopril,Abbreviation:,CPT
2020-09-18T05:01:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/captopril,Chemical structure:,(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Synonym:,Timazin
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Synonym:,topical 5-fluorouracil
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Carac
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Efudex
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Fluoroplex
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Tolak
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Actino-Hermal
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Arumel
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Cytosafe
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Efurix
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Fiverocil
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Flurox
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Abbreviation:,5-FU topical
2020-09-18T05:02:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caracemide,Chemical structure:,"acetamide, N-[(methylamino)carbonyl]-N-[[(methylamino)carbonyl]oxy]-(9CI)N-acetyl-N-(methylcarbamoyloxy)-N'-methylurea"
2020-09-18T05:02:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbamazepine,US brand name:,Epitol
2020-09-18T05:02:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbamazepine,US brand name:,Tegretol
2020-09-18T05:02:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbamazepine,Chemical structure:,"5H-Dibenz(b,f)azepine-5-carboxamide"
2020-09-18T05:02:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793473,Synonym:,carbidopa levodopa
2020-09-18T05:02:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793473,Synonym:,carbidopa-levodopa
2020-09-18T05:02:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793473,US brand name:,Sinemet
2020-09-18T05:02:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepivacaine-hydrochloride,US brand name:,Carbocaine
2020-09-18T05:02:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepivacaine-hydrochloride,US brand name:,Polocaine
2020-09-18T05:02:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepivacaine-hydrochloride,Chemical structure:,"1-methyl-2',6'-pipecoloxylidide hydrochloride (SY), (1-methyl-DL-piperidine-2-carboxylic acid)-2,6-dimethylanilide hydrochloride"
2020-09-18T05:02:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbogen,Abbreviation:,UN1014
2020-09-18T05:02:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbohydrate-supplement-drink,Synonym:,carbohydrate drink
2020-09-18T05:02:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-alpha-methyltryptophan,Synonym:,11C-alpha-methyltryptophan
2020-09-18T05:02:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-alpha-methyltryptophan,Synonym:,α-[11C]methyl-L-tryptophan
2020-09-18T05:02:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-alpha-methyltryptophan,Abbreviation:,[11C] AMT
2020-09-18T05:02:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-alpha-methyltryptophan,Abbreviation:,11C-AMT
2020-09-18T05:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-choline,Synonym:,11C-choline
2020-09-18T05:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-choline,Synonym:,C11 choline
2020-09-18T05:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-choline,Synonym:,C-11 choline
2020-09-18T05:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-choline,Chemical structure:,"Ethanaminium, 2-hydroxy-N,N-dimethyl-N-(methyl-11C)-"
2020-09-18T05:02:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-erlotinib-hydrochloride,Synonym:,C11-erlotinib
2020-09-18T05:02:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-glutamine,Synonym:,[11C]-glutamine
2020-09-18T05:02:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-glutamine,Synonym:,11C-Gln
2020-09-18T05:02:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-glutamine,Synonym:,11C-glutamine
2020-09-18T05:03:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797648,Synonym:,[11C]martinostat
2020-09-18T05:03:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797648,Synonym:,martinostat C-11
2020-09-18T05:03:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-metformin,Synonym:,[11C]-metformin
2020-09-18T05:03:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-metformin,Synonym:,11C-metformin
2020-09-18T05:03:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-metformin,Synonym:,carbon-11 metformin
2020-09-18T05:03:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-n-desmethyl-loperamide,Synonym:,carbon C 11 loperamide hydrochloride
2020-09-18T05:03:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-n-desmethyl-loperamide,Abbreviation:,(11C)dLop
2020-09-18T05:03:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-n-desmethyl-loperamide,Chemical structure:,(11C)N-desmethyl-loperamide
2020-09-18T05:03:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-pbr-28,Synonym:,(11C)PBR-28
2020-09-18T05:03:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-pbr-28,Synonym:,[11C] PBR28
2020-09-18T05:03:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-pbr-28,Chemical structure:,"acetamide, N-((2-(methoxy-11C)-phenyl)methyl)-N-(6-phenoxy-3-pyridinyl)-"
2020-09-18T05:03:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-sarcosine,Synonym:,11C-labeled sarcosine
2020-09-18T05:03:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-sarcosine,Synonym:,11C-sarcosine
2020-09-18T05:03:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-sepantronium-bromide,Synonym:,11C-YM155
2020-09-18T05:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-temozolomide,Synonym:,[11C] temozolomide
2020-09-18T05:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-temozolomide,Synonym:,Carbon C11 Temozolomide
2020-09-18T05:03:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792629,Synonym:,11C-JNJ-63779586
2020-09-18T05:03:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795702,Synonym:,[11C] osimertinib
2020-09-18T05:03:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795702,Synonym:,[11C]AZD9291
2020-09-18T05:03:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795702,Synonym:,11C-osimertinib
2020-09-18T05:03:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-acetate,Synonym:,"1,2-13C acetate"
2020-09-18T05:03:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-acetate,Synonym:,2-13C acetate
2020-09-18T05:03:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-dextromethorphan,Synonym:,Carbon C-13 Dextromethorphan
2020-09-18T05:03:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-dextromethorphan,Abbreviation:,[(13)C]-DM
2020-09-18T05:03:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-dextromethorphan,Abbreviation:,13C-dextromethorphan
2020-09-18T05:03:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-idasanutlin,Synonym:,[13C]-radiolabeled idasanutlin
2020-09-18T05:03:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-idasanutlin,Synonym:,C13 idasanutlin
2020-09-18T05:04:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-lycopene,Abbreviation:,13C-lycopene
2020-09-18T05:04:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-octanoate,Synonym:,[13C] octanoate
2020-09-18T05:04:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-octanoate,Synonym:,13C-octanoate
2020-09-18T05:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-phytoene,Synonym:,13C-phytoene
2020-09-18T05:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-phytoene,Abbreviation:,13C-PE
2020-09-18T05:04:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-phytofluene,Synonym:,13C-phytofluene
2020-09-18T05:04:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-phytofluene,Abbreviation:,C13-PF
2020-09-18T05:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-nitrogen-n-15-labeled-valine,Synonym:,C13 N15 valine
2020-09-18T05:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-nitrogen-n-15-labeled-valine,Synonym:,carbonomic
2020-09-18T05:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-nitrogen-n-15-labeled-valine,Chemical structure:,"(+)-2-amino-3-methylbutyric Acid-13C5,15N (SY); L-valine-13C5,15N (SY); L-2-amino-3-methylbutanoic acid-13C5,15N"
2020-09-18T05:04:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-anlotinib-hydrochloride,Synonym:,[14C] anlotinib hydrochloride
2020-09-18T05:04:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-anlotinib-hydrochloride,Synonym:,14C-labeled anlotinib hydrochloride
2020-09-18T05:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-dacomitinib,Synonym:,[14C]PF-00299804
2020-09-18T05:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-dacomitinib,Synonym:,carbon C 14 PF-00299804
2020-09-18T05:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-dacomitinib,Synonym:,carbon C-14 dacomitinib
2020-09-18T05:04:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-eribulin-acetate,Synonym:,14C-eribulin acetate
2020-09-18T05:04:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-gilteritinib,Synonym:,[14C] ASP2215
2020-09-18T05:04:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-gilteritinib,Synonym:,14C-labeled gilteritinib
2020-09-18T05:04:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-idasanutlin-index-term-drug-agent,Synonym:,[14C]-radiolabeled idasanutlin
2020-09-18T05:04:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-idasanutlin-index-term-drug-agent,Synonym:,C14 idasanutlin
2020-09-18T05:04:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-ombrabulin,Abbreviation:,[14C]-AVE8062
2020-09-18T05:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-oxaliplatin,Abbreviation:,[14C] oxaliplatin
2020-09-18T05:05:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792532,Synonym:,[14 C]-pevonedistat
2020-09-18T05:05:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792532,Synonym:,carbon C 14-pevonedistat
2020-09-18T05:05:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-roniciclib,Synonym:,[14C]-BAY1000394
2020-09-18T05:05:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-roniciclib,Abbreviation:,[14C]-roniciclib
2020-09-18T05:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-selumetinib,Abbreviation:,[14C] selumetinib
2020-09-18T05:05:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-telotristat-etiprate,Synonym:,[14C]-LX1606
2020-09-18T05:05:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-telotristat-etiprate,Synonym:,[14C]-telotristat etiprate
2020-09-18T05:05:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-telotristat-etiprate,Synonym:,14C-telotristat etiprate
2020-09-18T05:05:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-vemurafenib,Synonym:,14 C-labeled vemurafenib
2020-09-18T05:05:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-ac0010,Synonym:,[14C] AC0010
2020-09-18T05:05:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-ac0010,Synonym:,14C-AC0010
2020-09-18T05:05:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-labeled-ixazomib,Synonym:,[14C]-ixazomib
2020-09-18T05:05:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-labeled-ixazomib,Synonym:,[14C]-MLN9708
2020-09-18T05:05:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-labeled-ixazomib,Chemical structure:,"[14C]--1, 4-(R,S)-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid"
2020-09-18T05:05:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801792,Synonym:,[14C]-pamiparib
2020-09-18T05:05:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801792,Synonym:,14C-pamiparib
2020-09-18T05:05:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794993,Synonym:,[14 C]-TAK-659
2020-09-18T05:05:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794993,Synonym:,[14C]TAK 659
2020-09-18T05:05:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794993,Synonym:,[14C]TAK659
2020-09-18T05:05:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794993,Synonym:,[14C]TAK-659
2020-09-18T05:05:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-egfr-inhibitor-asp8273,Synonym:,[14C] EGFR inhibitor ASP8273
2020-09-18T05:05:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-egfr-inhibitor-asp8273,Synonym:,[14C]ASP8273
2020-09-18T05:05:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-egfr-inhibitor-asp8273,Synonym:,14C ASP8273
2020-09-18T05:05:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-egfr-inhibitor-asp8273,Synonym:,14C EGFR inhibitor ASP8273
2020-09-18T05:05:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-lenvatinib-mesylate,Synonym:,14C lenvatinib mesylate
2020-09-18T05:05:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-lenvatinib-mesylate,Synonym:,14C-lenvatinib mesylate
2020-09-18T05:05:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-lenvatinib-mesylate,Abbreviation:,14C-E7080
2020-09-18T05:06:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-nanoparticle-based-formulation,Synonym:,carbon nanoparticles
2020-09-18T05:06:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-nanoparticle-based-formulation,Abbreviation:,CNP
2020-09-18T05:06:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-11-acetate,NA,NA
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Synonym:,Carboplatin Hexal
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Synonym:,Carboplatino
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Blastocarb
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Carboplat
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Carbosin
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Carbosol
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Carbotec
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Displata
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Ercar
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Nealorin
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Novoplatinum
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Paraplatin AQ
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Paraplatine
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Platinwas
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Ribocarbo
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Abbreviation:,CBDCA
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Code name:,JM-8
2020-09-18T05:06:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-taxol-regimen,Synonym:,carboplatin-paclitaxel regimen
2020-09-18T05:06:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-taxol-regimen,Synonym:,carbo-Tax regimen
2020-09-18T05:06:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-taxol-regimen,Synonym:,CaT regimen
2020-09-18T05:06:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-taxol-regimen,Synonym:,PC regimen
2020-09-18T05:06:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-taxol-bevacizumab-regimen,Synonym:,carboplatin-paclitaxel-bevacizumab regimen
2020-09-18T05:06:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole,Synonym:,carboxyamido-triazole
2020-09-18T05:06:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole,Synonym:,carboxyaminoimidazole
2020-09-18T05:06:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole,Abbreviation:,CAI
2020-09-18T05:06:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole,Code name:,L651582
2020-09-18T05:06:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole,Chemical structure:,"1H-1,2,3-Triazole-4-carboxamide, 5-amino-1-((3,5-dichloro-4(4-chlorobenzoyl)phenyl)methyl)5-Amino-1-((3,5-dichloro-4-(4-chlorobenzoyl)phenyl)methyl)-1H-1,2,3-triazole-4-carboxamide"
2020-09-18T05:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole-orotate,Abbreviation:,CTO
2020-09-18T05:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole-orotate,Chemical structure:,"1,2,3-carboxyamido-triazole orotate"
2020-09-18T05:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxylesterase-expressing-allogeneic-neural-stem-cells,Synonym:,CE-secreting allogeneic NSCs
2020-09-18T05:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxylesterase-expressing-allogeneic-neural-stem-cells,Abbreviation:,hCE1m6-NSC
2020-09-18T05:06:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyphenyl-retinamide,Synonym:,RII
2020-09-18T05:06:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyphenyl-retinamide,Chemical structure:,4-carboxyphenyl retinamideN-(4-carboxyphenyl)retinamide
2020-09-18T05:06:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbutamide,Chemical structure:,1-(4-aminophenyl)sulfonyl-3-butylurea
2020-09-18T05:06:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1,Synonym:,CAP-1
2020-09-18T05:06:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1,Synonym:,Carcinoembryonic Antigen Peptide-1
2020-09-18T05:06:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1,Synonym:,Carcinoembryonic Peptide-1
2020-09-18T05:06:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1,Synonym:,CEA Peptide 1
2020-09-18T05:06:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1,Synonym:,CEA Peptide 9-mer
2020-09-18T05:07:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1-6d,Synonym:,CEA:571-579 (576D)
2020-09-18T05:07:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1-6d,Synonym:,mCEA Peptide
2020-09-18T05:07:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1-6d,Synonym:,Modified CEA Peptide
2020-09-18T05:07:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1-6d,Abbreviation:,CAP-1-6D peptide
2020-09-18T05:07:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1-6d,Abbreviation:,CEA PEP 1-6D
2020-09-18T05:07:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1-6d-virus-like-replicon-particles-vaccine,Abbreviation:,CEA(6D) VRP vaccine
2020-09-18T05:07:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-rna-pulsed-dc-cancer-vaccine,Synonym:,carcinoembryonic antigen RNA-pulsed dendritic cell cancer vaccine
2020-09-18T05:07:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-rna-pulsed-dc-cancer-vaccine,Synonym:,CEA RNA-pulsed DC cancer vaccine
2020-09-18T05:07:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-rna-pulsed-dc-cancer-vaccine,Synonym:,CEA RNA-pulsed dendritic cell cancer vaccine
2020-09-18T05:07:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-rna-pulsed-dc-cancer-vaccine,Abbreviation:,CEARNAVAC
2020-09-18T05:07:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-expressing-measles-virus,Abbreviation:,MV-CEA
2020-09-18T05:07:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tc-99m-sestamibi,Synonym:,technetium 99m sestamibi
2020-09-18T05:07:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tc-99m-sestamibi,Synonym:,technetium Tc 99m sestamibi
2020-09-18T05:07:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tc-99m-sestamibi,US brand name:,Cardiolite
2020-09-18T05:07:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tc-99m-sestamibi,US brand name:,Miraluma
2020-09-18T05:07:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tc-99m-sestamibi,Abbreviation:,Tc-99m MIBI
2020-09-18T05:07:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diltiazem-hydrochloride,Synonym:,diltiazem HCl
2020-09-18T05:07:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diltiazem-hydrochloride,US brand name:,Cardizem
2020-09-18T05:07:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxazosin-mesylate,US brand name:,Cardura
2020-09-18T05:07:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carfilzomib,US brand name:,Kyprolis
2020-09-18T05:07:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carfilzomib,Code name:,PR-171
2020-09-18T05:07:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carfilzomib,Chemical structure:,(2S)-N-((1S)-1-benzyl-2-(((1S)-3-methyl-1-(((2R)-2-methyloxiran-2-yl)carbonyl)butyl)amino)-2-oxoethyl)-4-methyl-2-(((2S)-2-((morpholin-4-ylacetyl)amino)-4-phenylbutanoyl)amino)pentanamide
2020-09-18T05:07:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caricotamide-tretazicar,US brand name:,Prolarix
2020-09-18T05:07:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caricotamide-tretazicar,Code name:,EP-0152R/CB1954
2020-09-18T05:07:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caricotamide-tretazicar,Chemical structure:,"1-carbamoylmethyl-3-carbamoyl-1,4-dihydropyridine/5-(aziridin-1-yl)-2,4-dinitrobenzamide"
2020-09-18T05:07:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carlumab,Synonym:,anti-CCL2 human monoclonal antibody CNTO 888
2020-09-18T05:07:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carlumab,Code name:,CNTO 888
2020-09-18T05:07:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Synonym:,bis(chloroethyl) nitrosourea
2020-09-18T05:07:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Synonym:,bis-chloronitrosourea
2020-09-18T05:07:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Synonym:,carmustin
2020-09-18T05:07:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,US brand name:,BiCNU
2020-09-18T05:07:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Foreign brand name:,Becenun
2020-09-18T05:07:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Foreign brand name:,Carmustinum
2020-09-18T05:07:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Foreign brand name:,Nitrourean
2020-09-18T05:07:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Foreign brand name:,Nitrumon
2020-09-18T05:07:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Abbreviation:,BCNU
2020-09-18T05:07:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Code name:,FDA 0345
2020-09-18T05:07:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Code name:,SK 27702
2020-09-18T05:07:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Code name:,SRI 1720
2020-09-18T05:07:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Code name:,WR-139021
2020-09-18T05:07:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Chemical structure:,"1,3-bis(2-chloroethyl)-1-nitrosourea1,3-bis(beta-chloroethyl)-1-nitrosoureaN,N'-bis(2-chloroethyl)-N-nitrosourea"
2020-09-18T05:15:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799135,Code name:,BEY-A
2020-09-18T05:08:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine-implant,Synonym:,polifeprosan 20 with carmustine implant
2020-09-18T05:08:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine-implant,US brand name:,Gliadel Wafer
2020-09-18T05:08:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine-sustained-release-implant-wafer,Foreign brand name:,CASANT wafer
2020-09-18T05:08:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levocarnitine,Synonym:,L-carnitine
2020-09-18T05:08:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levocarnitine,US brand name:,Carnitor
2020-09-18T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine,Synonym:,(2S)-2-[(3-amino-1-oxopropyl)Amino]-3-(3H-imidazol-4-Yl)propanoic acid
2020-09-18T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine,Synonym:,beta-alanylhistidine
2020-09-18T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine,Synonym:,beta-alanyl-L-histidine
2020-09-18T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine,Synonym:,L-carnosine
2020-09-18T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine,Synonym:,"L-histidine, beta-alanyl-"
2020-09-18T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine,Synonym:,"L-histidine, N-beta-alanyl-"
2020-09-18T05:08:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799646,Synonym:,oral mucoadhesive tablet
2020-09-18T05:08:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799646,Foreign brand name:,Aqualief
2020-09-18T05:08:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-endoglin-monoclonal-antibody-trc105,Code name:,TRC105
2020-09-18T05:08:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carrageenan-containing-gel,US brand name:,Divine 9 with Carragel
2020-09-18T05:08:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801877,Synonym:,biotechspiramycin
2020-09-18T05:08:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801877,Synonym:,shengjimycin
2020-09-18T05:08:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801877,Foreign brand name:,Bite
2020-09-18T05:08:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carrot-ji-lin-ginseng-licorice-root-tangerine-peel-soy-beverage,Foreign brand name:,Nutriall
2020-09-18T05:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793448,Synonym:,AMG 119 CAR-T cells
2020-09-18T05:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793448,Code name:,AMG 119
2020-09-18T05:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793448,Code name:,AMG119
2020-09-18T05:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793448,Code name:,AMG-119
2020-09-18T05:08:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage,US brand name:,Benefin
2020-09-18T05:08:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage,US brand name:,Cartilade
2020-09-18T05:08:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carubicin,Synonym:,carminomycin
2020-09-18T05:08:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carubicin,Synonym:,carminomycin I
2020-09-18T05:08:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carubicin,Synonym:,Demethyldaunomycin
2020-09-18T05:08:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carubicin,Synonym:,Karminomitsin
2020-09-18T05:08:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carubicin,Synonym:,karminomycin
2020-09-18T05:08:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carubicin,Abbreviation:,CMM
2020-09-18T05:09:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carvedilol,US brand name:,Coreg
2020-09-18T05:09:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carvedilol-phosphate-extended-release-capsule,US brand name:,Coreg CR
2020-09-18T05:09:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/770796,US brand name:,Nutrison
2020-09-18T05:09:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caseinate-protein-isolate,NA,NA
2020-09-18T05:09:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bicalutamide,US brand name:,Casodex
2020-09-18T05:09:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bicalutamide,Foreign brand name:,Cosudex
2020-09-18T05:09:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bicalutamide,Abbreviation:,CDX
2020-09-18T05:09:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bicalutamide,Code name:,"ICI 176,334"
2020-09-18T05:09:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/casopitant-mesylate,Code name:,GW679769
2020-09-18T05:09:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caspofungin-acetate,US brand name:,Cancidas
2020-09-18T05:09:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caspofungin-acetate,Code name:,"L-743,873"
2020-09-18T05:09:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caspofungin-acetate,Code name:,MK-0991
2020-09-18T05:09:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clonidine-hydrochloride,US brand name:,Catapres
2020-09-18T05:09:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cathepsin-activatable-cy5-fluorescent-imaging-probe-lum015,Code name:,LUM015
2020-09-18T05:09:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800448,Synonym:,fluorescently quenched protease substrate probe 6QC-ICG
2020-09-18T05:09:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800448,Code name:,6QC ICG
2020-09-18T05:09:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800448,Code name:,6QCICG
2020-09-18T05:09:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800448,Code name:,6QC-ICG
2020-09-18T05:09:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cationic-liposome-encapsulated-paclitaxel,Foreign brand name:,EndoTAG-1
2020-09-18T05:09:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cationic-liposome-encapsulated-paclitaxel,Foreign brand name:,LipoPac
2020-09-18T05:09:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cationic-liposome-encapsulated-paclitaxel,Code name:,MBT-0206
2020-09-18T05:10:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/catumaxomab,Foreign brand name:,Removab
2020-09-18T05:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,US brand name:,Cavatak
2020-09-18T05:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,Foreign brand name:,Cavatak
2020-09-18T05:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,Abbreviation:,CVA21
2020-09-18T05:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,Code name:,V 937
2020-09-18T05:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,Code name:,V937
2020-09-18T05:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,Code name:,V-937
2020-09-18T05:10:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cb10-277,Chemical structure:,"1-p-carboxy-3,3-dimethylphenyltriazine"
2020-09-18T05:10:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cbp-beta-catenin-antagonist-pri-724,Synonym:,Wnt signaling pathway inhibitor PRI-724
2020-09-18T05:10:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cbp-beta-catenin-antagonist-pri-724,Code name:,PRI-724
2020-09-18T05:10:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793902,Code name:,E 7386
2020-09-18T05:10:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793902,Code name:,E7386
2020-09-18T05:10:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdr-modulator-cbt-1,US brand name:,CBT-1
2020-09-18T05:10:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cc-1088,NA,NA
2020-09-18T05:10:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cc-401,NA,NA
2020-09-18T05:10:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cc-8490,Code name:,SPC8490
2020-09-18T05:10:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccl21-expressing-h1944-cell-vaccine,Synonym:,recombinant human 6C cytokine-expressing H1944 cell vaccine
2020-09-18T05:10:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr2-antagonist-ccx872-b,Code name:,CCX872-B
2020-09-18T05:11:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr2-antagonist-pf-04136309,Code name:,PF-04136309
2020-09-18T05:11:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr2-ccr5-antagonist-bms-813160,Code name:,BMS-813160
2020-09-18T05:11:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr2-ccr5-antagonist-bms-813160,Chemical structure:,"(S)-1-[(1S,2R,4R)-4-isopropyl(methyl)amino)-2-propylcyclohexyl]-3-(6 (trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-2-one"
2020-09-18T05:11:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796771,Code name:,FLX 475
2020-09-18T05:11:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796771,Code name:,FLX475
2020-09-18T05:11:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796771,Code name:,FLX-475
2020-09-18T05:11:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd105-yb-1-sox2-cdh3-mdm2-polypeptide-plasmid-dna-vaccine,Synonym:,CD105/Yb-1/SOX2/CDH3/MDM2 plasmid vaccine
2020-09-18T05:11:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd105-yb-1-sox2-cdh3-mdm2-polypeptide-plasmid-dna-vaccine,Synonym:,STEMVAC Th1 polyepitope plasmid-based vaccine
2020-09-18T05:11:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd105-yb-1-sox2-cdh3-mdm2-polypeptide-plasmid-dna-vaccine,Code name:,STEMVAC
2020-09-18T05:11:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799988,Synonym:,integrin alpha-M agonist GB1275
2020-09-18T05:11:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799988,Synonym:,integrin CD11b agonist GB1275
2020-09-18T05:11:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799988,Code name:,GB 1275
2020-09-18T05:11:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799988,Code name:,GB1275
2020-09-18T05:11:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799988,Code name:,GB-1275
2020-09-18T05:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802178,Synonym:,123b-33bcCAR-T cells
2020-09-18T05:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802178,Synonym:,CD123/CD33-expressing compound CAR-T cells
2020-09-18T05:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802178,Synonym:,CD123-CD33 cCAR T cells
2020-09-18T05:11:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd133-antigen-peptide-pulsed-autologous-dendritic-cell-vaccine,Synonym:,CD133 DC vaccine
2020-09-18T05:11:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd133-antigen-peptide-pulsed-autologous-dendritic-cell-vaccine,Synonym:,CD-133 dendritic cell vaccine
2020-09-18T05:11:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793585,Synonym:,CD137L/Epstein-Barr virus-targeting autologous DC vaccine
2020-09-18T05:11:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793585,Synonym:,CD137L-DC-EBV-VAX
2020-09-18T05:11:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd138car-cd137-tcrzeta-expressing-t-lymphocytes,Synonym:,CART-138 TCR zeta:CD137
2020-09-18T05:11:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793158,Synonym:,CD16/IL-15/CD33 161533 tri-specific killer engagers
2020-09-18T05:11:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793158,Synonym:,CD16/IL15/CD33 TriKE
2020-09-18T05:11:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793158,Code name:,161533
2020-09-18T05:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19-cd3-dual-affinity-retargeting-protein-jnj-64052781,Synonym:,CD19 x CD3 DART protein JNJ-64052781
2020-09-18T05:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19-cd3-dual-affinity-retargeting-protein-jnj-64052781,Code name:,JNJ-64052781
2020-09-18T05:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-lymphocytes,Synonym:,CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
2020-09-18T05:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-lymphocytes,Synonym:,CD19-CAR-specific/truncated EGFR lentiviral vector-transduced T cells
2020-09-18T05:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-lymphocytes,Synonym:,CD19R(EQ)28zeta/EGFRt+ TCM
2020-09-18T05:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-lymphocytes,Synonym:,CD19R(EQ)28zeta/truncated human EGFR+ central memory T cells
2020-09-18T05:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-lymphocytes,Synonym:,CD19R:CD28:lentiviral/EGFRt+ T cells
2020-09-18T05:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794795,Code name:,CPXPOM
2020-09-18T05:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tn-mem-enriched-t-lymphocytes,Synonym:,CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T cells
2020-09-18T05:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tn-mem-enriched-t-lymphocytes,Synonym:,CD19R(EQ)28zeta/EGFRt+ naive and memory T cells
2020-09-18T05:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tn-mem-enriched-t-lymphocytes,Synonym:,CD19R(EQ)28zetaEGFRt+ Tn/mem cells
2020-09-18T05:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tn-mem-enriched-t-lymphocytes,Synonym:,CD19R(EQ)28zetaEGFRt+ Tn/Tmem
2020-09-18T05:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28zeta-4-1bb-expressing-allogeneic-t-lymphocytes,Synonym:,allogeneic CD19.CAR/28137zeta T-lymphocytes
2020-09-18T05:12:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd3zeta-4-1bb-cd28-expressing-autologous-t-lymphocytes,NA,NA
2020-09-18T05:12:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd3zeta-4-1bb-expressing-allogeneic-t-lymphocytes,Acronym:,CART-19 cells
2020-09-18T05:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd3zeta-expressing-autologous-t-lymphocytes,Synonym:,aCD19z T cells
2020-09-18T05:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd3zeta-expressing-autologous-t-lymphocytes,Synonym:,autologousCART-19:TCR cells
2020-09-18T05:12:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800608,Synonym:,CD19-4-1BBL RO7227166
2020-09-18T05:12:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800608,Code name:,RO 7227166
2020-09-18T05:12:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800608,Code name:,RO7227166
2020-09-18T05:12:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800608,Code name:,RO-7227166
2020-09-18T05:12:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802177,Synonym:,CD19/CD20-expressing compound CAR-T cells
2020-09-18T05:12:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802177,Synonym:,CD20-CD19 cCAR T cells
2020-09-18T05:12:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802177,Synonym:,CD20-CD19 cCAR-T cells
2020-09-18T05:12:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd20-targeted-polypeptide-tru-015,Code name:,TRU-015
2020-09-18T05:12:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801521,Synonym:,anti-CD22 immunotoxin
2020-09-18T05:12:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd24-extracellular-domain-igg1-fc-domain-recombinant-fusion-protein-cd24fc,Abbreviation:,CD24Fc
2020-09-18T05:12:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd24-extracellular-domain-igg1-fc-domain-recombinant-fusion-protein-cd24fc,Abbreviation:,CD24Fc CD24IgG
2020-09-18T05:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800691,Synonym:,ICOSL vIgD-Fc
2020-09-18T05:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800691,Code name:,ALPN 101
2020-09-18T05:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800691,Code name:,ALPN101
2020-09-18T05:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800691,Code name:,ALPN-101
2020-09-18T05:13:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd28car-cd137car-expressing-t-lymphocytes,NA,NA
2020-09-18T05:13:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd3-cd28-costimulated-vaccine-primed-autologous-t-cells,NA,NA
2020-09-18T05:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798991,Synonym:,CD3+ and CD19+ cell-depleted allogeneic PBSCs derived from an unrelated or partially matched donor
2020-09-18T05:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798991,Synonym:,CD3+ T-cell-depleted/CD19+ B-cell-depleted unrelated or partially matched donor-derived allogeneic peripheral blood stem cells
2020-09-18T05:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798991,Synonym:,CD3+/CD19+ cell-depleted unrelated or partially matched donor-derived allogeneic PBSCs
2020-09-18T05:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd30-car-expressing-autologous-t-lymphocytes,Synonym:,CAR.CD30-expressing autologous T lymphocytes
2020-09-18T05:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd30-car-expressing-autologous-t-lymphocytes,Synonym:,ICAR30 T cells
2020-09-18T05:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,Synonym:,anti-CD33 TCR zeta:CD137 CAR T cells
2020-09-18T05:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,Synonym:,CART33 TCR zeta:CD137 cells
2020-09-18T05:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,Synonym:,CART-33 TCR zeta:CD137 cells
2020-09-18T05:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792699,Synonym:,autologous anti-CD33 CAR-T cells
2020-09-18T05:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792699,Synonym:,autologous anti-CD33 chimeric antigen receptor T cells
2020-09-18T05:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792699,Synonym:,autologous CD33-CAR-T cells
2020-09-18T05:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33-targeting-antibody-drug-conjugate-imgn779,Synonym:,ADC IMGN779
2020-09-18T05:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33-targeting-antibody-drug-conjugate-imgn779,Synonym:,anti-CD33 ADC IMGN779
2020-09-18T05:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33-targeting-antibody-drug-conjugate-imgn779,Code name:,IMGN779
2020-09-18T05:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd34-tk75-transduced-donor-lymphocytes,NA,NA
2020-09-18T05:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd4cd25-regulatory-t-cells,Synonym:,nTregs
2020-09-18T05:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonist-monoclonal-antibody-cp-870893,Code name:,"CP-870,893"
2020-09-18T05:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonistic-monoclonal-antibody-apx005m,Code name:,APX 005
2020-09-18T05:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonistic-monoclonal-antibody-apx005m,Code name:,APX 005M
2020-09-18T05:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonistic-monoclonal-antibody-apx005m,Code name:,APX005M
2020-09-18T05:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794795,Code name:,CPX-POM
2020-09-18T05:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonistic-monoclonal-antibody-apx005m,Code name:,APX-005M
2020-09-18T05:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonistic-monoclonal-antibody-apx005m,Code name:,EPI-0050
2020-09-18T05:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792628,Code name:,MEDI 5083
2020-09-18T05:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792628,Code name:,MEDI5083
2020-09-18T05:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd44-targeted-agent-spl-108,Code name:,SPL 108
2020-09-18T05:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd44-targeted-agent-spl-108,Code name:,SPL-108
2020-09-18T05:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801822,Synonym:,4SCAR-CD44v6 T cells
2020-09-18T05:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801822,Synonym:,4SCAR-CD44v6 T cells
2020-09-18T05:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801822,Synonym:,anti-CD44v6 CAR T cells
2020-09-18T05:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801822,Synonym:,CD44v6 CAR-T cells
2020-09-18T05:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801822,Synonym:,CD44v6-specific CAR gene-engineered T cells
2020-09-18T05:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796920,Synonym:,CD45RA-depleted allogeneic T cells
2020-09-18T05:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796920,Synonym:,CD45RA-depleted allogeneic T lymphocytes
2020-09-18T05:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796920,Synonym:,CD45RA-depleted donor T cells
2020-09-18T05:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796920,Synonym:,donor CD45RA-depleted (memory) T cells
2020-09-18T05:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd47-antagonist-alx-148,Synonym:,CD47/SIRPa-blocking agent ALX148
2020-09-18T05:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd47-antagonist-alx-148,Synonym:,lgGl-ALX-148
2020-09-18T05:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd47-antagonist-alx-148,Synonym:,SIRPa variant ALX148
2020-09-18T05:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd47-antagonist-alx-148,Code name:,ALX 148
2020-09-18T05:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd47-antagonist-alx-148,Code name:,ALX148
2020-09-18T05:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd47-antagonist-alx-148,Code name:,ALX-148
2020-09-18T05:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796843,Synonym:,CD56+/CD3+ donor cells
2020-09-18T05:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796843,Synonym:,CD56-enriched donor cells
2020-09-18T05:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796843,Synonym:,CD56-enriched donor lymphocytes
2020-09-18T05:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800218,Code name:,AB 680
2020-09-18T05:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800218,Code name:,AB680
2020-09-18T05:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800218,Code name:,AB-680
2020-09-18T05:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801213,Code name:,LY 3475070
2020-09-18T05:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801213,Code name:,LY3475070
2020-09-18T05:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801213,Code name:,LY-3475070
2020-09-18T05:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd8-and-cd4-donor-memory-t-cells-expressing-ha1-specific-tcr,Synonym:,CD8+ and CD4+ donor memory T cells-expressing pRRLSIN iC9-HA1 TCR2-RQR-CD8
2020-09-18T05:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd8-and-cd4-donor-memory-t-cells-expressing-ha1-specific-tcr,Synonym:,HA-1 TCR CD8+ and CD4+ Tm cells
2020-09-18T05:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd8-and-cd4-donor-memory-t-cells-expressing-ha1-specific-tcr,Synonym:,HA-1 TCR T cells
2020-09-18T05:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd8nkg2d-akt-cells,Synonym:,NKG2D/AKT-expressing CD8-positive T cells
2020-09-18T05:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800619,Code name:,FPT 155
2020-09-18T05:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800619,Code name:,FPT155
2020-09-18T05:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800619,Code name:,FPT-155
2020-09-18T05:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdc7-inhibitor-tak-931,Synonym:,cell division cycle 7 inhibitor TAK-931
2020-09-18T05:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdc7-inhibitor-tak-931,Code name:,TAK-931
2020-09-18T05:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdc7-kinase-inhibitor-bms-863233,Code name:,BMS-863233
2020-09-18T05:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792646,Code name:,LY3143921 hydrate
2020-09-18T05:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792646,Code name:,LY-3143921 hydrate
2020-09-18T05:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdc7-kinase-inhibitor-nms-1116354,Code name:,NMS-1116354
2020-09-18T05:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd-expressing-bifidobacterium-aps001f,Code name:,APS001F
2020-09-18T05:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-p276-00,Synonym:,cyclin-dependent kinase inhibitor P276
2020-09-18T05:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-p276-00,Code name:,P276
2020-09-18T05:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-p276-00,Code name:,P276-00
2020-09-18T05:15:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-sns-032,Code name:,BMS-387032
2020-09-18T05:15:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-sns-032,Code name:,SNS-032
2020-09-18T05:15:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799135,Code name:,BEY 1107
2020-09-18T05:15:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799135,Code name:,BEY1107
2020-09-18T05:15:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799135,Code name:,BEY-1107
2020-09-18T05:15:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799135,Code name:,BEY1107G
2020-09-18T05:15:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799135,Code name:,BEY1107P
2020-09-18T05:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795267,Synonym:,CDK/FLT3 inhibitor FN-1501
2020-09-18T05:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795267,Code name:,FN 1501
2020-09-18T05:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795267,Code name:,FN1501
2020-09-18T05:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795267,Code name:,FN-1501
2020-09-18T05:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795267,Chemical structure:,"4-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide"
2020-09-18T05:15:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk2-5-9-inhibitor-cyc065,Synonym:,cyclin dependent kinase inhibitor 2/5/9 CYC065
2020-09-18T05:15:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk2-5-9-inhibitor-cyc065,Code name:,CYC065
2020-09-18T05:15:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-inhibitor-p1446a-05,Code name:,P1446A-05
2020-09-18T05:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796716,Code name:,BPI 16350
2020-09-18T05:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796716,Code name:,BPI16350
2020-09-18T05:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796716,Code name:,BPI-16350
2020-09-18T05:16:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799711,Synonym:,cyclin-dependent kinase 4/6 inhibitor FCN-437
2020-09-18T05:16:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799711,Code name:,FCN 437
2020-09-18T05:16:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799711,Code name:,FCN437
2020-09-18T05:16:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799711,Code name:,FCN-437
2020-09-18T05:16:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799711,Code name:,FCN-437c
2020-09-18T05:16:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-g1t38,Code name:,G1T38
2020-09-18T05:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-shr6390,Code name:,SHR6390
2020-09-18T05:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794642,Code name:,CT 7001
2020-09-18T05:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794642,Code name:,CT7001
2020-09-18T05:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794642,Code name:,CT-7001
2020-09-18T05:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794642,Code name:,ICEC0942
2020-09-18T05:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk7-inhibitor-sy-1365,Code name:,SY 1365
2020-09-18T05:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk7-inhibitor-sy-1365,Code name:,SY-1365
2020-09-18T05:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800129,Code name:,SEL 120
2020-09-18T05:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800129,Code name:,SEL 120-34
2020-09-18T05:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800129,Code name:,SEL 120-34A
2020-09-18T05:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800129,Code name:,SEL120
2020-09-18T05:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800129,Code name:,SEL-120
2020-09-18T05:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793903,Code name:,AZD 4573
2020-09-18T05:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793903,Code name:,AZD4573
2020-09-18T05:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793903,Code name:,AZD-4573
2020-09-18T05:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-at7519,Synonym:,CDKI AT7519M
2020-09-18T05:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-at7519,Synonym:,cyclin-dependent kinase inhibitor AT7519
2020-09-18T05:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-at7519,Synonym:,cyclin-dependent kinase inhibitor AT7519M
2020-09-18T05:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-at7519,Code name:,AT7519
2020-09-18T05:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-at7519,Code name:,AT7519M
2020-09-18T05:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-r547,Synonym:,cyclin-dependent kinase inhibitor R547
2020-09-18T05:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-r547,Code name:,R547
2020-09-18T05:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdks-jak2-flt3-inhibitor-tg02-citrate,Code name:,TG02 citrate
2020-09-18T05:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/666096,Abbreviation:,tetwtCEA DNA
2020-09-18T05:17:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arcitumomab,Synonym:,anti-Carcinoembryonic Antigen Monoclonal Antibody Fab' Fragment
2020-09-18T05:17:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arcitumomab,Synonym:,IMMU-4
2020-09-18T05:17:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arcitumomab,US brand name:,CEA-Scan
2020-09-18T05:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797964,Code name:,RG 6123
2020-09-18T05:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797964,Code name:,RG6123
2020-09-18T05:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797964,Code name:,RG-6123
2020-09-18T05:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797964,Code name:,RO 7172508
2020-09-18T05:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797964,Code name:,RO7172508
2020-09-18T05:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797964,Code name:,RO-7172508
2020-09-18T05:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3h1-anti-idiotype-vaccine,Synonym:,3H1 anti-idiotype vaccine
2020-09-18T05:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3h1-anti-idiotype-vaccine,Synonym:,CEA-Vac
2020-09-18T05:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3h1-anti-idiotype-vaccine,Synonym:,MOAB 3H1 anti-idiotype vaccine
2020-09-18T05:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3h1-anti-idiotype-vaccine,US brand name:,CeaVac
2020-09-18T05:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3h1-anti-idiotype-vaccine,Abbreviation:,MOAB 3H1
2020-09-18T05:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide-nanoliposome,Synonym:,nanoliposomal ceramide
2020-09-18T05:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cebpa-targeting-sarna-mtl-cebpa-liposome,Abbreviation:,MTL-CEBPA
2020-09-18T05:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cebpa-targeting-sarna-mtl-cebpa-liposome,Code name:,MTL-501
2020-09-18T05:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cebranopadol,Code name:,GRT 6005
2020-09-18T05:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cebranopadol,Code name:,GRT6005
2020-09-18T05:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cebranopadol,Code name:,GRT-6005
2020-09-18T05:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cebranopadol,Chemical structure:,"spiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-amine, 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenyl-, (1alpha,4beta)-"
2020-09-18T05:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,C vitamin
2020-09-18T05:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,L-ascorbic acid
2020-09-18T05:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,vitamin C
2020-09-18T05:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Asorbicap
2020-09-18T05:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cecon
2020-09-18T05:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cenolate
2020-09-18T05:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cetane
2020-09-18T05:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cevalin
2020-09-18T05:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Ce-Vi-Sol
2020-09-18T05:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Foreign brand name:,C-Long
2020-09-18T05:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Abbreviation:,VIT C
2020-09-18T05:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Chemical structure:,"2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one"
2020-09-18T05:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799445,Synonym:,CDA inhibitor E7727
2020-09-18T05:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799445,Code name:,E7727
2020-09-18T05:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799445,Chemical structure:,"(4R)-2'-deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridineuridine, 2'-deoxy-2',2'-difluoro-3,4,5,6-tetrahydro-, (4R)"
2020-09-18T05:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cediranib-maleate,Synonym:,AZD2171 maleate
2020-09-18T05:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cediranib-maleate,US brand name:,Recentin
2020-09-18T05:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cediranib-maleate,Foreign brand name:,Recentin
2020-09-18T05:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cediranib-maleate,Code name:,AZD2171
2020-09-18T05:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cediranib-maleate,Chemical structure:,"4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1- yl)propoxy]quinazoline (2Z)-but-2-enedioatequinazoline, 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1- pyrrolidinyl)propoxy]-, (2Z)-2-butenedioate (1:1)"
2020-09-18T05:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefepime-hydrochloride,US brand name:,Maxipime
2020-09-18T05:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefepime-hydrochloride,Chemical structure:,"pyrrolidinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, hydroxide, inner salt, (6R-(6alpha,7beta(Z)))"
2020-09-18T05:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefixime,US brand name:,Suprax
2020-09-18T05:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefixime,Code name:,FK 027
2020-09-18T05:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefmetazole-sodium,NA,NA
2020-09-18T05:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefotaxime,US brand name:,Claforan
2020-09-18T05:18:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefoxitin-sodium,US brand name:,Mefoxin
2020-09-18T05:18:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefoxitin-sodium,Foreign brand name:,Pacetin
2020-09-18T05:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefpodoxime-proxetil,US brand name:,Vantin
2020-09-18T05:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-sodium,US brand name:,Fortaz
2020-09-18T05:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-sodium,US brand name:,Tazicef
2020-09-18T05:18:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-avibactam-sodium,Synonym:,CAZ-AVI
2020-09-18T05:18:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-avibactam-sodium,Synonym:,ceftazidime-avibactam sodium
2020-09-18T05:18:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-avibactam-sodium,US brand name:,Avycaz
2020-09-18T05:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftobiprole-medocaril,Code name:,BAL5788
2020-09-18T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795424,Synonym:,ceftolozane/tazobactam
2020-09-18T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795424,US brand name:,Zerbaxa
2020-09-18T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795424,Code name:,CXA 201
2020-09-18T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795424,Code name:,CXA201
2020-09-18T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795424,Code name:,CXA-201
2020-09-18T05:18:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftriaxone-sodium,US brand name:,Rocephin
2020-09-18T05:18:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib,Synonym:,YM 177
2020-09-18T05:18:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib,US brand name:,Celebrex
2020-09-18T05:18:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib,Abbreviation:,SC-58635
2020-09-18T05:18:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib,Code name:,SC-58635
2020-09-18T05:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide-nanoliposome,Abbreviation:,CNL
2020-09-18T05:18:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib,Chemical structure:,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
2020-09-18T05:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib,Synonym:,YM 177
2020-09-18T05:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib,US brand name:,Celebrex
2020-09-18T05:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib,Abbreviation:,SC-58635
2020-09-18T05:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib,Code name:,SC-58635
2020-09-18T05:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib,Chemical structure:,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
2020-09-18T05:18:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betamethasone,US brand name:,Celestone
2020-09-18T05:18:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citalopram-hydrobromide,US brand name:,Celexa
2020-09-18T05:18:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citalopram-hydrobromide,Chemical structure:,"(±)-1-(3-dimethylaminopropyl)-1- (4-fluorophenyl)-1,3 dihydroisobenzofuran-5-carbonitrile, HBr"
2020-09-18T05:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate,US brand name:,Celiptium
2020-09-18T05:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate,Abbreviation:,9-HME
2020-09-18T05:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate,Abbreviation:,HME
2020-09-18T05:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate,Abbreviation:,NMHE
2020-09-18T05:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate,Chemical structure:,"9-hydroxy-2,5,11-trimethyl-6H-pyrido[4,3-b]carbazolium acetate (salt)9-hydroxy-2-methylellipticinium acetateN-2-methyl-9-hydroxyellipticinium acetate"
2020-09-18T05:19:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cell-cycle-checkpoint-dna-repair-antagonist-ic83,Code name:,IC83
2020-09-18T05:19:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolate-mofetil,US brand name:,Cellcept
2020-09-18T05:19:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolate-mofetil,Abbreviation:,MMF
2020-09-18T05:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cem-regimen,Synonym:,carboplatin/etoposide/melphalan regimen
2020-09-18T05:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cem-regimen,Synonym:,CEM
2020-09-18T05:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-regn2810,Synonym:,anti-PD-1 monoclonal antibody REGN2810
2020-09-18T05:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-regn2810,Synonym:,cemiplimab
2020-09-18T05:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-regn2810,US brand name:,Libtayo
2020-09-18T05:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-regn2810,Code name:,REGN2810
2020-09-18T05:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-regn2810,Chemical structure:,"immunoglobulin G4, anti-(human programmed cell death protein 1) (human monoclonal REGN2810 heavy chain), disulfide with human monoclonal REGN2810 kappa-chain, dimer"
2020-09-18T05:19:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenisertib,Synonym:,Aurora kinase inhibitor AS703569
2020-09-18T05:19:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenisertib,Synonym:,Aurora kinase Inhibitor R763
2020-09-18T05:19:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenisertib,Code name:,AS703569
2020-09-18T05:19:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenisertib,Code name:,R763
2020-09-18T05:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,C vitamin
2020-09-18T05:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,L-ascorbic acid
2020-09-18T05:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,vitamin C
2020-09-18T05:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Asorbicap
2020-09-18T05:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cecon
2020-09-18T05:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cenolate
2020-09-18T05:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cetane
2020-09-18T05:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cevalin
2020-09-18T05:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Ce-Vi-Sol
2020-09-18T05:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Foreign brand name:,C-Long
2020-09-18T05:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Abbreviation:,VIT C
2020-09-18T05:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Chemical structure:,"2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one"
2020-09-18T05:19:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceop-regimen,Synonym:,Cyclophosphamide/Epirubicin/Vincristine/Prednisone
2020-09-18T05:19:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceop-regimen,Synonym:,Cyclophosphamide-Epirubicin-Oncovin-Prednisone regimen
2020-09-18T05:19:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794778,US brand name:,Cepacol
2020-09-18T05:19:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794778,US brand name:,Dyclone
2020-09-18T05:19:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794778,Chemical structure:,"1-propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-,hydrochloride"
2020-09-18T05:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cephalexin,US brand name:,Keflex
2020-09-18T05:19:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-azd6738,Synonym:,ATR kinase inhibitor AZD6738
2020-09-18T05:19:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-azd6738,Code name:,AZD6738
2020-09-18T05:20:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide,Synonym:,Ceramide (lipids)
2020-09-18T05:20:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide,Chemical structure:,N-Acyl Sphingosine
2020-09-18T05:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide-nanoliposome,Code name:,KN 001
2020-09-18T05:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide-nanoliposome,Code name:,KN-001
2020-09-18T05:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide-nanoliposome,Code name:,KN-01
2020-09-18T05:20:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desogestral,US brand name:,Cerazette
2020-09-18T05:20:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/syk-jak-inhibitor-prt062070,Synonym:,Syk/JAK inhibitor PRT062070
2020-09-18T05:20:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/syk-jak-inhibitor-prt062070,Synonym:,Syk-JAK inhibitor PRT062070
2020-09-18T05:20:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/syk-jak-inhibitor-prt062070,Code name:,PRT062070
2020-09-18T05:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792155,Synonym:,CELMoD CC-92480
2020-09-18T05:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792155,Synonym:,cereblon E3 ligase modulation drug CC-92480
2020-09-18T05:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792155,Synonym:,cereblon modulator CC-92480
2020-09-18T05:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792155,Code name:,CC 92480
2020-09-18T05:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792155,Code name:,CC-92480
2020-09-18T05:20:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801633,Synonym:,CelMod CC-99282
2020-09-18T05:20:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801633,Synonym:,cereblon E3 ubiquitin ligase modulating drug CC-99282
2020-09-18T05:20:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801633,Synonym:,cereblon modulator CC-99282
2020-09-18T05:20:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801633,Code name:,CC 99282
2020-09-18T05:20:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801633,Code name:,CC99282
2020-09-18T05:20:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801633,Code name:,CC-99282
2020-09-18T05:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-modulator-cc-90009,Code name:,CC 90009
2020-09-18T05:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-modulator-cc-90009,Code name:,CC-90009
2020-09-18T05:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797055,US brand name:,Cerebyx
2020-09-18T05:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797055,Code name:,NPC-06
2020-09-18T05:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797055,Chemical structure:,"2,4-Imidazolidinedione, 5,5-diphenyl-3-((phosphonooxy)methyl)-, disodium salt"
2020-09-18T05:20:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lobradimil,Synonym:,RMP-7
2020-09-18T05:20:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lobradimil,US brand name:,Cereport
2020-09-18T05:20:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lobradimil,Code name:,DRG-0182
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,US brand name:,Cerespan
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,US brand name:,Pavabid
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,US brand name:,Therapav
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,US brand name:,Vasal
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,US brand name:,Vaso-Pav
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,US brand name:,Vasospan
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,Foreign brand name:,Cerebid
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,Foreign brand name:,Pavacap
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,Abbreviation:,Pap-H
2020-09-18T05:20:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,Synonym:,vitamin B12
2020-09-18T05:20:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Berubigen
2020-09-18T05:20:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Betalin 12
2020-09-18T05:20:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Calomist
2020-09-18T05:20:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Cobavite
2020-09-18T05:21:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cergutuzumab-amunaleukin,Synonym:,CEA-IL2v
2020-09-18T05:21:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cergutuzumab-amunaleukin,Synonym:,CEA-IL-2variant
2020-09-18T05:21:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cergutuzumab-amunaleukin,Code name:,RG7813
2020-09-18T05:21:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cergutuzumab-amunaleukin,Code name:,RG-7813
2020-09-18T05:21:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cergutuzumab-amunaleukin,Code name:,RO6895882
2020-09-18T05:21:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cergutuzumab-amunaleukin,Code name:,RO-6895882
2020-09-18T05:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceritinib,US brand name:,Zykadia
2020-09-18T05:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceritinib,Code name:,LDK 378
2020-09-18T05:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceritinib,Code name:,LDK378
2020-09-18T05:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceritinib,Chemical structure:,"2,4-pyrimidinediamine, 5-chloro-N4-(2-((1-methylethyl)sulfonyl)phenyl)-N2-(5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl)-"
2020-09-18T05:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/certolizumab,NA,NA
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Synonym:,cloridrato de daunorubicina
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Synonym:,daunoblastine
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Synonym:,daunomycin hydrochloride
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Synonym:,rubidomycin hydrochloride
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,US brand name:,Cerubidine
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Foreign brand name:,Cerubidin
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Foreign brand name:,Daunoblastin
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Foreign brand name:,Daunoblastina
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Foreign brand name:,Ondena
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Foreign brand name:,Rubilem
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Code name:,FI-6339
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Code name:,RP-13057
2020-09-18T05:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-bivalent-vaccine,Synonym:,human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine
2020-09-18T05:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-bivalent-vaccine,US brand name:,Cervarix
2020-09-18T05:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-bivalent-vaccine,Foreign brand name:,Cervarix
2020-09-18T05:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-bivalent-vaccine,Abbreviation:,HPV 16/18 L1 VLP/AS04 VAC
2020-09-18T05:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-bivalent-vaccine,Code name:,GSK-580299
2020-09-18T05:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfa-pe38-immunotoxin,Synonym:,TP-38
2020-09-18T05:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfa-pe38-immunotoxin,US brand name:,Cervene
2020-09-18T05:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfa-pe38-immunotoxin,Abbreviation:,TP-38
2020-09-18T05:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cesium-cs-131,Synonym:,cesium Cs-131
2020-09-18T05:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cesium-cs-131,Abbreviation:,131-Cs
2020-09-18T05:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cesium-cs-137,NA,NA
2020-09-18T05:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792660,Synonym:,ASO AZD4785
2020-09-18T05:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792660,Synonym:,cEt KRAS ASO AZD4785
2020-09-18T05:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792660,Synonym:,generation 2.5 drug AZD4785
2020-09-18T05:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792660,Synonym:,IONIS-KRAS-2.5Rx
2020-09-18T05:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792660,Code name:,AZD 4785
2020-09-18T05:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792660,Code name:,AZD4785
2020-09-18T05:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,C vitamin
2020-09-18T05:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,L-ascorbic acid
2020-09-18T05:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,vitamin C
2020-09-18T05:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Asorbicap
2020-09-18T05:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cecon
2020-09-18T05:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cenolate
2020-09-18T05:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cetane
2020-09-18T05:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cevalin
2020-09-18T05:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Ce-Vi-Sol
2020-09-18T05:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Foreign brand name:,C-Long
2020-09-18T05:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Abbreviation:,VIT C
2020-09-18T05:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Chemical structure:,"2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one"
2020-09-18T05:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdcd1-monoclonal-antibody-jnj-63723283,Code name:,JNJ 63723283
2020-09-18T05:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdcd1-monoclonal-antibody-jnj-63723283,Code name:,JNJ63723283
2020-09-18T05:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdcd1-monoclonal-antibody-jnj-63723283,Code name:,JNJ-63723283
2020-09-18T05:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdcd1-monoclonal-antibody-jnj-63723283,Code name:,WHO 10757
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,Anti-EGFR Monoclonal Antibody
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,Anti-Epidermal Growth Factor Receptor Monoclonal Antibody
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,C225 monoclonal antibody
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,cetuximab biosimilar CDP-1
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,cetuximab biosimilar CMAB009
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,cetuximab biosimilar KL 140
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,Chimeric Anti-EGFR Monoclonal Antibody
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,Chimeric Monoclonal Antibody C225
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,"Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 gamma1-chain), disulfide with human-mouse monoclonal C225 kappa-chain, dimer"
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,monoclonal antibody C225
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,US brand name:,Erbitux
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Abbreviation:,Chimeric MoAb C225
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Abbreviation:,MOAB C225
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Code name:,C225
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Code name:,IMC-C225
2020-09-18T05:22:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-ir700-conjugate-rm-1929,Synonym:,cet-IR700
2020-09-18T05:22:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-ir700-conjugate-rm-1929,Code name:,RM-1929
2020-09-18T05:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-irdye-800,Synonym:,Cetuximab-IRDye800
2020-09-18T05:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-irdye-800,Synonym:,Cetuximab-IRDye800CW
2020-09-18T05:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797050,Synonym:,cetuximab-loaded polymeric nanoparticles decorated with octreotide
2020-09-18T05:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797050,Synonym:,polymeric nanoparticles loaded with cetuximab and decorated with octreotide
2020-09-18T05:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cev-regimen,Synonym:,carboplatin/etoposide/vincristine regimen
2020-09-18T05:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cev-regimen,Synonym:,carboplatin-etoposide-vincristine regimen
2020-09-18T05:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cev-regimen,Abbreviation:,CEV
2020-09-18T05:22:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,C vitamin
2020-09-18T05:22:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,L-ascorbic acid
2020-09-18T05:22:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,vitamin C
2020-09-18T05:22:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Asorbicap
2020-09-18T05:22:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cecon
2020-09-18T05:22:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cenolate
2020-09-18T05:22:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cetane
2020-09-18T05:22:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cevalin
2020-09-18T05:22:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Ce-Vi-Sol
2020-09-18T05:22:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Foreign brand name:,C-Long
2020-09-18T05:22:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Abbreviation:,VIT C
2020-09-18T05:22:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Chemical structure:,"2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one"
2020-09-18T05:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801206,Code name:,SKI O 703
2020-09-18T05:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801206,Code name:,SKIO703
2020-09-18T05:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801206,Code name:,SKI-O-703
2020-09-18T05:22:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cevimeline-hydrochloride,US brand name:,Evoxac
2020-09-18T05:22:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cevimeline-hydrochloride,Code name:,AF-102B
2020-09-18T05:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,C vitamin
2020-09-18T05:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,L-ascorbic acid
2020-09-18T05:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,vitamin C
2020-09-18T05:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Asorbicap
2020-09-18T05:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cecon
2020-09-18T05:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cenolate
2020-09-18T05:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cetane
2020-09-18T05:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cevalin
2020-09-18T05:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Ce-Vi-Sol
2020-09-18T05:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Foreign brand name:,C-Long
2020-09-18T05:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Abbreviation:,VIT C
2020-09-18T05:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Chemical structure:,"2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one"
2020-09-18T05:22:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cfms-tyrosine-kinase-inhibitor-arry-382,Code name:,ARRY-382
2020-09-18T05:22:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chamomile,NA,NA
2020-09-18T05:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varenicline,US brand name:,Chantix
2020-09-18T05:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varenicline,Foreign brand name:,Champix
2020-09-18T05:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varenicline,Code name:,CP-526555
2020-09-18T05:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varenicline,Chemical structure:,"6,10-methano-6H-pyrazino[2,3-h][3]benzazeprine, 7,8,9,10-tetrahydro, (2R,3R)-2,3-dihydroxybutanedioate (1:1)7,8,9,10-tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine (2R,3R)-2,3-dihydroxybutqanedioate"
2020-09-18T05:23:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/checkpoint-kinase-inhibitor-azd7762,Code name:,AZD7762
2020-09-18T05:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798947,Synonym:,"Meso 2, 3-Dimercaptosuccinic Acid"
2020-09-18T05:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798947,US brand name:,Chemet
2020-09-18T05:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798947,Abbreviation:,DMSA
2020-09-18T05:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798947,Chemical structure:,"Butanedioic Acid, 2,3-Dimercapto-, (2R,3S)-rel-"
2020-09-18T05:23:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-hyaluronidase,US brand name:,Chemophase
2020-09-18T05:23:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-hyaluronidase,Abbreviation:,rHuPH20
2020-09-18T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808,Synonym:,episcleral topotecan
2020-09-18T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808,Synonym:,SR topotecan episcleral plaque
2020-09-18T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808,Synonym:,sustained-release episcleral topotecan
2020-09-18T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808,Synonym:,sustained-release topotecan episcleral plaque
2020-09-18T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808,Synonym:,topotecan SR episcleral plaque
2020-09-18T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808,Synonym:,transscleral topotecan
2020-09-18T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808,US brand name:,Chemoplaque
2020-09-18T05:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chewing-gum,Synonym:,chewing gum dosage form
2020-09-18T05:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chewing-gum,Synonym:,chewing gum dose form
2020-09-18T05:23:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chiauranib,Code name:,CS2164
2020-09-18T05:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798735,Synonym:,CCCR-modified NK92
2020-09-18T05:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798735,Synonym:,CCCR-NK92 cells
2020-09-18T05:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798735,Synonym:,chimeric co-stimulatory converting receptor-modified NK92 cells
2020-09-18T05:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-111f4,Synonym:,c11-1F4 mAb
2020-09-18T05:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-111f4,Synonym:,chimeric amyloid-reactive monoclonal antibody 111F4
2020-09-18T05:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-111f4,Synonym:,mAb-11-1F4
2020-09-18T05:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-111f4,Code name:,111F4
2020-09-18T05:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-111f4,Code name:,11-1F4
2020-09-18T05:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-humanized-anti-cd47-antibody,Synonym:,humanized high-chimeric antibody CD47
2020-09-18T05:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-lc09,Synonym:,Herba Epimedii compound extraction LC09
2020-09-18T05:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-lc09,Synonym:,TCM formula LC09
2020-09-18T05:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-lc09,Synonym:,TCM LC09
2020-09-18T05:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-lc09,Synonym:,traditional Chinese medicine formula LC09
2020-09-18T05:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-lc09,Code name:,LC09
2020-09-18T05:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-phy906,Synonym:,KD018
2020-09-18T05:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-phy906,Code name:,PHY-906
2020-09-18T05:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-phy906,Code name:,YIV 906
2020-09-18T05:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-phy906,Code name:,YIV906
2020-09-18T05:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-phy906,Code name:,YIV-906
2020-09-18T05:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-medicine-yq1,Synonym:,YQ1
2020-09-18T05:24:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbs,Synonym:,"herbs, Chinese"
2020-09-18T05:24:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbs,Abbreviation:,CHIHERB
2020-09-18T05:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chining-decoction,NA,NA
2020-09-18T05:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-human-secretin,Synonym:,secretin human
2020-09-18T05:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-human-secretin,US brand name:,ChiRhoStim
2020-09-18T05:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-human-secretin,Abbreviation:,SHS
2020-09-18T05:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-human-secretin,Code name:,RG1068
2020-09-18T05:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levobupivacaine-hydrochloride,US brand name:,Chirocaine
2020-09-18T05:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chitin-oligosaccharides-supplement-t-chos,Synonym:,therapeutic CHOS
2020-09-18T05:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chitin-oligosaccharides-supplement-t-chos,Foreign brand name:,Benecta
2020-09-18T05:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chitin-oligosaccharides-supplement-t-chos,Code name:,T-ChOs
2020-09-18T05:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-cct245737,Synonym:,checkpoint kinase 1 inhibitor CCT245737
2020-09-18T05:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-cct245737,Code name:,CCT245737
2020-09-18T05:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-cct245737,Chemical structure:,(R)-5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile
2020-09-18T05:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-gdc-0425,Code name:,GDC-0425
2020-09-18T05:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-gdc-0425,Code name:,RG7602
2020-09-18T05:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-gdc-0575,Code name:,ARRY-575
2020-09-18T05:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-gdc-0575,Code name:,GDC-0575
2020-09-18T05:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-gdc-0575,Code name:,RG7741
2020-09-18T05:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-pf-477736,Code name:,PF-0047736
2020-09-18T05:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-pf-477736,Code name:,PF-477736
2020-09-18T05:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-sch-900776,Code name:,SCH 900776
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,chlorambucilum
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,chloraminophen
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,Chlorbutin
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,chlorbutine
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,chlorbutinum
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,chloroambucil
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,chlorobutin
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,chlorobutine
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,Leukersan
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,Leukoran
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,Lympholysin
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,phenylbutyric acid nitrogen mustard
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,US brand name:,Leukeran
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Foreign brand name:,Alti-chlorambucil
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Foreign brand name:,Chloraminophene
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Foreign brand name:,Linfolysin
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Abbreviation:,CHL
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Abbreviation:,CLB
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Code name:,CB-1348
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Code name:,WR-139013
2020-09-18T05:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil-prednisone-regimen,Synonym:,CP
2020-09-18T05:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil-prednisone-regimen,Acronym:,CP regimen
2020-09-18T05:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine-ethyl-alcohol-mouthwash,Synonym:,chlorhexidine/ethyl alcohol mouth rinse
2020-09-18T05:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine-ethyl-alcohol-mouthwash,US brand name:,Chloraprep
2020-09-18T05:25:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine,NA,NA
2020-09-18T05:25:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine-gluconate,US brand name:,Peridex
2020-09-18T05:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800700,Synonym:,skin cleanser with chlorhexidine gluconate
2020-09-18T05:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine-ethyl-alcohol-mouthwash,Synonym:,chlorhexidine/ethyl alcohol mouth rinse
2020-09-18T05:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine-ethyl-alcohol-mouthwash,US brand name:,Chloraprep
2020-09-18T05:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799647,NA,NA
2020-09-18T05:25:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorogenic-acid,Synonym:,3-caffeoylquinic acid
2020-09-18T05:25:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorogenic-acid,Chemical structure:,"5-O-(3,4-dihydroxycinnamoyl)-L-quinic acid"
2020-09-18T05:25:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chloroquine,NA,NA
2020-09-18T05:25:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chloroquinoxaline-sulfonamide,Synonym:,chlorosulfaquinoxaline
2020-09-18T05:25:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chloroquinoxaline-sulfonamide,Synonym:,chlorsulfaquinoxaline
2020-09-18T05:25:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chloroquinoxaline-sulfonamide,Abbreviation:,CQS
2020-09-18T05:25:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chloroquinoxaline-sulfonamide,Chemical structure:,"benzenesulfonamide, 4-amino-N-(5-chloro-2-quinoxalinyl)-"
2020-09-18T05:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorotoxin-indocyanine-green-imaging-agent-blz-100,Code name:,BLZ-100
2020-09-18T05:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorotoxin-indocyanine-green-imaging-agent-blz-100,Code name:,CyTP 007
2020-09-18T05:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin,Synonym:,Chlorozotocyna
2020-09-18T05:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin,Synonym:,D-glucopyranose
2020-09-18T05:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin,Abbreviation:,CLZ
2020-09-18T05:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin,Abbreviation:,CZT
2020-09-18T05:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin,Abbreviation:,DCNU
2020-09-18T05:26:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpromazine,US brand name:,Thorazine
2020-09-18T05:26:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpromazine,Foreign brand name:,Chlor-PZ
2020-09-18T05:26:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpromazine,Chemical structure:,2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine
2020-09-18T05:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpropamide,US brand name:,Diabinese
2020-09-18T05:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpropamide,US brand name:,Prodiaben
2020-09-18T05:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpropamide,Chemical structure:,"4-chloro-4-((propylamino)carbonyl)benzenesulfonamidebenzenesulfonamide, 4-chloro-N-((propylamino)carbonyl)-urea, 1-((p-chlorophenyl)sulfonyl)-3-propyl-"
2020-09-18T05:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorzoxazone,US brand name:,Paraflex
2020-09-18T05:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecalciferol,Synonym:,Calciol
2020-09-18T05:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecalciferol,Synonym:,delsterol
2020-09-18T05:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecalciferol,Synonym:,Vitamin D3
2020-09-18T05:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecalciferol,Chemical structure:,"(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol9,10-secocholesta-5,7,10(19)-trien-3-beta-ol9,10-secocholesta-5,7,10(19)-trien-3-ol"
2020-09-18T05:26:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/596155,US brand name:,PHC
2020-09-18T05:26:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/596155,US brand name:,Prostate Health Cocktail
2020-09-18T05:26:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecalciferol-whey-protein-isolate-epa-dha-based-nutritional-supplement,Synonym:,Nutrifriend Cachexia
2020-09-18T05:26:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecalciferol-whey-protein-isolate-epa-dha-based-nutritional-supplement,Foreign brand name:,Nutrifriend 1100
2020-09-18T05:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colesevelam-hydrochloride,US brand name:,CholestaGel
2020-09-18T05:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colesevelam-hydrochloride,US brand name:,Welchol
2020-09-18T05:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colesevelam-hydrochloride,Chemical structure:,"1-hexaminium, N,N,N-trimethyl-6-(2-propenylamino)-, chloride, polymer with (chloromethyl)oxirane, 2-propen-4-amine and N-2-propenyl-1-decanamine, hydrochlorideGT 31-104HB"
2020-09-18T05:26:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-mebrofenin,US brand name:,Choletec
2020-09-18T05:26:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-mebrofenin,Abbreviation:,Tc 99m MEB
2020-09-18T05:26:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-mebrofenin,Abbreviation:,Tc 99m mebrofenin
2020-09-18T05:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798636,Synonym:,24-13C cholate
2020-09-18T05:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798636,Synonym:,carbon C 13 cholic acid
2020-09-18T05:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798635,Synonym:,"2,2,4,4-2H cholate"
2020-09-18T05:27:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/choline-kinase-alpha-inhibitor-tcd-717,Synonym:,TCD-717
2020-09-18T05:27:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/choline-kinase-alpha-inhibitor-tcd-717,Abbreviation:,CHKA inhibitor TCD-717
2020-09-18T05:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/choline-magnesium-trisalicylate,Synonym:,Trisalicylate
2020-09-18T05:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/choline-magnesium-trisalicylate,US brand name:,Trilisate
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Synonym:,ACOP
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Synonym:,CAVP
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Synonym:,COPA
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Synonym:,cyclophosphamide/doxorubicin/prednisone/vincristine
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Synonym:,Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone regimen
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Synonym:,VACP
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Synonym:,VCAP
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Acronym:,CHOP
2020-09-18T05:27:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chp-ny-eso-1-peptide-vaccine-imf-001,Synonym:,cholesterol-bearing hydrophobized pullulan NY-ESO-1 protein
2020-09-18T05:27:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chp-ny-eso-1-peptide-vaccine-imf-001,Code name:,IMF-001
2020-09-18T05:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chromomycin-a3,Synonym:,aburamycin B
2020-09-18T05:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chromomycin-a3,Synonym:,antibiotic B 599
2020-09-18T05:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chromomycin-a3,Synonym:,toyomycin
2020-09-18T05:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chromomycin-a3,Chemical structure:,"3B-O-(4-O-acetyl-2,6-dideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-7-methylolivomycin Dolivomycin D, 3B-O-(4-O-Acetyl-2, 6-dideoxy-3-C-methyl-.alpha.-L-arabino-hexopyranosyl)-7-methyl- (9CI)"
2020-09-18T05:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tadalafil,US brand name:,Cialis
2020-09-18T05:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tadalafil,Code name:,Ic351
2020-09-18T05:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tadalafil,Chemical structure:,"(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione"
2020-09-18T05:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-cd3-bispecific-antibody-ro6958688,Synonym:,anti-CEA/CD3 bispecific antibody RO6958688
2020-09-18T05:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-cd3-bispecific-antibody-ro6958688,Code name:,RG7802
2020-09-18T05:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-cd3-bispecific-antibody-ro6958688,Code name:,RG-7802
2020-09-18T05:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-cd3-bispecific-antibody-ro6958688,Code name:,RO6958688
2020-09-18T05:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-cd3-bispecific-antibody-ro6958688,Code name:,WHO 10636
2020-09-18T05:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciclopirox-olamine-lotion,US brand name:,Loprox Lotion
2020-09-18T05:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciclopirox-olamine-oral,NA,NA
2020-09-18T05:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794795,Synonym:,ciclopirox prodrug
2020-09-18T05:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794795,Synonym:,CPX prodrug
2020-09-18T05:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794795,Code name:,CPX POM
2020-09-18T05:27:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cidan-herbal-capsule,Synonym:,Zedoary rhizome/Pseudobulbus cremastrae seu pleiones/Yatantzu/Strychni pulveratum/beehive/artificial bezoar/Bombyx mori/Danshen root/Radix astragali/Angelica/camphol alcohol capsule
2020-09-18T05:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cidofovir,US brand name:,Vistide
2020-09-18T05:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cidofovir,Abbreviation:,CDV
2020-09-18T05:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cidofovir,Abbreviation:,HPMPC
2020-09-18T05:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cidofovir,Chemical structure:,1(3-hydroxy-2-phosphonomethoxypropyl) Cytosine
2020-09-18T05:28:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cilengitide,Abbreviation:,EMD 121974
2020-09-18T05:28:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cilengitide,Code name:,EMD 121974
2020-09-18T05:28:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cilengitide,Chemical structure:,cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-N-methyl-L-valyl)
2020-09-18T05:28:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cimetidine,US brand name:,Tagamet
2020-09-18T05:28:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cimetidine,Chemical structure:,N-cyano-N'-methyl-N''-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidine
2020-09-18T05:28:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinacalcet-hydrochloride,US brand name:,Sensipar
2020-09-18T05:28:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinacalcet-hydrochloride,Foreign brand name:,Mimpara
2020-09-18T05:28:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinacalcet-hydrochloride,Chemical structure:,N-[1(R)-(1-Naphthyl)ethyl]-N-[3-[3-(trifluoromethyl)phenyl]propyl]amine hydrochloride
2020-09-18T05:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797004,Synonym:,Cinnamomum aromaticum bark capsules
2020-09-18T05:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinobufagin,Synonym:,cinobufacin
2020-09-18T05:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinobufagin,Synonym:,cinobufacini
2020-09-18T05:28:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793122,Abbreviation:,CB
2020-09-18T05:28:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793122,Chemical structure:,"14,15b-epoxy-3b,5a,16b-trihydroxy-5b,20(22)-bufadienolide 16-acetate5b,20(22)-bufadienolide-14,15b-epoxy-3b,5a,16b-triol 16-acetate5-beta-bufa-20,22-dienolide, 14,15-beta-epoxy-3-beta,5,16-beta-trihydroxy-, 16-acetate"
2020-09-18T05:28:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cintredekin-besudotox,Synonym:,Interleukin-13 PE38QQR Immunotoxin|
2020-09-18T05:28:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cintredekin-besudotox,Abbreviation:,IL13-PE38QQR
2020-09-18T05:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciprofloxacin,US brand name:,Cipro
2020-09-18T05:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciprofloxacin,Abbreviation:,CPFX
2020-09-18T05:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciprofloxacin,Chemical structure:,"1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid"
2020-09-18T05:28:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciprofloxacin,US brand name:,Cipro
2020-09-18T05:28:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciprofloxacin,Abbreviation:,CPFX
2020-09-18T05:28:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciprofloxacin,Chemical structure:,"1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid"
2020-09-18T05:28:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-melatonin,US brand name:,Circadin
2020-09-18T05:28:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-melatonin,Foreign brand name:,melaxen
2020-09-18T05:28:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-melatonin,Abbreviation:,MLT
2020-09-18T05:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cirmtuzumab,Code name:,UC-961
2020-09-18T05:29:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisatracurium-besylate,US brand name:,Nimbex
2020-09-18T05:29:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisatracurium-besylate,Code name:,51W89
2020-09-18T05:29:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisatracurium-besylate,Chemical structure:,"(1R,2R)-2-(2-carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium benzenesulfonate, pentamethylene esteratracurium besylate 1R-cis,1R'-cis form"
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,CACP
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-DDP
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-diamminedichloridoplatinum
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-diamminedichloro platinum (II)
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-diamminedichloroplatinum
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,Cis-dichloroammine Platinum (II)
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,Cismaplat
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,Cisplatina
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-platinous diamine dichloride
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-platinum
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-platinum II
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-platinum II diamine dichloride
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,CPDD
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,Cysplatyna
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,DDP
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,PDD
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,Peyrone's Chloride
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,Peyrone's Salt
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,Platinoxan
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,platinum diamminodichloride
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Abiplatin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Blastolem
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Briplatin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Cisplatyl
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Citoplatino
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Citosin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Lederplatin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Metaplatin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Neoplatin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Placis
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platamine
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platiblastin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platiblastin-S
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platinex
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platinol- AQ
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platinol-AQ VHA Plus
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platiran
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platistin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platosin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Abbreviation:,CDDP
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Abbreviation:,DDP
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Chemical structure:,"(SP-4-2)-diamminedichloroplatinumplatinum, diaminedichloro-, cis- (8CI)"
2020-09-18T05:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795340,Synonym:,cisplatin drug-loaded patch
2020-09-18T05:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795340,Synonym:,cisplatin transmucosal system
2020-09-18T05:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795340,Code name:,PRV 111
2020-09-18T05:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795340,Code name:,PRV111
2020-09-18T05:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795340,Code name:,PRV-111
2020-09-18T05:29:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-vinblastine-cell-penetration-enhancer-formulation-int230-6,Synonym:,cisplatin/vinblastine formulation with cell penetration enhancer INT230-6
2020-09-18T05:29:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-vinblastine-cell-penetration-enhancer-formulation-int230-6,Code name:,INT 230-6
2020-09-18T05:29:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-vinblastine-cell-penetration-enhancer-formulation-int230-6,Code name:,INT230-6
2020-09-18T05:29:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-e-therapeutic-implant,Synonym:,CDDP/epi gel
2020-09-18T05:29:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-e-therapeutic-implant,Synonym:,cisplatin/epinephrine gel
2020-09-18T05:29:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-e-therapeutic-implant,US brand name:,IntraDose
2020-09-18T05:29:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-e-therapeutic-implant,Abbreviation:,CEG
2020-09-18T05:29:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-e-therapeutic-implant,Code name:,MPI 5010
2020-09-18T05:29:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cis-urocanic-acid,Abbreviation:,cis-UCA
2020-09-18T05:29:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citalopram-hydrobromide,US brand name:,Celexa
2020-09-18T05:29:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citalopram-hydrobromide,Chemical structure:,"(±)-1-(3-dimethylaminopropyl)-1- (4-fluorophenyl)-1,3 dihydroisobenzofuran-5-carbonitrile, HBr"
2020-09-18T05:29:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prilocaine-hydrochloride,US brand name:,Citanest
2020-09-18T05:29:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prilocaine-hydrochloride,US brand name:,Xylonest
2020-09-18T05:29:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prilocaine-hydrochloride,Code name:,L-67
2020-09-18T05:29:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prilocaine-hydrochloride,Chemical structure:,2-(propylamino)-o-propionotoluidide hydrochloride
2020-09-18T05:29:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citatuzumab-bogatox,Code name:,VB6-845
2020-09-18T05:29:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citicoline,Synonym:,cytidine 5'-diphosphocholine
2020-09-18T05:29:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citicoline,Synonym:,cytidine diphosphate choline
2020-09-18T05:29:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citicoline,Abbreviation:,CDP-choline
2020-09-18T05:29:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate,Synonym:,Tricalcium Citrate
2020-09-18T05:29:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate,US brand name:,Citracal
2020-09-18T05:29:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate,Foreign brand name:,Acicontral
2020-09-18T05:29:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate,Abbreviation:,CALCIT
2020-09-18T05:29:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate,Chemical structure:,"2-Hydroxy-1,2,3-propanetricarboxylic Acid, Calcium Salt (2:3)"
2020-09-18T05:30:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-citrate,Synonym:,citrate of magnesia
2020-09-18T05:30:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-citrate,US brand name:,Citroma
2020-09-18T05:30:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-citrate,Foreign brand name:,Citramag
2020-09-18T05:30:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-c-immune-globulin-intravenous,Synonym:,anti-HCV immunoglobulin
2020-09-18T05:30:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-c-immune-globulin-intravenous,US brand name:,Biotest-HCIG
2020-09-18T05:30:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-c-immune-globulin-intravenous,US brand name:,Civacir
2020-09-18T05:30:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-c-immune-globulin-intravenous,Abbreviation:,HCIG
2020-09-18T05:30:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cixutumumab,Synonym:,anti-IGF-1R recombinant monoclonal antibody IMC-A12
2020-09-18T05:30:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cixutumumab,Code name:,IMC-A12
2020-09-18T05:30:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ck2-targeting-synthetic-peptide-cigb-300,Code name:,CIGB-300
2020-09-18T05:30:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ck2-targeting-synthetic-peptide-cigb-300,Code name:,P15-tat
2020-09-18T05:30:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-kit-inhibitor-plx9486,Code name:,PLX9486
2020-09-18T05:30:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine,Synonym:,Cladribina
2020-09-18T05:30:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine,Foreign brand name:,Leustat
2020-09-18T05:30:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine,Foreign brand name:,Leustatine
2020-09-18T05:30:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine,Abbreviation:,2-CdA
2020-09-18T05:30:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine,Abbreviation:,2CDA
2020-09-18T05:30:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine,Code name:,RWJ-26251
2020-09-18T05:30:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine,Chemical structure:,2-chloro-2-deoxyadenosine2-chlorodeoxyadenosine
2020-09-18T05:30:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefotaxime,US brand name:,Claforan
2020-09-18T05:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,Synonym:,"9,11-conjugated linoleic acid"
2020-09-18T05:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,Synonym:,"9,11-linoleic acid"
2020-09-18T05:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,US brand name:,Clarinol
2020-09-18T05:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,US brand name:,Pamolyn 300
2020-09-18T05:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,Abbreviation:,CLA
2020-09-18T05:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,Chemical structure:,"9,11-octadecadienoic acid"
2020-09-18T05:30:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clarithromycin,Synonym:,Abbott-56268
2020-09-18T05:30:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clarithromycin,US brand name:,Biaxin
2020-09-18T05:30:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clarithromycin,Abbreviation:,CLARITH
2020-09-18T05:30:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clarithromycin,Chemical structure:,6-O-Methylerythromycin
2020-09-18T05:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loratadine,US brand name:,Claritin
2020-09-18T05:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loratadine,Chemical structure:,"1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-, Ethyl Ester"
2020-09-18T05:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/class-1-pi3k-family-inhibitor-xl147,Synonym:,PI3K inhibitor XL147
2020-09-18T05:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/class-1-pi3k-family-inhibitor-xl147,Synonym:,SAR245408
2020-09-18T05:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/class-1-pi3k-family-inhibitor-xl147,Code name:,XL147
2020-09-18T05:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801634,Synonym:,class-1/4 HDACi OKI-179
2020-09-18T05:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801634,Synonym:,HDAC inhibitor OKI-179
2020-09-18T05:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801634,Synonym:,HDAC1/4i OKI-179
2020-09-18T05:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801634,Synonym:,HDACi 1/4 OKI-179
2020-09-18T05:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801634,Synonym:,HDACi OKI-179
2020-09-18T05:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801634,Code name:,OKI 179
2020-09-18T05:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801634,Code name:,OKI-179
2020-09-18T05:31:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevidipine-butyrate-injectable-emulsion,US brand name:,Cleviprex
2020-09-18T05:31:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevidipine-butyrate-injectable-emulsion,US brand name:,Cleviprex
2020-09-18T05:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevudine,Foreign brand name:,Levovir
2020-09-18T05:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevudine,Foreign brand name:,Revovir
2020-09-18T05:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevudine,Abbreviation:,L-FMAU
2020-09-18T05:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevudine,Chemical structure:,"1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)-5-methyl-1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)thymine; 2,4(1H,3H)-pyrimidinedione2'-Fluoro-5-methyl-beta-L-arabinofuranosyluracil"
2020-09-18T05:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clindamycin-phosphate,Code name:,U 28508
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Code name:,MIYAIRI 588
2020-09-18T05:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clindamycin-phosphate,Chemical structure:,7(S)-chloro-7-deoxylincomycin 2-phosphate
2020-09-18T05:31:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clindamycin-hydrocortisone-lotion,NA,NA
2020-09-18T05:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olive-oil-soya-oil-egg-lecithin-based-emulsion,US brand name:,ClinOleic
2020-09-18T05:31:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clino-san-vaginal-lubricant,Foreign brand name:,Clino-San
2020-09-18T05:31:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clioquinol,Chemical structure:,5–chloro-7–iodo-quinolin-8-ol
2020-09-18T05:31:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clobetasol-propionate,NA,NA
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Synonym:,"clodronic acid, disodium salt"
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Synonym:,disodium dichloromethylene diphosphonate
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Foreign brand name:,Bonefos
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Foreign brand name:,Clasteon
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Foreign brand name:,Difosfonal
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Foreign brand name:,Loron
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Foreign brand name:,Mebonat
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Foreign brand name:,Ossiten
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Code name:,CL2MDP
2020-09-18T05:32:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofarabine,US brand name:,Clolar
2020-09-18T05:32:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofarabine,Abbreviation:,CAFdA
2020-09-18T05:32:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofarabine,Chemical structure:,2-Chloro-9-(2-deoxy-2-fluoroarabinofuranosyl)adenine2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine
2020-09-18T05:32:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofibrate,US brand name:,Atromid-S
2020-09-18T05:32:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofibrate,Abbreviation:,CFB
2020-09-18T05:32:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofibrate,Chemical structure:,2-(4-chlorophenoxy)-2-methylpropanoic acid ethyl esterethyl 2-(4-chlorophenoxy)-2-methylpropanoateethyl p-chlorophenoxyisobyturate
2020-09-18T05:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofarabine,US brand name:,Clolar
2020-09-18T05:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofarabine,Abbreviation:,CAFdA
2020-09-18T05:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofarabine,Chemical structure:,2-Chloro-9-(2-deoxy-2-fluoroarabinofuranosyl)adenine2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine
2020-09-18T05:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clomiphene-citrate,US brand name:,Clomid
2020-09-18T05:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clomiphene-citrate,US brand name:,Serophene
2020-09-18T05:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clomiphene-citrate,Chemical structure:,"2-[p-(2-chloro-1,2-diphenylvinyl)phenoxy]triethylamine citrate (1:1)"
2020-09-18T05:32:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clomiphene-citrate,US brand name:,Clomid
2020-09-18T05:32:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clomiphene-citrate,US brand name:,Serophene
2020-09-18T05:32:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clomiphene-citrate,Chemical structure:,"2-[p-(2-chloro-1,2-diphenylvinyl)phenoxy]triethylamine citrate (1:1)"
2020-09-18T05:32:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clonidine-hydrochloride,US brand name:,Catapres
2020-09-18T05:32:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clonidine-containing-mucoadhesive-buccal-tablet,US brand name:,Clonidine Lauriad
2020-09-18T05:32:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clonidine-containing-mucoadhesive-buccal-tablet,US brand name:,Clonidine Lauriad
2020-09-18T05:32:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clopidogrel-bisulfate,Synonym:,Plavix
2020-09-18T05:32:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clopidogrel-bisulfate,US brand name:,Plavix
2020-09-18T05:32:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clopidogrel-bisulfate,Abbreviation:,CLOBI
2020-09-18T05:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laromustine,US brand name:,Cloretazine
2020-09-18T05:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laromustine,US brand name:,Onrigin
2020-09-18T05:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laromustine,Code name:,VNP40101M
2020-09-18T05:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laromustine,Chemical structure:,"1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylaminocarbonyl)hydrazine2'-(2-chloroethyl)-N-methyl-1',2'-bis(methylsulfonyl)carbamohydrazidemethanesulfonic acid, 1-(2-chloroethyl)-2-[(methylamino)carbonyl]-2- (methylsulfonyl)hydrazide"
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Synonym:,C. butyricum CBM 588 probiotic strain
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Synonym:,C. butyricum MIYAIRI strain
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Synonym:,C. butyricum MIYAIRI strain CBM 588
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Synonym:,C. butyricum strain MIYAIRI 588
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Synonym:,Clostridium butyricum MIYAIRI 588
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Synonym:,Clostridium butyricum MIYAIRI 588 probiotic strain
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Synonym:,MIYAIRI 588 strain of C. butyricum
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Code name:,CBM 588
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Code name:,CBM588
2020-09-18T05:32:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-butyricum-containing-probiotic,Synonym:,C. butyricum-containing probiotic
2020-09-18T05:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-novyi-nt-spores,Abbreviation:,C. novyi-NT spores
2020-09-18T05:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole,US brand name:,Gyne-Lotrimin
2020-09-18T05:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole,US brand name:,Lotrimin
2020-09-18T05:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole,US brand name:,Mycelex
2020-09-18T05:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole,US brand name:,Mycelex Troche
2020-09-18T05:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole,Abbreviation:,CLOT
2020-09-18T05:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole,Chemical structure:,1-[(2-Chlorophenyl)diphenylmethyl]-1H-imidazole
2020-09-18T05:33:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800675,Chemical structure:,"8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine"
2020-09-18T05:33:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmet-car-mrna-electroporated-autologous-t-lymphocytes,Synonym:,cMet RNA CAR T cells
2020-09-18T05:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800797,Code name:,ABN 401
2020-09-18T05:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800797,Code name:,ABN401
2020-09-18T05:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800797,Code name:,ABN-401
2020-09-18T05:33:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-al2846,Code name:,AL 2846
2020-09-18T05:33:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-al2846,Code name:,AL2846
2020-09-18T05:33:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-al2846,Code name:,AL-2846
2020-09-18T05:33:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-amg-208,Code name:,AMG 208
2020-09-18T05:33:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-amg-337,Code name:,AMG 337
2020-09-18T05:33:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-amg-337,Code name:,AMG337
2020-09-18T05:33:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793087,Code name:,CBT-101
2020-09-18T05:33:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-hs-10241,Code name:,HS-10241
2020-09-18T05:33:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-jnj-38877605,Code name:,JNJ-38877605
2020-09-18T05:34:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-msc2156119j,Code name:,MSC2156119J
2020-09-18T05:34:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-plb1001,Code name:,PLB1001
2020-09-18T05:34:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-plb1001,Code name:,PLB-1001
2020-09-18T05:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmf-regimen,Synonym:,cyclophosphamide-methotrexate-fluorouracil regimen
2020-09-18T05:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmf-regimen,Abbreviation:,CMF
2020-09-18T05:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmf-regimen,Abbreviation:,CTX/5-FU/MTX
2020-09-18T05:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmf-regimen,Code name:,cyclophosphamide/fluorouracil/methotrexate
2020-09-18T05:34:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmv-pp65-peptide,Abbreviation:,CMV-PEP
2020-09-18T05:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792787,Synonym:,CMV/EBV/ADV/BKV-specific CTLs
2020-09-18T05:34:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmvpp65-gb-plasmid-vaccine-asp0113,Synonym:,TransVax
2020-09-18T05:34:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmvpp65-gb-plasmid-vaccine-asp0113,Code name:,ASP0113
2020-09-18T05:34:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmvpp65-a0201-peptide-vaccine,NA,NA
2020-09-18T05:34:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-myb-antisense-oligonucleotide-g4460,Code name:,G4460
2020-09-18T05:34:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-myb-antisense-oligonucleotide-g4460,Code name:,INX-3001
2020-09-18T05:34:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-myb-antisense-oligonucleotide-g4460,Code name:,LR3001
2020-09-18T05:34:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cndo-109-activated-allogeneic-natural-killer-cells,Synonym:,CNDO-109-AANK cells
2020-09-18T05:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cngrc-peptide-tnf-alpha-conjugate,Synonym:,CNGRC peptide-tumor necrosis factor alpha conjugate
2020-09-18T05:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cngrc-peptide-tnf-alpha-conjugate,Synonym:,tumor vasculature-targeted tumor necrosis factor alpha
2020-09-18T05:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cngrc-peptide-tnf-alpha-conjugate,Abbreviation:,NGR-hTNF
2020-09-18T05:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cngrc-peptide-tnf-alpha-conjugate,Abbreviation:,NGR-TNF
2020-09-18T05:34:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobimetinib,US brand name:,Cotellic
2020-09-18T05:34:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobimetinib,Code name:,GDC-0973
2020-09-18T05:34:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobimetinib,Code name:,XL518
2020-09-18T05:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lna-based-antimir-155-mrg-106,Synonym:,anti-miR-155 oligonucleotide MRG-106
2020-09-18T05:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lna-based-antimir-155-mrg-106,Synonym:,LNA antimiR-155 MRG-106
2020-09-18T05:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lna-based-antimir-155-mrg-106,Synonym:,LNA-based antimiR-155 MRG-106
2020-09-18T05:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lna-based-antimir-155-mrg-106,Synonym:,microRNA-155 antagonist MRG-106
2020-09-18T05:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lna-based-antimir-155-mrg-106,Synonym:,MiR-155 antagonist MRG-106
2020-09-18T05:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lna-based-antimir-155-mrg-106,Code name:,MRG-106
2020-09-18T05:37:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/combretastatin-a1-diphosphate,Code name:,OXi4503
2020-09-18T05:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cocculus-nux-vomica-tabacum-petroleum-extract,Foreign brand name:,Cocculine
2020-09-18T05:35:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cocoa-extract,Synonym:,cocoa extract supplement
2020-09-18T05:35:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/codeine-phosphate,Synonym:,tricodein
2020-09-18T05:35:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/codeine-phosphate,Chemical structure:,"morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5-alpha,6-alpha)-, phosphate"
2020-09-18T05:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coenzyme-q10,Synonym:,coenzyme-Q
2020-09-18T05:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coenzyme-q10,Synonym:,Ubidecarenone
2020-09-18T05:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coenzyme-q10,Synonym:,Ubiquinone
2020-09-18T05:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coenzyme-q10,Synonym:,Ubiquinone 10
2020-09-18T05:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coenzyme-q10,Abbreviation:,Co-Q10
2020-09-18T05:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coenzyme-q10,Chemical structure:,"2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecanyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione"
2020-09-18T05:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,Synonym:,"5,10 methylenetetrahydrofolate"
2020-09-18T05:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,Synonym:,"5,10-methylenetetrahydrofolate"
2020-09-18T05:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,US brand name:,CoFactor
2020-09-18T05:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,Abbreviation:,"5,10-MTHF"
2020-09-18T05:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,Abbreviation:,MTHF
2020-09-18T05:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,Code name:,ANX-510
2020-09-18T05:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-pf-06647020,Synonym:,ADC PF-06647020
2020-09-18T05:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-pf-06647020,Synonym:,ADC PF-7020
2020-09-18T05:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-pf-06647020,Code name:,h6M24-vc0101
2020-09-18T05:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-pf-06647020,Code name:,PF 06647020
2020-09-18T05:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-pf-06647020,Code name:,PF 7020
2020-09-18T05:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-pf-06647020,Code name:,PF-06647020
2020-09-18T05:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-pf-06647020,Code name:,PF-7020
2020-09-18T05:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794158,Synonym:,coffee bean extract
2020-09-18T05:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794158,Synonym:,green coffee bean extract
2020-09-18T05:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794158,Synonym:,green coffee beans extract
2020-09-18T05:35:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coffee-dietary-supplement,NA,NA
2020-09-18T05:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colchicine,Chemical structure:,"(S)-N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide"
2020-09-18T05:35:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cold-contaminant-free-iobenguane-i-131,Synonym:,cold contaminant-free I 131-MIBG
2020-09-18T05:35:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cold-contaminant-free-iobenguane-i-131,Synonym:,cold contaminant-free iodine I 131 metaiodobenzylguanidine
2020-09-18T05:35:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cold-contaminant-free-iobenguane-i-131,Synonym:,ultratrace iodine I 131 metaiodobenzylguanidine
2020-09-18T05:35:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cold-contaminant-free-iobenguane-i-131,US brand name:,Azedra
2020-09-18T05:36:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/north-american-ginseng-extract-afx-2,Synonym:,Panax quinquefolius Extract AFX-2
2020-09-18T05:36:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/north-american-ginseng-extract-afx-2,US brand name:,COLD-fX
2020-09-18T05:36:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/north-american-ginseng-extract-afx-2,Code name:,AFX-2
2020-09-18T05:36:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/north-american-ginseng-extract-afx-2,Code name:,CVT-E002
2020-09-18T05:36:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colesevelam-hydrochloride,US brand name:,CholestaGel
2020-09-18T05:36:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colesevelam-hydrochloride,US brand name:,Welchol
2020-09-18T05:36:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colesevelam-hydrochloride,Chemical structure:,"1-hexaminium, N,N,N-trimethyl-6-(2-propenylamino)-, chloride, polymer with (chloromethyl)oxirane, 2-propen-4-amine and N-2-propenyl-1-decanamine, hydrochlorideGT 31-104HB"
2020-09-18T05:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium,Synonym:,colimyscine
2020-09-18T05:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium,Synonym:,colistin sodium methanesulfonate
2020-09-18T05:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium,Synonym:,pentasodium colistinmethanesulfonate
2020-09-18T05:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium,US brand name:,Coly-Mycin
2020-09-18T05:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium,Code name:,W-1929
2020-09-18T05:36:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/collagen-aloe-vera-vitamin-e-lidocaine-topical-hydrogel,US brand name:,Regenecare
2020-09-18T05:36:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Synonym:,colloidal gold-bound recombinant human tumor necrosis factor
2020-09-18T05:36:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Synonym:,colloidal gold-bound rhTNF
2020-09-18T05:36:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Synonym:,colloidal gold-bound TNF
2020-09-18T05:36:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,US brand name:,Aurimmune
2020-09-18T05:36:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Code name:,CYT-6091
2020-09-18T05:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794070,Synonym:,colloidal succinylated gelatine plasma substitute
2020-09-18T05:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794070,Foreign brand name:,Gelaspan
2020-09-18T05:36:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-oatmeal-cream,US brand name:,Aveeno cream
2020-09-18T05:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794166,Synonym:,PolyPEPI1018 CRC peptide vaccine
2020-09-18T05:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794166,Synonym:,PolyPEPI1018 CRC vaccine
2020-09-18T05:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794166,Code name:,PolyPEPI 1018
2020-09-18T05:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794166,Code name:,PolyPEPI1018
2020-09-18T05:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794166,Code name:,PolyPEPI-1018
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Synonym:,progesterone
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,US brand name:,Colprosterone
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,US brand name:,Gesterol 100
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,US brand name:,Lipo-Lutin
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,US brand name:,Lucorteum Sol
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,US brand name:,Luteohormone
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,US brand name:,Progestin
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,US brand name:,Prolutin
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Corlutina
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Corluvite
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Cyclogest
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Gestiron
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Gestone
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Lutocyclin
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Lutocylin
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Lutocylin M
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Lutogyl
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Lutromone
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Progestasert
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Progesterol
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Progestogel
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Progestol
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Progeston
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Prolidon
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Syngesterone
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Utrogestan
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Abbreviation:,PRG
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Chemical structure:,"delta4-pregnene-3,20-dione"
2020-09-18T05:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium,Synonym:,colimyscine
2020-09-18T05:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium,Synonym:,colistin sodium methanesulfonate
2020-09-18T05:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium,Synonym:,pentasodium colistinmethanesulfonate
2020-09-18T05:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium,US brand name:,Coly-Mycin
2020-09-18T05:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium,Code name:,W-1929
2020-09-18T05:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,Synonym:,Ultrasmall Particulate Iron Oxide
2020-09-18T05:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,US brand name:,Combidex
2020-09-18T05:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,Foreign brand name:,Sinerem
2020-09-18T05:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,Abbreviation:,USPIO
2020-09-18T05:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,Code name:,AMI-227
2020-09-18T05:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,Code name:,G-53425
2020-09-18T05:36:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deglycosylated-ricin-a-chain-conjugated-anti-cd19-anti-cd22-immunotoxins,Synonym:,IgG-HD37-dgA/IgG-RFB4-dgA immunotoxins
2020-09-18T05:36:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deglycosylated-ricin-a-chain-conjugated-anti-cd19-anti-cd22-immunotoxins,US brand name:,Combotox
2020-09-18T05:37:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,US brand name:,Cabometyx
2020-09-18T05:37:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,US brand name:,Cometriq
2020-09-18T05:37:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,Code name:,BMS-907351
2020-09-18T05:37:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,Code name:,XL184
2020-09-18T05:37:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,Chemical structure:,"butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1)"
2020-09-18T05:37:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-lozenge,US brand name:,Commit
2020-09-18T05:37:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792524,Synonym:,FD inhibitor ACH-4471
2020-09-18T05:37:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792524,Code name:,ACH-0144471
2020-09-18T05:37:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792524,Code name:,ACH-4471
2020-09-18T05:37:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/compound-kushen-injection,Synonym:,KS injection
2020-09-18T05:37:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/compound-kushen-injection,Synonym:,Yanshu injection
2020-09-18T05:37:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/compound-kushen-injection,Abbreviation:,CKI
2020-09-18T05:37:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/compound-sodium-lactate-solution,Synonym:,CSL solution
2020-09-18T05:37:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/compound-sodium-lactate-solution,Synonym:,Hartmann's solution
2020-09-18T05:37:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/compound-sodium-lactate-solution,Synonym:,"sodium chloride, potassium chloride, calcium chloride dihydrate, sodium lactate 60% solution"
2020-09-18T05:37:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801668,US brand name:,Comtan
2020-09-18T05:37:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conatumumab,Synonym:,anti-TRAIL receptor 2 monoclonal antibody AMG 655
2020-09-18T05:37:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conatumumab,Code name:,AMG 655
2020-09-18T05:37:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798956,Synonym:,UNII: 1P05PW62F3
2020-09-18T05:37:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798956,Code name:,KH 902
2020-09-18T05:37:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798956,Code name:,KH902
2020-09-18T05:37:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798956,Code name:,KH-902
2020-09-18T05:37:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,US brand name:,Concentraid
2020-09-18T05:37:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,US brand name:,DDAVP
2020-09-18T05:37:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,US brand name:,Stimate
2020-09-18T05:37:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,Foreign brand name:,Octostim
2020-09-18T05:37:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,Chemical structure:,1-(3-mercaptopropionic acid)-8-D-arginine vasopression monoacetate
2020-09-18T05:37:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/concentrated-beet-crystals,US brand name:,BeetElite NeoShot
2020-09-18T05:38:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799459,Synonym:,concentrated Ganoderma lucidum extract
2020-09-18T05:38:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799459,Synonym:,concentrated red Reishi mushroom extract
2020-09-18T05:38:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799459,Foreign brand name:,Mikei Red Reishi Essence EX
2020-09-18T05:38:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/concentrated-fortified-collagen-protein-hydrolysate-liquid-supplement,US brand name:,Pro-Stat 101
2020-09-18T05:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylphenidate-hydrochloride,Synonym:,d-methylphenidate
2020-09-18T05:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylphenidate-hydrochloride,US brand name:,Concerta
2020-09-18T05:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylphenidate-hydrochloride,US brand name:,Quillivant XR
2020-09-18T05:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylphenidate-hydrochloride,US brand name:,Ritalin
2020-09-18T05:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylphenidate-hydrochloride,Chemical structure:,alpha-phenyl-2-piperidineacetic acid methyl ester hydrochloride
2020-09-18T05:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795303,Synonym:,ADC BA3011
2020-09-18T05:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795303,Synonym:,CAB anti-AXL ADC BA3011
2020-09-18T05:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795303,Synonym:,CAB-AXL-ADC BA3011
2020-09-18T05:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795303,Code name:,BA 3011
2020-09-18T05:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795303,Code name:,BA3011
2020-09-18T05:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795303,Code name:,BA-3011
2020-09-18T05:38:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-replicative-adenovirus-5-3-delta24,Synonym:,conditionally replicative adenovirus 3/5-delta
2020-09-18T05:38:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-replicative-adenovirus-5-3-delta24,Abbreviation:,Ad5/3-delta24
2020-09-18T05:38:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-replicative-adenovirus-5-3-delta24,Abbreviation:,CRAd 3/5-delta
2020-09-18T05:38:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-replicative-adenovirus-5-3-delta24,Abbreviation:,CRAd 5/3-delta24
2020-09-18T05:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,US brand name:,Femest
2020-09-18T05:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,US brand name:,Premarin
2020-09-18T05:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,Foreign brand name:,Conestron
2020-09-18T05:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,Foreign brand name:,Sodestrin
2020-09-18T05:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,Abbreviation:,EST
2020-09-18T05:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,Code name:,Tag-39
2020-09-18T05:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens-bazedoxifene,Synonym:,CE/BZA formulation
2020-09-18T05:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens-bazedoxifene,US brand name:,Duavee
2020-09-18T05:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens-bazedoxifene,Abbreviation:,CE/BZA
2020-09-18T05:38:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,Synonym:,"9,11-conjugated linoleic acid"
2020-09-18T05:38:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,Synonym:,"9,11-linoleic acid"
2020-09-18T05:38:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,US brand name:,Clarinol
2020-09-18T05:38:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,US brand name:,Pamolyn 300
2020-09-18T05:38:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,Abbreviation:,CLA
2020-09-18T05:38:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,Chemical structure:,"9,11-octadecadienoic acid"
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,Synonym:,theophylline monohydrate
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Constant-T
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Elixophyllin
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,LaBID
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Respbid
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Slo-bid
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Slo-Phyllin
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Somophyllin-CRT
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Somophyllin-T
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Theo-24
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Theobid Duracap
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Theochron
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,T-Phyl
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Uniphyl
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,Chemical structure:,"1,3-dimethylxanthine monohydrate3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione monohydrate"
2020-09-18T05:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-144,Synonym:,autologous TIL LN-144
2020-09-18T05:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-144,US brand name:,Contego
2020-09-18T05:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-144,Code name:,LN-144
2020-09-18T05:38:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/contrast-agent-cs-1000,Code name:,CS-1000
2020-09-18T05:39:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copdac-regimen,Synonym:,cyclophosphamide/Oncovin/prednisone/dacarbazine regimen
2020-09-18T05:39:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copdac-regimen,Synonym:,cyclophosphamide/vincristine sulfate (Oncovin)/prednisone/dacarbazine
2020-09-18T05:39:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copdac-regimen,Synonym:,cyclophosphamide/vincristine sulfate/prednisone/dacarbazine
2020-09-18T05:39:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copdac-regimen,Synonym:,cyclophosphamide/vincristine/prednisone/dacarbazine regimen
2020-09-18T05:39:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copdac-regimen,Abbreviation:,COPDAC
2020-09-18T05:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvelisib,US brand name:,Copiktra
2020-09-18T05:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvelisib,Code name:,INK-1197
2020-09-18T05:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvelisib,Code name:,IPI-145
2020-09-18T05:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvelisib,Chemical structure:,"1(2H)-isoquinolinone, 8-chloro-2-phenyl-3-((1S)-1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenyl-3-((1S)-1-(7H-purin-6-ylamino)ethyl)isoquinolin-1(2H)-one"
2020-09-18T05:39:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-regimen,Synonym:,cyclophosphamide/prednisone/procarbazine/vincristine
2020-09-18T05:39:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-regimen,Synonym:,cyclophosphamide-Oncovin-procarbazine-prednisone regimen
2020-09-18T05:39:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-regimen,Abbreviation:,CTX/PCB/PRED/VCR
2020-09-18T05:39:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-regimen,Acronym:,COPP
2020-09-18T05:39:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-abv-regimen,Synonym:,COPP-ABV
2020-09-18T05:39:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-abv-regimen,Synonym:,Cytoxan-Oncovin-procarbazine-prednisone/adriamycin-bleomycin-vinblastine regimen
2020-09-18T05:39:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-chloride-formulation,Synonym:,CuCl2 formulation
2020-09-18T05:39:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cr2-fh-fusion-protein-tt30,Synonym:,recombinant chimeric human fusion protein TT30
2020-09-18T05:39:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cr2-fh-fusion-protein-tt30,Code name:,TT30
2020-09-18T05:39:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-62-ethylglyoxal-bisthiosemicarbazone,Synonym:,62Cu-ethylglyoxal bis
2020-09-18T05:39:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-62-ethylglyoxal-bisthiosemicarbazone,Synonym:,62Cu-ethylglyoxal bis(thiosemicarbazone)
2020-09-18T05:39:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-62-ethylglyoxal-bisthiosemicarbazone,Abbreviation:,62Cu-ETS
2020-09-18T05:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-62-atsm,Abbreviation:,62Cu-ATSM
2020-09-18T05:39:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-62-ptsm,Abbreviation:,62Cu-PTSM
2020-09-18T05:39:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-anti-cea-monoclonal-antibody-m5a,Synonym:,64Cu-DOTA-M5A
2020-09-18T05:39:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-anti-cea-monoclonal-antibody-m5a,Synonym:,Cu 64-M5A
2020-09-18T05:39:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-daratumumab,Synonym:,64Cu-DOTA-daratumumab
2020-09-18T05:39:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-daratumumab,Synonym:,copper Cu 64 daratumumab
2020-09-18T05:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800203,Synonym:,(64Cu)-labeled PSMA-targeting -PEG Cy5.5-C' dots
2020-09-18T05:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800203,Synonym:,64Cu-NOTA-PSMAi-PEG-Cy5.5-C' dots
2020-09-18T05:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800203,Synonym:,64Cu-NOTA-PSMA-PEG-Cy5.5-C' dot tracer
2020-09-18T05:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800203,Synonym:,64Cu-NOTA-PSMA-PEG-Cy5.5-C' dots
2020-09-18T05:40:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-plerixafor,Synonym:,64-Cu-plerixafor
2020-09-18T05:40:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-tp3805,Abbreviation:,Cu-64-TP3805
2020-09-18T05:40:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-trastuzumab,Synonym:,Cu-64 labeled trastuzumab
2020-09-18T05:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-atsm,Synonym:,(64)Cu-ATSM
2020-09-18T05:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-atsm,Chemical structure:,Cu-64(II)-diacetyl-bis(N-4-methylthiosemicarbazone)
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,(64)Cu-CB-TE1A1P-PEG4-LLP2A
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,(64)Cu-labeled CB-TE1A1P-PEG4 LLP2A
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,(64)Cu-labeled CB-TE1A1P-PEG4-LLP2A
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,64Cu-CB-TE1A1P-PEG4-LLP2A
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,64Cu-LLP2A
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,64Cu-PEG4-LLP2A
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,copper Cu 64-LLP2A
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,Cu[64]-CB-TE1A1P-PEG4-LLP2A
2020-09-18T05:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-b-fab,Synonym:,64 Cu-DOTA B-Fab
2020-09-18T05:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-b-fab,Synonym:,64 Cu-DOTA DS6 B-Fab
2020-09-18T05:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-b-fab,Synonym:,Cu 64-labeled B-Fab DS6 antibody-like binding protein
2020-09-18T05:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-ae105,Synonym:,64Cu-DOTA-AE105
2020-09-18T05:40:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-anti-her3-monoclonal-antibody-u3-1287,Synonym:,[64Cu]-DOTA-AMG 888
2020-09-18T05:40:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-anti-her3-monoclonal-antibody-u3-1287,Abbreviation:,64Cu-DOTA-U3-1287
2020-09-18T05:40:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797547,Synonym:,64Cu-d(LGTFLKC)
2020-09-18T05:40:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797547,Synonym:,64Cu-DOTA-ECL1i
2020-09-18T05:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-rituximab,Synonym:,64Cu-DOTA-rituximab
2020-09-18T05:40:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-trastuzumab,Synonym:,64Cu-DOTA-trastuzumab
2020-09-18T05:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801332,Synonym:,67Cu-labelled MeCOSar-Tyr3-octreotate
2020-09-18T05:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801332,Synonym:,copper 67 SARTATE
2020-09-18T05:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801332,Synonym:,copper Cu 67 TATE
2020-09-18T05:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801332,Synonym:,copper Cu 67-SARTATE
2020-09-18T05:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801332,Synonym:,Cu-67 SARTATE
2020-09-18T05:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801332,Abbreviation:,67Cu-SARTATE
2020-09-18T05:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793386,Synonym:,[64Cu]-DOTA-alendronate
2020-09-18T05:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793386,Synonym:,64Cu-DOTA-alendronate
2020-09-18T05:41:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-gluconate,Synonym:,cupric gluconate
2020-09-18T05:41:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-supplement,Synonym:,copper
2020-09-18T05:41:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-supplement,Abbreviation:,Cu
2020-09-18T05:41:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801490,Synonym:,CB-derived CAR T cells
2020-09-18T05:41:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801490,Synonym:,cord blood CAR T cells
2020-09-18T05:41:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798318,Synonym:,allogeneic cord blood-derived CMV/AdV/EBV/BKV-specific CTLs
2020-09-18T05:41:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798318,Synonym:,cord blood-derived CMV/AdV/EBV/BKV-specific T cells
2020-09-18T05:41:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798318,Synonym:,UCB-derived CMV/AdV/EBV/BKV-specific T cells
2020-09-18T05:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793416,Synonym:,allogeneic CB-derived ex vivo-expanded NK cells
2020-09-18T05:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793416,Synonym:,CB-derived expanded allogeneic NK cells
2020-09-18T05:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793416,Synonym:,UCB-derived expanded allogeneic NK cells
2020-09-18T05:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793416,Synonym:,umbilical cord blood-derived expanded allogeneic natural killer cells
2020-09-18T05:41:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cordycepin,Synonym:,Cordycepine
2020-09-18T05:41:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cordycepin,Synonym:,Kordicepin
2020-09-18T05:41:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cordycepin,Abbreviation:,COR
2020-09-18T05:41:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cordycepin,Chemical structure:,3'-dA-CE Phosphoramidite3-dAdenosine3'-Deoxyadenosine3'-Deoxyadenosine-5'-triphosphate9-Cordyceposidoadenine
2020-09-18T05:41:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carvedilol,US brand name:,Coreg
2020-09-18T05:41:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carvedilol-phosphate-extended-release-capsule,US brand name:,Coreg CR
2020-09-18T05:41:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadolol,US brand name:,Corgard
2020-09-18T05:42:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coriolus-versicolor-extract,Synonym:,Yunzhi extract
2020-09-18T05:42:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792710,US brand name:,Corlanor
2020-09-18T05:42:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792710,Code name:,S-16257
2020-09-18T05:42:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801632,Synonym:,"starch, corn"
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Synonym:,delta(1)hydrocortisone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Synonym:,delta1-dehydro-hydrocortisone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Synonym:,deltahydrocortisone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Synonym:,metacortandralone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Cortalone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Delta-Cortef
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Hydeltra
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Hydeltrasol
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Meti-derm
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Prelone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Adnisolone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Aprednislon
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Capsoid
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Cortisolone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Dacortin H
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Decaprednil
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Decortin H
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Delta- Cortef
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Deltacortril
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Delta-Diona
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Delta-Phoricol
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Deltasolone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Deltidrosol
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Dhasolone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Di-Adreson-F
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Dontisolon D
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Estilsona
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Fisopred
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Frisolona
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Gupisone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Hostacortin H
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Klismacort
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Kuhlprednon
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Lenisolone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Lepi-Cortinolo
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Linola-H N
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Linola-H-Fett N
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Longiprednil
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Meticortelone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Opredsone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Panafcortelone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Precortisyl
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Pred-Clysma
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Predeltilone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Predni-Coelin
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Prednicortelone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Predni-Helvacort
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Prenilone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Abbreviation:,PRDL
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Chemical structure:,"(11beta)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione1,2-dehydrohydrocortisone"
2020-09-18T05:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticorelin-acetate,Synonym:,corticoliberin
2020-09-18T05:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticorelin-acetate,Synonym:,corticorelin
2020-09-18T05:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticorelin-acetate,Synonym:,hCRF
2020-09-18T05:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticorelin-acetate,Synonym:,recombinant human corticotropin releasing factor
2020-09-18T05:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticorelin-acetate,Synonym:,synthetic human corticotropin-releasing factor
2020-09-18T05:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticorelin-acetate,US brand name:,Xerecept
2020-09-18T05:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticotropin-releasing-hormone,Synonym:,corticotropin-releasing factor
2020-09-18T05:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticotropin-releasing-hormone,Synonym:,CRF
2020-09-18T05:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticotropin-releasing-hormone,Synonym:,CRH
2020-09-18T05:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corynebacterium-granulosum-p40,Synonym:,Adjuvant P40
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,ACT-D
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin C1
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin D
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin I1
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin IV
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin X 1
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin-[thr-val-pro-sar-meval]
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,AD
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,dactinomycine
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,meractinomycin
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,US brand name:,Cosmegen
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Foreign brand name:,Lyovac Cosmegen
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Abbreviation:,DACT
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Chemical structure:,"2-bis[cyclo(N-methyl-L-valyl-sarcosyl-L-prolyl-D-valyl-L-threonyl)]-1,9 dimethyl-4,6 3H-phenoxazinone-3"
2020-09-18T05:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-tnt-1-b,Synonym:,iodine I 131 MOAB TNT-1/B
2020-09-18T05:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-tnt-1-b,US brand name:,Cotara
2020-09-18T05:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-tnt-1-b,Abbreviation:,I 131 MOAB TNT-1/B
2020-09-18T05:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobimetinib,US brand name:,Cotellic
2020-09-18T05:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobimetinib,Code name:,GDC-0973
2020-09-18T05:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobimetinib,Code name:,XL518
2020-09-18T05:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Synonym:,cotrimoxazole
2020-09-18T05:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Synonym:,Eslectin
2020-09-18T05:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Synonym:,insozalin
2020-09-18T05:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Synonym:,trimedin
2020-09-18T05:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Synonym:,trimezole
2020-09-18T05:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Bactrim
2020-09-18T05:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Cotrim
2020-09-18T05:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Septra
2020-09-18T05:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Sulfamethoprim
2020-09-18T05:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Sulfatrim
2020-09-18T05:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Sulmeprim
2020-09-18T05:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Abbreviation:,SMZ-TMP
2020-09-18T05:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Abbreviation:,TMP-SMX
2020-09-18T05:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium,Synonym:,prothromadin
2020-09-18T05:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium,Synonym:,tintorane
2020-09-18T05:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium,US brand name:,Coumadin
2020-09-18T05:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium,US brand name:,Panwarfin
2020-09-18T05:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium,Foreign brand name:,Marevan
2020-09-18T05:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium,Foreign brand name:,Waran
2020-09-18T05:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium,Foreign brand name:,Warfilone
2020-09-18T05:43:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coumarin,Synonym:,chromen-2-one
2020-09-18T05:43:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coumarin,Synonym:,tonka bean camphor
2020-09-18T05:43:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coumarin,Chemical structure:,"1,2-benzopyrone2H-1-benzopyran-2-one"
2020-09-18T05:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795332,Synonym:,complement C5-inhibitor rEV576
2020-09-18T05:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795332,Synonym:,recombinant EV576
2020-09-18T05:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795332,Synonym:,recombinant OmCI
2020-09-18T05:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795332,Synonym:,recombinant Ornithodoros moubata complement inhibitor
2020-09-18T05:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795332,Synonym:,rEV576
2020-09-18T05:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795332,US brand name:,Coversin
2020-09-18T05:43:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,US brand name:,Cavatak
2020-09-18T05:43:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,Foreign brand name:,Cavatak
2020-09-18T05:43:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,Abbreviation:,CVA21
2020-09-18T05:43:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,Code name:,V 937
2020-09-18T05:43:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,Code name:,V937
2020-09-18T05:43:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,Code name:,V-937
2020-09-18T05:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/losartan-potassium,US brand name:,Cozaar
2020-09-18T05:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/losartan-potassium,Chemical structure:,"2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, monopotassium salt"
2020-09-18T05:43:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cp-724714,NA,NA
2020-09-18T05:43:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide,Abbreviation:,CpG ODN
2020-09-18T05:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-gnkg168,Abbreviation:,CpG ODN GNKG168
2020-09-18T05:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-gnkg168,Code name:,GNKG168
2020-09-18T05:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-tlr9-agonist-dv281,Synonym:,CpG ODN TLR9 agonist DV281
2020-09-18T05:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-tlr9-agonist-dv281,Synonym:,TLR9 agonist DV281
2020-09-18T05:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-tlr9-agonist-dv281,Code name:,DV 281
2020-09-18T05:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-tlr9-agonist-dv281,Code name:,DV281
2020-09-18T05:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-tlr9-agonist-dv281,Code name:,DV-281
2020-09-18T05:43:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daptomycin,US brand name:,Cubicin
2020-09-18T05:43:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daptomycin,Code name:,LY146032
2020-09-18T05:43:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daptomycin,Chemical structure:,N-Decanoyl-L-tryptophyl-L-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine epsilon1-lactone
2020-09-18T05:43:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/creatine-monohydrate,Synonym:,creatine supplement
2020-09-18T05:43:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/creatine-monohydrate,Chemical structure:,N-(aminoiminomethyl)-N-methylglycine monohydrate
2020-09-18T05:43:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crenolanib,Synonym:,PDGFR inhibitor CP-868596
2020-09-18T05:43:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crenolanib,Code name:,CP-868596
2020-09-18T05:44:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crenolanib-besylate,Code name:,"CP-868,596-26"
2020-09-18T05:44:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crenolanib-besylate,Code name:,CP-86859626
2020-09-18T05:44:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crenolanib-besylate,Chemical structure:,"[1-[2-[5-(3-methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine monobenzenesulfonate4-piperidinamine, 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1Hbenzimidazol-1-yl]-8-quinolinyl]-, benzenesulfonate (1:1)"
2020-09-18T05:44:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase,US brand name:,Creon
2020-09-18T05:44:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase,US brand name:,Pancrease
2020-09-18T05:44:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase,US brand name:,Ultresa
2020-09-18T05:44:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase,US brand name:,Viokace
2020-09-18T05:44:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase,US brand name:,Zenpep
2020-09-18T05:44:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase,US brand name:,Zymase
2020-09-18T05:44:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosuvastatin-calcium,US brand name:,Crestor
2020-09-18T05:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cridanimod-sodium,Synonym:,cridanimod
2020-09-18T05:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cridanimod-sodium,Foreign brand name:,Virexxa
2020-09-18T05:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cridanimod-sodium,Chemical structure:,2-(9-oxoacridin-10yl)acetic acidsodium 2-(9-oxoacridin-10yl) acetate
2020-09-18T05:44:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792534,Synonym:,CRISPR/Cas9 targeting HPV16/18 E6 and E7 genes
2020-09-18T05:44:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792534,Synonym:,CRISPR/Cas9-HPV16 E6/E7T1 plus CRISPR/Cas9-HPV18 E6/ E7T2
2020-09-18T05:44:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792534,Synonym:,CRISPR/Cas9-HPV16 E6/E7T1;CRISPR/Cas9-HPV18 E6/ E7T2
2020-09-18T05:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797099,Synonym:,anti-mesothelin CAR T cells
2020-09-18T05:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797099,Synonym:,anti-mesothelin CAR-transduced CRISPR-Cas9-edited T cells
2020-09-18T05:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797099,Synonym:,CRISPR-Cas9 mediated PD-1 and TCR gene-knocked-out mesothelin-directed CAR-T cells
2020-09-18T05:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797099,Synonym:,CRISPR-Cas9-mediated anti-mesothelin CAR T cells
2020-09-18T05:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797099,Synonym:,CRISPR-Cas9-mediated gene-edited anti-mesothelin CAR-T cells
2020-09-18T05:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indinavir-sulfate,US brand name:,Crixivan
2020-09-18T05:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indinavir-sulfate,Abbreviation:,IDV
2020-09-18T05:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizanlizumab,Code name:,SEG101
2020-09-18T05:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizanlizumab,Code name:,SelG1
2020-09-18T05:44:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib,Synonym:,c-met/hepatocyte growth factor receptor tyrosine kinase inhibitor PF-02341066
2020-09-18T05:44:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib,Synonym:,c-met/HGFR tyrosine kinase inhibitor PF-02341066
2020-09-18T05:44:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib,Synonym:,MET Tyrosine Kinase Inhibitor PF-02341066
2020-09-18T05:44:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib,US brand name:,Xalkori
2020-09-18T05:44:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib,Code name:,PF-02341066
2020-09-18T05:44:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib,Code name:,PF-2341066
2020-09-18T05:44:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib,Chemical structure:,"2-Pyridinamine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H- pyrazol-4-yl]3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4- yl)pyridin-2-amine"
2020-09-18T05:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crofelemer,US brand name:,Fulyzaq
2020-09-18T05:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crofelemer,US brand name:,Virend
2020-09-18T05:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crofelemer,Code name:,SP 303
2020-09-18T05:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crofelemer,Code name:,SP-303
2020-09-18T05:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crolibulin,Synonym:,microtubulin inhibitor EPC2407
2020-09-18T05:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crolibulin,Code name:,EPC2407
2020-09-18T05:45:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cromolyn-sodium-inhalant-pa101,Synonym:,sodium cromoglicate inhalant PA101
2020-09-18T05:45:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cromolyn-sodium-inhalant-pa101,Code name:,PA 101
2020-09-18T05:45:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cromolyn-sodium-inhalant-pa101,Code name:,PA101
2020-09-18T05:45:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crotoxin,NA,NA
2020-09-18T05:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798382,Synonym:,prostaglandin D2 receptor 2 antagonist ACT-774312
2020-09-18T05:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798382,Code name:,ACT 774312
2020-09-18T05:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798382,Code name:,ACT774312
2020-09-18T05:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798382,Code name:,ACT-774312
2020-09-18T05:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crystalline-genistein-formulation-axp107-11,Code name:,AXP107-11
2020-09-18T05:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf-1r-inhibitor-blz945,Synonym:,"4-[2((1R,2R)-2-hydroxycyclohexylamino)-benzothiazol-6-yloxyl]-pyridine- 2-carboxylic acid methylamide"
2020-09-18T05:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf-1r-inhibitor-blz945,Code name:,BLZ 945
2020-09-18T05:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf-1r-inhibitor-blz945,Code name:,BLZ945
2020-09-18T05:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf-1r-inhibitor-blz945,Code name:,BLZ-945
2020-09-18T05:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf-1r-inhibitor-blz945,Chemical structure:,"4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)benzo[d]thiazol-6-yl)oxy)-N-methylpicolinamide"
2020-09-18T05:45:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf1r-inhibitor-dcc-3014,Synonym:,CSF-1R inhibitor DCC-3014
2020-09-18T05:45:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf1r-inhibitor-dcc-3014,Code name:,DCC 3014
2020-09-18T05:45:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf1r-inhibitor-dcc-3014,Code name:,DCC3014
2020-09-18T05:45:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf1r-inhibitor-dcc-3014,Code name:,DCC-3014
2020-09-18T05:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792162,Synonym:,CTLA-4 probody BMS-986249
2020-09-18T05:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792162,Synonym:,protease-activated anti-CTLA-4 antibody prodrug BMS-986249
2020-09-18T05:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792162,Code name:,BMS 986249
2020-09-18T05:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792162,Code name:,BMS986249
2020-09-18T05:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792162,Code name:,BMS-986249
2020-09-18T05:45:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ctp-37-dt-vaccine,Synonym:,CTP37-DT
2020-09-18T05:45:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ctp-37-dt-vaccine,Foreign brand name:,Avicine
2020-09-18T05:45:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daptomycin,US brand name:,Cubicin
2020-09-18T05:45:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daptomycin,Code name:,LY146032
2020-09-18T05:45:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daptomycin,Chemical structure:,N-Decanoyl-L-tryptophyl-L-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine epsilon1-lactone
2020-09-18T05:45:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-gg,US brand name:,Culturelle
2020-09-18T05:45:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-gg,Foreign brand name:,Gefilus
2020-09-18T05:45:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-gg,Foreign brand name:,LGG
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Synonym:,Depamine
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Synonym:,D-mercaptovaline
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Synonym:,D-Penicillamine
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Cuprenil
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Cuprimine
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Depen
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Perdolat
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Sufortan
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Atamir
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Cupripen
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Distamine
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Kelatin
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Mercaptyl
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Metalcaptase
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Pendramine
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Trolovol
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Chemical structure:,"3-mercapto-D-valinealpha-amino-beta-methyl-beta-mercaptobutyric acidbeta,beta-dimethylcysteinebeta-thiovaline"
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Synonym:,Depamine
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Synonym:,D-mercaptovaline
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Synonym:,D-Penicillamine
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Cuprenil
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Cuprimine
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Depen
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Perdolat
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Sufortan
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Atamir
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Cupripen
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Distamine
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Kelatin
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Mercaptyl
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Metalcaptase
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Pendramine
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Trolovol
2020-09-18T05:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Chemical structure:,"3-mercapto-D-valinealpha-amino-beta-methyl-beta-mercaptobutyric acidbeta,beta-dimethylcysteinebeta-thiovaline"
2020-09-18T05:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin,Synonym:,C.I. Natural Yellow 3
2020-09-18T05:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin,Synonym:,Diferuloylmethane
2020-09-18T05:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin,Synonym:,Turmeric Yellow
2020-09-18T05:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin,Abbreviation:,CU
2020-09-18T05:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin,Code name:,C.I. 75300
2020-09-18T05:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin,Chemical structure:,"(E,E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione"
2020-09-18T05:46:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795369,Foreign brand name:,Ialuril
2020-09-18T05:46:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795369,Foreign brand name:,Ialuril Soft Gels
2020-09-18T05:46:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794327,Synonym:,Stat3/NF-kB/poly-tyrosine kinase inhibitor/doxorubicin-encapsulating nanoparticle IMX-110
2020-09-18T05:46:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794327,Code name:,IMX 110
2020-09-18T05:46:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794327,Code name:,IMX110
2020-09-18T05:46:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794327,Code name:,IMX-110
2020-09-18T05:46:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/612154,NA,NA
2020-09-18T05:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-based-gel,Synonym:,curcumin gel
2020-09-18T05:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-based-gel,Synonym:,topical curcumin
2020-09-18T05:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-based-gel,US brand name:,Psoria-Gold
2020-09-18T05:46:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-monoclonal-antibody-argx-110,Synonym:,anti-CD70 monoclonal antibody ARGX-110
2020-09-18T05:46:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-monoclonal-antibody-argx-110,Code name:,ARGX-110
2020-09-18T05:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium,Synonym:,Antisense Clusterin
2020-09-18T05:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium,Synonym:,Antisense Testosterone-Repressed Prostate Message 2
2020-09-18T05:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium,Synonym:,Antisense TRPM-2
2020-09-18T05:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium,Synonym:,clusterin antisense oligonucleotide
2020-09-18T05:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium,Synonym:,TRPM-2 Antisense
2020-09-18T05:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium,Code name:,ISIS 112989
2020-09-18T05:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium,Code name:,OGX-011
2020-09-18T05:46:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-visa-bikdd-liposome,Synonym:,BikDD nanoparticle
2020-09-18T05:46:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-visa-bikdd-liposome,Synonym:,C-VISA BikDD nanoparticle
2020-09-18T05:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cvp-regimen,Synonym:,cyclophosphamide/prednisone/vincristine
2020-09-18T05:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cvp-regimen,Synonym:,cyclophosphamide-vincristine-prednisone regimen
2020-09-18T05:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cvp-regimen,Abbreviation:,CTX/PRED/VCR
2020-09-18T05:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cvp-regimen,Abbreviation:,CVP
2020-09-18T05:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cvp-regimen,Abbreviation:,VCP
2020-09-18T05:46:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxc-chemokine-receptor-2-antagonist-azd5069,Synonym:,CXCR2 antagonist AZD5069
2020-09-18T05:46:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxc-chemokine-receptor-2-antagonist-azd5069,Code name:,AZD5069
2020-09-18T05:46:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792795,Code name:,SX 682
2020-09-18T05:46:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792795,Code name:,SX682
2020-09-18T05:46:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792795,Code name:,SX-682
2020-09-18T05:46:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792795,Chemical structure:,(2-(((5-((4-fluorophenyl)carbamoyl)pyrimidin-2-yl)thio)methyl)-4-(trifluoromethoxy)phenyl)boronic acid
2020-09-18T05:47:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793940,Code name:,QBM 076
2020-09-18T05:47:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793940,Code name:,QBM076
2020-09-18T05:47:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793940,Code name:,QBM-076
2020-09-18T05:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-antagonist-bl-8040,Synonym:,CXCR4 antagonist BKT140
2020-09-18T05:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-antagonist-bl-8040,Synonym:,CXCR4 chemokine receptor antagonist BKT140
2020-09-18T05:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-antagonist-bl-8040,Code name:,BKT140
2020-09-18T05:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-antagonist-bl-8040,Code name:,BL-8040
2020-09-18T05:47:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-antagonist-usl311,Synonym:,CXCR4 inhibitor USL311
2020-09-18T05:47:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-antagonist-usl311,Code name:,USL311
2020-09-18T05:47:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-msx-122,Synonym:,CXC chemokine receptor 4 inhibitor MSX-122
2020-09-18T05:47:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-msx-122,Code name:,MSX-122
2020-09-18T05:47:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-peptide-antagonist-ly2510924,Code name:,LY2510924
2020-09-18T05:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,Synonym:,vitamin B12
2020-09-18T05:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Berubigen
2020-09-18T05:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Betalin 12
2020-09-18T05:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Calomist
2020-09-18T05:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Cobavite
2020-09-18T05:47:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin-dexamethasone-gentamicin-procaine-formulation,Synonym:,cyanocobalamin/dexamethasone/gentamicin/procaine oral formulation
2020-09-18T05:47:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin-dexamethasone-gentamicin-procaine-formulation,Synonym:,quadruple mixture
2020-09-18T05:47:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclin-b1-peptide-pulsed-autologous-dendritic-cell-vaccine,Abbreviation:,CCNB1 peptide-pulsed autologous dendritic cell vaccine
2020-09-18T05:47:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792544,Synonym:,CDK8/19 inhibitor BCD 115
2020-09-18T05:47:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792544,Code name:,BCD 115
2020-09-18T05:47:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792544,Code name:,BCD115
2020-09-18T05:47:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792544,Code name:,BCD-115
2020-09-18T05:47:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793673,Synonym:,CDK inhibitor PF-06873600
2020-09-18T05:47:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793673,Code name:,PF 06873600
2020-09-18T05:47:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793673,Code name:,PF-06873600
2020-09-18T05:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Synonym:,cloben
2020-09-18T05:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Synonym:,Novo-Cycloprine
2020-09-18T05:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,US brand name:,Cycloflex
2020-09-18T05:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,US brand name:,Flexeril
2020-09-18T05:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,US brand name:,Flexiban
2020-09-18T05:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Code name:,FR2100873
2020-09-18T05:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Chemical structure:,"10,11delta-amitriptyline hydrochloride1-propanamine, 3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)propyl(dimethyl)ammonium chloride"
2020-09-18T05:48:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclodextrin-based-polymer-camptothecin-crlx101,Synonym:,cyclodextrin-based polymer-camptothecin IT-101
2020-09-18T05:48:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclodextrin-based-polymer-camptothecin-crlx101,Code name:,CRLX101
2020-09-18T05:48:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclodextrin-based-polymer-camptothecin-crlx101,Code name:,IT-101
2020-09-18T05:48:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Synonym:,cloben
2020-09-18T05:48:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Synonym:,Novo-Cycloprine
2020-09-18T05:48:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,US brand name:,Cycloflex
2020-09-18T05:48:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,US brand name:,Flexeril
2020-09-18T05:48:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,US brand name:,Flexiban
2020-09-18T05:48:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Code name:,FR2100873
2020-09-18T05:48:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Chemical structure:,"10,11delta-amitriptyline hydrochloride1-propanamine, 3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)propyl(dimethyl)ammonium chloride"
2020-09-18T05:48:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloleucine,Synonym:,1-Aminocyclopentane
2020-09-18T05:48:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloleucine,Abbreviation:,ACP
2020-09-18T05:48:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloleucine,Abbreviation:,ACPC
2020-09-18T05:48:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloleucine,Abbreviation:,CL
2020-09-18T05:48:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloleucine,Abbreviation:,CYL
2020-09-18T05:48:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloleucine,Code name:,CB-1639
2020-09-18T05:48:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloleucine,Chemical structure:,1-aminocyclopentanecarboxylic acid
2020-09-18T05:48:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclopentenyl-cytosine,Abbreviation:,CPEC
2020-09-18T05:48:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclopentenyl-cytosine,Chemical structure:,"2(1H)-pyrimidinone, 4-amino-1-[4, 5-dihydroxy- 3-(hydroxymethyl)-2-cyclopenten-1-yl]-"
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,(-)-cyclophosphamide
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Ciclofosfamida
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Ciclofosfamide
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Claphene
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,CP monohydrate
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Cyclophospham
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Cyclophosphamid monohydrate
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Cyclophosphamidum
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Cyclophosphan
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Cyclophosphanum
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Cytophosphane
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Genoxal
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Mitoxan
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Syklofosfamid
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Carloxan
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Cicloxal
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Cycloblastin
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Cycloblastine
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,CYCLO-cell
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Cyclophosphane
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Cyclostin
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Cyclostine
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Cytophosphan
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Fosfaseron
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Genoxal
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Genuxal
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Ledoxina
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Abbreviation:,CTX
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Code name:,WR-138719
2020-09-18T05:48:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799673,Synonym:,153 Sm-DOTMP
2020-09-18T05:48:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799673,Synonym:,153Sm-DOTMP
2020-09-18T05:48:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799673,Synonym:,Sm-153-DOTMP
2020-09-18T05:48:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799673,US brand name:,CycloSam
2020-09-18T05:48:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799673,Chemical structure:,"Sm-153-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetra(methylene)phosphonic acidSm-153-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayltetrakis(methylene)tetrakisphosphonic acid"
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Synonym:,ciclosporin
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Synonym:,cyclosporin
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Synonym:,cyclosporin A
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,US brand name:,Gengraf
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,US brand name:,Neoral
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,US brand name:,Sandimmun
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,US brand name:,Sandimmune
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,US brand name:,SangCya
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Abbreviation:,CsA
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Abbreviation:,CYA
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Abbreviation:,CYSP
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Code name:,27-400
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Code name:,OL 27-400
2020-09-18T05:48:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine-ophthalmic-emulsion,US brand name:,Restasis
2020-09-18T05:48:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tranexamic-acid,US brand name:,Cyklokapron
2020-09-18T05:48:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyl-02-plasmid-dna,Synonym:,CYL-02
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,Synonym:,micellar nanoparticle-encapsulated NANT-008
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,Synonym:,nant-paclitaxel
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,Synonym:,paclitaxel-loaded micellar diblock copolymer NANT-008
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,US brand name:,Cynviloq™
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,US brand name:,Genexol-PM
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,Code name:,IG-001
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,Code name:,NANT 008
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,Code name:,NANT008
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,Code name:,NANT-008
2020-09-18T05:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795704,Code name:,ODM 208
2020-09-18T05:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795704,Code name:,ODM208
2020-09-18T05:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795704,Code name:,ODM-208
2020-09-18T05:49:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801473,Code name:,ODM 209
2020-09-18T05:49:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801473,Code name:,ODM209
2020-09-18T05:49:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801473,Code name:,ODM-209
2020-09-18T05:49:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp17-inhibitor-cfg920,Code name:,CFG920
2020-09-18T05:49:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp17-lyase-inhibitor-asn001,Code name:,ASN001
2020-09-18T05:49:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp17-androgen-receptor-inhibitor-odm-204,Code name:,ODM 204
2020-09-18T05:49:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp17-androgen-receptor-inhibitor-odm-204,Code name:,ODM-204
2020-09-18T05:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproheptadine-hydrochloride,US brand name:,Periactin
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Synonym:,cyproterone
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Foreign brand name:,Androcur
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Foreign brand name:,Andro-Diane
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Foreign brand name:,Cyprone
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Foreign brand name:,Cyprostat
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Foreign brand name:,Dianette
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Abbreviation:,CPTR
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Abbreviation:,CyPat
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Code name:,SH 714
2020-09-18T05:49:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramucirumab,Synonym:,anti-VEGFR-2 fully human monoclonal antibody IMC-1121B
2020-09-18T05:49:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramucirumab,US brand name:,Cyramza
2020-09-18T05:49:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramucirumab,Code name:,IMC-1121B
2020-09-18T05:49:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramucirumab,Code name:,LY3009806
2020-09-18T05:49:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cysteine-rich-non-denatured-whey-protein-isolate-imn1207,Synonym:,cysteine-rich protein formulation
2020-09-18T05:49:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cysteine-rich-non-denatured-whey-protein-isolate-imn1207,Synonym:,Cysteine-Rich Whey-Derived Protein Formulation
2020-09-18T05:49:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cysteine-rich-non-denatured-whey-protein-isolate-imn1207,Foreign brand name:,Immunocal
2020-09-18T05:49:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cysteine-rich-non-denatured-whey-protein-isolate-imn1207,Code name:,IMN1207
2020-09-18T05:49:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hexaminolevulinate-hydrochloride,US brand name:,Cysview
2020-09-18T05:49:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hexaminolevulinate-hydrochloride,Foreign brand name:,Hexvix
2020-09-18T05:49:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytadine-analogue-rx-3117,Synonym:,fluorocyclopentenylcytosine
2020-09-18T05:49:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytadine-analogue-rx-3117,Code name:,RX-3117
2020-09-18T05:49:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytadine-analogue-rx-3117,Code name:,TV-1360
2020-09-18T05:49:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytadine-analogue-rx-3117,Chemical structure:,"4-amino-1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl)pyrimidin-2(1H)-one"
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,.beta.-Cytosine arabinoside
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,arabinofuranosylcytosine
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,arabinosylcytosine
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,aracytidine
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,beta-cytosine arabinoside
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,cytarabine hydrochloride
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,cytarabinum
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,cytosine arabinoside
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,cytosine arabinosine hydrochloride
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,cytosine-.beta.-arabinoside
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,Tarabine PFS
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Alexan
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Arabine
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,ARA-cell
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Aracytin
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Aracytine
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Cytarbel
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Cytosar
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Erpalfa
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Starasid
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Udicil
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Abbreviation:,ARA-C
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Code name:,CHX-3311
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Code name:,U 19920
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Code name:,U-19920
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Code name:,U-29920A HCl
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Code name:,WR-28453
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Chemical structure:,"1-.beta.-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone1.beta.-D-arabinofuranosylcytosine1-beta-D-arabinofuranosylcytosine2(1H)-pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone"
2020-09-18T05:50:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-liposome,Synonym:,DepoFoam-encapsulated cytarabine
2020-09-18T05:50:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-liposome,Synonym:,liposomal cytarabine
2020-09-18T05:50:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-liposome,Foreign brand name:,DepoCyte
2020-09-18T05:50:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-liposome,Code name:,DTC 101
2020-09-18T05:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-monophosphate-prodrug-mb07133,Synonym:,cytarabine prodrug MB07133
2020-09-18T05:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-monophosphate-prodrug-mb07133,Code name:,MB07133
2020-09-18T05:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-monophosphate-prodrug-mb07133,Chemical structure:,"(2R,4S)-4-amino-1-[5-O-[2-oxo-4-(4-pyridyl)-1,3,2-dioxaphosphorinan-2-yl]-beta-d-arabinofuranosyl]-2(1H)-pyrimidinone"
2020-09-18T05:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795601,Synonym:,Ara-C asparagine conjugate
2020-09-18T05:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795601,Synonym:,asparagine Ara-C conjugate
2020-09-18T05:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795601,Synonym:,asparagine cytarabine conjugate
2020-09-18T05:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795601,Synonym:,astarabine
2020-09-18T05:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795601,Synonym:,cytarabine asparagine conjugate
2020-09-18T05:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795601,Code name:,BST 236
2020-09-18T05:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795601,Code name:,BST-236
2020-09-18T05:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytochlor,Abbreviation:,CldC
2020-09-18T05:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irx-2,NA,NA
2020-09-18T05:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-induced-killer-cells,Synonym:,autologous cytokine-induced killer cells
2020-09-18T05:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-induced-killer-cells,Acronym:,CIK cells
2020-09-18T05:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794144,Synonym:,activated veto cells
2020-09-18T05:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794144,Synonym:,activated veto T cells
2020-09-18T05:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794144,Synonym:,veto CD8-positive T cells
2020-09-18T05:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794144,Synonym:,veto cell
2020-09-18T05:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794144,Synonym:,veto cells
2020-09-18T05:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794144,Synonym:,veto-enhanced CTL
2020-09-18T05:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794144,Synonym:,veto-enhanced cytotoxic T cell
2020-09-18T05:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytomegalovirus-ie-1-specific-cytotoxic-t-lymphocytes,Abbreviation:,CMV IE-1-specific CTL
2020-09-18T05:50:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytomegalovirus-pp65-specific-cytotoxic-t-lymphocytes,NA,NA
2020-09-18T05:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liothyronine-sodium,US brand name:,Cytomel
2020-09-18T05:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liothyronine-sodium,US brand name:,Triostat
2020-09-18T05:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d1-3-mage-3-his-fusion-protein,Synonym:,D1/3-Mage-3 Fusion Protein
2020-09-18T05:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d1-3-mage-3-his-fusion-protein,Synonym:,D1/3-Mage-3 Fusion Protein (SB MAGE-3)
2020-09-18T05:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d1-3-mage-3-his-fusion-protein,Synonym:,SB MAGE-3
2020-09-18T05:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d1-3-mage-3-his-fusion-protein,Abbreviation:,D1/3 MAGE3 HIS
2020-09-18T05:51:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dab389-epidermal-growth-factor,Acronym:,DAB389 EGF
2020-09-18T05:51:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabigatran-etexilate-mesylate,US brand name:,Pradaxa
2020-09-18T05:51:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabigatran-etexilate-mesylate,Code name:,BIBR 1048 MS
2020-09-18T05:51:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabigatran-etexilate-mesylate,Code name:,BIBR 1048MS
2020-09-18T05:51:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabigatran-etexilate-mesylate,Chemical structure:,"beta-alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl] phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester, methanesulfonate"
2020-09-18T05:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib,Synonym:,dabrafenib methanesulfonate
2020-09-18T05:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib,Synonym:,GSK2118436B
2020-09-18T05:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib,US brand name:,Tafinlar
2020-09-18T05:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib,Code name:,GSK2118436 methane sulfate salt
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Biocarbazine
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Dacarbazina
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Dacarbazina Almirall
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Dacarbazine - DTIC
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Dakarbazin
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Dimethyl (triazeno) imidazolecarboxamide
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Dimethyl Triazeno Imidazol Carboxamide
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Dimethyl Triazeno Imidazole Carboxamide
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Imidazole Carboxamide
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Imidazole Carboxamide Dimethyltriazeno
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Foreign brand name:,Asercit
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Foreign brand name:,Dacatic
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Foreign brand name:,Deticene
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Foreign brand name:,Detimedac
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Foreign brand name:,Fauldetic
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Abbreviation:,DIC
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Abbreviation:,DTIC
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Code name:,WR-139007
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Chemical structure:,"1H-imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-5-(3-3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide5-(dimethyltriazeno)imidazole-4-carboxamide5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide"
2020-09-18T05:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacetuzumab,Synonym:,anti-huCD40 mAb
2020-09-18T05:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacetuzumab,Synonym:,monoclonal antibody SGN-40
2020-09-18T05:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacetuzumab,Code name:,huS2C6
2020-09-18T05:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacetuzumab,Code name:,SGN-40
2020-09-18T05:51:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dach-polymer-platinate-ap5346,Code name:,AP5346
2020-09-18T05:51:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dach-platin-micelle-nc-4016,Synonym:,DACH-Pt/m NC-4016
2020-09-18T05:51:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dach-platin-micelle-nc-4016,Synonym:,diaminocyclohexane platinum micelle NC-4016
2020-09-18T05:51:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dach-platin-micelle-nc-4016,Code name:,NC-4016
2020-09-18T05:51:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclatasvir,Abbreviation:,DCV
2020-09-18T05:51:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclatasvir,Code name:,BMS-790052
2020-09-18T05:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclizumab,Synonym:,anti-Tac
2020-09-18T05:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclizumab,Synonym:,Anti-Tac Humanized Monoclonal Antibody
2020-09-18T05:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclizumab,Synonym:,anti-Tac monoclonal antibody
2020-09-18T05:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclizumab,Synonym:,Dacliximab
2020-09-18T05:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclizumab,US brand name:,Zenapax
2020-09-18T05:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclizumab,Abbreviation:,MOAB anti-Tac
2020-09-18T05:51:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Synonym:,5-aza-dCyd
2020-09-18T05:51:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Synonym:,deoxyazacytidine
2020-09-18T05:51:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Synonym:,dezocitidine
2020-09-18T05:51:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,US brand name:,Dacogen
2020-09-18T05:51:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Abbreviation:,5AZA
2020-09-18T05:51:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Abbreviation:,DAC
2020-09-18T05:51:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Chemical structure:,"2'-deoxy-5-azacytidine4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one5-aza-2'-deoxycytidine5-aza-2-deoxycytidine5-azadeoxycytidine"
2020-09-18T05:51:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacomitinib,Synonym:,EGFR inhibitor PF-00299804
2020-09-18T05:51:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacomitinib,US brand name:,Vizimpro
2020-09-18T05:51:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacomitinib,Code name:,PF-00299804
2020-09-18T05:51:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacomitinib,Code name:,PF-00299804-03
2020-09-18T05:51:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacomitinib,Chemical structure:,(2E)-N-(4-((3-chloro-4-fluorophenyl)Amino)-7-methoxyquinazolin-6-yl)-4-piperidin-1-ylbut-2-enamide
2020-09-18T05:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,ACT-D
2020-09-18T05:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin C1
2020-09-18T05:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin D
2020-09-18T05:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin I1
2020-09-18T05:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin IV
2020-09-18T05:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin X 1
2020-09-18T05:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin-[thr-val-pro-sar-meval]
2020-09-18T05:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,AD
2020-09-18T05:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,dactinomycine
2020-09-18T05:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,meractinomycin
2020-09-18T05:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,US brand name:,Cosmegen
2020-09-18T05:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Foreign brand name:,Lyovac Cosmegen
2020-09-18T05:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Abbreviation:,DACT
2020-09-18T05:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Chemical structure:,"2-bis[cyclo(N-methyl-L-valyl-sarcosyl-L-prolyl-D-valyl-L-threonyl)]-1,9 dimethyl-4,6 3H-phenoxazinone-3"
2020-09-18T05:52:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dakins-solution,Synonym:,aqueous solution of sodium hypochlorite
2020-09-18T05:52:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dakins-solution,Synonym:,Dakin's fluid
2020-09-18T05:52:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalantercept,Synonym:,activin receptor-like kinase 1 inhibitor ACE-041
2020-09-18T05:52:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalantercept,Synonym:,ALK1-Fc fusion protein ACE-041
2020-09-18T05:52:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalantercept,Code name:,ACE-041
2020-09-18T05:52:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/682691,US brand name:,Zeven
2020-09-18T05:52:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/682691,Code name:,A-A-1
2020-09-18T05:52:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/682691,Code name:,BI397
2020-09-18T05:52:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/682691,Code name:,"MDL 63,397"
2020-09-18T05:52:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/682691,Code name:,VER001
2020-09-18T05:52:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/682691,Chemical structure:,"ristomycin A aglycone, 5,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-O-[2-deoxy-2-[(10-methyl-1-oxoundecyl)amino]-α-D-glucopyranuronosyl]-38-[[[3-(dimethylamino)propyl]amino]carbonyl]-42-O-α-D-mannopyranosyl-N15-methyl-"
2020-09-18T05:52:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roflumilast,US brand name:,Daliresp
2020-09-18T05:52:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roflumilast,Code name:,B9302-107
2020-09-18T05:52:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roflumilast,Code name:,BY21
2020-09-18T05:52:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roflumilast,Code name:,BYK20869
2020-09-18T05:52:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roflumilast,Chemical structure:,"3-cyclopropylmethoxy-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide"
2020-09-18T05:52:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalotuzumab,Synonym:,anti-IGF-1R recombinant monoclonal antibody MK-0646
2020-09-18T05:52:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalotuzumab,Code name:,MK-0646
2020-09-18T05:52:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,US brand name:,Depo-Heparin
2020-09-18T05:52:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,US brand name:,Fragmin
2020-09-18T05:52:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,US brand name:,Fragmin V
2020-09-18T05:52:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,Code name:,ALFA 87-120
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,US brand name:,Danocrine
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,US brand name:,Winobanin
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Bonzol
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Chronogyn
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Cyclomen
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Danol
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Danoval
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Ladogal
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Abbreviation:,DAN
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Code name:,Win-17757
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Chemical structure:,"(17alpha)-pregna-2,4-dien-20-yno[2,3-d]-isoxazol-17-ol17alpha-ethynyl-17beta-hydroxy-4-androsteno[2,3-d]isoxazole1-ethynyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-10a,12a-dimethyl-1H-cyclopental[7,8]phenanthro[3,2-d]isoxazol-1-ol"
2020-09-18T05:52:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daniquidone,Synonym:,batracylin
2020-09-18T05:52:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daniquidone,Chemical structure:,"8-aminoisoindolo(1,2-b)quinazolin-12(10H)-one"
2020-09-18T05:52:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,US brand name:,Danocrine
2020-09-18T05:52:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,US brand name:,Winobanin
2020-09-18T05:52:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Bonzol
2020-09-18T05:52:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Chronogyn
2020-09-18T05:52:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Cyclomen
2020-09-18T05:52:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Danol
2020-09-18T05:52:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Danoval
2020-09-18T05:52:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Ladogal
2020-09-18T05:52:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Abbreviation:,DAN
2020-09-18T05:52:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Code name:,Win-17757
2020-09-18T05:52:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Chemical structure:,"(17alpha)-pregna-2,4-dien-20-yno[2,3-d]-isoxazol-17-ol17alpha-ethynyl-17beta-hydroxy-4-androsteno[2,3-d]isoxazole1-ethynyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-10a,12a-dimethyl-1H-cyclopental[7,8]phenanthro[3,2-d]isoxazol-1-ol"
2020-09-18T05:52:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danusertib,Synonym:,Aurora kinase inhibitor PHA-739358
2020-09-18T05:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-antisense-oligonucleotide-isis-481464,Synonym:,STAT3 antisense oligonucleotide ISIS 481464
2020-09-18T05:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-antisense-oligonucleotide-isis-481464,US brand name:,ISIS-STAT3rx
2020-09-18T05:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-antisense-oligonucleotide-isis-481464,Code name:,AZD9150
2020-09-18T05:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-antisense-oligonucleotide-isis-481464,Code name:,ISIS 481464
2020-09-18T05:53:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daporinad,Code name:,APO866
2020-09-18T05:53:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrimethamine,US brand name:,Daraprim
2020-09-18T05:53:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab,Synonym:,anti-CD38 monoclonal antibody
2020-09-18T05:53:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab,Synonym:,JNJ-54767414
2020-09-18T05:53:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab,US brand name:,Darzalex
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,DARA co-formulated with rHuPH20
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,DARA/rHuPH20
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,daratumumab + rHuPH20
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,daratumumab with rHuPH20
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,daratumumab/rHuPH20 co-formulation
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,daratumumab-rHuPH20
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,darzalex/rHuPH20
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,HuMax-CD38-rHuPH20
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,recombinant human hyaluronidase mixed with daratumumab
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,US brand name:,Darzalex Faspro
2020-09-18T05:53:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Synonym:,Novel Erythropoiesis Stimulating Protein
2020-09-18T05:53:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,US brand name:,Aranesp
2020-09-18T05:53:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Foreign brand name:,Nespo
2020-09-18T05:53:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Abbreviation:,NESP
2020-09-18T05:53:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Code name:,KRN321
2020-09-18T05:53:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darinaparsin,Foreign brand name:,SP-02L
2020-09-18T05:53:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darinaparsin,Code name:,ZIO-101
2020-09-18T05:53:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darinaparsin,Chemical structure:,S-dimethylarsino-glutathione
2020-09-18T05:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201,Synonym:,antiandrogen ODM-201
2020-09-18T05:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201,US brand name:,Nubeqa
2020-09-18T05:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201,Code name:,BAY 1841788
2020-09-18T05:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201,Code name:,BAY1841788
2020-09-18T05:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201,Code name:,BAY-1841788
2020-09-18T05:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201,Code name:,ODM 201
2020-09-18T05:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201,Code name:,ODM-201
2020-09-18T05:53:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794649,Synonym:,darleukin and fibromun
2020-09-18T05:53:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794649,Synonym:,darleukin/fibromun
2020-09-18T05:53:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794649,Synonym:,L19-IL2 and L19-TNF-alpha
2020-09-18T05:53:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794649,Synonym:,L19IL2/L19TNF
2020-09-18T05:53:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794649,Synonym:,L19-IL2/L19-TNF-alpha
2020-09-18T05:53:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab,Synonym:,anti-CD38 monoclonal antibody
2020-09-18T05:53:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab,Synonym:,JNJ-54767414
2020-09-18T05:53:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab,US brand name:,Darzalex
2020-09-18T05:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,DARA co-formulated with rHuPH20
2020-09-18T05:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,DARA/rHuPH20
2020-09-18T05:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,daratumumab + rHuPH20
2020-09-18T05:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,daratumumab with rHuPH20
2020-09-18T05:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,daratumumab/rHuPH20 co-formulation
2020-09-18T05:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,daratumumab-rHuPH20
2020-09-18T05:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,darzalex/rHuPH20
2020-09-18T05:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,HuMax-CD38-rHuPH20
2020-09-18T05:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,recombinant human hyaluronidase mixed with daratumumab
2020-09-18T05:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,US brand name:,Darzalex Faspro
2020-09-18T05:53:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasabuvir,Foreign brand name:,EXVIERA
2020-09-18T05:53:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasabuvir,Code name:,ABT 333
2020-09-18T05:53:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasabuvir,Code name:,ABT333
2020-09-18T05:53:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasabuvir,Code name:,ABT-333
2020-09-18T05:53:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasabuvir,Chemical structure:,"methanesulfonamide, N-(6-(5-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-(1,1-dimethylethyl)-2-methoxyphenyl)-2-naphthalenyl)-N-(6-(3-tert-Butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide"
2020-09-18T05:54:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasatinib,US brand name:,Sprycel
2020-09-18T05:54:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasatinib,Code name:,BMS-354825
2020-09-18T05:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Synonym:,cloridrato de daunorubicina
2020-09-18T05:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Synonym:,daunoblastine
2020-09-18T05:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Synonym:,daunomycin hydrochloride
2020-09-18T05:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Synonym:,rubidomycin hydrochloride
2020-09-18T05:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,US brand name:,Cerubidine
2020-09-18T05:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Foreign brand name:,Cerubidin
2020-09-18T05:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Foreign brand name:,Daunoblastin
2020-09-18T05:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Foreign brand name:,Daunoblastina
2020-09-18T05:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Foreign brand name:,Ondena
2020-09-18T05:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Foreign brand name:,Rubilem
2020-09-18T05:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Code name:,FI-6339
2020-09-18T05:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Code name:,RP-13057
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,Synonym:,cytarabine-daunorubicin liposome for injection
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,Synonym:,liposomal AraC-daunorubicin CPX-351
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,Synonym:,liposomal cytarabine-daunorubicin
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,Synonym:,liposomal cytarabine-daunorubicin CPX-351
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,Synonym:,liposome-encapsulated combination of daunorubicin and cytarabine
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,Synonym:,liposome-encapsulated daunorubicin-cytarabine
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,US brand name:,Vyxeos
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,Code name:,CPX-351
2020-09-18T05:54:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-daunorubicin-citrate,Synonym:,daunorubicin liposomal
2020-09-18T05:54:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-daunorubicin-citrate,Synonym:,liposomal daunorubicin
2020-09-18T05:54:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-daunorubicin-citrate,US brand name:,DaunoXome
2020-09-18T05:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hedgehog-inhibitor-pf-04449913,US brand name:,Daurismo
2020-09-18T05:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hedgehog-inhibitor-pf-04449913,Code name:,PF-04449913 maleate
2020-09-18T05:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hedgehog-inhibitor-pf-04449913,Chemical structure:,"1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate"
2020-09-18T05:54:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galactomannan-derivative,Synonym:,"1,4-beta-D-galactomannan"
2020-09-18T05:54:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galactomannan-derivative,US brand name:,DAVANAT
2020-09-18T05:54:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galactomannan-derivative,Abbreviation:,GD
2020-09-18T05:54:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dc-cholesterol-liposome,Abbreviation:,DC-CHOL LIP
2020-09-18T05:54:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dc-cholesterol-liposome,Abbreviation:,DC-chol liposomes
2020-09-18T05:54:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dc-cholesterol-liposome,Chemical structure:,dimethylaminoethane-carbamoyl-cholesterol liposomes
2020-09-18T05:54:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dc-ova-vaccine,Abbreviation:,DC-OVA
2020-09-18T05:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dcr-ligand-bearing-liposome-encapsulated-melanoma-antigens-vaccine,Synonym:,dendritic cell receptor ligand-bearing liposome-encapsulated melanoma antigens vaccine
2020-09-18T05:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dcr-ligand-bearing-liposome-encapsulated-melanoma-antigens-vaccine,Foreign brand name:,Lipovaxin-MM
2020-09-18T05:54:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-cycloserine,Synonym:,Oxamycin
2020-09-18T05:54:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-cycloserine,Synonym:,Tisomycin
2020-09-18T05:54:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-cycloserine,US brand name:,Seromycin
2020-09-18T05:54:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-cycloserine,Chemical structure:,"(+)-4-Amino-3-isoxazolidinone3-Isoxazolidinone, 4-amino-, d-"
2020-09-18T05:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,US brand name:,Concentraid
2020-09-18T05:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,US brand name:,DDAVP
2020-09-18T05:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,US brand name:,Stimate
2020-09-18T05:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,Foreign brand name:,Octostim
2020-09-18T05:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,Chemical structure:,1-(3-mercaptopropionic acid)-8-D-arginine vasopression monoacetate
2020-09-18T05:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dec-205-ny-eso-1-fusion-protein-cdx-1401,Code name:,CDX-1401
2020-09-18T05:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-vaccine-adsorbed,US brand name:,Decavac
2020-09-18T05:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-vaccine-adsorbed,Abbreviation:,DT
2020-09-18T05:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-vaccine-adsorbed,Abbreviation:,Td adsorbed
2020-09-18T05:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Synonym:,5-aza-dCyd
2020-09-18T05:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Synonym:,deoxyazacytidine
2020-09-18T05:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Synonym:,dezocitidine
2020-09-18T05:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,US brand name:,Dacogen
2020-09-18T05:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Abbreviation:,5AZA
2020-09-18T05:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Abbreviation:,DAC
2020-09-18T05:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Chemical structure:,"2'-deoxy-5-azacytidine4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one5-aza-2'-deoxycytidine5-aza-2-deoxycytidine5-azadeoxycytidine"
2020-09-18T05:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cda-inhibitor-e7727-decitabine-combination-agent-astx727,Synonym:,CDA inhibitor E7727/decitabine combination agent ASTX727
2020-09-18T05:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cda-inhibitor-e7727-decitabine-combination-agent-astx727,US brand name:,Inqovi
2020-09-18T05:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cda-inhibitor-e7727-decitabine-combination-agent-astx727,Code name:,ASTX727
2020-09-18T05:55:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demeclocycline-hydrochloride,US brand name:,Declomycin
2020-09-18T05:55:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demeclocycline-hydrochloride,Chemical structure:,"7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride"
2020-09-18T05:55:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/defactinib,Code name:,PF-04554878
2020-09-18T05:55:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/defactinib,Code name:,VS-6063
2020-09-18T05:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferasirox,US brand name:,Exjade
2020-09-18T05:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferasirox,Code name:,ICL670
2020-09-18T05:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferoxamine-mesylate,Synonym:,deferoxamine methanesulfonate
2020-09-18T05:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferoxamine-mesylate,US brand name:,Desferal
2020-09-18T05:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferoxamine-mesylate,Abbreviation:,DFM
2020-09-18T05:55:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/defibrotide-sodium,US brand name:,Defitelio
2020-09-18T05:55:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren-lipid-microspheres,US brand name:,Definity
2020-09-18T05:55:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren,Synonym:,freon 218
2020-09-18T05:55:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren,Synonym:,octafluoropropane
2020-09-18T05:55:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren,Synonym:,perfluoropropane
2020-09-18T05:55:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren,US brand name:,Definity
2020-09-18T05:55:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren,Abbreviation:,PFP
2020-09-18T05:56:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/defibrotide-sodium,US brand name:,Defitelio
2020-09-18T05:56:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/degarelix,US brand name:,Firmagon
2020-09-18T05:56:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/degarelix,Code name:,ASP3550
2020-09-18T05:56:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/degarelix,Code name:,FE200486
2020-09-18T05:56:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deglycosylated-ricin-a-chain-conjugated-anti-cd19-anti-cd22-immunotoxins,Synonym:,IgG-HD37-dgA/IgG-RFB4-dgA immunotoxins
2020-09-18T05:56:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deglycosylated-ricin-a-chain-conjugated-anti-cd19-anti-cd22-immunotoxins,US brand name:,Combotox
2020-09-18T05:56:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/delanzomib,Synonym:,proteasome inhibitor CEP 18770
2020-09-18T05:56:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/delanzomib,Code name:,CEP 18770
2020-09-18T05:56:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/delta-8-tetrahydrocannabinol,Abbreviation:,delta-8-THC
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Synonym:,delta(1)hydrocortisone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Synonym:,delta1-dehydro-hydrocortisone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Synonym:,deltahydrocortisone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Synonym:,metacortandralone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Cortalone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Delta-Cortef
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Hydeltra
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Hydeltrasol
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Meti-derm
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Prelone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Adnisolone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Aprednislon
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Capsoid
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Cortisolone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Dacortin H
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Decaprednil
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Decortin H
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Delta- Cortef
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Deltacortril
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Delta-Diona
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Delta-Phoricol
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Deltasolone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Deltidrosol
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Dhasolone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Di-Adreson-F
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Dontisolon D
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Estilsona
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Fisopred
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Frisolona
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Gupisone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Hostacortin H
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Klismacort
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Kuhlprednon
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Lenisolone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Lepi-Cortinolo
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Linola-H N
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Linola-H-Fett N
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Longiprednil
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Meticortelone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Opredsone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Panafcortelone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Precortisyl
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Pred-Clysma
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Predeltilone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Predni-Coelin
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Prednicortelone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Predni-Helvacort
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Prenilone
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Abbreviation:,PRDL
2020-09-18T05:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Chemical structure:,"(11beta)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione1,2-dehydrohydrocortisone"
2020-09-18T05:56:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retrovector-encoding-mutant-anti-cyclin-g1,Synonym:,Mx-dnG1 retroviral vector
2020-09-18T05:56:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retrovector-encoding-mutant-anti-cyclin-g1,Synonym:,retroviral expression vector bearing anti-cyclin G1 gene construct
2020-09-18T05:56:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retrovector-encoding-mutant-anti-cyclin-g1,US brand name:,DeltaRex-G
2020-09-18T05:56:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retrovector-encoding-mutant-anti-cyclin-g1,US brand name:,REXIN-G
2020-09-18T05:56:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/delta-tocopherol,Chemical structure:,"[2R-[2R*(4R*,8R*)]]-3,4-dihydro-2,8-dimethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol2,8-dimethyl-2-(4,8,12-trimethyltridecyl)chroman-6-ol"
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,anti-infective vitamin
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,antixerophthalmic vitamin
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Axerophthol
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Axerophtholum
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Biosterol
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Lard-Factor
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Oleovitamin A
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Ophthalamin
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,vitamin A alcohol
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,vitamin A USP
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,vitamin A1
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Vitaminum A
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,US brand name:,Aquasol A
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,US brand name:,Del-Vi-A
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,US brand name:,Pedi-Vit-A
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,A 313
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Arovit
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Avibon
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Avitol
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Axerol
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Biovit-A
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Ido A 50
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Idrurto A
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Ledovit A
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Micelle A
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Mulsal A Megadosis
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Rinocusi Vitaminico
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Vitaminoftalmina
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Vogan
2020-09-18T05:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Chemical structure:,"3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol"
2020-09-18T05:56:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demcizumab,Synonym:,anti-delta-like 4 monoclonal antibody OMP-21M18
2020-09-18T05:56:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demcizumab,Synonym:,anti-DLL4 monoclonal antibody OMP-21M18
2020-09-18T05:56:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demcizumab,Code name:,OMP-21M18
2020-09-18T05:56:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demeclocycline-hydrochloride,US brand name:,Declomycin
2020-09-18T05:56:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demeclocycline-hydrochloride,Chemical structure:,"7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride"
2020-09-18T05:56:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meperidine-hydrochloride,Synonym:,meperidine
2020-09-18T05:56:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meperidine-hydrochloride,US brand name:,Demerol
2020-09-18T05:57:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demineralized-bone-matrix,Acronym:,DBM
2020-09-18T05:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metyrosine,Synonym:,Alpha-methyl-p-tyrosine
2020-09-18T05:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metyrosine,Synonym:,methyl-tyrosine
2020-09-18T05:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metyrosine,Synonym:,Metirosine
2020-09-18T05:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metyrosine,US brand name:,DEMSER
2020-09-18T05:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metyrosine,Code name:,L-588357-0
2020-09-18T05:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metyrosine,Code name:,MK-781
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Synonym:,1beta-D-2'-Deoxyribofuranosyl-5-iodouracil
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Synonym:,2'-deoxy-5-iodouridine
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Synonym:,5-iododeoxyuridine
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Synonym:,5-IUdR
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Synonym:,IDU
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Synonym:,"uracil, 5-iodo-1-(2-deoxy-beta-D-ribofuranosyl)-"
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Synonym:,"uridine, 2'-deoxy-5-iodo-"
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,US brand name:,Dendrid
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,US brand name:,Herplex
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,US brand name:,Stoxil
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Foreign brand name:,Idexur
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Foreign brand name:,Idoxene
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Foreign brand name:,Idulea
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Foreign brand name:,Iduridin
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Foreign brand name:,Kerecid
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Foreign brand name:,Virudox
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Abbreviation:,IDUR
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Abbreviation:,IdURD
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Abbreviation:,IUdR
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Code name:,SKF 14287
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Chemical structure:,1-(2-deoxy-beta-D-ribofuranosyl)-5-iodouracil2'-deoxy-5-iodouridine5-iodo-2'-deoxyuridine
2020-09-18T05:57:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-autologous-lung-tumor-vaccine,Synonym:,DCVax-Lung
2020-09-18T05:57:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-cea-peptide-vaccine,Synonym:,CEA peptide-pulsed DC vaccine
2020-09-18T05:57:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-cea-peptide-vaccine,Synonym:,CEA peptide-pulsed dendritic cell vaccine
2020-09-18T05:57:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-cea-peptide-vaccine,Synonym:,Dendritic cell-carcinoembryonic antigen peptide vaccine
2020-09-18T05:57:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-gp100-mart-1-antigen-vaccine,Synonym:,gp100/Mart-1-transduced dendritic cell vaccine
2020-09-18T05:57:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-gp100-mart-1-antigen-vaccine,Abbreviation:,DC-gp100-MART-1
2020-09-18T05:57:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-idiotype-keyhole-limpet-hemocyanin-vaccine,Abbreviation:,DC-Id-KLH vaccine
2020-09-18T05:57:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-mart-1-peptide-vaccine,Synonym:,MART-1 peptide-pulsed DC vaccine
2020-09-18T05:57:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-mart-1-peptide-vaccine,Synonym:,MART-1 peptide-pulsed dendritic cell vaccine
2020-09-18T05:57:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-precision-multiple-antigen-t-lymphocytes,Synonym:,dendritic cell-precision multiple antigen T cells
2020-09-18T05:57:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-precision-multiple-antigen-t-lymphocytes,Abbreviation:,DC-PMAT
2020-09-18T05:57:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-targeting-lentiviral-vector-id-lv305,Synonym:,DCvex-NY-ESO-1
2020-09-18T05:57:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-targeting-lentiviral-vector-id-lv305,Code name:,ID-LV305
2020-09-18T05:57:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802041,Synonym:,Chinese herbal compound Dendrobium huoshanense
2020-09-18T05:57:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802041,Synonym:,D. huoshanense granules
2020-09-18T05:58:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denenicokin,Synonym:,recombinant human interleukin-21
2020-09-18T05:58:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denenicokin,Abbreviation:,rhIL-21
2020-09-18T05:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801795,Synonym:,dengue virus-1 PV-001-DV
2020-09-18T05:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801795,Synonym:,PV-001-dengue virus
2020-09-18T05:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801795,Code name:,PV 001-DV
2020-09-18T05:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801795,Code name:,PV001-DV
2020-09-18T05:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801795,Code name:,PV-001-DV
2020-09-18T05:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denibulin-hydrochloride,Code name:,MN-029
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Synonym:,DAB(389)-interleukin-2
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Synonym:,DAB389 interleukin-2
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Synonym:,DAB389 interleukin-2 immunotoxin
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Synonym:,DABIL2
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,US brand name:,Ontak
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Abbreviation:,DAB389IL2
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Abbreviation:,DAB389IL-2
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Abbreviation:,DAB389-IL2
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Code name:,LY335348
2020-09-18T05:58:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denintuzumab-mafodotin,Synonym:,anti-CD19 antibody-drug conjugate SGN-CD19A
2020-09-18T05:58:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denintuzumab-mafodotin,Code name:,ADC SGN-19A
2020-09-18T05:58:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denintuzumab-mafodotin,Code name:,SGN-19A
2020-09-18T05:58:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denintuzumab-mafodotin,Code name:,SGN-CD19A
2020-09-18T05:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab,Synonym:,denosumab biosimilar TK-006
2020-09-18T05:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab,US brand name:,Prolia
2020-09-18T05:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab,US brand name:,Xgeva
2020-09-18T05:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab,Foreign brand name:,Prolia
2020-09-18T05:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab,Code name:,AMG 162
2020-09-18T05:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab,Code name:,AMG-162
2020-09-18T05:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab,Code name:,TK-006
2020-09-18T05:58:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deoxycytidine-analogue-tas-109,Code name:,TAS-109
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Synonym:,Stavzor
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Synonym:,Valproate
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Synonym:,Valproate Sodium
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,US brand name:,Depacon
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,US brand name:,Depakene
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Foreign brand name:,Alti-Valproic
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Foreign brand name:,Ergenyl
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Foreign brand name:,Novo-Valproic
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Abbreviation:,VA
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Chemical structure:,2-Propylpentanoic Acid2-Propylvaleric AcidDi-n-propylacetic Acid
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Synonym:,sodium divalproex
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Synonym:,valproate semisodium
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depacon
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depakote
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depakote ER
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Epilex
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Epival
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Synonym:,Aiheng
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Valparin
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Code name:,Abbott 50711
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Chemical structure:,sodium hydrogen bis(2-propylpentanoate)
2020-09-18T05:58:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naltrexone-hydrochloride,US brand name:,Depade
2020-09-18T05:58:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naltrexone-hydrochloride,US brand name:,Revia
2020-09-18T05:58:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naltrexone-hydrochloride,Chemical structure:,"(5alpha)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride"
2020-09-18T05:58:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Synonym:,Stavzor
2020-09-18T05:58:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Synonym:,Valproate
2020-09-18T05:58:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Synonym:,Valproate Sodium
2020-09-18T05:58:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,US brand name:,Depacon
2020-09-18T05:58:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,US brand name:,Depakene
2020-09-18T05:58:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Foreign brand name:,Alti-Valproic
2020-09-18T05:58:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Foreign brand name:,Ergenyl
2020-09-18T05:58:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Foreign brand name:,Novo-Valproic
2020-09-18T05:58:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Abbreviation:,VA
2020-09-18T05:58:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Chemical structure:,2-Propylpentanoic Acid2-Propylvaleric AcidDi-n-propylacetic Acid
2020-09-18T05:59:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Synonym:,sodium divalproex
2020-09-18T05:59:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Synonym:,valproate semisodium
2020-09-18T05:59:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depacon
2020-09-18T05:59:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depakote
2020-09-18T05:59:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depakote ER
2020-09-18T05:59:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Epilex
2020-09-18T05:59:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Epival
2020-09-18T05:59:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Valparin
2020-09-18T05:59:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Code name:,Abbott 50711
2020-09-18T05:59:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Chemical structure:,sodium hydrogen bis(2-propylpentanoate)
2020-09-18T05:59:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Synonym:,sodium divalproex
2020-09-18T05:59:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Synonym:,valproate semisodium
2020-09-18T05:59:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depacon
2020-09-18T05:59:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depakote
2020-09-18T05:59:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depakote ER
2020-09-18T05:59:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Epilex
2020-09-18T05:59:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Epival
2020-09-18T05:59:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Valparin
2020-09-18T05:59:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Code name:,Abbott 50711
2020-09-18T05:59:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Chemical structure:,sodium hydrogen bis(2-propylpentanoate)
2020-09-18T05:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,depAndro
2020-09-18T05:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,Depotest
2020-09-18T05:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,Depo-Testosterone
2020-09-18T05:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,Virilon
2020-09-18T05:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,Foreign brand name:,Depovirin
2020-09-18T05:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,Foreign brand name:,Pertestis
2020-09-18T05:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,Chemical structure:,17beta-cyclopentanepropionate
2020-09-18T05:59:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/depdc1-mphosh1-peptide-vaccine,NA,NA
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Synonym:,Depamine
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Synonym:,D-mercaptovaline
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Synonym:,D-Penicillamine
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Cuprenil
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Cuprimine
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Depen
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Perdolat
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Sufortan
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Atamir
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Cupripen
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Distamine
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Kelatin
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Mercaptyl
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Metalcaptase
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Pendramine
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Trolovol
2020-09-18T05:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Chemical structure:,"3-mercapto-D-valinealpha-amino-beta-methyl-beta-mercaptobutyric acidbeta,beta-dimethylcysteinebeta-thiovaline"
2020-09-18T05:59:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-methylfolate,Synonym:,5-methyl terahydrofolic acid
2020-09-18T05:59:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-methylfolate,US brand name:,Deplin
2020-09-18T05:59:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-methylfolate,Abbreviation:,5-MTHF
2020-09-18T05:59:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-methylfolate,Chemical structure:,5-methyltetrahydrofolateL-methyltetrahydrofolate
2020-09-18T05:59:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,US brand name:,Depo-Heparin
2020-09-18T05:59:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,US brand name:,Fragmin
2020-09-18T05:59:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,US brand name:,Fragmin V
2020-09-18T05:59:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,Code name:,ALFA 87-120
2020-09-18T05:59:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate,Synonym:,Depo-Medrone
2020-09-18T05:59:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate,Synonym:,D-Med
2020-09-18T05:59:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate,US brand name:,Depo-Medrol
2020-09-18T05:59:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate,Foreign brand name:,Depo-Medrate
2020-09-18T05:59:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate,Foreign brand name:,Depo-Medrone
2020-09-18T05:59:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate,Foreign brand name:,D-Med
2020-09-18T05:59:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate,Chemical structure:,"11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate"
2020-09-18T05:59:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,depAndro
2020-09-18T05:59:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,Depotest
2020-09-18T05:59:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,Depo-Testosterone
2020-09-18T05:59:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,Virilon
2020-09-18T05:59:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,Foreign brand name:,Depovirin
2020-09-18T05:59:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,Foreign brand name:,Pertestis
2020-09-18T05:59:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,Chemical structure:,17beta-cyclopentanepropionate
2020-09-18T05:59:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,depAndro
2020-09-18T05:59:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,Depotest
2020-09-18T05:59:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,Depo-Testosterone
2020-09-18T05:59:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,Virilon
2020-09-18T05:59:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,Foreign brand name:,Depovirin
2020-09-18T05:59:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,Foreign brand name:,Pertestis
2020-09-18T05:59:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,Chemical structure:,17beta-cyclopentanepropionate
2020-09-18T05:59:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-fgfr-inhibitor-arq-087,Synonym:,pan FGFR inhibitor ARQ 087
2020-09-18T05:59:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-fgfr-inhibitor-arq-087,Code name:,ARQ 087
2020-09-18T05:59:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799709,Synonym:,D-ADM
2020-09-18T05:59:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799709,Synonym:,human ADM
2020-09-18T05:59:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799709,US brand name:,DermACELL
2020-09-18T05:59:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799709,Abbreviation:,hADM
2020-09-18T06:00:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/derma-membrane-structure-topical-cream,Foreign brand name:,Fisiogel Cream
2020-09-18T06:00:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/derma-membrane-structure-topical-cream,Foreign brand name:,Physiogel Cream
2020-09-18T06:00:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/derma-membrane-structure-topical-cream,Abbreviation:,DMS topical cream
2020-09-18T06:00:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferoxamine-mesylate,Synonym:,deferoxamine methanesulfonate
2020-09-18T06:00:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferoxamine-mesylate,US brand name:,Desferal
2020-09-18T06:00:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferoxamine-mesylate,Abbreviation:,DFM
2020-09-18T06:00:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desflurane,US brand name:,Suprane
2020-09-18T06:00:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desflurane,Code name:,I 653
2020-09-18T06:00:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desflurane,Chemical structure:,"Ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro-,(+-)-"
2020-09-18T06:00:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desipramine-hydrochloride,US brand name:,Norpramin
2020-09-18T06:00:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desipramine-hydrochloride,US brand name:,Pertofrane
2020-09-18T06:00:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deslorelin-acetate,Chemical structure:,5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-tryptophyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide acetate6-D-tryptophan-9-(N-ethyl-L-prolinamide)-1-9-luteinizing hormone-releasing factor (Swine) acetate
2020-09-18T06:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,US brand name:,Concentraid
2020-09-18T06:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,US brand name:,DDAVP
2020-09-18T06:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,US brand name:,Stimate
2020-09-18T06:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,Foreign brand name:,Octostim
2020-09-18T06:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,Chemical structure:,1-(3-mercaptopropionic acid)-8-D-arginine vasopression monoacetate
2020-09-18T06:00:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desogestral,US brand name:,Cerazette
2020-09-18T06:00:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desvenlafaxine-succinate,US brand name:,Pristiq
2020-09-18T06:00:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desvenlafaxine-succinate,Chemical structure:,"butanedioic acid compound with 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol (1:1), monohydrate"
2020-09-18T06:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detorubicin,Chemical structure:,"14-DiethoxyacetoxydaunorubicinDiethoxy-,2-(4-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl)-2-oxoethyl ester,(2S-cis) Acetic Acid"
2020-09-18T06:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detox-b-adjuvant,Synonym:,Detox-B SE Adjuvant
2020-09-18T06:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detox-b-adjuvant,Synonym:,Detox-B Stable Emulsion
2020-09-18T06:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detox-b-adjuvant,US brand name:,Enhanzyn
2020-09-18T06:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detox-b-adjuvant,Abbreviation:,DETOXB
2020-09-18T06:00:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detoxpc,Synonym:,Detox PC
2020-09-18T06:00:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detoxpc,Synonym:,Detox PC adjuvant
2020-09-18T06:00:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detoxpc,Synonym:,DetoxPC adjuvant
2020-09-18T06:01:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-3-methylhistidine,Abbreviation:,D-3MH
2020-09-18T06:01:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-3-methylhistidine,Abbreviation:,deuterated 3MH
2020-09-18T06:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797006,Synonym:,D3-ENT
2020-09-18T06:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797006,Synonym:,enzalutamide deuterated
2020-09-18T06:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797006,Synonym:,N-trideuteromethyl enzalutamide
2020-09-18T06:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797006,Code name:,HC 1119
2020-09-18T06:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797006,Code name:,HC1119
2020-09-18T06:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797006,Code name:,HC-1119
2020-09-18T06:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-phenanthrene,Synonym:,[D10] phenanthrene
2020-09-18T06:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-phenanthrene,Synonym:,phenanthrene-D10
2020-09-18T06:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-phenanthrene,Abbreviation:,[D10]Phe
2020-09-18T06:01:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterium-oxide,Synonym:,heavy water
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Synonym:,Desamethasone
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Synonym:,Dexamethasonum
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Synonym:,disaimisong
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Synonym:,DXM
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Synonym:,Hexadecadrol
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Synonym:,Maxidex
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Synonym:,Methylfluorprednisolone
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Aacidexam
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Adexone
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Aknichthol Dexa
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Alin
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Alin Depot
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Alin Oftalmico
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Amplidermis
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Anemul mono
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Auricularum
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Auxiloson
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Baycuten
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Baycuten N
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Cortidexason
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Cortisumman
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Decacort
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Decalix
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Decameth
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dectancyl
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dekacort
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Deltafluorene
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Desameton
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexacortal
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexacortin
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexafarma
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexafluorene
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexalocal
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexa-Mamallet
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexamecortin
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexamonozon
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexapos
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexa-Rhinosan
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexa-Scheroson
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexa-sine
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexinoral
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexone
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dinormon
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Fluorodelta
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Fortecortin
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Lokalison-F
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Loverine
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Millicorten
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Mymethasone
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Orgadrone
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Spersadex
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Visumetazone
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Abbreviation:,DM
2020-09-18T06:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone-intravitreal-implant,US brand name:,Ozurdex
2020-09-18T06:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,Synonym:,d-amphetamine sulphate
2020-09-18T06:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dexampex
2020-09-18T06:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dexedrine
2020-09-18T06:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dextrostat
2020-09-18T06:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Ferndex
2020-09-18T06:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,Chemical structure:,"(+)-alpha-methylphenethylamine sulphate (2:1)(S)-alpha-methylbenzeneethanamine sulfatebenzeneethanamine, alpha-methyl-, (S)-, sulfate (2:1)d-alpha-methylphenethylamine sulfate"
2020-09-18T06:01:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexanabinol,Code name:,HU-211
2020-09-18T06:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,Synonym:,d-amphetamine sulphate
2020-09-18T06:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dexampex
2020-09-18T06:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dexedrine
2020-09-18T06:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dextrostat
2020-09-18T06:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Ferndex
2020-09-18T06:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,Chemical structure:,"(+)-alpha-methylphenethylamine sulphate (2:1)(S)-alpha-methylbenzeneethanamine sulfatebenzeneethanamine, alpha-methyl-, (S)-, sulfate (2:1)d-alpha-methylphenethylamine sulfate"
2020-09-18T06:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexmedetomidine-hydrochloride,US brand name:,Precedex
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Synonym:,dexpanthenol
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Synonym:,d-pantothenol
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Synonym:,D-pantothenyl alcohol
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Synonym:,motilyn
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Synonym:,pantenyl
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Synonym:,provitamin B5
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,US brand name:,Ilopan
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Foreign brand name:,Bepanthenol
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Code name:,302962
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Chemical structure:,"D-(+)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide"
2020-09-18T06:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-mouthwash,Synonym:,5% dexpanthenol mouthwash
2020-09-18T06:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexrazoxane-hydrochloride,US brand name:,Totect
2020-09-18T06:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexrazoxane-hydrochloride,US brand name:,Zinecard
2020-09-18T06:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexrazoxane-hydrochloride,Foreign brand name:,Cardioxane
2020-09-18T06:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexrazoxane-hydrochloride,Foreign brand name:,Savene
2020-09-18T06:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin,US brand name:,Dextri-Maltose
2020-09-18T06:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin,US brand name:,Glucidex
2020-09-18T06:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin,US brand name:,Glucodry
2020-09-18T06:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin,US brand name:,Maldex
2020-09-18T06:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin,US brand name:,Maldrin
2020-09-18T06:02:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,Synonym:,d-amphetamine sulphate
2020-09-18T06:02:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dexampex
2020-09-18T06:02:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dexedrine
2020-09-18T06:02:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dextrostat
2020-09-18T06:02:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Ferndex
2020-09-18T06:02:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,Chemical structure:,"(+)-alpha-methylphenethylamine sulphate (2:1)(S)-alpha-methylbenzeneethanamine sulfatebenzeneethanamine, alpha-methyl-, (S)-, sulfate (2:1)d-alpha-methylphenethylamine sulfate"
2020-09-18T06:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextromethorphan-hydrobromide,Abbreviation:,DXM
2020-09-18T06:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextropropoxyphene-hydrochloride,NA,NA
2020-09-18T06:02:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,Synonym:,d-amphetamine sulphate
2020-09-18T06:02:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dexampex
2020-09-18T06:02:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dexedrine
2020-09-18T06:02:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dextrostat
2020-09-18T06:02:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Ferndex
2020-09-18T06:02:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,Chemical structure:,"(+)-alpha-methylphenethylamine sulphate (2:1)(S)-alpha-methylbenzeneethanamine sulfatebenzeneethanamine, alpha-methyl-, (S)-, sulfate (2:1)d-alpha-methylphenethylamine sulfate"
2020-09-18T06:02:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexverapamil,Synonym:,R verapamil
2020-09-18T06:02:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexverapamil,Synonym:,R-verapamil
2020-09-18T06:02:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexverapamil,Synonym:,R-Verapamil Hydrochloride
2020-09-18T06:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794047,Synonym:,anti-SAP mAb
2020-09-18T06:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794047,Synonym:,anti-SAP monoclonal antibody
2020-09-18T06:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794047,Code name:,GSK 2398852
2020-09-18T06:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794047,Code name:,GSK2398852
2020-09-18T06:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794047,Code name:,GSK-2398852
2020-09-18T06:02:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dhap-regimen,Synonym:,Dexamethasone-High-dose-Ara-C-cis-Platin
2020-09-18T06:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dha-paclitaxel,Synonym:,Docosahexaenoic Acid-Paclitaxel conjugate
2020-09-18T06:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dha-paclitaxel,US brand name:,Taxoprexin
2020-09-18T06:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dha-paclitaxel,Abbreviation:,DHA-TAX
2020-09-18T06:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dha-paclitaxel,Abbreviation:,TXP
2020-09-18T06:02:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dhea-mustard,Synonym:,dehydroepiandrosterone mustard
2020-09-18T06:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dher2as15-vaccine,Synonym:,dHER2+AS15 antigen-specific cancer immunotherapeutic
2020-09-18T06:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dher2as15-vaccine,Synonym:,dHER2+AS15 ASCI
2020-09-18T06:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glyburide,Synonym:,glibenclamide
2020-09-18T06:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glyburide,US brand name:,Diabeta
2020-09-18T06:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glyburide,US brand name:,Micronase
2020-09-18T06:03:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpropamide,US brand name:,Diabinese
2020-09-18T06:03:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpropamide,US brand name:,Prodiaben
2020-09-18T06:03:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpropamide,Chemical structure:,"4-chloro-4-((propylamino)carbonyl)benzenesulfonamidebenzenesulfonamide, 4-chloro-N-((propylamino)carbonyl)-urea, 1-((p-chlorophenyl)sulfonyl)-3-propyl-"
2020-09-18T06:03:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diacetylmorphine-hydrochloride,Synonym:,diamorphine hydrochloride
2020-09-18T06:03:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diacetylmorphine-hydrochloride,Synonym:,heroin hydrochloride
2020-09-18T06:03:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diacetylmorphine-hydrochloride,Chemical structure:,"morphinan-3,6alpha-diol, 7,8-didehydro-4,5alpha-epoxy-17-methyl-, morphine, Diacetate (ester), hydrochloride"
2020-09-18T06:03:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diammonium-glycyrrhizinate,NA,NA
2020-09-18T06:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol,Synonym:,dianhydrodulcitol
2020-09-18T06:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol,Synonym:,diepoxydulcitol
2020-09-18T06:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol,Synonym:,diepoxygalactitol
2020-09-18T06:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol,Synonym:,dulcitol diepoxide
2020-09-18T06:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol,Synonym:,galactitol
2020-09-18T06:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol,Abbreviation:,DAG
2020-09-18T06:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol,Chemical structure:,"1,2,5,6 dianhydrogalactitol1,2:5, 6-diepoxydulcitol1,2:5,6 dianhydrogalactitol1,2:5,6-dianhydrodulcitolgalactitol, 1,2:5,6-dianhydro- (8CI 9CI)"
2020-09-18T06:03:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazepinomicin,Code name:,ECO-4601
2020-09-18T06:03:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazepinomicin,Code name:,TLN-4601
2020-09-18T06:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diaziquone,Synonym:,Aziridinyl Benzoquinone
2020-09-18T06:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diaziquone,Synonym:,aziridinylbenzoquinone
2020-09-18T06:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diaziquone,Synonym:,Aziridinylbenzoquinone carbamic acid
2020-09-18T06:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diaziquone,Abbreviation:,AZQ
2020-09-18T06:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diaziquone,Code name:,CI-904
2020-09-18T06:03:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazooxonorleucine,Abbreviation:,DON
2020-09-18T06:03:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazooxonorleucine,Chemical structure:,6-diazo-5-oxo-L-norleucine
2020-09-18T06:03:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazoxide,US brand name:,Proglycem
2020-09-18T06:03:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazoxide,Code name:,SRG-95213
2020-09-18T06:03:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazoxide,Chemical structure:,"3-methyl-7-chloro-1,2,4-benzothiadiazine 1,1-dioxide"
2020-09-18T06:03:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenoxybenzamine-hydrochloride,US brand name:,Dibenzyline
2020-09-18T06:03:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenoxybenzamine-hydrochloride,Chemical structure:,N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-benzenemethanamine
2020-09-18T06:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dichloromethotrexate,Synonym:,dichloroamethopterin
2020-09-18T06:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dichloromethotrexate,Synonym:,"methotrexate, dichloro"
2020-09-18T06:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dichloromethotrexate,Abbreviation:,DCM
2020-09-18T06:04:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diclofenac-epolamine-patch,US brand name:,Flector Patch
2020-09-18T06:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diclofenac-sodium-gel,US brand name:,Solaraze
2020-09-18T06:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didanosine,Synonym:,Didanosine EC
2020-09-18T06:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didanosine,Synonym:,dideoxyinosine
2020-09-18T06:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didanosine,US brand name:,Videx
2020-09-18T06:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didanosine,US brand name:,Videx EC
2020-09-18T06:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didanosine,Abbreviation:,ddI
2020-09-18T06:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didanosine,Chemical structure:,"2',3'-Dideoxyinosine"
2020-09-18T06:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didemnin-b,Synonym:,didemnin
2020-09-18T06:04:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dideoxyadenosine,Abbreviation:,ddA
2020-09-18T06:04:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dideoxyadenosine,Chemical structure:,"2',3'-Dideoxyadenosine6-Amino-9-(2''3'-dideoxy-beta-D-glycero-pentofuranosyl)purine"
2020-09-18T06:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dienogest,Code name:,M 18575
2020-09-18T06:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dienogest,Code name:,STS 557
2020-09-18T06:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dienogest,Code name:,ZK 37659
2020-09-18T06:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dienogest,Chemical structure:,"17-hydroxy-3-oxo-19-nor-17.alpha.-pregna-4,9-diene-21-nitrile19-norpregna-4,9-diene-21-nitrile, 17-hydroxy-3-oxo-, (17.alpha.)-"
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Synonym:,Diethylcarbamodithioic Acid
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Synonym:,Diethyldione
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Synonym:,diethyldithiocarbamic acid
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Synonym:,diethyldithiocarbaminic acid
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Synonym:,diethyldithione
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Foreign brand name:,Imuthiol
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Abbreviation:,DDTC
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Abbreviation:,DIECA
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Abbreviation:,DTC
2020-09-18T06:04:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzydamine-hydrochloride,Synonym:,benzydamine HCl
2020-09-18T06:04:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzydamine-hydrochloride,US brand name:,Difflam
2020-09-18T06:04:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzydamine-hydrochloride,Foreign brand name:,Tantum
2020-09-18T06:04:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethicone-containing-botanicals-based-lotion,US brand name:,Difinsa53
2020-09-18T06:04:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluconazole,US brand name:,Diflucan
2020-09-18T06:04:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluconazole,Abbreviation:,FCZ
2020-09-18T06:04:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluconazole,Chemical structure:,"alpha-(2,4-difluorophenyl)-alpha- (1,2,4-triazol-1-ylmethyl)-1,2, 4- triazole-1-ethanol"
2020-09-18T06:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,US brand name:,Dolobid
2020-09-18T06:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,Foreign brand name:,Apo-Diflunisal
2020-09-18T06:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,Foreign brand name:,Flovacil
2020-09-18T06:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,Foreign brand name:,Novo-Diflunisal
2020-09-18T06:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,Foreign brand name:,Nu-Diflunisal
2020-09-18T06:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,Chemical structure:,"(1,1'-biphenyl)-3-carboxylic acid, 2',4'-difluoro-4-hydroxy-2',4'-difluoro-4-hydroxy-(1,1'-biphenyl)-3-carboxylic acid"
2020-09-18T06:05:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799712,Synonym:,digestive starch
2020-09-18T06:05:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799712,Abbreviation:,DS
2020-09-18T06:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/digoxin,US brand name:,Lanoxin
2020-09-18T06:05:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydro-5-azacytidine,Abbreviation:,DHAC
2020-09-18T06:05:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydro-5-azacytidine,Chemical structure:,"1,3,5-triazin-2(1H)-one, 4-amino-3, 6-dihydro-1-beta-D-ribofuranosyl monohydrochloride5,6-dihydro-5-azacytidine HCl5,6-dihydro-5-azacytidine hydrochloride"
2020-09-18T06:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydrolenperone,Synonym:,Dihydro-lenperone
2020-09-18T06:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydrolenperone,Chemical structure:,"1-butanone, 1-(4-fluorophenyl)-4-[4-[(4-fluorophenyl)hydroxymethyl]-1-piperidinyl]-"
2020-09-18T06:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797356,Synonym:,DHODH inhibitor AG-636
2020-09-18T06:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797356,Code name:,AG 636
2020-09-18T06:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797356,Code name:,AG636
2020-09-18T06:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797356,Code name:,AG-636
2020-09-18T06:05:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795787,Synonym:,DHODH inhibitor ASLAN003
2020-09-18T06:05:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795787,Code name:,ASLAN 003
2020-09-18T06:05:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795787,Code name:,ASLAN003
2020-09-18T06:05:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795787,Code name:,ASLAN-003
2020-09-18T06:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793941,Synonym:,DHODH inhibitor BAY2402234
2020-09-18T06:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793941,Code name:,BAY 2402234
2020-09-18T06:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793941,Code name:,BAY2402234
2020-09-18T06:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793941,Code name:,BAY-2402234
2020-09-18T06:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydrotestosterone,Synonym:,Androstanolone
2020-09-18T06:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydrotestosterone,Abbreviation:,DHT
2020-09-18T06:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydrotestosterone,Chemical structure:,"(5alpha,17beta)-17-hydroxyandrostan-3-one"
2020-09-18T06:05:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diindolylmethane,Abbreviation:,DIM
2020-09-18T06:05:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diindolylmethane,Chemical structure:,"3,3'-diindoylmethane"
2020-09-18T06:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Dilaudid
2020-09-18T06:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Dilaudid HP
2020-09-18T06:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Dimorphone
2020-09-18T06:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Hydrostat
2020-09-18T06:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Hymorphan
2020-09-18T06:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Laudicon
2020-09-18T06:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Novolauden
2020-09-18T06:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Dilaudid
2020-09-18T06:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Dilaudid HP
2020-09-18T06:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Dimorphone
2020-09-18T06:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Hydrostat
2020-09-18T06:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Hymorphan
2020-09-18T06:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Laudicon
2020-09-18T06:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Novolauden
2020-09-18T06:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/di-leu16-il2-immunocytokine,Synonym:,de-immunized anti-CD20-IL-2 immunocytokine DI-Leu16-IL-2
2020-09-18T06:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/di-leu16-il2-immunocytokine,Abbreviation:,DI-Leu16-IL-2
2020-09-18T06:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diltiazem-hydrochloride,Synonym:,diltiazem HCl
2020-09-18T06:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diltiazem-hydrochloride,US brand name:,Cardizem
2020-09-18T06:06:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-t4n5-lotion,Synonym:,bacteriophage T4 endonuclease V in liposomal lotion
2020-09-18T06:06:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-t4n5-lotion,Synonym:,T4 endonuclease V liposomal lotion
2020-09-18T06:06:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-t4n5-lotion,Synonym:,T4N5 liposomal lotion
2020-09-18T06:06:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-t4n5-lotion,US brand name:,Dimericine
2020-09-18T06:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimesna,Synonym:,mesna disulfide
2020-09-18T06:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimesna,US brand name:,Tavocept
2020-09-18T06:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimesna,Abbreviation:,DIM
2020-09-18T06:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimesna,Code name:,BNP7787
2020-09-18T06:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimesna,Chemical structure:,"2,2'-dithio-bis-ethanesulfonate, disodium salt"
2020-09-18T06:06:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethicone-containing-botanicals-based-lotion,US brand name:,Difinsa53
2020-09-18T06:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-fumarate,Synonym:,"fumaric acid, dimethyl ester"
2020-09-18T06:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-fumarate,US brand name:,Tecfidera
2020-09-18T06:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-fumarate,Abbreviation:,DMF
2020-09-18T06:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-fumarate,Code name:,BG00012
2020-09-18T06:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-fumarate,Code name:,BG-00012
2020-09-18T06:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-fumarate,Chemical structure:,"(E)-2-butenedioic acid, dimethyl esterdimethyl (E)-butenedioate"
2020-09-18T06:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-sulfoxide,Foreign brand name:,Demasorb
2020-09-18T06:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-sulfoxide,Foreign brand name:,Demeso
2020-09-18T06:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-sulfoxide,Foreign brand name:,Domoso
2020-09-18T06:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-sulfoxide,Foreign brand name:,Dromisol
2020-09-18T06:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-sulfoxide,Abbreviation:,DMSO
2020-09-18T06:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-sulfoxide,Code name:,SQ-9453
2020-09-18T06:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-sulfoxide,Chemical structure:,Sulfinylbismethane
2020-09-18T06:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylbusulfan,Synonym:,Dimethyl Myleran
2020-09-18T06:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylbusulfan,Synonym:,Dimethylmyleran
2020-09-18T06:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylbusulfan,Synonym:,Dimethyl-Myleran
2020-09-18T06:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylbusulfan,Abbreviation:,DMB
2020-09-18T06:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylbusulfan,Abbreviation:,DMM
2020-09-18T06:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Dilaudid
2020-09-18T06:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Dilaudid HP
2020-09-18T06:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Dimorphone
2020-09-18T06:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Hydrostat
2020-09-18T06:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Hymorphan
2020-09-18T06:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Laudicon
2020-09-18T06:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Novolauden
2020-09-18T06:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinaciclib,Synonym:,CDK inhibitor SCH 727965
2020-09-18T06:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinaciclib,Synonym:,cyclin-dependent kinase inhibitor SCH 727965
2020-09-18T06:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinaciclib,Code name:,MK-7965
2020-09-18T06:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinaciclib,Code name:,SCH 727965
2020-09-18T06:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinitrophenyl,Abbreviation:,DNP
2020-09-18T06:07:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinoprost-tromethamine,NA,NA
2020-09-18T06:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinutuximab,Synonym:,Ch14.18
2020-09-18T06:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinutuximab,Synonym:,MOAB Ch14.18
2020-09-18T06:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinutuximab,Synonym:,monoclonal antibody Ch14.18
2020-09-18T06:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinutuximab,US brand name:,Unituxin
2020-09-18T06:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinutuximab,Foreign brand name:,Unituxin
2020-09-18T06:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinutuximab,Abbreviation:,MOAB Ch14.18
2020-09-18T06:07:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dioscorea-nipponica-makino-extract-dne3,Synonym:,Dioscorea nipponica extract with ethyl acetate
2020-09-18T06:07:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dioscorea-nipponica-makino-extract-dne3,Code name:,DNE3
2020-09-18T06:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valsartan,US brand name:,Diovan
2020-09-18T06:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valsartan,Code name:,CGP 48933
2020-09-18T06:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valsartan,Chemical structure:,"L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine"
2020-09-18T06:07:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphencyprone,Synonym:,diphenylcyclopropenone
2020-09-18T06:07:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphencyprone,US brand name:,Samcyprone
2020-09-18T06:07:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphencyprone,Abbreviation:,DPCP
2020-09-18T06:07:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride,US brand name:,Benadryl
2020-09-18T06:07:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride,US brand name:,SK-Diphenhydramine
2020-09-18T06:07:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride,Foreign brand name:,Bendylate
2020-09-18T06:07:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride,Foreign brand name:,Eldadryl
2020-09-18T06:07:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride-dexamethasone-nystatin-magic-mouthwash,NA,NA
2020-09-18T06:07:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxin-fragment-interleukin-2-fusion-protein-e7777,Code name:,E7777
2020-09-18T06:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-vaccine-adsorbed,US brand name:,Decavac
2020-09-18T06:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-vaccine-adsorbed,Abbreviation:,DT
2020-09-18T06:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-vaccine-adsorbed,Abbreviation:,Td adsorbed
2020-09-18T06:08:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/561774,US brand name:,PEDIARIX
2020-09-18T06:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/772556,Synonym:,DTaP(5)-IPV-Hib
2020-09-18T06:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/772556,Synonym:,DTaP-IPV-Hib
2020-09-18T06:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/772556,Foreign brand name:,Pediacel
2020-09-18T06:08:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/propofol,US brand name:,Diprivan
2020-09-18T06:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dipyridamole,US brand name:,Persantine
2020-09-18T06:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dipyridamole,Abbreviation:,DP
2020-09-18T06:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dipyridamole,Chemical structure:,"2,2',2'',2''''-[(4,8-Dipiperidinopyrimido-[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol"
2020-09-18T06:08:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disaccharide-tripeptide-glycerol-dipalmitoyl,US brand name:,ImmTher
2020-09-18T06:08:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disaccharide-tripeptide-glycerol-dipalmitoyl,Abbreviation:,DTP-GDP
2020-09-18T06:08:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disaccharide-tripeptide-glycerol-dipalmitoyl,Chemical structure:,N-acetylglucosaminyl-N-acetyhnuramyl-L-Ala-isoGlu-L-Ala-glycerol dipalmitate
2020-09-18T06:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902,Synonym:,o-salicylsalicylic acid
2020-09-18T06:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902,Synonym:,salicylsalicylic scid
2020-09-18T06:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902,US brand name:,Disalcid
2020-09-18T06:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902,US brand name:,Mono-Gesic
2020-09-18T06:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902,US brand name:,Salflex
2020-09-18T06:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902,US brand name:,Salsitab
2020-09-18T06:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902,Chemical structure:,"benzoic Acid, 2-hydroxy-, 2-carboxyphenyl ester"
2020-09-18T06:08:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/distilled-water,NA,NA
2020-09-18T06:08:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Synonym:,sodium divalproex
2020-09-18T06:08:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Synonym:,valproate semisodium
2020-09-18T06:08:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depacon
2020-09-18T06:08:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depakote
2020-09-18T06:08:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depakote ER
2020-09-18T06:08:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Epilex
2020-09-18T06:08:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Epival
2020-09-18T06:08:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Valparin
2020-09-18T06:08:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Code name:,Abbott 50711
2020-09-18T06:08:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Chemical structure:,sodium hydrogen bis(2-propylpentanoate)
2020-09-18T06:08:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carrageenan-containing-gel,US brand name:,Divine 9 with Carragel
2020-09-18T06:08:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dj-927,Synonym:,oral taxane derivative DJ-927
2020-09-18T06:08:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dj-927,Code name:,DJ927
2020-09-18T06:08:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dkk1-neutralizing-monoclonal-antibody-dkn-01,Code name:,DKN-01
2020-09-18T06:09:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/757880,Synonym:,tumor blood vessel antigen peptide-pulsed alpha-type-1 polarized dendritic cell vaccine
2020-09-18T06:09:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/757880,Synonym:,αDC1-TBVA vaccine
2020-09-18T06:09:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dm4-conjugated-anti-cripto-monoclonal-antibody-biib015,Code name:,BIIB015
2020-09-18T06:09:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dm-choc-pen,Chemical structure:,4-demethyl-4-cholestryloxycarbonylpenclomedine4-demethylcholesteryloxycarbonylpenclomedine
2020-09-18T06:09:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-methionine-formulation-mrx-1024,Code name:,MRX-1024
2020-09-18T06:09:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-interference-oligonucleotide-pnt2258,Synonym:,DNA interference drug PNT2258
2020-09-18T06:09:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-interference-oligonucleotide-pnt2258,US brand name:,DNAi® drug PNT2258
2020-09-18T06:09:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-interference-oligonucleotide-pnt2258,Code name:,PNT2258
2020-09-18T06:09:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-minor-groove-binding-agent-pm060184,Code name:,PM060184
2020-09-18T06:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-minor-groove-binding-agent-sg2000,Code name:,BN2629
2020-09-18T06:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-minor-groove-binding-agent-sg2000,Code name:,NSC 694501
2020-09-18T06:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-minor-groove-binding-agent-sg2000,Code name:,SG2000
2020-09-18T06:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-minor-groove-binding-agent-sg2000,Code name:,SJG-136
2020-09-18T06:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-plasmid-encoding-interleukin-12-ino-9012,Code name:,INO-9012
2020-09-18T06:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-plasmid-vector-ppra-psm-vaccine,NA,NA
2020-09-18T06:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/775854,Synonym:,INO-3112 vaccine
2020-09-18T06:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/775854,Synonym:,VGX-3100 plus INO-9012
2020-09-18T06:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/775854,Code name:,INO-3112
2020-09-18T06:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/775854,Code name:,MEDI0457
2020-09-18T06:10:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-vaccine-vb1016,Synonym:,VB10.16 vaccine
2020-09-18T06:10:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-vaccine-vb1016,Code name:,VB10.16
2020-09-18T06:10:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-dependent-protein-kinase-inhibitor-vx-984,Synonym:,DNA-PK inhibitor VX-984
2020-09-18T06:10:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-dependent-protein-kinase-inhibitor-vx-984,Code name:,VX984
2020-09-18T06:10:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-dependent-protein-kinase-inhibitor-vx-984,Code name:,VX-984
2020-09-18T06:10:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-dependent-protein-kinase-targeting-sidna-dt01,Synonym:,DNA-PK-targeting siDNA DT01
2020-09-18T06:10:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-dependent-protein-kinase-targeting-sidna-dt01,Code name:,DT01
2020-09-18T06:10:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-interference-oligonucleotide-pnt2258,Synonym:,DNA interference drug PNT2258
2020-09-18T06:10:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-interference-oligonucleotide-pnt2258,US brand name:,DNAi® drug PNT2258
2020-09-18T06:10:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-interference-oligonucleotide-pnt2258,Code name:,PNT2258
2020-09-18T06:10:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800695,Synonym:,DNA-dependent protein kinase inhibitor AZD7648
2020-09-18T06:10:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800695,Code name:,AZD 7648
2020-09-18T06:10:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800695,Code name:,AZD7648
2020-09-18T06:10:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800695,Code name:,AZD-7648
2020-09-18T06:10:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800695,Chemical structure:,"7-methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one"
2020-09-18T06:10:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801432,Code name:,BR 101801
2020-09-18T06:10:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801432,Code name:,BR101801
2020-09-18T06:10:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801432,Code name:,BR-101801
2020-09-18T06:10:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-tor-kinase-inhibitor-cc-115,Code name:,CC-115
2020-09-18T06:10:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802300,Code name:,NTX 301
2020-09-18T06:10:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802300,Code name:,NTX301
2020-09-18T06:10:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802300,Code name:,NTX-301
2020-09-18T06:10:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dnp-modified-autologous-renal-cell-carcinoma-tumor-cell-vaccine,Synonym:,dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine
2020-09-18T06:10:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dnr-expressing-nasopharyngeal-carcinoma-specific-cytotoxic-t-lymphocytes,Abbreviation:,DNR NPC-specific CTL
2020-09-18T06:10:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dobutamine,NA,NA
2020-09-18T06:10:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel,US brand name:,Taxotere
2020-09-18T06:10:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel,Foreign brand name:,Docecad
2020-09-18T06:10:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel,Abbreviation:,TXT
2020-09-18T06:10:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel,Code name:,RP 56976
2020-09-18T06:11:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-emulsion-anx-514,Code name:,ANX-514
2020-09-18T06:11:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-formulation-ckd-810,Code name:,CKD-810
2020-09-18T06:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801859,Code name:,JSI-1187
2020-09-18T06:11:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-lipid-microspheres,Synonym:,docetaxel lipid emulsion
2020-09-18T06:11:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-lipid-microspheres,Abbreviation:,DT-LM
2020-09-18T06:11:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-docetaxel,Synonym:,docetaxel containing CriPec (R) nanoparticles
2020-09-18T06:11:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-docetaxel,Synonym:,docetaxel-containing CriPec (R) nanoparticles CPC634
2020-09-18T06:11:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-docetaxel,Synonym:,nanoparticle-encapsulated docetaxel CPC634
2020-09-18T06:11:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-docetaxel,Foreign brand name:,CriPec® docetaxel
2020-09-18T06:11:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-docetaxel,Code name:,CPC 634
2020-09-18T06:11:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-docetaxel,Code name:,CPC634
2020-09-18T06:11:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-docetaxel,Code name:,CPC-634
2020-09-18T06:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799405,Synonym:,docetaxel-loaded PMs
2020-09-18T06:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799405,Synonym:,docetaxel-loaded polymeric micelles
2020-09-18T06:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799405,Synonym:,docetaxel-PM
2020-09-18T06:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799405,Foreign brand name:,NanoxelM
2020-09-18T06:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799405,Foreign brand name:,Nanoxel-M
2020-09-18T06:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799405,Code name:,docetaxel-loaded PM
2020-09-18T06:11:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798993,Synonym:,ModraDoc006/r
2020-09-18T06:11:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798993,Synonym:,oral docetaxel/ritonavir
2020-09-18T06:11:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-loaded-nanopharmaceutical-crlx301,Code name:,CRLX301
2020-09-18T06:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-pnp,NA,NA
2020-09-18T06:11:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docosahexaenoic-acid,NA,NA
2020-09-18T06:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolasetron-mesylate,Code name:,"MDL 73,147EF"
2020-09-18T06:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolastatin-10,Synonym:,Dolastatin-10
2020-09-18T06:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolastatin-10,Code name:,B720389K560
2020-09-18T06:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolastatin-10,Chemical structure:,"L-Valinamide, N,N-dimethyl-L-valyl-N-[2-methoxy-4-[2-[1- methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(2-thiazolyl)ethyl]amino]propyl]-1-pyrrolidinyl]-1-(1-methylpropyl)-4-oxobutyl]-N-methyl-, [2S-[1[1R*(R*),2S*],2R*[1S*,2S*,3(R*)]]]"
2020-09-18T06:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794176,Code name:,SP 333
2020-09-18T06:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794176,Code name:,SP333
2020-09-18T06:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794176,Code name:,SP-333
2020-09-18T06:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794176,Chemical structure:,"D-leucine, D-asparaginyl-L-alpha-aspartyl-L-alpha-glutamyl-L-cysteinyl-L-alpha-glutamyl-L-leucyl-L-cysteinyl-L-valyl-L-asparaginyl-L-valyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (4->12),(7->15)-bis(disulfide)"
2020-09-18T06:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,US brand name:,Dolobid
2020-09-18T06:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,Foreign brand name:,Apo-Diflunisal
2020-09-18T06:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,Foreign brand name:,Flovacil
2020-09-18T06:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,Foreign brand name:,Novo-Diflunisal
2020-09-18T06:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,Foreign brand name:,Nu-Diflunisal
2020-09-18T06:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,Chemical structure:,"(1,1'-biphenyl)-3-carboxylic acid, 2',4'-difluoro-4-hydroxy-2',4'-difluoro-4-hydroxy-(1,1'-biphenyl)-3-carboxylic acid"
2020-09-18T06:12:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolutegravir,US brand name:,Tivicay
2020-09-18T06:12:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolutegravir,Abbreviation:,DTG
2020-09-18T06:12:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolutegravir,Code name:,GSK 1349572
2020-09-18T06:12:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolutegravir,Code name:,GSK-1349572
2020-09-18T06:12:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolutegravir,Chemical structure:,"2H-pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide, N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS)-"
2020-09-18T06:12:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-4sc-202,Synonym:,HDAC Inhibitor 4SC-202
2020-09-18T06:12:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-4sc-202,Code name:,4SC-202
2020-09-18T06:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donepezil-hydrochloride,US brand name:,Aricept
2020-09-18T06:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donepezil-hydrochloride,Code name:,E-2020
2020-09-18T06:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donepezil-hydrochloride,Chemical structure:,"1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine Hydrochloride"
2020-09-18T06:12:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donor-lymphocytes,NA,NA
2020-09-18T06:12:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donor-regulatory-t-lymphocytes,Synonym:,donor CD4+CD25+FoxP3+ T cells
2020-09-18T06:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793675,Synonym:,donor-derived CD34+ HPCs/CD3+ T cells MDR-101
2020-09-18T06:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793675,Code name:,MDR 101
2020-09-18T06:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793675,Code name:,MDR-101
2020-09-18T06:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800217,Code name:,CPI-0209
2020-09-18T06:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792552,Synonym:,allogeneic CIML NK cells
2020-09-18T06:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792552,Synonym:,allogeneic CIML NKs
2020-09-18T06:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792552,Synonym:,allogeneic cytokine-induced memory-like NK cell
2020-09-18T06:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792552,Synonym:,CIML-NK cells
2020-09-18T06:12:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donor-derived-wt1-prame-ny-eso-1-survivin-specific-t-lymphocytes,Abbreviation:,multi-TAA-specific T cells
2020-09-18T06:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dopamine-somatostatin-chimeric-molecule-bim-23a760,Code name:,BIM-23A760
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Synonym:,L-dopa
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Bendopa
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Dopar
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Eldopar
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Laradopa
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Larodopa
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Levopa
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Cidandopa
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Deadopa
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopaflex
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopaidan
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopal
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopalina
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Doparkine
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Doparl
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopasol
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopaston
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopastral
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Doprin
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Eldopal
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Eldopatec
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Eurodopa
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Ledopa
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Maipedopa
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Parda
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Veldopa
2020-09-18T06:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Chemical structure:,"(--)-2amino-3-)3,4-dihydroxyphenyl)propanoic acid(--)-3-(3,4-dihydroxyphenyl)-L-alanine3-hydroxy-L-tyrosinebeta-(3,4-dihydroxyphenyl)-L-alanine"
2020-09-18T06:13:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793425,US brand name:,Doptelet
2020-09-18T06:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dornase-alfa,Synonym:,recombinant human deoxyribonuclease I
2020-09-18T06:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dornase-alfa,Synonym:,recombinanthuman deoxyribonuclease I
2020-09-18T06:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dornase-alfa-inhalation-solution,Synonym:,recombinant human deoxyribonuclease I inhalation solution
2020-09-18T06:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dornase-alfa-inhalation-solution,US brand name:,Pulmozyme
2020-09-18T06:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dornase-alfa-inhalation-solution,Foreign brand name:,Pulmozyme
2020-09-18T06:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dornase-alfa-inhalation-solution,Abbreviation:,rhDNase inhalation solution
2020-09-18T06:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-tsr-042,Synonym:,"immunoglobulin G4, anti-programmed cell death protein 1 (PDCD1) (humanized clone ABT1 gamma4-chain), disulfide with humanized clone ABT1 kappa-chain, dimer"
2020-09-18T06:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-tsr-042,Code name:,ANB011
2020-09-18T06:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-tsr-042,Code name:,TSR 042
2020-09-18T06:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-tsr-042,Code name:,TSR042
2020-09-18T06:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-tsr-042,Code name:,TSR-042
2020-09-18T06:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabergoline,US brand name:,Dostinex
2020-09-18T06:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabergoline,Code name:,FCE 21336
2020-09-18T06:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabergoline,Chemical structure:,1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
2020-09-18T06:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dotapchol-fus1-liposome-complex,Synonym:,DOTAP:cholesterol-Fus1
2020-09-18T06:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dotapchol-fus1-liposome-complex,Synonym:,DOTAP:cholesterol-Fus1 liposome complex
2020-09-18T06:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dotapchol-fus1-liposome-complex,Synonym:,DOTAP:chol-Fus1
2020-09-18T06:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prasterone,Code name:,GL701
2020-09-18T06:13:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoterate-meglumine,Synonym:,Gd-DOTA
2020-09-18T06:13:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoterate-meglumine,US brand name:,DOTAREM
2020-09-18T06:13:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoterate-meglumine,Foreign brand name:,DOTAREM
2020-09-18T06:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dovitinib-lactate,Synonym:,receptor tyrosine kinase inhibitor TKI258
2020-09-18T06:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dovitinib-lactate,Synonym:,RTK inhibitor TKI258
2020-09-18T06:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dovitinib-lactate,Code name:,CHIR-258
2020-09-18T06:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dovitinib-lactate,Code name:,TKI258
2020-09-18T06:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcipotriene,Synonym:,calcipotriol
2020-09-18T06:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcipotriene,US brand name:,Dovonex
2020-09-18T06:13:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxazosin-mesylate,US brand name:,Cardura
2020-09-18T06:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxercalciferol,US brand name:,Hectorol
2020-09-18T06:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxercalciferol,Chemical structure:,"(1alpha,3beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol1-alpha-hydroxyvitamin D2"
2020-09-18T06:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxifluridine,Abbreviation:,5-DFUR
2020-09-18T06:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxifluridine,Chemical structure:,5'-deoxy-5-fluorouridine
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,ATI-0918
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,doxorubicin hydrochloride liposome injection
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,duomeisu
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,liposomal adriamycin
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,liposomal doxorubicin
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,liposomal doxorubicin hydrochloride
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,liposome-encapsulated doxorubicin
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,pegylated doxorubicin HCl liposome
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,Pegylated Liposomal Doxorubicin
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,pegylated liposomal doxorubicin hydrochloride
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,S-Liposomal Doxorubicin
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,Stealth Liposomal Doxorubicin
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,US brand name:,Doxil
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Foreign brand name:,Caelyx
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Foreign brand name:,Doxilen
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Abbreviation:,doxorubicin HCl liposome
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Code name:,TLC D-99
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Chemical structure:,"(8S-cis)-8-acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-tri-hydroxy-1-methoxy-5,12-naphthacenedione Hydrochloride"
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Synonym:,ADR
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Synonym:,adriamycin
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Synonym:,adriamycin hydrochloride
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Synonym:,Adriamycine
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Synonym:,chloridrato de doxorrubicina
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Synonym:,doxorubicin.HCl
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Synonym:,hydroxydaunorubicin
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Adriablastin
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Adriacin
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Adriblastina
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Adriblastine
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Adrimedac
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,DOXO-CELL
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Doxolem
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Doxorubin
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Farmiblastina
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Abbreviation:,ADM
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Abbreviation:,Adria
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Abbreviation:,DOX
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Code name:,FI-106
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,ATI-0918
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,doxorubicin hydrochloride liposome injection
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,duomeisu
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,liposomal adriamycin
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,liposomal doxorubicin
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,liposomal doxorubicin hydrochloride
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,liposome-encapsulated doxorubicin
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,pegylated doxorubicin HCl liposome
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,Pegylated Liposomal Doxorubicin
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,pegylated liposomal doxorubicin hydrochloride
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,S-Liposomal Doxorubicin
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,Stealth Liposomal Doxorubicin
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,US brand name:,Doxil
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Foreign brand name:,Caelyx
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Foreign brand name:,Doxilen
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Abbreviation:,doxorubicin HCl liposome
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Code name:,TLC D-99
2020-09-18T06:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Chemical structure:,"(8S-cis)-8-acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-tri-hydroxy-1-methoxy-5,12-naphthacenedione Hydrochloride"
2020-09-18T06:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800071,Synonym:,doxorubicin prodrug SQP33/prodrug-activating biomaterial SQL70
2020-09-18T06:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800071,Code name:,SQ 3370
2020-09-18T06:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800071,Code name:,SQ3370
2020-09-18T06:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800071,Code name:,SQ-3370
2020-09-18T06:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800071,Code name:,SQL70/SQP33
2020-09-18T06:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800071,Code name:,SQL70-SQP33
2020-09-18T06:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-eluting-beads,NA,NA
2020-09-18T06:14:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hpma-conjugate,Synonym:,doxorubicin-HPMA
2020-09-18T06:14:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hpma-conjugate,Synonym:,doxorubicin-HPMA copolymer conjugate
2020-09-18T06:14:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hpma-conjugate,Synonym:,HPMA-doxorubicin
2020-09-18T06:14:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hpma-conjugate,Abbreviation:,P(GFLG)-ADR
2020-09-18T06:14:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hpma-conjugate,Code name:,PK1
2020-09-18T06:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-loaded-egfr-targeting-nanocells,Synonym:,doxorubicin-loaded EGFR-targeting nanocell
2020-09-18T06:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-loaded-egfr-targeting-nanocells,Synonym:,EGFR (vectibix sequence)-targeted EnGeneIC dream vectors containing doxorubicin
2020-09-18T06:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-loaded-egfr-targeting-nanocells,Synonym:,EGFR(V)-EDV-Dox
2020-09-18T06:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-loaded-egfr-targeting-nanocells,Synonym:,EGFR-targeted EnGeneIC dream vectors containing doxorubicin
2020-09-18T06:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-magnetic-targeted-carrier-complex,Abbreviation:,DOX-MTC
2020-09-18T06:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-magnetic-targeted-carrier-complex,Abbreviation:,MTC-DOX
2020-09-18T06:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxycycline-calcium,US brand name:,Vibramycin
2020-09-18T06:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxycycline-hyclate-injection,NA,NA
2020-09-18T06:15:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dpt-bcg-measles-serratia-pneumococcus-vaccine,Synonym:,"diphtheria, pertussis, tetanus/Bacille Calmette-Guerin/measles/Serratia/pneumococcus vaccine"
2020-09-18T06:15:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dpt-typhoid-staphylococcus-aureus-paratyphoid-a-paratyphoid-b-vaccine,Synonym:,"diphtheria, pertussis, tetanus/typhoid/Staphylococcus aureus/paratyphoid A/paratyphoid B vaccine"
2020-09-18T06:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794053,Synonym:,HexaBody-DR5/DR5
2020-09-18T06:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794053,Synonym:,HexaBody-DR5-01/DR5-05
2020-09-18T06:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794053,Synonym:,Hx-DR5-01/05
2020-09-18T06:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794053,Code name:,GEN 1029
2020-09-18T06:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794053,Code name:,GEN1029
2020-09-18T06:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol,Synonym:,delta 9-tetrahydrocannabinol
2020-09-18T06:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol,Synonym:,tetrahydrocannabinol
2020-09-18T06:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol,US brand name:,Marinol
2020-09-18T06:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol,US brand name:,Syndros
2020-09-18T06:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol,Abbreviation:,THC
2020-09-18T06:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol,Code name:,Abbott 40566
2020-09-18T06:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol,Code name:,SP-104
2020-09-18T06:15:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/droperidol,US brand name:,Inapsine
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Synonym:,HYD
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Synonym:,Hydroxycarbamide
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Synonym:,Hydurea
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,US brand name:,Droxia
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,US brand name:,Hydrea
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Foreign brand name:,Litalir
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Foreign brand name:,Onco-Carbide
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Foreign brand name:,Oxeron
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Foreign brand name:,Syrea
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Abbreviation:,HU
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Code name:,SQ 1089
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Code name:,SQ-1089
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Code name:,WR 83799
2020-09-18T06:15:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dta-h19-plasmid,Synonym:,diphtheria toxin A-H19 plasmid
2020-09-18T06:15:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dta-h19-plasmid,Code name:,DTA-H19
2020-09-18T06:15:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-pi3-kinase-mtor-inhibitor-gdc-0980,Code name:,GDC-0980
2020-09-18T06:15:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-variable-domain-immunoglobulin-abt-165,Synonym:,DVD-Ig ABT-165
2020-09-18T06:15:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-variable-domain-immunoglobulin-abt-165,Code name:,ABT-165
2020-09-18T06:15:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-affinity-b7-h3-cd3-targeted-protein-mgd009,Synonym:,B7-H3 x CD3 DART protein
2020-09-18T06:15:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-affinity-b7-h3-cd3-targeted-protein-mgd009,Synonym:,B7-H3 x CD3 dual-affinity re-targeting protein MGD009
2020-09-18T06:15:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-affinity-b7-h3-cd3-targeted-protein-mgd009,Synonym:,DART protein MGD009
2020-09-18T06:15:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-affinity-b7-h3-cd3-targeted-protein-mgd009,Code name:,MGD 009
2020-09-18T06:15:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-affinity-b7-h3-cd3-targeted-protein-mgd009,Code name:,MGD009
2020-09-18T06:15:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-affinity-b7-h3-cd3-targeted-protein-mgd009,Code name:,MGD-009
2020-09-18T06:15:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens-bazedoxifene,Synonym:,CE/BZA formulation
2020-09-18T06:15:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens-bazedoxifene,US brand name:,Duavee
2020-09-18T06:15:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens-bazedoxifene,Abbreviation:,CE/BZA
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Synonym:,13-Hydroxydaunomycin
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Synonym:,Daunomycinol
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Synonym:,Daunomycinol HCl
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Synonym:,Daunorubicineal
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Synonym:,Duborimycin Hydrochloride
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Synonym:,Duborimycine
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Synonym:,"Duborimycine, Hydrochloride"
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Chemical structure:,"5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, (8S-cis)-, hydrochloride"
2020-09-18T06:16:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dulanermin,Synonym:,recombinant human Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand
2020-09-18T06:16:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dulanermin,Synonym:,recombinant TNF-related apoptosis-inducing ligand
2020-09-18T06:16:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dulanermin,Abbreviation:,RhApo2L/TRAIL
2020-09-18T06:16:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dulanermin,Code name:,AMG 951
2020-09-18T06:16:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duloxetine-hydrochloride,NA,NA
2020-09-18T06:16:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783,Synonym:,didrogesterone
2020-09-18T06:16:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783,Synonym:,hydrogestrone
2020-09-18T06:16:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783,Synonym:,isopregnenone
2020-09-18T06:16:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783,US brand name:,Duphaston
2020-09-18T06:17:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,US brand name:,BOTOX
2020-09-18T06:16:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783,Chemical structure:,"(9-beta,10-alpha)-pregna-4,6-diene-3,20-dioneretro-6-dehydroprogesterone"
2020-09-18T06:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,US brand name:,Dupixent
2020-09-18T06:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,REGN 668
2020-09-18T06:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,REGN668
2020-09-18T06:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,REGN-668
2020-09-18T06:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,SAR 231893
2020-09-18T06:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,SAR231893
2020-09-18T06:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,SAR-231893
2020-09-18T06:16:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,US brand name:,Dupixent
2020-09-18T06:16:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,REGN 668
2020-09-18T06:16:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,REGN668
2020-09-18T06:16:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,REGN-668
2020-09-18T06:16:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,SAR 231893
2020-09-18T06:16:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,SAR231893
2020-09-18T06:16:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,SAR-231893
2020-09-18T06:16:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/durvalumab,US brand name:,Imfinzi
2020-09-18T06:16:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/durvalumab,Code name:,MEDI4736
2020-09-18T06:16:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/durvalumab,Code name:,MEDI-4736
2020-09-18T06:16:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/durvalumab,Chemical structure:,"immunoglobulin G1, anti-(human protein B7-H1) (human monoclonal MEDI4736 heavy chain), disulfide with human monoclonal MEDI4736 kappa-chain, dimer"
2020-09-18T06:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutasteride,US brand name:,Avodart
2020-09-18T06:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutasteride,Code name:,GG 745
2020-09-18T06:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutasteride,Chemical structure:,"alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidideAvolve,(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide"
2020-09-18T06:16:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutpase-inhibitor-tas-114,Code name:,TAS-114
2020-09-18T06:16:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvelisib,US brand name:,Copiktra
2020-09-18T06:16:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvelisib,Code name:,INK-1197
2020-09-18T06:16:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvelisib,Code name:,IPI-145
2020-09-18T06:16:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvelisib,Chemical structure:,"1(2H)-isoquinolinone, 8-chloro-2-phenyl-3-((1S)-1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenyl-3-((1S)-1-(7H-purin-6-ylamino)ethyl)isoquinolin-1(2H)-one"
2020-09-18T06:16:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dwj1319,NA,NA
2020-09-18T06:17:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794778,US brand name:,Cepacol
2020-09-18T06:17:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794778,US brand name:,Dyclone
2020-09-18T06:17:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794778,Chemical structure:,"1-propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-,hydrochloride"
2020-09-18T06:17:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794778,US brand name:,Cepacol
2020-09-18T06:17:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794778,US brand name:,Dyclone
2020-09-18T06:17:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794778,Chemical structure:,"1-propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-,hydrochloride"
2020-09-18T06:17:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783,Synonym:,didrogesterone
2020-09-18T06:17:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783,Synonym:,hydrogestrone
2020-09-18T06:17:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783,Synonym:,isopregnenone
2020-09-18T06:17:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783,US brand name:,Duphaston
2020-09-18T06:17:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783,Chemical structure:,"(9-beta,10-alpha)-pregna-4,6-diene-3,20-dioneretro-6-dehydroprogesterone"
2020-09-18T06:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride,Synonym:,Minomax
2020-09-18T06:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride,Synonym:,Minomycin
2020-09-18T06:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride,Synonym:,Tri-minocycline
2020-09-18T06:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride,US brand name:,Dynacin
2020-09-18T06:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride,US brand name:,Minocin
2020-09-18T06:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride,US brand name:,Vectrin
2020-09-18T06:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride,Chemical structure:,"4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide Monohydrochloride"
2020-09-18T06:17:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,abobotulinumtoxinA
2020-09-18T06:17:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,botulinum A toxin
2020-09-18T06:17:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,botulinum neurotoxin type A
2020-09-18T06:17:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,botulinum toxin A
2020-09-18T06:17:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,onabotulinumtoxinA
2020-09-18T06:17:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,onaclostox
2020-09-18T06:17:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,US brand name:,Botox cosmetic
2020-09-18T06:17:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,US brand name:,Dysport
2020-09-18T06:17:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Abbreviation:,BTX-A
2020-09-18T06:17:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/e-coli-cd-expressing-genetically-modified-neural-stem-cells,Abbreviation:,HB1.F3.CD neural stem cells
2020-09-18T06:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/e-101-solution,Code name:,E-101
2020-09-18T06:17:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/e2f1-pathway-activator-arq-171,Code name:,ARQ 171
2020-09-18T06:17:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/e7820,NA,NA
2020-09-18T06:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792786,Synonym:,EISO cream
2020-09-18T06:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792786,Synonym:,Santalum album oil cream
2020-09-18T06:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792786,Code name:,SAN 007
2020-09-18T06:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792786,Code name:,VIR 003
2020-09-18T06:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792786,Code name:,VIR 007
2020-09-18T06:17:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/east-indian-sandalwood-oil-mouth-rinse,Synonym:,0.25% EISO mouth rinse
2020-09-18T06:17:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/east-indian-sandalwood-oil-mouth-rinse,Synonym:,EISO mouth rinse
2020-09-18T06:18:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797645,Synonym:,Epstein-Barr nuclear antigen 1 inhibitor VK-2019
2020-09-18T06:18:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797645,Code name:,VK 2019
2020-09-18T06:18:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797645,Code name:,VK2019
2020-09-18T06:18:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797645,Code name:,VK-2019
2020-09-18T06:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebselen-containing-oral-capsule-spi-1005,Code name:,SPI-1005
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,EBV latent membrane protein-2a-specific Eutil autologous blood-derived T lymphocytes
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,EBV/LMP-2A-specific CD8 T cells
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,EBV-induced natural T cells
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,EBV-induced T lymphocytes
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,EBViNT cell
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,EBViNT cells
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,Epstein-Barr virus induced natural T cells
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,Eutil autologous T lymphocytes
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Abbreviation:,EBViNT
2020-09-18T06:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin,Synonym:,bis-quinoline analogue
2020-09-18T06:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin,Synonym:,echinomycin A
2020-09-18T06:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin,Synonym:,levomycin
2020-09-18T06:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin,Synonym:,quinomycin A
2020-09-18T06:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin,Code name:,BRN 0078671
2020-09-18T06:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin,Code name:,SK 302B
2020-09-18T06:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin,Chemical structure:,"N,N'-(2,4,12,15,17,25-hexamethyl-11,24-bis(1-methylethyl)-27-(methylthio)-3,6,10,13,16,19,23,26-octaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo(12.12.3)nonacosane-7,20-diyl)bis(2-quinoxalinecarboxamide)"
2020-09-18T06:18:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ecromeximab,Synonym:,monoclonal antibody KW-2871
2020-09-18T06:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801658,Synonym:,ectoine mouth wash
2020-09-18T06:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801658,Synonym:,ectoine mouth wash EML03
2020-09-18T06:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801658,Foreign brand name:,Ectoin
2020-09-18T06:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801658,Code name:,EML 03
2020-09-18T06:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801658,Code name:,EML03
2020-09-18T06:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801658,Code name:,EML-03
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,Synonym:,Alexion
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,Synonym:,eculizumab biosimilar ABP 959
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,Synonym:,eculizumab biosimilar BCD-148
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,Synonym:,eculizumab biosimilar SB12
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,Synonym:,monoclonal antibody 5G1.1
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,Synonym:,monoclonal antibody anti-C5
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,US brand name:,Soliris
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,Abbreviation:,h5G1.1
2020-09-18T06:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edatrexate,Abbreviation:,10-EdAM
2020-09-18T06:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edatrexate,Abbreviation:,EDAM
2020-09-18T06:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edatrexate,Code name:,CGP-30694
2020-09-18T06:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edatrexate,Chemical structure:,"10-ethyl-10-deaza-aminopterinN-[4-[1-[(2,4-diamino-6-pteridinyl)-methyl]propyl]benzoyl]-L-glutamic acid"
2020-09-18T06:18:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethacrynic-acid,US brand name:,Edecrin
2020-09-18T06:18:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethacrynic-acid,Abbreviation:,EA
2020-09-18T06:18:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethacrynic-acid,Chemical structure:,"[2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic Acid"
2020-09-18T06:18:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edotecarin,Synonym:,PHA-782615
2020-09-18T06:18:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edotecarin,Code name:,J-107088
2020-09-18T06:18:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edotecarin,Chemical structure:,"6-N-(1-hydroxymethyla-2-hydroxy)ethylamino-12,13-dihydro-13-(beta-D-gluco pyranosyl)-5H-indolo[2,3-a]-pyrrolol[3,4-c]-carbazole-5,7(6H)-dione"
2020-09-18T06:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edoxaban-tosylate,Code name:,DU-176b
2020-09-18T06:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edoxaban-tosylate,Chemical structure:,"N-(5-chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N- dimethylcarbamoyl)-2-(5-methyl-4,5,6,7- tetrahydro(1,3)thiazolo(5,4-c)pyridine-2- carboxamido)cyclohexyl)oxamide, 4- methylbenzenesulfonate"
2020-09-18T06:18:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edrecolomab,Synonym:,monoclonal antibody 17-1A
2020-09-18T06:18:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edrecolomab,Foreign brand name:,Panorex
2020-09-18T06:18:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edrecolomab,Abbreviation:,MOAB 17-1A
2020-09-18T06:19:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eed-inhibitor-mak683,Synonym:,ectodermal embryonic development inhibitor MAK683
2020-09-18T06:19:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eed-inhibitor-mak683,Synonym:,EED PPI inhibitor MAK683
2020-09-18T06:19:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eed-inhibitor-mak683,Synonym:,EED protein-protein interaction inhibitor MAK683
2020-09-18T06:19:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eed-inhibitor-mak683,Code name:,MAK 683
2020-09-18T06:19:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eed-inhibitor-mak683,Code name:,MAK683
2020-09-18T06:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ef5,Chemical structure:,"2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) Acetamide"
2020-09-18T06:19:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efalizumab,NA,NA
2020-09-18T06:19:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efaproxiral,Synonym:,2-dacmpp
2020-09-18T06:19:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efaproxiral,Synonym:,Efaproxyn
2020-09-18T06:19:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efaproxiral,Code name:,RSR13
2020-09-18T06:19:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efaproxiral,Chemical structure:,"2-(4-(((3,5-dimethylanilino)Carbonyl)methyl)phenoxy)-2-methylpropionic acid"
2020-09-18T06:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efatutazone-dihydrochloride,Synonym:,inolitazone dihydrochloride
2020-09-18T06:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efatutazone-dihydrochloride,Synonym:,PPAR-gamma agonist CS-7017
2020-09-18T06:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efatutazone-dihydrochloride,Code name:,CS-7017
2020-09-18T06:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efatutazone-dihydrochloride,Code name:,RS5444
2020-09-18T06:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efatutazone-dihydrochloride,Chemical structure:,"2,4-thiazolidinedione, 5-((4-((6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1h-benzimidazol-2-yl)methoxy)phenyl)methyl)-, Hydrochloride (1:2)"
2020-09-18T06:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efavirenz,US brand name:,Sustiva
2020-09-18T06:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efavirenz,Foreign brand name:,Stocrin
2020-09-18T06:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efavirenz,Code name:,DMP-266
2020-09-18T06:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efavirenz,Code name:,L743726
2020-09-18T06:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venlafaxine,US brand name:,Effexor
2020-09-18T06:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venlafaxine,Abbreviation:,VNF
2020-09-18T06:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793527,Synonym:,Venlafaxine HCl ER
2020-09-18T06:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793527,US brand name:,Effexor XR
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Synonym:,Hyleukin-7
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Synonym:,Il-7 hybrid Fc
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Synonym:,IL-7-hyFc
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Synonym:,rhIL-7-hyFc
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Code name:,GX-I7
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Code name:,NT-I7
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Code name:,TJ 107
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Code name:,TJ107
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Code name:,TJ-107
2020-09-18T06:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-acting-granulocyte-colony-stimulating-factor-receptor-spi-2012,Synonym:,long-acting granulocyte colony-stimulating factor receptor SPI-2012
2020-09-18T06:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-acting-granulocyte-colony-stimulating-factor-receptor-spi-2012,US brand name:,Rolontis
2020-09-18T06:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-acting-granulocyte-colony-stimulating-factor-receptor-spi-2012,Abbreviation:,LAPS-GCSF
2020-09-18T06:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-acting-granulocyte-colony-stimulating-factor-receptor-spi-2012,Code name:,HM10460A
2020-09-18T06:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-acting-granulocyte-colony-stimulating-factor-receptor-spi-2012,Code name:,SPI-2012
2020-09-18T06:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride,Synonym:,2-difluoromethylornithine hydrochloride
2020-09-18T06:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride,Synonym:,alpha-difluoromethylornithine hydrochloride
2020-09-18T06:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride,Synonym:,eflornithine HCl
2020-09-18T06:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride,US brand name:,Vaniqa
2020-09-18T06:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride,Code name:,MDL 71782
2020-09-18T06:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride,Code name:,RMI-71782
2020-09-18T06:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride,Chemical structure:,"2-(difluoromethyl)-dl-ornithine hydrochloride, monohydrate2-(difluoromethyl)-DL-ornithine hydrochloride, monohydrate"
2020-09-18T06:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride-ointment,Synonym:,DL-alpha-difluoromethylornitine hydrochloride ointment
2020-09-18T06:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efs-ada-lentiviral-vector-transduced-cd34-positive-autologous-lymphocytes,NA,NA
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Synonym:,Efti
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Synonym:,hLAG-31g
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Synonym:,LAG-3Ig
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Synonym:,LAG-3-Ig-fusion protein
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Synonym:,sLAG-3-Ig
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Foreign brand name:,ImmuFact IMP321
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Foreign brand name:,ImmuFact-IMP321
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Code name:,EDP-202
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Code name:,EOC-202
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Code name:,IMP321
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Code name:,IMP-321
2020-09-18T06:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Synonym:,Timazin
2020-09-18T06:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Synonym:,topical 5-fluorouracil
2020-09-18T06:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Carac
2020-09-18T06:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Efudex
2020-09-18T06:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Fluoroplex
2020-09-18T06:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Tolak
2020-09-18T06:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Actino-Hermal
2020-09-18T06:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Arumel
2020-09-18T06:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Cytosafe
2020-09-18T06:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Efurix
2020-09-18T06:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Fiverocil
2020-09-18T06:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Flurox
2020-09-18T06:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Abbreviation:,5-FU topical
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Synonym:,5-fluorouracil injection
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Synonym:,5-Fluracil
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Synonym:,fluouracil
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Synonym:,Fluracil
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,US brand name:,Efudex
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,AccuSite
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,Flurablastin
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,Fluracedyl
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,Fluril
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,Fluroblastin
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,Ribofluor
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Abbreviation:,5-FU injection
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Abbreviation:,FU
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Code name:,Ro-2-9757
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Chemical structure:,"2,4-dioxo-5-fluoropyrimidine5-fluoro-2,4(1H,3H)-pyrimidinedione"
2020-09-18T06:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eg5-kinesin-related-motor-protein-inhibitor-4sc-205,Synonym:,Eg5 kinesin inhibitor 4SC-205
2020-09-18T06:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eg5-kinesin-related-motor-protein-inhibitor-4sc-205,Code name:,4SC-205
2020-09-18T06:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eg5-kinesin-related-motor-protein-inhibitor-arq-621,Synonym:,Eg5 inhibitor ARQ 621
2020-09-18T06:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eg5-kinesin-related-motor-protein-inhibitor-arq-621,Code name:,ARQ 621
2020-09-18T06:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egb761,Synonym:,ginkgo biloba
2020-09-18T06:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798974,Synonym:,EGF pathway targeted immunization agent
2020-09-18T06:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798974,Synonym:,EGF pathway targeted immunotherapy agent
2020-09-18T06:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798974,Synonym:,EGF pathway-targeted immunotherapeutic
2020-09-18T06:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798974,Synonym:,EGF-PTI
2020-09-18T06:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-antagonist-hemay022,Synonym:,EGFR inhibitor Hemay022
2020-09-18T06:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-antagonist-hemay022,Code name:,Hemay022
2020-09-18T06:20:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-antisense-dna,NA,NA
2020-09-18T06:21:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,Synonym:,CART-EGFR TCR zeta:CD1 27 cells
2020-09-18T06:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-abt-414,Code name:,ABT-414
2020-09-18T06:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-asp8273,Code name:,ASP8273
2020-09-18T06:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-azd3759,Code name:,AZD3759
2020-09-18T06:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794067,Code name:,DBPR 112
2020-09-18T06:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794067,Code name:,DBPR112
2020-09-18T06:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794067,Code name:,DBPR-112
2020-09-18T06:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-egf816,Code name:,EGF816
2020-09-18T06:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801857,Synonym:,epidermal growth factor receptor inhibitor TQB3804
2020-09-18T06:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801857,Code name:,TQB 3804
2020-09-18T06:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801857,Code name:,TQB3804
2020-09-18T06:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801857,Code name:,TQB-3804
2020-09-18T06:21:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794290,Code name:,BPI 7711
2020-09-18T06:21:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794290,Code name:,BPI7711
2020-09-18T06:21:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794290,Code name:,BPI-7711
2020-09-18T06:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-ck-101,Code name:,CK 101
2020-09-18T06:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-ck-101,Code name:,CK101
2020-09-18T06:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-ck-101,Code name:,CK-101
2020-09-18T06:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-ck-101,Code name:,RX-518
2020-09-18T06:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795785,Synonym:,D 0316
2020-09-18T06:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795785,Code name:,D0316
2020-09-18T06:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795785,Code name:,D-0316
2020-09-18T06:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793946,Code name:,ZN e4
2020-09-18T06:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793946,Code name:,ZNe4
2020-09-18T06:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793946,Code name:,ZN-e4
2020-09-18T06:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-t790m-antagonist-bpi-15086,Synonym:,EGFR T790M inhibitor BPI-15086
2020-09-18T06:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-t790m-antagonist-bpi-15086,Code name:,BPI 15086
2020-09-18T06:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-t790m-antagonist-bpi-15086,Code name:,BPI15086
2020-09-18T06:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-t790m-antagonist-bpi-15086,Code name:,BPI-15086
2020-09-18T06:22:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-t790m-inhibitor-pf-06747775,Code name:,PF-06747775
2020-09-18T06:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-tyrosine-kinase-inhibitor-hs-10296,Code name:,HS-10296
2020-09-18T06:22:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800200,Synonym:,BBB penetrable EGFR/EGFRvIII inhibitor WSD0922-FU
2020-09-18T06:22:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800200,Synonym:,EGFR mutant inhibitor WSD0922-FU
2020-09-18T06:22:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800200,Code name:,WSD 0922-FU
2020-09-18T06:22:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800200,Code name:,WSD0922-FU
2020-09-18T06:22:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800200,Code name:,WSD-0922-FU
2020-09-18T06:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-flt3-abl-inhibitor-sklb1028,Synonym:,multikinase inhibitor SKLB1028
2020-09-18T06:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-flt3-abl-inhibitor-sklb1028,Code name:,SKLB 1028
2020-09-18T06:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-flt3-abl-inhibitor-sklb1028,Code name:,SKLB1028
2020-09-18T06:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-flt3-abl-inhibitor-sklb1028,Code name:,SKLB-1028
2020-09-18T06:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-flt3-abl-inhibitor-sklb1028,Chemical structure:,"9H-purine-2,8-diamine, 9-(1-methylethyl)-N2-[4-(4-methyl-1-piperazinyl)phenyl]-N8-3-pyridinyl9-isopropyl-N2-(4-(4-methylpiperazin-1-yl)phenyl)-N8-(pyridin-3-yl)-9H-purine-2,8-diamine"
2020-09-18T06:22:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-av-412,Code name:,AV-412
2020-09-18T06:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800418,Code name:,DZD 9008
2020-09-18T06:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800418,Code name:,DZD9008
2020-09-18T06:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800418,Code name:,DZD-9008
2020-09-18T06:22:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-ap32788,Code name:,AP 32788
2020-09-18T06:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,Code name:,PDL-063
2020-09-18T06:22:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-ap32788,Code name:,AP32788
2020-09-18T06:22:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-ap32788,Code name:,AP-32788
2020-09-18T06:22:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-ap32788,Code name:,TAK 788
2020-09-18T06:22:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-ap32788,Code name:,TAK788
2020-09-18T06:22:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-ap32788,Code name:,TAK-788
2020-09-18T06:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801763,Code name:,HA 121-28
2020-09-18T06:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801763,Code name:,HA-121 28
2020-09-18T06:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801763,Code name:,HA121-28
2020-09-18T06:22:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfrbi-armed-autologous-activated-t-cells,Synonym:,anti-CD3 OKT3/anti-EGFR bispecific antibody armed activated T lymphocytes
2020-09-18T06:22:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid,Synonym:,"all cis-5,8,11,14,17-eicosapentaenoic acid"
2020-09-18T06:22:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid,Synonym:,icosapentaenoic acid
2020-09-18T06:22:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid,Synonym:,timnodonic acid
2020-09-18T06:22:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid,Abbreviation:,EPA
2020-09-18T06:22:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid,Abbreviation:,IPA
2020-09-18T06:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797223,Synonym:,monoglyceride eicosapentaenoic acid
2020-09-18T06:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797223,Abbreviation:,MAG-EPA
2020-09-18T06:23:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid-enriched-nutritional-supplement,Synonym:,EPA-enriched nutritional supplement
2020-09-18T06:23:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eif4e-antisense-oligonucleotide-isis-183750,Synonym:,eIF4E inhibitor ISIS 183750
2020-09-18T06:23:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eif4e-antisense-oligonucleotide-isis-183750,Synonym:,eIF4E modulator ISIS 183750
2020-09-18T06:23:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eif4e-antisense-oligonucleotide-isis-183750,Code name:,ISIS 183750
2020-09-18T06:23:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eif4e-antisense-oligonucleotide-isis-183750,Code name:,LY2275796
2020-09-18T06:23:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-modulator-rad1901,Synonym:,selective estrogen receptor degrader/modulator RAD1901
2020-09-18T06:23:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-modulator-rad1901,Synonym:,SERD/SERM RAD1901
2020-09-18T06:23:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-modulator-rad1901,Code name:,RAD1901
2020-09-18T06:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elacytarabine,Code name:,CP-4055
2020-09-18T06:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elacytarabine,Chemical structure:,"2(1H)-Pyrimidinone, 4-amino-1-[5-O-[(9E)-1-oxo-9-octadecenyl]-β-D-arabinofuranosyl]-4-amino-1-[5-O-[(9E)-octadec-9-enoyl]-β-D-arabinofuranosyl]pyrimidin-2(1H)-one"
2020-09-18T06:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793786,US brand name:,Orilissa
2020-09-18T06:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793786,Code name:,ABT-620
2020-09-18T06:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793786,Code name:,NBI 56418
2020-09-18T06:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793786,Code name:,NBI-56418
2020-09-18T06:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793786,Chemical structure:,"butanoic acid, 4-(((1R)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl)-1-phenylethyl)amino)-"
2020-09-18T06:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797922,Synonym:,elbasvir-grazoprevir
2020-09-18T06:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797922,Synonym:,grazoprevir/elbasvir
2020-09-18T06:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797922,Synonym:,grazoprevir-elbasvir
2020-09-18T06:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797922,US brand name:,Zepatier
2020-09-18T06:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797922,Code name:,MK-8742/MK-5172
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,Synonym:,desacetyl vinblastine amide sulfate
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,Synonym:,vindesine sulphate
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,Synonym:,vindesini sulfas
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,US brand name:,Eldisine
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,Foreign brand name:,Eldisin
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,Foreign brand name:,Enison
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,Foreign brand name:,Gesidine
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,Code name:,LY-099094
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Synonym:,L-dopa
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Bendopa
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Dopar
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Eldopar
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Laradopa
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Larodopa
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Levopa
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Cidandopa
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Deadopa
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopaflex
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopaidan
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopal
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopalina
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Doparkine
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Doparl
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopasol
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopaston
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopastral
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Doprin
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Eldopal
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Eldopatec
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Eurodopa
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Ledopa
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Maipedopa
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Parda
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Veldopa
2020-09-18T06:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Chemical structure:,"(--)-2amino-3-)3,4-dihydroxyphenyl)propanoic acid(--)-3-(3,4-dihydroxyphenyl)-L-alanine3-hydroxy-L-tyrosinebeta-(3,4-dihydroxyphenyl)-L-alanine"
2020-09-18T06:23:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/electrokinetically-modified-water,Synonym:,electro-kinetically altered beverage
2020-09-18T06:23:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/electrokinetically-modified-water,Abbreviation:,EMW
2020-09-18T06:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/electrolyte-free-parenteral-nutrition-emulsion,Foreign brand name:,SmofKabiven
2020-09-18T06:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elesclomol,Code name:,STA-4783
2020-09-18T06:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elesclomol,Chemical structure:,"1-N'-benzenecarbothioyl-3-(2-benzenecarbothioyl-2-methylhydrazinyl)-N'-methyl- oxopropanehydrazididepropanedioic acid, bis[2-methyl-2-(phenylthioxomethyl)hydrazide],"
2020-09-18T06:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elesclomol-sodium,Code name:,STA-4783
2020-09-18T06:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elesclomol-sodium,Chemical structure:,"propanedioic acid, bis[2-methyl-2-(phenylthioxomethyl)hydrazide], sodium salt"
2020-09-18T06:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimecrolimus-cream,US brand name:,Elidel
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Synonym:,leuprorelin acetate
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,US brand name:,Eligard
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,US brand name:,Lupron
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,US brand name:,Lupron Depot
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Carcinil
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Depo-Eligard
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Enanton
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Enantone
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Enantone-Gyn
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Ginecrin
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Leuplin
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Lucrin
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Lucrin Depot
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Lutrate
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Procren
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Procrin
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Prostap
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Trenantone
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Uno-Enantone
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Abbreviation:,LEUP
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Code name:,A-43818
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Code name:,Abbott 43818
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Code name:,DWJ108J
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Code name:,TAP-144
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Synonym:,Ai Heng
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Chemical structure:,6-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide luteinizing hormone-releasing factor (pig) monoacetate6-D-leucine-9-(N-ethyl-L-prolinamide)-1-9-luteinizing hormone-releasing factor (pig) monoacetate
2020-09-18T06:24:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apixaban,US brand name:,Eliquis
2020-09-18T06:24:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apixaban,Code name:,BMS-562247
2020-09-18T06:24:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apixaban,Code name:,BMS-562247-01
2020-09-18T06:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elisidepsin,Synonym:,depsipeptide PM02734
2020-09-18T06:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elisidepsin,Foreign brand name:,Irvalec
2020-09-18T06:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elisidepsin,Code name:,PM02734
2020-09-18T06:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rasburicase,Synonym:,recombinant urate oxidase
2020-09-18T06:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rasburicase,Synonym:,Urate Oxidase
2020-09-18T06:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rasburicase,US brand name:,Elitek
2020-09-18T06:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rasburicase,Code name:,NK-631
2020-09-18T06:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rasburicase,Code name:,SR-29142
2020-09-18T06:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,Synonym:,theophylline monohydrate
2020-09-18T06:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Constant-T
2020-09-18T06:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Elixophyllin
2020-09-18T06:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,LaBID
2020-09-18T06:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Respbid
2020-09-18T06:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Slo-bid
2020-09-18T06:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Slo-Phyllin
2020-09-18T06:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Somophyllin-CRT
2020-09-18T06:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Somophyllin-T
2020-09-18T06:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Theo-24
2020-09-18T06:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Theobid Duracap
2020-09-18T06:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Theochron
2020-09-18T06:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,T-Phyl
2020-09-18T06:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Uniphyl
2020-09-18T06:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,Chemical structure:,"1,3-dimethylxanthine monohydrate3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione monohydrate"
2020-09-18T06:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ellagic-acid-annona-muricata-supplement,NA,NA
2020-09-18T06:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epirubicin-hydrochloride,US brand name:,Ellence
2020-09-18T06:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epirubicin-hydrochloride,Foreign brand name:,Pharmorubicin PFS
2020-09-18T06:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epirubicin-hydrochloride,Code name:,IMI-28
2020-09-18T06:24:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate,US brand name:,Celiptium
2020-09-18T06:24:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate,Abbreviation:,9-HME
2020-09-18T06:24:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate,Abbreviation:,HME
2020-09-18T06:24:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate,Abbreviation:,NMHE
2020-09-18T06:24:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate,Chemical structure:,"9-hydroxy-2,5,11-trimethyl-6H-pyrido[4,3-b]carbazolium acetate (salt)9-hydroxy-2-methylellipticinium acetateN-2-methyl-9-hydroxyellipticinium acetate"
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,US brand name:,Elmiron
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,Foreign brand name:,Fibrezym
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,Foreign brand name:,Fibrocid
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,Foreign brand name:,Hemoclar
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,Foreign brand name:,HOE/BAY 946
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,Foreign brand name:,Tavan SP-54
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,Acronym:,PPS
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,Code name:,SP-54
2020-09-18T06:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mometasone-furoate,US brand name:,Elocon
2020-09-18T06:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mometasone-furoate,Chemical structure:,"(11beta,16alpha)-9,21-Dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methylpregna-1,4-diene-3,20-dione"
2020-09-18T06:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,Synonym:,anti-CS1 monoclonal antibody HuLuc63
2020-09-18T06:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,US brand name:,Empliciti
2020-09-18T06:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,Code name:,BMS-901608
2020-09-18T06:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,Code name:,HuLuc63
2020-09-18T06:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,Code name:,PDL063
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Synonym:,diaminocyclohexane oxalatoplatinum
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Synonym:,oxalatoplatin
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Synonym:,oxalatoplatinum
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Synonym:,oxaliplatine
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,US brand name:,Eloxatin
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Foreign brand name:,Dacotin
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Foreign brand name:,Dacplat
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Foreign brand name:,Eloxatine
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Abbreviation:,1-OHP
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Abbreviation:,L-OHP
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Code name:,JM-83
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Code name:,RP-54780
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Code name:,SR-96669
2020-09-18T06:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsamitrucin,Synonym:,10-O-elsaminosylelsarosylchartarin
2020-09-18T06:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsamitrucin,Synonym:,elsamicin A
2020-09-18T06:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsamitrucin,Code name:,BBM 2478A
2020-09-18T06:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsamitrucin,Code name:,BMY-28090
2020-09-18T06:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsamitrucin,Code name:,BRN 5214813
2020-09-18T06:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsamitrucin,Chemical structure:,"benzo(h)(1)benzopyrano(5,4,3-cde)(1)ebnzopyran-5,12-dione,10((2-O-(2-amino-2,6-dideoxy-3-O-methyl-alpha-D-galactopyranosyl)-6-deoxy-3-C-methyl-beta-D-galactopyranosyl)oxy)-6-hydroxy-1-methyl"
2020-09-18T06:25:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsiglutide,Code name:,ZP1846
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,ASP-1
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,asparaginase II
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,Colaspase
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,L-ASP
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,L-asparaginase
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,L-asparagine amidohydrolase
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,US brand name:,Elspar
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,US brand name:,L-Asnase
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Kidrolase
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Laspar
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Leucogen
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Leunase
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Paronal
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Spectrila
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Abbreviation:,L-ASP
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Abbreviation:,Lcf-ASP
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Code name:,MK-965
2020-09-18T06:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Code name:,Re-82-TAD-15
2020-09-18T06:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltrombopag-olamine,US brand name:,Promacta
2020-09-18T06:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltrombopag-olamine,Code name:,SB 497115
2020-09-18T06:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltrombopag-olamine,Code name:,SB497115
2020-09-18T06:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltrombopag-olamine,Code name:,SB-497115
2020-09-18T06:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltrombopag-olamine,Code name:,SB-497115-GR
2020-09-18T06:25:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruquintinib,Synonym:,VEGFR-1/2/3 inhibitor HMPL-013
2020-09-18T06:25:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruquintinib,US brand name:,Elunate
2020-09-18T06:25:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruquintinib,Code name:,HMPL-013
2020-09-18T06:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dt388il3-fusion-protein-sl-401,Synonym:,diphtheria toxin(388)-interleukin-3 fusion protein
2020-09-18T06:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dt388il3-fusion-protein-sl-401,Synonym:,DT(388)IL3 fusion protein SL-401
2020-09-18T06:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dt388il3-fusion-protein-sl-401,Synonym:,IL3R-targeting fusion protein SL-401
2020-09-18T06:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dt388il3-fusion-protein-sl-401,US brand name:,Elzonris
2020-09-18T06:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dt388il3-fusion-protein-sl-401,Code name:,SL-401
2020-09-18T06:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emactuzumab,Code name:,RG7155
2020-09-18T06:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emactuzumab,Code name:,RG-7155
2020-09-18T06:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emactuzumab,Code name:,RO5509554
2020-09-18T06:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emactuzumab,Code name:,RO-5509554
2020-09-18T06:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interferon-gamma-monoclonal-antibody-ni-0501,Synonym:,anti-IFN gamma monoclonal antibody NI-0501
2020-09-18T06:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interferon-gamma-monoclonal-antibody-ni-0501,Synonym:,anti-IFNg mAb NI-0501
2020-09-18T06:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interferon-gamma-monoclonal-antibody-ni-0501,Synonym:,anti-interferon gamma monoclonal antibody NI-0501
2020-09-18T06:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interferon-gamma-monoclonal-antibody-ni-0501,Synonym:,emapalumab
2020-09-18T06:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interferon-gamma-monoclonal-antibody-ni-0501,US brand name:,Gamifant
2020-09-18T06:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interferon-gamma-monoclonal-antibody-ni-0501,Code name:,NI-0501
2020-09-18T06:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tris-acryl-gelatin-microspheres,Synonym:,trisacryl gelatin microspheres
2020-09-18T06:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tris-acryl-gelatin-microspheres,US brand name:,Embospheres
2020-09-18T06:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tris-acryl-gelatin-microspheres,Abbreviation:,TAGM
2020-09-18T06:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Synonym:,estramustine phosphate
2020-09-18T06:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Synonym:,estramustine sodium phosphate
2020-09-18T06:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,US brand name:,Emcyt
2020-09-18T06:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Foreign brand name:,Estracyt
2020-09-18T06:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Code name:,Leo-299
2020-09-18T06:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Code name:,Ro-21-8837/001
2020-09-18T06:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Chemical structure:,"estra-1,3,5(10)-triene-3,17-diol(17(beta))-, 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate), disodium salt, monohydrateestramustine 17-(dihydrogenphosphate) disodium salt"
2020-09-18T06:26:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,US brand name:,Emend
2020-09-18T06:26:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,Code name:,L-754030
2020-09-18T06:26:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,Code name:,MK-0869
2020-09-18T06:26:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,Code name:,ONO-7436
2020-09-18T06:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emepepimut-s,Synonym:,liposomal BLP25 vaccine
2020-09-18T06:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emepepimut-s,Synonym:,tecemotide
2020-09-18T06:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emepepimut-s,US brand name:,Stimuvax
2020-09-18T06:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emepepimut-s,Abbreviation:,BP1-7-KLH
2020-09-18T06:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emepepimut-s,Abbreviation:,L-BLP25
2020-09-18T06:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emepepimut-s,Code name:,BLP25
2020-09-18T06:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,Synonym:,anti-CS1 monoclonal antibody HuLuc63
2020-09-18T06:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,US brand name:,Empliciti
2020-09-18T06:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,Code name:,BMS-901608
2020-09-18T06:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,Code name:,HuLuc63
2020-09-18T06:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,Code name:,PDL063
2020-09-18T06:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,Code name:,PDL-063
2020-09-18T06:26:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emtricitabine,Synonym:,coviracil
2020-09-18T06:26:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emtricitabine,Synonym:,FTC
2020-09-18T06:26:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emtricitabine,US brand name:,Emtriva
2020-09-18T06:26:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emtricitabine,Chemical structure:,"(-)-2'-deoxy-5-fluoro-3'-thiacytidine2(1H)-pyrimidinone, 4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-,(2R-cis)-"
2020-09-18T06:26:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emtricitabine,Synonym:,coviracil
2020-09-18T06:26:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emtricitabine,Synonym:,FTC
2020-09-18T06:26:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emtricitabine,US brand name:,Emtriva
2020-09-18T06:26:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emtricitabine,Chemical structure:,"(-)-2'-deoxy-5-fluoro-3'-thiacytidine2(1H)-pyrimidinone, 4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-,(2R-cis)-"
2020-09-18T06:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,E-Mycin
2020-09-18T06:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,ERYC
2020-09-18T06:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,Ery-Tab
2020-09-18T06:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,Ilotycin
2020-09-18T06:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,Robimycin
2020-09-18T06:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,RP-Mycin
2020-09-18T06:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enalapril-maleate,US brand name:,Enacard
2020-09-18T06:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enalapril-maleate,US brand name:,Vasotec
2020-09-18T06:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enalapril-maleate,Foreign brand name:,Renitec
2020-09-18T06:26:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev,Synonym:,chimeric Ad11p/Ad3 oncolytic virus
2020-09-18T06:26:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev,Synonym:,ColoAd1
2020-09-18T06:26:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev,Synonym:,ColoAd1 oncolytic virus
2020-09-18T06:26:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797804,Synonym:,oncolytic adenoviral vector expressing anti-CD40 antibody NG-350A
2020-09-18T06:26:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797804,Synonym:,oncolytic adenoviral vector-expressing anti-CD40 agonistic antibody NG-350A
2020-09-18T06:26:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797804,Code name:,NG 350A
2020-09-18T06:26:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797804,Code name:,NG350A
2020-09-18T06:26:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797804,Code name:,NG-350A
2020-09-18T06:26:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800703,Synonym:,oncolytic adenoviral vector expressing FAP/CD3 bispecific molecule NG-641
2020-09-18T06:26:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800703,Synonym:,oncolytic adenoviral vector-expressing FAP/CD3 bispecific FAP-TAc NG-641
2020-09-18T06:26:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800703,Code name:,NG 641
2020-09-18T06:26:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800703,Code name:,NG641
2020-09-18T06:26:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800703,Code name:,NG-641
2020-09-18T06:27:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enalapril-maleate,US brand name:,Enacard
2020-09-18T06:27:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enalapril-maleate,US brand name:,Vasotec
2020-09-18T06:27:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enalapril-maleate,Foreign brand name:,Renitec
2020-09-18T06:27:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enasidenib-mesylate,Synonym:,AG-221 mesylate
2020-09-18T06:27:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enasidenib-mesylate,Synonym:,enasidenib methanesulfonate
2020-09-18T06:27:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enasidenib-mesylate,US brand name:,Idhifa
2020-09-18T06:27:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enasidenib-mesylate,Code name:,CC-90007
2020-09-18T06:27:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enavatuzumab,Synonym:,anti-tumor necrosis factor-like weak inducer of apoptosis monoclonal antibody PDL192
2020-09-18T06:27:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enavatuzumab,Synonym:,anti-TWEAKR monoclonal antibody PDL192
2020-09-18T06:27:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enavatuzumab,Code name:,PDL192
2020-09-18T06:27:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanercept,Synonym:,Tumor Necrosis Factor Receptor IgG Chimera
2020-09-18T06:27:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanercept,US brand name:,Enbrel
2020-09-18T06:27:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanercept,Abbreviation:,ETN
2020-09-18T06:27:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanercept,Abbreviation:,TNFR:Fc
2020-09-18T06:27:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enclomiphene-citrate,NA,NA
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Synonym:,cochleate lipid-crystal nano-particles-containing amphotericin B
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Synonym:,cochleate-amphotericin B
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Synonym:,lipid-crystal nano-particle formulation of amphotericin B
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Synonym:,lipid-crystal nanoparticle-based amphotericin B formulation
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Synonym:,nano-cochleated-particles containing amphotericin B
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Synonym:,oral encochleated amphotericin B
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Abbreviation:,CAMB
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Code name:,MAT2203
2020-09-18T06:27:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encorafenib,US brand name:,Braftovi
2020-09-18T06:27:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encorafenib,Code name:,LGX 818
2020-09-18T06:27:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encorafenib,Code name:,LGX818
2020-09-18T06:27:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encorafenib,Code name:,LGX-818
2020-09-18T06:27:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/progesterone-vaginal-insert,US brand name:,Endometrin
2020-09-18T06:27:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/endothelin-b-receptor-agonist-spi-1620,Code name:,SPI-1620
2020-09-18T06:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nectin-4-antibody-drug-conjugate-asg-22ce,Synonym:,anti-nectin 4 ADC ASG-22CE
2020-09-18T06:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nectin-4-antibody-drug-conjugate-asg-22ce,Synonym:,enfortumab vedotin
2020-09-18T06:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nectin-4-antibody-drug-conjugate-asg-22ce,US brand name:,Padcev
2020-09-18T06:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nectin-4-antibody-drug-conjugate-asg-22ce,Code name:,ASG-22CE
2020-09-18T06:27:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-b-vaccine-recombinant,US brand name:,Engerix-B
2020-09-18T06:27:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-b-vaccine-recombinant,US brand name:,Recombivax HB
2020-09-18T06:27:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-b-vaccine-recombinant,Foreign brand name:,Engerix-B
2020-09-18T06:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798637,Synonym:,AB-205 cell product
2020-09-18T06:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798637,Synonym:,engineered HUVEC AB-205
2020-09-18T06:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798637,Code name:,AB 205
2020-09-18T06:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798637,Code name:,AB205
2020-09-18T06:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798637,Code name:,AB-205
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Synonym:,ETB targeting HER2 MT-5111
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Synonym:,HER2-targeted ETB MT-5111
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Synonym:,immunotoxin MT-5111
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Synonym:,recombinant fusion protein MT-5111
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Synonym:,targeted engineered toxin body MT-5111
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Code name:,MT 5111
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Code name:,MT5111
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Code name:,MT-5111
2020-09-18T06:28:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detox-b-adjuvant,Synonym:,Detox-B SE Adjuvant
2020-09-18T06:28:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detox-b-adjuvant,Synonym:,Detox-B Stable Emulsion
2020-09-18T06:28:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detox-b-adjuvant,US brand name:,Enhanzyn
2020-09-18T06:28:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detox-b-adjuvant,Abbreviation:,DETOXB
2020-09-18T06:28:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,Synonym:,trastuzumab deruxtecan
2020-09-18T06:28:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,US brand name:,Enhertu
2020-09-18T06:28:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,Code name:,DS-8201
2020-09-18T06:28:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,Code name:,DS-8201a
2020-09-18T06:28:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,Code name:,DS-8201a
2020-09-18T06:28:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,Code name:,WHO 10516
2020-09-18T06:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eniluracil,Synonym:,5-ethynyluracil
2020-09-18T06:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eniluracil,Synonym:,ethynyluracil
2020-09-18T06:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eniluracil,Code name:,776C85
2020-09-18T06:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eniluracil,Code name:,ADH300004
2020-09-18T06:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eniluracil,Code name:,GW776
2020-09-18T06:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eniluracil,Code name:,GW776C85
2020-09-18T06:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eniluracil,Chemical structure:,"5-ethynyl-2,4(1H,3H)-pyrimidinedione"
2020-09-18T06:28:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enoblituzumab,Synonym:,monoclonal antibody MGA271
2020-09-18T06:28:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enoblituzumab,Code name:,MGA271
2020-09-18T06:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enobosarm,Synonym:,selective androgen receptor modulator GTx-024
2020-09-18T06:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enobosarm,US brand name:,Ostarine
2020-09-18T06:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enobosarm,Code name:,GTx-024
2020-09-18T06:28:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enoxaparin-sodium,US brand name:,Lovenox
2020-09-18T06:28:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensartinib,Synonym:,ALK inhibitor X-396
2020-09-18T06:28:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensartinib,Synonym:,anaplastic lymphoma kinase inhibitor X-396
2020-09-18T06:28:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensartinib,Code name:,X-396
2020-09-18T06:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensituximab,Synonym:,anti-CPAA monoclonal antibody NPC-1C
2020-09-18T06:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensituximab,Synonym:,anti-pancreatic and colorectal carcinoma-associated antigen monoclonal antibody NPC-1C
2020-09-18T06:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensituximab,Code name:,NPC-1C
2020-09-18T06:28:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritional-supplement-drink,US brand name:,Boost
2020-09-18T06:28:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritional-supplement-drink,US brand name:,Ensure
2020-09-18T06:28:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801668,US brand name:,Comtan
2020-09-18T06:29:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entecavir,US brand name:,Baraclude
2020-09-18T06:29:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entecavir,Abbreviation:,ETV
2020-09-18T06:29:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serum-derived-bovine-immunoglobulin-protein-isolate,Synonym:,serum bovine immunoglobulin
2020-09-18T06:29:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serum-derived-bovine-immunoglobulin-protein-isolate,US brand name:,EnteraGam
2020-09-18T06:29:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serum-derived-bovine-immunoglobulin-protein-isolate,Abbreviation:,SBI
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Synonym:,2-aminoglutaramic acid
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Synonym:,glutamic acid 5-amide
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Synonym:,levoglutamide
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Synonym:,L-glutamine
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Synonym:,Q. Levoglutamide
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,US brand name:,Enterex Glutapak-10
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,US brand name:,Glutapak-10
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,US brand name:,GlutaSolve
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,US brand name:,Glutasolve Resource
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,US brand name:,NutreStore
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,US brand name:,Sympt-X
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,US brand name:,Sympt-X G.I.
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Foreign brand name:,Glutacerebro
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Foreign brand name:,Glutaven
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Foreign brand name:,Memoril
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Abbreviation:,Gln
2020-09-18T06:29:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enteric-coated-trpm8-agonist-d-3263-hydrochloride,Synonym:,EC D-3263 HCl
2020-09-18T06:29:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enteric-coated-zoledronic-acid-tablet-mer-101,US brand name:,Orazol
2020-09-18T06:29:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enteric-coated-zoledronic-acid-tablet-mer-101,Code name:,MER-101
2020-09-18T06:29:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798317,Synonym:,E. gallinarum MRx0518
2020-09-18T06:29:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798317,Synonym:,gut microbiota-derived strain MRx0518
2020-09-18T06:29:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798317,Synonym:,strain MRx0518
2020-09-18T06:29:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798317,Code name:,MRx 0518
2020-09-18T06:29:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798317,Code name:,MRx0518
2020-09-18T06:29:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798317,Code name:,MRx-0518
2020-09-18T06:29:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entinostat,Synonym:,HDAC inhibitor SNDX-275
2020-09-18T06:29:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entinostat,Synonym:,KHK2375
2020-09-18T06:29:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entinostat,Code name:,MS 275
2020-09-18T06:29:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entinostat,Code name:,SNDX-275
2020-09-18T06:29:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entinostat,Chemical structure:,"carbamic acid, N-[[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]-, 3- pyridinylmethyl esterpyridin-3-ylmethyl ({4-[(2-aminophenyl)carbamoyl]phenyl}methyl)carbamate"
2020-09-18T06:29:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entolimod,Synonym:,TLR5 agonist CBLB502
2020-09-18T06:29:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entolimod,Synonym:,toll-like receptor 5 agonist CBLB502
2020-09-18T06:29:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entolimod,Code name:,CBLB502
2020-09-18T06:29:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entospletinib,Synonym:,ENTO
2020-09-18T06:29:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entospletinib,Synonym:,spleen tyrosine kinase inhibitor GS-9973
2020-09-18T06:29:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entospletinib,Synonym:,SYK inhibitor GS-9973
2020-09-18T06:29:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entospletinib,Code name:,GS-9973
2020-09-18T06:29:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entospletinib,Chemical structure:,"6-(1H-indazol-6-yl)-N-(4-(morpholin-4-yl)phenyl)imidazo(1,2-a)pyrazin-8-amine"
2020-09-18T06:29:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entrectinib,Synonym:,TrkA/B/C/ROS1/ALK tyrosine kinase inhibitor RXDX-101
2020-09-18T06:29:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entrectinib,US brand name:,Rozlytrek
2020-09-18T06:29:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entrectinib,Code name:,RXDX-101
2020-09-18T06:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798813,US brand name:,Entresto
2020-09-18T06:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798813,Code name:,AHU 377
2020-09-18T06:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798813,Code name:,AHU377
2020-09-18T06:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798813,Code name:,AHU-377
2020-09-18T06:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798813,Chemical structure:,"(2R,4S)-5-(biphenyl-4-yl)-4-((3-carboxypropionyl)amino)-2-methylpentanoic acid ethyl ester"
2020-09-18T06:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vedolizumab,Synonym:,"immunoglobulin G1, anti-(human integrin LPAM-1 (lymphocyte Peyer's patch adhesion molecule 1)) (human-Mus musculus heavy chain), disulfide with human-Mus musculus kappa-chain, dimer"
2020-09-18T06:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vedolizumab,US brand name:,Entyvio
2020-09-18T06:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vedolizumab,Code name:,LDP02
2020-09-18T06:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vedolizumab,Code name:,MLN0002
2020-09-18T06:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vedolizumab,Code name:,MLN02
2020-09-18T06:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzalutamide,Synonym:,selective androgen receptor modulator MDV3100
2020-09-18T06:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzalutamide,US brand name:,Xtandi
2020-09-18T06:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzalutamide,Code name:,ASP9785
2020-09-18T06:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzalutamide,Code name:,MDV3100
2020-09-18T06:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzalutamide,Chemical structure:,"benzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-"
2020-09-18T06:30:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzastaurin-hydrochloride,Code name:,LY-317615
2020-09-18T06:30:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzastaurin-hydrochloride,Chemical structure:,"3-(1-Methyl-1H-indol-3-yl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-1H-indol-3-yl]-1H-pyrrole-2,5-dione Dihydrochloride"
2020-09-18T06:30:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzymatically-hydrolyzed-whey-protein-based-nutritional-supplement,US brand name:,Peptamen
2020-09-18T06:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,US brand name:,Eoquin
2020-09-18T06:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,US brand name:,Neoquin
2020-09-18T06:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,US brand name:,Qapzola
2020-09-18T06:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,Code name:,E09
2020-09-18T06:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,Chemical structure:,"3-hydroxymethyl-5-aziridinyl-1-methyl-2-(1H-indole-4,7-dione) prop-beta-en-alpha-ol"
2020-09-18T06:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,Synonym:,"gadoxetic acid, disodium"
2020-09-18T06:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,US brand name:,Eovist
2020-09-18T06:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,Foreign brand name:,EOB Primavist
2020-09-18T06:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,Foreign brand name:,Primovist
2020-09-18T06:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,Abbreviation:,Gd-EOB-DTPA
2020-09-18T06:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,Chemical structure:,"(4S)-4-(4-ththoxylmethyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanedoic acid, gadolinium complex, disodium salt"
2020-09-18T06:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792745,Synonym:,PGE2 receptor antagonist ONO-4578
2020-09-18T06:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792745,Synonym:,prostaglandin E2 receptor antagonist ONO-4578
2020-09-18T06:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792745,Synonym:,selective PGE2 receptor 4 antagonist ONO-4578
2020-09-18T06:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792745,Code name:,BMS-986310
2020-09-18T06:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792745,Code name:,ONO-4578
2020-09-18T06:30:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epacadostat,Synonym:,IDO1 inhibitor INCB024360
2020-09-18T06:30:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epacadostat,Synonym:,"indoleamine-2,3-dioxygenase inhibitor INCB024360"
2020-09-18T06:30:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epacadostat,Code name:,INCB 024360
2020-09-18T06:30:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epacadostat,Code name:,INCB024360
2020-09-18T06:30:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epacadostat,Chemical structure:,"1,2,5-Oxadiazole-3-carboximidamide, 4-((2-((Aminosulfonyl)amino)ethyl)amino)-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-, (C(Z))-"
2020-09-18T06:30:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epcam-specific-car-expressing-autologous-t-lymphocytes,Synonym:,EpCAM-specific CAR autologous T cells
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Synonym:,bicycle BT5528
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Synonym:,bicycle toxin conjugate-targeting EphA2 BT5528
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Synonym:,bicyclic peptide conjugate BT5528
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Synonym:,BTC BT5528
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Synonym:,EphA2-targeting BTC BT5528
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Synonym:,EphA2-targeting-MMAE bicycle toxin BT5528
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Code name:,BT 5528
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Code name:,BT-5528
2020-09-18T06:30:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epha2-targeting-dopc-encapsulated-sirna,Synonym:,siRNA-EphA2-DOPC
2020-09-18T06:30:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketamine-amitriptyline-np-h-cream,US brand name:,EpiCept NP-1
2020-09-18T06:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epidermal-growth-factor-ointment,Synonym:,EGF ointment
2020-09-18T06:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epidermal-growth-factor-ointment,Synonym:,sesal yeongo
2020-09-18T06:31:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799672,Abbreviation:,EDP
2020-09-18T06:31:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol,Synonym:,CBD oil
2020-09-18T06:31:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol,US brand name:,Epidiolex
2020-09-18T06:31:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol,Abbreviation:,CBD
2020-09-18T06:31:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol,Code name:,GWP42003-P
2020-09-18T06:31:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol,Chemical structure:,"1,3-benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-"
2020-09-18T06:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epigallocatechin-gallate,Synonym:,(-)-epigallocatechin-3-gallate
2020-09-18T06:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epigallocatechin-gallate,Synonym:,"[(2R,3R)-2-(3,4,5-trihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] 3,4,5-trihydroxybenzoate"
2020-09-18T06:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epigallocatechin-gallate,Synonym:,epigallocatechin-3-gallate
2020-09-18T06:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epigallocatechin-gallate,Synonym:,epigallocatechingallate
2020-09-18T06:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epigallocatechin-gallate,Synonym:,tea catechin
2020-09-18T06:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epigallocatechin-gallate,Abbreviation:,EGCG
2020-09-18T06:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epigallocatechin-gallate,Chemical structure:,"(2R-cis)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate"
2020-09-18T06:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Synonym:,sodium divalproex
2020-09-18T06:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Synonym:,valproate semisodium
2020-09-18T06:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depacon
2020-09-18T06:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depakote
2020-09-18T06:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depakote ER
2020-09-18T06:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Epilex
2020-09-18T06:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Epival
2020-09-18T06:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Valparin
2020-09-18T06:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Code name:,Abbott 50711
2020-09-18T06:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Chemical structure:,sodium hydrogen bis(2-propylpentanoate)
2020-09-18T06:31:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epirubicin-hydrochloride,US brand name:,Ellence
2020-09-18T06:31:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epirubicin-hydrochloride,Foreign brand name:,Pharmorubicin PFS
2020-09-18T06:31:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epirubicin-hydrochloride,Code name:,IMI-28
2020-09-18T06:31:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793471,Code name:,HMPL 813
2020-09-18T06:31:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793471,Code name:,HMPL813
2020-09-18T06:31:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793471,Code name:,HMPL-813
2020-09-18T06:31:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbamazepine,US brand name:,Epitol
2020-09-18T06:31:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbamazepine,US brand name:,Tegretol
2020-09-18T06:31:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbamazepine,Chemical structure:,"5H-Dibenz(b,f)azepine-5-carboxamide"
2020-09-18T06:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Synonym:,sodium divalproex
2020-09-18T06:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Synonym:,valproate semisodium
2020-09-18T06:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depacon
2020-09-18T06:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depakote
2020-09-18T06:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depakote ER
2020-09-18T06:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Epilex
2020-09-18T06:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Epival
2020-09-18T06:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Valparin
2020-09-18T06:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Code name:,Abbott 50711
2020-09-18T06:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Chemical structure:,sodium hydrogen bis(2-propylpentanoate)
2020-09-18T06:31:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamivudine,US brand name:,Epivir
2020-09-18T06:31:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamivudine,Abbreviation:,3TC
2020-09-18T06:31:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamivudine,Abbreviation:,LAM
2020-09-18T06:31:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eplerenone,US brand name:,Inspra
2020-09-18T06:31:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eplerenone,Chemical structure:,"9,11alpha-epoxy-17-hydroxy-3-oxo-17alpha-pregn-4-ene-7alpha,21-dicarboxylic acid, gamma-lactone, methyl ester"
2020-09-18T06:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-regimen,Synonym:,CHEOP regimen
2020-09-18T06:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-regimen,Synonym:,DA-EPOCH
2020-09-18T06:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-regimen,Synonym:,dose-adjusted etoposide/vincristine/doxorubicin/cyclophosphamide/prednisone regimen
2020-09-18T06:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-regimen,Synonym:,EPOCH
2020-09-18T06:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-regimen,Synonym:,etoposide-prednisone-Oncovin-cyclophosphamide-hydroxydaunorubicin regimen
2020-09-18T06:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-regimen,Acronym:,CHEOP regimen
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,DA EPOCH-O
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,dose-adjusted EPOCH-ofatumumab
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,dose-adjusted etoposide/vincristine/doxorubicin/cyclophosphamide/prednisone plus ofatumumab regimen
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,dose-adjusted etoposide-prednisone-vincristine-cyclophosphamide-ofatumumab
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,EPOCH plus Arzerra
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,EPOCH plus ofatumumab
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,etoposide-prednisone-Oncovin-cyclophosphamide-hydroxydaunorubicin-ofatumumab regimen
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,O-EPOCH
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,O-EPOCH regimen
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Abbreviation:,EPOCH-O
2020-09-18T06:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,Synonym:,erythropoietin
2020-09-18T06:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,Synonym:,r-HuEPO
2020-09-18T06:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,US brand name:,Epogen
2020-09-18T06:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,US brand name:,Procrit
2020-09-18T06:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,US brand name:,Retacrit
2020-09-18T06:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,Foreign brand name:,Eprex
2020-09-18T06:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,Abbreviation:,EPO
2020-09-18T06:32:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-beta,US brand name:,Recormon
2020-09-18T06:32:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-beta,Foreign brand name:,NeoRecormon
2020-09-18T06:32:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-beta,Acronym:,EPOB
2020-09-18T06:32:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-zeta,Foreign brand name:,Retacrit
2020-09-18T06:32:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-zeta,Foreign brand name:,Silapo
2020-09-18T06:32:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-zeta,Code name:,SB309
2020-09-18T06:32:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,Synonym:,erythropoietin
2020-09-18T06:32:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,Synonym:,r-HuEPO
2020-09-18T06:32:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,US brand name:,Epogen
2020-09-18T06:32:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,US brand name:,Procrit
2020-09-18T06:32:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,US brand name:,Retacrit
2020-09-18T06:32:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,Foreign brand name:,Eprex
2020-09-18T06:32:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,Abbreviation:,EPO
2020-09-18T06:32:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-analog-utd1,Code name:,UTD1
2020-09-18T06:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-d,Synonym:,"12,13-Deoxyepothilone B"
2020-09-18T06:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-d,Synonym:,desoxyepothilone B
2020-09-18T06:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-d,Code name:,KOS 862
2020-09-18T06:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-d,Chemical structure:,"(4S-(4R*,7S,8R*,9R*,13Z,16R*(E)))-4,8-Dihydroxy-5,5,7,9,13-pentamethyl-16-(1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)oxacyclohexadec-13-ene-2,6-dione"
2020-09-18T06:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-kos-1584,Code name:,KOS-1584
2020-09-18T06:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-kos-1584,Chemical structure:,"9,10-didehydroepothilone D"
2020-09-18T06:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab,Synonym:,AMG 412
2020-09-18T06:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab,Synonym:,Humanized Anti-CD22 Monoclonal Antibody IgG1
2020-09-18T06:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab,Synonym:,LL2
2020-09-18T06:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab,Synonym:,monoclonal antibody LL2
2020-09-18T06:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab,US brand name:,LymphoCide
2020-09-18T06:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab,Abbreviation:,hLL2
2020-09-18T06:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab,Abbreviation:,MOAB LL2
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Synonym:,ADC ADCT-602
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Synonym:,antibody-drug conjugate ADCT-602
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Synonym:,anti-CD22/PBD ADC ADCT-602
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Synonym:,epratuzumab-cys-SG3249
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Synonym:,hLL2-cys-PBD
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Synonym:,hLL2-cys-SG3249
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Code name:,ADCT 602
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Code name:,ADCT602
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Code name:,ADCT-602
2020-09-18T06:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eprodisate-disodium,US brand name:,Kiacta
2020-09-18T06:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eprodisate-disodium,Code name:,NC 503
2020-09-18T06:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eprodisate-disodium,Chemical structure:,"1,3-propanedisulfonic acid, disodium salt"
2020-09-18T06:33:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792670,Synonym:,EPS8 peptide-specific DCs
2020-09-18T06:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799764,Synonym:,ER alpha PROTAC protein degrader ARV-471
2020-09-18T06:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799764,Synonym:,estrogen receptor alpha PROTAC protein degrader ARV-471
2020-09-18T06:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799764,Synonym:,PROTAC protein degrader ARV-471
2020-09-18T06:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799764,Code name:,ARV 471
2020-09-18T06:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799764,Code name:,ARV471
2020-09-18T06:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799764,Code name:,ARV-471
2020-09-18T06:33:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/era36-modulator-icaritin,Synonym:,icaritin
2020-09-18T06:33:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/era36-modulator-icaritin,Chemical structure:,"4H-1-benzopyran-4-one, 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-"
2020-09-18T06:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erastin-analogue-prlx-93936,Code name:,PRLX 93936
2020-09-18T06:33:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erb-38-immunotoxin,Synonym:,erb-38
2020-09-18T06:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,Anti-EGFR Monoclonal Antibody
2020-09-18T06:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,Anti-Epidermal Growth Factor Receptor Monoclonal Antibody
2020-09-18T06:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,C225 monoclonal antibody
2020-09-18T06:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,cetuximab biosimilar CDP-1
2020-09-18T06:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,cetuximab biosimilar CMAB009
2020-09-18T06:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,cetuximab biosimilar KL 140
2020-09-18T06:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,Chimeric Anti-EGFR Monoclonal Antibody
2020-09-18T06:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,Chimeric Monoclonal Antibody C225
2020-09-18T06:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,"Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 gamma1-chain), disulfide with human-mouse monoclonal C225 kappa-chain, dimer"
2020-09-18T06:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,monoclonal antibody C225
2020-09-18T06:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,US brand name:,Erbitux
2020-09-18T06:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Abbreviation:,Chimeric MoAb C225
2020-09-18T06:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Abbreviation:,MOAB C225
2020-09-18T06:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Code name:,C225
2020-09-18T06:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Code name:,IMC-C225
2020-09-18T06:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erdafitinib,Synonym:,pan-FGFR tyrosine kinase inhibitor JNJ-42756493
2020-09-18T06:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erdafitinib,US brand name:,Balversa
2020-09-18T06:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erdafitinib,Code name:,JNJ-42756493
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Synonym:,l-tetramisole hydrochloride
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,US brand name:,Ergamisol
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Foreign brand name:,Ascaridil
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Foreign brand name:,Decaris
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Foreign brand name:,Ergamisole
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Foreign brand name:,Ketrax
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Foreign brand name:,Solaskil
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Abbreviation:,LEV
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Code name:,ICI-59623
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Code name:,R 12564
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Code name:,RP-20605
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Chemical structure:,"(-)-( S)-2,3,5, 6-tetrahydro-6-phenylimidazo [2,1-b] thiazole monohydrochloride"
2020-09-18T06:33:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ergocalciferol,Synonym:,vitamin D2
2020-09-18T06:33:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ergocalciferol,Chemical structure:,"9,10-secoergosta-5,7,10(19),22-tetraen-3-beta-ol"
2020-09-18T06:33:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eribulin-mesylate,Synonym:,halichrondrin B analog
2020-09-18T06:33:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eribulin-mesylate,US brand name:,Halaven
2020-09-18T06:33:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eribulin-mesylate,Code name:,B1939 mesylate
2020-09-18T06:33:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eribulin-mesylate,Code name:,E7389
2020-09-18T06:33:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eribulin-mesylate,Code name:,ER-086526
2020-09-18T06:34:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eritoran-tetrasodium,Code name:,E5564
2020-09-18T06:34:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eritoran-tetrasodium,Chemical structure:,"alpha-D-glucopyranose,3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-[(3R)-3-methoxydecyl]-6-O-methyl-2-[[(11Z)-1-oxo-11-octadecenyl]amino]-4-O-phosphono--D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]-1-(dihydrogen phosphate), tetrasodium salt"
2020-09-18T06:34:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vismodegib,Synonym:,Hedgehog antagonist GDC-0449
2020-09-18T06:34:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vismodegib,US brand name:,Erivedge
2020-09-18T06:34:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vismodegib,Code name:,GDC-0449
2020-09-18T06:34:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vismodegib,Chemical structure:,2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide
2020-09-18T06:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794989,Synonym:,ERK inhibitor ASTX029
2020-09-18T06:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794989,Synonym:,extracellular signal-regulated kinase 1/2 inhibitor ASTX029
2020-09-18T06:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794989,Synonym:,extracellular signal-regulated kinase inhibitor ASTX029
2020-09-18T06:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794989,Code name:,ASTX 029
2020-09-18T06:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794989,Code name:,ASTX029
2020-09-18T06:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794989,Code name:,ASTX-029
2020-09-18T06:34:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-inhibitor-cc-90003,Code name:,CC-90003
2020-09-18T06:34:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-inhibitor-gdc-0994,Code name:,GDC-0994
2020-09-18T06:34:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-inhibitor-ltt462,Code name:,LTT 462
2020-09-18T06:34:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-inhibitor-ltt462,Code name:,LTT462
2020-09-18T06:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801859,Synonym:,ERK Inhibitor JSI-1187
2020-09-18T06:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801859,Synonym:,extracellular signal-regulated kinase 1/2 inhibitor JSI-1187
2020-09-18T06:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801859,Code name:,JSI 1187
2020-09-18T06:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ko-947,Synonym:,ERK inhibitor KO-947
2020-09-18T06:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ko-947,Synonym:,extracellular signal-regulated kinase 1/2 inhibitor KO-947
2020-09-18T06:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ko-947,Code name:,KO 947
2020-09-18T06:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ko-947,Code name:,KO947
2020-09-18T06:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ko-947,Code name:,KO-947
2020-09-18T06:34:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ly3214996,Code name:,LY 3214996
2020-09-18T06:34:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ly3214996,Code name:,LY3214996
2020-09-18T06:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-hydrochloride,US brand name:,Tarceva
2020-09-18T06:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-hydrochloride,Code name:,"CP-358,774"
2020-09-18T06:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-hydrochloride,Code name:,CP358774
2020-09-18T06:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-hydrochloride,Code name:,OSI774
2020-09-18T06:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-hydrochloride,Code name:,OSI-774
2020-09-18T06:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-hydrochloride,Chemical structure:,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride"
2020-09-18T06:34:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ertapenem-sodium,US brand name:,Invanz
2020-09-18T06:34:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ertumaxomab,Synonym:,anti-CD3 x anti-HER-2-neu bispecific monoclonal antibody
2020-09-18T06:34:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ertumaxomab,Synonym:,MOAB anti-CD3 x anti-HER-2-neu
2020-09-18T06:34:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ertumaxomab,Abbreviation:,CD3-HER2neu MOAB
2020-09-18T06:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,asparaginase-Erwinia
2020-09-18T06:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,crisantaspasum
2020-09-18T06:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,cristantaspase
2020-09-18T06:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,Erwinia L-asparginase
2020-09-18T06:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,krisantaspaasi
2020-09-18T06:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,krisantaspas
2020-09-18T06:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,US brand name:,Erwinaze
2020-09-18T06:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Foreign brand name:,Erwinase
2020-09-18T06:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,E-Mycin
2020-09-18T06:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,ERYC
2020-09-18T06:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,Ery-Tab
2020-09-18T06:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,Ilotycin
2020-09-18T06:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,Robimycin
2020-09-18T06:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,RP-Mycin
2020-09-18T06:35:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,E-Mycin
2020-09-18T06:35:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,ERYC
2020-09-18T06:35:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,Ery-Tab
2020-09-18T06:35:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,Ilotycin
2020-09-18T06:35:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,Robimycin
2020-09-18T06:35:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,RP-Mycin
2020-09-18T06:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythrocyte-encapsulated-l-asparaginase-suspension,Synonym:,GRASPA
2020-09-18T06:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,E-Mycin
2020-09-18T06:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,ERYC
2020-09-18T06:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,Ery-Tab
2020-09-18T06:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,Ilotycin
2020-09-18T06:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,Robimycin
2020-09-18T06:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,RP-Mycin
2020-09-18T06:35:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin-topical-cream,Foreign brand name:,Eritex
2020-09-18T06:35:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/escitalopram-oxalate,US brand name:,Lexapro
2020-09-18T06:35:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/escitalopram-oxalate,Code name:,Lu 26-054-0
2020-09-18T06:35:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/escitalopram-oxalate,Chemical structure:,"5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-,(1S)-, ethanedioate(1:1)"
2020-09-18T06:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate,Synonym:,Lithium
2020-09-18T06:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate,US brand name:,Eskalith
2020-09-18T06:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate,US brand name:,Lithane
2020-09-18T06:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate,US brand name:,Lithobid
2020-09-18T06:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate,US brand name:,Lithonate
2020-09-18T06:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate,US brand name:,Lithotabs
2020-09-18T06:35:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esmolol,NA,NA
2020-09-18T06:35:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esomeprazole-magnesium,US brand name:,Nexium
2020-09-18T06:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esorubicin,Synonym:,deoxyadriamycin
2020-09-18T06:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esorubicin,Synonym:,deoxyadriamycin hydrochloride
2020-09-18T06:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esorubicin,Synonym:,deoxydoxorubicin
2020-09-18T06:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esorubicin,Code name:,IMI-58
2020-09-18T06:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esorubicin,Chemical structure:,4'-deoxyadriamycin hydrochloride4'deoxydoxorubicin
2020-09-18T06:36:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/essiac,Synonym:,Esiak
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Estinyl
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Ethinoral
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Feminone
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Orestralyn
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Diogyn E
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Eticylol
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Inestra
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Lynoral
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Abbreviation:,EE
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Chemical structure:,"(17alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol"
2020-09-18T06:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Synonym:,17 beta-estradiol
2020-09-18T06:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Synonym:,Estraldine
2020-09-18T06:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Aquadiol
2020-09-18T06:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Estrace
2020-09-18T06:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Vagifem
2020-09-18T06:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Vivelle
2020-09-18T06:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Dimenformon
2020-09-18T06:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Diogyn
2020-09-18T06:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Diogynets
2020-09-18T06:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Ovocylin
2020-09-18T06:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Progynon
2020-09-18T06:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Abbreviation:,ESDL
2020-09-18T06:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Chemical structure:,"(17beta)-estra-1,3,5(10)-triene-3,17-diol"
2020-09-18T06:36:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estradiol-vaginal-ring,US brand name:,ESTRING
2020-09-18T06:36:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estradiol-valerate,NA,NA
2020-09-18T06:36:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Synonym:,estramustine phosphate
2020-09-18T06:36:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Synonym:,estramustine sodium phosphate
2020-09-18T06:36:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,US brand name:,Emcyt
2020-09-18T06:36:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Foreign brand name:,Estracyt
2020-09-18T06:36:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Code name:,Leo-299
2020-09-18T06:36:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Code name:,Ro-21-8837/001
2020-09-18T06:36:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Chemical structure:,"estra-1,3,5(10)-triene-3,17-diol(17(beta))-, 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate), disodium salt, monohydrateestramustine 17-(dihydrogenphosphate) disodium salt"
2020-09-18T06:36:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estradiol-vaginal-ring,US brand name:,ESTRING
2020-09-18T06:36:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estriol-vaginal-gel,Foreign brand name:,Blissel
2020-09-18T06:36:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estriol-vaginal-gel,Foreign brand name:,Gelistrol
2020-09-18T06:36:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transdermal-estrogen,US brand name:,EstroGel
2020-09-18T06:36:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogen-receptor-agonist-gtx-758,US brand name:,Capesaris
2020-09-18T06:36:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogen-receptor-agonist-gtx-758,Code name:,GTx-758
2020-09-18T06:36:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rigosertib-sodium,Synonym:,PI-3 kinase inhibitor ON 01910.Na
2020-09-18T06:36:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rigosertib-sodium,US brand name:,Estybon
2020-09-18T06:36:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rigosertib-sodium,Code name:,ON 01910.Na
2020-09-18T06:36:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rigosertib-sodium,Code name:,SyB L-1101
2020-09-18T06:37:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eszopiclone,US brand name:,Lunesta
2020-09-18T06:37:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanercept,Synonym:,Tumor Necrosis Factor Receptor IgG Chimera
2020-09-18T06:37:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanercept,US brand name:,Enbrel
2020-09-18T06:37:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanercept,Abbreviation:,ETN
2020-09-18T06:37:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanercept,Abbreviation:,TNFR:Fc
2020-09-18T06:37:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanidazole,Synonym:,2-nitro-imidazole derivative
2020-09-18T06:37:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanidazole,Code name:,SR-2508
2020-09-18T06:37:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanidazole,Chemical structure:,"1H-imidazole-1-acetamide, N-(2-hydroxyethyl)-2-nitro-2-nitroimidazole-1-acetamide, N-(2-hydroxyethyl)-"
2020-09-18T06:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide,Synonym:,velcalcetide
2020-09-18T06:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide,US brand name:,Parsabiv
2020-09-18T06:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide,Code name:,AMG 416
2020-09-18T06:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide,Code name:,KAI 4169
2020-09-18T06:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide,Code name:,KAI4169
2020-09-18T06:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide,Code name:,KAI-4169
2020-09-18T06:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide,Chemical structure:,N-acetyl-D-cysteinyl-S-(L-cysteine disulfide)-D-alanyl-D-arginyl-D-arginyl-D-arginyl-D-alanyl-D-argininamide
2020-09-18T06:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethacrynic-acid,US brand name:,Edecrin
2020-09-18T06:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethacrynic-acid,Abbreviation:,EA
2020-09-18T06:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethacrynic-acid,Chemical structure:,"[2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic Acid"
2020-09-18T06:37:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethambutol,NA,NA
2020-09-18T06:37:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800780,Synonym:,Ethanol-based Intranasal Solution
2020-09-18T06:37:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800780,Synonym:,Ethanol-based Nasal Sanitizer
2020-09-18T06:37:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800780,US brand name:,Nozin
2020-09-18T06:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethaselen,Abbreviation:,BBSKE
2020-09-18T06:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethaselen,Chemical structure:,"1,2-[bis(1,2-benzisoselenazolone-3(2H)-ketone)]-ethane"
2020-09-18T06:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Estinyl
2020-09-18T06:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Ethinoral
2020-09-18T06:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Feminone
2020-09-18T06:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Orestralyn
2020-09-18T06:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Diogyn E
2020-09-18T06:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Eticylol
2020-09-18T06:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Inestra
2020-09-18T06:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Lynoral
2020-09-18T06:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Abbreviation:,EE
2020-09-18T06:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Chemical structure:,"(17alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol"
2020-09-18T06:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Estinyl
2020-09-18T06:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Ethinoral
2020-09-18T06:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Feminone
2020-09-18T06:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Orestralyn
2020-09-18T06:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Diogyn E
2020-09-18T06:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Eticylol
2020-09-18T06:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Inestra
2020-09-18T06:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Lynoral
2020-09-18T06:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Abbreviation:,EE
2020-09-18T06:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Chemical structure:,"(17alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol"
2020-09-18T06:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,Synonym:,Ortho-Novum 1/35
2020-09-18T06:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Aranelle
2020-09-18T06:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Balziva
2020-09-18T06:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Brevicon
2020-09-18T06:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Gencept
2020-09-18T06:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Modicon
2020-09-18T06:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norcept-E
2020-09-18T06:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norethin
2020-09-18T06:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norinyl
2020-09-18T06:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flaxseed,Synonym:,lint bells
2020-09-18T06:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Nortrel
2020-09-18T06:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Ortho-Novum
2020-09-18T06:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Ovcon
2020-09-18T06:37:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethiodized-oil,Synonym:,Ethiodol
2020-09-18T06:37:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethiodized-oil,Synonym:,Iodized Oil
2020-09-18T06:37:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethiodized-oil,US brand name:,Lipiodol
2020-09-18T06:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethosuximide,US brand name:,Zarontin
2020-09-18T06:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethosuximide,Chemical structure:,"3-ethyl-3-methylpyrrolidine-2,5-dione"
2020-09-18T06:38:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethyl-alcohol-mouthwash,Synonym:,ethyl alcohol mouth rinse
2020-09-18T06:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethyl-icosapentate,Synonym:,icosapent ethyl
2020-09-18T06:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethyl-icosapentate,US brand name:,Vascepa
2020-09-18T06:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethyl-icosapentate,Code name:,AMR 101
2020-09-18T06:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethyl-icosapentate,Code name:,AMR101
2020-09-18T06:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethyl-icosapentate,Chemical structure:,"ethyl (all cis)-5,8,11,14,17-icosapentaenoate"
2020-09-18T06:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethylene-vinyl-alcohol-copolymer-based-embolic-agent,Synonym:,EVOH-based embolic agent
2020-09-18T06:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethylene-vinyl-alcohol-copolymer-based-embolic-agent,US brand name:,Onyx
2020-09-18T06:38:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etidronate-cytarabine-conjugate-mbc-11,Synonym:,etidronate-ara-C conjugate MBC-11
2020-09-18T06:38:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etidronate-cytarabine-conjugate-mbc-11,Code name:,MBC-11
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Synonym:,buserelin acetate
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Synonym:,busereline
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,US brand name:,Etilamide
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Bigonist
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Profact
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Profact Depot
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Receptal
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Suprecur
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Suprefact
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Suprefact Depot
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Suprefact Flakon
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Abbreviation:,BSRL
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Code name:,HOE 766
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Code name:,ICI 123215
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Code name:,S74-6766
2020-09-18T06:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Chemical structure:,"6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide luteinizing hormone-releasing factor (pig)D-ser (bu(t))(6) pro(9) NEt LHRH Acetate"
2020-09-18T06:38:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etirinotecan-pegol,Synonym:,pegylated irinotecan NKTR 102
2020-09-18T06:38:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etirinotecan-pegol,Abbreviation:,PEG-irinotecan
2020-09-18T06:38:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etirinotecan-pegol,Code name:,NKTR 102
2020-09-18T06:38:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etodolac,Synonym:,Etodolic Acid
2020-09-18T06:38:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etodolac,Synonym:,Ultradol
2020-09-18T06:38:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etodolac,US brand name:,Lodine
2020-09-18T06:38:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etodolac,Chemical structure:,"1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic Acid"
2020-09-18T06:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide-phosphate,US brand name:,Etopophos
2020-09-18T06:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide-phosphate,Abbreviation:,ETOP
2020-09-18T06:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide,Synonym:,Demethyl Epipodophyllotoxin Ethylidine Glucoside
2020-09-18T06:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide,Synonym:,epipodophyllotoxin
2020-09-18T06:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide,Foreign brand name:,Lastet
2020-09-18T06:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide,Abbreviation:,EPEG
2020-09-18T06:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide,Code name:,VP-16
2020-09-18T06:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide,Code name:,VP-16-213
2020-09-18T06:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide,Chemical structure:,"4'-Demethylepipodophyllotoxin 9-[4,6-O-ethylidene-beta-D-glucopyranoside9-[(4,6-O-Ethylidene-beta-D-glucopyranosyl]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one"
2020-09-18T06:38:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide-phosphate,US brand name:,Etopophos
2020-09-18T06:38:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide-phosphate,Abbreviation:,ETOP
2020-09-18T06:39:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide-prodrug-cap71,Code name:,CAP7.1
2020-09-18T06:39:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,US brand name:,Arcoxia
2020-09-18T06:39:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,Code name:,L-791456
2020-09-18T06:39:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,Code name:,MK-0663
2020-09-18T06:39:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,Chemical structure:,5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl) Pyridine
2020-09-18T06:39:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hycanthone,Synonym:,Hycanthone mesylate
2020-09-18T06:39:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hycanthone,US brand name:,Etrenol
2020-09-18T06:39:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hycanthone,Abbreviation:,HYC
2020-09-18T06:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ets-family-transcription-factor-inhibitor-tk216,Code name:,TK216
2020-09-18T06:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ets-family-transcription-factor-inhibitor-tk216,Code name:,TK-216
2020-09-18T06:39:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-lotion,US brand name:,Eucerin
2020-09-18T06:39:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-spring-water-based-cream,US brand name:,Evoskin cream
2020-09-18T06:39:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-spring-water-based-topical-spray,Synonym:,spring water/polysorbate 20/phenoxyethanol/zinc gluconate/caprylyl glycol/chlorphenesin topical spray
2020-09-18T06:39:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-spring-water-based-topical-spray,Foreign brand name:,EVOZAC
2020-09-18T06:39:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-thermal-spring-water-based-solution,Synonym:,Evaux thermal spring water/polyacrylate-16/chlorphenesin/xanthan gum/phenoxyethanol/caprylyl glycol/piroctone olamine solution
2020-09-18T06:39:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-thermal-spring-water-based-solution,US brand name:,EvoNail
2020-09-18T06:39:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus-exemestane-regimen,Synonym:,Afinitor/Aromasin
2020-09-18T06:39:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus-exemestane-regimen,Synonym:,everolimus + exemestane
2020-09-18T06:39:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus-exemestane-regimen,Synonym:,everolimus-exemestane
2020-09-18T06:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raloxifene-hydrochloride,Synonym:,Raloxifene HCl
2020-09-18T06:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raloxifene-hydrochloride,US brand name:,Evista
2020-09-18T06:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raloxifene-hydrochloride,Foreign brand name:,Optruma
2020-09-18T06:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raloxifene-hydrochloride,Code name:,LY-139481
2020-09-18T06:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raloxifene-hydrochloride,Chemical structure:,[6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride
2020-09-18T06:39:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792152,Synonym:,enveloped virus-like particles CMV gB-pp65 plus GM-CSF VBI-1901
2020-09-18T06:39:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792152,Synonym:,VBI-1901 vaccine
2020-09-18T06:39:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792152,Code name:,VBI 1901
2020-09-18T06:39:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792152,Code name:,VBI-1901
2020-09-18T06:40:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793594,Foreign brand name:,Orkedia
2020-09-18T06:40:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793594,Code name:,KHK7580
2020-09-18T06:40:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793594,Code name:,MT-4580
2020-09-18T06:40:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793594,Chemical structure:,"benzeneacetic acid, 4-((3S)-3-(((1R)-1-(1-naphthalenyl)ethyl)amino)-1-pyrrolidinyl)-"
2020-09-18T06:40:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evofosfamide,Abbreviation:,HAP TH-302
2020-09-18T06:40:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evofosfamide,Code name:,TH-302
2020-09-18T06:40:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evofosfamide,Chemical structure:,"phosphorodiamidic acid, N,N'-bis(2-bromoethyl)-, (1-methyl-2-nitro-1H-imidazol-5-yl)methyl ester"
2020-09-18T06:40:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-hydrochloride,US brand name:,Evomela
2020-09-18T06:40:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-hydrochloride,Foreign brand name:,Alkerana
2020-09-18T06:40:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-hydrochloride,Chemical structure:,"3-(p-(bis(2-chloroethyl)amino)phenyl)-L-alanine, hydrochloride"
2020-09-18T06:40:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-thermal-spring-water-based-solution,Synonym:,Evaux thermal spring water/polyacrylate-16/chlorphenesin/xanthan gum/phenoxyethanol/caprylyl glycol/piroctone olamine solution
2020-09-18T06:40:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-thermal-spring-water-based-solution,US brand name:,EvoNail
2020-09-18T06:40:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-spring-water-based-cream,US brand name:,Evoskin cream
2020-09-18T06:40:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cevimeline-hydrochloride,US brand name:,Evoxac
2020-09-18T06:40:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cevimeline-hydrochloride,Code name:,AF-102B
2020-09-18T06:40:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-activated-autologous-lymph-node-lymphocytes,Synonym:,X-ACT
2020-09-18T06:40:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-activated-autologous-lymph-node-lymphocytes,Synonym:,X-ACT autologous lymph node lymphocytes
2020-09-18T06:40:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-expanded-her2-specific-t-cells,NA,NA
2020-09-18T06:40:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exatecan-mesylate,Synonym:,exatecan mesylate hydrate
2020-09-18T06:40:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exatecan-mesylate,Code name:,DX-8951f
2020-09-18T06:40:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivastigmine-tartrate,US brand name:,Exelon
2020-09-18T06:40:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivastigmine-tartrate,Code name:,SDZ-ENA 713
2020-09-18T06:40:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivastigmine-tartrate,Chemical structure:,"carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester,(2R,3R)-2,3-dihydroxybutanedioate(1:1)"
2020-09-18T06:40:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,US brand name:,Aromasin
2020-09-18T06:40:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,Abbreviation:,PNU 155971
2020-09-18T06:40:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,Code name:,FCE-24304
2020-09-18T06:40:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,Chemical structure:,"6-Methyleneandrosta-1,4-diene-3,17-dione"
2020-09-18T06:41:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exenatide,US brand name:,Byetta
2020-09-18T06:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exendin-9-39,Synonym:,9-39-exendin 4
2020-09-18T06:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exendin-9-39,Synonym:,ex(9-39)NH2
2020-09-18T06:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exendin-9-39,Synonym:,exendin (9-39)
2020-09-18T06:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exendin-9-39,Synonym:,exendin(9-39)amide
2020-09-18T06:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exendin-9-39,Chemical structure:,"exendin 3, 1-de-L-histidine-2-de-L-serine-3-de-L-aspartic acid-4-deglycine-5-de-L-threonine-6-de-L-phenylalanine-7-de-L-threonine-8-de-L-serine-LYS-ASN-GIY-GIY-PRO-SER-SER-GIY-ALA-PRO-PRO-PRO-SER-NH2"
2020-09-18T06:41:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,Synonym:,Sulindac Sulfone
2020-09-18T06:41:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,US brand name:,Aptosyn
2020-09-18T06:41:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,Code name:,FGN-1
2020-09-18T06:41:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,Chemical structure:,"(Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfonyl)phenyl]methylene]-1H-indene-3-acetic Acid1H-Indene-3-acetic Acid, 5-Fluoro-2-methyl-1-((4-(methylsulfonyl)phenyl)methylene), (Z)"
2020-09-18T06:41:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferasirox,US brand name:,Exjade
2020-09-18T06:41:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferasirox,Code name:,ICL670
2020-09-18T06:41:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795709,Synonym:,ECT-001 expanded UCB
2020-09-18T06:41:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795709,Synonym:,ECT-001 expanded umbilical cord blood
2020-09-18T06:41:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795709,Synonym:,UM171 expanded cord blood
2020-09-18T06:41:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795709,Code name:,ECT-001
2020-09-18T06:41:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795709,Code name:,UM171
2020-09-18T06:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795426,Synonym:,AB-110 cell product
2020-09-18T06:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795426,Synonym:,CD34+ Cord-Blood Derived Hematopoietic Stem Cells Co-Cultured and Co-Infused with Genetically Modified Endothelial Cells AB-110
2020-09-18T06:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795426,Synonym:,CD34-positive Enriched HPCs Mixed with Engineered Human ECs AB-110
2020-09-18T06:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795426,Synonym:,Cord Blood-derived HPCs Co-cultured and Expanded with E-CEL UVEC Cells AB-110
2020-09-18T06:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795426,Synonym:,Genetically-modified Endothelial Cells Plus Expanded Cord Blood Hematopoietic Stem Cells AB-110
2020-09-18T06:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795426,Code name:,AB 110
2020-09-18T06:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795426,Code name:,AB-110
2020-09-18T06:41:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796975,Synonym:,EAGD T cells
2020-09-18T06:41:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796975,Synonym:,EAGD T lymphocytes
2020-09-18T06:41:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796975,Synonym:,expanded and activated gamma delta T cells
2020-09-18T06:41:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796975,Synonym:,expanded and activated gamma/delta T cells
2020-09-18T06:41:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796975,Synonym:,expanded/activated gamma/delta T cells
2020-09-18T06:41:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride-liposome-injectable-suspension,Synonym:,bupivacaine liposome injectable suspension
2020-09-18T06:41:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride-liposome-injectable-suspension,US brand name:,Exparel
2020-09-18T06:41:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-bupivacaine-hydrochloride-resorbable-matrix-formulation,Synonym:,ER bupivacaine HCl
2020-09-18T06:41:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-bupivacaine-hydrochloride-resorbable-matrix-formulation,Synonym:,extended release bupivacaine hydrochloride
2020-09-18T06:41:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-bupivacaine-hydrochloride-resorbable-matrix-formulation,Synonym:,SABER-bupivacaine chloride
2020-09-18T06:41:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-bupivacaine-hydrochloride-resorbable-matrix-formulation,Synonym:,sustained release bupivacaine hydrochloride
2020-09-18T06:41:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-bupivacaine-hydrochloride-resorbable-matrix-formulation,US brand name:,Posidur
2020-09-18T06:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-flucytosine,Synonym:,extended release 5-FC
2020-09-18T06:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-flucytosine,Synonym:,extended release 5-fluorocytosine
2020-09-18T06:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-flucytosine,Synonym:,extended-release 5-FC
2020-09-18T06:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-flucytosine,Synonym:,extended-release 5-fluorocytosine
2020-09-18T06:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-flucytosine,US brand name:,Toca FC
2020-09-18T06:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797963,Synonym:,ER galantamine hydrobromide
2020-09-18T06:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797963,Synonym:,galantamine hydrobromide ER
2020-09-18T06:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797963,Synonym:,galantamine hydrobromide extended release
2020-09-18T06:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797963,US brand name:,Razadyne ER
2020-09-18T06:41:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-granisetron-polymer-formulation,Synonym:,ER granisetron injectable formulation
2020-09-18T06:41:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-granisetron-polymer-formulation,Synonym:,granisetron extended-release injection
2020-09-18T06:41:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-granisetron-polymer-formulation,Synonym:,granisetron extended-release polymer-based injectable formulation
2020-09-18T06:41:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-granisetron-polymer-formulation,US brand name:,Sustol
2020-09-18T06:42:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794051,Synonym:,oxycodone ER microsphere capsule
2020-09-18T06:42:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794051,US brand name:,Xtampza ER
2020-09-18T06:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-onapristone,Synonym:,ER onapristone
2020-09-18T06:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-onapristone,Synonym:,"onapristone, extended-release formulation"
2020-09-18T06:42:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Synonym:,Betadine topical
2020-09-18T06:42:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Synonym:,iodine povidone topical
2020-09-18T06:42:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Synonym:,iodopovidone solution
2020-09-18T06:42:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Betadine
2020-09-18T06:42:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Betadine Solution
2020-09-18T06:42:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,E-Z Prep
2020-09-18T06:42:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,E-Z Scrub
2020-09-18T06:42:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Traumasept
2020-09-18T06:42:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Ultradine
2020-09-18T06:42:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Videne
2020-09-18T06:42:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Foreign brand name:,Betaisodona
2020-09-18T06:42:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Abbreviation:,PVP iodine
2020-09-18T06:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Synonym:,Betadine topical
2020-09-18T06:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Synonym:,iodine povidone topical
2020-09-18T06:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Synonym:,iodopovidone solution
2020-09-18T06:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Betadine
2020-09-18T06:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Betadine Solution
2020-09-18T06:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,E-Z Prep
2020-09-18T06:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,E-Z Scrub
2020-09-18T06:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Traumasept
2020-09-18T06:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Ultradine
2020-09-18T06:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Videne
2020-09-18T06:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Foreign brand name:,Betaisodona
2020-09-18T06:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Abbreviation:,PVP iodine
2020-09-18T06:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezatiostat-hydrochloride,US brand name:,Telintra
2020-09-18T06:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezatiostat-hydrochloride,Code name:,TLK199
2020-09-18T06:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezatiostat-hydrochloride,Chemical structure:,"ethyl (2R)-[(4S)-4-amino-5-ethoxy-5-oxopentanoyl]-S-benzyl-L-cysteinyl-2- phenylglycinate hydrochlorideglycine, L-γ-glutamyl-S-(phenylmethyl)-L-cysteinyl-2-phenyl-, diethyl ester, monohydrochloride, (2R)-"
2020-09-18T06:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezetimibe,Synonym:,ezedoc
2020-09-18T06:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezetimibe,US brand name:,Zetia
2020-09-18T06:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezetimibe,Chemical structure:,1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone
2020-09-18T06:42:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezetimibe-simvastatin,US brand name:,Vytorin
2020-09-18T06:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802064,Synonym:,EZH1 and EZH2 inhibitor HH2853
2020-09-18T06:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802064,Code name:,HH 2853
2020-09-18T06:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802064,Code name:,HH2853
2020-09-18T06:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802064,Code name:,HH-2853
2020-09-18T06:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800217,Code name:,CPI 0209
2020-09-18T06:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800217,Code name:,CPI0209
2020-09-18T06:42:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-cpi-1205,Code name:,CPI-1205
2020-09-18T06:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795703,Code name:,PF 06821497
2020-09-18T06:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795703,Code name:,PF06821497
2020-09-18T06:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795703,Code name:,PF-06821497
2020-09-18T06:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797374,Synonym:,enhancer of Zeste homolog 2 inhibitor SHR2554
2020-09-18T06:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797374,Code name:,SHR 2554
2020-09-18T06:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797374,Code name:,SHR2554
2020-09-18T06:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797374,Code name:,SHR-2554
2020-09-18T06:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-fluorodeoxygalactose,Synonym:,18-F-deoxygalactose
2020-09-18T06:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-fluorodeoxygalactose,Synonym:,18-F-deoxy-galactose
2020-09-18T06:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-fluorodeoxygalactose,Synonym:,fluorodeoxygalactose F-18
2020-09-18T06:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-fluorodeoxygalactose,Abbreviation:,FDGal
2020-09-18T06:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f16-il2-fusion-protein,Synonym:,teleukin
2020-09-18T06:43:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-16-alpha-fluoroestradiol,Synonym:,fluorine-18 16 alpha-fluoroestradiol
2020-09-18T06:43:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-16-alpha-fluoroestradiol,Abbreviation:,F-18 FES
2020-09-18T06:43:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-fluoroethyltyrosine,Abbreviation:,F-18 FET
2020-09-18T06:43:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-fluoroethyltyrosine,Chemical structure:,O-(2-[F 18]fluoroethyl)-1-tyrosine
2020-09-18T06:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fact-complex-targeting-curaxin-cbl0137,Code name:,CBL0137
2020-09-18T06:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795707,Code name:,LNP 023
2020-09-18T06:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795707,Code name:,LNP023
2020-09-18T06:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795707,Code name:,LNP-023
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Synonym:,FD inhibitor ALXN2050
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ACH 0145228
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ACH 5228
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ACH0145228
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ACH-0145228
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ACH5228
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ACH-5228
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ALXN 2050
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ALXN2050
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ALXN-2050
2020-09-18T06:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-viia-inhibitor-pci-27483,Code name:,PCI-27483
2020-09-18T06:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-vii-targeting-immunoconjugate-protein-icon-1,Synonym:,FVII modified conjugate ICON-1
2020-09-18T06:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-vii-targeting-immunoconjugate-protein-icon-1,Synonym:,FVII-targeting immunoconjugate protein ICON-1
2020-09-18T06:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-vii-targeting-immunoconjugate-protein-icon-1,Synonym:,human immuno-conjugate 1
2020-09-18T06:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-vii-targeting-immunoconjugate-protein-icon-1,Synonym:,VII-Fc fusion protein ICON-1
2020-09-18T06:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-vii-targeting-immunoconjugate-protein-icon-1,Code name:,ICON-1
2020-09-18T06:43:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fadrozole-hydrochloride,Code name:,CGS-16949A
2020-09-18T06:43:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-gsk2256098,Synonym:,focal adhesion kinase inhibitor GSK2256098
2020-09-18T06:43:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-gsk2256098,Code name:,GSK2256098
2020-09-18T06:44:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-pf-00562271,Synonym:,focal adhesion kinase inhibitor PF-00562271
2020-09-18T06:44:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-pf-00562271,Code name:,PF-00562271
2020-09-18T06:44:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-vs-4718,Code name:,VS-4718
2020-09-18T06:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801583,Code name:,APG 2449
2020-09-18T06:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801583,Code name:,APG2449
2020-09-18T06:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801583,Code name:,APG-2449
2020-09-18T06:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/falimarev,Synonym:,recombinant fowlpox-CEA-MUC-1-TRICOM vaccine
2020-09-18T06:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/falimarev,Synonym:,rfowlpox-CEA(D609)/MUC1(L93)/TRICOM vaccine
2020-09-18T06:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/falimarev,US brand name:,PANVAC-F
2020-09-18T06:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/falimarev,Abbreviation:,fCEA-MUC-1-TRI
2020-09-18T06:44:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/famitinib,NA,NA
2020-09-18T06:44:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/famotidine,US brand name:,Pepcid
2020-09-18T06:44:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/famotidine,US brand name:,Pepcid AC
2020-09-18T06:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,Synonym:,trastuzumab deruxtecan
2020-09-18T06:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,US brand name:,Enhertu
2020-09-18T06:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,Code name:,DS-8201
2020-09-18T06:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,Code name:,DS-8201a
2020-09-18T06:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,Code name:,DS-8201a
2020-09-18T06:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,Code name:,WHO 10516
2020-09-18T06:44:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fap-specific-cd8-positive-t-cells,NA,NA
2020-09-18T06:44:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toremifene-citrate,US brand name:,Fareston
2020-09-18T06:44:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toremifene-citrate,Code name:,FC-1157a
2020-09-18T06:44:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toremifene-citrate,Code name:,GTx-006
2020-09-18T06:44:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toremifene-citrate,Chemical structure:,"(Z)-2-[4-(4-chloro-1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine 2-Hydroxy-1,2,3-propanetricarboxylate (1:1)2-(p-[(Z)-4-chloro-1,2-diphenyl-1-butenyl]-phenoxy)- N,N-dimethylethylamine citrate (1:1)"
2020-09-18T06:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/farletuzumab,Synonym:,anti-GP-3 monoclonal antibody
2020-09-18T06:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/farletuzumab,Code name:,MORAb-003
2020-09-18T06:44:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat,Synonym:,HDAC inhibitor LBH589
2020-09-18T06:44:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat,Synonym:,histone deacetylase inhibitor LBH589
2020-09-18T06:44:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat,US brand name:,Farydak
2020-09-18T06:44:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat,Foreign brand name:,Faridak
2020-09-18T06:44:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat,Code name:,LBH589
2020-09-18T06:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fas-receptor-agonist-apo010,Synonym:,mega-FasLigand
2020-09-18T06:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fas-receptor-agonist-apo010,Code name:,APO010
2020-09-18T06:45:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinidazole,US brand name:,Fasigyn
2020-09-18T06:45:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinidazole,US brand name:,Tindamax
2020-09-18T06:45:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinidazole,Foreign brand name:,Simplotan
2020-09-18T06:45:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinidazole,Abbreviation:,TDZ
2020-09-18T06:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulvestrant,US brand name:,Faslodex
2020-09-18T06:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulvestrant,Code name:,"ICI 182,780"
2020-09-18T06:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulvestrant,Code name:,ZD9238
2020-09-18T06:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulvestrant,Chemical structure:,"7a-[9-[(4,4,5,5,5,-Pentafluoropentyl)sulphinyl]nonyl]-estra-1,3,5(10)-triene-3,17b-diol"
2020-09-18T06:45:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fasn-inhibitor-tvb-2640,Code name:,TVB-2640
2020-09-18T06:45:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fat-emulsion,Synonym:,intravenous fat emulsion
2020-09-18T06:45:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fat-emulsion,US brand name:,Intralipid
2020-09-18T06:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fazarabine,Synonym:,Kymarabine
2020-09-18T06:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fazarabine,Abbreviation:,Ara AC
2020-09-18T06:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fazarabine,Abbreviation:,ARA-AC
2020-09-18T06:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fazarabine,Chemical structure:,"1,3, 5-triazin-2(1H)-one, 4-Amino-1-beta-D- arabinofuranosyl- (9CI)1-beta-D-arabinofuranosyl-5-azacytosine"
2020-09-18T06:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800787,Synonym:,anti-CD40 agonist antibody 2141-V11
2020-09-18T06:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800787,Synonym:,anti-CD40 agonistic antibody 2141-V11
2020-09-18T06:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800787,Synonym:,Fc-engineered anti-CD40 agonistic antibody 2141-V11
2020-09-18T06:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800787,Synonym:,Fc-enhanced wnti-CD40 wntibody 2141-V11
2020-09-18T06:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800787,Code name:,2141 V11
2020-09-18T06:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800787,Code name:,2141 V-11
2020-09-18T06:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800787,Code name:,2141-V11
2020-09-18T06:45:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/febuxostat,US brand name:,Uloric
2020-09-18T06:45:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/febuxostat,Code name:,TMX 67
2020-09-18T06:45:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/febuxostat,Chemical structure:,2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methylthiazole-5-carboxylic acid
2020-09-18T06:45:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fec-regimen,Synonym:,CEF
2020-09-18T06:45:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fec-regimen,Synonym:,CEF regimen
2020-09-18T06:45:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fec-regimen,Synonym:,CTX/EPI/5-FU
2020-09-18T06:45:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fec-regimen,Synonym:,FEC
2020-09-18T06:45:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fec-regimen,Synonym:,FEC 100
2020-09-18T06:45:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fec-regimen,Synonym:,fluorouracil-epirubicin-cyclophosphamide regimen
2020-09-18T06:45:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800681,Synonym:,fecal microbiota preparation delivery capsule
2020-09-18T06:45:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800681,Synonym:,FMPCapDE
2020-09-18T06:45:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800681,Synonym:,FMT Capsule DE
2020-09-18T06:45:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800681,Synonym:,FMT capsule delivery
2020-09-18T06:45:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800681,Synonym:,FMT DE capsule
2020-09-18T06:45:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-tg101348,Synonym:,fedratinib dihydrochloride monohydrate
2020-09-18T06:45:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-tg101348,US brand name:,Inrebic
2020-09-18T06:45:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-tg101348,Code name:,SAR302503a
2020-09-18T06:46:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piroxicam,US brand name:,Feldene
2020-09-18T06:46:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piroxicam,Abbreviation:,PXM
2020-09-18T06:46:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piroxicam,Chemical structure:,"4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboximide-1,1-dioxide"
2020-09-18T06:46:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole,US brand name:,Femara
2020-09-18T06:46:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole,Abbreviation:,LTZ
2020-09-18T06:46:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole,Code name:,CGS 20267
2020-09-18T06:46:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole,Chemical structure:,"4,4'-(1H-1,2,4triazol-1-ylmethylene)dibenzonitrile"
2020-09-18T06:46:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,US brand name:,Femest
2020-09-18T06:46:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,US brand name:,Premarin
2020-09-18T06:46:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,Foreign brand name:,Conestron
2020-09-18T06:46:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,Foreign brand name:,Sodestrin
2020-09-18T06:46:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,Abbreviation:,EST
2020-09-18T06:46:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,Code name:,Tag-39
2020-09-18T06:46:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Estinyl
2020-09-18T06:46:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Ethinoral
2020-09-18T06:46:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Feminone
2020-09-18T06:46:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Orestralyn
2020-09-18T06:46:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Diogyn E
2020-09-18T06:46:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Eticylol
2020-09-18T06:46:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Inestra
2020-09-18T06:46:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Lynoral
2020-09-18T06:46:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Abbreviation:,EE
2020-09-18T06:46:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Chemical structure:,"(17alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol"
2020-09-18T06:46:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenofibrate,US brand name:,Tricor
2020-09-18T06:46:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide,Synonym:,fenretinimide
2020-09-18T06:46:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide,Abbreviation:,4-HPR
2020-09-18T06:46:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide,Code name:,McN-R-1967
2020-09-18T06:46:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide,Chemical structure:,4-(all-trans-retino-yl)aminophenol4-hydroxyphenylretinamideAll-trans-4'-hydroxyretinanilideall-trans-N-(4-hydroxyphenyl)retinamideall-trans-N-4'-hydroxyretinanilideN-(4-hydroxyphenyl)retinamide
2020-09-18T06:46:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide-lipid-matrix,Synonym:,fenretinide LXS
2020-09-18T06:46:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide-lipid-matrix,US brand name:,Fenretinide Lym-X-Sorb
2020-09-18T06:46:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide-lipid-matrix,Synonym:,fenretinide LXS
2020-09-18T06:46:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide-lipid-matrix,US brand name:,Fenretinide Lym-X-Sorb
2020-09-18T06:46:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-buccal-soluble-film,US brand name:,Onsolis
2020-09-18T06:46:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-buccal-tablet,Synonym:,fentanyl buccal tablet
2020-09-18T06:46:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-buccal-tablet,US brand name:,Fentora
2020-09-18T06:46:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-pectin-based-nasal-spray,US brand name:,Lazanda
2020-09-18T06:46:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-pectin-based-nasal-spray,US brand name:,Nasalfent
2020-09-18T06:46:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-pectin-based-nasal-spray,Foreign brand name:,Nasalfent
2020-09-18T06:46:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-pectin-based-nasal-spray,Foreign brand name:,PecFent
2020-09-18T06:46:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-containing-nasal-spray,Synonym:,intranasal fentanyl spray
2020-09-18T06:46:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-containing-nasal-spray,Foreign brand name:,Instanyl
2020-09-18T06:47:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-matrix-transdermal-patch,Synonym:,fentanyl matrix transdermal delivery system
2020-09-18T06:47:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-matrix-transdermal-patch,Foreign brand name:,Durogesic DTrans
2020-09-18T06:47:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-sublingual-spray,Abbreviation:,fentanyl SL spray
2020-09-18T06:47:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-sublingual-spray,Abbreviation:,FSS
2020-09-18T06:47:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-buccal-tablet,Synonym:,fentanyl buccal tablet
2020-09-18T06:47:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-buccal-tablet,US brand name:,Fentora
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,black iron oxide
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,ferrosoferric oxide
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,iron black
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,magnetic black
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,magnetite
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,Sienna+
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,US brand name:,Feraheme
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Abbreviation:,Fe3O4
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Chemical structure:,iron oxidetriiron tetraoxide
2020-09-18T06:47:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxides-injectable-solution,US brand name:,Feridex
2020-09-18T06:47:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800204,Synonym:,fermented soy
2020-09-18T06:47:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800204,Synonym:,fermented soy extract
2020-09-18T06:47:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800204,US brand name:,Q-Can Plus
2020-09-18T06:47:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-soybean-protein-beverage,US brand name:,Haelan 951
2020-09-18T06:47:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-wheat-germ-extract,US brand name:,Avemar
2020-09-18T06:47:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-wheat-germ-extract,Foreign brand name:,Avemar
2020-09-18T06:47:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-wheat-germ-extract,Acronym:,FWGE
2020-09-18T06:47:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,Synonym:,d-amphetamine sulphate
2020-09-18T06:47:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dexampex
2020-09-18T06:47:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dexedrine
2020-09-18T06:47:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dextrostat
2020-09-18T06:47:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Ferndex
2020-09-18T06:47:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,Chemical structure:,"(+)-alpha-methylphenethylamine sulphate (2:1)(S)-alpha-methylbenzeneethanamine sulfatebenzeneethanamine, alpha-methyl-, (S)-, sulfate (2:1)d-alpha-methylphenethylamine sulfate"
2020-09-18T06:47:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferric-carboxymaltose-solution,Synonym:,ferric carboxymaltose injection
2020-09-18T06:47:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferric-carboxymaltose-solution,US brand name:,Injectafer
2020-09-18T06:47:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferric-carboxymaltose-solution,Foreign brand name:,Ferinject
2020-09-18T06:47:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferric-carboxymaltose-solution,Abbreviation:,FCM
2020-09-18T06:47:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-ferric-gluconate-complex-in-sucrose,US brand name:,Ferrlecit
2020-09-18T06:48:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrous-fumarate,NA,NA
2020-09-18T06:48:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrous-sulfate,Synonym:,Iron(II) Sulfate
2020-09-18T06:48:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxides-injectable-solution,US brand name:,Feridex
2020-09-18T06:48:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxsil-oral-suspension,US brand name:,GastroMARK
2020-09-18T06:48:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxsil-oral-suspension,US brand name:,Lumirem
2020-09-18T06:48:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,Synonym:,Ultrasmall Particulate Iron Oxide
2020-09-18T06:48:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,US brand name:,Combidex
2020-09-18T06:48:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,Foreign brand name:,Sinerem
2020-09-18T06:48:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,Abbreviation:,USPIO
2020-09-18T06:48:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,Code name:,AMI-227
2020-09-18T06:48:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,Code name:,G-53425
2020-09-18T06:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,black iron oxide
2020-09-18T06:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,ferrosoferric oxide
2020-09-18T06:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,iron black
2020-09-18T06:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,magnetic black
2020-09-18T06:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,magnetite
2020-09-18T06:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,Sienna+
2020-09-18T06:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,US brand name:,Feraheme
2020-09-18T06:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Abbreviation:,Fe3O4
2020-09-18T06:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Chemical structure:,iron oxidetriiron tetraoxide
2020-09-18T06:48:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fesoterodine-fumarate,US brand name:,Toviaz
2020-09-18T06:48:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgf-fgfr-pathway-inhibitor-e7090,Code name:,E7090
2020-09-18T06:48:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgf401-inhibitor-fgf401,Code name:,FGF401
2020-09-18T06:48:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-asp5878,Code name:,ASP5878
2020-09-18T06:48:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-azd4547,Code name:,AZD4547
2020-09-18T06:49:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802158,Code name:,CPL 304110
2020-09-18T06:49:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802158,Code name:,CPL304110
2020-09-18T06:49:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802158,Code name:,CPL-304110
2020-09-18T06:49:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802158,Code name:,PG19
2020-09-18T06:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-debio-1347,Synonym:,CH5183284
2020-09-18T06:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-debio-1347,Synonym:,debiopharm 1347
2020-09-18T06:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-debio-1347,Synonym:,FF284
2020-09-18T06:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-debio-1347,Code name:,debio 1347
2020-09-18T06:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-debio-1347,Code name:,debio 1347-101
2020-09-18T06:49:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792789,Synonym:,FGFR inhibitor HMPL-453
2020-09-18T06:49:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792789,Code name:,HMPL 453
2020-09-18T06:49:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792789,Code name:,HMPL-453
2020-09-18T06:49:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr1-receptor-antagonist-hgs1036,Synonym:,FGFR1 receptor antagonist FP-1039
2020-09-18T06:49:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr1-receptor-antagonist-hgs1036,Synonym:,GSK3052230
2020-09-18T06:49:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr1-receptor-antagonist-hgs1036,Code name:,FP-1039
2020-09-18T06:49:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr1-receptor-antagonist-hgs1036,Code name:,HGS1036
2020-09-18T06:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-antagonist-incb062079,Synonym:,fibroblast growth factor receptor 4 antagonist INCB062079
2020-09-18T06:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-antagonist-incb062079,Code name:,INCB 062079
2020-09-18T06:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-antagonist-incb062079,Code name:,INCB062079
2020-09-18T06:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-antagonist-incb062079,Code name:,INCB-062079
2020-09-18T06:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-antagonist-incb062079,Code name:,INCB62079
2020-09-18T06:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-h3b-6527,Synonym:,fibroblast growth factor receptor 4 inhibitor H3B-6527
2020-09-18T06:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-h3b-6527,Code name:,H3B 6527
2020-09-18T06:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-h3b-6527,Code name:,H3B6527
2020-09-18T06:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-h3b-6527,Code name:,H3B-6527
2020-09-18T06:49:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798826,Synonym:,FGFR4 antagonist ICP-105
2020-09-18T06:49:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798826,Code name:,ICP 105
2020-09-18T06:49:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798826,Code name:,ICP105
2020-09-18T06:49:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798826,Code name:,ICP-105
2020-09-18T06:49:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibrin-sealant,US brand name:,Fibrocaps
2020-09-18T06:49:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibrin-sealant,US brand name:,TISSEEL VH
2020-09-18T06:49:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibrin-sealant,Foreign brand name:,Beriplast P
2020-09-18T06:49:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibrin-sealant,US brand name:,Fibrocaps
2020-09-18T06:49:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibrin-sealant,US brand name:,TISSEEL VH
2020-09-18T06:49:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibrin-sealant,Foreign brand name:,Beriplast P
2020-09-18T06:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-fusion-protein-l19tnfalpha,Synonym:,recombinant human fusion protein L19TNFalpha
2020-09-18T06:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-fusion-protein-l19tnfalpha,Abbreviation:,L19TNF alpha
2020-09-18T06:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-fusion-protein-l19tnfalpha,Abbreviation:,L19-TNF-alpha
2020-09-18T06:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ficlatuzumab,Synonym:,anti-HGF monoclonal antibody SCH900105
2020-09-18T06:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ficlatuzumab,Code name:,AV-299
2020-09-18T06:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ficlatuzumab,Code name:,SCH 900105
2020-09-18T06:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fidaxomicin,Synonym:,clostomicin B1
2020-09-18T06:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fidaxomicin,Synonym:,difimicin
2020-09-18T06:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fidaxomicin,Synonym:,lipiamycin A3
2020-09-18T06:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fidaxomicin,Code name:,OPT-80
2020-09-18T06:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fidaxomicin,Code name:,PAR-101
2020-09-18T06:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prasterone,Synonym:,Dehydroisoandrosterone
2020-09-18T06:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prasterone,Synonym:,therapeutic dehydroepiandrosterone
2020-09-18T06:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prasterone,US brand name:,Fidelin
2020-09-18T06:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prasterone,Abbreviation:,DHEA
2020-09-18T06:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prasterone,Chemical structure:,3beta-Hydroxyandrost-5-en-17-one
2020-09-18T06:50:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/figitumumab,Code name:,"CP-751,871"
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Synonym:,filgrastim XM02
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Synonym:,filgrastim-sndz
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Synonym:,G-CSF
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Synonym:,granulocyte colony-stimulating factor
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Synonym:,Recombinant Methionyl Human Granulocyte Colony Stimulating Factor
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Synonym:,tbo-filgrastim
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Synonym:,Tbo-filgrastim
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,US brand name:,Granix
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,US brand name:,Neupogen
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,US brand name:,Zarxio
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Foreign brand name:,Grasin
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Foreign brand name:,Nivestim
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Foreign brand name:,Tevagrastim
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Abbreviation:,G-CSF
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Abbreviation:,r-metHuG-CSF
2020-09-18T06:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim-primed-peripheral-blood-progenitor-cells,Synonym:,G-CSF-primed peripheral blood progenitor cells
2020-09-18T06:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim-primed-peripheral-blood-progenitor-cells,Abbreviation:,filgrastim-primed PBPC
2020-09-18T06:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim-primed-peripheral-blood-progenitor-cells,Abbreviation:,GPBPCI
2020-09-18T06:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799987,Chemical structure:,"4,4'-(15,20-diphenyl-7,8(or 12,13 or 17,18)-dihydro-21H,23H-porphine-5,10-diyl)bisbenzenesulfonic acid, mixture of three isomers A, B and C (25%,50%,25%)"
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,US brand name:,Proscar
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,Foreign brand name:,Chibro-Proscar
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,Foreign brand name:,Finastid
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,Foreign brand name:,Pro-Cure
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,Foreign brand name:,Prostide
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,Foreign brand name:,Uprosan
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,Code name:,MK 906
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,Chemical structure:,"(5alpha,17beta)-N-(1,1-dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide"
2020-09-18T06:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/degarelix,US brand name:,Firmagon
2020-09-18T06:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/degarelix,Code name:,ASP3550
2020-09-18T06:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/degarelix,Code name:,FE200486
2020-09-18T06:50:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fish-oil,Synonym:,"oil, fish"
2020-09-18T06:50:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fish-oil,Synonym:,seafood oil
2020-09-18T06:50:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fish-oil-glycerol-egg-lecithin-based-emulsion,Synonym:,omega-3 fatty acid infusion
2020-09-18T06:50:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fish-oil-glycerol-egg-lecithin-based-emulsion,Foreign brand name:,Omegaven
2020-09-18T06:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-blu-554,Synonym:,fibroblast growth factor receptor 4 inhibitor BLU-554
2020-09-18T06:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-blu-554,Code name:,BLU 554
2020-09-18T06:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-blu-554,Code name:,BLU554
2020-09-18T06:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-blu-554,Code name:,CS 3008
2020-09-18T06:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-blu-554,Code name:,CS3008
2020-09-18T06:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-blu-554,Chemical structure:,"2-propenamide, N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl)amino)tetrahydro-2H-pyran-4-yl)-N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)oxan-4-yl)prop-2-enamide"
2020-09-18T06:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metronidazole-hydrochloride,US brand name:,Flagyl
2020-09-18T06:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metronidazole-hydrochloride,US brand name:,Satric
2020-09-18T06:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metronidazole-hydrochloride,Code name:,SC 32642
2020-09-18T06:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flanvotumab,Code name:,IMC-20D7S
2020-09-18T06:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flavone-acetic-acid,Abbreviation:,FAA
2020-09-18T06:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flavone-acetic-acid,Code name:,LM 975
2020-09-18T06:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flavone-acetic-acid,Chemical structure:,"4H-1-benzopyran-8-acetic acid, 4-oxo-2-phenylflavone-8-acetic acid"
2020-09-18T06:51:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flavonoid-tablet,NA,NA
2020-09-18T06:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flaxseed,Synonym:,linseed
2020-09-18T06:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flaxseed,Synonym:,linum
2020-09-18T06:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flaxseed,Synonym:,Linum usitatissimum
2020-09-18T06:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799713,Synonym:,flax lignan
2020-09-18T06:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diclofenac-epolamine-patch,US brand name:,Flector Patch
2020-09-18T06:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-biphosphate-sodium-phosphate-oral-laxative,US brand name:,Fleet Phospho-soda
2020-09-18T06:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-biphosphate-sodium-phosphate-oral-laxative,Foreign brand name:,Fleet Phospho-soda
2020-09-18T06:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Synonym:,cloben
2020-09-18T06:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Synonym:,Novo-Cycloprine
2020-09-18T06:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,US brand name:,Cycloflex
2020-09-18T06:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,US brand name:,Flexeril
2020-09-18T06:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,US brand name:,Flexiban
2020-09-18T06:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Code name:,FR2100873
2020-09-18T06:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Chemical structure:,"10,11delta-amitriptyline hydrochloride1-propanamine, 3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)propyl(dimethyl)ammonium chloride"
2020-09-18T06:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Synonym:,cloben
2020-09-18T06:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Synonym:,Novo-Cycloprine
2020-09-18T06:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,US brand name:,Cycloflex
2020-09-18T06:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,US brand name:,Flexeril
2020-09-18T06:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,US brand name:,Flexiban
2020-09-18T06:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Code name:,FR2100873
2020-09-18T06:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Chemical structure:,"10,11delta-amitriptyline hydrochloride1-propanamine, 3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)propyl(dimethyl)ammonium chloride"
2020-09-18T06:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797893,NA,NA
2020-09-18T06:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamsulosin-hydrochloride,US brand name:,Flomax
2020-09-18T06:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluticasone-propionate,US brand name:,Flonase
2020-09-18T06:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluticasone-propionate,US brand name:,Flovent
2020-09-18T06:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluticasone-propionate,Chemical structure:,"(6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic Acid, S-(Fluoromethyl) Ester"
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,US brand name:,Florafur
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,US brand name:,Fluorofur
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Citofur
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Coparogin
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Exonal
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Fental
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,ftorafur
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Ftoral
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Ftoralon
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Fulaid
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Fulfeel
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Furafluor
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Furofutran
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Futraful
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Lamar
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Lifril
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Neberk
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Nitobanil
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Riol
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Sinoflurol
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Sunfural
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Tefsiel
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Utefos
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Abbreviation:,FT
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Code name:,FT-207
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Code name:,MJF-12264
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Code name:,WR-220066
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Chemical structure:,"5-fluoro-1-(tetrahydro-2-furanyl)-2,4(1H,3H)-pyrimidinedione5-fluoro-1-(tetrahydro-2-furyl)-uracilN1-(2'-furanidyl)-5-fluorouracil"
2020-09-18T06:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludrocortisone-acetate,Synonym:,Florinef acetate
2020-09-18T06:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludrocortisone-acetate,Synonym:,fludrocortisone
2020-09-18T06:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludrocortisone-acetate,US brand name:,Florinef
2020-09-18T06:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-monoclonal-antibody-mgd006,Synonym:,anti-CD123/CD3 monoclonal antibody MGD006
2020-09-18T06:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-monoclonal-antibody-mgd006,Synonym:,CD123 x CD3 DART bi-specific antibody MGD006
2020-09-18T06:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-monoclonal-antibody-mgd006,Synonym:,CD123 x CD3 dual affinity re-targeting bi-specific antibody MGD006
2020-09-18T06:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-monoclonal-antibody-mgd006,Code name:,MGD006
2020-09-18T06:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-monoclonal-antibody-mgd006,Code name:,RES234
2020-09-18T06:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-monoclonal-antibody-mgd006,Code name:,S80880
2020-09-18T06:52:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluticasone-propionate,US brand name:,Flonase
2020-09-18T06:52:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluticasone-propionate,US brand name:,Flovent
2020-09-18T06:52:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluticasone-propionate,Chemical structure:,"(6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic Acid, S-(Fluoromethyl) Ester"
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Synonym:,FdUrD
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Synonym:,floxuridin
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Synonym:,fluorodeoxyuridine
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Synonym:,fluorouridine deoxyribose
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Synonym:,fluoruridine deoxyribose
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,US brand name:,FUDF
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Abbreviation:,5-FUDR
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Abbreviation:,FDUR
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Abbreviation:,FUdR
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Code name:,WR-138720
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Chemical structure:,1-(2-deoxy-beta-D-ribofuranosyl)-5-fluorouracil2'-deoxy-5-fluorouridine5-fluoro-2'-deoxy-beta-uridine5-fluoro-2'-deoxyuridine5-fluorodeoxyuridine5-fluorouridine deoxyribose
2020-09-18T06:52:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-ff-10101-succinate,Synonym:,FF-10101 succinate
2020-09-18T06:52:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-ff-10101-succinate,Synonym:,FF10101 Succinate
2020-09-18T06:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799742,Synonym:,FMS-like tyrosine kinase 3 inhibitor HM43239
2020-09-18T06:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799742,Code name:,HM 43239
2020-09-18T06:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799742,Code name:,HM43239
2020-09-18T06:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799742,Code name:,HM-43239
2020-09-18T06:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794986,Synonym:,FLT3 kinase inhibitor SKI-G-801
2020-09-18T06:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794986,Synonym:,FLT3 tyrosine kinase inhibitor SKI-G-801
2020-09-18T06:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794986,Synonym:,G-749 HCl salt
2020-09-18T06:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794986,Synonym:,G749 hydrochloride
2020-09-18T06:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794986,Code name:,G-801
2020-09-18T06:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794986,Code name:,SKI-G-801
2020-09-18T06:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-cdk4-6-inhibitor-flx925,Code name:,FLX925
2020-09-18T06:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-kit-kinase-inhibitor-akn-028,Code name:,AKN-028
2020-09-18T06:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-kit-kinase-inhibitor-akn-028,Code name:,BVT-II
2020-09-18T06:53:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801585,Code name:,NMS 03592088
2020-09-18T06:53:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801585,Code name:,NMS P088
2020-09-18T06:53:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801585,Code name:,NMS03592088
2020-09-18T06:53:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801585,Code name:,NMS-03592088
2020-09-18T06:53:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793562,Code name:,MRX 2843
2020-09-18T06:53:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793562,Code name:,MRX2843
2020-09-18T06:53:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793562,Code name:,MRX-2843
2020-09-18T06:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flu-matrix-peptide-p58-66,NA,NA
2020-09-18T06:53:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluconazole,US brand name:,Diflucan
2020-09-18T06:53:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluconazole,Abbreviation:,FCZ
2020-09-18T06:53:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluconazole,Chemical structure:,"alpha-(2,4-difluorophenyl)-alpha- (1,2,4-triazol-1-ylmethyl)-1,2, 4- triazole-1-ethanol"
2020-09-18T06:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludarabine-phosphate,Synonym:,fludarabine monophosphate
2020-09-18T06:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludarabine-phosphate,Foreign brand name:,Beneflur
2020-09-18T06:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludarabine-phosphate,Abbreviation:,2-F-ara-AMP
2020-09-18T06:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludarabine-phosphate,Code name:,SH T 586
2020-09-18T06:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludarabine-phosphate,Chemical structure:,"9H-purin-6-amine, 2-fluoro-9-(5-O-phosphono-.beta.-D-arabinofuranosyl)fludarabine-5'-monophosphate"
2020-09-18T06:53:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cell-surface-anchored-sialidase-das181,Synonym:,273-666-neuraminidase [273-methionine] (actinomyces viscosus clone DAS181) fusion protein with 125-145-preproamphiregulin (human)
2020-09-18T06:53:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cell-surface-anchored-sialidase-das181,US brand name:,Fludase
2020-09-18T06:53:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cell-surface-anchored-sialidase-das181,Code name:,DAS181
2020-09-18T06:53:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cell-surface-anchored-sialidase-das181,Code name:,DAS181-F02
2020-09-18T06:53:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludeoxyglucose-f-18,Synonym:,Fluorine-18 2-Fluoro-2-deoxy-D-Glucose
2020-09-18T06:53:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludeoxyglucose-f-18,Synonym:,fluorodeoxyglucose F 18
2020-09-18T06:53:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludeoxyglucose-f-18,Abbreviation:,18FDG
2020-09-18T06:53:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludeoxyglucose-f-18,Abbreviation:,FDG
2020-09-18T06:53:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludeoxyglucose-f-18,Chemical structure:,2-F18-fluoro-2-deoxy-D-glucose2-F18-fluoro-2-deoxyglucose
2020-09-18T06:53:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludrocortisone-acetate,Synonym:,Florinef acetate
2020-09-18T06:53:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludrocortisone-acetate,Synonym:,fludrocortisone
2020-09-18T06:53:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludrocortisone-acetate,US brand name:,Florinef
2020-09-18T06:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flumatinib-mesylate,Code name:,HH-GV678
2020-09-18T06:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flumatinib-mesylate,Code name:,HH-GV-678
2020-09-18T06:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flumatinib-mesylate,Chemical structure:,4-(4-Methyl-piperazin-1-ylmethyl)-N-[6-methyl-5-(4-pyridin-3-yl-pyrimidin-2-ylamino)-pyridin-3-yl]-3-trifluoromethyl-benzamide Mesylate
2020-09-18T06:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-live-attenuated-influenza-vaccine,Synonym:,"trivalent intranasal influenza vaccine, live"
2020-09-18T06:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-live-attenuated-influenza-vaccine,US brand name:,FluMist
2020-09-18T06:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-live-attenuated-influenza-vaccine,Foreign brand name:,Fluenz
2020-09-18T06:53:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluocinonide-cream,Synonym:,fluocinonide
2020-09-18T06:53:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluocinonide-cream,US brand name:,Lidex
2020-09-18T06:53:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluocinonide-cream,US brand name:,Vanos
2020-09-18T06:53:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluocinonide-cream,Chemical structure:,"(6alpha,11beta,16alpha)-21-(acetyloxy)-6,9-difluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione"
2020-09-18T06:54:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescein-sodium-injection,Synonym:,AK-FLUOR
2020-09-18T06:54:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescein-sodium-injection,US brand name:,Fluorescite
2020-09-18T06:54:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescein-sodium-injection,Chemical structure:,"spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one, 3'6'-dihydroxy,disodium salt"
2020-09-18T06:54:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792555,Synonym:,fluorescein-labeled WFA
2020-09-18T06:54:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792555,Synonym:,fluorescein-labeled WFL
2020-09-18T06:54:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792555,Synonym:,fluorescein-labeled Wisteria floribunda lectin
2020-09-18T06:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescence-imaging-agent-emi-137,Code name:,EMI-137
2020-09-18T06:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-antibody-sgm-101,Synonym:,anti-CEA fluorescent antibody SGM-101
2020-09-18T06:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-antibody-sgm-101,Code name:,SGM-101
2020-09-18T06:54:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-crgdy-peg-cy55-c-dots,Synonym:,cRGDY-PEG-Cy5.5-C dots
2020-09-18T06:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-dye-ls301,Synonym:,NIR fluorescent probe LS301
2020-09-18T06:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-dye-ls301,Code name:,LS 301
2020-09-18T06:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-dye-ls301,Code name:,LS301
2020-09-18T06:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-dye-ls301,Code name:,LS-301
2020-09-18T06:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-dye-ls301,Chemical structure:,cypate-cyclo (D-Cys-Gly-Arg--Asp-Ser-Pro-Cys)-Lys-OH
2020-09-18T06:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-imaging-ligand-otl38,Code name:,OTL38
2020-09-18T06:54:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-protease-activated-peptide-avb-620,Code name:,AVB-620
2020-09-18T06:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescein-sodium-injection,Synonym:,AK-FLUOR
2020-09-18T06:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescein-sodium-injection,US brand name:,Fluorescite
2020-09-18T06:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescein-sodium-injection,Chemical structure:,"spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one, 3'6'-dihydroxy,disodium salt"
2020-09-18T06:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-18-f-fludarabine,Synonym:,18F-fludarabine
2020-09-18T06:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-18-f-fludarabine,Synonym:,2-[(18)F]fludarabine
2020-09-18T06:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-18-f-fludarabine,Synonym:,fluorine 18 F fludarabine
2020-09-18T06:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alphavbeta6-binding-peptide,Synonym:,18F-alphaVbeta6-binding peptide
2020-09-18T06:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alphavbeta6-binding-peptide,Synonym:,18F-alphaVbeta6-binding-peptide
2020-09-18T06:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alphavbeta6-binding-peptide,Synonym:,fluorine F 18-alphaVbeta6-binding peptide
2020-09-18T06:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alphavbeta6-binding-peptide,Synonym:,fluorine F 18-alphaVbeta6-binding-peptide
2020-09-18T06:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alphavbeta6-binding-peptide,Abbreviation:,18F-aVb6-BP
2020-09-18T06:55:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-choline,Synonym:,18F-fluorocholine
2020-09-18T06:55:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-choline,Abbreviation:,[18F]-choline
2020-09-18T06:55:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-choline,Abbreviation:,18F-choline
2020-09-18T06:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-clofarabine,Synonym:,[18F]-clofarabine
2020-09-18T06:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-clofarabine,Synonym:,18F-clofarabine
2020-09-18T06:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-clofarabine,Synonym:,cl-18F-ara-A
2020-09-18T06:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-clofarabine,Abbreviation:,18F-CA
2020-09-18T06:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-clofarabine,Chemical structure:,2-chloro-9-(2'-deoxy-2'-18F-fluoro-beta-D-arabinofuranosyl)adenine
2020-09-18T06:55:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-cp18-peptide,Synonym:,[F18]CP-18 peptide
2020-09-18T06:55:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-cp18-peptide,Synonym:,18F-CP18 peptide
2020-09-18T06:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799978,Synonym:,[18F]-C-SNAT4
2020-09-18T06:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799978,Synonym:,18F C SNAT4
2020-09-18T06:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799978,Synonym:,18F-C-SNAT4
2020-09-18T06:55:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dabrafenib,Synonym:,[F18]dabrafenib
2020-09-18T06:55:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796994,Synonym:,18F-DASA-23
2020-09-18T06:55:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796994,Synonym:,F18-labeled PKM2 inhibitor DASA-23
2020-09-18T06:55:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796994,Synonym:,F18-labeled pyruvate kinase M2 inhibitor DASA-23
2020-09-18T06:55:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796994,Chemical structure:,1-((2-fluoro-6-[18F]fluorophenyl)sulfonyl)-4-((4-methoxyphenyl)sulfonyl)piperazine
2020-09-18T06:55:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dcfbc,Abbreviation:,[18]F-DCFBC
2020-09-18T06:55:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dcfbc,Abbreviation:,18F-DCFBC
2020-09-18T06:55:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dcfbc,Chemical structure:,"N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine"
2020-09-18T06:55:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dcfpyl,Abbreviation:,18F-DCFPyL
2020-09-18T06:55:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dcfpyl,Chemical structure:,2-(3-{1-carboxy-5-[(6-[(18)F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid
2020-09-18T06:55:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-d-fmau,Chemical structure:,1-(2'-deoxy-2'-[18F]fluoro-beta-D-arabinofuranosyl)thymine18F-2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil-clevudine2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-D-arabinofuranosyluracil
2020-09-18T06:55:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ef5,Abbreviation:,18F-EF5
2020-09-18T06:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fdht,Synonym:,fluorine F 18 16-beta-fluoro-5-alpha-dihydrotestosterone
2020-09-18T06:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fdht,Synonym:,fluorine F 18-FDHT
2020-09-18T06:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fdht,Synonym:,fluorine F18-FDHT
2020-09-18T06:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fdht,Abbreviation:,(18)F-FDHT
2020-09-18T06:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fdht,Abbreviation:,18F-FDHT
2020-09-18T06:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fdht,Abbreviation:,fluorine F 18 dihydrotestosterone
2020-09-18T06:56:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-feqa,Abbreviation:,F-18 FEQA
2020-09-18T06:56:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-feqa,Chemical structure:,N-{4-[(3'- [F-18] fluoroethylphenyl)amino]-6-quinazolinyl}-acrylamide
2020-09-18T06:56:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoro-furanyl-norprogesterone,Abbreviation:,F18-FFNP
2020-09-18T06:56:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorobenzyl-triphenyl-phosphonium,Synonym:,18F-fluorobenzyl triphenyl phosphonium
2020-09-18T06:56:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorobenzyl-triphenyl-phosphonium,Abbreviation:,(18)F-FBnTP
2020-09-18T06:56:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorodopa,Abbreviation:,(18)F-FDOPA
2020-09-18T06:56:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorodopa,Abbreviation:,18F-6- L-fluorodopa
2020-09-18T06:56:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorodopa,Abbreviation:,18F-DOPA
2020-09-18T06:56:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorodopa,Abbreviation:,18F-FDOPA
2020-09-18T06:59:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluciclovine,Synonym:,fluciclovine (18F)
2020-09-18T06:56:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorodopa,Chemical structure:,"3,4-dihydroxy-6-(18)F-fluoro-l-phenylalanineL-6-[ 18F]fluoro-3, 4-dihydroxyphenylalanine"
2020-09-18T06:56:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoroethylcholine,Abbreviation:,18F-ethylcholine
2020-09-18T06:56:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoromethylcholine,Synonym:,18F-fluoromethylcholine
2020-09-18T06:56:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoropaclitaxel,Abbreviation:,18-F FPAC
2020-09-18T06:56:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoro-peg6-ipqa,Abbreviation:,[(18)F]F-PEG6-IPQA
2020-09-18T06:56:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoro-peg6-ipqa,Abbreviation:,18F-fluoro-PEG6-IPQA
2020-09-18T06:56:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoro-peg6-ipqa,Chemical structure:,4-[(3-iodophenyl)amino]-7-{2-[2-{2-(2-[2-{2-([(18)F]fluoroethoxy)-ethoxy}-ethoxy]-ethoxy)-ethoxy}-ethoxy]-quinazoline-6-yl-acrylamide
2020-09-18T06:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorthanatrace,Synonym:,[18F]FluorThanatrace
2020-09-18T06:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorthanatrace,Abbreviation:,[18F]FTT
2020-09-18T06:56:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fmdht,Synonym:,18F FMDHT
2020-09-18T06:56:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fmdht,Chemical structure:,[7alpha-18F]fluoro-17alpha-methyl-5alpha-dihydrotestosterone
2020-09-18T06:56:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fp-r01-mg-f2,Synonym:,[18F] FP-R01-MG-F2
2020-09-18T06:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-galacto-rgd-peptide,Synonym:,[18F]Galacto-RGD
2020-09-18T06:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-galacto-rgd-peptide,Synonym:,18F-Galacto-RGD
2020-09-18T06:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-galacto-rgd-peptide,Synonym:,fluorine F 18 glycosylated RGD peptide
2020-09-18T06:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792848,Synonym:,18F-alphavbeta6-binding peptide
2020-09-18T06:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792848,Synonym:,18F-aVb6-binding-peptide
2020-09-18T06:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792848,Abbreviation:,18F-αvβ6-BP
2020-09-18T06:57:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-iso-1,Abbreviation:,[18F]ISO-1
2020-09-18T06:57:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-l-glutamate-derivative-bay94-9392,Synonym:,(4S)-(3-[F-18]fluoropropyl)-L-glutamic acid
2020-09-18T06:57:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-l-glutamate-derivative-bay94-9392,Synonym:,18F-FSPG
2020-09-18T06:57:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-l-glutamate-derivative-bay94-9392,Code name:,BAY94-9392
2020-09-18T06:57:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-l-glutamate-derivative-bay94-9392,Code name:,FSPG
2020-09-18T06:57:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-l-glutamate-derivative-bay94-9392,Chemical structure:,(4S)-4-(3-18F-fluoropropyl)-L-glutamate(S)-4-(3-18F-fluoropropyl)-L-glutamic acid
2020-09-18T06:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800445,Synonym:,(18)F-NOS
2020-09-18T06:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800445,Synonym:,[18F]NOS
2020-09-18T06:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800445,Synonym:,18F NOS
2020-09-18T06:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800445,Synonym:,18F-NOS
2020-09-18T06:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800445,Synonym:,FNOS
2020-09-18T06:57:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ods2004436,Synonym:,[18F]-ODS2004436
2020-09-18T06:57:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ods2004436,Synonym:,18F-ODS2004436
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,[18F]PARP1-targeted probe
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,[18F]PARPi
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,[18F]PARPi imaging agent
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,18F fluorinated PARP1-targeted probe
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,18F-1(2H)phthalazinone-based PARPi imaging agent
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,18F-radiolabeled 1(2H)phthalazinone PARPi
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,fluorine F 18 PARPi
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,fluorine F 18 poly(ADP-ribose) polymerase inhibitor
2020-09-18T06:57:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-rgd-based-integrin-peptide-polymer-ah111585,Abbreviation:,18F-AH111585
2020-09-18T06:57:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-rgd-k5,Abbreviation:,F18 RGD-K5
2020-09-18T06:57:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ski-249380,Synonym:,[18F] SKI-249380
2020-09-18T06:57:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ski-249380,Synonym:,F-SKI249380
2020-09-18T06:57:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ski-249380,Chemical structure:,[18F]-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-fluoroethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
2020-09-18T06:57:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-sodium-fluoride,Abbreviation:,18 F-NaF
2020-09-18T06:57:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-sodium-fluoride,Abbreviation:,F-18 NaF
2020-09-18T06:58:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792157,Synonym:,18F-tetrafluoroborate
2020-09-18T06:58:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792157,Abbreviation:,18F-TFB
2020-09-18T06:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-4-l-fluoroglutamine-2s4r,Synonym:,"(2S,4R)4-FGln"
2020-09-18T06:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-4-l-fluoroglutamine-2s4r,Synonym:,"[18F] 4-L-fluoroglutamine (2S,4R)"
2020-09-18T06:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-4-l-fluoroglutamine-2s4r,Synonym:,F-glutamine
2020-09-18T06:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-4-l-fluoroglutamine-2s4r,Synonym:,"fluorine F 18 4-L-fluoroglutamine (2S,4R)"
2020-09-18T06:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-4-l-fluoroglutamine-2s4r,Abbreviation:,18F fluoroglutamine
2020-09-18T06:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-5-fluoro-2-deoxycytidine,Synonym:,[F-18]-5-fluoro-2'-deoxycytidine
2020-09-18T06:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-5-fluoro-2-deoxycytidine,Synonym:,fluorine F 18 5-fluoro-2-deoxycytidine
2020-09-18T06:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-5-fluoro-2-deoxycytidine,Abbreviation:,[F-18]FdCyd
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Synonym:,18F]-6F-dopamine
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Synonym:,18F-fluorodopamine
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Synonym:,"3,4-dihydroxy-6-fluorophenethylamine F-18"
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Synonym:,6-fluorodopamine F-18
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Synonym:,fluorine F 18 6-fluorodopamine
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Abbreviation:,[18F]-6F-DA
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Abbreviation:,18F-DA
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Abbreviation:,6-[18F]FDA
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Chemical structure:,"1,2-benzenediol, 4-(2-aminoethyl)-5-(fluoro-18F)-"
2020-09-18T06:58:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796741,Abbreviation:,18F-ASIS
2020-09-18T06:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795028,Synonym:,[18F]AlF-NOTA-neurotensin
2020-09-18T06:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795028,Synonym:,"[18F]aluminum fluoride-1,4,7-triazacyclononane-1,4,7-triacetic acid-neurotensin"
2020-09-18T06:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795028,Synonym:,18F-AlF-NOTA-neurotensin
2020-09-18T06:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795028,Synonym:,18F-AlF-NOTA-NT
2020-09-18T06:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795028,Synonym:,"18F-aluminum fluoride-1,4,7-triazacyclononane-1,4,7-triacetic acid-neurotensin"
2020-09-18T06:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795028,Synonym:,fluorine F 18-Al-NOTA-neurotensin
2020-09-18T06:58:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alfatide-ii,Synonym:,(18)F-AlF-NOTA-E[PEG4-c(RGDfk)]2
2020-09-18T06:58:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alfatide-ii,Synonym:,18F-Alfatide II
2020-09-18T06:58:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alfatide-ii,Synonym:,18F-AlF-NOTA-PRGD2
2020-09-18T06:58:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alfatide-ii,Synonym:,18F-Al-NOTA-PRGD2
2020-09-18T06:58:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alfatide-ii,Synonym:,fluorine F 18 alfatide II
2020-09-18T06:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799307,Synonym:,[18F]AlF-cysVar3 pHLIP
2020-09-18T06:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799307,Synonym:,18F-AlF-Var3 pHLIP
2020-09-18T06:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799307,Synonym:,fluorine F 18-cys-Var3 pHLIP
2020-09-18T06:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792640,Synonym:,18F-Al-NOTA-MATBBN
2020-09-18T06:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801491,Synonym:,18F-AlF-NOTA-octreotide
2020-09-18T06:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801491,Synonym:,18F-IMP-466
2020-09-18T06:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801491,Synonym:,Al18F-OC
2020-09-18T06:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801491,Synonym:,fluorine F 18-IMP-466
2020-09-18T06:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801491,Synonym:,fluorine F 18-NOTA octreotide
2020-09-18T06:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801491,Chemical structure:,"Al18F-1,4,7-triazacyclononane-1,4,7-triacetate-octreotide"
2020-09-18T06:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ara-g,Synonym:,[18F]F-ara-G
2020-09-18T06:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ara-g,Synonym:,18F-F-ara-G
2020-09-18T06:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ara-g,Synonym:,fluorine F 18 ara-G
2020-09-18T06:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ara-g,Chemical structure:,2'-deoxy-2'-[18F]fluoro-9-beta-D-arabinofuranosylguanine
2020-09-18T06:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-av-133,Synonym:,18F-AV-133
2020-09-18T06:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-av-133,Synonym:,18F-FP-(+)-DTBZ
2020-09-18T06:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794120,Synonym:,[18F]-azafol
2020-09-18T06:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794120,Synonym:,3'-Aza-2'-[(18)F]fluorofolic acid
2020-09-18T06:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794120,Synonym:,fluorine F 18 azafol
2020-09-18T06:59:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800220,Synonym:,18F-BMS-986229
2020-09-18T06:59:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800220,Synonym:,fluorine F 18-labeled BMS-986229
2020-09-18T06:59:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluciclovine,Synonym:,anti-1-amino-3-[18F ]fluorocyclobutane-1-carboxylic acid
2020-09-18T06:59:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluciclovine,US brand name:,Axumin
2020-09-18T06:59:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluciclovine,Abbreviation:,[18F]FACBC
2020-09-18T06:59:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fluoroazomycin-arabinoside,Synonym:,18F-fluoroazomycin arabinoside
2020-09-18T06:59:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fluoroazomycin-arabinoside,Abbreviation:,18F-FAZA
2020-09-18T06:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorothymidine,Synonym:,18F-FLT
2020-09-18T06:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorothymidine,Synonym:,3'-deoxy-3'-(18F) fluorothymidine
2020-09-18T06:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorothymidine,Synonym:,3'-deoxy-3'-[18F]fluorothymidine
2020-09-18T06:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorothymidine,Synonym:,fluorothymidine F 18
2020-09-18T06:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorothymidine,Synonym:,fluorothymidine F-18
2020-09-18T06:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorothymidine,Synonym:,"Thymidine, 3'-deoxy-3'-(18F)fluoro-"
2020-09-18T06:59:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-labeled-s-3-fluoropropylhomocysteine-hydrochloride,Synonym:,S-(3-[18F]fluoropropyl) homocysteine hydrochloride
2020-09-18T06:59:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-labeled-s-3-fluoropropylhomocysteine-hydrochloride,Abbreviation:,[(18)F]FPHCys
2020-09-18T06:59:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-labeled-s-3-fluoropropylhomocysteine-hydrochloride,Abbreviation:,18F-FPM
2020-09-18T06:59:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800312,Synonym:,[18F]-PSMA-1007
2020-09-18T06:59:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800312,Synonym:,18FPSMA-1007
2020-09-18T06:59:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800312,Synonym:,fluorine-18 PSMA-1007
2020-09-18T06:59:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800312,Abbreviation:,18F-PSMA-1007
2020-09-18T06:59:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800312,Abbreviation:,F-18-PSMA-1007
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,US brand name:,Florafur
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,US brand name:,Fluorofur
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Citofur
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Coparogin
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Exonal
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Fental
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,ftorafur
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Ftoral
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Ftoralon
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Fulaid
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Fulfeel
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Furafluor
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Furofutran
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Futraful
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Lamar
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Lifril
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Neberk
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Nitobanil
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Riol
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Sinoflurol
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Sunfural
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Tefsiel
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Utefos
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Abbreviation:,FT
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Code name:,FT-207
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Code name:,MJF-12264
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Code name:,WR-220066
2020-09-18T06:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Chemical structure:,"5-fluoro-1-(tetrahydro-2-furanyl)-2,4(1H,3H)-pyrimidinedione5-fluoro-1-(tetrahydro-2-furyl)-uracilN1-(2'-furanidyl)-5-fluorouracil"
2020-09-18T06:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Synonym:,Timazin
2020-09-18T06:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Synonym:,topical 5-fluorouracil
2020-09-18T06:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Carac
2020-09-18T06:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Efudex
2020-09-18T06:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Fluoroplex
2020-09-18T06:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Tolak
2020-09-18T06:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Actino-Hermal
2020-09-18T06:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Arumel
2020-09-18T06:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Cytosafe
2020-09-18T06:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Efurix
2020-09-18T06:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Fiverocil
2020-09-18T06:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Flurox
2020-09-18T06:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Abbreviation:,5-FU topical
2020-09-18T06:59:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801791,Synonym:,5-fluoropyrimidine
2020-09-18T07:00:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-implant,Foreign brand name:,Sinofuan
2020-09-18T07:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Synonym:,5-fluorouracil injection
2020-09-18T07:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Synonym:,5-Fluracil
2020-09-18T07:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Synonym:,fluouracil
2020-09-18T07:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Synonym:,Fluracil
2020-09-18T07:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,US brand name:,Efudex
2020-09-18T07:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,AccuSite
2020-09-18T07:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,Flurablastin
2020-09-18T07:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,Fluracedyl
2020-09-18T07:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,Fluril
2020-09-18T07:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,Fluroblastin
2020-09-18T07:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,Ribofluor
2020-09-18T07:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Abbreviation:,5-FU injection
2020-09-18T07:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Abbreviation:,FU
2020-09-18T07:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Code name:,Ro-2-9757
2020-09-18T07:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Chemical structure:,"2,4-dioxo-5-fluoropyrimidine5-fluoro-2,4(1H,3H)-pyrimidinedione"
2020-09-18T07:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-e-therapeutic-implant,Synonym:,5-fluorouracil/epi
2020-09-18T07:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-e-therapeutic-implant,Synonym:,5-FU/epi gel
2020-09-18T07:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-e-therapeutic-implant,Synonym:,fluorouracil/epi
2020-09-18T07:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-e-therapeutic-implant,Synonym:,fluorouracil-epinephrine therapeutic implant
2020-09-18T07:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-e-therapeutic-implant,Abbreviation:,5-FU-e TI
2020-09-18T07:00:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluphenazine-hydrochloride,US brand name:,Permitil
2020-09-18T07:00:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluphenazine-hydrochloride,US brand name:,Prolixin
2020-09-18T07:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarenflurbil,Synonym:,R-flurbiprofen
2020-09-18T07:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarenflurbil,US brand name:,Flurizan
2020-09-18T07:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarenflurbil,Code name:,E-7869
2020-09-18T07:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarenflurbil,Code name:,MPC-7869
2020-09-18T07:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarenflurbil,Chemical structure:,"(R)-2-Fluoro-alpha-methyl[1,1'-biphenyl]-4-acetic Acid"
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Synonym:,Flucinom
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Synonym:,Flugerel
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Synonym:,Niftolide
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Apimid
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Cebatrol
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Chimax
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Cytomid
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Drogenil
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Euflex
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Eulexine
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flucinome
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Fluken
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flulem
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flutabene
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flutacan
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Fluta-Gry
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flutamex
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flutamin
2020-09-18T07:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798450,Code name:,SLS-001
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flutan
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flutaplex
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Fugerel
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Grisetin
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Oncosal
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Profamid
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Prostacur
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Prostadirex
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Prostica
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Prostogenat
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Tafenil
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Tecnoflut
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Testotard
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Abbreviation:,FLUT
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Code name:,Sch 13521
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Chemical structure:,"2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide4'-nitro-3'-trifluoromethylisobutyranilidealpha,alpha,alpha-trifluoro-2-methy-4'-nitro-m-propionotoluidide"
2020-09-18T07:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutemetamol-f-18,Synonym:,[18F]flutemetamol
2020-09-18T07:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutemetamol-f-18,Synonym:,[18F]FPIB
2020-09-18T07:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutemetamol-f-18,Synonym:,[18F]GE-067
2020-09-18T07:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutemetamol-f-18,Synonym:,fluorine F 18 flutemetamol
2020-09-18T07:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutemetamol-f-18,US brand name:,Vizamyl
2020-09-18T07:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutemetamol-f-18,Chemical structure:,"2-[3-(18F)fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol"
2020-09-18T07:00:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluticasone-propionate,US brand name:,Flonase
2020-09-18T07:00:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluticasone-propionate,US brand name:,Flovent
2020-09-18T07:00:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluticasone-propionate,Chemical structure:,"(6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic Acid, S-(Fluoromethyl) Ester"
2020-09-18T07:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluvastatin-sodium,US brand name:,Lescol
2020-09-18T07:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluvastatin-sodium,Chemical structure:,"(3R,5S,6E)-(+/-)-7-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoic Acid"
2020-09-18T07:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluvoxamine-maleate,Synonym:,fluoxamine
2020-09-18T07:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluvoxamine-maleate,US brand name:,Luvox
2020-09-18T07:00:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluzoparib,Code name:,SHR-3162
2020-09-18T07:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fms-inhibitor-jnj-40346527,Code name:,JNJ-40346527
2020-09-18T07:01:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fms-trk-tyrosine-kinase-inhibitor-plx7486,Code name:,PLX7486
2020-09-18T07:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-binding-protein-e39-peptide-vaccine,Synonym:,E39 peptide vaccine
2020-09-18T07:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-binding-protein-e39-peptide-vaccine,Synonym:,FBP E39 peptide vaccine
2020-09-18T07:01:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-binding-protein-j65-peptide-vaccine,Synonym:,FBP J65 peptide vaccine
2020-09-18T07:01:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-binding-protein-j65-peptide-vaccine,Synonym:,J65 peptide vaccine
2020-09-18T07:01:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-alpha-loaded-dendritic-cell-vaccine,Abbreviation:,FRalphaDC vaccine
2020-09-18T07:01:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-alpha-loaded-dendritic-cell-vaccine,Abbreviation:,FRαDC vaccine
2020-09-18T07:01:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-epothilone-bms753493,Code name:,BMS753493
2020-09-18T07:01:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-technetium-tc-99m-ec20,Synonym:,technetium Tc 99m EC20
2020-09-18T07:01:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-technetium-tc-99m-ec20,Abbreviation:,99mTc-EC20
2020-09-18T07:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-tubulysin-conjugate-ec1456,Synonym:,folate receptor-targeting folate-tubulysin conjugate EC1456
2020-09-18T07:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-tubulysin-conjugate-ec1456,Code name:,EC1456
2020-09-18T07:01:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-vinca-alkaloid-ec0489,NA,NA
2020-09-18T07:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-vinca-alkaloid-mitomycin-c-ec0225,Code name:,EC0225
2020-09-18T07:01:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-fitc,Synonym:,folate fluorescein isothiocyanate conjugate
2020-09-18T07:01:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-fitc,Code name:,EC17
2020-09-18T07:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-regimen,Synonym:,FOLinic acid-Fluorouracil-IRInotecan regimen
2020-09-18T07:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-regimen,Abbreviation:,FOLFIRI
2020-09-18T07:02:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-bevacizumab-regimen,Synonym:,FOLFIRI-Avastin regimen
2020-09-18T07:02:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-bevacizumab-regimen,Synonym:,folinic acid-fluorouracil-irinotecan-bevacizumab regimen
2020-09-18T07:02:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-cetuximab-regimen,Synonym:,FOLFIRI-Erbitux regimen
2020-09-18T07:02:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-cetuximab-regimen,Synonym:,leucovorin-fluorouracil-irinotecan-cetuximab regimen
2020-09-18T07:02:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfirinox-regimen,Synonym:,"fluorouracil with irinotecan hydrochloride, leucovorin calcium and oxaliplatin"
2020-09-18T07:02:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfirinox-regimen,Synonym:,fluorouracil-leucovorin-irinotecan-oxaliplatin regimen
2020-09-18T07:02:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfirinox-regimen,Synonym:,FOLFIRINOX protocol
2020-09-18T07:02:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfox-regimen,Synonym:,fluorouracil/leucovorin calcium/oxaliplatin
2020-09-18T07:02:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfox-regimen,Synonym:,FOLinic acid-Fluororuracil-OXaliplatin regimen
2020-09-18T07:02:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfox-regimen,Abbreviation:,CF/5-FU/L-OHP
2020-09-18T07:02:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folic-acid,Synonym:,folicin
2020-09-18T07:02:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folic-acid,Synonym:,pteroylmonoglutamic acid
2020-09-18T07:02:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folic-acid,Acronym:,FA
2020-09-18T07:02:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folic-acid,Chemical structure:,"2-[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]aminopentanedioic acidN-[4-[[(2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic Acid"
2020-09-18T07:02:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,Synonym:,"5,10 methylenetetrahydrofolate"
2020-09-18T07:02:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,Synonym:,"5,10-methylenetetrahydrofolate"
2020-09-18T07:02:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,US brand name:,CoFactor
2020-09-18T07:02:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,Abbreviation:,"5,10-MTHF"
2020-09-18T07:02:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,Abbreviation:,MTHF
2020-09-18T07:02:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,Code name:,ANX-510
2020-09-18T07:02:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin,Synonym:,human chorionic gonadotropin
2020-09-18T07:02:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin,US brand name:,Follutein
2020-09-18T07:02:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin,US brand name:,Novarel
2020-09-18T07:02:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin,US brand name:,Pregnyl
2020-09-18T07:02:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin,US brand name:,Profasi
2020-09-18T07:02:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin,Abbreviation:,rhCG
2020-09-18T07:02:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin,Code name:,LDI-200
2020-09-18T07:02:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pralatrexate,US brand name:,Folotyn
2020-09-18T07:02:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pralatrexate,Code name:,PDX
2020-09-18T07:02:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pralatrexate,Chemical structure:,"(2S)-2-[[4-[(1RS)-1-[(2, 4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]pentanedioic acid10-propargyl-10-deazaaminopterin"
2020-09-18T07:02:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fondaparinux-sodium,US brand name:,Arixtra
2020-09-18T07:02:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foretinib,Code name:,GSK1363089G
2020-09-18T07:02:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foretinib,Code name:,XL880
2020-09-18T07:03:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formestane,Synonym:,4-hydroxyandrostenedione
2020-09-18T07:03:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formestane,Foreign brand name:,Lentaron
2020-09-18T07:03:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formestane,Abbreviation:,4-OHA
2020-09-18T07:03:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formestane,Abbreviation:,4-OHAD
2020-09-18T07:03:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formestane,Code name:,CGP-32349
2020-09-18T07:03:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formestane,Chemical structure:,"4-Hydroxyandrost-4-ene-3,17-dione"
2020-09-18T07:03:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formoterol-fumarate-oral,Code name:,APD209
2020-09-18T07:03:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formoterol-fumarate-roxithromycin,US brand name:,BetaMarc
2020-09-18T07:03:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/forodesine-hydrochloride,Synonym:,immucillin-H
2020-09-18T07:03:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/forodesine-hydrochloride,Code name:,BCX-1777
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,Synonym:,Metformin HCl
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,US brand name:,Fortamet
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,US brand name:,Glucophage
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,US brand name:,Glucophage XR
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,US brand name:,Glumetza
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,US brand name:,Riomet
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,Foreign brand name:,Cidophage
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,Foreign brand name:,Dimefor
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,Foreign brand name:,Glifage
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,Foreign brand name:,Glucoformin
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,Foreign brand name:,Siofor
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,Chemical structure:,"1,1-dimethylbiguanide hydrochlorideN,N-dimethylimidodicarbonimidic diamide monohydrochloride"
2020-09-18T07:03:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-sodium,US brand name:,Fortaz
2020-09-18T07:03:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-sodium,US brand name:,Tazicef
2020-09-18T07:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-disodium,Synonym:,Combretastatin
2020-09-18T07:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-disodium,Synonym:,Combretastatin A4 Disodium Phosphate
2020-09-18T07:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-disodium,Synonym:,Combretastatin A4 Prodrug
2020-09-18T07:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-disodium,US brand name:,ZYBRESTAT
2020-09-18T07:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-disodium,Abbreviation:,CA4PD
2020-09-18T07:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-disodium,Chemical structure:,"2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl disodium phosphate"
2020-09-18T07:03:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-tromethamine,Synonym:,combretastatin A4 phosphate
2020-09-18T07:03:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-tromethamine,US brand name:,Zybrestat
2020-09-18T07:03:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-tromethamine,Abbreviation:,CA4P
2020-09-18T07:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosfomycin-tromethamine,Synonym:,fosfomycin compound with trometamol
2020-09-18T07:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosfomycin-tromethamine,Synonym:,fosfomycin trometamol salt
2020-09-18T07:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosfomycin-tromethamine,US brand name:,Monurol
2020-09-18T07:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosfomycin-tromethamine,Chemical structure:,"(1R,2S)-(1,2-epoxypropyl)phosphonic acid, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol(1:1)"
2020-09-18T07:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-trx-818,Code name:,CVM 1118
2020-09-18T07:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-trx-818,Code name:,CVM1118
2020-09-18T07:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-trx-818,Code name:,CVM-1118
2020-09-18T07:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-trx-818,Code name:,TRX 818
2020-09-18T07:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-trx-818,Code name:,TRX818
2020-09-18T07:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-trx-818,Code name:,TRX-818
2020-09-18T07:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-trx-818,Chemical structure:,"4(1H)-quinolinone, 2-(3-fluorophenyl)-6-methoxy-5-(phosphonooxy)-"
2020-09-18T07:03:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792159,Synonym:,fosnetupitant/palonosetron HCl combination
2020-09-18T07:03:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792159,Synonym:,fosnetupitant-palonosetron HCl
2020-09-18T07:03:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792159,Synonym:,pronetupitant/palonosetron HCl
2020-09-18T07:03:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792159,Synonym:,pro-netupitant/palonosetron HCl
2020-09-18T07:03:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792159,Abbreviation:,IV NEPA FDC
2020-09-18T07:04:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797055,US brand name:,Cerebyx
2020-09-18T07:04:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797055,Code name:,NPC-06
2020-09-18T07:04:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797055,Chemical structure:,"2,4-Imidazolidinedione, 5,5-diphenyl-3-((phosphonooxy)methyl)-, disodium salt"
2020-09-18T07:04:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosquidone,Code name:,GR63178A
2020-09-18T07:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostamatinib-disodium,Synonym:,fostamatinib disodium hexahydrate
2020-09-18T07:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostamatinib-disodium,Synonym:,Syk kinase inhibitor R935788
2020-09-18T07:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostamatinib-disodium,US brand name:,Tavalisse
2020-09-18T07:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostamatinib-disodium,Code name:,R788 sodium
2020-09-18T07:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostamatinib-disodium,Code name:,R935788 sodium
2020-09-18T07:04:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostriecin,Synonym:,phosphotrienin
2020-09-18T07:04:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostriecin,Abbreviation:,FST
2020-09-18T07:04:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostriecin,Chemical structure:,"2H-pyran-2-one,5,6-dihydro-6-(3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11,-tridecatetraenyl)-,trans"
2020-09-18T07:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fotemustine,Foreign brand name:,Muphoran
2020-09-18T07:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fotemustine,Code name:,S 10036
2020-09-18T07:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fotemustine,Chemical structure:,[1-[[[(2-chloroethyl)nitrosamino]-carbonyl]amino]ethyl]phosphonic acid diethyl ester1-[N-(2-chloroethyl)-N-nitrosoureido]ethylphosphonic acid diethyl esterdiethyl[1-[3-(2-chloroethyl)-3-nitrosoureido]ethyl]phosphonate
2020-09-18T07:04:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fowlpox-virus-vaccine-vector,Abbreviation:,FOWLVAC
2020-09-18T07:09:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galiximab,Synonym:,anti-B7-1
2020-09-18T07:04:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fowlpox-ny-eso-1-vaccine,Abbreviation:,rF-NY-ESO-1
2020-09-18T07:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,US brand name:,Depo-Heparin
2020-09-18T07:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,US brand name:,Fragmin
2020-09-18T07:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,US brand name:,Fragmin V
2020-09-18T07:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,Code name:,ALFA 87-120
2020-09-18T07:04:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,US brand name:,Depo-Heparin
2020-09-18T07:04:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,US brand name:,Fragmin
2020-09-18T07:04:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,US brand name:,Fragmin V
2020-09-18T07:04:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,Code name:,ALFA 87-120
2020-09-18T07:04:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/freeze-dried-black-raspberry-bioadhesive-gel,Abbreviation:,FBR gel
2020-09-18T07:04:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/french-maritime-pine-bark-extract,US brand name:,Pycnogenol
2020-09-18T07:04:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/french-maritime-pine-bark-extract,Abbreviation:,PYC
2020-09-18T07:04:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fresolimumab,Synonym:,anti-TGF-beta monoclonal antibody GC1008
2020-09-18T07:04:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fresolimumab,Synonym:,human anti-TGF-beta monoclonal antibody GC1008
2020-09-18T07:04:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fresolimumab,Code name:,GC1008
2020-09-18T07:05:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fructooligosaccharide-supplement,Synonym:,FOS supplement
2020-09-18T07:05:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fructooligosaccharide-supplement,Synonym:,fructo-oligosaccharide supplement
2020-09-18T07:05:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fructooligosaccharide-supplement,Synonym:,fructo-oligosaccharides supplement
2020-09-18T07:05:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fructooligosaccharide-supplement,Synonym:,oligofructan supplement
2020-09-18T07:05:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fructooligosaccharide-supplement,Synonym:,oligofructose supplement
2020-09-18T07:05:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778524,Synonym:,fructooligosaccharide/L. paracasei/L. rhamnosus/L. acidophilus/B. lactis probiotic supplement
2020-09-18T07:05:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778524,Foreign brand name:,LactoFos
2020-09-18T07:05:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruit-and-vegetable-extracts,US brand name:,Juice Plus
2020-09-18T07:05:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruquintinib,Synonym:,VEGFR-1/2/3 inhibitor HMPL-013
2020-09-18T07:05:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruquintinib,US brand name:,Elunate
2020-09-18T07:05:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruquintinib,Code name:,HMPL-013
2020-09-18T07:05:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Synonym:,FdUrD
2020-09-18T07:05:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Synonym:,floxuridin
2020-09-18T07:05:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Synonym:,fluorodeoxyuridine
2020-09-18T07:05:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Synonym:,fluorouridine deoxyribose
2020-09-18T07:05:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Synonym:,fluoruridine deoxyribose
2020-09-18T07:05:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,US brand name:,FUDF
2020-09-18T07:05:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Abbreviation:,5-FUDR
2020-09-18T07:05:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Abbreviation:,FDUR
2020-09-18T07:05:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Abbreviation:,FUdR
2020-09-18T07:05:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Code name:,WR-138720
2020-09-18T07:05:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Chemical structure:,1-(2-deoxy-beta-D-ribofuranosyl)-5-fluorouracil2'-deoxy-5-fluorouridine5-fluoro-2'-deoxy-beta-uridine5-fluoro-2'-deoxyuridine5-fluorodeoxyuridine5-fluorouridine deoxyribose
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Synonym:,Filgrastim SD-01
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Synonym:,pegfilgrastim biosimilar pegcyte
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Synonym:,PEG-rhG-CSF
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Synonym:,SD-01
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Synonym:,SD-01 sustained duration G-CSF
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,US brand name:,Fulphila
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,US brand name:,Neulasta
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Foreign brand name:,Jinyouli
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Foreign brand name:,Neulastim
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Abbreviation:,GCSF-SD01
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Code name:,HSP-130
2020-09-18T07:05:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulranumab,Synonym:,anti-nerve growth factor monoclonal antibody JNJ-42160443
2020-09-18T07:05:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulranumab,Synonym:,Anti-NGF monoclonal antibody JNJ-42160443
2020-09-18T07:05:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulranumab,Code name:,JNJ-42160443
2020-09-18T07:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fu-lv-regimen,Synonym:,5FU/LV
2020-09-18T07:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fu-lv-regimen,Synonym:,de Gramont regimen
2020-09-18T07:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fu-lv-regimen,Synonym:,fluorouracil-leucovorin regimen
2020-09-18T07:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulvestrant,US brand name:,Faslodex
2020-09-18T07:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulvestrant,Code name:,"ICI 182,780"
2020-09-18T07:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulvestrant,Code name:,ZD9238
2020-09-18T07:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulvestrant,Chemical structure:,"7a-[9-[(4,4,5,5,5,-Pentafluoropentyl)sulphinyl]nonyl]-estra-1,3,5(10)-triene-3,17b-diol"
2020-09-18T07:05:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crofelemer,US brand name:,Fulyzaq
2020-09-18T07:05:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crofelemer,US brand name:,Virend
2020-09-18T07:05:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crofelemer,Code name:,SP 303
2020-09-18T07:05:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crofelemer,Code name:,SP-303
2020-09-18T07:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fumagillin-derived-polymer-conjugate-xmt-1107,Code name:,XMT-1107
2020-09-18T07:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793140,Synonym:,IC2000 fluorescence imaging agent
2020-09-18T07:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793140,Code name:,IC 2000
2020-09-18T07:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793140,Code name:,IC2000
2020-09-18T07:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide,US brand name:,Lasix
2020-09-18T07:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide,US brand name:,SK-Furosemide
2020-09-18T07:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide,Abbreviation:,FRS
2020-09-18T07:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide,Code name:,LB-502
2020-09-18T07:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793933,Synonym:,furosemide topical gel CLS 006
2020-09-18T07:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793933,Synonym:,furosemide topical gel CLS-006
2020-09-18T07:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793933,Code name:,CLS 006
2020-09-18T07:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793933,Code name:,CLS006
2020-09-18T07:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793933,Code name:,CLS-006
2020-09-18T07:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798476,Synonym:,digoxin-furosemide topical gel CLS003
2020-09-18T07:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798476,Synonym:,ICVT product CLS003
2020-09-18T07:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798476,Code name:,CLS 003
2020-09-18T07:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798476,Code name:,CLS003
2020-09-18T07:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798476,Code name:,CLS-003
2020-09-18T07:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fursultiamine,Synonym:,thiamine tetrahydrofurfuryl disulfide
2020-09-18T07:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fursultiamine,Abbreviation:,TTFD
2020-09-18T07:06:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fusidic-acid-betamethasone-valerate-topical-cream,Foreign brand name:,Verutex B
2020-09-18T07:06:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoleucovorin-calcium,Synonym:,calcium levoleucovorin
2020-09-18T07:06:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoleucovorin-calcium,US brand name:,Fusilev
2020-09-18T07:06:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-tas-120,Synonym:,FGFR inhibitor TAS-120
2020-09-18T07:06:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-tas-120,Code name:,TAS-120
2020-09-18T07:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793850,Code name:,992 DS
2020-09-18T07:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793850,Code name:,992DS
2020-09-18T07:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793850,Code name:,992-DS
2020-09-18T07:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793850,Chemical structure:,"immunoglobulin G1, anti-(human epidermal growth factor receptor extracellular domain III) (human-Mus musculus monoclonal 992 DS heavy chain), disulfide with human-Mus musculus monoclonal 992 DS light chain, dimer"
2020-09-18T07:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perampanel,US brand name:,Fycompa
2020-09-18T07:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perampanel,Code name:,E2007
2020-09-18T07:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perampanel,Chemical structure:,"3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-onebenzonitrile, 2-(1',6'-dihydro-6'-oxo-1'-phenyl(2,3'-bipyridin)-5'-yl)-"
2020-09-18T07:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799991,Synonym:,GPER agonist LNS8801
2020-09-18T07:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799991,Code name:,LNS 8801
2020-09-18T07:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799991,Code name:,LNS8801
2020-09-18T07:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799991,Code name:,LNS-8801
2020-09-18T07:07:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g2-checkpoint-inhibitor-cbp501,Code name:,CBP501
2020-09-18T07:07:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g207,Synonym:,oncolytic HSV-1 G207
2020-09-18T07:07:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g250-peptide-vaccine,NA,NA
2020-09-18T07:07:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ga-68-labeled-fab-2--trastuzumab,NA,NA
2020-09-18T07:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gabapentin,US brand name:,Gralise
2020-09-18T07:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gabapentin,US brand name:,Neurontin
2020-09-18T07:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gabapentin,Chemical structure:,1-(aminomethyl)cyclohexaneacetic Acid
2020-09-18T07:07:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobutrol,US brand name:,Gadavist
2020-09-18T07:07:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobutrol,US brand name:,Gadovist
2020-09-18T07:07:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobenate-dimeglumine,Synonym:,gadolinium benzyloxypropionictetraacetate
2020-09-18T07:07:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobenate-dimeglumine,US brand name:,MultiHance
2020-09-18T07:07:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobenate-dimeglumine,Abbreviation:,Gd-BOPTA
2020-09-18T07:07:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobenate-dimeglumine,Chemical structure:,"(4RS)-[4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-)] gadolinate(2-) dihydrogen compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2)"
2020-09-18T07:07:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobutrol,US brand name:,Gadavist
2020-09-18T07:07:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobutrol,US brand name:,Gadovist
2020-09-18T07:07:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadodiamide,Synonym:,Gadolinium-DTPA-BMA
2020-09-18T07:07:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadodiamide,US brand name:,OmniScan
2020-09-18T07:07:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadodiamide,Abbreviation:,Gd-DTPA-BMA
2020-09-18T07:07:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadodiamide,Code name:,DV 7572
2020-09-18T07:07:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadodiamide,Code name:,HSDB 7547
2020-09-18T07:07:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadodiamide,Chemical structure:,"gadolinium, (5,8-bis((carboxy-kappaO)methyl)-11-(2-(methylamino)-2-(oxo-kappaO)ethyl)-3-(oxo-kappaO)-2,5,8,11-tetraazatridecan-13-oato(3-)-kappaN5,kappaN8,kappaN11,kappaO13)-"
2020-09-18T07:07:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadolinium-chelate,Synonym:,Gadolinium Coordination Complex
2020-09-18T07:07:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadolinium-chelate,Synonym:,Gadolinium-Chelant Complex
2020-09-18T07:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadopentetate-dimeglumine,Synonym:,gadolinium DTPA
2020-09-18T07:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadopentetate-dimeglumine,US brand name:,Magnevist
2020-09-18T07:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadopentetate-dimeglumine,US brand name:,MultiHance
2020-09-18T07:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadopentetate-dimeglumine,Abbreviation:,Gd-DTPA
2020-09-18T07:08:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadolinium-based-contrast-agent-p03277,Code name:,P 03277
2020-09-18T07:08:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadolinium-based-contrast-agent-p03277,Code name:,P03277
2020-09-18T07:08:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadolinium-based-contrast-agent-p03277,Code name:,P-03277
2020-09-18T07:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoterate-meglumine,Synonym:,Gd-DOTA
2020-09-18T07:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoterate-meglumine,US brand name:,DOTAREM
2020-09-18T07:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoterate-meglumine,Foreign brand name:,DOTAREM
2020-09-18T07:08:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobutrol,US brand name:,Gadavist
2020-09-18T07:08:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobutrol,US brand name:,Gadovist
2020-09-18T07:08:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,Synonym:,"gadoxetic acid, disodium"
2020-09-18T07:08:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,US brand name:,Eovist
2020-09-18T07:08:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,Foreign brand name:,EOB Primavist
2020-09-18T07:08:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,Foreign brand name:,Primovist
2020-09-18T07:08:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,Abbreviation:,Gd-EOB-DTPA
2020-09-18T07:08:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,Chemical structure:,"(4S)-4-(4-ththoxylmethyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanedoic acid, gadolinium complex, disodium salt"
2020-09-18T07:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gag267-274-peptide-vaccine,Synonym:,ILGLNKIV
2020-09-18T07:08:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galactomannan-derivative,Synonym:,"1,4-beta-D-galactomannan"
2020-09-18T07:08:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galactomannan-derivative,US brand name:,DAVANAT
2020-09-18T07:08:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galactomannan-derivative,Abbreviation:,GD
2020-09-18T07:08:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galactose,NA,NA
2020-09-18T07:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galantamine-hydrobromide,Synonym:,lycoremine hydrobromide
2020-09-18T07:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galantamine-hydrobromide,Synonym:,Nivalin
2020-09-18T07:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galantamine-hydrobromide,US brand name:,Razadyne
2020-09-18T07:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galantamine-hydrobromide,US brand name:,Reminyl
2020-09-18T07:08:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galectin-inhibitor-gr-md-02,Synonym:,galactoarabino-rhamnogalacturonate
2020-09-18T07:08:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galectin-inhibitor-gr-md-02,Code name:,GR-MD-02
2020-09-18T07:08:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galectin-1-inhibitor-otx008,Synonym:,Gal-1 inhibitor OTX008
2020-09-18T07:08:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galectin-1-inhibitor-otx008,Code name:,OTX008
2020-09-18T07:08:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galeterone,Synonym:,SARM/LI TOK-001
2020-09-18T07:08:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galeterone,Code name:,TOK-001
2020-09-18T07:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798450,Synonym:,WT-1 analog peptide vaccine SLS-001
2020-09-18T07:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798450,Code name:,SLS 001
2020-09-18T07:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798450,Code name:,SLS001
2020-09-18T07:09:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galiximab,Synonym:,anti-CD80
2020-09-18T07:09:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galiximab,Synonym:,MOAB anti-CD80
2020-09-18T07:09:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galiximab,Synonym:,monoclonal antibody anti-CD80
2020-09-18T07:09:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galiximab,Abbreviation:,MOAB IDEC-114
2020-09-18T07:09:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-citrate-ga-67,US brand name:,Neoscan
2020-09-18T07:09:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-citrate-ga-67,Chemical structure:,"1,2,3-Propanetricarboxylic Acid, 2-hydroxy-, Gallium-(sup 67)Ga(1:1) Salt"
2020-09-18T07:09:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799979,Synonym:,68Ga-FAPi-46
2020-09-18T07:09:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799979,Synonym:,gallium-68-FAPi-46
2020-09-18T07:09:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796976,Synonym:,[68Ga]CBP8
2020-09-18T07:09:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796976,Synonym:,[68Ga]CBP-8
2020-09-18T07:09:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796976,Synonym:,gallium-68 NODAGA-CBP8
2020-09-18T07:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-citrate,Abbreviation:,(68)Ga-citrate
2020-09-18T07:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-citrate,Abbreviation:,68Ga-citrate
2020-09-18T07:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-citrate,Abbreviation:,gallium-68 citrate
2020-09-18T07:09:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dota-exendin-4,Synonym:,[Lys40(Ahx-DOTA-68Ga)NH2]-exendin-4
2020-09-18T07:09:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dota-exendin-4,Synonym:,68Ga-DOTA-exendin-4
2020-09-18T07:09:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801864,Synonym:,68Ga-DOTA-FAPI-04
2020-09-18T07:09:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801864,Synonym:,68Ga-DOTA-FAPI-04
2020-09-18T07:09:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801864,Synonym:,68Ga-FAPi-04
2020-09-18T07:09:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801864,Synonym:,gallium-68-FAPi-04
2020-09-18T07:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dotanoc,Synonym:,Ga68-DOTANOC
2020-09-18T07:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dotatate,Synonym:,"gallium-68 DOTA-DPhe1, Tyr3-octreotate"
2020-09-18T07:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dotatate,Abbreviation:,(68)Ga-DOTA-TATE
2020-09-18T07:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dotatate,Abbreviation:,68Ga-DOTATATE
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,68Ga-DOTA-d-Phe1-Tyr3-octreotide
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,68Ga-DOTA-TOC
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,Ga-68 DOTA0-Tyr3-octreotide
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,Ga-68 DOTATOC
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,Ga-68-[Tyr3]-octreotide
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,Ga-68-DOTA-TOC
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,Ga-68-DOTA-tyr(3)-octreotide
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,gallium Ga 68-DOTATOC
2020-09-18T07:09:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-affibody-molecule-aby-025,Synonym:,gallium Ga 68-maleimide-DOTA-Cys61-ZHER2:2891-Cys
2020-09-18T07:09:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-affibody-molecule-aby-025,Abbreviation:,[68Ga]ABY-025
2020-09-18T07:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-bnota-prgd2,Synonym:,68Ga-BNOTA-PRGD2
2020-09-18T07:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-bnota-prgd2,Synonym:,68Ga-p-SCN-Bn-NOTA-PEG3-RGD2
2020-09-18T07:10:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-dota-di-hsg-peptide-imp-288,Synonym:,Ga-68-IMP-288
2020-09-18T07:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801839,Synonym:,gallium Ga 68-ACE2 inhibitor DX600
2020-09-18T07:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801839,Abbreviation:,(68)Ga-DX600
2020-09-18T07:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801839,Abbreviation:,68Ga-DX600
2020-09-18T07:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-mln6907,Abbreviation:,[68Ga]MLN6907
2020-09-18T07:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-nodaga-mj9,Synonym:,Ga-68-NODAGA-MJ9
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,(68)Ga labeled Glu-NH-CO-NH-Lys(Ahx)-HBED-CC
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,(68)Ga-labeled Glu-urea-Lys(Ahx)-HBED-CC
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,(68)gallium-PSMA ligand Glu-urea-Lys(Ahx)-HBED-CC
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,(68)Ga-PSMA ligand Glu-urea-Lys(Ahx)-HBED-CC
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,[68Ga] prostate-specific membrane antigen 11
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,[68Ga]GaPSMA-11
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,68Ga-DKFZ-PSMA-11
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,68Ga-HBED-CC-PSMA
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,68Ga-labeled Glu-NH-CO-NH-Lys(Ahx)-HBED-CC
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,68Ga-PSMA-11
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,Ga-68-labeled PSMA-11
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,gallium Ga 68 PSMA-11
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,gallium-68 PSMA ligand Glu-urea-Lys(Ahx)-HBED-CC
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,PSMA-HBED-CC GA-68
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,(68)Ga-DOTA-4-amino-1-carboxymethylpiperidine-d-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,[68Ga]-labeled bombesin analog BAY86-7548
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,[68Ga]RM2
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,68-Ga RM2
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,68Ga-bombesin antagonist BAY86-7548
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,68Ga-DOTA RM2
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,68Ga-DOTA-bombesin analog BAY86-7548
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,Ga-68-labeled bombesin antagonist BAY 86-7548
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,gallium Ga 68-labeled GRPR antagonist BAY86-7548
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,gallium Ga68-labeled GRPR antagonist RM2
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Code name:,BAY 86-7548
2020-09-18T07:10:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-neb,Synonym:,68Ga-NOTA conjugated truncated form of Evans blue
2020-09-18T07:10:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-neb,Abbreviation:,68Ga-NEB
2020-09-18T07:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794408,Synonym:,[68Ga]-NeoB
2020-09-18T07:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794408,Synonym:,68Ga-DOTA-NeoBOMB1
2020-09-18T07:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794408,Synonym:,68Ga-NeoB
2020-09-18T07:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794408,Synonym:,gallium Ga 68 NeoBOMB1
2020-09-18T07:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794408,Synonym:,gallium-68 DOTA-NeoBOMB1
2020-09-18T07:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-ac-cys-zegfr1907,Synonym:,[68Ga]-labeled anti-EGFR affibody molecule Ac-Cys-ZEGFR:1907
2020-09-18T07:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-ac-cys-zegfr1907,Synonym:,68Ga-NODAGA-Ac-Cys-ZEGFR:1907
2020-09-18T07:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-ac-cys-zegfr1907,Synonym:,gallium Ga 68-NODAGA-Ac-Cys-Z(EGFR:1907)
2020-09-18T07:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-ecrgdyk2,Synonym:,68Ga-NODAGA-E(c[RGDyK])2
2020-09-18T07:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-zigf-1r440,Synonym:,[68Ga]-labeled anti-IGF-1R affibody molecule ZIGF-1R:4:40
2020-09-18T07:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-zigf-1r440,Synonym:,68Ga-NODAGA-ZIGF-1R:4:40
2020-09-18T07:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-zigf-1r440,Synonym:,68Ga-NODAGA-ZIGF-1R:4：40
2020-09-18T07:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-zigf-1r440,Synonym:,68Ga-NODAGA-ZIGF-1R:4Z:40
2020-09-18T07:11:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-3ptate-rgd,Synonym:,68Ga-NOTA-3PTATE-RGD
